Citrus Sinensis ID: 047263
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 804 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.958 | 0.926 | 0.470 | 0.0 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.940 | 0.866 | 0.319 | 1e-105 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.883 | 0.856 | 0.338 | 1e-103 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.845 | 0.853 | 0.323 | 2e-90 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.924 | 0.909 | 0.310 | 1e-87 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.874 | 0.849 | 0.324 | 4e-87 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.930 | 0.881 | 0.307 | 1e-83 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.871 | 0.803 | 0.293 | 7e-77 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.356 | 0.349 | 0.484 | 1e-76 | |
| O64782 | 805 | G-type lectin S-receptor- | no | no | 0.894 | 0.893 | 0.291 | 2e-74 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 701 bits (1808), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/826 (47%), Positives = 519/826 (62%), Gaps = 55/826 (6%)
Query: 11 VLLLLLQPFLTFAQT--RGKITIGASLSASQN---SSSWLSPNGDFAFGFHSLDSNKDLF 65
VL+L LQ F F+Q G + +G SL+AS++ SSSW SP+GDFAFGF + N D F
Sbjct: 12 VLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPN-DGF 70
Query: 66 LLSIWYAKIPQKTIVWFANGDSPAA----SGTKVELTADQGLVLTSPQGRELWKSDPIIG 121
LSIW+ KI KTIVW A + +G+KV LTAD GLV+ P+G+ELW++ G
Sbjct: 71 TLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALSG-G 129
Query: 122 TVAYGLMNDTGNFVLLSDNTNK----LWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFS 177
+V+ G D GNFVL D + LW SF NPTDT+LP+Q + G+ LSS++++ +F
Sbjct: 130 SVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFK 189
Query: 178 KGRFRFELNSNGNLVLTTVNLPSDYTNE---PYYESKTNGSSN---QLVFNQSGYMYILQ 231
KGRF L +GNL L ++N + ++ YYES TN +N QLVFNQSG +Y+LQ
Sbjct: 190 KGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIYVLQ 249
Query: 232 EYDQRFALTRR-VETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKA 290
+ RF + R + S + +Y +T G PK + G D++C
Sbjct: 250 RNNSRFVVKDRDPDFSIAAPFYIST----GFLLSTIIPKEARRIVGGCLLGLCRDNMCSP 305
Query: 291 SFVSTGSGTCGFNSVCRL-NNRRPICECPRGYTLIDPNDQYGSCKPNY-TQSCVDDDEPG 348
+ G+ CG+N++C L NN+RP CECP + L DP+++YG C P++ Q+C +++
Sbjct: 306 D-DALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTA 364
Query: 349 SPE-DLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGD--MCWKKK 405
+ + +LY+F + T+WP DY+ + EE C+ SCL DC+CA IF + CWKKK
Sbjct: 365 NSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKK 424
Query: 406 LPLSNGRFDANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSV 465
PLS+G + IK+R ++ D P V N+ K + LII SVLLG S
Sbjct: 425 FPLSHGERSPRGDSDTFIKVRNRSIA----DVP---VTGNRAKKLDWLIIACSVLLGTSA 477
Query: 466 FFNCLLVGALCLCFFFVYNKKN---------SQVPSHDGVVETNLHCFTYKDLEAATNGF 516
F ++ C + KN + + E NL FTY +L AT F
Sbjct: 478 F---VIFDTSC-SYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDF 533
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
EELG+GAFG+VYKG + +A +V VAVKKL + D KEFK EV VIGQ HHKNLVR
Sbjct: 534 TEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVR 593
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
L+GFC++G ++++VYEFL GTLA+FLF +P W R +IA IARG+LYLHEECS QI
Sbjct: 594 LIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQI 653
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
IHCDIKPQNILLD+YY RISDFGLAKLLL++Q+ T T IRGTKGYVAPEWFRN PIT K
Sbjct: 654 IHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSK 713
Query: 697 VDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756
VDVYS+GV+LLEI+CC++ VD+E N +L +WAYDC+ +G E L E D EA+ND +
Sbjct: 714 VDVYSYGVMLLEIVCCKKAVDLEDN---VILINWAYDCFRQGRLEDLTEDDSEAMNDMET 770
Query: 757 LARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPCPFTV 802
+ R+V +AIWCIQE+ +RP MR VTQMLEGV++V DPP P P++
Sbjct: 771 VERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYST 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 383 bits (984), Expect = e-105, Method: Compositional matrix adjust.
Identities = 264/826 (31%), Positives = 423/826 (51%), Gaps = 70/826 (8%)
Query: 19 FLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIP-QK 77
FL T I +G+ L AS+ + +W+S NG FA GF D FLLSIW+A++P
Sbjct: 20 FLVSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPT-DRFLLSIWFAQLPGDP 78
Query: 78 TIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLL 137
TIVW N +SP +EL A LVL S Q +W S+ V +M+++GNF+LL
Sbjct: 79 TIVWSPNRNSPVTKEAVLELEATGNLVL-SDQNTVVWTSNTSNHGVESAVMSESGNFLLL 137
Query: 138 SDNTNK---LWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVL- 193
+W+SF+ P+DT+LP+Q L+S S + L + +L L
Sbjct: 138 GTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLKM-LQQHTSLSLG 196
Query: 194 TTVNLPSD-YTNEPYYE----SKTNG---------SSNQLVFNQS--GYMYILQ---EYD 234
T N+ D + N Y+ S G S ++V+ +S G +Y+ + + +
Sbjct: 197 LTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDN 256
Query: 235 QRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVS 294
+ + + + + + R + +G Y+ + G+ W W+ + C +
Sbjct: 257 RNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIA--- 313
Query: 295 TGSGTCGFNSVCRLNNRRPICEC---PRGYTLID-PNDQYGSCKPNYTQSCVDD-DEPGS 349
G CG N VC L+ + +C P L D N + S + Q C + + GS
Sbjct: 314 ---GICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGS 369
Query: 350 PEDLYDFEVITNTDWPTSDYQLLTPFTE----EGCRQSCLHDCMCAVAIFRSGD---MCW 402
+ + T++ S+ ++ ++ C + CL DC C +++ D CW
Sbjct: 370 ----FKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCW 425
Query: 403 KKKLPLSNGRFDANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLG 462
K L+ G F + +K R P++ + + + Q+ L+I +++G
Sbjct: 426 ILK-SLNFGGF-RDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVI--PIVVG 481
Query: 463 GSVFFNCLLVGALCLCFFFVYNKKNS--QVPSHDGVVETNLHCFTYKDLEAATNGFKEEL 520
V LV L + ++ ++K + + + ++ + FTY+DL+ TN F + L
Sbjct: 482 MLV-----LVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLL 536
Query: 521 GKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGF 580
G G FG VYKG + ++ VAVK+L + G +EF TEVN IG HH NLVRL G+
Sbjct: 537 GSGGFGTVYKGTVAGETL----VAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGY 592
Query: 581 CDDGLNRLLVYEFLSNGTLASFLFGDLKPG----WSRRTDIAFGIARGLLYLHEECSTQI 636
C + +RLLVYE++ NG+L ++F + W R +IA A+G+ Y HE+C +I
Sbjct: 593 CSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRI 652
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
IHCDIKP+NILLDD + ++SDFGLAK++ + S T IRGT+GY+APEW N PITVK
Sbjct: 653 IHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVK 712
Query: 697 VDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756
DVYS+G+LLLEI+ RRN+DM + + WAY G + V+ ++ + ++++
Sbjct: 713 ADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEE 772
Query: 757 LARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPCPFTV 802
+ + + VA WCIQ++ S+RP+M +V ++LEG + ++ P P P T+
Sbjct: 773 VVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLP-PMPQTI 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (969), Expect = e-103, Method: Compositional matrix adjust.
Identities = 271/801 (33%), Positives = 399/801 (49%), Gaps = 91/801 (11%)
Query: 29 ITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYA-KIPQKTIVWFANGDS 87
I +G+ + AS ++ +W SPN F+ F S + FL ++ +A +P +W A
Sbjct: 27 IPLGSVIYASGSNQNWPSPNSTFSVSFVPSPS-PNSFLAAVSFAGSVP----IWSAG--- 78
Query: 88 PAASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLLSDNTNKLWES 147
S + L L LT+ G +W S V G + DTG F+LL++ + +W S
Sbjct: 79 TVDSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSS 138
Query: 148 FNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNE-- 205
F+NPTDT++ SQ F G+ L S G + F+L +GNL L N + Y N
Sbjct: 139 FDNPTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLR-WNTSAIYWNHGL 188
Query: 206 ----------PYYESKTNGSSNQLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRAT 255
P +TNG + N G I+ D SN +
Sbjct: 189 NSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDY----------GDSNTFRFLK 238
Query: 256 INFDGVFTQYQHPKNSTG--NEGWTAFWSLPDDICKASFVSTGSGTCGFNSVCRLNNRRP 313
++ DG Y ++G N W+A D C G CG +C N+ P
Sbjct: 239 LDDDGNLRIYSSASRNSGPVNAHWSAV-----DQCLVY------GYCGNFGICSYNDTNP 287
Query: 314 ICECP-RGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDLYDFEVITNTDWPTSD--YQ 370
IC CP R + +D ND+ CK S D + DL + T D P S+ +
Sbjct: 288 ICSCPSRNFDFVDVNDRRKGCKRKVELS--DCSGNTTMLDLVHTRLFTYEDDPNSESFFA 345
Query: 371 LLTPFTEEGCRQSCLHD--CMCAVAIFRSGDMCWKKKLPLS--NGRFDANLNGKALIKIR 426
+P CR +CL C+ +V++ CW+K P S G ++ + +K+
Sbjct: 346 GSSP-----CRANCLSSVLCLASVSMSDGSGNCWQKH-PGSFFTGYQWPSVPSTSYVKV- 398
Query: 427 KGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVGAL-CLCFFFVYNK 485
P + K + + +L I+ ++ G + + +G C C N
Sbjct: 399 ---CGPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCC---RKNP 452
Query: 486 KNSQVPSHDGVVETNLHC---FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVP 542
+ + SH ++E FTYK+L+ T FKE+LG G FG VY+G + +
Sbjct: 453 RFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTV 508
Query: 543 VAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASF 602
VAVK+L I+ G K+F+ EV I THH NLVRL+GFC G +RLLVYEF+ NG+L +F
Sbjct: 509 VAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNF 567
Query: 603 LFGDLKPG---WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659
LF W R +IA G A+G+ YLHEEC I+HCDIKP+NIL+DD + A++SDF
Sbjct: 568 LFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDF 627
Query: 660 GLAKLL-LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM 718
GLAKLL D +++RGT+GY+APEW N+PIT K DVYS+G++LLE++ +RN D+
Sbjct: 628 GLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDV 687
Query: 719 EVNEAEALLTDWAYDCYCEGITEALVEFDI--EALNDKKKLARFVMVAIWCIQEDPSLRP 776
+ WAY+ + +G T+A+++ + + D +++ R V + WCIQE P RP
Sbjct: 688 SEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRP 747
Query: 777 TMRKVTQMLEGVVEVLDPPCP 797
TM KV QMLEG+ E+ +P CP
Sbjct: 748 TMGKVVQMLEGITEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 334 bits (856), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 249/770 (32%), Positives = 370/770 (48%), Gaps = 90/770 (11%)
Query: 45 LSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAAS--GTKVELTADQG 102
LS F GF S + + L I YA +P T VW AN P + + +ELT+
Sbjct: 34 LSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELTSTGY 93
Query: 103 LVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFD 162
L++++ + +W++D + ++TGN +L++D+ + +W+SF+NPTDT LP
Sbjct: 94 LIVSNLRDGVVWQTDNKQPGTDF-RFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVT 152
Query: 163 NGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSSNQLVFN 222
++S +S + S G + L+ + N Y Y S N + V
Sbjct: 153 GLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLV------YKGTTPYWSTGNWTGEAFV-- 204
Query: 223 QSGYMYILQEYDQRFALTRRVETSASNFYY-------------RATINFDGVFTQYQHPK 269
G + Y RF +AS +Y R + +G QY
Sbjct: 205 --GVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDP 262
Query: 270 NSTGNEGWTAFWSLPDDICKASFVSTGSGTCGFNSVCRLNNRRPICECPRGYTLIDPNDQ 329
+ + W FW P+D C+ + CG C +P C C RG+ P +
Sbjct: 263 QT---QSWNMFWLQPEDPCRVYNL------CGQLGFCSSELLKP-CACIRGFR---PRND 309
Query: 330 YGSCKPNYTQSC-VDDDEPGSPEDLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDC 388
+Y+ C ++ + G D FE + + + ++ C ++CL +
Sbjct: 310 AAWRSDDYSDGCRRENGDSGEKSD--TFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNS 367
Query: 389 MCAVAIFRSGDMCWKKKLPLSNGRFDANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKK 448
C V + K+K L K L++ SP+ N+KN++
Sbjct: 368 SC-VGFYH------KEKSNLC----------KILLE---------SPN----NLKNSKGN 397
Query: 449 DQENLIILGSVLLGGSVFFNCLLVGALCLCFFFVYNKKNSQVPSHDGVVETNLHCFTYKD 508
+++IIL SV+ SV LLV + L K Q DG NL F++K+
Sbjct: 398 ISKSIIILCSVVGSISVLGFTLLVPLILLKRSRKRKKTRKQ--DEDGFAVLNLKVFSFKE 455
Query: 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ 568
L++ATNGF +++G G FG V+KG + +S + VAVK+L G EF+ EV IG
Sbjct: 456 LQSATNGFSDKVGHGGFGAVFKGTLPGSSTF---VAVKRLERP-GSGESEFRAEVCTIGN 511
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP---GWSRRTDIAFGIARGL 625
H NLVRL GFC + L+RLLVY+++ G+L+S+L P W R IA G A+G+
Sbjct: 512 IQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL-SRTSPKLLSWETRFRIALGTAKGI 570
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
YLHE C IIHCDIKP+NILLD YNA++SDFGLAKLL D S+ +RGT GYVAP
Sbjct: 571 AYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAP 630
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRRNV--------DMEVNEAEALLTDWAYDCYCE 737
EW +PIT K DVYSFG+ LLE+I RRNV + E + WA +
Sbjct: 631 EWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQ 690
Query: 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787
G +++V+ + + +++ R VAIWCIQ++ +RP M V +MLEG
Sbjct: 691 GNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 262/843 (31%), Positives = 401/843 (47%), Gaps = 100/843 (11%)
Query: 5 LLHSLSVLLLLLQPFLTFAQTRGKITIGASLSA-SQNSSSWLSPNGDFAFGFHSLDSNKD 63
LL + +L + F A +R + +G+SL S SS+ S +G F+ GF+ + ++
Sbjct: 8 LLSTACILSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHA- 66
Query: 64 LFLLSIWYAKIP-----QKTIVWFANGDSPA-ASGTKVELTADQGLVLTSPQGRELWKSD 117
F S+WY+K KTIVW AN D P A + + L D +VLT G +W++D
Sbjct: 67 -FTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRAD 125
Query: 118 PIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFL---SSKQSD 173
T V + DTGN V+ N +W+SF++PTDT LP+Q+ L + +S
Sbjct: 126 GNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSP 185
Query: 174 GNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEP----YYESKTNGSSNQL-VFNQSGYMY 228
GN+ FRF S +L+ + Y +P Y + + +S +L + SG +
Sbjct: 186 GNYI---FRFSDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLA 242
Query: 229 ILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDIC 288
D + + V R T++ DG Y +S G+ W+ C
Sbjct: 243 SSDFADGQALVASDVGPGVKR---RLTLDPDGNLRLYSM-NDSDGS--WSVSMVAMTQPC 296
Query: 289 KASFVSTGSGTCGFNSVCRLNNRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPG 348
G CG N +C + P C CP GY +P + C +C
Sbjct: 297 NIH------GLCGPNGICHYSPT-PTCSCPPGYATRNPGNWTEGCMAIVNTTC------- 342
Query: 349 SPEDLYD-----FEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGD-MCW 402
D YD F + NTD+ SD Q L + CR C+ DC C ++ G C+
Sbjct: 343 ---DRYDKRSMRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCY 399
Query: 403 KKKLPLSNGRFDANLNGKALIKIRKG-----NLPPTSPDF------------------PR 439
K S + + +K+ G L P S F P
Sbjct: 400 PKAYLFSGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPF 459
Query: 440 PNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVGALCLCFFFVYNKK---NSQVPSHDG- 495
P+V + + G + + FF + V + +FFV ++ + S G
Sbjct: 460 PDVHKTGGGESKWFYFYGFI----AAFF-VVEVSFISFAWFFVLKRELRPSELWASEKGY 514
Query: 496 -VVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD 554
+ +N ++Y++L AT FK ELG+G G VYKG + VAVKKL +V Q
Sbjct: 515 KAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRH----VAVKKLENVRQ- 569
Query: 555 GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGW 611
G + F+ E++VIG+ +H NLVR+ GFC +G +RLLV E++ NG+LA+ LF G++ W
Sbjct: 570 GKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDW 629
Query: 612 SRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670
R +IA G+A+GL YLH EC +IHCD+KP+NILLD + +I+DFGL KLL S
Sbjct: 630 EGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGST 689
Query: 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM--EVNEAEALLT 728
Q + +RGT GY+APEW ++PIT KVDVYS+GV+LLE++ R ++ +E ++L
Sbjct: 690 QNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLR 749
Query: 729 DWA--YDCYCEGITEALVEFDIEALNDKK----KLARFVMVAIWCIQEDPSLRPTMRKVT 782
EG ++ ++ +++ ++ + + +A+ C++ED S RPTM
Sbjct: 750 KLVRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAV 809
Query: 783 QML 785
Q L
Sbjct: 810 QTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 4e-87, Method: Compositional matrix adjust.
Identities = 256/790 (32%), Positives = 375/790 (47%), Gaps = 87/790 (11%)
Query: 45 LSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQG-- 102
+S +G + GF S+ + F + +WY ++ Q TI+W AN D + G
Sbjct: 39 VSSDGTYEMGFFKPGSSSN-FYIGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNL 96
Query: 103 LVLTSPQGRELWKSDPIIGTVAYGL---MNDTGNFVLLSDNT----NKLWESFNNPTDTM 155
++L +W + + L + D GN VL + + N LW+SF++P DT
Sbjct: 97 ILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTW 156
Query: 156 LPS------QIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYE 209
LP + Q L+S +S + S G F EL+ + T + + +NE +
Sbjct: 157 LPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDES-----TAYKILWNGSNEYWSS 211
Query: 210 SKTNGSSNQLVFNQSGYMYILQEYDQRFALTRRVETSASNFYY---------RATINFDG 260
N S +F+ M + Y+ F T+ S F Y R ++ G
Sbjct: 212 GPWNPQSR--IFDSVPEMRLNYIYNFSFF----SNTTDSYFTYSIYNQLNVSRFVMDVSG 265
Query: 261 VFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVSTGSGTCGFNSVCRLNNRRPICECPRG 320
Q+ + GN+ W FWS P C+ CG +C + P C CP+G
Sbjct: 266 QIKQFTWLE---GNKAWNLFWSQPRQQCQVYRY------CGSFGICS-DKSEPFCRCPQG 315
Query: 321 YTLIDPNDQYGSCKPNYTQSCVDDDE-PGSPEDLYDFEVITNTDWPTSDYQLLTPFTEEG 379
+ P Q +Y+ CV E S D+ F + N + ++LT +
Sbjct: 316 FR---PMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKL-ADNSEVLTRTSLSI 371
Query: 380 CRQSCLHDCMCAVAIFRSGD---MCWKKKLPLSNGRFDANLNGKALIKIRKGNLPPTSPD 436
C +C DC C + G + W K + D N G L + D
Sbjct: 372 CASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFY------LRLAASD 425
Query: 437 FPRPNVKNNQKKDQENLIILGSVL--LGGSVFFNCLLVGALCLCFFFVYNKKNSQVPSHD 494
P NV + K + + LI G+VL LG V +++ L + D
Sbjct: 426 VP--NVGASGKSNNKGLI-FGAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKG-----D 477
Query: 495 GVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD 554
G L F+Y++L+ AT F ++LG G FG V+KGA+ +S +AVK+L + Q
Sbjct: 478 GT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSS----DIAVKRLEGISQ- 528
Query: 555 GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF-----GDLKP 609
G K+F+TEV IG H NLVRL GFC +G +LLVY+++ NG+L S LF +
Sbjct: 529 GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVL 588
Query: 610 GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669
GW R IA G ARGL YLH+EC IIHCDIKP+NILLD + +++DFGLAKL+ D
Sbjct: 589 GWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDF 648
Query: 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTD 729
S+ T +RGT+GY+APEW + IT K DVYS+G++L E++ RRN + NE
Sbjct: 649 SRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPS 708
Query: 730 WAYDCYC-EGITEALVEFDIEA-LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787
WA +G +LV+ +E D +++ R VA WCIQ++ S RP M +V Q+LEG
Sbjct: 709 WAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEG 768
Query: 788 VVEVLDPPCP 797
V+EV PP P
Sbjct: 769 VLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 262/852 (30%), Positives = 388/852 (45%), Gaps = 104/852 (12%)
Query: 10 SVLLLLLQPFLTFAQTRGKITI--GASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLL 67
S+ L L F + + TI G SL N +SP F GF S S+ FL
Sbjct: 8 SLYLSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFL- 66
Query: 68 SIWYAKIPQKTIVWFANGDSPAASGTKVELTADQG-LVLTSPQGRELWKSDPIIGTVAYG 126
IWY I K +VW AN +P + + V + ++ G LVL + +W S+ T
Sbjct: 67 GIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNN 126
Query: 127 ----LMNDTGNFVLLSDNTNK-LWESFNNPTDTMLPS-------QIFDNGQFLSSKQSDG 174
++DTGNFVL +T++ +WESFN+PTDT LP Q DN F+S + S+
Sbjct: 127 NRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWR-SET 185
Query: 175 NFSKGRFRFELNSNG--NLVLTTVNLPSDYTNEPYYESKTNGSSNQLVFNQSGYMYILQE 232
+ S G + ++ +G +VL N + + G N +F M +L
Sbjct: 186 DPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRS---------GQWNSAIFTGIPNMSLLTN 236
Query: 233 YDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNE--------GWTAFWSLP 284
Y F L+ + + S Y+ + V +++ N T E WT F S P
Sbjct: 237 YLYGFKLSSPPDETGS-VYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEP 295
Query: 285 DDICKASFVSTGSGTCGFNSVCRLNNRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDD 344
D C CG +C + IC C GY + + C+ C +
Sbjct: 296 DSECDQY------NRCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERN 349
Query: 345 DEPGSPEDLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMC--W 402
G E L + + D+ ++ L+ P E CR+ CL +C C G C W
Sbjct: 350 ISVGEDEFL-TLKSVKLPDFEIPEHNLVDP---EDCRERCLRNCSCNAYSLVGGIGCMIW 405
Query: 403 KKKLPLSNGRFDANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLI--ILGSVL 460
+ L + +F+A G + + IR + V N+K ++ ++G +L
Sbjct: 406 NQDL-VDLQQFEA---GGSSLHIRLAD----------SEVGENRKTKIAVIVAVLVGVIL 451
Query: 461 LGGSVFFNCLL---------VGALC------LCFFFVYNKKNSQVPSHDGVVE------- 498
+G F LL GA C K + G V+
Sbjct: 452 IG---IFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKA 508
Query: 499 ---TNLHCFTYKDLEAATNGF--KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ 553
+ L F+ + ATN F + ELG+G FG VYKG + +AVK+L
Sbjct: 509 VNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGR----EIAVKRLSGKSG 564
Query: 554 DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG--- 610
GV EFK E+ +I + H+NLVRLLG C +G ++LVYE++ N +L FLF + K
Sbjct: 565 QGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALID 624
Query: 611 WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670
W R I GIARGLLYLH + +IIH D+K N+LLD N +ISDFG+A++ +Q+
Sbjct: 625 WKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQN 684
Query: 671 QTHTA-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTD 729
+ +T + GT GY++PE+ +VK DVYSFGVLLLEI+ +RN + +E +L+
Sbjct: 685 EANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLI-G 743
Query: 730 WAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789
+A+ Y G +E LV+ I K++ R + VA+ C+Q+ + RP M V MLE
Sbjct: 744 YAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDT 803
Query: 790 EVLDPPCPCPFT 801
L P FT
Sbjct: 804 ATLAAPRQPTFT 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 289 bits (739), Expect = 7e-77, Method: Compositional matrix adjust.
Identities = 238/811 (29%), Positives = 372/811 (45%), Gaps = 110/811 (13%)
Query: 45 LSPNGDFAFGFHSL--DSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQG 102
LS N F G S D + F S+ + + + +W +N DSP +S + LT
Sbjct: 51 LSRNSIFKAGLFSPGGDDSSTGFYFSVVH--VDSGSTIWSSNRDSPVSSSGTMNLTPQGI 108
Query: 103 LVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIF 161
V+ + + S P++ + L + D GN +LL LWESF+ PTD+++ Q
Sbjct: 109 SVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRL 168
Query: 162 DNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSSN---- 217
G FLS S +FS G ++F + + L+ + + Y++ + + +N
Sbjct: 169 KLGMFLSGSVSRSDFSTGDYKFLVGESDGLM--------QWRGQNYWKLRMHIRANVDSN 220
Query: 218 ----QLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTG 273
L SG + + + RV S+ + A ++ G F + +
Sbjct: 221 FPVEYLTVTTSGLALMARNGT---VVVVRVALPPSSDFRVAKMDSSGKFIVSRFSGKNLV 277
Query: 274 NEGWTAFWSLPDDICKASFVSTGSGTCGFNSVCRLNN--RRPICECPRGYTLIDPNDQYG 331
E +S P D C+ FV CG +C L+N C CP + + G
Sbjct: 278 TE-----FSGPMDSCQIPFV------CGKLGLCNLDNASENQSCSCPDEMRM---DAGKG 323
Query: 332 SCKPNYTQSCVDDDEPGSPE--DLYDFEVITNTDWPTSDYQLLTPFTEEG-----CRQSC 384
C P +QS P S E ++ E+ + ++ + T E G C C
Sbjct: 324 VCVP-VSQSL---SLPVSCEARNISYLELGLGVSYFSTHF---TDPVEHGLPLLACHDIC 376
Query: 385 LHDCMCAVAIFR-SGDMCWKKK-----LPL-SNGRFDANLNGKALIKIRKGNLPPTSPDF 437
+C C + + C+ K L L N + +L G + IRK N P
Sbjct: 377 SKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQP----- 431
Query: 438 PRPNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVGALC--LCFFFVYNKKNSQVPSHDG 495
N + + ++ VLL S FF + +G L C Y+ + + G
Sbjct: 432 -----PGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPG 486
Query: 496 VVET----NLHC------FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAV 545
E+ + H F +++LE AT FK ++G G FG VYKG + ++ +AV
Sbjct: 487 SFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETL----IAV 542
Query: 546 KKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG 605
KK+ + G +EF TE+ +IG H NLV+L GFC G LLVYE++++G+L LF
Sbjct: 543 KKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS 602
Query: 606 DLKP--GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
P W R DIA G ARGL YLH C +IIHCD+KP+NILL D++ +ISDFGL+K
Sbjct: 603 GNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSK 662
Query: 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA 723
LL ++S T +RGT+GY+APEW N I+ K DVYS+G++LLE++ R+N + +
Sbjct: 663 LLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFR-SRS 721
Query: 724 EALLTD--------------------WAYDCYCEGITEALVEFDIEALNDKKKLARFVMV 763
++ D +A D + +G L + +E ++ + V +
Sbjct: 722 NSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRI 781
Query: 764 AIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794
A+ C+ E+P+LRPTM V M EG + + +P
Sbjct: 782 ALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (736), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 144/297 (48%), Positives = 198/297 (66%), Gaps = 10/297 (3%)
Query: 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEV 563
F YKDL++ATN F +LG+G FG VY+G + S +AVKKL + Q G KEF+ EV
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSR----LAVKKLEGIGQ-GKKEFRAEV 537
Query: 564 NVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAF 619
++IG HH +LVRL GFC +G +RLL YEFLS G+L ++F GD+ W R +IA
Sbjct: 538 SIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIAL 597
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
G A+GL YLHE+C +I+HCDIKP+NILLDD +NA++SDFGLAKL+ +QS T +RGT
Sbjct: 598 GTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGT 657
Query: 680 KGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
+GY+APEW N I+ K DVYS+G++LLE+I R+N D + +A+ EG
Sbjct: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGK 717
Query: 740 TEALVEFDIEALN-DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795
+V+ ++ ++ +++ R + A+WCIQED RP+M KV QMLEGV V+ PP
Sbjct: 718 LMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64782|SD129_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 OS=Arabidopsis thaliana GN=SD129 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 242/831 (29%), Positives = 392/831 (47%), Gaps = 112/831 (13%)
Query: 11 VLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIW 70
+LLL++ P +A I + LS Q SS P G + GF S ++ ++ ++ IW
Sbjct: 9 LLLLIIFPTCGYA----AINTSSPLSIRQTLSS---PGGFYELGFFSPNNTQNQYV-GIW 60
Query: 71 YAKIPQKTIVWFANGDSPA-ASGTKVELTADQGLVLTSPQGRELWKS-DPIIGTVAYGLM 128
+ KI + +VW AN D+P +S + ++++ L+L + +W + + +
Sbjct: 61 FKKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHAEL 120
Query: 129 NDTGNFVLLSD-NTNKLWESFNNPTDTMLP--SQIFD--NGQ--FLSSKQSDGNFSKGRF 181
DTGNFV++ D + NKLW+SF + +TMLP S ++D NG+ L++ +S+ + S G F
Sbjct: 121 LDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEF 180
Query: 182 RFELNSNGNLVLTTVNLPSD----YTNEPYYESKTNGSSNQLVFNQSGYMYILQEYDQRF 237
E+ T +P+ + PY+ G + F SG I Y F
Sbjct: 181 SLEI---------TPQIPTQGLIRRGSVPYWRC---GPWAKTRF--SGISGIDASYVSPF 226
Query: 238 ALTRRVETSASNFYYRATINFDGVFTQYQHPKNST------GNEGWTAFWSLPDDICKAS 291
++ + +F Y N++ + P+ GN W SLP++ C
Sbjct: 227 SVVQDTAAGTGSFSYSTLRNYNLSYVTLT-PEGKMKILWDDGNN-WKLHLSLPENPCDL- 283
Query: 292 FVSTGSGTCGFNSVCRLNNRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDE----- 346
G CG +C + + P CEC +G+ + ++++G K N+T CV +
Sbjct: 284 -----YGRCGPYGLC-VRSDPPKCECLKGF-VPKSDEEWG--KGNWTSGCVRRTKLSCQA 334
Query: 347 ------PGSPEDLYDFEVITNTDWPTSD-YQLLTPFTEEGCRQSCLHDCMCAVAIFRSGD 399
G D++ TD T D +Q + E C Q CL +C C + SG
Sbjct: 335 KSSMKTQGKDTDIF----YRMTDVKTPDLHQFASFLNAEQCYQGCLGNCSCTAFAYISGI 390
Query: 400 MC--WKKKLP-----LSNGRFDANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQEN 452
C W +L LS+G F I++ L +S +
Sbjct: 391 GCLVWNGELADTVQFLSSGEF-------LFIRLASSELAGSS---------------RRK 428
Query: 453 LIILGSVLLGGSVFFNCLLVGALCLCFFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAA 512
+I+ +V L S+F +LV A + + + + ++ + + ++ F + A
Sbjct: 429 IIVGTTVSL--SIFL--ILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNFFEMHTIRTA 484
Query: 513 TNGF--KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH 570
TN F +LG+G FG VYKG + + + VK+L S G +EF E+ +I +
Sbjct: 485 TNNFSPSNKLGQGGFGPVYKGKL----VDGKEIGVKRLASSSGQGTEEFMNEITLISKLQ 540
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG---DLKPGWSRRTDIAFGIARGLLY 627
H+NLVRLLG+C DG +LL+YEF+ N +L F+F + W +R +I GIARGLLY
Sbjct: 541 HRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLY 600
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-AIRGTKGYVAPE 686
LH + ++IH D+K NILLDD N +ISDFGLA++ Q Q +T + GT GY++PE
Sbjct: 601 LHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPE 660
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
+ + K D+YSFGVL+LEII +R + L + +D +CE L++
Sbjct: 661 YAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWCETGGSNLLDR 720
Query: 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797
D+ ++AR V + + C+Q + RP +V ML ++ P P
Sbjct: 721 DLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQP 771
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 804 | ||||||
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.965 | 0.968 | 0.699 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.978 | 0.984 | 0.662 | 0.0 | |
| 356555135 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.978 | 0.965 | 0.585 | 0.0 | |
| 356503095 | 807 | PREDICTED: G-type lectin S-receptor-like | 0.973 | 0.970 | 0.577 | 0.0 | |
| 356503089 | 807 | PREDICTED: G-type lectin S-receptor-like | 0.973 | 0.970 | 0.577 | 0.0 | |
| 356528738 | 816 | PREDICTED: G-type lectin S-receptor-like | 0.985 | 0.970 | 0.575 | 0.0 | |
| 109676362 | 2037 | CCHC-type integrase [Populus trichocarpa | 0.922 | 0.364 | 0.591 | 0.0 | |
| 255544746 | 800 | ATP binding protein, putative [Ricinus c | 0.961 | 0.966 | 0.566 | 0.0 | |
| 224057535 | 775 | predicted protein [Populus trichocarpa] | 0.955 | 0.990 | 0.557 | 0.0 | |
| 224053032 | 752 | predicted protein [Populus trichocarpa] | 0.924 | 0.988 | 0.563 | 0.0 |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1155 bits (2988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 556/795 (69%), Positives = 653/795 (82%), Gaps = 19/795 (2%)
Query: 1 MAFPLLHSLSVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDS 60
MAFP+LH LL++L PF +QT G IT+GASLS S+N+S WLSP+GDFAFGFH L
Sbjct: 1 MAFPILHLSFSLLIMLPPF-AVSQTGGNITVGASLSTSENTS-WLSPSGDFAFGFHPLYG 58
Query: 61 NKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPII 120
NK LFLL+IWY KIP+KTIVW+ANGD PA +G+K LTA++G+ LT PQGRELW+S+ II
Sbjct: 59 NKYLFLLAIWYDKIPEKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETII 118
Query: 121 GTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGR 180
G VAYG M D GNFVL ++KLWESF NP DT+LPSQ+ D G LSS+QS+ NFS GR
Sbjct: 119 GVVAYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGR 178
Query: 181 FRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSSN------QLVFNQSGYMYILQEYD 234
F+ +L +GNL L T+NLPSDYTNEPYY+S T+G + Q+VFN+SGY+YIL+E D
Sbjct: 179 FQLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILREND 238
Query: 235 QRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVS 294
Q F+LT+RV S +FY RAT+NFDG+FTQY HPK STGNE WT WS PD+IC+ASFVS
Sbjct: 239 QIFSLTQRVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNICQASFVS 298
Query: 295 TGSGTCGFNSVCRLN-NRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDL 353
+GSGTCGFNSVCRLN +RRPICECP GY+L+DP+DQYGSC+PNYTQSC ++DE EDL
Sbjct: 299 SGSGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSC-EEDEVAPVEDL 357
Query: 354 YDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKLPLSNGRF 413
YDFE +TNTDWPTSDY LL PFTEE CRQSCL+DCMCAVAIFRSGDMCWKKKLPLSNGR
Sbjct: 358 YDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRV 417
Query: 414 DANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVG 473
NL+GKAL+K+R+ N+ P SP FP N KKD++ LI++GSV LG SVF N LLV
Sbjct: 418 QTNLDGKALLKVRRSNVNPRSPYFP------NNKKDRDGLILVGSVFLGCSVFVNFLLVC 471
Query: 474 ALCLCFFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAI 533
A+ +CFFF+Y ++ ++P DG VETNL CFTY++L AT GFKEELG+GAFGVVYKG +
Sbjct: 472 AIFMCFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVV 531
Query: 534 GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593
+ S + VAVKKL++V +D V+EFKTEVNVIGQTHHKNLVRLLGFC++G RLLVYEF
Sbjct: 532 HIGS--SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEF 589
Query: 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653
+SNG+L+SF+F D KPGW R IAFG+ARGLLYLHEECS QIIHCDIKPQNILLD+YYN
Sbjct: 590 MSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYN 649
Query: 654 ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN+P+TVKVDVYS+GVLLLEIICCR
Sbjct: 650 ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCR 709
Query: 714 RNVDMEVN-EAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDP 772
RNVD + E +A+LTDWAYDCY EG +ALV D AL+D +KL RF+M+A WCIQEDP
Sbjct: 710 RNVDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDP 769
Query: 773 SLRPTMRKVTQMLEG 787
SLRPTMRKVTQMLEG
Sbjct: 770 SLRPTMRKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1091 bits (2821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/808 (66%), Positives = 643/808 (79%), Gaps = 21/808 (2%)
Query: 1 MAFPLLHSLSVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDS 60
MAFP+LH LL++L PF +QT G IT+GASLS S N+S WLSP+GDFAFGF+ L
Sbjct: 1 MAFPILHLSFSLLIMLPPF-AVSQTGGNITVGASLSTSDNTS-WLSPSGDFAFGFYQLYG 58
Query: 61 NKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPII 120
NKDLFLL+IWY KIP KTIVW+ANGD PA +G+K LTA++G+ LT PQGRELW+S+ II
Sbjct: 59 NKDLFLLAIWYDKIPDKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETII 118
Query: 121 GTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGR 180
G VAYG M DTGNFVL ++KLWESF NP DT+LPSQ+ D G LSS+QS+ NFS GR
Sbjct: 119 GDVAYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGR 178
Query: 181 FRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSSN------QLVFNQSGYMYILQEYD 234
F+ +L +GNLVL T+NLPSDYTNEPYY+S T+G + Q+VFN+SGY+YIL++ D
Sbjct: 179 FQLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKND 238
Query: 235 QRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVS 294
Q F+LT+RV S +FY+RAT+NFDGVFTQY HPK STGNE WT WS PD+IC+AS VS
Sbjct: 239 QIFSLTQRVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNICQASSVS 298
Query: 295 TGSGTCGFNSVCRLN-NRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDL 353
GSGTCGFNSVCRLN + RPICECP GY+L+DP+DQYGSC+PNYTQSC ++DE EDL
Sbjct: 299 AGSGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSC-EEDEVAPVEDL 357
Query: 354 YDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKLPLSNGRF 413
YDFE +TNTDWPTSDY LL PFTEE CRQSCL+DCMCAVAIFRSGDMCWKKKLPLSNGR
Sbjct: 358 YDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRV 417
Query: 414 DANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVG 473
++ KAL+K+R+ N+ P SP FP N KKD++ LI++GSV LG SVF N LLV
Sbjct: 418 QTIVDAKALLKVRRSNVNPRSPYFP------NNKKDRDGLILVGSVFLGCSVFVNFLLVC 471
Query: 474 ALCLCFFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAI 533
A+C+ FFF+Y ++ ++P DG VETNL CFTY++L AT GFKEELG+GAFGVVY+G +
Sbjct: 472 AICMGFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVV 531
Query: 534 GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593
+ S + VAVKKL++V +D V+EFKTEVNVIGQTHHKNLVRLLGFC++G RLLVYEF
Sbjct: 532 HIGS--SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEF 589
Query: 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653
+SNG+L+SF+F D KPGW R IAFG+ARGLLYLHE+ +QIIHCDIKPQNILLD+ N
Sbjct: 590 MSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILLDESLN 647
Query: 654 ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
ARISDFGLAKLL DQ++T TAIRGTKGYVAPEWF+N+P+T KVD YSFG+LLLE++CCR
Sbjct: 648 ARISDFGLAKLLKTDQTKTTTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCR 707
Query: 714 RNVDME-VNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDP 772
+N ++ + E + +L DWA DC EG LVE D EA+ D K++ RFVMVAIWCIQEDP
Sbjct: 708 KNFEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDP 767
Query: 773 SLRPTMRKVTQMLEGVVEVLDPPCPCPF 800
SLRP M+KV QMLEG V+V PP P F
Sbjct: 768 SLRPGMKKVVQMLEGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555135|ref|XP_003545892.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 478/817 (58%), Positives = 590/817 (72%), Gaps = 30/817 (3%)
Query: 1 MAFPLLHSL--SVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWL--SPNGDFAFGFH 56
MA PLL L S++LL Q AQT+ I IG S +A ++S WL SP+GDFAFGF
Sbjct: 1 MASPLLPFLFLSMVLLPFQHINVMAQTKSNIAIGDSHTAGASTSPWLVSSPSGDFAFGFL 60
Query: 57 SLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL-TSPQGRELWK 115
L+ D F+L IWYAKI KTIVWFAN D PA G+KV LTAD GLVL T+P G +LWK
Sbjct: 61 PLEDTPDHFMLCIWYAKIQDKTIVWFANRDKPAPKGSKVVLTADDGLVLITAPNGNQLWK 120
Query: 116 SDPIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGN 175
+ + V+ G++N+TGNFVL ++N +WESF + DT+LP Q + GQ LSSK
Sbjct: 121 TGGLTVRVSSGVLNNTGNFVLQDGDSNTVWESFKDYRDTLLPYQTMERGQKLSSKLRRNY 180
Query: 176 FSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT-----NGSSNQLVFNQSGYMYIL 230
F+KGRF ++GNLV+ ++NLPS Y NE YYES T + + QLVF+ SG MY+L
Sbjct: 181 FNKGRFVLFFQNDGNLVMHSINLPSGYANEHYYESGTVESNISSAGTQLVFDGSGDMYVL 240
Query: 231 QEYDQRFALTRRVETSASN---FYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDI 287
+E ++++ L+R ++S FY RAT++FDGVFT YQHPK S+G GWT WS PD+I
Sbjct: 241 RENNEKYNLSRGGSGASSTTQFFYLRATLDFDGVFTLYQHPKGSSGTGGWTPVWSHPDNI 300
Query: 288 CKASFVSTGSGTCGFNSVCRL-NNRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDE 346
CK S GSG CG+NS+C L +++RP C+CP+ Y+L+DPND GSCKP++ Q+C D E
Sbjct: 301 CKDYVASAGSGVCGYNSICSLRDDKRPNCKCPKWYSLVDPNDPNGSCKPDFVQACAVD-E 359
Query: 347 PGSPEDLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKL 406
+ +DLYDFEV+ +TDWP SDY L PF EE CRQSC+ DCMC+VAIFR GD CWKKKL
Sbjct: 360 LSNRKDLYDFEVLIDTDWPQSDYVLQRPFNEEQCRQSCMEDCMCSVAIFRLGDSCWKKKL 419
Query: 407 PLSNGRFDANLNG-KALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSV 465
PLSNGR DA LNG KA +K+RK N P + N K++ I++GSVLLG S
Sbjct: 420 PLSNGRVDATLNGAKAFMKVRKDN-----SSLIVPTIIVN--KNRNTSILVGSVLLGSSA 472
Query: 466 FFNCLLVGALCLC--FFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKG 523
F N +L+GA+CL + F Y KK + D +VETNL CFTYK+LE AT+GF + LGKG
Sbjct: 473 FLNLILLGAICLSTSYVFRYKKKLRSIGRSDTIVETNLRCFTYKELEKATDGFDKVLGKG 532
Query: 524 AFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD 582
AFG+VY+G I M S VAVK+L++ +++D KEFK E+N IG THHKNLVR+LGFC+
Sbjct: 533 AFGIVYEGVINMGS--DTRVAVKRLNTFLLEDVHKEFKNELNAIGLTHHKNLVRILGFCE 590
Query: 583 DGLNRLLVYEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDI 641
RLLVYE++SNGTLAS LF L KP W R IA G+ARGLLYLHEECSTQIIHCDI
Sbjct: 591 TEEKRLLVYEYMSNGTLASLLFNILEKPSWELRLQIAIGVARGLLYLHEECSTQIIHCDI 650
Query: 642 KPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYS 701
KPQNILLDDYYNARISDFGLAKLL ++QS+T+TAIRGTKGYVA EWF+NMPIT KVDVYS
Sbjct: 651 KPQNILLDDYYNARISDFGLAKLLNMNQSRTNTAIRGTKGYVALEWFKNMPITAKVDVYS 710
Query: 702 FGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARF 760
+GVLLLEI+ CR++V+ E + E A+L +WAYDCY E ALVE D EAL+D K L +
Sbjct: 711 YGVLLLEIVSCRKSVEFETEDKEKAILAEWAYDCYTERTLHALVEGDKEALDDMKNLEKL 770
Query: 761 VMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797
VM+A+WC+QEDP LRPTMR VTQMLEGVVEV PPCP
Sbjct: 771 VMIALWCVQEDPDLRPTMRNVTQMLEGVVEVKVPPCP 807
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503095|ref|XP_003520347.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 923 bits (2386), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/810 (57%), Positives = 589/810 (72%), Gaps = 27/810 (3%)
Query: 1 MAFPLLHSLSVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWL--SPNGDFAFGFHSL 58
MA LL ++L PF+ AQT+ I IG S +A ++++ WL SP+GDFAFGF L
Sbjct: 1 MASSLLLFFLFCSVILLPFVV-AQTKTNIAIGDSHTAGKSTTPWLVSSPSGDFAFGFLPL 59
Query: 59 DSNKDLFLLSIWYAKIPQKTIVWFANGDS-PAASGTKVELTADQGLVLTSPQGRELWKSD 117
++ D F+L IWYA I +TIVWFAN D+ PA G+KVEL+AD GLVLT+P G +LW +
Sbjct: 60 EATPDHFILCIWYANIQDRTIVWFANRDNKPAPKGSKVELSADDGLVLTAPNGDKLWNTG 119
Query: 118 PIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFS 177
V+ G+ NDTGN VLL ++ WESF++ DT+LPSQ + GQ LSSK +F+
Sbjct: 120 GFTARVSSGVFNDTGNLVLLDGASSSTWESFDDYRDTLLPSQTMERGQKLSSKLRRNDFN 179
Query: 178 KGRFRFELNSNGNLVLTTVNLPSDYTNEPYY-----ESKTNGSSNQLVFNQSGYMYILQE 232
GRF ++GNLV+ ++NLPS+Y N YY ES T+ + QLVF++SG +YIL++
Sbjct: 180 IGRFELFFQNDGNLVMHSINLPSEYVNANYYASGTIESNTSSAGTQLVFDRSGDVYILRD 239
Query: 233 YDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASF 292
+++ L+ S + FY RAT++FDGVFT YQHPK S+G+ GWT WS PD+ICK
Sbjct: 240 NKEKYNLSDGGSISTTQFYLRATLDFDGVFTLYQHPKGSSGSVGWTPVWSHPDNICKDYL 299
Query: 293 VSTGSGTCGFNSVCRLNN-RRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPE 351
+T SG CG+NS+C L + +RPIC+CP+ Y+L+DPND GSCKP++ QSC +DE E
Sbjct: 300 SATSSGVCGYNSICSLGDYKRPICKCPKWYSLVDPNDPNGSCKPDFVQSC-SEDELSQRE 358
Query: 352 DLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKLPLSNG 411
DLYDFEV+ +TDWP+SDY L PFTEE CRQSC+ DC+C+VAIFR GD CWKKKLPLSNG
Sbjct: 359 DLYDFEVLIDTDWPSSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKKLPLSNG 418
Query: 412 RFDANLNG-KALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFNCL 470
R DA LNG KA +K+RK N P P + KK+ N +I VLL GS N +
Sbjct: 419 RVDATLNGAKAFMKVRKDNSSLVVP----PII---VKKNSRNTLI---VLLSGSACLNLI 468
Query: 471 LVGALCLCFFFVY--NKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVV 528
LVGA+CL F+V+ KK +V VETNL CFTY++LE ATNGF++ LGKGAFG+V
Sbjct: 469 LVGAICLSSFYVFWCKKKLRRVGKSGTNVETNLRCFTYEELEEATNGFEKVLGKGAFGIV 528
Query: 529 YKGAIGMASMYQVPVAVKKLHSVIQDGV-KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587
Y+G I M S+ VAVK+L++ + + V KEFK E+N IG THHKNLVRLLGFC+ R
Sbjct: 529 YEGVINMGSL--TLVAVKRLNTFLLEEVQKEFKNELNAIGLTHHKNLVRLLGFCETQDER 586
Query: 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647
LLVYE++SNGTLAS +F KP W R IA G+ARGLLYLHEECSTQIIHCDIKPQNIL
Sbjct: 587 LLVYEYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKPQNIL 646
Query: 648 LDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLL 707
LDDYYNARISDFGLAK+L ++QS+T+TAIRGTKGYVA EWF+NMPIT KVDVYS+GVLLL
Sbjct: 647 LDDYYNARISDFGLAKILNMNQSRTNTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLL 706
Query: 708 EIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWC 767
EI+ CR++V+ E +E +A+LT+WA+DCY EG+ LVE D EAL+D K L + VM+A+WC
Sbjct: 707 EIVSCRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVMIALWC 766
Query: 768 IQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797
+QEDP LRPTMR VTQMLEGVVEV PPCP
Sbjct: 767 VQEDPGLRPTMRNVTQMLEGVVEVQIPPCP 796
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503089|ref|XP_003520344.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2384), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/810 (57%), Positives = 588/810 (72%), Gaps = 27/810 (3%)
Query: 1 MAFPLLHSLSVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWL--SPNGDFAFGFHSL 58
MA LL ++L PF+ AQT+ I IG S +A ++++ WL SP+GDFAFGF L
Sbjct: 1 MASSLLLFFLFCSVILLPFVV-AQTKTNIAIGDSHTAGKSTTPWLVSSPSGDFAFGFLPL 59
Query: 59 DSNKDLFLLSIWYAKIPQKTIVWFANGDS-PAASGTKVELTADQGLVLTSPQGRELWKSD 117
++ D F+L IWYA I +TIVWFAN D+ PA G+KVEL+AD GLVLT+P G +LW +
Sbjct: 60 EATPDHFILCIWYANIQDRTIVWFANRDNKPAPKGSKVELSADDGLVLTAPNGDKLWNTG 119
Query: 118 PIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFS 177
V+ G+ NDTGN VLL ++ WESF++ DT+LPSQ + GQ LSSK +F+
Sbjct: 120 GFTARVSSGVFNDTGNLVLLDGASSSTWESFDDYRDTLLPSQTMERGQKLSSKLRRNDFN 179
Query: 178 KGRFRFELNSNGNLVLTTVNLPSDYTNEPYY-----ESKTNGSSNQLVFNQSGYMYILQE 232
GRF ++GNLV+ ++NLPS+Y N YY ES T+ + QLVF++SG +YIL++
Sbjct: 180 IGRFELFFQNDGNLVMHSINLPSEYVNANYYASGTIESNTSSAGTQLVFDRSGDVYILRD 239
Query: 233 YDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASF 292
+++ L+ S + FY RAT++FDGVFT YQHPK S+G+ GWT WS PD+ICK
Sbjct: 240 NKEKYNLSDGGSISTTQFYLRATLDFDGVFTLYQHPKGSSGSVGWTPVWSHPDNICKDYL 299
Query: 293 VSTGSGTCGFNSVCRLNN-RRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPE 351
+ SG CG+NS+C L + +RPIC+CP+ Y+L+DPND GSCKP++ QSC +DE E
Sbjct: 300 SAASSGVCGYNSICSLGDYKRPICKCPKWYSLVDPNDPNGSCKPDFVQSC-SEDELSQRE 358
Query: 352 DLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKLPLSNG 411
DLYDFEV+ +TDWP SDY L PFTEE CRQSC+ DC+C+VAIFR GD CWKKKLPLSNG
Sbjct: 359 DLYDFEVLIDTDWPLSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKKLPLSNG 418
Query: 412 RFDANLNG-KALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFNCL 470
R DA LNG KA +K+RK N P P + KK+ N +I VLL GS N +
Sbjct: 419 RVDATLNGAKAFMKVRKDNSSLVVP----PII---VKKNSRNTLI---VLLSGSACLNLI 468
Query: 471 LVGALCLCFFFVY--NKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVV 528
LVGA+CL F+V+ KK +V VETNL CFTY++LE ATNGF++ LGKGAFG+V
Sbjct: 469 LVGAICLSSFYVFWCKKKLRRVGKSGTNVETNLRCFTYEELEEATNGFEKVLGKGAFGIV 528
Query: 529 YKGAIGMASMYQVPVAVKKLHSVIQDGV-KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587
Y+G I M S+ VAVK+L++ + + V KEFK E+NVIG THHKNLVRLLGFC+ R
Sbjct: 529 YEGVINMGSL--TLVAVKRLNTFLLEEVQKEFKNELNVIGLTHHKNLVRLLGFCETQDER 586
Query: 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647
LLVYE++SNGTLAS +F KP W R IA G+ARGLLYLHEECSTQIIHCDIKPQNIL
Sbjct: 587 LLVYEYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKPQNIL 646
Query: 648 LDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLL 707
LDDYYNARISDFGLAK+L ++QS+T+TAIRGTKGYVA EWF+NMPIT KVDVYS+GVLLL
Sbjct: 647 LDDYYNARISDFGLAKILNMNQSRTNTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLL 706
Query: 708 EIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWC 767
EI+ CR++V+ E +E +A+LT+WA+DCY EG+ LVE D EAL+D K L + VM+A+WC
Sbjct: 707 EIVSCRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVMIALWC 766
Query: 768 IQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797
+QEDP LRPTMR VTQMLEGVVEV PPCP
Sbjct: 767 VQEDPGLRPTMRNVTQMLEGVVEVQIPPCP 796
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528738|ref|XP_003532956.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2350), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/823 (57%), Positives = 592/823 (71%), Gaps = 31/823 (3%)
Query: 1 MAFPLLHSLSVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWL--SPNGDFAFGFHSL 58
MA LL L + ++LL PF T AQT+ I IG S +A ++S WL SP+GDFAFGF L
Sbjct: 1 MASTLLPFLFLSMVLL-PFQTIAQTKSNIAIGESHTAGASTSPWLVSSPSGDFAFGFLPL 59
Query: 59 DSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL-TSPQGRELWKSD 117
+ D F+L IWYAKI KTIVWFAN D PA G+KV LTAD GLVL T+P G LWK+
Sbjct: 60 EDTPDHFMLCIWYAKIQDKTIVWFANRDQPAPKGSKVVLTADDGLVLITAPNGHMLWKTG 119
Query: 118 PIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFS 177
+ V+ G++NDTGNFVL ++ +WESF + DT+LP Q + G LSSK F+
Sbjct: 120 GLTLRVSSGVLNDTGNFVLQDGHSKTVWESFKDYRDTLLPYQTMEKGHKLSSKLGRNYFN 179
Query: 178 KGRFRFELNSNGNLVLTTVNLPSDYTNEPYY-----ESKTNGSSN---QLVFNQSGYMYI 229
KGRF ++G+LV+ ++N+PS Y NE YY ES TN S++ QLVF+ +G MY+
Sbjct: 180 KGRFVLFFQNDGSLVMHSINMPSGYANENYYQSGTIESNTNTSTSAGTQLVFDGTGDMYV 239
Query: 230 LQEYDQRFALTR---RVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDD 286
L++ ++++ L++ R ++ +Y RAT++FDGVFT YQHPK S+G+ GW+ WS PD+
Sbjct: 240 LRKNNEKYNLSKGGSRASSTTQFYYLRATLDFDGVFTLYQHPKGSSGSGGWSQVWSHPDN 299
Query: 287 ICKASFVSTGSGTCGFNSVCRL-NNRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDD 345
ICK S GSG CG+NS+C L +++RP C CP+ Y+L+DPND GSCKP++ Q+C D
Sbjct: 300 ICKDYVASAGSGVCGYNSICSLRDDKRPNCRCPKWYSLVDPNDPNGSCKPDFVQACAVD- 358
Query: 346 EPGSPEDLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKK 405
+ + +DLYDFEV+ +TDWP SDY L PF EE CRQSC+ DCMC+VAIFR GD CWKKK
Sbjct: 359 KLSNRQDLYDFEVLIDTDWPQSDYVLQRPFNEEQCRQSCMEDCMCSVAIFRLGDSCWKKK 418
Query: 406 LPLSNGRFDANLNG-KALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGS 464
LPLSNGR DA LNG KA +K+RK N P P + N K+ I++GSVLLG S
Sbjct: 419 LPLSNGRVDATLNGAKAFMKVRKDNSSLIVP----PIIVNKNNKNTS--ILVGSVLLGSS 472
Query: 465 VFFNCLLVGALCLC--FFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGK 522
F N +LVGA+CL + F Y KK + D +VETNL FTY++L+ ATN F + LGK
Sbjct: 473 AFLNLILVGAICLSTSYVFRYKKKLRSIGRSDTIVETNLRRFTYEELKKATNDFDKVLGK 532
Query: 523 GAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV-KEFKTEVNVIGQTHHKNLVRLLGFC 581
GAFG+VY+G I M S VAVK+L++ + + V KEFK E+N IG THHKNLVRLLGFC
Sbjct: 533 GAFGIVYEGVINMCS--DTRVAVKRLNTFLMEDVHKEFKNELNAIGLTHHKNLVRLLGFC 590
Query: 582 DDGLNRLLVYEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCD 640
+ RLLVYE++SNGTLAS LF + KP W R IA GIARGLLYLHEECSTQIIHCD
Sbjct: 591 ETEEKRLLVYEYMSNGTLASLLFNIVEKPSWKLRLQIAIGIARGLLYLHEECSTQIIHCD 650
Query: 641 IKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVY 700
IKPQNILLDDYYNARISDFGLAKLL ++QS+T+TAIRGTKGYVA EWF+NMPIT KVDVY
Sbjct: 651 IKPQNILLDDYYNARISDFGLAKLLNMNQSRTNTAIRGTKGYVALEWFKNMPITAKVDVY 710
Query: 701 SFGVLLLEIICCRRNVDMEV-NEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLAR 759
S+GVLLLEI+ CR++V+ E +E +A+L +WAYDCY EG ALVE D EAL+D K +
Sbjct: 711 SYGVLLLEIVSCRKSVEFEAEDEEKAILAEWAYDCYIEGTLHALVEGDKEALDDMKTFEK 770
Query: 760 FVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPCPFTV 802
VM+A+WC+QEDPSLRPTMR VTQMLEGVVEV PPCP F+V
Sbjct: 771 LVMIALWCVQEDPSLRPTMRNVTQMLEGVVEVKMPPCPSQFSV 813
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2331), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/767 (59%), Positives = 559/767 (72%), Gaps = 25/767 (3%)
Query: 12 LLLLLQPFLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWY 71
L ++L + AQT G++ GAS++A+ +S SW S +G+FAFGF L+ NKD FLLSIWY
Sbjct: 43 LTMVLLQLMAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQLE-NKDYFLLSIWY 101
Query: 72 AKIPQKTIVWFANGDSP-----AASGTKVELTADQGLVLTSPQGRELWKSD-PIIGTVAY 125
KIP+KT+VW+A G+ P G+K+ELT D+GL+L PQG ++W S P V+
Sbjct: 102 EKIPEKTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGIPPGAAVSS 161
Query: 126 GLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFEL 185
G+MNDTGNFVL + N+ +LWESFNNPTDT+LP+QI + G +SS++++ NFS GRF+ L
Sbjct: 162 GVMNDTGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRL 221
Query: 186 NSNGNLVLTTVNLPSDYTNEPYYESKTNGSSN------QLVFNQSGYMYILQEYDQRFAL 239
NGNLVL +NLP+ + + YY S+T+ +SN +L+FN+SGYMYIL+ L
Sbjct: 222 LDNGNLVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDL 281
Query: 240 TRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVSTGSGT 299
T+ + +FY+RAT+NFDGVFTQY +PK S+GN W++ WS PDDIC GSG
Sbjct: 282 TKTALPTI-DFYHRATLNFDGVFTQYFYPKASSGNRSWSSVWSKPDDICVNMGADLGSGA 340
Query: 300 CGFNSVCRLN-NRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDLYDFEV 358
CG+NS+C L ++RP C+CP+G++L+D ND+YGSC P++ SC DD S ED YDF
Sbjct: 341 CGYNSICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDG-LNSTEDQYDFVE 399
Query: 359 ITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKLPLSNGRFDANLN 418
+ N DWPTSDY+ P E+ CR+SCL+DC+C+VAIFR G CWKKKLPLSNGRFD +N
Sbjct: 400 LINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRDG--CWKKKLPLSNGRFDIGMN 457
Query: 419 GKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVGALCLC 478
GKA +K KG +P D P P + +KK I GSV+LG SVF N +LVGA CL
Sbjct: 458 GKAFLKFPKGYVPL---DRPPPQLPGEKKKPDIKFIT-GSVVLGTSVFVNFVLVGAFCLT 513
Query: 479 FFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASM 538
F+Y KK +V +ETNL FTYK+L ATN FK+E+G+G FGVVYKG I S
Sbjct: 514 SSFIYRKKTEKVKEGGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAGST 573
Query: 539 YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGT 598
VAVKKL V+QDG KEFKTEV VIGQTHHKNLVRLLGFCD+G NRLLVYEFLSNGT
Sbjct: 574 R--VVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGT 631
Query: 599 LASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658
LA+FLFG KP W +RT IAFGIARGLLYLHEEC TQIIHCDIKPQNILLD+YYNARISD
Sbjct: 632 LANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISD 691
Query: 659 FGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM 718
FGLAKLL++DQS+T TAIRGTKGYVAPEWFRN PITVKVDVYSFGV+LLEIICCRRNVD+
Sbjct: 692 FGLAKLLVMDQSKTQTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDL 751
Query: 719 EVNEAE-ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVA 764
E+ E E +LTDWAYDCY +G + L+ D EA ND L R + A
Sbjct: 752 EIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKPA 798
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/803 (56%), Positives = 582/803 (72%), Gaps = 30/803 (3%)
Query: 1 MAFPLLHSLSVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDS 60
MA PL L ++LL P L AQ I +G L+A+ + SWLSP+GDFAFGF L+
Sbjct: 1 MASPLSRPLLLILLCCLPCLLLAQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLE- 59
Query: 61 NKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPII 120
NK+L+LL+I Y KI KTIVW+ANGD PA +G+KVELTAD+GLVLTSPQG+E+WKS I
Sbjct: 60 NKNLYLLAICYNKISDKTIVWYANGDDPAPTGSKVELTADRGLVLTSPQGKEIWKSGINI 119
Query: 121 GTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNG-QFLSSKQSDGNFSKG 179
G A G+MNDTGNF +++ KLW++F++P DT+LP Q + G + LSS+ + NFS+G
Sbjct: 120 GDAARGMMNDTGNFRIVNTGGEKLWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRG 179
Query: 180 RFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT-----NGSSNQLVFNQSGYMYILQEYD 234
RF+F L +GN VL NL + + YY + T + + ++VFN+SGY+Y L+ +
Sbjct: 180 RFQFRLIPDGNGVLNANNLRTGDAYDAYYWTNTVDANLSNAGLRIVFNESGYLYTLRASN 239
Query: 235 QRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVS 294
+R +T + +Y+R T+NFDGV TQY HPKNST N W+ +S P++IC
Sbjct: 240 KRELITPERVVPTTEYYHRVTLNFDGVLTQYSHPKNSTDNGNWSIIFSAPENICFL-ITD 298
Query: 295 TGSGTCGFNSVCRLN-NRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDL 353
G+G CGFNSVC+LN ++R IC CP ++ +DP D Y CKP+++ +D SPED
Sbjct: 299 IGTGPCGFNSVCQLNADQRAICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPED- 357
Query: 354 YDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKLPLSNGRF 413
YDF +TNTDWPTSDY+ + E C+++C+ DC C V +FR CWKKKLPLSNGR
Sbjct: 358 YDFLELTNTDWPTSDYERYDSYNIEECQKACIQDCFCNVVVFRGS--CWKKKLPLSNGRQ 415
Query: 414 DANLNGKALIKIRKGN-----LPPTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFN 468
+NG+A IK+RK + LPP P PN K +DQ++L+++ SVLLG SVF N
Sbjct: 416 SEKVNGRAFIKVRKDDYMGRGLPPR----PFPNAK----EDQDSLVLVISVLLGSSVFIN 467
Query: 469 CLLVGALCLCFFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVV 528
+L+G + CF F Y+KK++ +P + ++NL CF+YK+L AT GFKEELG+G+FG+V
Sbjct: 468 FILIGLVTFCFLFFYHKKSTGIPQGE---KSNLRCFSYKELVEATKGFKEELGRGSFGIV 524
Query: 529 YKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588
YKG I M + VPVAVKKL V++ G KE+K EV IGQTHHKNLV+LLGFCD+G +L
Sbjct: 525 YKGLIEMGTT--VPVAVKKLDRVVEYGEKEYKAEVKAIGQTHHKNLVQLLGFCDEGQQKL 582
Query: 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648
LVYE LSNGTLA+FLFGD K W +RT IAFGIARGL+YLHEEC+TQIIHCDIKPQNIL+
Sbjct: 583 LVYELLSNGTLANFLFGDTKLSWKQRTQIAFGIARGLVYLHEECNTQIIHCDIKPQNILV 642
Query: 649 DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLE 708
D+YY+A+ISDFGLAKLLLLDQSQT T IRGTKGYVAPEWFRN+PITVKVD YSFGVLLLE
Sbjct: 643 DEYYDAKISDFGLAKLLLLDQSQTFTTIRGTKGYVAPEWFRNVPITVKVDAYSFGVLLLE 702
Query: 709 IICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCI 768
IIC RR+VD E++ A+LTDWAYDCY EG + LVE D EAL+D KK+ RF+MVAIWCI
Sbjct: 703 IICSRRSVDTEISGERAILTDWAYDCYMEGRIDDLVENDEEALSDLKKVERFLMVAIWCI 762
Query: 769 QEDPSLRPTMRKVTQMLEGVVEV 791
QEDP+LRPTM+ V MLEG+++V
Sbjct: 763 QEDPTLRPTMKTVILMLEGIIQV 785
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2304), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/811 (55%), Positives = 575/811 (70%), Gaps = 43/811 (5%)
Query: 1 MAFPLLHSLSVLLLLLQPFLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDS 60
MAF L L LL P AQ G T+G SL+A ++ WLSP DFAFGF LD
Sbjct: 1 MAFDLPCILYFFFLLF-PSSLVAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDK 59
Query: 61 NKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPII 120
KDL+LL+IWY KIP KTIVW+ANGD PA + V+LTA+ G+VL +PQG E+WKS P
Sbjct: 60 -KDLYLLAIWYNKIPDKTIVWYANGDRPAPKKSTVKLTAELGVVLNNPQGGEIWKSGPGN 118
Query: 121 GTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGR 180
G AYG MNDTGNF++ + N KLW+SF TDT+LP+QI + G LSS+ S+ NFS+GR
Sbjct: 119 GEAAYGFMNDTGNFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGR 178
Query: 181 FRFELNSNGNLVLTTVNLPSDYTNEPYYESKT--NGSSN---QLVFNQSGYMYILQEYDQ 235
F+F L +GN VL T+NLP+ + E Y+ SKT + SSN Q+VFN+SGY+Y+L+ +
Sbjct: 179 FQFRLIPDGNAVLNTINLPTGFPYEAYFWSKTVDSNSSNAGYQVVFNESGYLYVLRANNT 238
Query: 236 RFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVST 295
R ALT A+ Y+RAT++FDGVF Y HPKNS GNE W+ ++P++IC
Sbjct: 239 REALTLGRVVPATENYHRATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVRGLK 298
Query: 296 GSGTCGFNSVCRLN-NRRPICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDLY 354
GSG CG+N VC ++ ++R IC CP+ ++L+DP+D YG CKP++ ++ P +PED Y
Sbjct: 299 GSGPCGYNGVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPED-Y 357
Query: 355 DFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMCWKKKLPLSNGRFD 414
+ +TN DWP SDY++ TP+ E C+++CL D C V +F G CWKK+LPLSNGR
Sbjct: 358 ELVPLTNIDWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEG-TCWKKRLPLSNGRQG 416
Query: 415 ANLNGKALIKIRKGNLP-PTSPDFPRPNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVG 473
++NG + +K+RKGN P P P+ N +++ SVLLGGSVFFN +LVG
Sbjct: 417 ESVNGASFMKVRKGNYTLPGPPPIPKKN------------LLVVSVLLGGSVFFNFVLVG 464
Query: 474 ALCLCFFFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAI 533
+ FFF+Y+ K ++ P + V++NL CF+YK+L ATNGFKEELG+GAFG+VYKG
Sbjct: 465 VVSFAFFFIYHNKFTRTPQVERAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLT 524
Query: 534 GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593
+ S VPVA+KK+ +++ KEFKTEV+VIG FCD+G +R+LVYEF
Sbjct: 525 QIGS--GVPVAIKKVDRFVKESDKEFKTEVDVIG------------FCDEGQHRMLVYEF 570
Query: 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653
LSNG LASFLFGD+K W++RT IAFGIARGLLYLH+ECSTQIIHCDIKPQNILLD++Y+
Sbjct: 571 LSNGALASFLFGDVKLSWNQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYD 630
Query: 654 ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
ARI+DFGLAKL Q +GTKGYVAPEWFRNM ITVKVDVY+FGVLLLEIICCR
Sbjct: 631 ARIADFGLAKLFRNPQH------KGTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCR 684
Query: 714 RNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPS 773
R+VD EV E A+LTDWAYDCY EG+ ALVE D EALND KKL RFVMVAIWCIQEDP+
Sbjct: 685 RSVDTEVGEERAILTDWAYDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPN 744
Query: 774 LRPTMRKVTQMLEGVVEVLDPPCPCPFTVAN 804
LRPTM+ V MLEG+++V PPCP PF++A+
Sbjct: 745 LRPTMKMVMLMLEGIIQVPVPPCPSPFSIAS 775
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2287), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/785 (56%), Positives = 565/785 (71%), Gaps = 42/785 (5%)
Query: 27 GKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGD 86
G T+G SL+A ++ WLSP DFAFGF LD KDL+LL+IWY KIP KTIVW+ANGD
Sbjct: 3 GNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDK-KDLYLLAIWYNKIPDKTIVWYANGD 61
Query: 87 SPAASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLLSDNTNKLWE 146
PA + V+LTA+ G+VL +PQG E+WKS P G AYG MNDTGNF++ + N KLW+
Sbjct: 62 RPAPKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANANGEKLWQ 121
Query: 147 SFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEP 206
SF TDT+LP+QI + G LSS+ S+ NFS+GRF+F L +GN VL T+NLP+ + E
Sbjct: 122 SFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLPTGFPYEA 181
Query: 207 YYESKT--NGSSN---QLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGV 261
Y+ SKT + SSN Q+VFN+SGY+Y+L+ + R ALT A+ Y+RAT++FDGV
Sbjct: 182 YFWSKTVDSNSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHRATLHFDGV 241
Query: 262 FTQYQHPKNSTGNEGWTAFWSLPDDICKASFVSTGSGTCGFNSVCRLN-NRRPICECPRG 320
F Y HPKNS GNE W+ ++P++IC GSG CG+N VC ++ ++R IC CP+
Sbjct: 242 FVLYSHPKNSPGNENWSVVRTMPENICTVVRGLKGSGPCGYNGVCTISTDKRAICRCPQR 301
Query: 321 YTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDLYDFEVITNTDWPTSDYQLLTPFTEEGC 380
++L+DP+D YG CKP++ ++ P +PED Y+ +TN DWP SDY++ TP+ E C
Sbjct: 302 FSLLDPDDPYGGCKPDFPTQVCAEEVPNAPED-YELVPLTNIDWPESDYEMYTPYNIEDC 360
Query: 381 RQSCLHDCMCAVAIFRSGDMCWKKKLPLSNGRFDANLNGKALIKIRKGNLP-PTSPDFPR 439
+++CL D C V +F G CWKK+LPLSNGR ++NG + +K+RKGN P P P+
Sbjct: 361 KKACLQDFFCNVIVFGEG-TCWKKRLPLSNGRQGESVNGASFMKVRKGNYTLPGPPPIPK 419
Query: 440 PNVKNNQKKDQENLIILGSVLLGGSVFFNCLLVGALCLCFFFVYNKKNSQVPSHDGVVET 499
N +++ SVLLGGSVFFN +LVG + FFF+Y+ K ++ P + V++
Sbjct: 420 KN------------LLVVSVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVERAVQS 467
Query: 500 NLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEF 559
NL CF+YK+L ATNGFKEELG+GAFG+VYKG + S VPVA+KK+ +++ KEF
Sbjct: 468 NLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQIGS--GVPVAIKKVDRFVKESDKEF 525
Query: 560 KTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF 619
KTEV+VIG FCD+G +R+LVYEFLSNG LASFLFGD+K W++RT IAF
Sbjct: 526 KTEVDVIG------------FCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQRTQIAF 573
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
GIARGLLYLH+ECSTQIIHCDIKPQNILLD++Y+ARI+DFGLAKL Q +GT
Sbjct: 574 GIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLFRNPQH------KGT 627
Query: 680 KGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
KGYVAPEWFRNM ITVKVDVY+FGVLLLEIICCRR+VD EV E A+LTDWAYDCY EG+
Sbjct: 628 KGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWAYDCYQEGM 687
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPCP 799
ALVE D EALND KKL RFVMVAIWCIQEDP+LRPTM+ V MLEG+++V PPCP P
Sbjct: 688 MHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPVPPCPSP 747
Query: 800 FTVAN 804
F++A+
Sbjct: 748 FSIAS 752
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 804 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.356 | 0.349 | 0.484 | 3e-91 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.735 | 0.712 | 0.350 | 2.7e-84 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.370 | 0.351 | 0.414 | 6.4e-78 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.572 | 0.555 | 0.370 | 3.7e-71 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.390 | 0.401 | 0.381 | 7.5e-69 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.383 | 0.365 | 0.379 | 8.5e-69 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.364 | 0.363 | 0.384 | 9.1e-69 | |
| TAIR|locus:2137010 | 849 | AT4G11900 [Arabidopsis thalian | 0.769 | 0.729 | 0.296 | 4.7e-68 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.365 | 0.361 | 0.378 | 6.5e-68 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.402 | 0.394 | 0.362 | 5.4e-66 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 3.0e-91, Sum P(2) = 3.0e-91
Identities = 144/297 (48%), Positives = 198/297 (66%)
Query: 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEV 563
F YKDL++ATN F +LG+G FG VY+G + S +AVKKL + Q G KEF+ EV
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSR----LAVKKLEGIGQ-GKKEFRAEV 537
Query: 564 NVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAF 619
++IG HH +LVRL GFC +G +RLL YEFLS G+L ++F GD+ W R +IA
Sbjct: 538 SIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIAL 597
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
G A+GL YLHE+C +I+HCDIKP+NILLDD +NA++SDFGLAKL+ +QS T +RGT
Sbjct: 598 GTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGT 657
Query: 680 KGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
+GY+APEW N I+ K DVYS+G++LLE+I R+N D + +A+ EG
Sbjct: 658 RGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGK 717
Query: 740 TEALVEFDIEALN-DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795
+V+ ++ ++ +++ R + A+WCIQED RP+M KV QMLEGV V+ PP
Sbjct: 718 LMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
Identities = 223/636 (35%), Positives = 322/636 (50%)
Query: 179 GRFRFELNSNGNLVLTTVNLPSDYTNEPYYES-KTNGSSNQLVFNQSGYMYILQEYDQRF 237
G + F+L +GNL L N + Y N S +N SS +L +G + I +
Sbjct: 161 GLYSFQLERSGNLTLRW-NTSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGG 219
Query: 238 A-LTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVSTG 296
A + + SN + ++ DG Y ++G A WS D C
Sbjct: 220 AEIVYSGDYGDSNTFRFLKLDDDGNLRIYSSASRNSGPVN--AHWSAVDQ-CLVY----- 271
Query: 297 SGTCGFNSVCRLNNRRPICECP-RGYTLIDPNDQYGSCKPNYTQSCVDDDEPGSPEDLYD 355
G CG +C N+ PIC CP R + +D ND+ CK S D + DL
Sbjct: 272 -GYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRRKGCKRKVELS--DCSGNTTMLDLVH 328
Query: 356 FEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDM--CWKKKLPLS--NG 411
+ T D P S+ CR +CL +C ++ S CW+K P S G
Sbjct: 329 TRLFTYEDDPNSESFFAG---SSPCRANCLSSVLCLASVSMSDGSGNCWQKH-PGSFFTG 384
Query: 412 RFDANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENXXXXXXXXXXXXXXXNCLL 471
++ + +K+ G P + R K + + + +
Sbjct: 385 YQWPSVPSTSYVKVC-G--PVVANTLERAT-KGDDNNSKVHLWIVAVAVIAGLLGLVAVE 440
Query: 472 VGAL-CLCFFFVYNKKNSQVPSHDGVVETNLHC---FTYKDLEAATNGFKEELGKGAFGV 527
+G C C N + + SH ++E FTYK+L+ T FKE+LG G FG
Sbjct: 441 IGLWWCCCR---KNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGT 497
Query: 528 VYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587
VY+G + ++ VAVK+L I+ G K+F+ EV I THH NLVRL+GFC G +R
Sbjct: 498 VYRGVLTNRTV----VAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHR 552
Query: 588 LLVYEFLSNGTLASFLFG-DLKP--GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQ 644
LLVYEF+ NG+L +FLF D W R +IA G A+G+ YLHEEC I+HCDIKP+
Sbjct: 553 LLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPE 612
Query: 645 NILLDDYYNARISDFGLAKLLL-LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFG 703
NIL+DD + A++SDFGLAKLL D +++RGT+GY+APEW N+PIT K DVYS+G
Sbjct: 613 NILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYG 672
Query: 704 VLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI--EALNDKKKLARFV 761
++LLE++ +RN D+ + WAY+ + +G T+A+++ + + D +++ R V
Sbjct: 673 MVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMV 732
Query: 762 MVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797
+ WCIQE P RPTM KV QMLEG+ E+ +P CP
Sbjct: 733 KTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 6.4e-78, Sum P(2) = 6.4e-78
Identities = 128/309 (41%), Positives = 180/309 (58%)
Query: 499 TNLHCFTYKDLEAATNGF-KE-ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV 556
+ L F+ + ATN F KE ELG+G FG VYKG + +AVK+L GV
Sbjct: 512 SELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGR----EIAVKRLSGKSGQGV 567
Query: 557 KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG---WSR 613
EFK E+ +I + H+NLVRLLG C +G ++LVYE++ N +L FLF + K W
Sbjct: 568 DEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKL 627
Query: 614 RTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
R I GIARGLLYLH + +IIH D+K N+LLD N +ISDFG+A++ +Q++ +
Sbjct: 628 RFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEAN 687
Query: 674 TA-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY 732
T + GT GY++PE+ +VK DVYSFGVLLLEI+ +RN + +E +L+ +A+
Sbjct: 688 TVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLI-GYAW 746
Query: 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792
Y G +E LV+ I K++ R + VA+ C+Q+ + RP M V MLE L
Sbjct: 747 YLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATL 806
Query: 793 DPPCPCPFT 801
P FT
Sbjct: 807 AAPRQPTFT 815
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 3.7e-71, P = 3.7e-71
Identities = 184/496 (37%), Positives = 259/496 (52%)
Query: 313 PICECPRGYTLIDPNDQYGSCKPNYTQSCVDDDE-PGSPEDLYDFEVITNTDWPTSDYQL 371
P C CP+G+ + D K +Y+ CV E S D+ F + N + ++
Sbjct: 308 PFCRCPQGFRPMSQKDW--DLK-DYSAGCVRKTELQCSRGDINQFFRLPNMKLADNS-EV 363
Query: 372 LTPFTEEGCRQSCLHDCMCAVAIFRSGDM-C--WKKKLPLSNGRFDANLNGKALIKIRKG 428
LT + C +C DC C + G C W K + D N G + +R
Sbjct: 364 LTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGN-IFYLRLA 422
Query: 429 NLPPTSPDFPRPNVKNNQKKDQENXXXXXXXXXXXXXXXNCLLVGALCLCFFFVYNKKNS 488
+ D P NV + K + + LLV L L + +K
Sbjct: 423 -----ASDVP--NVGASGKSNNKGLIFGAVLGSLGVIVL-VLLVVILILRY---RRRKRM 471
Query: 489 QVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL 548
+ DG L F+Y++L+ AT F ++LG G FG V+KGA+ +S +AVK+L
Sbjct: 472 RGEKGDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSS----DIAVKRL 523
Query: 549 HSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD-- 606
+ Q G K+F+TEV IG H NLVRL GFC +G +LLVY+++ NG+L S LF +
Sbjct: 524 EGISQ-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQV 582
Query: 607 ---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
+ GW R IA G ARGL YLH+EC IIHCDIKP+NILLD + +++DFGLAK
Sbjct: 583 EEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAK 642
Query: 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA 723
L+ D S+ T +RGT+GY+APEW + IT K DVYS+G++L E++ RRN + NE
Sbjct: 643 LVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEK 702
Query: 724 EALLTDWAYDCYC-EGITEALVEFDIEA-LNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
WA +G +LV+ +E D +++ R VA WCIQ++ S RP M +V
Sbjct: 703 VRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQV 762
Query: 782 TQMLEGVVEVLDPPCP 797
Q+LEGV+EV PP P
Sbjct: 763 VQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 532 (192.3 bits), Expect = 7.5e-69, Sum P(2) = 7.5e-69
Identities = 126/330 (38%), Positives = 193/330 (58%)
Query: 485 KKNSQVPSHDGVVETNLHCFTYKDLEA---ATNGFK--EELGKGAFGVVYKGAIGMASMY 539
+++S+V S E +L + DL+ AT+GF +LG+G FG VYKG +
Sbjct: 433 RESSRVSSRKQE-EEDLE-LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQ-- 488
Query: 540 QVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTL 599
VAVK+L + GV+EFK E+ +I + H+NLV++LG+C D R+L+YE+ N +L
Sbjct: 489 --EVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSL 546
Query: 600 ASFLFGDLKP---GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656
SF+F + W +R +I GIARG+LYLHE+ +IIH D+K N+LLD NA+I
Sbjct: 547 DSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKI 606
Query: 657 SDFGLAKLLLLDQSQTHTA-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRN 715
SDFGLA+ L D+++ +T + GT GY++PE+ + ++K DV+SFGVL+LEI+ RRN
Sbjct: 607 SDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRN 666
Query: 716 VDMEVNEAEALLTDWAYDCYCEGITEALVEFDI-EALNDKKKLARFVMVAIWCIQEDPSL 774
E + L A+ + E +++ + E+ D ++ R + + + C+Q+DP
Sbjct: 667 RGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKD 726
Query: 775 RPTMRKVTQMLEGVVEVLDPPCPCPFTVAN 804
RP M V ML + +LDP P F N
Sbjct: 727 RPNMSVVVLMLSSEMLLLDPRQPGFFNERN 756
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 8.5e-69, Sum P(2) = 8.5e-69
Identities = 121/319 (37%), Positives = 181/319 (56%)
Query: 483 YNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEE--LGKGAFGVVYKGAIGMASMYQ 540
Y+ +V D V +L F++ + +AT F EE LG+G FG VYKG
Sbjct: 492 YSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGR--- 548
Query: 541 VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLA 600
+AVK+L + G++EFK E+ +I + H+NLVRLLG C + ++L+YE++ N +L
Sbjct: 549 -EIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLD 607
Query: 601 SFLFGDLKPG---WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARIS 657
FLF + K G W +R ++ GIARGLLYLH + +IIH D+K NILLD N +IS
Sbjct: 608 RFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKIS 667
Query: 658 DFGLAKLLLLDQSQTHTA-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV 716
DFG+A++ Q +T + GT GY+APE+ + K DVYSFGVL+LEI+ R+NV
Sbjct: 668 DFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNV 727
Query: 717 DMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRP 776
+ +L+ +A+ + +G T+ +++ ++ D + R + V + C Q+ RP
Sbjct: 728 SFRGTDHGSLI-GYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRP 786
Query: 777 TMRKVTQMLEGVVEVLDPP 795
M V MLE L PP
Sbjct: 787 NMGSVLLMLESQTSQLPPP 805
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 491 (177.9 bits), Expect = 9.1e-69, Sum P(2) = 9.1e-69
Identities = 118/307 (38%), Positives = 176/307 (57%)
Query: 499 TNLHCFTYKDLEAATNGFK--EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV 556
+ ++ F + ATN F +LG+G FG VYKG + + VK+L S G
Sbjct: 471 SGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGK----EIGVKRLASSSGQGT 526
Query: 557 KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD-LK--PGWSR 613
+EF E+ +I + H+NLVRLLG+C DG +LL+YEF+ N +L F+F LK W +
Sbjct: 527 EEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPK 586
Query: 614 RTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
R +I GIARGLLYLH + ++IH D+K NILLDD N +ISDFGLA++ Q Q +
Sbjct: 587 RFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDN 646
Query: 674 TA-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEV--NEAEALLTDW 730
T + GT GY++PE+ + K D+YSFGVL+LEII +R + + +E++ LL +
Sbjct: 647 TRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKR-ISRFIYGDESKGLLA-Y 704
Query: 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
+D +CE L++ D+ ++AR V + + C+Q + RP +V ML +
Sbjct: 705 TWDSWCETGGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATD 764
Query: 791 VLDPPCP 797
+ P P
Sbjct: 765 LPVPKQP 771
|
|
| TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 4.7e-68, Sum P(2) = 4.7e-68
Identities = 203/685 (29%), Positives = 307/685 (44%)
Query: 130 DTGNFVLLSDNTNK----LWESFNNPTDTMLPS-QIFDNGQFLSSKQSDGNFSKGRFRFE 184
D+GN VL D N LW+SF++P+DT LP +I Q +S +S + S GR+ E
Sbjct: 161 DSGNLVL-RDGPNSSAAVLWQSFDHPSDTWLPGGKIRLGSQLFTSWESLIDPSPGRYSLE 219
Query: 185 LNSNGNLVLTTVNLPSDYTNEPYYESKTNGSSNQLVFNQSGYMYILQEYDQRFALTRRVE 244
+ + ++T N Y + + + L D+ + +T V+
Sbjct: 220 FDPKLHSLVTVWNRSKSYWSSGPLYDWLQSFKGFPELQGTKLSFTLN-MDESY-ITFSVD 277
Query: 245 TSASNFYYRATINFDGVFT-QYQHPKNSTGNEGWTAFWSLPDDICKASFVSTGSGTCGFN 303
+ YR + G F Q H + W S PD+ C +CG
Sbjct: 278 PQSR---YRLVMGVSGQFMLQVWH----VDLQSWRVILSQPDNRCDVY------NSCGSF 324
Query: 304 SVCRLNNRRPICECPRGYTLI------DPNDQYGSCKPNYTQSCVDDDEPGSPEDLYDFE 357
+C N P C C G+ D ND G CK C ++ P + + +
Sbjct: 325 GICNENREPPPCRCVPGFKREFSQGSDDSNDYSGGCKRETYLHCYKRNDEFLP--IENMK 382
Query: 358 VITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDMC--WKKKLPLSNGRFDA 415
+ T+ PT+ +LT T C C+ DC C A G+ C W K + + DA
Sbjct: 383 LATD---PTTA-SVLTSGTFRTCASRCVADCSCQ-AYANDGNKCLVWTKDA-FNLQQLDA 436
Query: 416 NLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQENXXXXXXXXXXXXXXXNCLLVGAL 475
N +++ N+ + N K K + C VG
Sbjct: 437 NKGHTFFLRLASSNISTAN------NRKTEHSKGKSIVLPLVLASLVATAA--CF-VGLY 487
Query: 476 CLCFFFVYNKKNSQVPSHD------GVVET---NLHCFTYKDLEAATNGF--KEELGKGA 524
C + KK + H G+++ N+ D+ ATN F K++LG+G
Sbjct: 488 CCISSRIRRKKKQRDEKHSRELLEGGLIDDAGENMCYLNLHDIMVATNSFSRKKKLGEGG 547
Query: 525 FGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG 584
FG VYKG + + VA+K+L G+ EFK EV +I + HKNLVRLLG+C +G
Sbjct: 548 FGPVYKGKLPNG----MEVAIKRLSKKSSQGLTEFKNEVVLIIKLQHKNLVRLLGYCVEG 603
Query: 585 LNRLLVYEFLSNGTLASFLFGDLKP---GWSRRTDIAFGIARGLLYLHEECSTQIIHCDI 641
+LL+YE++SN +L LF LK W R I G RGL YLHE +IIH D+
Sbjct: 604 DEKLLIYEYMSNKSLDGLLFDSLKSRELDWETRMKIVNGTTRGLQYLHEYSRLRIIHRDL 663
Query: 642 KPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA-IRGTKGYVAPEWFRNMPITVKVDVY 700
K NILLDD N +ISDFG A++ Q T I GT GY++PE+ I+ K D+Y
Sbjct: 664 KASNILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGYMSPEYALGGVISEKSDIY 723
Query: 701 SFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARF 760
SFGVLLLEII ++ N+ + L + ++ +CE ++++ + ++ R
Sbjct: 724 SFGVLLLEIISGKKATRFVHNDQKHSLIAYEWESWCETKGVSIIDEPMCCSYSLEEAMRC 783
Query: 761 VMVAIWCIQEDPSLRPTMRKVTQML 785
+ +A+ C+Q+ P RP + ++ ML
Sbjct: 784 IHIALLCVQDHPKDRPMISQIVYML 808
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 6.5e-68, Sum P(2) = 6.5e-68
Identities = 115/304 (37%), Positives = 178/304 (58%)
Query: 500 NLHCFTYKDLEAATNGFKEE--LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK 557
+++ F + + TN F E LG+G FG VYKG + +A+K+L S G++
Sbjct: 485 DVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGK----EIAIKRLSSTSGQGLE 540
Query: 558 EFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP---GWSRR 614
EF E+ +I + H+NLVRLLG C +G +LL+YEF++N +L +F+F K W +R
Sbjct: 541 EFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKR 600
Query: 615 TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674
+I GIA GLLYLH + +++H D+K NILLD+ N +ISDFGLA++ Q Q +T
Sbjct: 601 FEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANT 660
Query: 675 A-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD 733
+ GT GY++PE+ + K D+Y+FGVLLLEII +R + E L ++A+D
Sbjct: 661 RRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWD 720
Query: 734 CYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793
+CE L++ DI + + ++AR V + + CIQ+ RP + +V ML +++
Sbjct: 721 SWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPK 780
Query: 794 PPCP 797
P P
Sbjct: 781 PKQP 784
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 5.4e-66, Sum P(2) = 5.4e-66
Identities = 127/350 (36%), Positives = 188/350 (53%)
Query: 469 CL-LVGALCLCFFFVYNKKNSQVPSHDGVVE-----------TNLHCFTYKDLEAATNGF 516
CL LV C C+ + + S + S D V + L+ F DL+ ATN F
Sbjct: 439 CLILVLVACGCWRYRVKQNGSSLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTATNNF 498
Query: 517 K--EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+LG+G FG VYKG + +AVK+L S G +EF E+ +I + H+NL
Sbjct: 499 SVLNKLGQGGFGTVYKGKLQDGK----EIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNL 554
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP----GWSRRTDIAFGIARGLLYLHE 630
+RLLG C DG +LLVYE++ N +L F+F DLK W+ R +I GIARGLLYLH
Sbjct: 555 LRLLGCCIDGEEKLLVYEYMVNKSLDIFIF-DLKKKLEIDWATRFNIIQGIARGLLYLHR 613
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-AIRGTKGYVAPEWFR 689
+ +++H D+K NILLD+ N +ISDFGLA+L +Q Q T ++ GT GY++PE+
Sbjct: 614 DSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAW 673
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749
+ K D+YSFGVL+LEII + + L +A+D + E L++ D++
Sbjct: 674 TGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLD 733
Query: 750 ALNDKKKL--ARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797
+ + R V + + C+Q RP +++V ML ++ P P
Sbjct: 734 DSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTTDLPKPTQP 783
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4709 | 0.9589 | 0.9266 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_1505000001 | hypothetical protein (801 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 804 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-22 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 9e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-18 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 6e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-06 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-47
Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LG+G FG VY VA+K + ++E E+ ++ + +H N+V+L
Sbjct: 1 LGEGGFGTVYLA---RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECSTQII 637
G +D + LV E+ G+L L + I I GL YLH II
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 638 HCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-WFRNMPITV 695
H D+KP+NILLD D +++DFGL+KLL D+S T I GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 696 KVDVYSFGVLLLEI 709
K D++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 8e-46
Identities = 73/272 (26%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNL 574
E+LG+G+FG VY A + VA+K + I+ + E+ ++ + H N+
Sbjct: 3 ILEKLGEGSFGKVYL-ARDKKT--GKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
VRL +D LV E+ G L L G L +R I L YLH +
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSK- 116
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
I+H D+KP+NILLD+ + +++DFGLA+ LD + T GT Y+APE
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLAR--QLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
VD++S GV+L E++ + + E + I + F +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELF----------KKIGKPKPPFPPPEWD 222
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784
+ + + +DP R T + Q
Sbjct: 223 ISPEAKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 6e-45
Identities = 87/279 (31%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKL-HSVIQDGVKEFKTEVNVIGQTHHKN 573
++LG+GAFG VYKG G + VAVK L ++ +EF E +++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
+VRLLG C G +V E++ G L FL K +A IA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG---YVAPEWFR 689
S +H D+ +N L+ + +ISDFGL++ + D + G K ++APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED--DYYRKRGGGKLPIKWMAPESLK 177
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYC-EGITEALVEF 746
+ T K DV+SFGVLL EI M E LL D Y E + L E
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED-GYRLPRPENCPDELYE- 235
Query: 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785
+M+ C DP RPT ++ + L
Sbjct: 236 --------------LMLQ--CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 88/288 (30%), Positives = 129/288 (44%), Gaps = 51/288 (17%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKL-HSVIQDGVKEFKTEVNVIGQTHHKN 573
++LG+GAFG VYKG G +V VAVK L + ++EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP--GWSRRTDIAFGIARGLLYLHEE 631
+V+LLG C + +V E++ G L S+L +P S A IARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWF 688
IH D+ +N L+ + +ISDFGL++ L D RG K + APE
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESL 175
Query: 689 RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE----GITEALV 744
+ T K DV+SFGVLL EI T E G++ V
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEI-----------------FT------LGEQPYPGMSNEEV 212
Query: 745 EFDIEALNDKKKL-------ARFVMVAIWCIQEDPSLRPTMRKVTQML 785
+E L + +L + + C EDP RPT ++ ++L
Sbjct: 213 ---LEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 6e-44
Identities = 86/273 (31%), Positives = 120/273 (43%), Gaps = 32/273 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL--HSVIQDGVKEFKTEVNVIGQTHHKN 573
+LG G+FG VYK VAVK L S + + E+ ++ + H N
Sbjct: 3 LLRKLGSGSFGTVYKA---KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+VRL+ +D + LV E+ G L +L IA I RGL YLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN-- 117
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW-FRNMP 692
IIH D+KP+NILLD+ +I+DFGLAK LL S T GT Y+APE
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNG 175
Query: 693 ITVKVDVYSFGVLLLEIICCR------RNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
KVDV+S GV+L E++ + +D I +EF
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ-------------LIRR-ILGPPLEF 221
Query: 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMR 779
D + + A+ ++ C+ +DPS RPT
Sbjct: 222 DEPKWSSGSEEAKDLIK--KCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 87/289 (30%), Positives = 130/289 (44%), Gaps = 52/289 (17%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKL-HSVIQDGVKEFKTEVNVIGQTHHKN 573
++LG+GAFG VYKG G +V VAVK L + ++EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP---GWSRRTDIAFGIARGLLYLHE 630
+V+LLG C + ++V E++ G L +L +P S A IARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEW 687
+ IH D+ +N L+ + +ISDFGL++ L D +G K + APE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV---KGGKLPIRWMAPES 175
Query: 688 FRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE----GITEAL 743
+ T K DV+SFGVLL EI T E G++ A
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEI-----------------FT------LGEEPYPGMSNAE 212
Query: 744 VEFDIEALNDKKKLAR-------FVMVAIWCIQEDPSLRPTMRKVTQML 785
V +E L +L + + + C EDP RPT ++ ++L
Sbjct: 213 V---LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 83/295 (28%), Positives = 123/295 (41%), Gaps = 59/295 (20%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNLVR 576
++LG+GAFG VYKG + VAVK L + K+F E V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL------FGDLKPG---WSRRTDIAFGIARGLLY 627
LLG C + LV E++ G L +L F + A IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---- 683
L S + +H D+ +N L+ + +ISDFGL++ + D T G +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 684 -APEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE----G 738
APE ++ T K DV+SFGVLL EI G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIF-----------------------TLGATPYPG 210
Query: 739 ITEALVEFDIEALNDKKKLAR-------FVMVAIWCIQEDPSLRPTMRKVTQMLE 786
++ V +E L +L + + + C Q DP RPT ++ + LE
Sbjct: 211 LSNEEV---LEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 48/284 (16%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
E LG+G+FG VY + +AVK L ++ ++ + E+ ++ H N+V
Sbjct: 6 ELLGRGSFGSVYLA---LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 576 RLLGFC-DDGLNRLLVY-EFLSNGTLASFL--FGDLKPGWSRRTDI---AFGIARGLLYL 628
R G D+ N L ++ E++S G+L+S L FG L I I GL YL
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-----PVIRKYTRQILEGLAYL 117
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL--LLDQSQTHTAIRGTKGYVAPE 686
H I+H DIK NIL+D +++DFG AK L + T + +RGT ++APE
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWMAPE 173
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC----EGITEA 742
R D++S G ++E+ + E+ A L E ++E
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKP-PWSELGNPMAALYKIGSSGEPPEIPEHLSEE 232
Query: 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+F L + C++ DP RPT ++L+
Sbjct: 233 AKDF----------LRK-------CLRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 25/201 (12%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
E++GKG FG VYK VA+K + ++ ++ E+ ++ + H N+V+
Sbjct: 5 LEKIGKGGFGEVYKA---RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 577 LLG--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR---TDIAFGIARGLL----Y 627
G D L +V EF S G+L DL ++ + IA+ + + LL Y
Sbjct: 62 YYGSYLKKDEL--WIVMEFCSGGSLK-----DLLKSTNQTLTESQIAY-VCKELLKGLEY 113
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW 687
LH IIH DIK NILL ++ DFGL+ L +++ GT ++APE
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEV 168
Query: 688 FRNMPITVKVDVYSFGVLLLE 708
P K D++S G+ +E
Sbjct: 169 INGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQ-VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+GKG FG V G Y+ VAVK L + F E +V+ H NL
Sbjct: 10 LGATIGKGEFGDVMLG------DYRGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNL 62
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
V+LLG G +V E+++ G+L +L G +++ A + G+ YL E+
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
+H D+ +N+L+ + A++SDFGLAK + SQ + + + APE R
Sbjct: 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKK 175
Query: 693 ITVKVDVYSFGVLLLEI 709
+ K DV+SFG+LL EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVIQDGVKEFKTEVNVIGQTHHKN 573
+ +G+GAFGVVYKG + VA+K+ L + ++ +K E++++ H N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDF---VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+V+ +G + + ++ E+ NG+L + FG S + + +GL YLHE+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHEQ 118
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+IH DIK NIL +++DFG+A L D S+ ++ GT ++APE
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 692 PITVKVDVYSFGVLLLEIICCR 713
+ D++S G ++E++
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 9e-27
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+++GKG+FG VY +K+ L ++ + ++ EV ++ + +H N+
Sbjct: 5 IKQIGKGSFGKVYLVRRKSD---GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG--------WSRRTDIAFGIARGLL 626
++ ++ +V E+ G L+ + K G D + L
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL----DWFVQLCLALK 117
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
YLH +I+H DIKPQNI L ++ DFG++K+L T + GT Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRR 714
+N P K D++S G +L E+ +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (279), Expect = 2e-26
Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 39/284 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQ-THH 571
+LG+G+FG VY + VA+K L V+ F E+ ++ H
Sbjct: 4 ILRKLGEGSFGEVYLA------RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG---WSRRTDIAFGIARGLLYL 628
N+V+L F D + LV E++ G+L L + G S I I L YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 629 HEECSTQIIHCDIKPQNILLDDYYN-ARISDFGLAKLLLLDQS-----QTHTAIRGTKGY 682
H + IIH DIKP+NILLD ++ DFGLAKLL S + GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 683 VAPEWFRNM---PITVKVDVYSFGVLLLEIICCRR-----NVDMEVNEAEALLTDWAYDC 734
+APE + + D++S G+ L E++ ++ ++ +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTM 778
++ + E +A +D + + +DP R +
Sbjct: 235 LASPLSPSNPELISKAASD------LLKK---LLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 71/194 (36%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+ELG G FG V KG M S +V VAVK L I G KEF E +V+ Q H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
L+G C G +LV E G L +L + S ++A +A G+ YL E
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL-ESK--HF 116
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS--QTHTAIRGTKGYVAPEWFRNMPIT 694
+H D+ +N+LL + + A+ISDFG+++ L + TA R + APE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 695 VKVDVYSFGVLLLE 708
K DV+S+GV L E
Sbjct: 177 SKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 72/202 (35%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 520 LGKGAFGVVY---KGAIGMASMYQVPVAVKKLH--SVIQ-DGVKEFKTEVNVIGQTHHKN 573
LGKG+FG V K G +Y A+K L +I+ V+ TE N++ + +H
Sbjct: 1 LGKGSFGKVLLVRKKDTG--KLY----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPF 54
Query: 574 LVRLL-GFCDDGLNRL-LVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLH 629
+V+L F + +L LV E+ G L S L G +R A I L YLH
Sbjct: 55 IVKLHYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLH 110
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
II+ D+KP+NILLD + +++DFGLAK L + S+T+T GT Y+APE
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLL 166
Query: 690 NMPITVKVDVYSFGVLLLEIIC 711
VD +S GVLL E++
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQ--VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+ +LG G FG V+ G + VAVK L + F E ++ + H L
Sbjct: 11 ERKLGAGQFGEVWMG------TWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKL 63
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR----TDIAFGIARGLLYLHE 630
V+L C + +V E++S G+L FL G R D+A IA G+ YL
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
IH D+ +NIL+ + +I+DFGLA+L+ D+ + + APE
Sbjct: 122 R---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 691 MPITVKVDVYSFGVLLLEII 710
T+K DV+SFG+LL EI+
Sbjct: 179 GRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 42/279 (15%)
Query: 519 ELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDGV-KEFKTEVNVIGQTHH 571
LG+G+ GVVYK G I A+KK+H + K+ E+ +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKI---------YALKKIHVDGDEEFRKQLLRELKTLRSCES 58
Query: 572 KNLVRLLG-FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR--TDIAFGIARGLLYL 628
+V+ G F +G + V E++ G+LA L IA I +GL YL
Sbjct: 59 PYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
H + IIH DIKP N+L++ +I+DFG++K+L Q +T + GT Y++PE
Sbjct: 116 HTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERI 172
Query: 689 RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT-DWAYDCYCEGITEALVEFD 747
+ + D++S G+ LLE + + + +A+ +
Sbjct: 173 QGESYSYAADIWSLGLTLLECA-------LGKFPFLPPGQPSFF------ELMQAICDGP 219
Query: 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+L ++ F C+Q+DP RP+ ++L+
Sbjct: 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-25
Identities = 86/343 (25%), Positives = 148/343 (43%), Gaps = 42/343 (12%)
Query: 466 FFNCLLVGALCLC-----FFFVYNKKNSQ---VPSHDGVVETNL------HCFTYKDLEA 511
+ C L L L F F+ + N + V + DG E T D+ +
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS 690
Query: 512 ATNGFKEE--LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT 569
+ KEE + +G G YKG M V + ++S+ + + G+
Sbjct: 691 SL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM-------GKL 740
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
H N+V+L+G C L++E++ L+ L W RR IA GIA+ L +LH
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLH 797
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
CS ++ ++ P+ I++D + L LL D ++ YVAPE
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRE 851
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRNVDME--VNEAEALLTDWAYDCYCEGITEALVEFD 747
IT K D+Y FG++L+E++ + D E V+ + + +WA CY + + ++
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPS 908
Query: 748 I--EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788
I + ++ ++ + +A+ C DP+ RP V + LE
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVR 576
+ +G G FG V +G + + ++ VA+K L + D + +F TE +++GQ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLHEECS 633
L G +++ E++ NG+L FL G G + + GIA G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVG--QLVGMLRGIASGMKYLSEMNY 127
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG------YVAPEW 687
+H D+ +NIL++ ++SDFGL++ L D T+T TKG + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYT----TKGGKIPIRWTAPEA 179
Query: 688 FRNMPITVKVDVYSFGVLLLEII 710
T DV+SFG+++ E++
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 37/221 (16%)
Query: 516 FKEELGKGAFGVVYKGAI-GMASMYQV-PVAVKKL---HSV-IQDGVKEFKTEVNVIGQT 569
F EELG+GAFG VYKG + G VA+K L +Q EF+ E ++
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDL 65
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF-----GDLKPGWSRRT--------- 615
H N+V LLG C +++E+L++G L FL D+ T
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 616 --DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD----- 668
IA IA G+ YL S +H D+ +N L+ + +ISDFGL++ +
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
QS++ +R ++ PE T + D++SFGV+L EI
Sbjct: 183 QSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+LG G FG V++G PVAVK L D K+F E ++ + H L+
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNT----TPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLI 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEE 631
+L C +V E + G+L +L G LK + D+A +A G+ YL +
Sbjct: 65 QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK--LPQLIDMAAQVASGMAYLEAQ 122
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
IH D+ +N+L+ + +++DFGLA+++ D + + + APE
Sbjct: 123 ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 692 PITVKVDVYSFGVLLLEII 710
++K DV+SFG+LL EI+
Sbjct: 180 RFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 33/207 (15%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
K +LG G +G VY+G + Y + VAVK L + V+EF E V+ + H NLV+
Sbjct: 11 KHKLGGGQYGEVYEG---VWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 66
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD-----------IAFGIARGL 625
LLG C ++ EF++ G L +L R + +A I+ +
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAM 117
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GY 682
YL IH D+ +N L+ + + +++DFGL++L+ T+TA G K +
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKW 171
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEI 709
APE ++K DV++FGVLL EI
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVP-------VAVKKL-HSVIQDGVKEFKTEVNVIG 567
F ++LG+G FG V Y VAVK L HS + +F+ E+ ++
Sbjct: 8 FIKQLGEGHFGKVELCR------YDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61
Query: 568 QTHHKNLVRLLGFCDD--GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IAR 623
H+N+V+ G C+ G + L+ E+L +G+L +L + + + + F I +
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICK 120
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD------QSQTHTAIR 677
G+ YL + + IH D+ +NIL++ +ISDFGLAK+L D + + I
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
+ APE R + DV+SFGV L E+
Sbjct: 178 ----WYAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
+LG G FG V++G +V VA+K L S ++F+ EV + + HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGLW----KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT----DIAFGIARGLLYLHEECS 633
C G ++ E + G+L +FL G D+A +A G+ YL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
IH D+ +NIL+ + +++DFGLA+L+ D + K + APE +
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-WTAPEAASHGTF 181
Query: 694 TVKVDVYSFGVLLLEI 709
+ K DV+SFG+LL E+
Sbjct: 182 STKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 9e-23
Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMY--QVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHH 571
F +ELG G FGVV+ G + ++ VA+K + ++ +D +F E V+ + H
Sbjct: 8 FLKELGSGQFGVVHLG------KWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSH 58
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYL 628
NLV+L G C +V E+++NG L ++L G L W D+ + + YL
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYL 116
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAP 685
IH D+ +N L+ + ++SDFGLA+ +L DQ +T+ +GTK + P
Sbjct: 117 ESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPP 170
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICC 712
E F + K DV+SFGVL+ E+
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV---KEFKTEVNVIGQTHHK 572
+E+G G FG+V+ G + + VA+K I++G ++F E V+ + H
Sbjct: 8 LVQEIGSGQFGLVWLGYW----LEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHP 59
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHE 630
LV+L G C + LV+EF+ +G L+ +L + +S+ T + + G+ YL
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLES 118
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
+IH D+ +N L+ + ++SDFG+ + +L DQ + T + + +PE F
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 691 MPITVKVDVYSFGVLLLEI 709
+ K DV+SFGVL+ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK---KLHSVIQDGVKEFKTEVNVIGQ-THH 571
F + +G+G+F V A + A+K K + + VK K E V+ + H
Sbjct: 5 FGKIIGEGSFSTVVL-AKEKET--NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 572 KNLVRLLG-FCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIAR---GL 625
+++L F D+ N V E+ NG L ++ +G L F A L
Sbjct: 62 PGIIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLD-----EKCTRFYAAEILLAL 115
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL---------LLDQSQTHTAI 676
YLH S IIH D+KP+NILLD + +I+DFG AK+L D + + I
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 677 R----------GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
GT YV+PE P D+++ G ++ +++ +
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 42/285 (14%)
Query: 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIG 567
+L+ T G E +G+G FG V +G Q VAVK + + + F E V+
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEY----TGQ-KVAVKNIKCDVT--AQAFLEETAVMT 54
Query: 568 QTHHKNLVRLLG-FCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARG 624
+ HHKNLVRLLG +GL +V E +S G L +FL G + + +A G
Sbjct: 55 KLHHKNLVRLLGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVA 684
+ YL S +++H D+ +NIL+ + A++SDFGLA++ + + ++ T A
Sbjct: 113 MEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----A 165
Query: 685 PEWFRNMPITVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYCEGITEA 742
PE ++ + K DV+S+GVLL E+ R M + E + E
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----------------VKEC 209
Query: 743 LVE-FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ + + +E +M + W + +P RP+ K+ + LE
Sbjct: 210 VEKGYRMEPPEGCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 67/198 (33%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
F +ELG G FGVV G Y V + + K S+ +D EF E V+ + H+ LV
Sbjct: 8 FLKELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLV 62
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLK-PGWSRRTDIAFGIARGLLYLHEECST 634
+L G C +V E++SNG L ++L K S+ ++ + G+ YL S
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SK 119
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRNM 691
Q IH D+ +N L+DD ++SDFGL++ +L D+ +T+ G+K V PE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYS 176
Query: 692 PITVKVDVYSFGVLLLEI 709
+ K DV++FGVL+ E+
Sbjct: 177 KFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 28/205 (13%)
Query: 520 LGKGAFGVVYKGA-IGMASMYQVPVAVKKL-HSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
LG GAFG VYKG I ++PVA+K L KE E V+ H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKP----GWSRRTDIAFGIARGLLYLHE 630
LG C L+ + + G L ++ ++ W + IA+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH-----TAIRGTKGYVAP 685
+ +++H D+ +N+L+ + +I+DFGLAKLL +D+ + H I+ ++A
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMAL 180
Query: 686 EWFRNMPITVKVDVYSFGVLLLEII 710
E + T K DV+S+GV + E++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 7e-22
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
+G G FG V++G + M +V VA+K L + ++F +E +++GQ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLHEECSTQ 635
G +++ E++ NG L +L G+ + + GIA G+ YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS--YQLVGMLRGIAAGMKYLSD---MN 127
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG--YVAPEWFRNMPI 693
+H D+ +NIL++ ++SDFGL+++L D T+T G + APE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 694 TVKVDVYSFGVLLLEII 710
T DV+SFG+++ E++
Sbjct: 188 TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-22
Identities = 37/109 (33%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 76 QKTIVWFANGDSP-AASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGN 133
+T+VW AN +P S + L +D LVL GR +W S+ + D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 134 FVLLSDNTNKLWESFNNPTDTMLPSQIFDN-----GQFLSSKQSDGNFS 177
VL ++ LW+SF++PTDT+LP Q N + L+S +S+ + S
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 27/209 (12%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNLV 575
+E +G G FG V +G + + ++ VA+K L S + ++F +E +++GQ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF----------GIARGL 625
L G +++ EF+ NG L SFL R+ D F GIA G+
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL---------RQNDGQFTVIQLVGMLRGIAAGM 119
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTK---G 681
YL E +H D+ +NIL++ ++SDFGL++ L D S T+T+ G K
Sbjct: 120 KYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 682 YVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ APE T DV+S+G+++ E++
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 55/279 (19%)
Query: 516 FKEELGKGAFGVVYKG---AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHK 572
E++G+GA G VYK A G VA+KK+ + + + E+ ++ H
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKE------VAIKKMR-LRKQNKELIINEILIMKDCKHP 75
Query: 573 NLVRLLG--FCDDGLNRLLVYEFLSNGTLA---SFLFGDLKPGWSRRTDIAF---GIARG 624
N+V D L +V E++ G+L + F + IA+ + +G
Sbjct: 76 NIVDYYDSYLVGDEL--WVVMEYMDGGSLTDIITQNFVRMNEP-----QIAYVCREVLQG 128
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVA 684
L YLH S +IH DIK NILL + +++DFG A L ++S+ ++ + GT ++A
Sbjct: 129 LEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMA 184
Query: 685 PEWFRNMPITVKVDVYSFGVLLLEIICCRRNVD-----MEVNEAEALLTDWAYDCYCEGI 739
PE + KVD++S G++ +E+ + + AL I
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMA------EGEPPYLREPPLRALFL----------I 228
Query: 740 TEALVEFDIEALNDKKKLAR-FVMVAIWCIQEDPSLRPT 777
T I L + +K + F C+ +DP RP+
Sbjct: 229 TTK----GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 520 LGKGAFGVVYKG-AIGMASM-YQVPVAVKKLHSVIQD-GVKEFKTEVNV---IGQTHHKN 573
LG+GAFG V K A+G+ + VAVK L + + + +E+ + IG+ HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI---------------- 617
++ LLG C +V E+ ++G L FL PG D
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK-LLLLDQSQTHTAI 676
A+ +ARG+ +L S + IH D+ +N+L+ + + +I+DFGLA+ + +D + T
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
R ++APE + T + DV+SFGVLL EI
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT-EVNVIGQT 569
E +GKG+FG V K G I + K++ + + K+ EVN++ +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKI---------LVWKEIDYGNMTEKEKQQLVSEVNILREL 56
Query: 570 HHKNLVRLLGFCDDGLNR-----LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARG 624
H N+VR + D ++R +V E+ G LA + K + + I
Sbjct: 57 KHPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 625 LLYLHEEC------STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
LL EC ++H D+KP NI LD N ++ DFGLAK+L D S T + G
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-G 172
Query: 679 TKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
T Y++PE +M K D++S G L+ E+
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (231), Expect = 1e-20
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKT---EVNVIGQTHHK 572
E+LG+G +GVVYK A + VA+KK+ + +G+ T E++++ + H
Sbjct: 4 LEKLGEGTYGVVYK-ARDKKT--GEIVALKKIRLDNEEEGIP--STALREISLLKELKHP 58
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAFGIARGLLYLH 629
N+V+LL LV+E+ L +L G L P + I + + RGL Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCH 115
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWF 688
S +I+H D+KPQNIL++ +++DFGLA+ + TH + T Y APE
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL 170
Query: 689 RNMPI-TVKVDVYSFGVLLLEII 710
+ VD++S G + E+I
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 29/211 (13%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQV--PVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNL 574
ELG+G+FG+VY+G + VA+K ++ + +++ + EF E +V+ + + ++
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHV 71
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL-----------FGDLKPGWSRRTDIAFGIAR 623
VRLLG G L+V E ++ G L S+L P + +A IA
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP-PTLQKFIQMAAEIAD 130
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG-- 681
G+ YL + +H D+ +N ++ + +I DFG+ + D +T +G KG
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 682 ---YVAPEWFRNMPITVKVDVYSFGVLLLEI 709
++APE ++ T K DV+SFGV+L E+
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 61/216 (28%), Positives = 110/216 (50%), Gaps = 27/216 (12%)
Query: 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIG 567
++A+ ++ +G G FG V G + + ++PVA+K L + + + +F +E +++G
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF-------- 619
Q H N++ L G ++V E++ NG+L +FL R+ D F
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---------RKHDGQFTVIQLVGM 111
Query: 620 --GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
GIA G+ YL + +H D+ +NIL++ ++SDFGL+++L D +T R
Sbjct: 112 LRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-R 167
Query: 678 GTK---GYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
G K + APE T DV+S+G+++ E++
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 520 LGKGAFGVVYKGA-IGMASMYQ-VPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVR 576
LG GAFG VY+G G + VAVK L + +F E ++ + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD--------IAFGIARGLLYL 628
L+G + L R ++ E ++ G L SFL + +P R + A +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNAR---ISDFGLAKLLLLDQSQTHTAIRGTKG---- 681
E IH DI +N LL R I+DFG+A+ D + +G +
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPI 185
Query: 682 -YVAPEWFRNMPITVKVDVYSFGVLLLEI 709
++ PE F + T K DV+SFGVLL EI
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 68/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVK-EFKTEVNVIGQTHHKNLVR 576
ELG G FG V KG M + VAVK L + D +K E E NV+ Q + +VR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKS-EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
++G C+ + +LV E G L FL + T++ ++ G+ YL E T
Sbjct: 61 MIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLD----QSQTHTAIRGTKGYVAPEWFRNMP 692
+H D+ +N+LL + A+ISDFGL+K L D +++TH + + APE
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG--KWPVKWYAPECMNYYK 174
Query: 693 ITVKVDVYSFGVLLLE 708
+ K DV+SFGVL+ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQTHHKNL 574
E +GKG+FG VYK VA+K + + +D +++ + E+ + Q +
Sbjct: 7 ECIGKGSFGEVYKAIDKRT---NQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYI 61
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEE 631
+ G G ++ E+ G+ L KPG T IAF + GL YLHEE
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
IH DIK NILL + + +++DFG++ L S+ +T + GT ++APE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173
Query: 692 PITVKVDVYSFGVLLLEII 710
K D++S G+ +E+
Sbjct: 174 GYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQ--VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
++LG G FG V+ G Y VA+K L + F E N++ Q H LV
Sbjct: 12 KKLGAGQFGEVWMG------YYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLV 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECS 633
RL ++ E++ NG+L FL +K ++ D+A IA G+ ++ +
Sbjct: 65 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-- 121
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEWFRN 690
IH D++ NIL+ + +I+DFGLA+L+ ++ +TA G K + APE
Sbjct: 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 177
Query: 691 MPITVKVDVYSFGVLLLEII 710
T+K DV+SFG+LL EI+
Sbjct: 178 GTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 48/282 (17%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVP----VAVKKLH----SVIQDGVKEFKTEVNVIGQTH 570
ELG G GVV K + P +AVK + IQ K+ E++++ + +
Sbjct: 8 ELGAGNSGVVSK-------VLHRPTGKIMAVKTIRLEINEAIQ---KQILRELDILHKCN 57
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD-----IAFGIARGL 625
+V G + + + E++ G+L L K R + IA + +GL
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGL 113
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
YLHE+ +IIH D+KP NIL++ ++ DFG++ L+ ++T GT Y+AP
Sbjct: 114 TYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAP 168
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
E + +VK D++S G+ L+E+ R E + + + + + +V
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE----------LLQYIVN 218
Query: 746 FDIEAL-NDK--KKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784
L + K FV + C+ +DP RP+ +++ +
Sbjct: 219 EPPPRLPSGKFSPDFQDFVNL---CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQTHHKNLVR 576
E++GKG FG VYKG + VAVK S + +K F E ++ Q H N+V+
Sbjct: 1 EKIGKGNFGDVYKGVLKG----NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGI--ARGLLYLHEECST 634
L+G C +V E + G+L +FL K + + + + A G+ YL +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNC- 114
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK----GYVAPEWFRN 690
IH D+ +N L+ + +ISDFG+++ ++ +T G K + APE
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 691 MPITVKVDVYSFGVLLLEI 709
T + DV+S+G+LL E
Sbjct: 170 GRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 41/275 (14%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
LGKG++G VYK + S Q A+K+ L S+ Q ++ E+ ++ +H N++
Sbjct: 8 LGKGSYGSVYK--VKRLSDNQF-YALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 578 LGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPG--------WSRRTDIAFGIARGLLYL 628
DG N+L +V E+ G L+ + K W I + RGL L
Sbjct: 65 KEAFLDG-NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQAL 119
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
HE+ +I+H D+K NILL +I D G++K +L ++ T I GT Y+APE +
Sbjct: 120 HEQ---KILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMAPEVW 173
Query: 689 RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748
+ P + K D++S G LL E+ E + L G ++
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEM--ATFAPPFEARSMQDL-----RYKVQRG------KYPP 220
Query: 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
+ L F+ +Q P LRP K+
Sbjct: 221 IPPIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNLVR 576
++LG G+FGVV +G + +PVAVK L S + D + +F E ++ H+NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 577 LLGFC-DDGLNRLLVYEFLSNGTLASFLFGDLKPGW--SRRTDIAFGIARGLLYLHEECS 633
L G L ++V E G+L L D + S D A IA G+ YL S
Sbjct: 61 LYGVVLTHPL--MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---S 115
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ----SQTHTAIRGTKGYVAPEWFR 689
+ IH D+ +NILL +I DFGL + L ++ + H + + APE R
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 690 NMPITVKVDVYSFGVLLLEI 709
+ DV+ FGV L E+
Sbjct: 174 TRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 562 EVNVIGQTHHKNLVRLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTD--- 616
E+ + +V+ G F D+ + + + E+ G+L S ++ +K R +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL 107
Query: 617 --IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674
IA + +GL YLH +IIH DIKP NILL ++ DFG++ L+ + T T
Sbjct: 108 GKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164
Query: 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
GT Y+APE + P ++ DV+S G+ LLE+
Sbjct: 165 ---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 31/208 (14%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRL 577
+GKG FG VY G + + ++ AVK L+ + +++ V++F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVLSL 61
Query: 578 LGFC--DDGLNRLLVYEFLSNGTLASFL--------FGDLKPGWSRRTDIAFG--IARGL 625
LG C +G L+V ++ +G L +F+ DL I FG +A+G+
Sbjct: 62 LGICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVKDL---------IGFGLQVAKGM 111
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL---LDQSQTHTAIRGTKGY 682
YL S + +H D+ +N +LD+ + +++DFGLA+ + HT + +
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEII 710
+A E + T K DV+SFGVLL E++
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 48/283 (16%)
Query: 518 EELGKGAFGVVYKGAIG----MASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN 573
E LG G+FG VY+G ++ +V +A Q+ VK+ + E+ ++ + H N
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG--QEAVKQLEQEIALLSKLQHPN 63
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKP----GWSRRTDIAFGIARGLLY 627
+V+ LG + N + E + G+LA L +G ++R+ I GL Y
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEY 117
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG---YVA 684
LH +H DIK NIL+D +++DFG+AK Q + + KG ++A
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMA 169
Query: 685 PEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743
PE + D++S G +LE + + ++ A+ G ++ L
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLE-MATGKPPWSQLEGVAAVFK--------IGRSKEL 220
Query: 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ L+D+ K F++ C+Q DPSLRPT ++LE
Sbjct: 221 PPIP-DHLSDEAKD--FILK---CLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 71/220 (32%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 517 KEELGKGAFGVVYKGAIGMA-----SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH 571
++GKG+FGVV+K + A +M Q+ + K++ ++ E E V+ +
Sbjct: 5 LNKIGKGSFGVVFK-VVRKADKRVYAMKQI--DLSKMNRRERE---EAIDEARVLAKLDS 58
Query: 572 KNLVRLL-GFCDDG-LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR--GLLY 627
++R F D G LN +V E+ NG L L F I GL +
Sbjct: 59 SYIIRYYESFLDKGKLN--IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW 687
LH S +I+H DIK N+ LD Y N +I D G+AK LL D + I GT Y++PE
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPEL 172
Query: 688 FRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL 727
+ P K DV++ GV+L E CC + N AL+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYE--CCTGKHPFDANNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 78/285 (27%), Positives = 117/285 (41%), Gaps = 40/285 (14%)
Query: 518 EELGKGAFGVVYK-----GAIGMASMYQVPV---AVKKLHSVIQDGVKEFKTEVNVIG-Q 568
E LG GAFG VYK + ++ ++ V A K + + +EV +I Q
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD-----IAFGIAR 623
H N+VR + +V + + L F LK R T+ I +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH---TAIRGTK 680
L YLH+E +I+H D+ P NI+L + I+DFGLAK Q Q T++ GT
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTI 177
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGIT 740
Y PE +N P K DV++FG +L ++ C +L T
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSLATK----------- 224
Query: 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785
+VE E L + V C+ D RP + +V+ M+
Sbjct: 225 --IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
++LG G FG V+ G ++ VAVK L V+ F E N++ H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYNNST----KVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRL 66
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQ 635
++ E+++ G+L FL D K + D + IA G+ Y+ +
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---N 123
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEWFRNMP 692
IH D++ N+L+ + +I+DFGLA+++ + +TA G K + APE
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 693 ITVKVDVYSFGVLLLEII 710
T+K DV+SFG+LL EI+
Sbjct: 181 FTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 520 LGKGAFGVVY---KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+ KGA+G V+ K + G +Y + V +KK + ++ V + TE +++ Q +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTG--DIYAIKV-IKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 577 LL-GFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
L F N LV E+L G LAS L G L +R I L YLH S
Sbjct: 58 LYYSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVARI--YIAEIVLALEYLH---S 111
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA-------IRGTKGYVAPE 686
IIH D+KP NIL+D + +++DFGL+K+ L+ + I GT Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 687 WFRNMPITVKVDVYSFGVLLLEIIC 711
+ VD +S G +L E +
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG----VKEFKTEVNVIGQTHHKNLV 575
+G G FG VY A+ + + + AVK++ IQD +KE E+ V+ H NLV
Sbjct: 8 IGGGTFGKVYT-AVNLDTGELM--AVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 576 RLLGFCDDGLNRLLVY---EFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+ G ++R VY E+ S GTL L G + R + GL YLH
Sbjct: 63 KYYGV---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ-LLEGLAYLHSH 118
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA------IRGTKGYVAP 685
I+H DIKP NI LD ++ DFG A L ++ T T + GT Y+AP
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAP 172
Query: 686 EWFRNMPITVK---VDVYSFGVLLLEIICCRR 714
E D++S G ++LE+ +R
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
LG+G FG V +G + Q+ VAVK KL ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 578 LGFCDDGLNR------LLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAF--GIARGL 625
+G C + + +++ F+ +G L SFL G L +T + F IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ--SQTHTAIRGTKGYV 683
YL + IH D+ +N +L + ++DFGL+K + Q A K ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-WI 182
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEI 709
A E + T K DV++FGV + EI
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 22/221 (9%)
Query: 518 EELGKGAFGVVYKG---AIG-MASMYQV---PVAVKKLHSVIQDGVKEFKTEVNVIGQTH 570
E +GKG +G VY G M ++ QV + S +D VK ++E+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 571 HKNLVRLLGFCDDGLNRLLVY-EFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLY 627
H N+V+ LGF + L ++ E++ G++ S L +G + R + GL Y
Sbjct: 67 HLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF--FTEQVLEGLAY 123
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL--LLDQSQTHTAIRGTKGYVAP 685
LH S I+H D+K N+L+D +ISDFG++K + D Q +++G+ ++AP
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN-MSMQGSVFWMAP 179
Query: 686 EWFRN--MPITVKVDVYSFGVLLLEIICCRRN-VDMEVNEA 723
E + + KVD++S G ++LE+ RR D E A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL- 578
+G+GAFG+V+ A V + + + +D + E V+ H N++
Sbjct: 8 VGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 579 GFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQII 637
F +D L +V E+ GTLA ++ T + F + LL LH + I+
Sbjct: 67 NFLED--KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF-FVQILLALHHVHTKLIL 123
Query: 638 HCDIKPQNILLDDYYN-ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
H D+K QNILLD + +I DFG++K +L +S+ +T + GT Y++PE P K
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYTVV-GTPCYISPELCEGKPYNQK 181
Query: 697 VDVYSFGVLLLEIICCRRNVDME 719
D+++ G +L E+ +R +
Sbjct: 182 SDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 516 FKEELGKGAFGVV----YKGAIGMASMYQVPVAVKKLHS---VIQDGVKEFKTEVNVIGQ 568
F + LG G+FG V +KG+ A+K L V V+ E ++
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS-------GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLL 626
H LV L G D N LV E++ G L S L G +R F A+ +L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVL 112
Query: 627 ---YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
YLH I++ D+KP+N+LLD +I+DFG AK + + +T+T + GT Y+
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYL 165
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEIIC 711
APE + VD ++ G+L+ E++
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIG 567
+ E NG + LGKG +G+VY +++ QV +A+K++ V+ E+ +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAAR-DLST--QVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARG 624
H+N+V+ LG + + E + G+L++ L P I F I G
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
L YLH+ QI+H DIK N+L++ Y +ISDFG +K L T T GT Y+
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYM 176
Query: 684 APEWFRNMP--ITVKVDVYSFGVLLLEI 709
APE P D++S G ++E+
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVRL 577
ELG G FG V KG M Q+ VA+K L + + V+ E E ++ Q + +VR+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKK-QIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECSTQI 636
+G C+ +LV E S G L FL G S ++ ++ G+ YL +
Sbjct: 61 IGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS--QTHTAIRGTKGYVAPEWFRNMPIT 694
+H D+ +N+LL + + A+ISDFGL+K L D S + +A + + APE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 695 VKVDVYSFGVLLLE 708
+ DV+S+G+ + E
Sbjct: 177 SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 4e-18
Identities = 36/112 (32%), Positives = 53/112 (47%), Gaps = 4/112 (3%)
Query: 40 NSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTA 99
+ + +S N F GF +L D I Y +T+VW AN D+P + + L +
Sbjct: 6 SGQTLVSGNSLFELGFFTLIMQNDY--NLILYKSSS-RTVVWVANRDNPVSDSCTLTLQS 62
Query: 100 DQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWESFNN 150
D LVL GR +W S+ Y L + D GN V+ + N LW+SF+
Sbjct: 63 DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT-EVNVIGQT 569
E+G+GA+G VYK G VA+KK+ + ++G+ E+ ++ Q
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRF---------VALKKVRVPLSEEGIPLSTLREIALLKQL 55
Query: 570 ---HHKNLVRLLGFC-----DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAF 619
H N+VRLL C D L LV+E + LA++L KPG T D+
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
+ RG+ +LH S +I+H D+KPQNIL+ +I+DFGLA++ + + T + T
Sbjct: 115 QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--T 169
Query: 680 KGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
Y APE VD++S G + E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 516 FKEELGKGAFGVVYKG--AIGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQTHHK 572
K ELG+GAFG V+ G + VAVK L + ++ F+ E ++ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL-----------FGDLKPGWSRRTD---IA 618
N+V+ G C +G ++V+E++ +G L FL D G + IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
IA G++YL S +H D+ +N L+ +I DFG+++ + + + + G
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY---TTDYYRVGG 182
Query: 679 TK----GYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
++ PE T + DV+SFGV+L EI
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV---KEFKTEVNVIGQTHHK 572
F +ELG G FGVV+ G Q+ VA+K I +G ++F E V+ + H
Sbjct: 8 FMKELGSGQFGVVHLGKW----RAQIKVAIKA----INEGAMSEEDFIEEAKVMMKLSHP 59
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAFGIAR----GL 625
LV+L G C +V EF+ NG L ++L G L D+ + + G+
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK------DMLLSMCQDVCEGM 113
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
YL IH D+ +N L+ ++SDFG+ + +L D+ + + + + P
Sbjct: 114 EYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
Query: 686 EWFRNMPITVKVDVYSFGVLLLEI 709
E F + K DV+SFGVL+ E+
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E +GKG+FG VYKG I + V + + L +D +++ + E+ V+ Q + R
Sbjct: 10 ERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRY 67
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEECST 634
G G ++ E+L G+ L KPG T IA I +GL YLH E
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE--- 120
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+ IH DIK N+LL + + +++DFG+A L Q + +T + GT ++APE +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179
Query: 695 VKVDVYSFGVLLLEI 709
K D++S G+ +E+
Sbjct: 180 FKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVIQDGV-KEFKT---EVNVIGQTHH 571
E LGKGA+G VY G + +AVK+ L + KE++ EV+++ H
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDL-KPGWSRRTDIAFGIARGLLYL 628
N+V+ LG C D + EF+ G+++S L FG L +P + + T I G+ YL
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---QILDGVAYL 118
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLA-KLLLLDQSQTHT----AIRGTKGYV 683
H C ++H DIK N++L ++ DFG A +L + TH+ ++ GT ++
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEI 709
APE K D++S G + E+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 55/298 (18%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVP-------VAVKKLHSVIQDGVKEFKTEVNVIGQ 568
K ELG+GAFG V+ +A Y + VAVK L K+F+ E ++
Sbjct: 9 LKRELGEGAFGKVF-----LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG---------DLKP-------GWS 612
H+++V+ G C DG ++V+E++ +G L FL D +P G S
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 613 RRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ--- 669
+ IA IA G++YL S +H D+ +N L+ +I DFG+++ +
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 670 --SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL 727
T IR ++ PE T + DV+SFGV+L EI + +++ E +
Sbjct: 181 VGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI- 235
Query: 728 TDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785
E IT+ V +E K +M+ W Q +P R ++++ ++L
Sbjct: 236 ---------ECITQGRV---LERPRVCPKEVYDIMLGCW--QREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 76/287 (26%), Positives = 140/287 (48%), Gaps = 52/287 (18%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVP---VAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
ELG+G+FG+VY+G I + P VA+K ++ + +++ + EF E +V+ + + +
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 70
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLF----------GDLKPGWSRRTDIAFGIAR 623
+VRLLG G L++ E ++ G L S+L P + +A IA
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG-- 681
G+ YL+ + + +H D+ +N ++ + + +I DFG+ + D +T +G KG
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 682 ---YVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG 738
+++PE ++ T DV+SFGV+L EI A L + Y +G
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPY----QG 224
Query: 739 IT-EALVEFDIE-ALNDKKKLARFVMVAI--WCIQEDPSLRPTMRKV 781
++ E ++ F +E L DK ++ + C Q +P +RP+ ++
Sbjct: 225 MSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 66/206 (32%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 521 GKGAFG---VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
GKGAFG +V K M+ + K+ V + V+ E ++ + +H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTK--KMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 578 -LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR--------GLLYL 628
F D+ N LV + L L GDL+ S++ + + L YL
Sbjct: 66 WYSFQDEE-NMYLVVDLL--------LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
H + IIH DIKP NILLD+ + I+DF +A + D T T+ GT GY+APE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVL 171
Query: 689 RNMPITVKVDVYSFGVLLLEIICCRR 714
+V VD +S GV E + +R
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 65/245 (26%), Positives = 110/245 (44%), Gaps = 35/245 (14%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQ--VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN 573
K ELG+GAFG V+ Q + VAVK L + ++F+ E ++ H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLF-----------GDLKP----GWSRRTDIA 618
+VR G C +G L+V+E++ +G L FL G+ + IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-----SQTH 673
IA G++YL S +H D+ +N L+ +I DFG+++ + +T
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD 733
IR ++ PE T + D++SFGV+L EI + +++ EA+ +
Sbjct: 186 LPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI------E 235
Query: 734 CYCEG 738
C +G
Sbjct: 236 CITQG 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 41/212 (19%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDG-VKEFKT-EVNVIGQT 569
+G+GA+GVV K G I VA+KK D VK+ EV V+ Q
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEI---------VAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 570 HHKNLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGL 625
H+N+V L RL LV+E++ TL L G L P R + + + +
Sbjct: 58 RHENIVNLKEAFRRK-GRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAI 113
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
Y H S IIH DIKP+NIL+ + ++ DFG A+ L + T YVA
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD------YVAT 164
Query: 686 EWFRNMPITVK-------VDVYSFGVLLLEII 710
W+R + V VDV++ G ++ E++
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 81/288 (28%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 520 LGKGAFGVVYKGA-IGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVN---VIGQTHHKN 573
LG G FG V+KG I ++PVA+K IQD G + F+ + +G H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIK----TIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLHE 630
+VRLLG C G + LV + G+L + L P R + IA+G+ YL E
Sbjct: 71 IVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQIAKGMYYLEE 127
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFR 689
++H ++ +NILL +I+DFG+A LL D + ++ + ++A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 690 NMPITVKVDVYSFGVLLLEIIC--CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747
T + DV+S+GV + E++ M +E LL E L +
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK----------GERLAQPQ 234
Query: 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795
I ++ VMV W I E+ +RPT +++ + DPP
Sbjct: 235 ICTID-----VYMVMVKCWMIDEN--VRPTFKELANEFTRMAR--DPP 273
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-17
Identities = 56/187 (29%), Positives = 87/187 (46%), Gaps = 22/187 (11%)
Query: 538 MYQVPVAVKKLHSVIQDG---VKEFKTEVNVIGQTHHKNLVRLL--GFCDDGLNRLLVYE 592
M VA+K L + + F+ E + + +H N+V LL G GL V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59
Query: 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL-- 648
++ TL L D L G + R + + L H + I+H D+KPQNI++
Sbjct: 60 YVPGRTLREVLAADGALPAGETGR--LMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 649 -DDYYNARISDFGLAKLL-----LLDQSQTHTA-IRGTKGYVAPEWFRNMPITVKVDVYS 701
+A++ DFG+ LL + T T + GT Y APE R P+T D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 702 FGVLLLE 708
+G++ LE
Sbjct: 175 WGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 76/291 (26%), Positives = 138/291 (47%), Gaps = 50/291 (17%)
Query: 519 ELGKGAFGVVYKGAIG--MASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNL 574
ELG+G+FG+VY+G + + VAVK ++ + +++ + EF E +V+ ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHV 71
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLF----------GDLKPGWSRRTDIAFGIARG 624
VRLLG G L+V E +++G L S+L G P +A IA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG--- 681
+ YL+ + + +H D+ +N ++ + +I DFG+ + D +T +G KG
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 682 --YVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
++APE ++ T D++SFGV+L EI L + Y +G+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPY----QGL 225
Query: 740 T-EALVEFDIEA--LNDKKKLA-RFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ E +++F ++ L+ R + C Q +P +RPT ++ +L+
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 41/224 (18%)
Query: 520 LGKGAFGVVYKGAI----GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
LG+G FG V K G A V V + K ++ +++ +E N++ Q +H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVI 66
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLF-------GDLKPGWSRRTD------------ 616
+L G C LL+ E+ G+L SFL L +R +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 617 -----IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671
A+ I+RG+ YL E +++H D+ +N+L+ + +ISDFGL++ D +
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR----DVYE 179
Query: 672 THTAIRGTKG-----YVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ ++ +KG ++A E + T + DV+SFGVLL EI+
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 21/195 (10%)
Query: 520 LGKGAFGVVYKGAIGMASMYQ-VPVAVKKLHSVIQDGVKE-FKTEVNVIGQTHHKNLVRL 577
+GKG FG V M Y+ VAVK + D + F E +V+ Q H NLV+L
Sbjct: 14 IGKGEFGDV------MLGDYRGNKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 578 LG-FCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEECST 634
LG ++ +V E+++ G+L +L G G + + + YL +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---AN 121
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+H D+ +N+L+ + A++SDFGL K + S T + + APE R +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 695 VKVDVYSFGVLLLEI 709
K DV+SFG+LL EI
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 27/209 (12%)
Query: 516 FKEELGKGAFGVVYK----------GAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNV 565
F ++LGKG FG V G + VAVKKL + +++F+ E+ +
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEV---------VAVKKLQHSTAEHLRDFEREIEI 58
Query: 566 IGQTHHKNLVRLLGFC-DDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDI-AFGIA 622
+ H N+V+ G C G L LV E+L G+L +L + R+ + A I
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG- 681
+G+ YL S + +H D+ +NIL++ +I DFGL K+L D+ G
Sbjct: 119 KGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 682 -YVAPEWFRNMPITVKVDVYSFGVLLLEI 709
+ APE +V DV+SFGV+L E+
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 520 LGKGAFGVVYKGA---IGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNL 574
LG GAFG VY+G I + VAVK L + Q+ KEF E +++ +H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLK-----PGWSRR--TDIAFGIARGLLY 627
V+LLG C + ++ E + G L S+L P + + DI +A+G +Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 628 LHEECSTQIIHCDIKPQNILLD--DYYNAR---ISDFGLAKLLLLDQSQTHTAIRGTK-- 680
L + IH D+ +N L+ Y R I DFGLA+ + + G
Sbjct: 122 LEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY---KSDYYRKEGEGLL 175
Query: 681 --GYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
++APE + T + DV+SFGVL+ EI+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 520 LGKGAFGVVYKGAIGMAS---MYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKN 573
LGKG FG V A + + MY A KKL + G + E ++ + +
Sbjct: 1 LGKGGFGEVC--ACQVKATGKMY----ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IARGLLYLHEE 631
+V L + + LV ++ G L ++ +PG+ I + I GL +LH+
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+I++ D+KP+N+LLDD+ N RISD GLA + L + GT GY+APE +
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGE 169
Query: 692 PITVKVDVYSFGVLLLEIICCR 713
VD ++ G L E+I R
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 24/202 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
E+LG+G++G VYK AI + VA+K + +++ ++E E++++ Q +V
Sbjct: 7 ILEKLGEGSYGSVYK-AIHKET--GQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIV 61
Query: 576 RLLG--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD---IAF---GIARGLLY 627
+ G F + L +V E+ G+++ D+ ++ IA +GL Y
Sbjct: 62 KYYGSYFKNTDL--WIVMEYCGAGSVS-----DIMKITNKTLTEEEIAAILYQTLKGLEY 114
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW 687
LH S + IH DIK NILL++ A+++DFG++ L ++ +T I GT ++APE
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEV 170
Query: 688 FRNMPITVKVDVYSFGVLLLEI 709
+ + K D++S G+ +E+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 42/279 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
++LG G FG V+ G + VAVK L + F E ++ + H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNT----KVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQL 66
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR------TDIAFGIARGLLYLHEE 631
+ +V E++S G+L FL K G R D+A +A G+ Y+
Sbjct: 67 YAVVSEE-PIYIVTEYMSKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMAYIER- 120
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEWF 688
IH D++ NIL+ D +I+DFGLA+L+ + +TA +G K + APE
Sbjct: 121 --MNYIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAA 175
Query: 689 RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTDWAYDCYCEGITEALVEFD 747
T+K DV+SFG+LL E++ R +N E L + Y C
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI----- 230
Query: 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+L++ +M+ W ++DP RPT + LE
Sbjct: 231 --SLHE-------LMLQCW--KKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 35/220 (15%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVP-VAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKN 573
F EELG+ AFG +YKG + + M VA+K L + EF+ E +++ + HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLF-----GDLKPGWSRRTD------------ 616
+V LLG +++E+L+ G L FL D+ G S D
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDV--GCSSDEDGTVKSSLDHGDF 126
Query: 617 --IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD-----Q 669
IA IA G+ YL S +H D+ +NIL+ + + +ISD GL++ + Q
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
++ IR ++ PE + D++SFGV+L EI
Sbjct: 184 PKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 42/222 (18%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKN 573
F++ +G+G FG V K I + ++ A+K++ +D ++F E+ V+ + HH N
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA----------- 622
++ LLG C+ L E+ +G L FL + TD AF IA
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 623 ---------RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
RG+ YL ++ Q IH D+ +NIL+ + Y A+I+DFGL++
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQE 175
Query: 674 TAIRGTKGYVAPEWFR----NMPI-TVKVDVYSFGVLLLEII 710
++ T G + W N + T DV+S+GVLL EI+
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 51/230 (22%)
Query: 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVP----VAVKKLHS-VIQDGVKE 558
FT +DL+ E+G+GAFG V K M P +AVK++ S V + K
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK-------MLHKPSGTIMAVKRIRSTVDEKEQKR 48
Query: 559 FKTEVNVIGQTHH-KNLVRLLG---------FC----DDGLNRL--LVYEFLSNGTLASF 602
+++V+ ++ +V+ G C D L++ VYE L +
Sbjct: 49 LLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEE 107
Query: 603 LFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662
+ G IA + L YL EE +IIH D+KP NILLD N ++ DFG++
Sbjct: 108 ILGK----------IAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
Query: 663 KLLLLDQSQTHTAIRGTKGYVAPEW---FRNMPITVKVDVYSFGVLLLEI 709
L+ ++T A G + Y+APE V+ DV+S G+ L E+
Sbjct: 156 GQLVDSIAKTRDA--GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVIQDGVKE-------FKTEVNVIGQTH 570
+G G+FG VY +GM + +AVK+ L SV E+ ++ +
Sbjct: 8 IGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYL 628
H+N+V+ LG D + + E++ G++A+ L +G + R + I +GL YL
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--NFVRQILKGLNYL 122
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-----AIRGTKGYV 683
H + IIH DIK NIL+D+ +ISDFG++K L + T T +++G+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEII 710
APE + T K D++S G L++E++
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 73/269 (27%), Positives = 123/269 (45%), Gaps = 33/269 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVR 576
E +GKG+FG V+KG + + Q VA+K + +D +++ + E+ V+ Q + +
Sbjct: 10 ERIGKGSFGEVFKG---IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEECS 633
G G ++ E+L G+ L + G IA I +GL YLH E
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSE-- 120
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+ IH DIK N+LL + + +++DFG+A L Q + +T + GT ++APE +
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178
Query: 694 TVKVDVYSFGVLLLEIICCR-RNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
K D++S G+ +E+ N DM L+ ++ EF I+A
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEF-IDA-- 235
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
C+ +DPS RPT +++
Sbjct: 236 --------------CLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVI 566
+L+ + + LG G FG + +G + + S ++PVA+ L + D + F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 567 GQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIAR 623
GQ H N+VRL G G ++V E++SNG L SFL G L G + + G+A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAG--QLMGMLPGLAS 118
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT-HTAIRGTKG- 681
G+ YL E +H + +L++ +IS F L D+S+ +T + G
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172
Query: 682 -YVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ APE + + DV+SFG+++ E++
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTE-VNVIGQTHHKNLVR 576
+ + KGAFG VY Y +KK + ++ V K E ++ Q + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L LV E+L+ G AS + G L W+++ + G+ LH+
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQR--- 116
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
IIH DIKP+N+L+D + +++DFGL++ L ++ GT Y+APE +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDD 171
Query: 695 VKVDVYSFGVLLLEII 710
D +S G ++ E +
Sbjct: 172 KMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 79/279 (28%), Positives = 122/279 (43%), Gaps = 37/279 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNL 574
E +G GA VVY AI + VA+K++ Q V E + EV + Q +H N+
Sbjct: 5 LIEVIGVGATAVVYA-AICLP--NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEE 631
V+ G LV +LS G+L + G IA + +GL YLH
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH-- 119
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD---QSQTHTAIRGTKGYVAPEWF 688
S IH DIK NILL + + +I+DFG++ L + GT ++APE
Sbjct: 120 -SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 689 RNMP-ITVKVDVYSFGVLLLEIICCR----RNVDMEVNEAEALLTDWAYDCYCEGITEAL 743
+ K D++SFG+ +E+ + M+V +LT +
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLT----------LQNDP 224
Query: 744 VEFDIEALNDKKKLARFV--MVAIWCIQEDPSLRPTMRK 780
+ A D KK ++ M+++ C+Q+DPS RPT +
Sbjct: 225 PSLETGA--DYKKYSKSFRKMISL-CLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 520 LGKGAFGVVYKGA-IGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVRL 577
LG GAFG VYKG + ++PVA+K L+ EF E ++ H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLF-------GDLKPGWSRRTDIAFGIARGLLYLHE 630
LG C +L V + + +G L ++ L W + IA+G++YL E
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEW 687
+++H D+ +N+L+ + +I+DFGLA+LL D+ + + G K ++A E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALEC 182
Query: 688 FRNMPITVKVDVYSFGVLLLEII 710
T + DV+S+GV + E++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLV 575
E +G+G +G VYK VA+K + +I+D +E K E N++ + ++H N+
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQL---VAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 576 RLLGF--------CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD-IAF---GIAR 623
G DD L LV E G++ + G K G + + IA+ R
Sbjct: 67 TFYGAFIKKNPPGNDDQL--WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
GL YLHE ++IH DIK QNILL ++ DFG++ L + +T I GT ++
Sbjct: 125 GLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWM 180
Query: 684 APEWF-----RNMPITVKVDVYSFGVLLLE 708
APE + + DV+S G+ +E
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQ-VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+++LG G FG V+ MA+ + VAVK + V+ F E NV+ H L
Sbjct: 10 LEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKL 63
Query: 575 VRLLGFCDDGLNRLLVY---EFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLH 629
V+L + + +Y EF++ G+L FL D K + D + IA G+ ++
Sbjct: 64 VKLHAV----VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPE 686
+ IH D++ NIL+ +I+DFGLA+++ + +TA G K + APE
Sbjct: 120 QR---NYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPE 173
Query: 687 WFRNMPITVKVDVYSFGVLLLEII 710
T+K DV+SFG+LL+EI+
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 84/279 (30%), Positives = 125/279 (44%), Gaps = 44/279 (15%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
+LG+G FG V+ G + VA+K L + F E ++ + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTT----KVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLY 67
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLF-GDLKP-GWSRRTDIAFGIARGLLYLHEECSTQI 636
+ +V EF+ G+L FL GD K + D+A IA G+ Y+
Sbjct: 68 AVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEWFRNMPI 693
IH D++ NIL+ D +I+DFGLA+L+ + +TA +G K + APE
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 694 TVKVDVYSFGVLLLEIICCRR-----NVDMEVNEAEALLTDWAYDCYC-EGITEALVEFD 747
T+K DV+SFG+LL E++ R V+ EV E + Y C +G E+L E
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----VERGYRMPCPQGCPESLHE-- 234
Query: 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+M W ++DP RPT + LE
Sbjct: 235 -------------LMKLCW--KKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-16
Identities = 35/108 (32%), Positives = 50/108 (46%), Gaps = 3/108 (2%)
Query: 45 LSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLV 104
+S F GF L + I Y +T+VW AN D+P+ S + L +D LV
Sbjct: 11 VSSGSLFELGFFKL-IMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLV 68
Query: 105 LTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWESFNNP 151
+ G +W S+ Y L + D GN VL + N LW+SF+ P
Sbjct: 69 IYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVR 576
E LGKG FG V+KG + + PVAVK + +K +F +E ++ Q H N+V+
Sbjct: 1 ELLGKGNFGEVFKGTL----KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLHEECS 633
L+G C +V E + G SFL +LK + A A G+ YL S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLE---S 111
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG-------YVAPE 686
IH D+ +N L+ + +ISDFG+++ Q I + G + APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPE 164
Query: 687 WFRNMPITVKVDVYSFGVLLLE 708
+ + DV+S+G+LL E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVP----VAVKKLH-SVIQDGVKEFKTEVNVIGQTHH- 571
E +G+GA+G VY+G VP VA+K ++ D V + + EV ++ Q
Sbjct: 7 ELIGRGAYGAVYRG-------KHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQS 59
Query: 572 --KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLL--- 626
N+ + G G ++ E+ G++ + + K G I+ I R +L
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISV-IIREVLVAL 114
Query: 627 -YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
Y+H +IH DIK NIL+ + N ++ DFG+A LL + S+ T + GT ++AP
Sbjct: 115 KYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAP 170
Query: 686 EWFRN-MPITVKVDVYSFGVLLLEII 710
E K D++S G+ + E+
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 520 LGKGAFGVVYKGAIGMASMYQV----PVAVKK-----LHSVIQDGVKEFKTEVNVIGQTH 570
LG+GAFG VY Y V +AVK+ + V + E+ ++
Sbjct: 10 LGQGAFGRVY-------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYL 628
H+ +V+ G D + E++ G++ L +G L +R+ I G+ YL
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK--YTRQILEGVEYL 120
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR---GTKGYVAP 685
H S I+H DIK NIL D N ++ DFG +K L S T ++ GT +++P
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSP 176
Query: 686 EWFRNMPITVKVDVYSFGVLLLEII 710
E K DV+S G ++E++
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 71/301 (23%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMY-------QVPVAVKKLHSVIQDGVKEFKTEVNVIGQ 568
K ELG+GAFG V+ +A Y ++ VAVK L + K+F E ++
Sbjct: 9 LKRELGEGAFGKVF-----LAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN 63
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASF---------LFGDLKP----GWSRRT 615
H+++V+ G C +G ++V+E++ +G L F L + S+
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-----S 670
IA IA G++YL S +H D+ +N L+ + +I DFG+++ +
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW 730
T IR ++ PE T + DV+S GV+L EI + +++ E +
Sbjct: 181 HTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---- 232
Query: 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVM-VAIWCIQEDPSLRPTMRKVTQMLEGVV 789
+C +G L + + V + + C Q +P +R ++++ +L+ +
Sbjct: 233 --ECITQG----------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280
Query: 790 E 790
+
Sbjct: 281 K 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 520 LGKGAFGVVYKGAI-GMASMYQVPVAVKKLHSVIQDGVKEFK---TEVNVIGQTHHKNLV 575
LGKG FG V + +Y A KKL+ K ++ E ++ + H + +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLY----ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFG--DLKPGWSRRTDIAFG--IARGLLYLHEE 631
L + LV ++ G L ++ + PG+ + I GL +LH+
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+II+ D+KP+N+LLD+ N RISD GLA L QS+T GT G++APE +
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK-GYAGTPGFMAPELLQGE 172
Query: 692 PITVKVDVYSFGVLLLEIICCR 713
VD ++ GV L E+I R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 15/196 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVR 576
E++GKG+FG V+KG + + Q VA+K + +D +++ + E+ V+ Q + +
Sbjct: 10 EKIGKGSFGEVFKG---IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEECS 633
G ++ E+L G+ L +PG T IA I +GL YLH E
Sbjct: 67 YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE-- 120
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+ IH DIK N+LL ++ +++DFG+A L Q + +T + GT ++APE +
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 694 TVKVDVYSFGVLLLEI 709
K D++S G+ +E+
Sbjct: 179 DSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
+LG+G FG V+ G + VA+K L + F E V+ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR----VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLY 67
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKP--GWSRRTDIAFGIARGLLYLHEECSTQI 636
+ +V E++S G+L FL G++ + D+A IA G+ Y+
Sbjct: 68 AVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEWFRNMPI 693
+H D++ NIL+ + +++DFGLA+L+ + +TA +G K + APE
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 694 TVKVDVYSFGVLLLEI 709
T+K DV+SFG+LL E+
Sbjct: 181 TIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 23/202 (11%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
ELG GAFG VYK ++ A K + ++ +++F E++++ + H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLF---AAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 579 G--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR----GLLYLHEEC 632
F ++ L L+ EF G L S + +L+ G + I + + R L +LH
Sbjct: 69 EAYFYENKLWILI--EFCDGGALDS-IMLELERGLTE-PQIRY-VCRQMLEALNFLHSH- 122
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP-----EW 687
++IH D+K NILL + +++DFG++ + T I GT ++AP E
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACET 179
Query: 688 FRNMPITVKVDVYSFGVLLLEI 709
F++ P K D++S G+ L+E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 32/216 (14%)
Query: 520 LGKGAFG-VVYKGAIGM---ASMYQVPVAVKKL-----HSVIQDGVKEFKTEVNVIGQTH 570
LG+G FG VV A+G+ V VAVK L + D V E + + +IG+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM-MKMIGK-- 79
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA------------ 618
HKN++ LLG C ++ E+ S G L +L PG DIA
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 619 ----FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK-LLLLDQSQTH 673
+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + +D +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
T R ++APE + T + DV+SFGVL+ EI
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 518 EELGKGAFGVVYKGA-IGMASMYQVPVAVKKL------HSVIQDGVKEFKTEVNVIGQTH 570
++LG GAF Y+ + ++ +AVK++ S ++ V+ + E+ ++ + +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 571 HKNLVRLLG-FCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLY 627
H +++R+LG C+D L V E+++ G+++ L +G K + RGL Y
Sbjct: 62 HPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIIN--YTEQLLRGLSY 118
Query: 628 LHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLLLLDQSQT---HTAIRGTKGYV 683
LHE QIIH D+K N+L+D RI+DFG A L + + GT ++
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEIIC 711
APE R DV+S G +++E+
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 71/216 (32%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 520 LGKGAFG-VVYKGAIGM---ASMYQVPVAVKKLH-----SVIQDGVKEFKTEVNVIGQTH 570
LG+G FG VV AIG+ V VAVK L + D V E + + +IG+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEM-MKMIGK-- 76
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI------------- 617
HKN++ LLG C ++ E+ S G L +L PG D
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 618 ---AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK-LLLLDQSQTH 673
A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + +D +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
T R ++APE + T + DV+SFGVLL EI
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+ +G G +G VYK A +A+ VA+K + D + + E++++ + H N+V
Sbjct: 7 LIQRIGSGTYGDVYK-ARDIAT--GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 576 RLLG--FCDDGLNRLLVYEFLSNGTLA---SFLFGDLKPGWSRRTDIAFGIAR----GLL 626
G D L +V E+ G+L G L IA+ + R GL
Sbjct: 64 AYFGSYLRRDKL--WIVMEYCGGGSLQDIYQVTRGPLS-----ELQIAY-VCRETLKGLA 115
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
YLHE T IH DIK NILL + + +++DFG++ L ++ + I GT ++APE
Sbjct: 116 YLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPE 171
Query: 687 WF---RNMPITVKVDVYSFGVLLLE 708
R K D+++ G+ +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 520 LGKGAFGVVYKGA-IGMASMYQVPVAVKKLHSVIQDGV-KEFKTEVNVIGQTHHKNLVRL 577
LG GAFG VYKG I ++PVA+K+L KE E V+ + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT-DIAFGIARGLLYLHEECSTQI 636
LG C +L + + + G L ++ S+ + IA+G+ YL E ++
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RL 130
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEWFRNMPI 693
+H D+ +N+L+ + +I+DFGLAKLL D+ + H G K ++A E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--EGGKVPIKWMALESILHRIY 188
Query: 694 TVKVDVYSFGVLLLEII 710
T + DV+S+GV + E++
Sbjct: 189 THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 67/200 (33%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 520 LGKGAFGVV----YKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNL 574
LGKG+FG V KG +Y V V +KK + D V+ TE V+ H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKV-LKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+L C +RL V E+++ G L + + R A I GL +LHE
Sbjct: 59 TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-- 115
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
II+ D+K N+LLD + +I+DFG+ K +L T T GT Y+APE P
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPY 173
Query: 694 TVKVDVYSFGVLLLEIICCR 713
VD ++ GVLL E++ +
Sbjct: 174 GPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 520 LGKGAFGVVYKG---AIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLV 575
LG+G FG V+ I V VK L ++ EF+ E+++ + HKN+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGET-LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFL------FGDLKP---GWSRRTDIAFGIARGLL 626
RLLG C + ++ E+ G L FL LKP ++ + IA G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ----SQTHTAIRGTKGY 682
+L + + +H D+ +N L+ ++S L+K + + +R +
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----W 184
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEI 709
+APE + + K DV+SFGVL+ E+
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 82/283 (28%), Positives = 131/283 (46%), Gaps = 34/283 (12%)
Query: 516 FKEELGKGAFG-VVYKGAIGMA-SMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQT-HH 571
F + LG GAFG VV A G++ S + VAVK L +E +E+ ++ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IARGLLYLH 629
+N+V LLG C G L++ E+ G L +FL + + ++F +A+G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK----GYVAP 685
S IH D+ +N+LL +I DFGLA+ ++ D ++ ++G ++AP
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWMAP 212
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYCEGITEAL 743
E N T + DV+S+G+LL EI N M V+ Y EG A
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-------FYKLIKEGYRMAQ 265
Query: 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
E + D +M W DP RPT +++ Q++
Sbjct: 266 PEHAPAEIYD-------IMKTCW--DADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQ---VPVAVKKLHSV-----IQDGVKEFKTEVNVIGQTH 570
LG+G FG VV AIG+ VAVK L S + D + E + + +IG+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM-MKMIGK-- 82
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG----------------WSRR 614
HKN++ LLG C ++ E+ S G L +L PG +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 615 TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK-LLLLDQSQTH 673
A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + +D +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
T R ++APE + T + DV+SFGVLL EI
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 48/217 (22%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVP----VAVKKLHSVIQDG-VKEFKTEVNVIGQTHH- 571
EELG+GA+GVV K M VP +AVK++ + + K ++++ ++
Sbjct: 7 EELGRGAYGVVDK-------MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 572 KNLVRLLG---------FC----DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA 618
V G C D L++ + T+ + G IA
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK----------IA 109
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
I + L YLH + S +IH D+KP N+L++ ++ DFG++ L+ ++T A G
Sbjct: 110 VSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--G 165
Query: 679 TKGYVAPEWFRNMPIT------VKVDVYSFGVLLLEI 709
K Y+APE R P VK DV+S G+ ++E+
Sbjct: 166 CKPYMAPE--RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 36/183 (19%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG------VKEFKTEVNVIGQTHHKN 573
+G+GA G+V+K A + VA+KK+ +G ++E K H
Sbjct: 8 IGEGAHGIVFK-AKDRET--GETVALKKVALRRLEGGIPNQALREIKALQAC----QHPY 60
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA----------R 623
+V+LL G +LV E++ L+ L R + A +
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMP-SDLSEVL---------RDEERPLPEAQVKSYMRMLLK 110
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
G+ Y+H I+H D+KP N+L+ +I+DFGLA+L ++ + ++ T+ Y
Sbjct: 111 GVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167
Query: 684 APE 686
APE
Sbjct: 168 APE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 67/230 (29%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 516 FKEELGKGAFGVVYK-GAIGMASMYQVP----------VAVKKLHS-VIQDGVKEFKTEV 563
KE+LG+G FG V+ A G+A VAVK L + V + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 564 NVIGQTHHKNLVRLLGFC--DDGLNRLLVYEFLSNGTLASFL----------FGDLKPGW 611
++ + + N++RLLG C DD L ++ E++ NG L FL + P
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPL--CMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 612 SRRT--DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669
S +A IA G+ YL S +H D+ +N L+ ++Y +I+DFG+++ L
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY--- 180
Query: 670 SQTHTAIRGTKGYVAPEWFRNMPI-----TVKVDVYSFGVLLLEI-ICCR 713
S + I+G + + W I T DV++FGV L E+ C+
Sbjct: 181 SGDYYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 520 LGKGAFGVVYKGAI-GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-----HKN 573
LGKG FG V + MY A KKL + +K+ K E + + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMY----ACKKLE---KKRIKKRKGESMALNEKQILEKVNSR 60
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC- 632
V L + + + L + L NG GDLK + F R + Y E C
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNG-------GDLKFHIYHMGEAGFEEGRAVFYAAEICC 113
Query: 633 ------STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
+I++ D+KP+NILLDD+ + RISD GLA + + + QT GT GY+APE
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171
Query: 687 WFRNMPITVKVDVYSFGVLLLEII 710
+N T D ++ G LL E+I
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQ---VPVAVKKLHSV-----IQDGVKEFKTEVNVIGQTH 570
LG+G FG VV A G+ V VAVK L + D + E + + +IG+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIGK-- 76
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI------------- 617
HKN++ LLG C ++ E+ + G L FL PG DI
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 618 ---AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK-LLLLDQSQTH 673
A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ + +D +
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
+ R ++APE + T + DV+SFG+L+ EI
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 520 LGKGAFGVVYKGAI-GMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLV 575
LGKG FG V + MY A KKL + G K E ++ + + +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMY----ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIV 56
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEECS 633
L + + LV ++ G L ++ G+ R + I G+L+LH S
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---S 113
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
I++ D+KP+N+LLDD N R+SD GLA L ++ T A GT GY+APE + P
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPY 171
Query: 694 TVKVDVYSFGVLLLEIICCR 713
+ VD ++ G + E++ R
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 520 LGKGAFGVVYKGAIGMA-SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LGKG+FG V + + +Y V V +KK + D V+ TE ++ + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKV-LKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 579 GFCDDGLNRLL-VYEFLSNGTLASFLFGDLKPGWSRRTD------IAFGIARGLLYLHEE 631
C +RL V EF++ G L +F K SRR D A I L++LH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL---MFHIQK---SRRFDEARARFYAAEITSALMFLHDK 115
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
II+ D+K N+LLD + +++DFG+ K + + T T GT Y+APE + M
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEM 171
Query: 692 PITVKVDVYSFGVLLLEIICCRRNVDMEVNEA--EALLTD 729
VD ++ GVLL E++C + E + EA+L D
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 64/192 (33%), Positives = 92/192 (47%), Gaps = 5/192 (2%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLL 578
LGKG+FG V+ + + + A+KK ++ D V+ E V+ H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
N V E+L+ G L + K R T A I GL +LH S I++
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVY 119
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
D+K NILLD + +I+DFG+ K +L ++T T GT Y+APE VD
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSVD 178
Query: 699 VYSFGVLLLEII 710
+SFGVLL E++
Sbjct: 179 WWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 520 LGKGAFGVVYKGAIGMA-SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LG+G FG V +G + S+ +V V K+ + +++F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 579 GFCDDGLNR------LLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAF--GIARGLL 626
G C + +++ F+ +G L SFL GD + + F IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL-DQSQTHTAIRGTKGYVAP 685
YL S IH D+ +N +L++ N ++DFGL+K + D + + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 686 EWFRNMPITVKVDVYSFGVLLLEI 709
E + T K DV+SFGV + EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 67/200 (33%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 520 LGKGAFGVVYKGAI-GMASMYQVPVAVKKLHSVIQDGVKEFKTEV-----NVIGQTHHKN 573
LGKG FG V + MY A KKL + +K+ K E I + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMY----ACKKLE---KKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 574 LVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGW--SRRTDIAFGIARGLLYLHE 630
V L + + + L LV ++ G L ++ PG+ R A I GL LH
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
E +I++ D+KP+NILLDDY + RISD GLA + + + +T GT GY+APE +N
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 691 MPITVKVDVYSFGVLLLEII 710
T D + G L+ E+I
Sbjct: 176 ERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 61/194 (31%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIG-QTHHKNLVRLL 578
LGKG+FG V + + + A+KK + D V+ E V+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 579 GFCDDGLNRLL--VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
FC L V E+L+ G L + + +R A I GL +LH I
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGI 117
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
I+ D+K N+LLD + +I+DFG+ K + + + T GT Y+APE +
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNES 176
Query: 697 VDVYSFGVLLLEII 710
VD +SFGVLL E++
Sbjct: 177 VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 520 LGKGAFGVVYK------GAIGMASMYQVPVAVKK-LHSVIQDGVKEFKT-EVNVIGQTHH 571
+G+G++G+V K G I VA+KK L S VK+ E+ ++ Q H
Sbjct: 9 VGEGSYGMVMKCKHKETGQI---------VAIKKFLESEDDKMVKKIAMREIRMLKQLRH 59
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+NLV L+ LV+EF+ + L SR F I RG+ + H
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH-- 117
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
S IIH DIKP+NIL+ ++ DFG A+ L + +T YVA W+R
Sbjct: 118 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT------DYVATRWYRAP 169
Query: 692 PITVK-------VDVYSFGVLLLEII 710
+ V VD+++ G L+ E++
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVR 576
E +G+G FG V+ G + + PVAVK + +K +F E ++ Q H N+VR
Sbjct: 1 ERIGRGNFGEVFSGRLRADN---TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF--GIARGLLYLHEECST 634
L+G C +V E + G +FL + P + I A G+ YL +
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK----GYVAPEWFRN 690
IH D+ +N L+ + +ISDFG+++ ++ + + G K + APE
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 691 MPITVKVDVYSFGVLLLE 708
+ + DV+SFG+LL E
Sbjct: 171 GRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
++G+G +GVVYK + VA+KK+ + E+ ++ + +H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEI---VAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECST 634
+LL + LV+EF+ L + + S + + +GL + H S
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI- 693
I+H D+KP+N+L++ +++DFGLA+ + +T T+ Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 694 TVKVDVYSFGVLLLEII 710
+ VD++S G + E++
Sbjct: 177 STPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRL 577
LGKG+FG V+ G +Y + + K + +IQD V+ E V+ +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 578 LGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEECS 633
L C ++RL V E+++ G L ++ + G + F IA GL +LH S
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---S 119
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
II+ D+K N++LD + +I+DFG+ K + T T GT Y+APE P
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPY 178
Query: 694 TVKVDVYSFGVLLLEII 710
VD ++FGVLL E++
Sbjct: 179 GKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 26/205 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT-EVNVIGQTHHKNLV 575
E++G+G +GVVYKG VA+KK+ ++GV E++++ + H N+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQI---VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 576 RLLGFCDDGL---NRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIA----FGIARGLLY 627
L D L +RL L++EFLS L +L L G ++ + I +G+L+
Sbjct: 63 CLQ----DVLMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPE 686
H S +++H D+KPQN+L+D+ +++DFGLA+ + + TH + T Y APE
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPE 171
Query: 687 WFRNMP-ITVKVDVYSFGVLLLEII 710
P + VD++S G + E+
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 42/208 (20%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT---------EVNVIGQTH 570
+G GAFG+V + VA+KK+ +K F T E+ ++
Sbjct: 18 VGMGAFGLVCSARDQLTGQ---NVAIKKI-------MKPFSTPVLAKRTYRELKLLKHLR 67
Query: 571 HKNLVRLLGFCDDGLNRL----LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLL 626
H+N++ L D ++ L V E L L+ + + + I RGL
Sbjct: 68 HENIISL---SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY--FLYQILRGLK 122
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
Y+H S ++H D+KP NIL+++ + +I DFGLA++ Q T T+ Y APE
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPE 175
Query: 687 ----WFRNMPITVKVDVYSFGVLLLEII 710
W + V+VD++S G + E++
Sbjct: 176 IMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 520 LGKGAFGVVYKGA-IGMASMYQVPVAVKKL-HSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
LG GAFG VYKG I ++PVA+K L + KE E V+ + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQI 636
LG C +L V + + G L ++ + + G + IA+G+ YL E ++
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK---GYVAPEWFRNMPI 693
+H D+ +N+L+ + +I+DFGLA+LL +D+++ H G K ++A E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA--DGGKVPIKWMALESILHRRF 188
Query: 694 TVKVDVYSFGVLLLEII 710
T + DV+S+GV + E++
Sbjct: 189 THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVKEFKT-EVNVIGQTHHKNLV 575
E++G+G +GVVYK + +A+KK+ +D GV E++++ + H N+V
Sbjct: 8 EKIGEGTYGVVYKAR---DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA----FGIARGLLYLHEE 631
RL LV+E+L + L + D P +++ + + I RG+ Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYL-DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCH-- 119
Query: 632 CSTQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPE-WF 688
S +++H D+KPQN+L+D NA +++DFGLA+ + ++ TH + T Y APE
Sbjct: 120 -SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILL 176
Query: 689 RNMPITVKVDVYSFGVLLLEII 710
+ + VD++S G + E++
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 518 EELGKGAFGVV----YKGA-IGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQTHH 571
LG+G FG V Y A G M VAVK L +K E+N++ +H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEM----VAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 572 KNLVRLLGFCDDGLNR--LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
+N+V+ G C + + L+ E++ G+L +L K ++ A I G+ YLH
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLH 124
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG--YVAPEW 687
S IH D+ +N+LLD+ +I DFGLAK + G + A E
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 688 FRNMPITVKVDVYSFGVLLLEII 710
+ + DV+SFGV L E++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 48/235 (20%)
Query: 516 FKEELGKGAFGVVY-------------KGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT 561
F E+LG+G FG V+ A + V VAVK L + ++F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 562 EVNVIGQTHHKNLVRLLGFC--DDGLNRLLVYEFLSNGTLASFL-----------FGDLK 608
EV ++ + N+ RLLG C D L ++ E++ NG L FL
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPL--CMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 609 PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
+S +A IA G+ YL S +H D+ +N L+ Y +I+DFG+++ L
Sbjct: 127 LSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY-- 181
Query: 669 QSQTHTAIRGTKGYVAPEWFRNMP--------ITVKVDVYSFGVLLLEIIC-CRR 714
S + ++G AP R M T K DV++FGV L EI+ CR
Sbjct: 182 -SSDYYRVQGR----APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD------GVKEFKTEVNVIGQTHHK 572
ELG+GA+G+V A + + VA+KK+ +V ++E K + G HK
Sbjct: 7 ELGQGAYGIVCS-ARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HK 62
Query: 573 NLVRLLGF---CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
N+ L N L +YE L L + + + I GL Y+H
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
S ++H D+KP N+L++ +I DFGLA+ + + + YVA W+R
Sbjct: 123 ---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM---TEYVATRWYR 176
Query: 690 -------NMPITVKVDVYSFGVLLLEII 710
T +DV+S G +L E++
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 47/214 (21%)
Query: 520 LGKGAFGVVYKGAIGMASMYQV---PVAVKKLH----SVIQDGVKEFKT--EVNVIGQTH 570
LG+G + VVYK + VA+KK+ +DG+ F E+ ++ +
Sbjct: 8 LGEGTYAVVYKA------RDKETGRIVAIKKIKLGERKEAKDGI-NFTALREIKLLQELK 60
Query: 571 HKNLVRLLG-FC-DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA------ 622
H N++ LL F +N LV+EF+ DL+ + I A
Sbjct: 61 HPNIIGLLDVFGHKSNIN--LVFEFME---------TDLEKVI-KDKSIVLTPADIKSYM 108
Query: 623 ----RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTAIR 677
RGL YLH S I+H D+KP N+L+ +++DFGLA+ + TH +
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV- 164
Query: 678 GTKGYVAPE-WFRNMPITVKVDVYSFGVLLLEII 710
T+ Y APE F V VD++S G + E++
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 516 FKEELGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKN 573
F LGKG+FG V+ G +Y + + K + VIQD V+ E V+ +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALSGKPP 61
Query: 574 LVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLH 629
+ L C ++RL V E+++ G L ++ + G + F IA GL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
S II+ D+K N++LD + +I+DFG+ K + D T T GT Y+APE
Sbjct: 119 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIA 174
Query: 690 NMPITVKVDVYSFGVLLLEII 710
P VD ++FGVLL E++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 62/196 (31%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 520 LGKGAFGVVY--KGAIGMAS--MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
LG+G+FG V+ + G + +Y + V +KK ++D V+ K E +++ + +H +V
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKV-LKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 576 RL-LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
+L F +G L+ +FL G L + L K D+ F +A L L S
Sbjct: 62 KLHYAFQTEG-KLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
II+ D+KP+NILLD+ + +++DFGL+K + + + ++ GT Y+APE T
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGHT 176
Query: 695 VKVDVYSFGVLLLEII 710
D +SFGVL+ E++
Sbjct: 177 QSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQTHHKNLV 575
+G+G FG VY+G ++ VAVK + V+E F E ++ Q H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IARGLLYLHEECS 633
+L+G + +V E G L S+L + K + I + ++ L YL S
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---S 125
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK--GYVAPEWFRNM 691
+ +H DI +N+L+ ++ DFGL++ L+ + A +G ++APE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSR--YLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 692 PITVKVDVYSFGVLLLEII 710
T DV+ FGV + EI+
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQ-DGVKEFKTEVNVIGQTHHKNLVR 576
+G G FG V+ ++ Y A+K + VI+ + E V+ + H ++R
Sbjct: 9 VGTGTFGRVHLVRDRISEHY---YALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IARGLLYLHEECST 634
L D ++ E++ G L S+L + +S T + + I L YLH S
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLH---SK 120
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+I++ D+KP+NILLD + +++DFG AK L D++ T + GT Y+APE ++
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWT---LCGTPEYLAPEVIQSKGHN 176
Query: 695 VKVDVYSFGVLLLEII 710
VD ++ G+L+ E++
Sbjct: 177 KAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 39/212 (18%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLVRL 577
+G GA+G V VA+KKL Q + +T E+ ++ H+N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK---VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79
Query: 578 LG-FC-DDGLNRL----LVYEFLS---NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYL 628
L F L LV + N + D + + I RGL Y+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD-----DHIQFLVYQILRGLKYI 134
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
H S IIH D+KP NI +++ +I DFGLA+ HT T GYVA W+
Sbjct: 135 H---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR---------HTDDEMT-GYVATRWY 181
Query: 689 RN-------MPITVKVDVYSFGVLLLEIICCR 713
R M VD++S G ++ E++ +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 520 LGKGAFGVVY------KGAIGMASMYQVPVAVKKLH-SVI--QDGVKEFKTEVNVIGQTH 570
+G+GAFG V+ G + A+K L S + ++ + + E +++
Sbjct: 9 IGRGAFGEVWLVRDKDTGQV---------YAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 571 HKNLVRLL-GFCDDGLNRL-LVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLL 626
+V+L F D+ L LV E++ G L + L +R F IA +L
Sbjct: 60 SPWIVKLYYSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEETAR-----FYIAELVL 112
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK---------------LLLLDQSQ 671
L IH DIKP NIL+D + +++DFGL K LL +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 672 THTAIR-------------GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
R GT Y+APE R P ++ D +S GV+L E++
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 26/211 (12%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQ-THHK 572
++LGKGA+G+V+K AI + +V VA+KK+ + D + F+ E+ + + H
Sbjct: 12 LQKLGKGAYGIVWK-AIDRRT-KEV-VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHP 67
Query: 573 NLVRLLGF--CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHE 630
N+V+LL ++ + LV+E++ A L+ R I + + + L Y+H
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY--IMYQLLKALKYIH- 124
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL-LDQSQTHTAIRGTKGYVAPEWFR 689
S +IH D+KP NILL+ +++DFGLA+ L L+++ + + T YVA W+R
Sbjct: 125 --SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL--TD-YVATRWYR 179
Query: 690 NMPITVK-------VDVYSFGVLLLEIICCR 713
I + VD++S G +L E++ +
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 15/197 (7%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
LG G FG V + + VKK H V + +E ++ + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 580 FCDDGLNRLLVYEFLSNGTLASFL-----FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
D ++ E+ G L + L F + ++ R IA + YLH +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIAC-VVLAFEYLH---NR 112
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
II+ D+KP+N+LLD ++ DFG AK L +T T GT YVAPE N
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFC-GTPEYVAPEIILNKGYD 170
Query: 695 VKVDVYSFGVLLLEIIC 711
VD +S G+LL E++
Sbjct: 171 FSVDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 520 LGKGAFGVVYKGAI-GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-----HKN 573
LGKG FG V + MY A K+L + +K+ K E + + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMY----ACKRLE---KKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 574 LVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IARGLLYLHE 630
V L + + + L LV ++ G L ++ PG+ + + I GL LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
E ++ D+KP+NILLDDY + RISD GLA + + + ++ GT GY+APE N
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 691 MPITVKVDVYSFGVLLLEII 710
T+ D + G L+ E+I
Sbjct: 176 QRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV--KEFKTEV 563
Y+DL+ +G GA+G V VA+KKL+ Q + K E+
Sbjct: 17 YRDLKQ--------VGSGAYGTVCSALDRRTG---AKVAIKKLYRPFQSELFAKRAYREL 65
Query: 564 NVIGQTHHKNLVRLLGF--CDDGLNRL----LVYEFLSNGTLASFLFGDLKPGWSRRTDI 617
++ H+N++ LL D L+R LV F+ GT L K R +
Sbjct: 66 RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
+ + +GL Y+H + IIH D+KP N+ +++ +I DFGLA+ QT + +
Sbjct: 124 VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMT 173
Query: 678 G---TKGYVAPEWFRN-MPITVKVDVYSFGVLLLEII 710
G T+ Y APE N M T VD++S G ++ E++
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKN 573
F++ +G+G FG V + I + ++ A+K L ++ ++F E+ V+ + HH N
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGL-KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG----DLKPGWSRR------------TDI 617
++ LLG C++ + E+ G L FL + P +++
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
A +A G+ YL E+ Q IH D+ +N+L+ + ++I+DFGL++ ++
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVK 174
Query: 678 GTKGYVAPEWFR----NMPI-TVKVDVYSFGVLLLEII 710
T G + W N + T K DV+SFGVLL EI+
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 33/270 (12%)
Query: 527 VVYKGAIGMASMY-------QVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
V+ KGA G A++Y V L + + ++ E+ ++ H N++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 580 -FCDDGLNRLLV-YEFLSNGTLASFLFGDLKPGWSRRTDIA--FGIARGLLYLHEECSTQ 635
F DD N LL+ E+ + GTL + + + F I + Y+H+
Sbjct: 67 HFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITV 695
I+H DIK NI L ++ DFG++K+L + S T + GT Y++PE + +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 696 KVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKK 755
K D+++ G +L E++ +R +A L I +
Sbjct: 181 KSDIWALGCVLYELLTLKR-----TFDATNPLN------LVVKIVQG-----NYTPVVSV 224
Query: 756 KLARFVMVAIWCIQEDPSLRPTMRKVTQML 785
+ + + +Q+DP RPT +V
Sbjct: 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 31/207 (14%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQD-GVKEFKT-EVNVIGQT 569
E++G+G +GVVYK G I VA+KK+ +D GV E++++ +
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEI---------VALKKIRLETEDEGVPSTAIREISLLKEL 55
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI----AFGIARGL 625
+H N+VRLL LV+EFL + L ++ D P + + + +G+
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVA 684
Y H S +++H D+KPQN+L+D +++DFGLA+ + ++ TH + T Y A
Sbjct: 113 AYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRA 167
Query: 685 PEWFRNMP-ITVKVDVYSFGVLLLEII 710
PE + VD++S G + E++
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 9/210 (4%)
Query: 513 TNGFKEELGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTH 570
F LGKG+FG V+ G +Y + + K + VIQD V+ E V+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALQD 58
Query: 571 HKNLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
+ L C ++RL V E+++ G L + K + A I+ GL +LH
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
II+ D+K N++LD + +I+DFG+ K ++D T T GT Y+APE
Sbjct: 119 RR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIA 174
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRNVDME 719
P VD +++GVLL E++ + D E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 520 LGKGAFGVVY------KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNV-IGQTHHK 572
+GKG+FG V G Y V V KK + + K E NV + H
Sbjct: 3 IGKGSFGKVLLAKHKADGKF-----YAVKVLQKK-AILKKKEQKHIMAERNVLLKNVKHP 56
Query: 573 NLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
LV L + ++L V ++++ G L L + R A IA L YLH
Sbjct: 57 FLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH-- 113
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
S II+ D+KP+NILLD + ++DFGL K ++ S+T + GT Y+APE R
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 692 PITVKVDVYSFGVLLLEII 710
P VD + G +L E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 520 LGKGAFGVVYKGAI-GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-----HKN 573
LGKG FG V + MY A KKL + +K+ K E + + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMY----ACKKLE---KKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 574 LVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IARGLLYLHE 630
V L + + + L LV ++ G L ++ PG+ + I + + GL L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
E +I++ D+KP+NILLDD + RISD GLA + + + +T GT GY+APE N
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 691 MPITVKVDVYSFGVLLLEII 710
T D + G L+ E+I
Sbjct: 176 EKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 41/223 (18%)
Query: 519 ELGKGAFGVVYKG-AIGMASMY-QVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLV 575
++G+GAFG V++ A G+ VAVK L ++ +F+ E ++ + H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWS---------------RRTD---- 616
+LLG C G L++E+++ G L FL P
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFL-RHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 617 ----IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL------ 666
IA +A G+ YL E + +H D+ +N L+ + +I+DFGL++ +
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
++ IR ++ PE T + DV+++GV+L EI
Sbjct: 188 ASENDA-IPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 8/192 (4%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
++G+G+ G+V I VAVKK+ Q + EV ++ HH+N+V +
Sbjct: 29 KIGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
G +V EFL G L + + + + + R L YLH + +IH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
DIK +ILL ++SDFG + + + + + GT ++APE +P +VD
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 699 VYSFGVLLLEII 710
++S G++++E+I
Sbjct: 201 IWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 43/287 (14%)
Query: 513 TNGFKEE--LGKGAFGVVYKGAIGMASMYQVPVAVKKLH-------SVIQDGVKEFKTEV 563
FK E +GKG F VVYK + + VA+KK+ QD +KE +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---ICLLDGRVVALKKVQIFEMMDAKARQDCLKE----I 53
Query: 564 NVIGQTHHKNLVRLL-GFCDDGLNRL-LVYEFLSNGTLASFL--FGDLKPGWSRRT--DI 617
+++ Q H N+++ L F ++ N L +V E G L+ + F K RT
Sbjct: 54 DLLKQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
+ L ++H S +I+H DIKP N+ + ++ D GL + + H+ +
Sbjct: 112 FVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV- 167
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737
GT Y++PE K D++S G LL E+ + + + L C+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYS-----LCK 218
Query: 738 GITEALVEFD-IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
I + ++ + A + ++L V CI DP RP + V Q
Sbjct: 219 KIEKC--DYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRL 577
+G+G FG V K I + ++ A+K++ +D ++F E+ V+ + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGI------------ 621
LG C+ L E+ +G L FL + P ++ A +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG 681
ARG+ YL ++ Q IH D+ +NIL+ + Y A+I+DFGL++ ++ T G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMG 171
Query: 682 YVAPEWFR----NMPI-TVKVDVYSFGVLLLEII 710
+ W N + T DV+S+GVLL EI+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 519 ELGKGAFGVVYKGA-IGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTH---HK 572
E+G+GA+G V+K + + VA+K++ + T EV V+ H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRF---VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 573 NLVRLLGFC-----DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGL 625
N+VRL C D LV+E + L ++L +PG T D+ F + RGL
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
+LH S +++H D+KPQNIL+ +++DFGLA++ + T + T Y AP
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 178
Query: 686 EWFRNMPITVKVDVYSFGVLLLEI 709
E VD++S G + E+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT-EVNVIGQTHHKNLV 575
E++G+G +GVVYK + VA+KK+ +GV E++++ + +H N+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA----FGIARGLLYLHEE 631
+LL LV+EFL + L F+ D P + F + +GL + H
Sbjct: 63 KLLDVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPEWFRN 690
S +++H D+KPQN+L++ +++DFGLA+ + ++ TH + T Y APE
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 174
Query: 691 MPI-TVKVDVYSFGVLLLEII 710
+ VD++S G + E++
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRL 577
LGKG FG V + + VAVK L + I ++EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 578 LGFCDDGLNR---------LLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAF--GIA 622
+G L +++ F+ +G L +FL G+ +T + F IA
Sbjct: 67 IGV---SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL-DQSQTHTAIRGTKG 681
G+ YL S IH D+ +N +L++ ++DFGL+K + D + A +
Sbjct: 124 SGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 682 YVAPEWFRNMPITVKVDVYSFGVLLLEII 710
++A E + T DV++FGV + EI+
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 27/200 (13%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVRLL 578
+G GA G VYK I + A+K ++ +D V+ + E+ ++ +H N+V+
Sbjct: 82 IGSGAGGTVYK-VIHRPT--GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
D ++ EF+ G+L D + D+A I G+ YLH I+H
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIAYLH---RRHIVH 191
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKV- 697
DIKP N+L++ N +I+DFG++++L ++++ GT Y++PE I +
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-----RINTDLN 245
Query: 698 ---------DVYSFGVLLLE 708
D++S GV +LE
Sbjct: 246 HGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 62/192 (32%), Positives = 91/192 (47%), Gaps = 5/192 (2%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLL 578
LGKG+FG V + Y A+KK +I D V+ E V+ + L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
+ V EFL+ G L + + R T A I GL +LH S II+
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIY 119
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
D+K N++LD + +I+DFG+ K + ++ T GT Y+APE + + T VD
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSVD 178
Query: 699 VYSFGVLLLEII 710
+SFGVLL E++
Sbjct: 179 WWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIG 567
D E E LG G+FG V Y +KK + V+ E +++
Sbjct: 19 DFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM 73
Query: 568 QTHHKNLVRLL-GFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIA-FGIARG 624
+ H +V ++ F D+ NR+ + EF+ G L F L+ D+A F A
Sbjct: 74 ELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAEL 127
Query: 625 LL---YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG 681
+L YLH S II+ D+KP+N+LLD+ + +++DFG AK + +T T + GT
Sbjct: 128 VLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV---PDRTFT-LCGTPE 180
Query: 682 YVAPEWFRNMPITVKVDVYSFGVLLLEII 710
Y+APE ++ VD ++ GVLL E I
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/192 (31%), Positives = 88/192 (45%), Gaps = 6/192 (3%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
+GKG+FG V + ++K H V + V E V+ Q + +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 580 FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
F +L LV F++ G L L + G + F A L L +I+
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHKFNVIY 116
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
D+KP+NILLD + + DFGL KL + D +T+T GT Y+APE T VD
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAVD 175
Query: 699 VYSFGVLLLEII 710
++ GVLL E++
Sbjct: 176 WWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
++G+G+ G+V I VAVKK+ Q + EV ++ H N+V +
Sbjct: 26 KIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 579 G--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD-----IAFGIARGLLYLHEE 631
D L +V EFL G L + +R + + + + L +LH
Sbjct: 83 SSYLVGDEL--WVVMEFLEGGALTDIV------THTRMNEEQIATVCLAVLKALSFLH-- 132
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+ +IH DIK +ILL ++SDFG + + + + + GT ++APE +
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRL 190
Query: 692 PITVKVDVYSFGVLLLEII 710
P +VD++S G++++E++
Sbjct: 191 PYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
ELG GAFG VYK V A K + + ++ ++++ E++++ H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETG---VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG-IARGLLYLHEECSTQII 637
N ++ EF + G + + + +P + + L YLHE +II
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 638 HCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR-----GTKGYVAPEWF---- 688
H D+K NIL + +++DFG++ T T R GT ++APE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 689 -RNMPITVKVDVYSFGVLLLEI 709
++ P K DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 6e-12
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLVR 576
E +G G +G VYKG + +A K+ V D +E K E+N++ + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKGR----HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 577 LLGF--------CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGL 625
G DD L LV EF G++ L + K + IA+ I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGL 124
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
+LH+ ++IH DIK QN+LL + ++ DFG++ L + +T I GT ++AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180
Query: 686 EWFR-----NMPITVKVDVYSFGVLLLEI 709
E + K D++S G+ +E+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E++G+GA G VY AI +A+ +V A+K+++ Q + E+ V+ + H N+V
Sbjct: 25 EKIGQGASGTVYT-AIDVATGQEV--AIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLL----YLHEECS 633
L G +V E+L+ G+L D+ + R L +LH S
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLH---S 133
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
Q+IH DIK NILL + +++DFG + +QS+ T + GT ++APE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192
Query: 694 TVKVDVYSFGVLLLEII 710
KVD++S G++ +E++
Sbjct: 193 GPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 7e-12
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 59/222 (26%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDGVKEF----KTEVNVIG 567
++G+G +G VYK G + VA+KK+ +++ + F E+ ++
Sbjct: 5 AQIGEGTYGQVYKARNKKTGEL---------VALKKIR--MENEKEGFPITAIREIKLLQ 53
Query: 568 QTHHKNLVRLLGFC--DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA--- 622
+ H N+VRL + +V+E++ + DL G ++ F +
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH---------DLT-GLLDSPEVKFTESQIK 103
Query: 623 -------RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675
GL YLH S I+H DIK NIL+++ +++DFGLA+ S +T
Sbjct: 104 CYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
Query: 676 IRGTKGYVAPEWFRNMPI-------TVKVDVYSFGVLLLEII 710
T Y PE + +VD++S G +L E+
Sbjct: 161 RVITLWYRPPE------LLLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 9e-12
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E++G+GA G VY AI +A+ +V A+K+++ Q + E+ V+ + + N+V
Sbjct: 25 EKIGQGASGTVYT-AIDIATGQEV--AIKQMNLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQII 637
L G +V E+L+ G+L + + + + + L +LH S Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLH---SNQVI 137
Query: 638 HCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKV 697
H DIK NILL + +++DFG + +QS+ T + GT ++APE KV
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 698 DVYSFGVLLLEII 710
D++S G++ +E++
Sbjct: 197 DIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
ELG GAFG VYK A K + + ++ ++++ E+ ++ +H +V+LL
Sbjct: 19 ELGDGAFGKVYKAKNKETG---ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 579 G-FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECSTQ 635
G F DG +++ EF G + + + +L G + I + L YLH S +
Sbjct: 76 GAFYWDGKLWIMI-EFCPGGAVDAIML-ELDRGLTEPQIQVICRQMLEALQYLH---SMK 130
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLA----KLLLLDQSQTHTAIRGTKGYVAP-----E 686
IIH D+K N+LL + +++DFG++ K L Q + GT ++AP E
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-----QRRDSFIGTPYWMAPEVVMCE 185
Query: 687 WFRNMPITVKVDVYSFGVLLLEI 709
++ P K D++S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 508 DLEAATNGFKEELGKGAFGVVYKGAI-GMASMYQV-PVAVKKLHSVIQDGVKE-FKTEVN 564
++ +T F EELG+ FG VYKG + G A Q VA+K L + ++E FK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 565 VIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF-----GDLKPGWSRRT---- 615
+ + H N+V LLG +++ + S+ L FL D+ +T
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 616 -------DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
I IA G+ +L S ++H D+ +N+L+ D N +ISD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY-- 175
Query: 669 QSQTHTAIRGTK----GYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
+ + + G +++PE ++ D++S+GV+L E+
Sbjct: 176 -AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 31/185 (16%)
Query: 543 VAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR--LLVYEFLSNGTL 599
VAVK L + + + K E+ ++ +H+N+V+ G C + L+ EFL +G+L
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 600 ASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658
+L + K ++ A I +G+ YL S Q +H D+ +N+L++ + +I D
Sbjct: 96 KEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGD 152
Query: 659 FGLAKLLLLDQSQTHTAIRGTKGYV-------------APEWFRNMPITVKVDVYSFGVL 705
FGL K AI K Y APE + DV+SFGV
Sbjct: 153 FGLTK-----------AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVT 201
Query: 706 LLEII 710
L E++
Sbjct: 202 LYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDG-----VKEFKTEVNVIGQTHHK 572
E+G GA+G VYK + + VA+K + +DG V+E + + H
Sbjct: 7 EIGVGAYGTVYKARDPHSGHF---VALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHP 62
Query: 573 NLVRLLGFC-----DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGL 625
N+VRL+ C D LV+E + L ++L PG T D+ RGL
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
+LH C I+H D+KP+NIL+ +++DFGLA++ + T + T Y AP
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAP 176
Query: 686 EWFRNMPITVKVDVYSFGVLLLEI 709
E VD++S G + E+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 48/192 (25%), Positives = 90/192 (46%), Gaps = 8/192 (4%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
++G+G+ G+V + + VAVKK+ Q + EV ++ H+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKL---VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
G +V EFL G L + + + + + + L LH + +IH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIH 139
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
DIK +ILL ++SDFG + + ++ GT ++APE +P +VD
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 699 VYSFGVLLLEII 710
++S G++++E++
Sbjct: 199 IWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 78/340 (22%), Positives = 132/340 (38%), Gaps = 90/340 (26%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS---VIQDGVKEFKTEVNVIGQTHHKNL 574
E +G GA+GVV AI S +V A+KK+ V + + E+ ++ H N+
Sbjct: 11 ENIGSGAYGVVCS-AIDTRSGKKV--AIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNI 66
Query: 575 VRLLGFC----DDGLNRLLVYEFL---------SNGTLAS-----FLFGDLKPGWSRRTD 616
+ + D + +V + + S+ L FL+
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ----------- 115
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL---LDQSQTH 673
+ RGL Y+H S +IH D+KP N+L+++ RI DFG+A+ L +
Sbjct: 116 ----LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 674 TAIRGTKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEIICCR-----RNVDMEVNEAEALL 727
T T+ Y APE ++P T +D++S G + E++ R +N V++ + +L
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY---VHQLKLIL 225
Query: 728 T---------------DWAYDCYCEGITEALVEF-------DIEALNDKKKLARFVMVAI 765
+ D + V + EAL+ ++ +F
Sbjct: 226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF----- 280
Query: 766 WCIQEDPSLRPTMRKVTQ--MLEGVVEVLDPP-CPCPFTV 802
DP R T+ + Q L + D P CP PF
Sbjct: 281 -----DPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDF 315
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676
IA + GL YL+ +I+H DIKP NIL++ ++ DFG++ L+ + T
Sbjct: 108 IAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-- 163
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
GT Y++PE + TVK DV+S G+ ++E+
Sbjct: 164 -GTSTYMSPERIQGGKYTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 29/205 (14%)
Query: 518 EELGKGAFGVVY------KGAIGMASMYQVPVAVKKLH-SVIQ--DGVKEFKTEVNVIGQ 568
++G+G +G V+ G I VA+K++ S++ + V+ TE +++
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEI---------VALKRMKKSLLFKLNEVRHVLTERDILTT 57
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLL 626
T + LV+LL D L E++ G + L G L +R F +A
Sbjct: 58 TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR-----FYMAEMFE 112
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
+ IH D+KP+N L+D + +++DFGL+K ++ + ++ + G+ Y+APE
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPE 168
Query: 687 WFRNMPITVKVDVYSFGVLLLEIIC 711
R VD +S G +L E +C
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 60/195 (30%), Positives = 90/195 (46%), Gaps = 6/195 (3%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
LGKG FG V + Y +KK + +D V TE V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 580 FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
+ +RL V E+++ G L L + R I L YLH S +I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVY 118
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
D+K +N++LD + +I+DFGL K + D + T GT Y+APE + VD
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRAVD 177
Query: 699 VYSFGVLLLEIICCR 713
+ GV++ E++C R
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLVRL 577
+G GA+G V + + VAVKKL Q + +T E+ ++ H+N++ L
Sbjct: 25 VGSGAYGSV---CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKP--GWSRRTD-----IAFGIARGLLYLH 629
L D E ++ L + L G DL + TD + + I RGL Y+H
Sbjct: 82 L----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
S IIH D+KP N+ +++ +I DFGLA+ HT T GYVA W+R
Sbjct: 138 ---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTDDEMT-GYVATRWYR 184
Query: 690 N-------MPITVKVDVYSFGVLLLEIICCR 713
M VD++S G ++ E++ R
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
I RGL YLH S I+H DIKP N+L++ +I DFGLA++ D+S+ T T+
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 681 GYVAPEWFRNMP-ITVKVDVYSFGVLLLEII 710
Y APE T VD++S G + E++
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVRL 577
ELG G GVV K + + +A K +H I+ ++ + E+ V+ + + +V
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLI---MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 68
Query: 578 LG-FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
G F DG + + E + G+L L + ++ + RGL YL E+ QI
Sbjct: 69 YGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQI 125
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
+H D+KP NIL++ ++ DFG++ L+ + + GT+ Y++PE + +V+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 182
Query: 697 VDVYSFGVLLLEIICCR 713
D++S G+ L+E+ R
Sbjct: 183 SDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLVR 576
E +G G +G VYKG + +A K+ V +D +E K E+N++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKGR----HVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 577 LLGFC--------DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGL 625
G DD L LV EF G++ L + K + IA+ I RGL
Sbjct: 78 YYGAFIKKSPPGHDDQL--WLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGL 134
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
+LH + ++IH DIK QN+LL + ++ DFG++ L + +T I GT ++AP
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 686 EWFR-----NMPITVKVDVYSFGVLLLEI 709
E + + D++S G+ +E+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 65/225 (28%)
Query: 520 LGKGAFGVVYKGAIGMASMYQV---PVAVKKLHSVIQDGV--KEFKTEVNVIGQTHHKNL 574
+G GA+GVV +++ + VA+KK+ +V D + K E+ ++ H+N+
Sbjct: 8 IGSGAYGVVC------SAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 575 VRLL---------GFCD----------DGLNRLLVYE-FLSNGTLASFLFGDLKPGWSRR 614
+ LL F D D L++++ L++ + FL+
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQPLTDDHIQYFLYQ--------- 111
Query: 615 TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH- 673
I RGL YLH S +IH D+KP NIL++ + +I DFGLA+ + D+ +
Sbjct: 112 ------ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 674 -TAIRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLLEII 710
T YV W+R + T +D++S G + E++
Sbjct: 163 LT------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 4e-11
Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 14/196 (7%)
Query: 518 EELGKGAFGVVYKG---AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
E++G+GA G V+ A G VA+K+++ Q + E+ V+ + + N+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQE------VAIKQINLQKQPKKELIINEILVMKELKNPNI 78
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
V L G +V E+L+ G+L + + ++ + + L +LH +
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLH---AN 134
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
Q+IH DIK N+LL + +++DFG + +QS+ T + GT ++APE
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 695 VKVDVYSFGVLLLEII 710
KVD++S G++ +E++
Sbjct: 194 PKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 59/195 (30%), Positives = 87/195 (44%), Gaps = 6/195 (3%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
LGKG FG V Y ++K + +D V TE V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 61
Query: 580 FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
+ +RL V E+ + G L L + R I L YLH S +++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVY 118
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
DIK +N++LD + +I+DFGL K + D + T GT Y+APE + VD
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVD 177
Query: 699 VYSFGVLLLEIICCR 713
+ GV++ E++C R
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLVR 576
E +GKG +G VYK + + +A K+ I D +E + E N++ +H N+V+
Sbjct: 28 ETIGKGTYGKVYK----VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 577 LLG--FCDD---GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD------IAFGIARGL 625
G + D G LV E + G++ + G L G +R D I +G GL
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG--QRLDEAMISYILYGALLGL 141
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
+LH + +IIH D+K NILL ++ DFG++ L + + +T++ GT ++AP
Sbjct: 142 QHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAP 197
Query: 686 EWFR-----NMPITVKVDVYSFGVLLLEI 709
E + + DV+S G+ +E+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 67/228 (29%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVP----VAVKKL-----HSVIQDGVKEFKTEVNVIGQTH 570
+G+GA+G+V S P VA+KK+ + Q ++E K ++ +
Sbjct: 13 IGEGAYGMV-------CSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFK 61
Query: 571 HKNLVRLLG------------------FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWS 612
H+N++ +L + L +L+ + LSN + FL+
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ------- 114
Query: 613 RRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672
I RGL Y+H S ++H D+KP N+LL+ + +I DFGLA+ + D
Sbjct: 115 --------ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHD 161
Query: 673 HTAIRGTKGYVAPEWFRNMPI-------TVKVDVYSFGVLLLEIICCR 713
HT YVA W+R I T +D++S G +L E++ R
Sbjct: 162 HT--GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 6e-11
Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E++G+GA G VY A+ +A+ +V A+++++ Q + E+ V+ + + N+V
Sbjct: 26 EKIGQGASGTVYT-AMDVATGQEV--AIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQII 637
L G +V E+L+ G+L + + + + + L +LH S Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 638 HCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKV 697
H DIK NILL + +++DFG + +QS+ + + GT ++APE KV
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 698 DVYSFGVLLLEII 710
D++S G++ +E+I
Sbjct: 198 DIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 37/225 (16%)
Query: 516 FKEELGKGAFGVVYK-GAIGMASMYQ------------VPVAVKKLHS-VIQDGVKEFKT 561
FKE+LG+G FG V+ A GM V VAVK L ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 562 EVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD---IA 618
E+ ++ + N++RLL C ++ E++ NG L FL + + D I+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 619 FG--------IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670
+ IA G+ YL S +H D+ +N L+ Y +I+DFG+++ L S
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY---S 182
Query: 671 QTHTAIRGTKGYVAPEWFRNMPI-----TVKVDVYSFGVLLLEII 710
+ I+G + + W I T DV++FGV L EI+
Sbjct: 183 GDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 12/99 (12%)
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676
+ I + L YL E+ +IH D+KP NILLD N ++ DFG++ L+ S+ T
Sbjct: 119 MTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRS 174
Query: 677 RGTKGYVAPEWFRNMPIT------VKVDVYSFGVLLLEI 709
G Y+APE R P ++ DV+S G+ L+E+
Sbjct: 175 AGCAAYMAPE--RIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-------SVIQDGVKEFKTEVNVIGQT 569
++++G+G F VY+ + + PVA+KK+ QD VKE ++++ Q
Sbjct: 7 EKKIGRGQFSEVYRA---TCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLKQL 59
Query: 570 HHKNLVRLLG--FCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAF--GIAR 623
+H N+++ L D+ LN +V E G L+ + F K RT + +
Sbjct: 60 NHPNVIKYLDSFIEDNELN--IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
+ ++H S +++H DIKP N+ + ++ D GL + + H+ + GT Y+
Sbjct: 118 AVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEI 709
+PE K D++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-11
Identities = 39/99 (39%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL----DQSQTHTAIRGTK 680
LL +H S +IH DIK NILL ++ DFG +K+ D +T GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GTP 209
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDME 719
YVAPE +R P + K D++S GVLL E++ +R D E
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
|
Length = 496 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV--KEFKTEVNVIGQTHHKNLVRL 577
+G GA G+V ++ + VAVKKL Q+ K E+ ++ +HKN++ L
Sbjct: 29 IGSGAQGIV---CAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 578 LGF------CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
L ++ + LV E L + L + +L R + + + + G+ +LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHMELDH--ERMSYLLYQMLCGIKHLH-- 140
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
S IIH D+KP NI++ +I DFGLA+ + T + T+ Y APE M
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGM 197
Query: 692 PITVKVDVYSFGVLLLEII 710
VD++S G ++ E++
Sbjct: 198 GYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 46/213 (21%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-----FKTEVNVIGQTHHKNL 574
+G+G +G+VY+ A S V A+KK V D ++ E+ ++ H N+
Sbjct: 15 IGEGTYGIVYR-ARDTTSGEIV--ALKK---VRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 575 VRLL---------------GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF 619
V L +C+ L LL + F +K +
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLL------DNMPTPFSESQVKC-------LML 115
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL-LLDQSQTHTAIRG 678
+ RGL YLHE IIH D+K N+LL D +I+DFGLA+ L + T +
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-- 170
Query: 679 TKGYVAPE-WFRNMPITVKVDVYSFGVLLLEII 710
T Y APE T +D+++ G +L E++
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 36/213 (16%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT---EVNVIGQTHHK 572
+ELGKG +G VYK + V +A+K++ + + +F E++++ +
Sbjct: 5 VLDELGKGNYGSVYKV---LHRPTGVTMAMKEIRLELDES--KFNQIIMELDILHKAVSP 59
Query: 573 NLVRLLG-FCDDGLNRLLVY---EFLSNGTLASFLFGDLKPGWSRRTD------IAFGIA 622
+V G F +G VY E++ G+L G + I + +
Sbjct: 60 YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATE---GIPEDVLRRITYAVV 112
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
+GL +L EE IIH D+KP N+L++ ++ DFG++ L+ ++T+ G + Y
Sbjct: 113 KGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSY 167
Query: 683 VAPEWFR------NMPITVKVDVYSFGVLLLEI 709
+APE + N TV+ DV+S G+ +LE+
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 46/237 (19%)
Query: 516 FKEELGKGAFGVVYKGAIGMAS---MYQVPVAVKKLHSVI-----------QDGVKEFKT 561
FKE+LG+G FG V+ + Q P V+K ++ ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 562 EVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD--------------- 606
EV ++ + N++RLLG C D ++ E++ NG L FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 607 ----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662
+S +A IA G+ YL S +H D+ +N L+ + +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 663 KLLLLD-----QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII-CCR 713
+ L Q + IR ++A E T DV++FGV L EI+ C+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/195 (30%), Positives = 87/195 (44%), Gaps = 5/195 (2%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
LGKG FG V Y +KK V +D V TE V+ + H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-K 61
Query: 580 FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
+ +RL V E+ + G L L + R I L YLH E +++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 119
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
D+K +N++LD + +I+DFGL K + D + T GT Y+APE + VD
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVD 178
Query: 699 VYSFGVLLLEIICCR 713
+ GV++ E++C R
Sbjct: 179 WWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/193 (33%), Positives = 88/193 (45%), Gaps = 7/193 (3%)
Query: 520 LGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVI-GQTHHKNLVRL 577
+GKG+FG V + Y V V KK+ + + K E NV+ H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-VLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQII 637
V +F++ G L L + R A IA L YLH S I+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIV 118
Query: 638 HCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKV 697
+ D+KP+NILLD + ++DFGL K + QS T T GT Y+APE R P V
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 698 DVYSFGVLLLEII 710
D + G +L E++
Sbjct: 178 DWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 32/93 (34%), Positives = 58/93 (62%), Gaps = 5/93 (5%)
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676
I+ + RGL YL E+ +I+H D+KP NIL++ ++ DFG++ L+ S ++ +
Sbjct: 104 ISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 159
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
GT+ Y++PE + TV+ D++S G+ L+E+
Sbjct: 160 -GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 9/194 (4%)
Query: 520 LGKGAFGVVYKGAI-GMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNLVRL 577
LGKG+FG V + G +Y + V K ++QD V TE ++ +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKD--VILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 578 LGFCDDGLNRLL-VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
L C +RL V E+++ G L + K R A + L++LH +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GV 117
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
I+ D+K NILLD + +++DFG+ K +L+ T T GT Y+APE + +
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT-TTFCGTPDYIAPEILQELEYGPS 176
Query: 697 VDVYSFGVLLLEII 710
VD ++ GVL+ E++
Sbjct: 177 VDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 40/214 (18%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--------EVNVIGQ- 568
++LG G FG VY ++ VA+KK+ K+F + EV + +
Sbjct: 5 KQLGDGTFGSVYLARN--KETGEL-VAIKKMK-------KKFYSWEECMNLREVKSLRKL 54
Query: 569 THHKNLVRLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARG 624
H N+V+L F ++ + L V+E++ KP +S I + I +G
Sbjct: 55 NEHPNIVKLKEVFREN--DELYFVFEYMEGNLYQLMKDRKGKP-FSESVIRSIIYQILQG 111
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVA 684
L ++H H D+KP+N+L+ +I+DFGLA+ + +T T+ Y A
Sbjct: 112 LAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRA 166
Query: 685 PEW-----FRNMPITVKVDVYSFGVLLLEIICCR 713
PE + P VD+++ G ++ E+ R
Sbjct: 167 PEILLRSTSYSSP----VDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 30/204 (14%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE---FKTEVNVIGQTHHKNLVR 576
+G+G+FG +Y S + V +K++ + + VKE K EV ++ + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV---IKEI-DLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG----------IARGLL 626
+ +V E+ G DL +R+ + F I+ GL
Sbjct: 64 FFASFQENGRLFIVMEYCDGG--------DLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 627 YLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
++H+ +I+H DIK QNI L + A++ DFG+A+ L +T + GT Y++P
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSP 171
Query: 686 EWFRNMPITVKVDVYSFGVLLLEI 709
E +N P K D++S G +L E+
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 45/212 (21%)
Query: 520 LGKGAFGVVYKGAIGMASMYQV----PVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKN 573
+G GA+G V S Y VAVKKL Q + +T E+ ++ H+N
Sbjct: 23 VGSGAYGSV-------CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKP--GWSRRTD-----IAFGIARGL 625
++ LL D E + L + L G DL + +D + + + RGL
Sbjct: 76 VIGLL----DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
Y+H S IIH D+KP N+ +++ RI DFGLA+ D T GYVA
Sbjct: 132 KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT--------GYVAT 178
Query: 686 EWFRNMPITVK-------VDVYSFGVLLLEII 710
W+R I + VD++S G ++ E++
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+E+G G FG V G M + V VK+L S D F EV + +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEA-HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL-------FGDLKPGWSRRTDIAFGIARGLLYLH 629
LG C + + LLV EF G L ++L + +R +A +A GLL+LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLH 117
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLA-----KLLLLDQSQTHTAIRGTKGYVA 684
+ IH D+ +N L + +I D+GLA + + + +R +
Sbjct: 118 Q---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 685 PEWFRNM---PITVKVDVYSFGVLLLEI 709
+++ T K +++S GV + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
IA L YLHE+ I+H D+K QN+ L ++ D G+A++L +Q + + GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTP 166
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
Y++PE F N P K DV++ G + E+
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-10
Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 37/222 (16%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV---KEFKTEVNVIGQTHHKNLVR 576
+GKG G VY + S VA+KK+ + + K F E + H +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSR---RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFG---------DLKPGWSRRT--DIAFGIARGL 625
+ C DG ++ TL S L +L S I I +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK--------LLLLDQSQTHTA-- 675
Y+H S ++H D+KP NILL + I D+G A LL +D + +
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 676 -------IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
I GT Y+APE +P + D+Y+ GV+L +++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 52/197 (26%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVRL 577
ELG G GVV+K + + + +A K +H I+ ++ + E+ V+ + + +V
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLI---MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 68
Query: 578 LG-FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
G F DG + + E + G+L L + ++ + +GL YL E+ +I
Sbjct: 69 YGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 125
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
+H D+KP NIL++ ++ DFG++ L+ + + GT+ Y++PE + +V+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 182
Query: 697 VDVYSFGVLLLEIICCR 713
D++S G+ L+E+ R
Sbjct: 183 SDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 50/192 (26%), Positives = 89/192 (46%), Gaps = 8/192 (4%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
++G+G+ G+V I VAVK + Q + EV ++ H+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
G ++ EFL G L + + + + + + L YLH S +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVD 698
DIK +ILL ++SDFG + D + + + GT ++APE P +VD
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 699 VYSFGVLLLEII 710
++S G++++E++
Sbjct: 200 IWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 76/272 (27%), Positives = 109/272 (40%), Gaps = 46/272 (16%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKL-------HSVIQDGVKEFKTEVNVIGQTHH 571
E+G G+FG VY S VAVKK+ + QD +KE K + Q H
Sbjct: 28 EIGHGSFGAVY---FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK----FLQQLKH 80
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA---FGIARGLLYL 628
N + G LV E+ G+ + L KP + +IA G +GL YL
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP--LQEVEIAAITHGALQGLAYL 137
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
H +IH DIK NILL + +++DFG A S + GT ++APE
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPEVI 189
Query: 689 RNM---PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
M KVDV+S G+ +E + R+ +N AL + +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALY--------------HIAQ 234
Query: 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPT 777
D L + F +C+Q+ P RP
Sbjct: 235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 520 LGKGAFG---VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+G+G FG VV + A G +Y + V +KK + Q+ V F+ E +++ ++ + +
Sbjct: 9 VGRGHFGEVQVVREKATG--DIYAMKV-MKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD------IAFGIARGLLYLHE 630
L D N LV E+ G L S L +R D F +A +L +H
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLL--------NRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
+H DIKP+N+L+D + +++DFG A L ++ GT Y+APE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 691 M------PITVKVDVYSFGVLLLEIICCR 713
M V+ D +S GV+ E+I R
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQ----VPVAVKKLHS---VIQDGVKEFKTEVNVIGQ 568
F LG G+FG V + + Y+ PVA+K+ + Q V +E ++
Sbjct: 34 FIRTLGTGSFGRV------ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY 87
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT-----DIA-FGIA 622
+H V L G D LV EF+ G +FL RR D+ F A
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---------RRNKRFPNDVGCFYAA 138
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
+ +L S I++ D+KP+N+LLD +++DFG AK++ ++T+T + GT Y
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEY 194
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEII 710
+APE N+ D ++ G+ + EI+
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 8/196 (4%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LGKG FG V+ Y + + +KK + +D V TE V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKI-LKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 579 GFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQII 637
+ +RL V E+ + G L L + R I L YLH S ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVV 117
Query: 638 HCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKV 697
+ D+K +N++LD + +I+DFGL K + D + T GT Y+APE + V
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAV 176
Query: 698 DVYSFGVLLLEIICCR 713
D + GV++ E++C R
Sbjct: 177 DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 520 LGKGAFGVVYKGAIGMASMYQV----PVAVKKLH-----SVIQDGVKEFKTEVNVIGQTH 570
LG+GAFG VY Y +AVK++ V + E+ ++
Sbjct: 10 LGQGAFGRVY-------LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 571 HKNLVRLLGFCDDGLNRLL--VYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLL 626
H+ +V+ G D + R L E + G++ L +G L +R+ I G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK--YTRQILEGVS 120
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL--LLDQSQTHTAIRGTKGYVA 684
YLH S I+H DIK NIL D N ++ DFG +K L + ++ GT +++
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 685 PEWFRNMPITVKVDVYSFGVLLLEII 710
PE K D++S G ++E++
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 520 LGKGAFGVVY--KGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLV 575
LGKG +G V+ + G + + V K +++ Q K E N++ H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA-FGIARGLLYLHEECST 634
L+ G L+ E+LS G L F L+ D A F ++ L L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
II+ D+KP+NILLD + +++DFGL K + + + THT GT Y+APE
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMRSGHG 178
Query: 695 VKVDVYSFGVLLLEII 710
VD +S G L+ +++
Sbjct: 179 KAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-------SVIQDGVKEFKTEVNVIGQT 569
++++G+G F VY+ + VPVA+KK+ D +KE ++++ Q
Sbjct: 7 EKKIGRGQFSEVYRAT---CLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLKQL 59
Query: 570 HHKNLVRLLG-FCDDGLNRL-LVYEFLSNGTLASFL--FGDLKPGWSRRTDIAF--GIAR 623
+H N+++ F +D N L +V E G L+ + F K +T + +
Sbjct: 60 NHPNVIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
L ++H S +++H DIKP N+ + ++ D GL + + H+ + GT Y+
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEI 709
+PE K D++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
++E LG G G VYK A + + + V V L + + K+ +E+ ++ + ++
Sbjct: 5 YQEILGHGNGGTVYK-AYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSPYII 62
Query: 576 RLLG--FCDDGLNRL-LVYEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEE 631
G F + NR+ + EF+ G+L ++ + + R IA + +GL YL
Sbjct: 63 GFYGAFFVE---NRISICTEFMDGGSLD--VYRKIPEHVLGR---IAVAVVKGLTYL--- 111
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
S +I+H D+KP N+L++ ++ DFG++ L+ ++T+ GT Y+APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGE 168
Query: 692 PITVKVDVYSFGVLLLEI 709
+ DV+S G+ +E+
Sbjct: 169 QYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 517 KEELGKGAFGVVYKGAIGMASM-YQVPVAVKKLH---SVIQDGVKEFKTEVNVIGQTHHK 572
+ L +G FG ++ G + + V VK + S IQ V E ++ H+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQ 68
Query: 573 NLVRLLGFC-DDGLNRLLVYEFLSNGTLASFL----FGDLKPGWSRRT----DIAFGIAR 623
N++ +L C +DG ++Y +++ G L FL G+ + T +A IA
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL-------LLDQSQTHTAI 676
G+ YLH +IH DI +N ++D+ +I+D L++ L L D
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN----- 180
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
R K ++A E N + DV+SFGVLL E++
Sbjct: 181 RPVK-WMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 518 EELGKGAFGVVYKGAIGMA-SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+E+G G FG V G + + QV V ++ + +Q+ +K F E H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFG-----DLKPGWSRRTDIAFGIARGLLYLHEE 631
LG C + LLV EF G L +L + P + +A IA GLL+LH+
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKL-----LLLDQSQTHTAIRGTKGYVAPE 686
IH D+ +N LL +I D+GL+ + Q +R ++APE
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPE 172
Query: 687 WFR----NMPI---TVKVDVYSFGVLLLEI 709
N+ + T + +V+S GV + E+
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
E+LG+G++ VYKG ++ + VA+K + ++GV F E +++ H N+V
Sbjct: 11 EKLGEGSYATVYKG---ISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIV 66
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLHEEC 632
L V+E++ LA ++ G L P R F + RGL Y+H +
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL--FMFQLLRGLAYIHGQ- 122
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-WFRNM 691
I+H D+KPQN+L+ +++DFGLA+ + SQT+++ T Y P+
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVVTLWYRPPDVLLGAT 179
Query: 692 PITVKVDVYSFGVLLLEII 710
+ +D++ G + +E++
Sbjct: 180 DYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 44/213 (20%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLVRL 577
+G+GA+G+V S VA+KK+ + + + +T E+ ++ H+N++ +
Sbjct: 13 IGRGAYGIV---CSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 578 LGF----CDDGLNRL-LVYEFL---------SNGTLAS-----FLFGDLKPGWSRRTDIA 618
+ N + +VYE + S+ TL+ FL+ L
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL----------- 118
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
RGL Y+H S ++H D+KP N+LL+ + +I DFGLA+ ++ T
Sbjct: 119 ----RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVV 170
Query: 679 TKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEII 710
T+ Y APE N T +DV+S G + E++
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQ-------VPVAVKKLHSVIQDGVKEFKTEVNVIGQTH 570
E LG+G F +YKG + + S V V +K L S +D + F+T +++ Q
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLS 59
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGW-SRRTDIAFGIARGLLYLH 629
HK+LV+L G C N ++V E++ G L FL + + D+A +A L YL
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE 118
Query: 630 EECSTQIIHCDIKPQNILLDDYYN-------ARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
++ +++H ++ +NIL+ Y ++SD G+ +L + + +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PW 170
Query: 683 VAPEWFRNMP--ITVKVDVYSFGVLLLEIICCRRNVDM 718
+APE RN +T+ D +SFG LLE IC +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPL 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 60/194 (30%), Positives = 89/194 (45%), Gaps = 9/194 (4%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQT-HHKNLVR 576
+GKG+FG V+ S Y V V KK ++++ E NV+ + H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKK--TILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
L V ++++ G L L + R A +A + YLH S I
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNI 117
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVK 696
I+ D+KP+NILLD + ++DFGL K + + T T GT Y+APE R P
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYDRT 176
Query: 697 VDVYSFGVLLLEII 710
VD + G +L E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 38/94 (40%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
F IA +L L I++ D+KP+NILLD + + DFGL+K L D T+T G
Sbjct: 100 FYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-G 158
Query: 679 TKGYVAPE-WFRNMPITVKVDVYSFGVLLLEIIC 711
T Y+APE T VD +S GVL+ E+ C
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV--KEFKTEVNVIGQTHHKNLVRL 577
+G GA+G V AI + +V A+KKL Q + K E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCS-AIDKRTGEKV--AIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP--GWSRRTD----IAFGIARGLLYLHEE 631
L D + + EF + ++ DL+ G D + + + GL Y+H
Sbjct: 80 L---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH-- 134
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN- 690
S IIH D+KP N+ +++ +I DFGLA+ D T + T+ Y APE N
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPEVILNW 189
Query: 691 MPITVKVDVYSFGVLLLEII 710
M VD++S G ++ E++
Sbjct: 190 MHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVI-GQTHHKNLVR 576
E +GKG +G V+K + + A K+ I D +E + E N++ + H N+V+
Sbjct: 24 ETIGKGTYGKVFK----VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 577 LLGF-----CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD--IAFGIARGLLYLH 629
G +G LV E + G++ + G LK G R + IA+ + L+ L
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG-ERMEEPIIAYILHEALMGLQ 138
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
+ IH D+K NILL ++ DFG++ L + + +T++ GT ++APE
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 690 -----NMPITVKVDVYSFGVLLLEI 709
+ + DV+S G+ +E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 4/86 (4%)
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
G+ ++HE+ +++H DIK +NI L ++ DFG A+LL + T + GT YV
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEI 709
PE + NMP K D++S G +L E+
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 520 LGKGAFGVV----YKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNV---IGQTHHK 572
LG+G FG V YK +Y + A+KK + +D V+ E + H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 573 NLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
LV L C + + V E+ + G L + D+ R A + GL YLHE
Sbjct: 63 FLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE-PRAVFYAACVVLGLQYLHEN 120
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+I++ D+K N+LLD +I+DFGL K + +T T GT ++APE
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTET 176
Query: 692 PITVKVDVYSFGVLLLEIICC 712
T VD + GVL+ E++
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---------DGVKEFKTEVNVIGQTH 570
LG+GAFG VY Y V + +Q V + E+ ++
Sbjct: 10 LGQGAFGRVYL-------CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 571 HKNLVRLLGFCDDGLNRLLV--YEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLL 626
H+ +V+ G D + L E++ G++ L +G L +R+ I G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK--YTRQILEGMS 120
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS--QTHTAIR---GTKG 681
YLH S I+H DIK NIL D N ++ DFG +K L Q+ + T IR GT
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTPY 174
Query: 682 YVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+++PE K DV+S G ++E++
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDGV--KEFKTEVNVIGQT 569
++G+G++GVV+K G I VA+KK D V K E+ ++ Q
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQI---------VAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRT--DIAFGIARGLL 626
H NLV L+ LV+E+ + L + P G I + + +
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
+ H IH D+KP+NIL+ ++ DFG A+ +L +T YVA
Sbjct: 115 FCH---KHNCIHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYT------DYVATR 164
Query: 687 WFRNMPITV-------KVDVYSFGVLLLEIIC 711
W+R + V VDV++ G + E++
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 6/155 (3%)
Query: 557 KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT- 615
+E + EV V+ H N+V+ ++ N +V ++ G L + +
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI 103
Query: 616 -DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674
D I L ++H+ +I+H DIK QNI L ++ DFG+A++L T
Sbjct: 104 LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160
Query: 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
I GT Y++PE N P K D+++ G +L E+
Sbjct: 161 CI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA-I 676
+F +ARG+ +L S + IH D+ +NILL + +I DFGLA+ + D
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
R ++APE + T + DV+SFGVLL EI
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 41/215 (19%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-FKT----EVNVIGQTHHKN 573
++G+G +G VYK VA+KK V D KE F E+ ++ Q +H+N
Sbjct: 14 QIGEGTYGQVYKARDKDTGEL---VALKK---VRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 574 LVRL----------LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG---WSRRTDIAF- 619
+V L L F D LV+E++ + L G L+ G +S +F
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFM 122
Query: 620 -GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
+ GL Y H+ +H DIK NILL++ +++DFGLA+L ++S+ +T
Sbjct: 123 KQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 679 TKGYVAPEWF----RNMPITVKVDVYSFGVLLLEI 709
T Y PE R P +DV+S G +L E+
Sbjct: 180 TLWYRPPELLLGEERYGP---AIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 11/195 (5%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
+GKG+FG V + ++K + + K +E NV+ + + L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 580 FCDDGLNRL-LVYEFLSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQ 635
F ++L V ++++ G L L + L+P R A IA L YLH S
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASALGYLH---SLN 116
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITV 695
I++ D+KP+NILLD + ++DFGL K + T T GT Y+APE P
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYDR 175
Query: 696 KVDVYSFGVLLLEII 710
VD + G +L E++
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 520 LGKGAFGVVY---KGAIGMA-SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
LG+GAFG VY G ++ QVP + + V + E+ ++ H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE--VNALECEIQLLKNLRHDRIV 67
Query: 576 RLLGFCDDGLNRLL--VYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+ G D + L E++ G++ L +G L +RR I +G+ YLH
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR--YTRQILQGVSYLH-- 123
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAK-LLLLDQSQTH-TAIRGTKGYVAPEWFR 689
S I+H DIK NIL D N ++ DFG +K + + S T ++ GT +++PE
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 690 NMPITVKVDVYSFGVLLLEII 710
K DV+S ++E++
Sbjct: 183 GEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 51/200 (25%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT-EVNVIGQTHHKNLVR 576
E+LG+G + VYKG VA+K++H ++G E++++ + H+N+VR
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEI---VALKEIHLDAEEGTPSTAIREISLMKELKHENIVR 62
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL-----FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
L +LV+E++ L ++ G L P + + + +G+ + HE
Sbjct: 63 LHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN 119
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-WFRN 690
+++H D+KPQN+L++ +++DFGLA+ + + T + T Y AP+ +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGS 175
Query: 691 MPITVKVDVYSFGVLLLEII 710
+ +D++S G ++ E+I
Sbjct: 176 RTYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
E+LG+G++ VYKG + + VA+K + ++G F E +++ H N+V
Sbjct: 11 EKLGEGSYATVYKGK---SKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIV 66
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA---FGIARGLLYLHEEC 632
L LV+E++ L ++ D PG ++ F + RGL Y+H+
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYM--DKHPGGLHPENVKLFLFQLLRGLSYIHQR- 122
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-WFRNM 691
I+H D+KPQN+L+ D +++DFGLA+ + S T++ T Y P+ +
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLGST 179
Query: 692 PITVKVDVYSFGVLLLEII 710
+ +D++ G + +E+I
Sbjct: 180 EYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 67/219 (30%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL-------HSVIQDGV 556
F+ D E +E +G G+FG VY VA+KK+ + QD +
Sbjct: 8 FSKDDPEKLFTDLRE-IGHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDII 63
Query: 557 KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD 616
KE V + Q H N + G LV E+ G+ + L KP + +
Sbjct: 64 KE----VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP--LQEVE 116
Query: 617 IA---FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
IA G +GL YLH S + IH DIK NILL + +++DFG A L+ S
Sbjct: 117 IAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS--- 170
Query: 674 TAIRGTKGYVAPEWFRNM---PITVKVDVYSFGVLLLEI 709
GT ++APE M KVDV+S G+ +E+
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 24/156 (15%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQD-GVKEFKT-EVNVIGQT 569
E++G+G +G V+K I VA+K++ D GV E+ ++ +
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEI---------VALKRVRLDDDDEGVPSSALREICLLKEL 56
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASF--LFGDLKPGWSRRTDIAFGIARGLLY 627
HKN+VRL LV+E+ F GD+ P + F + +GL +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--SFMFQLLKGLAF 114
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
H ++H D+KPQN+L++ +++DFGLA+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 520 LGKGAFG---VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+G+GAFG +V K G ++ ++K + ++ V + E +++ + +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKI---LRKADMLEKEQVGHIRAERDILVEADSLWVVK 65
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
+ D LN L+ EFL G + + L +K + F IA +L +
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 637 IHCDIKPQNILLDDYYNARISDFGL----------------------------------A 662
IH DIKP N+LLD + ++SDFGL A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ ++ Q + GT Y+APE F D +S GV++ E++
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 43/149 (28%), Positives = 80/149 (53%), Gaps = 11/149 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVR 576
++LG+G + V+KG + + + VA+K++ ++G EV+++ H N+V
Sbjct: 11 DKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L LV+E+L + L +L G+L + + F + RGL Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKR--- 122
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAK 663
+I+H D+KPQN+L+++ +++DFGLA+
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 518 EELGKGAFGVVYKG----AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN 573
E LG+G F ++KG +++ V +K L ++ + F +++ Q HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHE 630
LV G C G ++V E++ G+L ++L + + W + ++A +A L +L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED 118
Query: 631 ECSTQIIHCDIKPQNILL----DDYYNA----RISDFG-----LAKLLLLDQSQTHTAIR 677
+ + H ++ +N+LL D ++SD G L K +LL++
Sbjct: 119 K---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP------ 169
Query: 678 GTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIIC 711
+V PE N +++ D +SFG L EI
Sbjct: 170 ----WVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 38/124 (30%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648
L+ ++++ G L + L+ + +++ IA +L L II+ DIK +NILL
Sbjct: 82 LILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138
Query: 649 DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI--TVKVDVYSFGVLL 706
D + ++DFGL+K L ++ + + GT Y+APE R VD +S GVL
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 707 LEII 710
E++
Sbjct: 199 FELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 6/182 (3%)
Query: 538 MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL-VYEFLSN 596
+Y + V K+L + +D + +TE +V Q + + L C +RL V E+++
Sbjct: 22 IYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80
Query: 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656
G L + K + I+ L YLHE II+ D+K N+LLD + ++
Sbjct: 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL 137
Query: 657 SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV 716
+D+G+ K L T + GT Y+APE R VD ++ GVL+ E++ R
Sbjct: 138 TDYGMCKEGL-RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 717 DM 718
D+
Sbjct: 197 DI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-AI 676
+F +ARG+ +L S + IH D+ +NILL + +I DFGLA+ + D +
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDC 734
R ++APE + T + DV+SFGVLL EI + +++NE
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----------- 285
Query: 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785
+C+ + + + A + +M+A W Q DP RPT + ++L
Sbjct: 286 FCQRLKDGT---RMRAPENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 520 LGKGAFGVVY--KGAIGMASMYQVPVAVKKLHSVIQDG--VKEFKTEVNVIGQTHHKNLV 575
LG GA+G V+ + G + + V + +++Q V+ +TE NV+ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 576 RLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L + +L L+ +++S G + + L+ + ++ F +L L
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKL 124
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
I++ DIK +NILLD + ++DFGL+K L ++ + + GT Y+APE R
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184
Query: 695 VK-VDVYSFGVLLLEII 710
K VD +S G+L+ E++
Sbjct: 185 GKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA-I 676
+F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ + D
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
R ++APE + T++ DV+SFGVLL EI
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 25/156 (16%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVR 576
E+LG+G + V+KG + + + VA+K++ ++G EV+++ H N+V
Sbjct: 12 EKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA---------FGIARGLLY 627
L + LV+E+L DLK +I + I RGL Y
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK---------DLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
H +++H D+KPQN+L+++ +++DFGLA+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 43/170 (25%)
Query: 521 GKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--------EVNVIGQTHHK 572
G+G +G VYK A A+KK G KE T E+ ++ + H+
Sbjct: 9 GRGTYGRVYK-AKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 573 NLVRLLG-FCDDGLNRL-LVYEFLSNGTLASF-LFGDLKPGWSRRTD-----------IA 618
N+V L+ F + + L++++ A L+ +K + R+ +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIK--FHRQAKRVSIPPSMVKSLL 114
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNAR----ISDFGLAKL 664
+ I G+ YLH S ++H D+KP NIL+ R I D GLA+L
Sbjct: 115 WQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 6/201 (2%)
Query: 538 MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL-LVYEFLSN 596
+Y + V K+L +D + +TE +V Q + L C +RL LV E+++
Sbjct: 22 IYAMKVVKKELVHDDED-IDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80
Query: 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656
G L + K A I L +LHE II+ D+K N+LLD + ++
Sbjct: 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKL 137
Query: 657 SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV 716
+D+G+ K L T T GT Y+APE R VD ++ GVL+ E++ R
Sbjct: 138 TDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 717 DMEVNEAEALLTDWAYDCYCE 737
D+ + + D+ + E
Sbjct: 197 DIITDNPDMNTEDYLFQVILE 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 15/100 (15%)
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
+ + R L Y+H + + H D+KP+NIL + +I DFGLA++ D T TAI
Sbjct: 110 YQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFW 163
Query: 679 TKGYVAPEWFRNMPI--------TVKVDVYSFGVLLLEII 710
T YVA W+R + T +D++S G + E++
Sbjct: 164 TD-YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
I GL YLH + +IIH D+K +NI ++D I D G A+ ++ + A GT
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTV 220
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
APE K D++S G++L E++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
G+ +LH S IIH D+KP NI++ +I DFGLA+ T + T+ Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 184
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEIIC 711
APE M VD++S G ++ E+I
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 505 TYKDLEAATNGFKE----------ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD 554
+ KD E A FKE E+G G+FG VY + VA+KK+ +
Sbjct: 8 SLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEV---VAIKKMSYSGKQ 64
Query: 555 GVKEFK---TEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGW 611
++++ EV + + H N + G LV E+ G+ + L KP
Sbjct: 65 SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-- 121
Query: 612 SRRTDIA---FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
+ +IA G +GL YLH S +IH DIK NILL + +++DFG A +
Sbjct: 122 LQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI---- 174
Query: 669 QSQTHTAIRGTKGYVAPEWFRNM---PITVKVDVYSFGVLLLEI 709
+ + GT ++APE M KVDV+S G+ +E+
Sbjct: 175 -ASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV--KEFKTEVNVIGQTHHKNLVRL 577
+G GA G+V ++ + VA+KKL Q+ K E+ ++ +HKN++ L
Sbjct: 32 IGSGAQGIV---CAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 578 LGFCD-----DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
L + + + L + L + +L R + + + + G+ +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH--ERMSYLLYQMLCGIKHLH--- 143
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
S IIH D+KP NI++ +I DFGLA+ T + T+ Y APE M
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMG 201
Query: 693 ITVKVDVYSFGVLLLEIIC 711
VD++S G ++ E+I
Sbjct: 202 YKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNLVR 576
++LG+G + VYKG + + VA+K++ ++G EV+++ H N+V
Sbjct: 12 DKLGEGTYATVYKGR---SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L + LV+E+L + L +L G+ + + F + RGL Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCHRR--- 123
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY---VAPEWFRNM 691
+++H D+KPQN+L+++ +++DFGLA+ + TK Y V W+R
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIP----------TKTYSNEVVTLWYRPP 173
Query: 692 PI-------TVKVDVYSFGVLLLEIICCR 713
I + ++D++ G + E+ R
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 520 LGKGAFGVV----YKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+G+GAFG V +K + + +M + K + + F E +++ + +V
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMK----LLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECST 634
+L D +V E++ G L + + D+ W++ F A +L L S
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAEVVLALDAIHSM 161
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS---QTHTAIRGTKGYVAPEWFRNM 691
+IH D+KP N+LLD + + +++DFG + +D++ + TA+ GT Y++PE ++
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 692 P----ITVKVDVYSFGVLLLEII 710
+ D +S GV L E++
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 53/286 (18%)
Query: 517 KEELGKGAFGVVY----KGAIGMASMY---QVPVAVKKLHSVIQDGVKEFKTEVNVIGQT 569
++ LGKG+FG VY K A+ + ++PV + +Q E ++ +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-----EAQLLSKL 59
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--------- 620
H +V+ + ++ E+ L D K + T
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDL------DCKLEELKHTGKTLSENQVCEWFI 113
Query: 621 -IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL--LDQSQTHTAIR 677
+ G+ Y+H+ +I+H D+K +NI L + +I DFG+++LL+ D + T T
Sbjct: 114 QLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT--- 166
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737
GT Y++PE ++ K D++S G +L E +CC + N +L E
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYE-MCCLAHAFEGQNFLSVVLR------IVE 219
Query: 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
G T +L E LN +M ++ + +DPSLRP+ ++ +
Sbjct: 220 GPTPSLPETYSRQLN-------SIMQSM--LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 520 LGKGAFG---VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+G+GAFG +V K G +Y + + ++K + ++ V + E +++ + +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTG--HIYAMKI-LRKADMLEKEQVAHIRAERDILVEADGAWVVK 65
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
+ D N L+ EFL G + + L +K F IA +L +
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 637 IHCDIKPQNILLDDYYNARISDFGL----------------------------------A 662
IH DIKP N+LLD + ++SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ ++ Q + GT Y+APE F D +S GV++ E++
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
I GL ++H +++ D+KP NILLD++ + RISD GLA + + H ++ GT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTH 159
Query: 681 GYVAPEWF-RNMPITVKVDVYSFGVLLLEII 710
GY+APE + D +S G +L +++
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 64/240 (26%)
Query: 520 LGKGAFG---VVYKGAIGMASMYQVPVAVKKLHS---VIQDGVKEFKTEVNVIGQTHHKN 573
+G+GAFG +V K G +Y A+KKL + ++ V + E +++ + +
Sbjct: 9 IGRGAFGEVRLVQKKDTG--HIY----AMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI------AFGIARGLLY 627
+V+L D L+ E+L G + + L + D F IA +L
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---------KKDTFTEEETRFYIAETILA 113
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL----------LLDQS------- 670
+ IH DIKP N+LLD + ++SDFGL L +L +
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 671 ----------QTHTAIR----------GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ T R GT Y+APE F + D +S GV++ E++
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
I+ L +LHE II+ D+K N+LLD + +++D+G+ K + T T GT
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTP 160
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM 718
Y+APE R VD ++ GVL+ E++ R D+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL-L 578
+G+GAFG V + A + K + + F+ E +V+ ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIA-FGIARGLLYLHEECSTQ 635
F D+ N LV ++ G L + L F D P D+A F +A ++ +
Sbjct: 69 AFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLP-----EDMARFYLAEMVIAIDSVHQLH 122
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP--- 692
+H DIKP NIL+D + R++DFG L+ D + + GT Y++PE + M
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 693 --ITVKVDVYSFGVLLLEII 710
+ D +S GV + E++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 7/91 (7%)
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
I GL ++H +++ D+KP NILLD++ + RISD GLA + + H ++ GT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTH 159
Query: 681 GYVAPEWF-RNMPITVKVDVYSFGVLLLEII 710
GY+APE + + D +S G +L +++
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 10/198 (5%)
Query: 520 LGKGAFGVVY--KGAIGMASMYQVPVAVKKLHSVIQDG--VKEFKTEVNVIGQTHHKNLV 575
LG GA+G V+ + G S + V K +++Q + +TE V+ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 576 RLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L + +L L+ ++++ G L + L + + I L +LH+
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---L 124
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR--NMP 692
II+ DIK +NILLD + ++DFGL+K D+ + + GT Y+AP+ R +
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 693 ITVKVDVYSFGVLLLEII 710
VD +S GVL+ E++
Sbjct: 185 HDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 522 KGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGF 580
+GAFG VY G S +Y V V VKK + ++ V + + E + + + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKV-VKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 581 CDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
N LV E+L G + S L +G + + I+ +A L YLH IIH
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-IS-EVALALDYLHRH---GIIH 127
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLL 666
D+KP N+L+ + + +++DFGL+K+ L
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
+ +A+G+ +L S IH D+ +N+LL D A+I DFGLA+ ++ D ++ ++
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND---SNYVVK 271
Query: 678 GTK----GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWA 731
G ++APE + TV+ DV+S+G+LL EI ++ + VN +
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331
Query: 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
Y A E +M W + +P+ RPT +++Q+++
Sbjct: 332 YQMSRPDF--APPEI------------YSIMKMCWNL--EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHS---VIQDGVKEFKTEVNVIGQTHHKNLVR 576
+G+GAFG V + M + QV A+K L+ + + F+ E +V+ + +
Sbjct: 9 IGRGAFGEV--AVVKMKNTGQV-YAMKILNKWEMLKRAETACFREERDVLVNGDRRWITN 65
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIA-FGIARGLLYLHEECS 633
L D N LV ++ G L + L F D P D+A F +A +L +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP-----EDMARFYLAEMVLAIDSVHQ 120
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP- 692
+H DIKP N+LLD + R++DFG LL D + GT Y++PE + M
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 693 ----ITVKVDVYSFGVLLLEII 710
+ D +S GV + E++
Sbjct: 181 GKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV--KEFKTEVNVIGQTHHKNLVRL 577
+G GA G+V ++ VA+KKL Q+ K E+ ++ +HKN++ L
Sbjct: 25 IGSGAQGIV---CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 578 LGF------CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
L ++ + LV E + + L + +L R + + + + G+ +LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDH--ERMSYLLYQMLCGIKHLH-- 136
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
S IIH D+KP NI++ +I DFGLA+ S T T+ Y APE M
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 692 PITVKVDVYSFGVLLLEII 710
VD++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 36/102 (35%), Positives = 47/102 (46%), Gaps = 8/102 (7%)
Query: 618 AFGIARGLL----YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA-KLLLLDQSQT 672
A I R LL YLH IIH D+K +NI LD+ NA + DFG A KL +
Sbjct: 187 AITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243
Query: 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR 714
GT +PE P K D++S G++L E+
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 9e-07
Identities = 30/110 (27%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLLLLDQSQTHTA 675
I + L LH IIH DIK +N+L D + D+GL K ++ +
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCY-- 166
Query: 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR----RNVDMEVN 721
GT Y +PE + V D ++ GVL E++ + + D E++
Sbjct: 167 -DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215
|
Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 519 ELGKGAFGVVYKG----AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
E+G G+FG VY + ++ ++ + K+ + QD +KE + + + H N
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR----FLQKLRHPNT 77
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR-TDIAFGIARGLLYLHEECS 633
++ G LV E+ G+ + L KP + G +GL YLH S
Sbjct: 78 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---S 133
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM-- 691
+IH D+K NILL + ++ DFG A ++ GT ++APE M
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDE 188
Query: 692 -PITVKVDVYSFGVLLLEI 709
KVDV+S G+ +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 12/171 (7%)
Query: 546 KKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGF---CDDGLNRL-LVYEFLSNGTLAS 601
KK H + + + E+ + + N++++ GF D L RL L+ E+ + G L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 602 FLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661
L + + + D+A +GL L++ + + ++ + L+ + Y +I GL
Sbjct: 112 VLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGL 169
Query: 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNM--PITVKVDVYSFGVLLLEII 710
K+L + + Y + + ++ T+K D+YS GV+L EI
Sbjct: 170 EKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 53/287 (18%)
Query: 518 EELGKGAFGVVYKGAI---------GMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ 568
E LG+G +Y G + G + ++ V +K L +D F +++ Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD---LKPGWSRRTDIAFGIARGL 625
HK++V L G C + ++V EF+ G L F+ L W + +A +A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASAL 118
Query: 626 LYLHEECSTQIIHCDIKPQNILL-----DDYYNA--RISDFGLAKLLLLDQSQTHTAIRG 678
YL ++ ++H ++ +NILL D ++SD G+ +L Q
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172
Query: 679 TKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEIICCRRNV---DMEVNEAEALLTDWAYDC 734
++APE + +++ D +SFG L E IC + D + E E Y+
Sbjct: 173 --PWIAPECVEDSKNLSIAADKWSFGTTLWE-ICYNGEIPLKDKTLAEKERF-----YEG 224
Query: 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
C +T K+LA + C+ DP+ RP R +
Sbjct: 225 QCMLVTP-----------SCKELADLMT---HCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 47/215 (21%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT-EVNVIGQTHHKNLVRL- 577
+G G+FGVVY+ AI + + +V A+KK V+QD ++K E+ ++ +H N++ L
Sbjct: 74 IGNGSFGVVYE-AICIDTSEKV--AIKK---VLQD--PQYKNRELLIMKNLNHINIIFLK 125
Query: 578 --------------------LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI 617
+ F +++ + + +N L FL
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV----------KLY 175
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAI 676
++ + R L Y+H S I H D+KPQN+L+D + + ++ DFG AK LL Q +
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--AGQRSVSY 230
Query: 677 RGTKGYVAPE-WFRNMPITVKVDVYSFGVLLLEII 710
++ Y APE T +D++S G ++ E+I
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHS---VIQDGVKEFKTEVNVIGQTHHKNLVR 576
+G+GAFG V + M ++ A+K L+ + + F+ E NV+ + +
Sbjct: 9 IGRGAFGEV--AVVKMKHTERI-YAMKILNKWEMLKRAETACFREERNVLVNGDCQWITT 65
Query: 577 L-LGFCDDGLNRL-LVYEFLSNGTLASFL--FGDLKPGWSRRTDIA-FGIARGLLYLHEE 631
L F D+ N L LV ++ G L + L F D P D+A F IA +L +H
Sbjct: 66 LHYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLP-----EDMARFYIAEMVLAIHSI 118
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+H DIKP N+LLD + R++DFG + D + + GT Y++PE + M
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 692 PITV-----KVDVYSFGVLLLEII 710
+ + D +S GV + E++
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFK-TEVNVIGQTHHKNLVRL 577
+G+GA+GVV K ++ VA+KK S + VKE E+ ++ +N+V L
Sbjct: 9 VGEGAYGVVLK--CRHKETKEI-VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 578 LGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGW--SRRTDIAFGIARGLLYLHEE 631
+ R LV+E++ L L ++ G + + + + + + H+
Sbjct: 66 ----KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHK- 118
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
I+H DIKP+N+L+ ++ DFG A+ L + +T T+ Y +PE
Sbjct: 119 --NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 692 PITVKVDVYSFGVLLLEI 709
P VD++S G +L E+
Sbjct: 177 PYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 17/79 (21%), Positives = 33/79 (41%), Gaps = 2/79 (2%)
Query: 348 GSPEDLYDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRSGDM-CWKKKL 406
G F + + P + + T + E CR++CL +C C + +G C
Sbjct: 6 GGDGSTDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNG 64
Query: 407 PLSNGRFDANLNGKALIKI 425
L+N R ++ G +++
Sbjct: 65 LLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 47/230 (20%)
Query: 518 EELGKGAFGVVY----KGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHK 572
+ LGKG G V+ KG ++ + V KK +I+ VK TE ++ H
Sbjct: 7 KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHP 61
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA-FGIARGLL---YL 628
L L LV ++ G L L +PG ++A F A LL YL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL----------LLDQSQTHTAIR- 677
H I++ D+KP+NILL + + +SDF L+K L S+ +
Sbjct: 120 HLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 678 -----------------GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
GT+ Y+APE VD ++ G+LL E++
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVKEFK-TEVNVIGQTHHKN-L 574
E++G+G +G VYK VA+KK + + G+ E++++ +
Sbjct: 7 EKIGEGTYGKVYKA---RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 575 VRLLGF----CDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTD------IAFGIAR 623
VRLL +G L LV+E+L + L F+ + + G R + + +
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGR-GPGRPLPAKTIKSFMYQLLK 121
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLLLD-QSQTHTAIRGTKG 681
G+ + H ++H D+KPQN+L+D +I+D GL + + +S TH + T
Sbjct: 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLW 176
Query: 682 YVAPE-WFRNMPITVKVDVYSFGVLLLEII 710
Y APE + + VD++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 64/254 (25%), Positives = 91/254 (35%), Gaps = 85/254 (33%)
Query: 520 LGKGAFGVVYKGA-IGMASMYQVPVAVKKLH------------------SVIQDGVKEFK 560
LG+GAFGVVYK + + S + +KK + D V F
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFL 199
Query: 561 TEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLA-------------SFLFG-- 605
V+ LV+ + TLA +L G
Sbjct: 200 EPVS----------------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKV 243
Query: 606 -DLKPGWSRRTDIAFGIARGLLY----LHEECSTQIIHCDIKPQNILLDDYYNA-RISDF 659
DL G R I I R +L+ LH ST I+H D+KPQNI+ + + +I D
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 660 GLA-----------KLLLLDQ--SQTHTAIRGTKGYVAPE-----------WFRNMPITV 695
G A K LLD + I T+ AP W N+P
Sbjct: 301 GAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD-- 358
Query: 696 KVDVYSFGVLLLEI 709
+ D+YS G++ L++
Sbjct: 359 RFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 34/165 (20%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKL--HSVIQDG--VKEFKTEVNVIGQTHHKN 573
+LG+G FG VYK A + + V A+KK+ H+ +DG + + E+ ++ + H N
Sbjct: 14 GKLGEGTFGEVYK-ARQIKTGRVV--ALKKILMHNE-KDGFPITALR-EIKILKKLKHPN 68
Query: 574 LVRLLGFC-----DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR----- 623
+V L+ R VY + ++ DL G + ++
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLS-GLLENPSVKLTESQIKCYM 121
Query: 624 -----GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
G+ YLHE I+H DIK NIL+D+ +I+DFGLA+
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 7/167 (4%)
Query: 549 HSVIQDGVKE-FKTEVNVIGQTHHKNLVRLLG-FCDDGLNRLLVYEFLSNGTLASFLFGD 606
H VI+ G + TE +++ +H ++++L G F + L++ + ++ L +L
Sbjct: 119 HVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAK 176
Query: 607 LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666
I + R + YLHE +IIH DIK +NI ++ + + DFG A +
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233
Query: 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
+ + GT APE P VD++S G++L E+ C
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 36/179 (20%)
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
++ +A+G+ +L S IH D+ +NILL +I DFGLA+ + D ++ ++
Sbjct: 220 SYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVVK 273
Query: 678 GTK----GYVAPEWFRNMPITVKVDVYSFGVLLLEIICC------RRNVDMEVNEAEALL 727
G ++APE N T + DV+S+G+LL EI VD +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF------- 326
Query: 728 TDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
Y EG E + D +M + W DP RPT +++ Q++E
Sbjct: 327 ----YKMIKEGYRMLSPECAPSEMYD-------IMKSCW--DADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 64/228 (28%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
LG G+ G+V+ + S VAVKK+ VK E+ +I + H N+V++
Sbjct: 13 LGCGSNGLVFSA---VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 580 FCDDGLNRL--------------LVYEF--------LSNGTLAS---FLFGDLKPGWSRR 614
+ L +V E+ L G L+ LF
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF---------- 119
Query: 615 TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTH 673
+ + RGL Y+H S ++H D+KP N+ ++ + +I DFGLA+ ++D +H
Sbjct: 120 ---MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR--IVDPHYSH 171
Query: 674 TAIRGTKGY----VAPEWFRNMPI-------TVKVDVYSFGVLLLEII 710
KGY + +W+R+ + T +D+++ G + E++
Sbjct: 172 ------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 6e-06
Identities = 22/73 (30%), Positives = 31/73 (42%), Gaps = 10/73 (13%)
Query: 248 SNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVSTGSGTCGFNSVCR 307
++ Y R T++ +G ++ NS W FWS P D C G CG C
Sbjct: 43 NSIYSRLTLSSEGSLERFTWIPNSQD---WNLFWSAPKDQCDV------YGRCGPYGYCD 93
Query: 308 LNNRRPICECPRG 320
+N P C C +G
Sbjct: 94 VNT-SPKCNCIKG 105
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 27/166 (16%)
Query: 505 TYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--E 562
TYK L+ +LG+G++ VYKG + Q+ VA+K++ ++G F E
Sbjct: 6 TYKKLD--------KLGEGSYATVYKGRSKL--TGQL-VALKEIRLEHEEGAP-FTAIRE 53
Query: 563 VNVIGQTHHKNLVRL--LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA-- 618
+++ H N+V L + L LV+E+L L ++ D G ++
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLT--LVFEYLDT-DLKQYM--DDCGGGLSMHNVRLF 108
Query: 619 -FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
F + RGL Y H+ +++H D+KPQN+L+ + +++DFGLA+
Sbjct: 109 LFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLG 579
+G+GAFG V + K + + F E +++ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 580 FCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
D +V E++ G L + + D+ W+R F A +L L S IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR-----FYTAEVVLALDAIHSMGFIH 165
Query: 639 CDIKPQNILLDDYYNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPEWFRNMP----I 693
D+KP N+LLD + +++DFG + + + TA+ GT Y++PE ++
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 694 TVKVDVYSFGVLLLEII 710
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 39/190 (20%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-FKT----EVNVIGQTHHKNL 574
+G+G FG V+K + VA+KK V+ + KE F E+ ++ H+N+
Sbjct: 20 IGQGTFGEVFKAR---HKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 575 VRLLGFCDD---GLNR-----LLVYEF-------LSNGTLASFLFGDLKPGWSRRTDIAF 619
V L+ C NR LV+EF L + F ++K +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK-------KVMK 126
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL---DQSQTHTAI 676
+ GL Y+H +I+H D+K NIL+ +++DFGLA+ L + +T
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 677 RGTKGYVAPE 686
T Y PE
Sbjct: 184 VVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 5/143 (3%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LG GAFG V + ++Y + KK ++++ V K E +++ + ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKK-DVLLRNQVAHVKAERDILAEADNEWVVRLY 67
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
D N V +++ G + S L ++ G F IA + IH
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCAVESVHKMGFIH 124
Query: 639 CDIKPQNILLDDYYNARISDFGL 661
DIKP NIL+D + +++DFGL
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
+ +G G +G VYK A + + V + KL D + E+ ++ + H N+V
Sbjct: 15 QRVGSGTYGDVYK-ARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 578 LG--FCDDGLNRLLVYEFLSNGTLASFL-----FGDLKPGWSRRTDIAFGIARGLLYLHE 630
G + L + E+ G+L +L+ + R + +GL YLH
Sbjct: 72 FGSYLSREKL--WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH- 123
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF-- 688
S +H DIK NILL D + +++DFG+A + ++ + I GT ++APE
Sbjct: 124 --SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAV 180
Query: 689 -RNMPITVKVDVYSFGVLLLEI 709
+N D+++ G+ +E+
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 34/93 (36%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 621 IARGLL----YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTA 675
+AR LL Y+H E IIH DIK +N+L++ + + DFG A S H
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLE 708
I GT APE P T VD++S G+++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-05
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 41/182 (22%)
Query: 562 EVNVIGQTHHKNLVRLLGFCDDGLNR-----LLVYEFLSNGTLASF------LFGDLKPG 610
EVNV+ + HKN+VR + D LN+ ++ EF G L+ +FG ++
Sbjct: 62 EVNVMRELKHKNIVR---YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE- 117
Query: 611 WSRRTDIAFGIARGLLYLHE----ECSTQIIHCDIKPQNILLDDYYN------------- 653
DI + L Y H +++H D+KPQNI L
Sbjct: 118 -HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 654 ----ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITV--KVDVYSFGVLLL 707
A+I DFGL+K + + +S H+ + GT Y +PE + + K D+++ G ++
Sbjct: 177 GRPIAKIGDFGLSKNIGI-ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 708 EI 709
E+
Sbjct: 235 EL 236
|
Length = 1021 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 38/128 (29%), Positives = 63/128 (49%), Gaps = 12/128 (9%)
Query: 589 LVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647
+V E++ G L + + D+ W+R F A +L L S IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNML 174
Query: 648 LDDYYNARISDFGLA-KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITV----KVDVYSF 702
LD + +++DFG K+ + TA+ GT Y++PE ++ + D +S
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 703 GVLLLEII 710
GV L E++
Sbjct: 234 GVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 41/168 (24%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKE-----------FKT--EVNV 565
LG+G +G V K ++ VA+KK+ + I + V + F T E+ +
Sbjct: 17 LGEGTYGKVEKA---YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 566 IGQTHHKNLVRLLG-FCDDG-LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD------- 616
+ + H+N++ L+ + + +N LV + ++ DLK R+
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFIN--LVMDIMA---------SDLKKVVDRKIRLTESQVK 122
Query: 617 -IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
I I GL LH +H D+ P NI ++ +I+DFGLA+
Sbjct: 123 CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKL----HSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+G+G F V K Y A+K + S+ Q V + E+ + + + H N+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKY---YAIKCMKKHFKSLEQ--VNNLR-EIQALRRLSPHPNI 60
Query: 575 VRLLGFCDDGL-NRL-LVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEE 631
+RL+ D RL LV+E L + L + G +P R + + + L ++H
Sbjct: 61 LRLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-- 117
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
I H DIKP+NIL+ D +++DFG + + +T T+ Y APE
Sbjct: 118 -RNGIFHRDIKPENILIKD-DILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 692 PI-TVKVDVYSFGVLLLEII 710
K+D+++ G + EI+
Sbjct: 174 GYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 516 FKEELGKGAFG-VVYKGAIGMASMYQV-PVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HH 571
F + LG GAFG VV A G+ V VAVK L + D + +E+ ++ H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL 603
KN+V LLG C G L++ E+ G L +FL
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 38/129 (29%), Positives = 66/129 (51%), Gaps = 20/129 (15%)
Query: 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFG--IARGLLYLHEECSTQIIHCDIKPQNILL 648
Y+ ++ + + L D G + ++F +ARG+ +L S +H D+ +N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 649 DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG-------YVAPE-WFRNMPITVKVDVY 700
+I DFGLA+ ++ D + +KG ++APE F N+ T+ DV+
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYV------SKGSTFLPVKWMAPESIFDNLYTTLS-DVW 323
Query: 701 SFGVLLLEI 709
S+G+LL EI
Sbjct: 324 SYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 520 LGKGAFG---VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+GKGAFG +V K G +Y + + K +D + K E +V+ ++ +V
Sbjct: 9 IGKGAFGEVRLVQKKDTG--KIYAMK-TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT-DIA-FGIARGLLYLHEECST 634
L D L+ EFL G L + L + + D+ F +A +L +
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLA 662
IH DIKP NIL+D + ++SDFGL+
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 57/238 (23%), Positives = 91/238 (38%), Gaps = 51/238 (21%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LG GAFG V + ++Y + KK + ++ V K E +++ + ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKK-DVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638
D N V +++ G + S L ++ F IA L + IH
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLL---IRMEVFPEVLARFYIAELTLAIESVHKMGFIH 124
Query: 639 CDIKPQNILLDDYYNARISDFGLA------------------------------------ 662
DIKP NIL+D + +++DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 663 ---KLLLLDQSQTHTAIR-------GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+L L+Q T R GT Y+APE T D +S GV+L E++
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 16/99 (16%)
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
++ +A G+ +L S +H D+ +N+L+ + +I DFGLA+ ++ D +
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYI----- 296
Query: 678 GTKG-------YVAPEWFRNMPITVKVDVYSFGVLLLEI 709
+KG ++APE N T DV+SFG+LL EI
Sbjct: 297 -SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 17/100 (17%)
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS----QTHTA----- 675
L YLH + I+H D+KP N+L+ + +++DFGL+K+ L+ + + H
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 676 -----IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ GT Y+APE VD ++ G++L E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 34/92 (36%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 516 FKEELGKGAFG-VVYKGAIGMA-SMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQT-HH 571
F + LG GAFG VV A G+ S + VAVK L +E +E+ V+ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL 603
N+V LLG C G L++ E+ G L +FL
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 56/215 (26%)
Query: 523 GAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDGVKE-FKT----EVNVIGQTHH 571
G +GVVY+ G I VA+KKL + KE F E+N++ + H
Sbjct: 16 GTYGVVYRARDKKTGEI---------VALKKL---KMEKEKEGFPITSLREINILLKLQH 63
Query: 572 KNLVRL----LGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA---- 622
N+V + +G L+++ +V E++ + DLK F +
Sbjct: 64 PNIVTVKEVVVG---SNLDKIYMVMEYVEH---------DLKSLMETMKQ-PFLQSEVKC 110
Query: 623 ------RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676
G+ +LH+ I+H D+K N+LL++ +I DFGLA+ + +T +
Sbjct: 111 LMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQL 166
Query: 677 RGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEII 710
T Y APE + +D++S G + E++
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 37/163 (22%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-------- 569
+E+G G FG V I + V + VKE K + Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDT------------GVARVVVKELKANASSKEQNEFLQQGDP 48
Query: 570 ----HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD-------IA 618
H N+++ LG C + + LLV+E+ G L S+L + W RR +A
Sbjct: 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMA 105
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661
IA G+ ++H+ +H D+ +N L ++ D+G+
Sbjct: 106 CEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 44/172 (25%), Positives = 67/172 (38%), Gaps = 38/172 (22%)
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLD----------------DYYNARISDFG 660
I F L Y H E ++H D+KP+NIL++ D RI D G
Sbjct: 236 IIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 661 LAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEV 720
D+ + TAI T+ Y +PE + D++S G ++ E+ + D
Sbjct: 294 GC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349
Query: 721 NEAEALL---------TDWAYDCYCEGITEALVEFD----IEALNDKKKLAR 759
N L ++WA C G EA + ++ + D K LAR
Sbjct: 350 NLEHLHLMEKTLGRLPSEWAGRC---GTEEARLLYNSAGQLRPCTDPKHLAR 398
|
Length = 467 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 4/135 (2%)
Query: 582 DDGLNRLLVYEFLSNGTLASFLFGDLKPGWS-RRTDIAFGIARGLLYLHEECSTQIIHCD 640
DD L LL+ E+ S G L + LK + ++ + +L L E S +++H D
Sbjct: 137 DDKL--LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194
Query: 641 IKPQNILLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDV 699
+K NI L ++ DFG +K S ++ GT Y+APE + + K D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254
Query: 700 YSFGVLLLEIICCRR 714
+S GV+L E++ R
Sbjct: 255 WSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 21/178 (11%)
Query: 543 VAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASF 602
V +K L +D F +++ Q H +L + G C G ++V EF+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 603 LF---GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNAR--IS 657
L G + W + +A +A L YL ++ ++H ++ +NILL AR ++
Sbjct: 107 LRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILL-----ARLGLA 156
Query: 658 DFGLAKLLLLDQSQTHTAIRGTK-----GYVAPEWFRNM-PITVKVDVYSFGVLLLEI 709
+ + L D + TA+ + ++APE ++ D +SFG LLEI
Sbjct: 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 15/148 (10%)
Query: 520 LGKGAFG-VVYKGAIGMASMYQVPVAVKKLHS--VIQ-DGVKEFKTEVNVIGQTHHKNLV 575
+G GAFG V + ++Y A+K L V+ + K E +++ + ++ +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALY----AMKTLRKADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+L D N V +++ G + S L G + +R F IA +
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR-----FYIAELTCAIESVHK 119
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGL 661
IH DIKP NIL+D + +++DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 42/279 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
+ +G G +G VYK A + + + V KL + + E+ ++ H N+V
Sbjct: 15 QRIGSGTYGDVYK-ARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFL-----FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
G + EF G+L + + + R + +GL YLH +
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKG 126
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF---R 689
+H DIK NILL D + +++DFG++ + ++ + I GT ++APE R
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRNV-DMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748
D+++ G+ +E+ + + D+ A L+T F
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--------------SNFQP 228
Query: 749 EALNDKKKLA----RFVMVAIWCIQEDPSLRPTMRKVTQ 783
L DK K + FV +A + ++P RPT K+ Q
Sbjct: 229 PKLKDKMKWSNSFHHFVKMA---LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 804 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.44 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.41 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.3 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.22 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.01 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.94 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.93 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.62 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.58 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.57 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.45 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.25 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.12 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.11 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.81 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.77 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.72 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.65 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.47 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.34 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.2 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.99 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.83 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.02 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.9 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.82 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.67 | |
| PLN02236 | 344 | choline kinase | 95.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.15 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.68 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.57 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.3 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=467.53 Aligned_cols=287 Identities=44% Similarity=0.740 Sum_probs=253.3
Q ss_pred cccccCHHHHHHHHhhhH--HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccce
Q 047263 500 NLHCFTYKDLEAATNGFK--EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577 (804)
Q Consensus 500 ~~~~~~~~~l~~at~~f~--~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l 577 (804)
....|++.+|.+||++|+ +.||+|+||.||+|.+.++. .||||++.....+..++|.+|++++.+++|||||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~----~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGT----VVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCC----EEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence 577899999999999998 58999999999999998763 699999886544326679999999999999999999
Q ss_pred eeEEeCCC-ceEEEEeecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCE
Q 047263 578 LGFCDDGL-NRLLVYEFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA 654 (804)
Q Consensus 578 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~ 654 (804)
+|||.+.+ +++||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.++|+|||||++|||||+++++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999999 5999999999999999999875 88999999999999999999999988899999999999999999999
Q ss_pred EEeecCcccccccCCCCccccc-cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHH
Q 047263 655 RISDFGLAKLLLLDQSQTHTAI-RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD 733 (804)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 733 (804)
||+|||+++..... ....... .||.+|+|||++..+..++|+|||||||+|+||+||+++.+...+.....+..|++.
T Consensus 217 KlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999999764331 1111122 799999999999999999999999999999999999999887664445558899999
Q ss_pred hhhcCcccceecchhh-hcccH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 734 CYCEGITEALVEFDIE-ALNDK-KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.+.++...+++|+.+. ..... +++.++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999999976 44443 7899999999999999999999999999999776554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=382.54 Aligned_cols=253 Identities=33% Similarity=0.500 Sum_probs=208.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc--cHHHHHHHHHHhcccccCCccceeeEEeCCC-ceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL-NRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~E 592 (804)
+.+.||+|+||+||+|...... .||||++...... ..++|.+|+.++.+++|||||+++|+|.+.. ...+|||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~----~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTD----VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhcccCCceeEEEEEeCCce----eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 4566999999999999987543 3999999864322 2568999999999999999999999999988 7999999
Q ss_pred ecCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCC-eeecCCCCCcEEEcCCC-CEEEeecCcccccccC
Q 047263 593 FLSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQ-IIHCDIKPQNILLDDYY-NARISDFGLAKLLLLD 668 (804)
Q Consensus 593 y~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~~ 668 (804)
||++|+|.++|+. +..+++..+++|+.+||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999988 68899999999999999999999966 5 99999999999999997 9999999999875432
Q ss_pred CCCccccccCCCccccccccc--cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 669 QSQTHTAIRGTKGYVAPEWFR--NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~--~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
. ...+...||..|||||++. ...|+.|+|||||||+||||+||+.||........ +......+...
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~~~Rp----- 265 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVGGLRP----- 265 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCCCC-----
Confidence 2 3344478999999999999 66999999999999999999999999987654211 11111111111
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
..+......+..++.+||+.||.+||++.+|+.+|+.+..-
T Consensus 266 ----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 266 ----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred ----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 11112456778889999999999999999999999987653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=357.56 Aligned_cols=255 Identities=28% Similarity=0.365 Sum_probs=211.4
Q ss_pred cCHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEe
Q 047263 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCD 582 (804)
Q Consensus 504 ~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 582 (804)
.+..||+. .+.||+|..|+|||++++.+++ .+|+|.+.... ....+++.+|++++++.+||+||+++|.|.
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~---i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGK---IYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCe---EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 55566653 5689999999999999986654 79999995443 345678999999999999999999999999
Q ss_pred CCCc-eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 583 DGLN-RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 583 ~~~~-~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
.+.. ..|+||||++|||++++...+++++...-+|+.+|++||.|||++ .+||||||||+|||++..|++||+|||.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 8884 999999999999999999888899999999999999999999963 5999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH--HHHHHHHHHHHhhhcCc
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE--AEALLTDWAYDCYCEGI 739 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~ 739 (804)
++.+-.. ...+..||..|||||.+++..|+.++||||||+.++|+.+|+.|+....+. ....+..
T Consensus 226 S~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~---------- 292 (364)
T KOG0581|consen 226 SGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC---------- 292 (364)
T ss_pred cHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH----------
Confidence 9976443 456688999999999999999999999999999999999999998765211 1111111
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+++...........+.++.+++..||++||.+||++.|+++
T Consensus 293 --~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 293 --AIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --HHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112211111112245678999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=367.27 Aligned_cols=260 Identities=29% Similarity=0.406 Sum_probs=214.2
Q ss_pred HHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 508 ~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
++.+....+.++||+|-||.|+.|.+.... .||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++.+
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~----~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGST----KVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCC----cccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 445555668899999999999999997654 4999999865 33457899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 588 LLVYEFLSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
+||||||++|+|.++|.. +..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||||+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999986 5778899999999999999999994 59999999999999999999999999999965
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHH-HHHHHHHHHHhhhcCcccce
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEA-EALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~ 743 (804)
..+.........-...|.|||.+....|+.|+|||||||+||||+| |+.|+......+ ...+
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l---------------- 417 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL---------------- 417 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH----------------
Confidence 5544444444445778999999999999999999999999999999 556654433221 1111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
+...+-..+......+++|+..||+.+|++|||++.+...|+.+....
T Consensus 418 -e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 418 -ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 111111223345678899999999999999999999999998776543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.48 Aligned_cols=200 Identities=30% Similarity=0.472 Sum_probs=179.6
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|.|++||+|+++..+ ..||||.+... ..+..+-...|+.+|+.++|||||++++++..++..+||||
T Consensus 13 ~~~~~iG~GsfavVykg~h~~~~---~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 13 ELSREIGSGSFAVVYKGRHKKSG---TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred eehhhccCcceEEEEEeEeccCC---ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 45678999999999999998665 48999999765 44555668899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC------CCEEEeecCcccccc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY------YNARISDFGLAKLLL 666 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~------~~~kl~Dfgla~~~~ 666 (804)
||.+|+|.++|+.+..+++.....++.|||.||++||+. +||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999999999999999999999999999999999965 99999999999999764 458999999999875
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE 722 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~ 722 (804)
......+.+|++-|||||+++..+|+.|+|+||.|+|||||++|+.||+.....
T Consensus 167 --~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 167 --PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred --chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 333445678999999999999999999999999999999999999999866544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.93 Aligned_cols=272 Identities=25% Similarity=0.424 Sum_probs=231.5
Q ss_pred ccccCHHHHHHHHhhhHH-----------hhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcc
Q 047263 501 LHCFTYKDLEAATNGFKE-----------ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQ 568 (804)
Q Consensus 501 ~~~~~~~~l~~at~~f~~-----------~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~ 568 (804)
...++|+|...|-.+|.+ .||.|.||.|++|.++..++..+.||||.++... ++..++|+.|+.+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 456899998888888754 4899999999999999888888899999998654 5667799999999999
Q ss_pred cccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEE
Q 047263 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 569 l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIL 647 (804)
+.||||++|.|+.......++|+|||+||+|+.+|+.+ ..+++.+..-++.+||.|++||.+. ++|||||.++|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 99999999999999999999999999999999999865 5689999999999999999999954 9999999999999
Q ss_pred EcCCCCEEEeecCcccccccCCCCccccccC--CCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcch-hHH
Q 047263 648 LDDYYNARISDFGLAKLLLLDQSQTHTAIRG--TKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEV-NEA 723 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~-~~~ 723 (804)
++.+..+||+|||+++.+..+.....+...| ..+|.|||.+..++++.++|||||||+|||+++ |.+|+-... .+.
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 9999999999999999876655444443333 468999999999999999999999999999887 788864433 332
Q ss_pred HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
...+ +...+-..++.....|.+|++.|||+|-.+||.+.+|+.+|++++..+
T Consensus 844 IkaI-----------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 844 IKAI-----------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHH-----------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 2211 112222345667789999999999999999999999999999987554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=351.32 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=204.1
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-------cHHHHHHHHHHhcccccCCccceeeEEeCC
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-------GVKEFKTEVNVIGQTHHKNLVRLLGFCDDG 584 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 584 (804)
..+-+.+.||+|+||.|-+|..+..++ .||||++...... ......+|+++|++|+|||||++++++++.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk---~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGK---QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCc---EEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 344567899999999999998875544 7999999753211 122357999999999999999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC---CCEEEeecCc
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY---YNARISDFGL 661 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfgl 661 (804)
+..|||+|||+||.|.+.+-.++.+.+..-..++.|++.|+.|||+. +|+||||||+|||+..+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999999999999999999999999999999965 99999999999999755 7799999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCC--C-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI--T-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
|+..+ ....+.+.+||+.|.|||++.++.. + .++|+||+||+||-+++|.+||.....+.. +.+. ...+
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQ----I~~G 397 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQ----ILKG 397 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHH----HhcC
Confidence 99865 4556778899999999999976543 3 478999999999999999999986654321 1000 0011
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ........+..++..+++.+||..||+.|||+.|+++
T Consensus 398 ~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 00 0011123345678899999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.32 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=207.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
++.-.+.||+|||..+|+++..+.++ .||+|.+.+.. ....+...+|+++.+.|+|||||+++++|++.++.||
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge---~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGE---VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCc---EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 34456789999999999999854433 79999997532 3445678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|.|+|++++|..+++.++.+++.+...++.||+.||.|||+. +|+|||||..|+||+++.++||+|||||..+..+
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 999999999999999999999999999999999999999954 9999999999999999999999999999987544
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-HHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-EALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.+...+.+||+.|+|||++.....+..+||||+||+||-||.|++||+...-.+ ...+. .. +.
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--------~~------~Y-- 235 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--------LN------EY-- 235 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--------hc------Cc--
Confidence 344567899999999999999999999999999999999999999998763222 11110 00 00
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+...+.+..+|+..+|+.||.+|||+++|+.
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111234456778999999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=373.67 Aligned_cols=267 Identities=27% Similarity=0.416 Sum_probs=217.0
Q ss_pred HHHHHHhhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCC
Q 047263 508 DLEAATNGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDG 584 (804)
Q Consensus 508 ~l~~at~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 584 (804)
++......|.++||+|.||+||+|+..... +....||||.++..... ..++|++|+++++.++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 444555567899999999999999876544 44568999999977665 778999999999999999999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCC----------CC----CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 585 LNRLLVYEFLSNGTLASFLFGD----------LK----PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~----------~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
+..+||+|||..|+|.++|..+ .. ++..+.+.||.|||.|+.||-++ ..|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999622 22 67889999999999999999954 9999999999999999
Q ss_pred CCCEEEeecCcccccccCCCCcc-ccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHH
Q 047263 651 YYNARISDFGLAKLLLLDQSQTH-TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLT 728 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~ 728 (804)
+..+||+||||++..-..+.... ..-.-..+||+||.+..++||+++|||||||+|||+++ |+.|+..-..++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 99999999999997543332222 23334679999999999999999999999999999998 777776543322
Q ss_pred HHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 729 DWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
+.+...++.. -..+.....+++.|+..||+.+|++||+++||...|+...+..+
T Consensus 714 --VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 714 --VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred --HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 1111122211 12344456789999999999999999999999999998765543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.99 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=205.2
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccc--cccccHHHHHHHHHHhcccccCCccceee-EEeCCCc-e
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS--VIQDGVKEFKTEVNVIGQTHHKNLVRLLG-FCDDGLN-R 587 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g-~~~~~~~-~ 587 (804)
+.+.+.++||+|.||+|||+....++. .+|.|++.- ...+..+....|+.+|++|+|||||++++ .+.+++. .
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~---l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGK---LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcc---hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 445678999999999999998765544 799999872 33456678999999999999999999999 5555555 8
Q ss_pred EEEEeecCCCcHHHhhc----CCCCCChhhHHHHHHHHHHHHHHhhhcc-CCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 588 LLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAFGIARGLLYLHEEC-STQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
+|||||+..|+|...++ +++.+++...+++..|+++||.++|... +.-|+||||||.||+|+.+|.+|++|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 89999999999999986 3577899999999999999999999642 123999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
+.+..... ......||+.||+||.+...+|+.|+||||+||++|||..-..||....-. .+. .....+
T Consensus 176 r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L~----~KI~qg---- 243 (375)
T KOG0591|consen 176 RFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SLC----KKIEQG---- 243 (375)
T ss_pred hHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HHH----HHHHcC----
Confidence 98765433 334578999999999999999999999999999999999999999876211 111 111111
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
+........++..+..|+..|+..||+.||+...+++.+
T Consensus 244 ----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 244 ----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 111122345678899999999999999999865555444
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=324.75 Aligned_cols=264 Identities=27% Similarity=0.408 Sum_probs=200.4
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcc--cccCCccceeeEEeCCC----ceEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ--THHKNLVRLLGFCDDGL----NRLL 589 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~l 589 (804)
+.+.||+|+||.||||++.+ +.||||++.. +..+.|++|-+++.. ++|+||+++++.-.... +++|
T Consensus 214 l~eli~~Grfg~V~KaqL~~-----~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-----RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hHHHhhcCccceeehhhccC-----ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 57889999999999999975 3699999984 456778888777765 58999999999876655 8899
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc------CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC------STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
|+||.++|+|.++|.. ..++|....+|+..+++||+|||+.. +++|+|||||.+||||..|+++.|+|||+|.
T Consensus 286 Vt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred EeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999999964 56799999999999999999999763 5679999999999999999999999999999
Q ss_pred ccccCCCCc-cccccCCCccccccccccC-CCC-----ccchhhHHHHHHHHHHcCCCCCCcc--------hhHH---HH
Q 047263 664 LLLLDQSQT-HTAIRGTKGYVAPEWFRNM-PIT-----VKVDVYSFGVLLLEIICCRRNVDME--------VNEA---EA 725 (804)
Q Consensus 664 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~~s-----~~~DV~S~Gvll~elltG~~p~~~~--------~~~~---~~ 725 (804)
.+....... .....||.+|||||++.+. .+. .+.||||+|.|||||++...-.+.. .+.+ ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 886544332 2237899999999999764 222 4799999999999999987554311 0100 00
Q ss_pred HHHHHHHH-hhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 726 LLTDWAYD-CYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 726 ~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
.+.+ .+. ..++.....+.+.. .....+..+.+.+..||..||+-|-|+.=|-+++.++.-+.+
T Consensus 445 t~e~-mq~~VV~kK~RP~~p~~W----~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 445 TLEE-MQELVVRKKQRPKIPDAW----RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CHHH-HHHHHHhhccCCCChhhh----hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0000 000 01111111222211 122456778899999999999999999999988877665543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.50 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=206.6
Q ss_pred CHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEe
Q 047263 505 TYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD 582 (804)
Q Consensus 505 ~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 582 (804)
.+.||......+.+.||+|+||+||+|.+-. .||||.+... ..+..+.|++|+..+++-+|.||+-+.|+|.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 3444444445567899999999999999853 3999999743 3456789999999999999999999999999
Q ss_pred CCCceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 583 DGLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 583 ~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
.... .+|+-+|++.+|..+|+.. .+++..+.+.||.|||+|+.|||. ++|||||||..||+|.+++.+||+|||+
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 8877 9999999999999999864 678888999999999999999994 5999999999999999999999999999
Q ss_pred ccccccCC-CCccccccCCCcccccccccc---CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 662 AKLLLLDQ-SQTHTAIRGTKGYVAPEWFRN---MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 662 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~---~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
+..-..-. ........|...|||||+++. .+|+.++||||||+|+|||++|..|+.....+ .++ +.-
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIi-------fmV 605 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QII-------FMV 605 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heE-------EEe
Confidence 97643321 122223447789999999964 47999999999999999999999999833221 111 111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+.-....+... .......+|.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 606 GrG~l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 GRGYLMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cccccCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11000011100 112234577788899999999999999999999887765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.24 Aligned_cols=240 Identities=26% Similarity=0.302 Sum_probs=198.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
..+.+.||+|+||+||.++.++.++ .+|+|.+++.. ....+..++|..++.+++||.||+++-.|.+....|||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~k---iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGK---IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCc---eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3457899999999999999885544 79999997532 23466789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+||+.||.|..+|.+...+++.....++..|+.||.|||+ .+||||||||+|||||++|+++|+|||+++.... .+
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DG 179 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-CC
Confidence 9999999999999999999999999999999999999995 4999999999999999999999999999996433 33
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
....+.+||+.|||||++....++.++|.||+|+++|||++|.+||........ ... ...+.. .
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~-I~~~k~---------~ 243 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDK-ILKGKL---------P 243 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHH-HhcCcC---------C
Confidence 344558999999999999999999999999999999999999999986643221 111 111110 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP 776 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP 776 (804)
..+.-...+..+++...++.||++|-
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 01111345677788888999999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=309.27 Aligned_cols=260 Identities=21% Similarity=0.250 Sum_probs=203.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-cc-HHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DG-VKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
-..++|+|+||.|||.+.++.+ +.||||++..... .. .+-.++|++++++++|+|+|.++..|......+||+||
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~Tg---qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTG---QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred hhhccccCcceEEEEeccCCcc---cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 3457999999999999987654 4899999975433 22 34568999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
++.--|.++=.....++.....+++.|+++|+.|+|.+ ++|||||||+|||++.++.+||+|||+|+.+.. .....
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99855555544456788889999999999999999954 999999999999999999999999999998754 55666
Q ss_pred ccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HHhh-hcCcccce
Q 047263 674 TAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YDCY-CEGITEAL 743 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~-~~~~~~~~ 743 (804)
+.+..|..|.|||.+-+ .+|...+||||.||++.||++|.+-|.....-....+.... .+.+ .+.....+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 77888999999999977 79999999999999999999999888766544332222111 0111 11122222
Q ss_pred ecchhhhccc-----HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 744 VEFDIEALND-----KKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 744 ~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
.-+......+ .....-+++++..|++.||.+|++-++++
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 2222222111 12245688999999999999999999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.91 Aligned_cols=261 Identities=30% Similarity=0.404 Sum_probs=210.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCcccc-ceeEEEEEccc---cccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMY-QVPVAVKKLHS---VIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~-~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
-.+.++||+|+||.||+|.+...... ...||||.... ......++|++|+++|++++|||||+++|++......++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 34558999999999999999765431 22399999985 345677899999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
|||+|.||+|.++|.... .++..++++++.+.|.||+|||. .+++||||..+|+|++.++.+||+|||+++.-.
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~-- 313 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS-- 313 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc--
Confidence 999999999999998876 59999999999999999999995 599999999999999999999999999987532
Q ss_pred CCCccc-cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 669 QSQTHT-AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 669 ~~~~~~-~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
...... ...-...|+|||.+....++.++|||||||++||+.+ |..|+........ ..++ ..++...
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI---~~~~~r~----- 382 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKI---VKNGYRM----- 382 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHH---HhcCccC-----
Confidence 111111 1234678999999999999999999999999999999 7788776543321 1111 0111111
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~p 794 (804)
..+......+..+...|++.+|++||+|.+|.+.|+.+.....+
T Consensus 383 ----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 ----PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11113345666778899999999999999999999988776654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.08 Aligned_cols=263 Identities=23% Similarity=0.233 Sum_probs=205.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 589 (804)
++-.++||+|.||.||||+....++ .||+|++.-.. ........+||.+|++|+||||++|.+...+. ..+||
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgk---ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGK---IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCc---EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3345789999999999999875544 89999997543 23345567999999999999999999998776 68999
Q ss_pred EEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
|+|||++ +|.-++.. ...++..++..++.|++.||.|+| +.+|+|||||.+|||||.+|.+||+|||||+.+...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 77777765 468999999999999999999999 559999999999999999999999999999988777
Q ss_pred CCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH-----HhhhcCccc-
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY-----DCYCEGITE- 741 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~~~- 741 (804)
.....+..+-|..|.|||.+.+ ..|+.++|+||.||||.||+.|++.+....+.+....+--.. ..|......
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 7777777788999999998876 479999999999999999999999998776554332221111 111100000
Q ss_pred -ceecc------hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 742 -ALVEF------DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 742 -~~~~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
..+.+ .+.+. -.......++|+..+|..||.+|.|+.++++-
T Consensus 352 ~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00110 00110 11112556788888999999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.68 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=200.7
Q ss_pred HHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhccc-ccCCccceeeEEeCC-Cc
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG-LN 586 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 586 (804)
..+.+.++||+|+||.||+|.... ....+..||||++..... ...+.+.+|+.++.++ +||||++++++|.+. ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 345567889999999999997531 222345799999975432 3346789999999999 899999999988764 45
Q ss_pred eEEEEeecCCCcHHHhhcCC------------------------------------------------------------
Q 047263 587 RLLVYEFLSNGTLASFLFGD------------------------------------------------------------ 606 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 606 (804)
.++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999999998642
Q ss_pred --CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC-ccccccCCCccc
Q 047263 607 --LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYV 683 (804)
Q Consensus 607 --~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ 683 (804)
..+++.....++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++........ ......++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2366778889999999999999954 9999999999999999999999999999865332221 122334567899
Q ss_pred cccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHH
Q 047263 684 APEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVM 762 (804)
Q Consensus 684 aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 762 (804)
|||++.+..++.++||||||+++|||++ |..||........ +. ....++.... ........+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~~~---------~~~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTRMR---------APENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCCCC---------CCCCCCHHHHH
Confidence 9999999999999999999999999997 9999875432211 10 1111111100 01123456889
Q ss_pred HHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 763 VAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 763 l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
++.+||+.||++|||+.||+++|+.+..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.44 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=206.1
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
.....+.+.||+|+||.||+|...........||+|.++.... ...+.|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 4455677899999999999998765555567899999986432 334578999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +++||||||+|||++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999764 5789999999999999999999965 9999999999999999999999999987653222
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.........++..|+|||.+.+..++.++||||||+++||+++ |+.||........ + .. ..++... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~-~~----~~~~~~~-----~ 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--I-KA----VEDGFRL-----P 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--H-HH----HHCCCCC-----C
Confidence 1111222334678999999999999999999999999999875 9999865433221 1 10 1111100 0
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
........+.+++..||+.+|++||++.+|.+.|+++
T Consensus 229 ----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 ----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112345688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.96 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=198.9
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC--ceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL--NRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E 592 (804)
...+.||+|.||.||++...+. +...|||..........+.+.+|+.++.+++|||||+++|...... ..+++||
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~---g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKT---GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhccccCccceEEEEEEecCC---CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 3467899999999999998764 3369999987643333667899999999999999999999854444 6889999
Q ss_pred ecCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCccccccc--C
Q 047263 593 FLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLL--D 668 (804)
Q Consensus 593 y~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~--~ 668 (804)
|+++|+|.+++.+.. .+++....++..||++||+|||+ ++|+||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998765 79999999999999999999994 59999999999999999 79999999999987653 2
Q ss_pred CCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.........||+.|||||++..+ ....++||||+||++.||+||+.||......... ......+....
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~-----~~~ig~~~~~P------ 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA-----LLLIGREDSLP------ 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH-----HHHHhccCCCC------
Confidence 23334567899999999999853 3345999999999999999999998753111111 11111111111
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
..+.....+..+++..|++.+|++|||++++++-.
T Consensus 243 ---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11222456788899999999999999999998654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.13 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=207.0
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
++||+|..|.||.+....... .||||++....+...+-..+|+.+|+..+|+|||+++..+..+++.++|||||++|
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~---~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQ---EVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred hhhccccccceeeeeeccCCc---eEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 589999999999998765544 79999998776666777899999999999999999999998889999999999999
Q ss_pred cHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccccc
Q 047263 598 TLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677 (804)
Q Consensus 598 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 677 (804)
+|.+.+... .+++.++..|+.++++||+|||. .+|+|||||.+|||++.+|.+||+|||++..+..... ...+..
T Consensus 356 sLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmV 430 (550)
T KOG0578|consen 356 SLTDVVTKT-RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMV 430 (550)
T ss_pred chhhhhhcc-cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccccc
Confidence 999999543 48899999999999999999995 4999999999999999999999999999987754433 566778
Q ss_pred CCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHH
Q 047263 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKL 757 (804)
Q Consensus 678 gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 757 (804)
||+.|||||+.....|..|+||||||++++||+-|.+||-.+.+-....++ ..++.. ........+
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng~P--------~lk~~~klS 496 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTP--------KLKNPEKLS 496 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcCCC--------CcCCccccC
Confidence 999999999999999999999999999999999999999765443322221 112211 112233455
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 758 ARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 758 ~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+.++..+||+.|+++||++.|+++
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 68889999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.05 Aligned_cols=247 Identities=25% Similarity=0.307 Sum_probs=203.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
..|.+.||+|+|.+|++++...... ++|||++.+.. ++..+-...|-..|.+| .||.|++|+-.|.++..+|+
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~k---eYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGK---EYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred cchhheeccccceeEEEeeecCCCc---eeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4578999999999999999876544 89999997532 23344577889999999 89999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|+||+++|+|.++|.+-..+++.....++.+|+.||+||| +.+||||||||+|||||+|+++||+|||-|+.+....
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999 5599999999999999999999999999999875322
Q ss_pred CC----------cc--ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 670 SQ----------TH--TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 670 ~~----------~~--~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
.. .. ..++||..|.+||++.....+..+|+|+|||+||+|+.|.+||....+-....- +
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk---I------ 299 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK---I------ 299 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH---H------
Confidence 11 11 447899999999999999999999999999999999999999987654321100 0
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+ ++....... .+...+|+..-|..||.+|+|.++|.+
T Consensus 300 --~~--l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 300 --QA--LDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --HH--hcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhh
Confidence 00 011111111 245667888889999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=373.41 Aligned_cols=269 Identities=27% Similarity=0.501 Sum_probs=210.3
Q ss_pred cCHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC
Q 047263 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD 583 (804)
Q Consensus 504 ~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 583 (804)
++++++..+. ...+.||+|+||.||+|+....+ ..||||++...... ...|++.+++++|||||+++++|.+
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSIKNG---MQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEECCCC---cEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 4455554332 23457999999999999986443 37999998754322 2346888999999999999999999
Q ss_pred CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
+...++||||+++|+|.++++ .++|.++.+|+.|||+||+|||..+.++|+||||||+||+++.++.+++. |+...
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 999999999999999999995 48999999999999999999998777899999999999999999888875 66554
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
.... .....++..|+|||++.+..++.++|||||||++|||++|+.|++...... ..+..|+............
T Consensus 831 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 831 LLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred cccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhhe
Confidence 3221 122357889999999999999999999999999999999999986543322 2233454443333333344
Q ss_pred ecchhhh--cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 744 VEFDIEA--LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 744 ~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.++.+.. ....++..++.+++.+|++.+|++||+|+||+++|+++..
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4443322 2344667788999999999999999999999999998765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.52 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=206.2
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHH--HHHHHHHhcccc-cCCccceeeEEeCCC-ce
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE--FKTEVNVIGQTH-HKNLVRLLGFCDDGL-NR 587 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~--f~~E~~~l~~l~-h~niv~l~g~~~~~~-~~ 587 (804)
..+...++||.|.||.||+|+.....+ .||||+++..... .++ =.+|+..|++|+ |||||++...+.+.+ ..
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~---~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGE---LVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCc---eeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 456678999999999999999875554 7999999865443 333 368999999998 999999999998888 89
Q ss_pred EEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 588 LLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
++|||||+. +|..+++++ ..+++..+..|+.||++||+|+|++ |+.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999999976 899998765 5679999999999999999999966 99999999999999999999999999999753
Q ss_pred cCCCCccccccCCCcccccccc-ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHH-----HHHHHHhhhcC--
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWF-RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL-----TDWAYDCYCEG-- 738 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l-----~~~~~~~~~~~-- 738 (804)
.....+.+..|..|+|||++ +.+-|+.+.|+||+|||++|+.+-++.|.+..+.++-.- -.-.+..|.++
T Consensus 162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 34556677889999999977 677899999999999999999999988876654332110 00001111111
Q ss_pred -------cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 739 -------ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 739 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
...+.....+....+. ...++++++.+|++.||.+|||++|.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111122222222222 66788999999999999999999999865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.43 Aligned_cols=261 Identities=18% Similarity=0.260 Sum_probs=204.8
Q ss_pred ccccCHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccccc---HHHHHHHHHHhcccccCCccce
Q 047263 501 LHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG---VKEFKTEVNVIGQTHHKNLVRL 577 (804)
Q Consensus 501 ~~~~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l 577 (804)
...++.++++..+ ...|++|++|.||+|+.. +..||||++....... .+.|.+|+.++.+++||||+++
T Consensus 12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIFN-----NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred ceecCHHHcCCCC---CeEEeeCCceEEEEEEEC-----CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 3445555553221 136999999999999874 3369999997643322 4678899999999999999999
Q ss_pred eeEEeC----CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC
Q 047263 578 LGFCDD----GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653 (804)
Q Consensus 578 ~g~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~ 653 (804)
+|++.+ ....++||||+++|+|.+++.....+++....+++.+++.||.|||+. .+++||||||+|||+++++.
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCc
Confidence 999876 356789999999999999998888899999999999999999999952 37789999999999999999
Q ss_pred EEEeecCcccccccCCCCccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH
Q 047263 654 ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA 731 (804)
Q Consensus 654 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 731 (804)
+||+|||+++.+... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ . ...
T Consensus 162 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~--~-~~i 234 (283)
T PHA02988 162 LKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI--Y-DLI 234 (283)
T ss_pred EEEcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH--H-HHH
Confidence 999999999865322 123457889999999976 6899999999999999999999999976543221 1 100
Q ss_pred HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
...+.. .. .+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 235 ---~~~~~~-----~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 ---INKNNS-----LK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---HhcCCC-----CC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 001100 00 011234568889999999999999999999999987654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=357.72 Aligned_cols=262 Identities=28% Similarity=0.408 Sum_probs=209.4
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCcccc--ceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMY--QVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~--~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
...-.+.+.||+|.||.||+|...+-... ...||||.+.... .+.+.+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 33334556799999999999998654432 4569999998654 45677899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCC-------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecC
Q 047263 588 LLVYEFLSNGTLASFLFGD-------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFG 660 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg 660 (804)
++++|||++|+|..+|++. ..+.....+.++.|||+|+.|||+ ++.|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999864 456788899999999999999995 499999999999999999999999999
Q ss_pred cccccccCC-CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCC-CCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 661 LAKLLLLDQ-SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR-RNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 661 la~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
||+.+...+ .+......-...|||||.+..+.|+.|+|||||||+|||++|.. .|+......+-. . .+.++
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~---~----~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL---L----DVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH---H----HHHhC
Confidence 999543332 22223323456899999999999999999999999999999954 555433322211 1 01111
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
- +-..+....+.+++|+..||+.+|++||++..|++.++.+.+-
T Consensus 921 g---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 G---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred C---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1 1122444567889999999999999999999999988877654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.49 Aligned_cols=251 Identities=31% Similarity=0.490 Sum_probs=195.4
Q ss_pred hHHhhCCCcceeEEEeeec-CccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIG-MASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~-~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.||.|.||.||+|.+. ........|+||.++... .+..++|.+|++.+++++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999998 455556789999996533 33478899999999999999999999999988889999999
Q ss_pred cCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 594 LSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
+++|+|.++|... ..+++..+..|+.||++||.|||+. +++|++|+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 7889999999999999999999965 899999999999999999999999999987622211
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
...........|+|||.+....++.++||||||+++|||++ |+.|+....... .. . ...++...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~-~----~~~~~~~~-------- 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--II-E----KLKQGQRL-------- 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HH-H----HHHTTEET--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--cc-c----cccccccc--------
Confidence 22233446778999999999899999999999999999999 677775542221 11 1 11111110
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
.........+.+++..||+.+|++||+|++|++.|
T Consensus 225 -~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01112345678899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.07 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=203.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+++.++||.|..++||+|+-.... +.||||++.-.. ......+++|+..+..++||||++++..|..+...|+||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~---e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTN---EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccC---CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3556789999999999999876444 379999997432 233688999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
.||.+||+.++++.. ..+++..+..|.+++++||.|||++ +.||||||+.||||+++|.+||+|||.+-.+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999764 5578888999999999999999965 99999999999999999999999999887654433
Q ss_pred CCc--c-ccccCCCccccccccc--cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 670 SQT--H-TAIRGTKGYVAPEWFR--NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 670 ~~~--~-~~~~gt~~y~aPE~l~--~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.+. . ....||+.|||||++. -..|+.|+|||||||...||.+|..||....+-. .++.. ..+....+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-vLl~t------Lqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-VLLLT------LQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-HHHHH------hcCCCCCcc
Confidence 221 1 4568999999999953 3479999999999999999999999997654322 11111 112111111
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+...........+.+++..||+.||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111222223334457888999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.58 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=206.2
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc----cc-ccHHHHHHHHHHhcccc-cCCccceeeEEeCCCc
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV----IQ-DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLN 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~----~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~ 586 (804)
.+.+.+.||+|.||+|+.|.....+ ..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~---~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTG---EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCC---CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4456788999999999999886554 47999976542 11 23456778999999999 9999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-CCEEEeecCccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLL 665 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfgla~~~ 665 (804)
.++||||+.+|.|.+++....++.+....+++.|++.|++|+| +.+|+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999999889999999999999999999999 4599999999999999999 99999999999976
Q ss_pred ccCCCCccccccCCCccccccccccCC-CC-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMP-IT-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+........ .....+.
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-------~ki~~~~---- 239 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-------RKIRKGE---- 239 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-------HHHhcCC----
Confidence 4 3345566788999999999999987 87 7899999999999999999999874322110 0011110
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
..+..... ..++..++.+|++.||.+|+++.+|+ .-.-+.
T Consensus 240 --~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 240 --FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred --ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 00111111 56788899999999999999999999 444444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.32 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=199.3
Q ss_pred HhhhHHhhCCCcceeEEEeeecCcc-------------ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCcccee
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMAS-------------MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLL 578 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~-------------~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~ 578 (804)
.+.+.++||+|+||.||++...... .....||+|.+.... .....+|.+|+.++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 3456788999999999999865432 123469999987543 33456799999999999999999999
Q ss_pred eEEeCCCceEEEEeecCCCcHHHhhcCC-------------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeec
Q 047263 579 GFCDDGLNRLLVYEFLSNGTLASFLFGD-------------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHC 639 (804)
Q Consensus 579 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 639 (804)
+++.+.+..++||||+++|+|.+++... ..+++....+++.||+.||.|||+. +|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 9999999999999999999999998542 2357788999999999999999965 99999
Q ss_pred CCCCCcEEEcCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcC--CCCC
Q 047263 640 DIKPQNILLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICC--RRNV 716 (804)
Q Consensus 640 dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG--~~p~ 716 (804)
||||+|||+++++.+||+|||+++.+..... .......++..|+|||++....++.++||||||+++|||+++ ..|+
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986533221 112233457889999999888999999999999999999874 4566
Q ss_pred CcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 717 DMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 717 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
....... . ................. .........+.+++.+||+.+|++||||.+|++.|+.
T Consensus 243 ~~~~~~~--~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDEQ--V-IENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHHH--H-HHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5432211 1 11111111111110000 0011223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.82 Aligned_cols=259 Identities=28% Similarity=0.384 Sum_probs=200.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCce
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 587 (804)
....+.++||+|+||.||+++... .......||||+++... ....+.+.+|+.++..+ +||||++++++|.++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 345678899999999999997521 12234579999987432 23445788999999999 899999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCC-------------------------------------------------------------
Q 047263 588 LLVYEFLSNGTLASFLFGD------------------------------------------------------------- 606 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------- 606 (804)
++||||+++|+|.+++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999998542
Q ss_pred --------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 607 --------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 607 --------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
..+++..+.+++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1467888899999999999999954 99999999999999999999999999998654332211
Q ss_pred -cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 673 -HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 673 -~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||........ ... ...++....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~----~~~~~~~~~-------- 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK----MIKEGYRML-------- 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH----HHHhCccCC--------
Confidence 122335668999999999999999999999999999998 7788764432211 111 111111000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.......++.+++.+|++.||++||++.+|+++|++.
T Consensus 338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.07 Aligned_cols=267 Identities=24% Similarity=0.365 Sum_probs=208.8
Q ss_pred HHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccccc-HHHHHHHHHHhcccccCCccceeeEEeCC
Q 047263 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNLVRLLGFCDDG 584 (804)
Q Consensus 506 ~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 584 (804)
.+|..+..--|.++||+|-||.|........ ..||||.++...... .++|..|+++|.+++|||||+++|.|..+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~----lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGP----LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCc----eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 4455555667889999999999999988653 469999998765544 57999999999999999999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCCCCC--ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDLKP--GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
+.+++|+|||++|+|..+|..++.. .-....+|+.|||.|++||. +.++|||||.+.|+|+|.++++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccc
Confidence 9999999999999999999887443 45566789999999999999 569999999999999999999999999999
Q ss_pred cccccCC-CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcC--CCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 663 KLLLLDQ-SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICC--RRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 663 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG--~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
+.+-..+ .....+..-..+|||+|.+..++++.++|||+||+.+||+++- ..|+.....+ .+.+..-..+....
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQG 761 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCC
Confidence 9654333 3334445567899999999999999999999999999998764 4565433221 11111111111111
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.. .+- ..+.-....+++++++||..|-++||+++++...|...
T Consensus 762 ~~-~~l-----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQ-VVL-----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cc-eec-----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 111 11223346788999999999999999999999988653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.95 Aligned_cols=238 Identities=31% Similarity=0.419 Sum_probs=198.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
+=||.|+.|.||+|++.+. .||||+++... ..+|+-|++|+|+||+.+.|+|....-++||||||..|
T Consensus 130 eWlGSGaQGAVF~Grl~ne-----tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNE-----TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhccCcccceeeeeccCc-----eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 4599999999999998643 69999987432 35788899999999999999999999999999999999
Q ss_pred cHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccccc
Q 047263 598 TLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677 (804)
Q Consensus 598 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 677 (804)
-|...|+....++-.....|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-++..... .....+.
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 9999999999999999999999999999999966 9999999999999999999999999999865432 2334478
Q ss_pred CCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHH
Q 047263 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKL 757 (804)
Q Consensus 678 gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 757 (804)
||..|||||++++.+.++|+|||||||||||||||..|+........ .-.+-...+.-.-+....
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccCCcccccCcccCc
Confidence 99999999999999999999999999999999999999864432210 000001111111233445
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 758 ARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 758 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
+.+.-|+.+||+..|..||++.+|+.-|+-
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 667778999999999999999999998864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=288.56 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=199.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-c-HHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-G-VKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.-.++||+|.||.||+|+.... ++.||||+++....+ + .....+|+..+++++|+||+.+++.|.+.+..-||+|
T Consensus 5 ~~~~~lGEG~~gvVyka~d~~t---~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 5 EKLEKLGEGTYGVVYKARDTET---GKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhcCcceEEEEEEEecCC---CcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3457899999999999997654 448999999754222 2 3457899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+. +|...++++ ..+.-.....++.++++||+|||.. .|+||||||.|+|++++|.+||+|||+++.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9986 899999876 5678889999999999999999954 9999999999999999999999999999988654433
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc---ceecch
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE---ALVEFD 747 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~~~~ 747 (804)
. +...-|..|.|||.+.+ +.|+..+|+||.|||+.||+-|.+-|.+...-++....-.+.-...+.... .+.|..
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 2 23367899999998875 579999999999999999999887776554332221111111000111110 111110
Q ss_pred --------hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 748 --------IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 748 --------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.....-.......++++..++..||.+|++++|++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000111234566899999999999999999999876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=332.42 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=201.4
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCc
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 586 (804)
...+.+.+.||+|+||.||+++.... ......||+|++.... ....+.+.+|+++++.+ +|+||++++++|.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 33455788999999999999985321 2223469999997543 23345688999999999 89999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC------------------------------------------------------------
Q 047263 587 RLLVYEFLSNGTLASFLFGD------------------------------------------------------------ 606 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 606 (804)
.++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999988532
Q ss_pred ----------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC-cccc
Q 047263 607 ----------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTA 675 (804)
Q Consensus 607 ----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 675 (804)
..+++.+..+++.||++||.|||+ .+|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 135677889999999999999995 49999999999999999999999999999865332221 1122
Q ss_pred ccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 676 ~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
..++..|+|||++....++.++||||||+++|||++ |+.||........ . ......+.... ...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~----~~~~~~~~~~~---------~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F----YKMVKRGYQMS---------RPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H----HHHHHcccCcc---------CCC
Confidence 335668999999998899999999999999999997 9999865432211 1 01111110000 001
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
....++.+++.+||+.||++||++.+|+++|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12356788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.28 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=203.9
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
+......+.+.||+|++|.||+|....+ ..||+|.+.... ...++|.+|+.++++++|+||+++++++......+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNT----TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCC----eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 3345566778999999999999987543 269999987542 34577999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 589 LVYEFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
++|||+++++|.+++.... .+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997643 689999999999999999999954 99999999999999999999999999998765
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
............+..|+|||++.+..++.++||||||++++||++ |+.|+........ + .. ...... .
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~-~~----~~~~~~--~-- 223 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV--L-QQ----VDQGYR--M-- 223 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--H-HH----HHcCCC--C--
Confidence 322221222223457999999999999999999999999999999 8888865432211 1 10 001100 0
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.........+.+++.+|++.+|++||++.++++.||.+
T Consensus 224 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 -----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.83 Aligned_cols=253 Identities=28% Similarity=0.381 Sum_probs=202.2
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
...+.++||+|++|.||+|....... .+++|.+... ....+++.+|+++++.++|+||+++++++..+...+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~---~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCc---eEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 34566789999999999999865433 7999998753 3345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999653 4578999999999999999999954 999999999999999999999999999986543322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........+..|+|||.+.+..++.++||||||+++|||++ |..|+......... .........
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~-------- 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKGYRM-------- 224 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCCC--------
Confidence 22222234568999999999999999999999999999998 88888654322110 111111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.........+.+++.+|++.+|++||++.+++++|+.+
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111235688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.16 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=204.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.+.||+|+||.||+|...........||||.+.... ....++|.+|+.++++++|+||+++++++.+....+++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 456788999999999999987654445579999987543 3345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++++|.+++... ..+++..+.+++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||+++.+......
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999764 468999999999999999999995 49999999999999999999999999999876422221
Q ss_pred -ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 672 -THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 672 -~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +.... ...... +
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~----~--- 228 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYRL----P--- 228 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCCC----C---
Confidence 1112334678999999998899999999999999999998 888885443221 11111 111000 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 --PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.33 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=204.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
..+.+.||+|+||.||+|...... .....|++|.+.... ....++|.+|+.++.+++||||+++++++.+....+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 456789999999999999875433 233579999987433 23456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCE
Q 047263 591 YEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA 654 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~ 654 (804)
|||+++++|.+++... ..+++...+.++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 9999999999999653 3467888999999999999999965 99999999999999999999
Q ss_pred EEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHH
Q 047263 655 RISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAY 732 (804)
Q Consensus 655 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 732 (804)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......... .
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~---~--- 237 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI---E--- 237 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---
Confidence 9999999986533221 22233446788999999998899999999999999999998 99998754332211 1
Q ss_pred HhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
....+.... .......++.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 238 -~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 -MIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111111110 1123346788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=316.19 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=205.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|.||.||||+.+.... .||+|.+.+.. ++..+...+|++++++++|||||.++..|+...+.++|.
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~---~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQ---VVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred hhHHHHhcCCccceeeeccccccee---EEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 3456889999999999999876544 79999997543 345667899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+.+ +|..+|.....++++....|+.+++.||.|||+ .+|+|||+||+||||+..+.+|++|||+|+.+.. ...
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 99988 999999999999999999999999999999994 5999999999999999999999999999997654 233
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
..+.+.||+-|||||...+.+|+..+|.||+|||+||+.+|++||...... +.+....++. . .
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~------~Lv~~I~~d~---------v--~ 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT------QLVKSILKDP---------V--K 218 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH------HHHHHHhcCC---------C--C
Confidence 445678999999999999999999999999999999999999999754221 1111111111 0 1
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+.+....+..++...+++||.+|-+-.+++.
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12245567778888889999999999988763
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.38 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=205.6
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
..++.+.+.||+|+||.||+|..... ......+|+|.+...... ..+.|.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45567789999999999999987543 233457999999765443 457899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCC--------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC
Q 047263 588 LLVYEFLSNGTLASFLFGD--------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~ 653 (804)
++||||+++++|.+++... ..+++.....++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 9999999999999999643 3467888999999999999999954 9999999999999999999
Q ss_pred EEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHH
Q 047263 654 ARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWA 731 (804)
Q Consensus 654 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 731 (804)
+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---ECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH
Confidence 99999999976433221 12223345678999999999999999999999999999998 99998654332211 111
Q ss_pred HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
..+.... ........+.+++.+||+.||++||++.||+++|++
T Consensus 238 ----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 ----TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111110 011234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=325.74 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=202.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||+|+....+. .||+|++.... ....+.+..|++++..++||||+++++++.+++..++||
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCC---EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 456789999999999999875443 79999987532 234567889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 9999999999998888889999999999999999999965 999999999999999999999999999986432
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..+ ... +..+ ...
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~----~~~~-~~~ 223 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-----KET----LQRP-VYD 223 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-----ccc----ccCC-CCC
Confidence 23345689999999999999999999999999999999999999976543321 111110 000 0000 000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.........+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0012235577889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=315.60 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=205.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
.+.||+|.||.||||...... +.||+|.+.-.. +...++.++|+.++.+++|+||.+++|.+..+...+++|||+.
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~---k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTK---KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred chhccccccceeeeeeecccc---ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 478999999999999987544 479999997433 3456788999999999999999999999999999999999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccc
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (804)
+|++.+.|.....+++....-|+.++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+....... .+
T Consensus 95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~t 170 (467)
T KOG0201|consen 95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KT 170 (467)
T ss_pred CcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cc
Confidence 999999998888888888889999999999999965 99999999999999999999999999998876655554 77
Q ss_pred ccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHH
Q 047263 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKK 755 (804)
Q Consensus 676 ~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (804)
..||+.|||||+++...|+.|+||||||++.+||++|.+|+....+.. .--++...........
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLDGD 234 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCccccc
Confidence 889999999999998899999999999999999999999987544311 0011111111111224
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 756 KLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 756 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+.+++..||+.||+.||++.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 5567889999999999999999998874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.77 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=201.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+++....+. .+|+|.+.... ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~---~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGL---IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCc---EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4456789999999999999875443 78999887532 2345679999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc---c
Confidence 999999999998888889999999999999999999963 36999999999999999999999999998765321 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC---ccc--------
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG---ITE-------- 741 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~-------- 741 (804)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||........... ........ ...
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCccccCccccc
Confidence 2335689999999999999999999999999999999999999965433221110 00000000 000
Q ss_pred -------------------c----eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 742 -------------------A----LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 742 -------------------~----~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
. +...............++.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000011234578899999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=322.97 Aligned_cols=242 Identities=24% Similarity=0.257 Sum_probs=196.8
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.||+|+||.||+++...++. .+|+|++.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGK---YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC---EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 368999999999998865443 79999987532 233456789999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~ 153 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMK 153 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCccc
Confidence 9999999998888899999999999999999999954 999999999999999999999999999875322 122233
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...||..|+|||.+.+..++.++|||||||++|||++|+.||.......... .. ..+.. . .+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---~~----~~~~~------~----~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LI----LMEEI------R----FPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH---HH----HcCCC------C----CCC
Confidence 4568999999999999999999999999999999999999997543322111 00 01100 0 111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2345678899999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.80 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=201.4
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
...+.++||+|++|.||+|...++. .||+|++.... ...+.+.+|+.+++.++|+||+++++.+.+....+++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~----~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNST----KVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCc----eEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3456789999999999999875443 59999886532 345689999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999653 5678899999999999999999954 999999999999999999999999999987543322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||++....++.++||||||+++|||++ |+.||........ .... ..... .+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~~----~~--- 224 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL----QRGYR----MP--- 224 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcCCC----CC---
Confidence 22223345678999999998899999999999999999998 8888865432211 1111 11100 00
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
........+.+++.+|++.+|++||+++++.++|+.+
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 --RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0111235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.52 Aligned_cols=264 Identities=19% Similarity=0.202 Sum_probs=200.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|+||.||+++...++. .+|+|++.... ....+.+.+|+.+++.++|+||+++++++.++...++||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKE---IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCc---EEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 3456789999999999999875443 79999987432 233567889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||++++.+..+......+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9999988877766566788999999999999999999954 9999999999999999999999999999876433333
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH--------HhhhcC-cccc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY--------DCYCEG-ITEA 742 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~-~~~~ 742 (804)
......|+..|+|||++.+..++.++|||||||++|||++|+.||................ ..+... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 3344568999999999998889999999999999999999999997643322111000000 000000 0000
Q ss_pred eecchhhh------cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEA------LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+.... .........+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001113456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.64 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=206.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.||+|+||.||+++.... ......+++|.+........+.+.+|++++++++|+||+++++++.+....++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 34567899999999999986432 2334468999988765556678999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEE
Q 047263 592 EFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNAR 655 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~k 655 (804)
||+++++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++.++
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 999999999999643 2378999999999999999999955 999999999999999999999
Q ss_pred EeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHH
Q 047263 656 ISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYD 733 (804)
Q Consensus 656 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 733 (804)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ + .
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~-~---- 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--I-E---- 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-H----
Confidence 999999976533221 12223446788999999999999999999999999999999 9998865433221 1 1
Q ss_pred hhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 734 CYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
....+..... .......+.+++.+|++.+|++||++.+|+++|+.+..
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111111111 11234568899999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.39 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=198.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.++||+|+||.||++...... .+|+|.+... ....++|.+|+.++++++||||+++++++.+....++||||
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~----~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQI----KVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCc----eEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 445678999999999999876442 5899987643 23456789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999753 4678999999999999999999955 99999999999999999999999999998653322222
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+........ + ... ..+.. ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--~-~~i----~~~~~--~~~------ 222 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--V-EMI----SRGFR--LYR------ 222 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--H-HHH----HCCCC--CCC------
Confidence 222335568999999998889999999999999999999 8888865433211 1 111 11100 000
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
+......+.+++.+||+.+|++||++.+++++|.
T Consensus 223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.21 Aligned_cols=233 Identities=28% Similarity=0.298 Sum_probs=194.5
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.||.|+||.|..++.+..+. -+|+|.++... .+..++..+|..+|+.+.||+++++.+.+.+....+||||
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~---yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGN---YYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred heeeeccCccceEEEEEEccCCc---eeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 46789999999999999876644 79999997532 2445678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++|.|..+|++..+++......+|.+|+.||+||| +.+|++|||||+|||||.+|.+||+|||+|+.+.. .
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----r 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----R 197 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC----c
Confidence 9999999999999999999999999999999999999 56999999999999999999999999999997532 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
..+.+||+.|+|||.++.+.+..++|-|||||++|||+.|..||....... .++...++... .
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v~----------f 260 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKVK----------F 260 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCccc----------C
Confidence 567899999999999999999999999999999999999999998765522 12222222111 1
Q ss_pred cHHHHHHHHHHHHHccccCCCCC
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLR 775 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~R 775 (804)
+..-...+.+|+...++.|-.+|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 11222345566666677777777
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.86 Aligned_cols=247 Identities=25% Similarity=0.253 Sum_probs=195.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
..+.||+|+||.||++....++. .+|+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|+|
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGK---MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCc---eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 45689999999999999865543 79999986432 2234467899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 99999999888543 467899999999999999999995 49999999999999999999999999999864322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||........... ......... .
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~----------~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKEDQ----------E 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhccc----------c
Confidence 222345689999999999999999999999999999999999999976543211100 000000000 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
.........+.+++.+||+.||.+||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 011123456788999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.00 Aligned_cols=242 Identities=25% Similarity=0.245 Sum_probs=194.0
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
||+|+||.||++.....+. .+|+|++... .......+..|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQR---IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCC---EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 7999999999999865443 7999998642 233456788999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 153 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTF 153 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccc
Confidence 99999998888899999999999999999999954 9999999999999999999999999999754222 2223345
Q ss_pred cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHH
Q 047263 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (804)
.||..|+|||.+.+..++.++|||||||++|||++|+.||........ . .. ...... ..+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~--~----~~-~~~~~~----------~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM--Y----RK-ILQEPL----------RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH--H----HH-HHcCCC----------CCCCcC
Confidence 689999999999999999999999999999999999999975432211 1 00 001100 001122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 757 LARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
...+.+++.+||+.||.+||++.++.+.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 35677899999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=289.54 Aligned_cols=260 Identities=24% Similarity=0.284 Sum_probs=207.2
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCC-----Cce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-----LNR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 587 (804)
++.+.++||+|||.-||.++.-... ..+|+|++.....+..+..++|++..++++|||++++++++..+ ...
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~---~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTG---HLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcc---cchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4556789999999999999854333 37999999877777888899999999999999999999988543 348
Q ss_pred EEEEeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 588 LLVYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
||+++|...|+|.+.+.. ...+++.+.+.|+.+|++||++||+. ..+++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999864 34688999999999999999999987 4579999999999999999999999999987
Q ss_pred ccccCCC--------CccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH
Q 047263 664 LLLLDQS--------QTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY 732 (804)
Q Consensus 664 ~~~~~~~--------~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 732 (804)
.....-. +......-|..|.|||.+. +...++++|||||||+||+|+.|..||+...+....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS------- 250 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS------- 250 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-------
Confidence 6532211 1112234688999999885 446789999999999999999999999865432111
Q ss_pred HhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
..-.+....+.-......++.+.+++.+|++.||.+||++.+++..++.++
T Consensus 251 ------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 ------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111212222223337789999999999999999999999999998764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.37 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=206.6
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
....+.+.||+|+||.||++..... ......+|+|.+........+.+.+|++++++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3445678899999999999986432 22344689999987655666789999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCC-------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEE
Q 047263 590 VYEFLSNGTLASFLFGDL-------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl 656 (804)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 478999999999999999999954 9999999999999999999999
Q ss_pred eecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHh
Q 047263 657 SDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDC 734 (804)
Q Consensus 657 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 734 (804)
+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..||........ + . .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~--~-~----~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--I-E----C 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-H----H
Confidence 99999986533221 11223345678999999998899999999999999999998 8888865433211 1 0 1
Q ss_pred hhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
...+..... .......+.+++.+|++.+|.+|||+.+|++.|+.+...
T Consensus 235 i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111111100 011234688999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=322.08 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=208.5
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.||.|+-|.|..|+... +++.+|||.+.... ......+.+|+.+|+.++|||++++++.+++..+.|+|.|
T Consensus 16 LgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 46789999999999998764 45589999997642 2223457889999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++|.|.++|-.++.+.+.+..+++.||+.|+.|+|.. +|+||||||+|+|||+.+++||+|||||.+- .....
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe--~~gkl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE--VPGKL 167 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc--cCCcc
Confidence 999999999999999999999999999999999999955 9999999999999999999999999999863 23445
Q ss_pred cccccCCCccccccccccCCCC-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPIT-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
..+.+|.+.|.|||++.+.+|. .++||||.|||||.||+|+.||+...... ++ .....|..+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--LL-----lKV~~G~f~---------- 230 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--LL-----LKVQRGVFE---------- 230 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH--HH-----HHHHcCccc----------
Confidence 5678899999999999999987 68999999999999999999999543321 11 111122111
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCccCCCC
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM--LEGVVEVLDP 794 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--Le~~~~~~~p 794 (804)
-+.....+..+|+.+|+..||++|.|++||++- |.+-..++.+
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 112334577889999999999999999999873 4554444433
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.89 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=205.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||.|+||.||+|....+ ..+++|.+.........++..|+.+++.++|+||+++++++.+....++|||
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNR----VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCC----CcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 456678999999999999998763 2699999987655556789999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..+.+++.||+.||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999753 4678999999999999999999965 899999999999999999999999999986543222
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......++..|+|||.+....++.++||||||+++++|++ |+.|+......... .... .+..
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~~----~~~~--------- 222 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQIT----AGYR--------- 222 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHH----hCCc---------
Confidence 1223345678999999998899999999999999999998 78888654322111 1110 1100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
..........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.03 Aligned_cols=203 Identities=24% Similarity=0.359 Sum_probs=174.6
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
....+.+.++||+|+||.||++.....+. .+|+|.+.... ....+.+.+|++++++++|+||+++++++.+++..+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~---~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGL---IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCc---EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34455677899999999999998875443 68888876532 234467899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+||||+++++|.+++.....+++.....++.+++.||.|||+. .+++|+||||+|||++.++.+||+|||++..+...
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999999998878889999999999999999999953 37999999999999999999999999998765321
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcch
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEV 720 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~ 720 (804)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1233468899999999998899999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.86 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=204.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
....+.||+|+||.||+|+..........+++|++.... ....+++..|++++++++|+||+++++++.+.+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 345678999999999999987655445579999987542 3345679999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++++|.+++..+ ..+++.++..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999999754 5689999999999999999999955 9999999999999999999999999999865432222
Q ss_pred ccc--cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 672 THT--AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 672 ~~~--~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
... ....+..|+|||++....++.++||||||+++|||++ |+.|+........ ... ..... ..+
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~---~~~----i~~~~----~~~-- 230 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---MKA----INDGF----RLP-- 230 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHH----HhcCC----CCC--
Confidence 111 1223457999999998889999999999999999997 9999865433211 110 11110 000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
........+.+++.+|++.+|++||+|.+|++.|++++
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01122356789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=324.64 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=201.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEcccccc-ccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 588 (804)
...+.++||+|+||.||+|+..... .....||||++..... ...+.|.+|+++++++. ||||+++++++.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3456789999999999999864221 2234699999975433 33457899999999996 999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCC--------------------------------------------------------------
Q 047263 589 LVYEFLSNGTLASFLFGD-------------------------------------------------------------- 606 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~-------------------------------------------------------------- 606 (804)
|||||+++|+|.++|...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999988532
Q ss_pred ----------------------------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC
Q 047263 607 ----------------------------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652 (804)
Q Consensus 607 ----------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~ 652 (804)
..+++..+..++.||++||.|||+. +|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 2356778889999999999999954 999999999999999999
Q ss_pred CEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHH
Q 047263 653 NARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDW 730 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 730 (804)
.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.........
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~----- 349 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF----- 349 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-----
Confidence 9999999999865432221 1222346778999999998899999999999999999997 88888654322111
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
......+... .........+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 350 -~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 -YNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111111100 0111234578899999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.51 Aligned_cols=243 Identities=23% Similarity=0.222 Sum_probs=197.9
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||++.....+ +.+|+|++.... .+..+.+.+|++++++++||||+++++++.++...++||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCC---CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 45678999999999999986543 379999986432 234456889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999998888899999999999999999999954 9999999999999999999999999999865321
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+.. .
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~----~------ 216 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------EKILAGKL----E------ 216 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCc----C------
Confidence 22346899999999999989999999999999999999999999765432211 00111100 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQM 784 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 784 (804)
.+......+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01112346788999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.37 Aligned_cols=261 Identities=28% Similarity=0.389 Sum_probs=201.8
Q ss_pred HHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeC-CCc
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD-GLN 586 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 586 (804)
..+.+.+.||+|+||.||+|.... .......||+|++.... ....+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 346678899999999999997543 22234579999987532 23345678899999999 89999999998854 466
Q ss_pred eEEEEeecCCCcHHHhhcCC------------------------------------------------------------
Q 047263 587 RLLVYEFLSNGTLASFLFGD------------------------------------------------------------ 606 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 606 (804)
.++++||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999988532
Q ss_pred -CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC-ccccccCCCcccc
Q 047263 607 -LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVA 684 (804)
Q Consensus 607 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~a 684 (804)
..++|..+.+++.||+.||.|||+. +|+||||||+|||+++++.++|+|||++..+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2568889999999999999999954 9999999999999999999999999999875432221 1223445678999
Q ss_pred ccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHH
Q 047263 685 PEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMV 763 (804)
Q Consensus 685 PE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 763 (804)
||++.+..++.++|||||||++|||++ |..||........ +.. ....+... ........++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~~---------~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTRM---------RAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999998 9988865332211 101 01111110 0011234578899
Q ss_pred HHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 764 AIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 764 ~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+.+|++.+|++||++.||+++|+.+++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.79 Aligned_cols=242 Identities=26% Similarity=0.288 Sum_probs=195.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.||+|+||.||+++....+ ..||+|.+.... ......+.+|+.+++.++||||+++++.+......++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 36899999999999876543 379999987532 234456788999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++|+|..++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 153 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccc
Confidence 9999999998888899999999999999999999954 9999999999999999999999999998753221 22223
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.......... . ...+.. .. +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~--~----~~~~~~-------~~----p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--L----ILMEEI-------RF----PR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH--H----HhcCCC-------CC----CC
Confidence 4568999999999999999999999999999999999999997543322110 0 000100 00 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2245677899999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.90 Aligned_cols=242 Identities=26% Similarity=0.303 Sum_probs=196.3
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.||+|+||.||++.....+ ..+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG---KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 36899999999999876543 379999987532 234567889999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++|+|..++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 9999999998888899999999999999999999954 9999999999999999999999999998753221 22233
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...||..|+|||.+.+..++.++|||||||++|||++|+.||........... . .... . .. +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~---~---~~~~----~---~~----p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I---LMED----I---KF----PR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH---h---ccCC----c---cC----CC
Confidence 45689999999999998999999999999999999999999975433221100 0 0000 0 00 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 2234678899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=318.10 Aligned_cols=261 Identities=27% Similarity=0.372 Sum_probs=212.9
Q ss_pred HHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 507 KDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 507 ~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
.|+++...-...+||-|-||.||.|+++... ..||||.++.. .-..++|..|..+|+.++|||+|+|+|+|..+..
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkys---lTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccc---eeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4445444456779999999999999998544 47999999865 3457899999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 587 RLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
.|||+|||..|+|.++|.+- ..++--..+.++.||+.|+.||. .++.|||||..+|+|+.++-.+||+|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999864 44566677899999999999999 45999999999999999999999999999999
Q ss_pred cccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
+..+....+....-.+.|.|||-+....++.|+|||+|||+|||+.| |..|+....-.. ++..+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LL-------- 479 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLL-------- 479 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHH--------
Confidence 87776655555555778999999999999999999999999999998 556654332111 11111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
....+-..+.-....+++|++.||+.+|.+||++.||.+.+|.+..
T Consensus 480 -EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 480 -EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1111112233345678899999999999999999999999998753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=316.56 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=202.8
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccc-cceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASM-YQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
...+...+.||+|+||.||+|+....+. ....||+|.+.... ....++|.+|+.+++.++|+||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3445556789999999999998754332 24458999987543 34456899999999999999999999999775 577
Q ss_pred EEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
+++||+++|+|.+++... ..+++...++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999764 4678999999999999999999954 999999999999999999999999999987643
Q ss_pred CCCCc-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 668 DQSQT-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 668 ~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
..... ......+..|+|||.+....++.++||||||+++|||++ |+.|++.......... ...+. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~--~~~~ 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE--RLPQ 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhCCC--CCCC
Confidence 32221 112234668999999999999999999999999999998 9999875433221110 11110 0000
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.......+.+++..||+.+|.+||++.+++..|..+..
T Consensus 233 -------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 233 -------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11123467789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.88 Aligned_cols=252 Identities=30% Similarity=0.406 Sum_probs=201.0
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
++||+|+||.||+|+..........+|+|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998765543345799999875433 34567999999999999999999999876 4568999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc--c
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH--T 674 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--~ 674 (804)
++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998877899999999999999999999955 899999999999999999999999999987643332211 1
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
...++..|+|||.+.+..++.++||||||+++|||++ |..||....... +..... .... . ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~~--~-------~~~ 220 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGER--L-------PRP 220 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCCc--C-------CCC
Confidence 1223567999999998899999999999999999998 899986553321 111111 1100 0 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
......+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 122356789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.81 Aligned_cols=245 Identities=24% Similarity=0.279 Sum_probs=197.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++...+...++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999876555556689999987432 22345678999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|.+++.....+.+.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcc
Confidence 99999999998888888899999999999999999954 9999999999999999999999999998753222 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....|+..|+|||++.+..++.++||||||+++|||++|+.||........ + .. ...+.. .+ +
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~--~----~~-~~~~~~------~~----~ 220 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT--I----DK-ILKGKL------NL----P 220 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH--H----HH-HHcCCC------CC----C
Confidence 345689999999999988899999999999999999999999976543211 1 00 111110 00 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
......+.+++.+|++.+|++|| +++++++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11234678899999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.86 Aligned_cols=243 Identities=25% Similarity=0.330 Sum_probs=204.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
++.+.||+|.||.||.|+.+.... .||+|++.+.. .+..+++.+|+++-..|+||||+++++++.+....||++
T Consensus 25 eigr~LgkgkFG~vYlarekks~~---IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLF---IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred cccccccCCccccEeEeeeccCCc---EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 357889999999999999876554 79999997532 234568999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhc--CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||..+|+|...|. ....++......++.|+|.||.|+| .++++||||||+|+|++.++..||+|||-+..- .
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~---p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---P 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec---C
Confidence 9999999999998 5577899999999999999999999 559999999999999999999999999998753 2
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....+.+||..|++||...+...+..+|+|++|++.||++.|.+||+.....+. . +... .-.+..
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Y------krI~---k~~~~~---- 241 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-Y------KRIR---KVDLKF---- 241 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-H------HHHH---HccccC----
Confidence 5556778899999999999999999999999999999999999999986552221 1 0000 001111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+........+++.+|+..+|.+|.+..||+.
T Consensus 242 ---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 ---PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1233456778999999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.56 Aligned_cols=252 Identities=23% Similarity=0.242 Sum_probs=198.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
.+.++||+|+||.||+++...+...+..+|+|.+.... ....+.+..|+.++.++ +|+||+++++++.++...++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 35678999999999999876544456689999986421 22345678899999999 59999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++..+..+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999998888899999999999999999999954 99999999999999999999999999998654443
Q ss_pred CCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcccceecch
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
........||..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..+.. . .... +..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~-~~~~------~~~ 229 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---R-ILKC------DPP 229 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---H-HhcC------CCC
Confidence 3334456789999999999865 478899999999999999999999964432111 11100 0 0000 000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
........+.+++.+||+.||++|| +++++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0112234677899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=324.07 Aligned_cols=256 Identities=19% Similarity=0.205 Sum_probs=193.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||++...... +.||+|+... +.+.+|++++++++||||+++++++..+...++|+|+
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~---~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTC---EHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCC---CEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 455688999999999999876544 3799997542 3567899999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+. ++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 85 68988988778889999999999999999999954 999999999999999999999999999975433222333
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH-----HHHHHHHHHHHh--------------
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE-----AEALLTDWAYDC-------------- 734 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~-----~~~~l~~~~~~~-------------- 734 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....+.......
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 4457999999999999989999999999999999999999876432210 001110000000
Q ss_pred -------hhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 735 -------YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 735 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........... .............+.+++.+||+.||.+|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGS-RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCC-CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0000001123457888999999999999999999985
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=305.43 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=198.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||+|...... .+|+|.+... .....+|.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~----~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQY----DVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCC----cEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 346778999999999999875432 5999988753 23356799999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++|+|.+++... ..+++..++.++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 4689999999999999999999955 99999999999999999999999999988654332222
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+......... .. ...+... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~----~~~~~~~----~----- 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV---EK----VSQGLRL----Y----- 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HH----HhcCCCC----C-----
Confidence 222335678999999998889999999999999999999 88888654332110 10 1111100 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.31 Aligned_cols=242 Identities=24% Similarity=0.252 Sum_probs=197.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++....+. .+|+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGE---YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCC---EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4556789999999999999875543 79999986432 23456788999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 99999999999998888889999999999999999999955 9999999999999999999999999999865321
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .+...++... .
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~~------~-- 234 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGRLK------F-- 234 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCCcC------C--
Confidence 2235689999999999999999999999999999999999999975433211 0111111110 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVT 782 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl 782 (804)
+.....++.+++..||+.||.+||+ +++++
T Consensus 235 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 235 --PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 0112346778999999999999996 67766
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=304.39 Aligned_cols=248 Identities=28% Similarity=0.429 Sum_probs=197.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.+.||+|+||.||++..... ..+|+|.+... .....+|.+|++++++++|+||+++++++.+....++|+||
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~----~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGK----IDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred cchhhhhccCCCceEEEeEecCC----ccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 45678999999999999987533 25899988643 22345788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++..+ ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999753 4678999999999999999999965 89999999999999999999999999998654322221
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ . . ....... ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~-~----~~~~~~~---------~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--V-E----SVSAGYR---------LY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--H-H----HHHcCCc---------CC
Confidence 122223457999999998899999999999999999999 7888865432211 1 0 0111100 00
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
.......++.+++.+|++.+|++||||.+|++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1112345788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.81 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=195.0
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
++||+|+||.||+|+....+. .+|+|...... .+....|.+|++++++++|+||+++++++.+....++|+||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNT---PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCc---eEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 469999999999999865433 79999876432 34456799999999999999999999999999999999999999
Q ss_pred CcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc-cc
Q 047263 597 GTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT-HT 674 (804)
Q Consensus 597 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~ 674 (804)
++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999999654 4678999999999999999999954 99999999999999999999999999987543211111 11
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....+..|+|||.+.+..++.++||||||+++|||++ |..|+........... . ...... ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---~----~~~~~~---------~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---I----EQGVRL---------PCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---H----HcCCCC---------CCc
Confidence 1123457999999999899999999999999999998 8888764433221110 0 011000 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
......+.+++.+|++.+|++||++.+|.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 122457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.81 Aligned_cols=248 Identities=29% Similarity=0.373 Sum_probs=196.7
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+||+|+||.||+|...... .+..+|+|+++... ....+++.+|+.+++.++|+||+++++++.+ ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCC-CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 6899999999999764332 24479999986432 2345679999999999999999999998854 567899999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc--cc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT--HT 674 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--~~ 674 (804)
++|.+++.....+++..+.+++.|++.||.|||+. +++||||||+||++++++.+||+|||+++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 99999998778889999999999999999999954 99999999999999999999999999998764333211 12
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
...++..|+|||.+....++.++||||||+++|||++ |..||........ .... ..+.... . +
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~i----~~~~~~~-----~----~ 220 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQMI----ESGERME-----C----P 220 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HCCCCCC-----C----C
Confidence 2234578999999988889999999999999999998 8999875433211 1111 1111100 0 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
......+.+++.+|++.||++||++.+|+++|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1234567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.44 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=199.7
Q ss_pred hhHHhhCCCcceeEEEeeecCcc-ccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||+|+....+ .....+++|.+..... ...+++..|+..+++++|+||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 35678999999999999875433 2234588888864332 334678889999999999999999999864 45788999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
|+++|+|.+++.. ...+++.....++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999999975 45789999999999999999999954 899999999999999999999999999986543222
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+.+..++.++||||||+++|||++ |..|+..........+ ...+.. ....
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~--~~~~--- 233 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGER--LAQP--- 233 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCc--CCCC---
Confidence 12233456778999999998899999999999999999998 9989876543321111 111110 0000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
......+.+++.+|++.+|.+|||+.|+++.|+.+..
T Consensus 234 ----~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 ----QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0122356778999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=298.74 Aligned_cols=248 Identities=22% Similarity=0.352 Sum_probs=207.0
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
.+..++|.+.||+|.||.|-++..... ++.||||.+++... +..-.+.+|+++|..|+||||+.++.+|+..+.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~s---gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKS---GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccC---CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 345678899999999999999876433 34799999976543 344468899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
+.|||||..+|.|.+++.....+++.+..++..||..|+.|+|.+ +++|||||.+|||||.++++||+|||++-++.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999999999999999999999999999999999955 99999999999999999999999999998764
Q ss_pred cCCCCccccccCCCccccccccccCCCC-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPIT-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
. .....+++|++-|.+||.+.+.+|. +.+|-||+||+||-|+.|..||+..+-. .+...+ ..+.
T Consensus 205 ~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQI----s~Ga------ 269 (668)
T KOG0611|consen 205 D--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQI----SRGA------ 269 (668)
T ss_pred c--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHh----hccc------
Confidence 3 3445678999999999999999986 7899999999999999999999865432 111111 1111
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+......-|+.|||-.||++|.|+++|..
T Consensus 270 -----YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 270 -----YREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----ccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 111122334556899999999999999999875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.38 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=199.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCc------e
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN------R 587 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 587 (804)
+.+.||+|+||.||+|....+......+|+|+++... .....++.+|++.++.++|+||+++++++.+... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4678999999999999987655445679999987432 2345679999999999999999999999876554 7
Q ss_pred EEEEeecCCCcHHHhhcCC------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 588 LLVYEFLSNGTLASFLFGD------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
++++||+++|+|..++... ..+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999998532 3678899999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCCc-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 662 AKLLLLDQSQT-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 662 a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
++......... ......+..|+|||.+....++.++||||||+++|||++ |..|+....... .. ... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~-~~~----~~~~ 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IY-DYL----RHGN 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HH-HHH----HcCC
Confidence 98654332211 112234668999999998899999999999999999999 778876543221 11 111 1111
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
... ........+.+++.+|++.||++||++.||++.|+.+
T Consensus 233 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 1112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=311.82 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=202.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||+|....++. ...+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+....++++|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGL-KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCC-cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 456789999999999999876543 234788888743 233456789999999999 79999999999999999999999
Q ss_pred ecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEE
Q 047263 593 FLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656 (804)
Q Consensus 593 y~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl 656 (804)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 99999999999643 2467889999999999999999954 9999999999999999999999
Q ss_pred eecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhh
Q 047263 657 SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 735 (804)
+|||++..... .........+..|+|||++....++.++||||||+++|||++ |..||........ . ...
T Consensus 161 ~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~--~-----~~~ 231 (297)
T cd05089 161 ADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL--Y-----EKL 231 (297)
T ss_pred CCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--H-----HHH
Confidence 99999864211 111111223457999999998899999999999999999998 9999865433221 1 001
Q ss_pred hcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCCC
Q 047263 736 CEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797 (804)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~P 797 (804)
..+... .........+.+++.+|++.+|.+||++++|++.|+.+.+...+..+
T Consensus 232 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~ 284 (297)
T cd05089 232 PQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVN 284 (297)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence 111100 00112335678999999999999999999999999988876555444
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.92 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=203.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
...+.+.||+|+||.||+|.....+.....||||.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 345678899999999999998766655567999998754 2344568999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++++|.+++... ..+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999753 5678999999999999999999965 999999999999999999999999999876543222
Q ss_pred Ccc-c-ccc--CCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 671 QTH-T-AIR--GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 671 ~~~-~-~~~--gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
... . ... .+..|+|||.+....++.++||||||+++|||++ |..||........ ..... ... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~----~~~-----~ 229 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIE----QDY-----R 229 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHH----cCC-----c
Confidence 111 1 111 2357999999999999999999999999999886 9999865433211 11111 100 0
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.. ........+.+++..|++.+|++||+|.+|+++|+++
T Consensus 230 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 LP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.91 Aligned_cols=257 Identities=25% Similarity=0.325 Sum_probs=201.3
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
..+.+.++||+|+||.||+|..... ......||+|++...... ..+.|.+|+.++.+++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4566789999999999999987543 233457999999754332 3456899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC
Q 047263 589 LVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~ 652 (804)
+++||+++++|.+++... ..+++..+.+++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999998521 3467888899999999999999954 999999999999999999
Q ss_pred CEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHH
Q 047263 653 NARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDW 730 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 730 (804)
.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..|+........ + .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~-~- 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--I-E- 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--H-H-
Confidence 999999999886533221 11223345678999999988889999999999999999998 7777765432211 1 1
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
......... ........+.+++..|++.+|++||++.+|++.|+.
T Consensus 238 ---~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ---MIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111110 011234567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.33 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=198.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
..+.+.++||+|+||.||+|..... ......+|+|++.... .....+|.+|+.+++.++|+||+++++++.++...+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 3455678899999999999986421 1234579999986432 233457899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCC----------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEee
Q 047263 589 LVYEFLSNGTLASFLFGD----------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~D 658 (804)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 999999999999998642 2346788899999999999999954 999999999999999999999999
Q ss_pred cCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhh
Q 047263 659 FGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYC 736 (804)
Q Consensus 659 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 736 (804)
||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......... .. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~~----~~ 235 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RF----VM 235 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH----HH
Confidence 9998765332221 1122345678999999998899999999999999999999 67787654332111 10 11
Q ss_pred cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 737 EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
+...... .......+.+++.+|++.+|++|||+.|++++|++
T Consensus 236 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111000 11123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.23 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=200.7
Q ss_pred hhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||.||++.... .......+++|.+........+.|.+|+++++.++|+||+++++++.+....++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 456889999999999997532 122344799999887666667789999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC---------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEe
Q 047263 593 FLSNGTLASFLFGD---------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARIS 657 (804)
Q Consensus 593 y~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~ 657 (804)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 99999999998653 2478899999999999999999954 99999999999999999999999
Q ss_pred ecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhh
Q 047263 658 DFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 658 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 735 (804)
|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||........... .
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~ 237 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC-------I 237 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-------H
Confidence 9999976533221 11222334678999999999999999999999999999998 8888754432221100 0
Q ss_pred hcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 736 CEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
..+... .........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 238 ~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 011000 0011223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=308.01 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=200.1
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
..+.||+|+||.||.++-++.+. .+|+|++++.. ....+..+.|..+|....++.||+|+-.|.+...+|||||
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~---iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGE---IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred hheeeccccceeEEEEEEccCCc---EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 35679999999999999887665 79999998643 3456678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc----C
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL----D 668 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~----~ 668 (804)
|++||++..+|.....+++.....++.+++.||.-||+. ++|||||||+|+|||..|++||+||||+.-+.. +
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999999999999999999999999999999999965 999999999999999999999999999854311 0
Q ss_pred ------------------CCC-----c-------------------cccccCCCccccccccccCCCCccchhhHHHHHH
Q 047263 669 ------------------QSQ-----T-------------------HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706 (804)
Q Consensus 669 ------------------~~~-----~-------------------~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll 706 (804)
... . .....||+.|||||++.+..|+..+|.||+|||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 000 0 0113499999999999999999999999999999
Q ss_pred HHHHcCCCCCCcchhHH-HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 047263 707 LEIICCRRNVDMEVNEA-EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPT---MRKVT 782 (804)
Q Consensus 707 ~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl 782 (804)
||||.|-+||..+.+.+ ...+..|-.. +..+. ......+..++|.+|+. ||++|-- ++||.
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~---------l~fP~-----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRET---------LKFPE-----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhh---------ccCCC-----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999998877654 3344333211 11111 11122577789999888 9999964 55554
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=329.67 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=211.2
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEE-eC------CCce
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFC-DD------GLNR 587 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~-~~------~~~~ 587 (804)
+.+.|.+|||+.||.+....+. ..+|+|++-...++..+..++|+++|++|+ |+|||.+++.. .. ..+.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~---~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGG---KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCC---ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 4568999999999999987663 379999998888889999999999999997 99999999932 11 2457
Q ss_pred EEEEeecCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 588 LLVYEFLSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
+|+||||.+|.|-+++.. ...+++.++++|+.++++|+++||.. ..+|||||||-+||||+.+++.||+|||-+...
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 899999999999999974 35689999999999999999999976 888999999999999999999999999998753
Q ss_pred ccCCCC--------ccccccCCCcccccccc---ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh
Q 047263 666 LLDQSQ--------THTAIRGTKGYVAPEWF---RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC 734 (804)
Q Consensus 666 ~~~~~~--------~~~~~~gt~~y~aPE~l---~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 734 (804)
...... ......-|+.|+|||.+ .+.++++|+|||+|||+||-|+....||+.....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------ 264 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------ 264 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------------
Confidence 222211 11123468999999987 5789999999999999999999999999854221
Q ss_pred hhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCC
Q 047263 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795 (804)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp 795 (804)
.++.....-.....+...+..||..||++||.+||++-+|++.+-.+...+.|-
T Consensus 265 -------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 265 -------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred -------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 122222222234578899999999999999999999999999998877665443
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.55 Aligned_cols=263 Identities=26% Similarity=0.372 Sum_probs=198.7
Q ss_pred hhhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC--CCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 590 (804)
..+.+.||+|+||.||++.... ....+..||+|++........+.|.+|++++++++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 3456789999999999998642 223355799999987666667789999999999999999999998743 3567899
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999754 4689999999999999999999965 99999999999999999999999999998754322
Q ss_pred CCc--cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH---------HHHHHHHhhhcC
Q 047263 670 SQT--HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL---------LTDWAYDCYCEG 738 (804)
Q Consensus 670 ~~~--~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~---------l~~~~~~~~~~~ 738 (804)
... .....++..|+|||.+.+..++.++||||||++++||++|..++.......... ..........+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 211 111223456999999998899999999999999999999876653221110000 000000000000
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
............+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 243 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 ---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.73 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=202.5
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhcccc-cCCccceeeEEeCC
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDG 584 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~ 584 (804)
+......+.++||+|+||.||+|+... .......||+|++..... ...+.++.|++++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 333444567899999999999998753 223345799999975432 33457899999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCCC---------------------------------------------------------
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDL--------------------------------------------------------- 607 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------------------------- 607 (804)
...++|+||+++|+|.++|+...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986431
Q ss_pred -----------------------------------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 608 -----------------------------------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 608 -----------------------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
.+++.....++.||+.||.|||+ .+++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence 24566788899999999999995 5999999999999
Q ss_pred EEcCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHH
Q 047263 647 LLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAE 724 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~ 724 (804)
|+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||++++||++ |+.|+........
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986533221 11223346788999999998889999999999999999998 8888764322211
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
+.. ....+.. .. .+.....++.+++..||+.+|.+||++.+|++.|+.++
T Consensus 351 --~~~----~~~~~~~--~~-------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 --FYN----AIKRGYR--MA-------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHH----HHHcCCC--CC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 100 0111100 00 01112457888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.08 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=199.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
...+.++||+|+||.||+|.... +......+++|.+.... .+...+|.+|+++++.++|+||+++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 34567899999999999998632 22334579999997432 33456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCC-----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC
Q 047263 591 YEFLSNGTLASFLFGD-----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~ 653 (804)
|||+++++|.+++... ..+++.+.+.++.|++.||.|||+. +++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 9999999999998522 2467888899999999999999965 9999999999999999999
Q ss_pred EEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHH
Q 047263 654 ARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWA 731 (804)
Q Consensus 654 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 731 (804)
+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||........ ....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IEMV 239 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH
Confidence 99999999986533221 12223345678999999988889999999999999999998 8888865432211 1111
Q ss_pred HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
...... . .......++.+++.+|++.+|.+||++.+|.+.|..
T Consensus 240 ----~~~~~~---~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQLL---P------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCcC---C------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111100 0 011123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.69 Aligned_cols=270 Identities=24% Similarity=0.320 Sum_probs=199.3
Q ss_pred hhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 590 (804)
.+.+.||+|+||.||++.... ....+..||+|.+.... ....+.|.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 456789999999998876432 12234479999987543 23456789999999999999999999988654 357899
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++++|.+++... .+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999654 589999999999999999999965 999999999999999999999999999986543222
Q ss_pred C--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 671 Q--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 671 ~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. ......++..|+|||.+....++.++||||||++++||++|+.|+..........+ ................+...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhhhhhhhcCC
Confidence 1 11223356679999999988999999999999999999999998764432211110 00000000000000000000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
....+......+.+++..|++.+|++|||+++|+++|+.+.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00111223467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.23 Aligned_cols=256 Identities=20% Similarity=0.306 Sum_probs=203.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|++|.||++....++. .++||.+.... .....++.+|+.+++.++|+||+++++++.+++..+++
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGV---PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCc---eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4567899999999999999764433 79999876422 23446789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 591 YEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
|||+++++|.+++.. ...+++.....++.+|++||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999998863 35678999999999999999999954 99999999999999999999999999987654
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.... ......++..|+|||++.+..++.++||||||+++|||++|..|+........... . .... ...
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~----~~~~-----~~~- 225 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-K----KIEQ-----CDY- 225 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh-h----hhhc-----CCC-
Confidence 3222 12234578899999999988999999999999999999999999864432211111 0 0000 000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
...........+.+++.+|++.+|++||||.+|+++++++.
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 --PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111224557889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.14 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=195.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
+.||+|+||.||+|++..++. ...+++|.+.... ....+.+..|++++.++ +||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC-eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 358999999999999876533 2357888887532 34456789999999999 89999999999999999999999999
Q ss_pred CCcHHHhhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeec
Q 047263 596 NGTLASFLFGDL----------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659 (804)
Q Consensus 596 ~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Df 659 (804)
+|+|.+++.... .+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 999999986432 467889999999999999999954 9999999999999999999999999
Q ss_pred CcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 660 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
|++..... .........+..|+|||++....++.++||||||++++||++ |..||........ . . .....
T Consensus 157 gl~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~-~----~~~~~ 227 (270)
T cd05047 157 GLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--Y-E----KLPQG 227 (270)
T ss_pred CCccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--H-H----HHhCC
Confidence 99863211 111112233567999999988899999999999999999997 9999865432211 0 0 01111
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
.... ........+.+++.+|++.+|.+|||+.++++.|+.+.
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000 01112346789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.61 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=203.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||+|+....+.....+|+|.+.... ....+.|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3456788999999999999876554445579999987532 334567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++++|.+++... ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.++++|||++..+.....
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999764 4678999999999999999999954 999999999999999999999999999987644322
Q ss_pred Cccc--cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 671 QTHT--AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 671 ~~~~--~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.... ...++..|+|||++.+..++.++||||||++++|+++ |..|+......... ... .++.. .
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~----~~~~~-----~- 228 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAI----EEGYR-----L- 228 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHH----hCCCc-----C-
Confidence 2211 1223567999999998899999999999999999887 99998654332111 111 11100 0
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.........+.+++.+|++.+|.+||+|.+|++.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112245678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=315.69 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=189.4
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.++||+|+||.||+++....+ +.||||++..... ...+.+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTG---RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCC---CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4678999999999999876543 3799999864332 33467899999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++++|.... ...+.....++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+.... ....
T Consensus 155 ~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 226 (353)
T PLN00034 155 DGGSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCN 226 (353)
T ss_pred CCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cccc
Confidence 999986543 345677889999999999999965 99999999999999999999999999998654321 1223
Q ss_pred cccCCCcccccccccc-----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 675 AIRGTKGYVAPEWFRN-----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~-----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
...|+..|+|||.+.. ...+.++|||||||++|||++|+.||..........+.... .... .
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~~-~--------- 293 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMSQ-P--------- 293 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hccC-C---------
Confidence 4568999999998853 23346899999999999999999999743222111111000 0000 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.........++.+++.+||+.||++||++.||++.
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111234568899999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=303.27 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=197.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--------------ccHHHHHHHHHHhcccccCCcccee
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------------DGVKEFKTEVNVIGQTHHKNLVRLL 578 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------------~~~~~f~~E~~~l~~l~h~niv~l~ 578 (804)
++.+.++||+|.||.|-+|+....+. .+|||++.+... ...+..++|+.+|++++|+|||+|+
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~---l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGK---LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCc---EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34567899999999999998765443 899999964211 1134789999999999999999999
Q ss_pred eEEeCC--CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEE
Q 047263 579 GFCDDG--LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656 (804)
Q Consensus 579 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl 656 (804)
.+..+. +..|||+|||..|.+...=-....++..+.++++.++..||+|||.+ +||||||||+|+||+++|++||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEe
Confidence 998654 67899999999988765443344488999999999999999999965 9999999999999999999999
Q ss_pred eecCcccccccCC----CCccccccCCCccccccccccCC----CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHH
Q 047263 657 SDFGLAKLLLLDQ----SQTHTAIRGTKGYVAPEWFRNMP----ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT 728 (804)
Q Consensus 657 ~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~----~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 728 (804)
+|||.+..+.... ........||+.|+|||...++. .+.+.||||+||.||.|+.|+.||......+-
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l---- 327 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL---- 327 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH----
Confidence 9999998662221 11122367999999999987632 34689999999999999999999976543321
Q ss_pred HHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 729 DWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
.++++...+.-....+..+++.+|++++|++||+.|.++.+|..-.-
T Consensus 328 -----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 -----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11122222222223356678889999999999999999999876553
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.33 Aligned_cols=262 Identities=24% Similarity=0.293 Sum_probs=196.2
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHh--cccccCCccceeeEEeCCC----ceEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVI--GQTHHKNLVRLLGFCDDGL----NRLL 589 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l--~~l~h~niv~l~g~~~~~~----~~~l 589 (804)
+.+.||+|+||.||+|.+... .||||++... .++.+.+|.++. -.|+|+||+.+++.-..++ +.+|
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe-----~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGE-----DVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred EEEEecCccccceeeccccCC-----ceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 346799999999999998643 5999999864 334455555554 4679999999999865443 4689
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhc-----cCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE-----CSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
|.+|.++|||.|+|.. ..++....++++..+|.||++||.+ .++.|.|||||+.|||+..++.+.|+|+|||..
T Consensus 287 vTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred eeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 9999999999999976 7889999999999999999999965 467899999999999999999999999999987
Q ss_pred cccCCC---CccccccCCCccccccccccCC----C--CccchhhHHHHHHHHHHcCC----------CCCCcchhHHHH
Q 047263 665 LLLDQS---QTHTAIRGTKGYVAPEWFRNMP----I--TVKVDVYSFGVLLLEIICCR----------RNVDMEVNEAEA 725 (804)
Q Consensus 665 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~----~--s~~~DV~S~Gvll~elltG~----------~p~~~~~~~~~~ 725 (804)
...+.. .......||.+|||||++.... + -..+||||||.|+||++... .||....+...
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP- 444 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP- 444 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-
Confidence 654432 2344577999999999996531 2 24799999999999997542 33332211110
Q ss_pred HHHHHHHHhhhcCcc-cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 726 LLTDWAYDCYCEGIT-EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 726 ~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
.. +..++-.. +++.........+.+.+..+.+++..||..||.-|-|+--|.+.|.++.+.+
T Consensus 445 s~-----eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 445 SF-----EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred CH-----HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 00 00001111 1111111223345677889999999999999999999999999998887643
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.31 Aligned_cols=266 Identities=25% Similarity=0.340 Sum_probs=206.6
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeec----CccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeC
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIG----MASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD 583 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~----~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 583 (804)
....+.+.+.||+|+||.||+++.. ........+|+|.+.... ....+++.+|+.++..+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3444556789999999999999753 222334579999987532 34456789999999999 89999999999999
Q ss_pred CCceEEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEE
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIL 647 (804)
....++||||+++|+|.+++... ..+++..+..++.||++||.|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 99999999999999999999653 2467888999999999999999955 9999999999999
Q ss_pred EcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHH
Q 047263 648 LDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEA 725 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~ 725 (804)
+++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999999876432222 1222345678999999998889999999999999999998 67777543222110
Q ss_pred HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCC
Q 047263 726 LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 726 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~p 794 (804)
....+.... .........+.+++.+||+.+|++||+|.+|++.|+++..+..+
T Consensus 250 -------~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 250 -------KLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred -------HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 011111100 01112345788899999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.94 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=199.4
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.++||+|+||.||+|+..... .||+|++.... ...++|.+|+.+++.++|+||+++++++.+ ...++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT----RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc----eEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 34567889999999999999875443 49999997532 234678999999999999999999998754 5679999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++|+|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.++.+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999753 4578999999999999999999954 99999999999999999999999999998654333
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
........++..|+|||++.+..++.++||||||+++|||++ |..||........ . . ........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~-~----~~~~~~~~------- 222 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--L-D----QVERGYRM------- 222 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--H-H----HHhcCCCC-------
Confidence 222223345678999999988899999999999999999999 7778765432211 1 0 00011000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.........+.+++.+|++.+|++||++.+++++|+..
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01123345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=312.42 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=198.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 590 (804)
.+.+.+.||+|+||.||+|.....+. ...+++|++.... ....++|.+|++++.++ +|+||+++++++.++...++|
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCc-eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34567889999999999999865432 2357888876532 34456789999999999 899999999999999999999
Q ss_pred EeecCCCcHHHhhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCE
Q 047263 591 YEFLSNGTLASFLFGDL----------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA 654 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~ 654 (804)
+||+++++|.+++.... .+++.+++.++.||++||+|||+ .+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999996432 46788999999999999999995 499999999999999999999
Q ss_pred EEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHH
Q 047263 655 RISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYD 733 (804)
Q Consensus 655 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 733 (804)
||+|||++..... ........++..|+|||++....++.++||||||++++||++ |..||......... .
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~---- 234 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E---- 234 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---H----
Confidence 9999999864211 111111224567999999988889999999999999999998 99998644322111 0
Q ss_pred hhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 734 CYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
........ .........+.+++.+|++.+|++||++.+++++|+.+.+
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 KLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00011000 0011123467889999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.69 Aligned_cols=257 Identities=27% Similarity=0.361 Sum_probs=202.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||++...... .....+|+|.+.... .+...++.+|+.++.++ +|+||+++++++.++...++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 445678999999999999876432 334579999987532 33456788999999999 79999999999999999999
Q ss_pred EEeecCCCcHHHhhcC----------------CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC
Q 047263 590 VYEFLSNGTLASFLFG----------------DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~ 653 (804)
+|||+++|+|.+++.. ...+++..+++++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence 9999999999999853 24578889999999999999999955 9999999999999999999
Q ss_pred EEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHH
Q 047263 654 ARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWA 731 (804)
Q Consensus 654 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 731 (804)
+||+|||+++.+..... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+..........
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----- 245 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK----- 245 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH-----
Confidence 99999999986543221 11222334678999999998899999999999999999998 888876443221111
Q ss_pred HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
....+... ..+......+.+++.+|++.+|++|||+.+|++.|+.++
T Consensus 246 --~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 --LLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 01111100 011123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=318.05 Aligned_cols=271 Identities=20% Similarity=0.266 Sum_probs=197.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC-----Cce
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-----LNR 587 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 587 (804)
.+.++||+|+||.||+|+....+ ..||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCC---CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 45678999999999999976543 379999987432 23345688999999999999999999988543 247
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++||||+. ++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 99999996 68999998888899999999999999999999955 999999999999999999999999999986433
Q ss_pred CCC--CccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HHhh
Q 047263 668 DQS--QTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YDCY 735 (804)
Q Consensus 668 ~~~--~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~ 735 (804)
... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||............... ....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 221 12234568999999999875 67899999999999999999999999654332111000000 0000
Q ss_pred hcCcccceecchh---h---hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCccCC
Q 047263 736 CEGITEALVEFDI---E---ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM--LEGVVEVL 792 (804)
Q Consensus 736 ~~~~~~~~~~~~~---~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--Le~~~~~~ 792 (804)
............. . ..........+.+++.+||+.||++|||++|+++. ++++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~ 300 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence 0000000000000 0 00000123457789999999999999999999853 44444443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=318.27 Aligned_cols=246 Identities=25% Similarity=0.284 Sum_probs=199.3
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
.+.+.+.||+|+||.||+|+..... ...||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNED--FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCC--CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3556788999999999999865432 2369999986432 2345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999999999998888899999999999999999999954 999999999999999999999999999986532
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+...
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~~~-------- 246 (340)
T PTZ00426 184 --RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGIIY-------- 246 (340)
T ss_pred --CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCCC--------
Confidence 12345689999999999988899999999999999999999999976543211 0111111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQM 784 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 784 (804)
.+......+.+++.+|++.+|++|+ +++++++.
T Consensus 247 --~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 --FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111224567899999999999995 88888653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.63 Aligned_cols=241 Identities=25% Similarity=0.305 Sum_probs=190.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcc-cccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQ-THHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+|+...... .||+|.+.... ....+.+..|..++.. .+||||+++++++..+...++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNE---FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC---EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 368999999999999865443 79999987432 2334455666666664 4899999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....++......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999999998888899999999999999999999964 99999999999999999999999999997543222 233
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||.+.+..++.++|||||||++|||++|+.||........ ... ..... .. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~~-----i~~~~------~~----~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FDS-----ILNDR------PH----FP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHcCC------CC----CC
Confidence 345689999999999998999999999999999999999999976543211 100 00110 00 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMR-KVT 782 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 782 (804)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234567899999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.10 Aligned_cols=262 Identities=21% Similarity=0.255 Sum_probs=194.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|.....+ ..||+|++.... ......+.+|+.++++++|+||+++++++.++...++|||
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTE---NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCC---CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 445678999999999999876543 379999986432 2334567899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++ +|.+++... ..+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 9985 898888654 4578889999999999999999954 99999999999999999999999999997543221 2
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH-----HhhhcCc-ccce-
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY-----DCYCEGI-TEAL- 743 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~-~~~~- 743 (804)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||................ ..+..-. .+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2233457889999998865 568999999999999999999999997654332211110000 0000000 0000
Q ss_pred --ecchhhhc----ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 --VEFDIEAL----NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 --~~~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+..... .......++.+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 00112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.63 Aligned_cols=243 Identities=26% Similarity=0.279 Sum_probs=195.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.||+|+||.||+++....+ ..+|+|.+.... ......+..|++++..++|+||+++++++.+....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATG---RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 36899999999999876443 379999987532 233456788999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++|+|..++.....+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccc
Confidence 9999999998888899999999999999999999951 48999999999999999999999999998753222 12223
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...||..|+|||++.+..++.++||||||+++|||++|+.||........... . ..... .. +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~---i----~~~~~------~~----p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I----LMEEI------RF----PR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH---H----hcCCC------CC----CC
Confidence 45689999999999999999999999999999999999999975543221111 0 00000 00 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.....+.+++.+||+.||++|+ ++.++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1234677899999999999996 8988874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.89 Aligned_cols=242 Identities=23% Similarity=0.234 Sum_probs=194.9
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
+.||+|+||.||+++...+...+..+|+|++..... .....+..|++++++++||||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 579999999999998754444566899999875322 234457889999999999999999999999999999999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccc
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (804)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 999999998888899999999999999999999954 99999999999999999999999999987643221 22334
Q ss_pred ccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHH
Q 047263 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKK 755 (804)
Q Consensus 676 ~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (804)
..|+..|+|||.+....++.++||||||+++|||++|+.||......... ... . .... . . +..
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~i---~-~~~~----~--~----p~~ 220 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---TMI---L-KAKL----G--M----PQF 220 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---HHH---H-cCCC----C--C----CCC
Confidence 56899999999999888999999999999999999999999765332111 000 0 1100 0 0 111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 047263 756 KLARFVMVAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 756 ~~~~l~~l~~~Cl~~dP~~RPsm~e 780 (804)
....+.+++.+||+.||++||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2346778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=300.59 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=198.3
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.++||+|+||.||++....+. .+|+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~----~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNT----KVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCc----eeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 34567789999999999999876443 589999875432 3567999999999999999999999885 45689999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||++++++.++|+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999753 4578999999999999999999965 89999999999999999999999999998654332
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
........++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+ ... ..+.. .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~-~~~----~~~~~-----~-- 222 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VL-EQV----ERGYR-----M-- 222 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HH-HHH----HcCCC-----C--
Confidence 222222335668999999988899999999999999999999 888886543221 11 111 01100 0
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.........+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.89 Aligned_cols=249 Identities=19% Similarity=0.238 Sum_probs=198.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|++|.||++...... +..||+|.+..........+.+|+.+++.++||||+++++++.+++..+|||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~--~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCC--CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 456788999999999999876441 236888877654444556788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 594 LSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 594 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+++|+|.++|.. ...+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988753 3457888899999999999999995 499999999999999999999999999998754322
Q ss_pred C-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 S-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ + . . ...+....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~--~-~---~-~~~~~~~~------ 290 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI--M-Q---Q-VLYGKYDP------ 290 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H---H-HHhCCCCC------
Confidence 2 123445689999999999999999999999999999999999999975433211 1 0 0 00111000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.+|++||++.+++.
T Consensus 291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01122356888999999999999999998864
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.21 Aligned_cols=250 Identities=29% Similarity=0.394 Sum_probs=201.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.||+|++|.||+|...........+|+|.+..... ...+.|..|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999866444445799999987655 556789999999999999999999999988 889999999999
Q ss_pred CcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC--c
Q 047263 597 GTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ--T 672 (804)
Q Consensus 597 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~ 672 (804)
++|.+++.... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997653 678999999999999999999954 9999999999999999999999999999876442221 1
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||.+.+..++.++||||||++++||++ |+.|+.......... . .. ... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--~-~~---~~~--~~~~------- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK--K-ID---KEG--ERLE------- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH--H-HH---hcC--CcCC-------
Confidence 123446788999999999899999999999999999999 999986543322111 0 00 000 0000
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
........+.+++.+|++.+|++||++.+|++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122457888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.45 Aligned_cols=242 Identities=22% Similarity=0.338 Sum_probs=188.7
Q ss_pred hhCCCcceeEEEeeecCcc---------------------ccceeEEEEEccccccccHHHHHHHHHHhcccccCCccce
Q 047263 519 ELGKGAFGVVYKGAIGMAS---------------------MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~---------------------~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l 577 (804)
.||+|+||.||+|.+.... .....|++|.+........++|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999864211 1124689999876544455678999999999999999999
Q ss_pred eeEEeCCCceEEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC----
Q 047263 578 LGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY---- 652 (804)
Q Consensus 578 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~---- 652 (804)
++++.++...++||||+++|+|..++.. ...+++..+..++.||++||+|||+. +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999965 46788999999999999999999954 999999999999997644
Q ss_pred ---CEEEeecCcccccccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHH-cCCCCCCcchhHHHHHH
Q 047263 653 ---NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEII-CCRRNVDMEVNEAEALL 727 (804)
Q Consensus 653 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~ell-tG~~p~~~~~~~~~~~l 727 (804)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+...........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 3799999988643221 12346778999998865 56899999999999999995 68888865433221110
Q ss_pred HHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 728 TDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
. ... .. .. ......+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ---~----~~~--~~-----~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 ---Y----EKK--HR-----LP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---H----Hhc--cC-----CC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 000 00 00 011235788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.54 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=195.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCC------Cce
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------LNR 587 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 587 (804)
+.++||+|+||.||+|+...... ...+|+|.++.. .....+.|..|+.+++.++|+||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~-~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDS-ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCC-eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 46789999999999999865542 236899988643 234456789999999999999999999987532 246
Q ss_pred EEEEeecCCCcHHHhhcC------CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 588 LLVYEFLSNGTLASFLFG------DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
++++||+++|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 23478999999999999999999964 999999999999999999999999999
Q ss_pred ccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 662 AKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 662 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
++.+...... ......++..|+|||.+....++.++||||||+++|||++ |+.||....... . ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~-----~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--I-----YDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H-----HHHHHcCC
Confidence 9875432211 1122345678999999999999999999999999999999 788876433221 1 11111111
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
... ........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 0112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.21 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=190.7
Q ss_pred HhhCCCcceeEEEeeecCcc---------ccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 518 EELGKGAFGVVYKGAIGMAS---------MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~---------~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
+.||+|+||.||+|+..... .....|++|.+..........|.+|+.+++.++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999864322 223468999887655555567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC-------EEEeecC
Q 047263 589 LVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN-------ARISDFG 660 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~-------~kl~Dfg 660 (804)
+||||+++++|..++... ..+++..+.+++.||++||+|||+ .+|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998754 568999999999999999999995 49999999999999987664 8999999
Q ss_pred cccccccCCCCccccccCCCccccccccc-cCCCCccchhhHHHHHHHHHH-cCCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 661 LAKLLLLDQSQTHTAIRGTKGYVAPEWFR-NMPITVKVDVYSFGVLLLEII-CCRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 661 la~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~~DV~S~Gvll~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
++..... .....++..|+|||.+. ...++.++||||||+++|||+ .|..|+........... . ..
T Consensus 158 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~-~~ 224 (262)
T cd05077 158 IPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y-EG 224 (262)
T ss_pred CCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H-hc
Confidence 9875422 12334678899999886 567899999999999999998 57777654322211110 0 11
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
... . .......+.+++.+||+.||.+||++.+|++.|+
T Consensus 225 ~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Ccc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0 0112346788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.39 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=194.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+|+....+ +.+|+|.+.... ....+.+..|.+++..+ +||||+++++++.++...++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD---EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 36999999999999886543 379999987532 23445677888888866 799999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTT 153 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC-Cccc
Confidence 99999999998888899999999999999999999965 9999999999999999999999999998753222 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....|+..|+|||++.+..++.++||||||+++|||++|+.||........ + . . ...+. .. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~-~---~-i~~~~---~~-------~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--F-E---S-ILHDD---VL-------YP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--H-H---H-HHcCC---CC-------CC
Confidence 345689999999999999999999999999999999999999976543321 1 0 0 11110 00 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRP-------TMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RP-------sm~eVl~ 783 (804)
......+.+++..||+.||++|| +++++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11234677899999999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.57 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=217.2
Q ss_pred HHHHHHhhhHHhhCCCcceeEEEeeecCc-cccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCC
Q 047263 508 DLEAATNGFKEELGKGAFGVVYKGAIGMA-SMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL 585 (804)
Q Consensus 508 ~l~~at~~f~~~LG~G~fG~Vykg~~~~~-~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 585 (804)
+|.++.....++||.|-||.||+|+..+. +.....||||..+.. ..+..+.|+.|..+|+++.|||||+++|.|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 34555555678999999999999998766 444567999999863 34557789999999999999999999999976 4
Q ss_pred ceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
..++|||.++-|.|..+|+.+ ..++......++.||..+|+||| +.+.|||||..+|||+...--+|++|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 789999999999999999865 56888888999999999999999 56999999999999999999999999999998
Q ss_pred cccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
+..+.........-...|||||.+.-+.++.++|||-|||.+||+++ |..||....... .-..
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~ 604 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGH 604 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEE
Confidence 87666555555556788999999999999999999999999999986 788886543211 1111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+....+...+......|+.++.+||..+|.+||++.++...|+.+.+
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11112223345567788999999999999999999999998887655
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.69 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=190.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++....+. .+|+|.+.... ....+.+..|+.++.++ +||||+++++++.+++..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTER---IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCC---EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 368999999999999875543 79999987532 23345678888888776 899999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT 153 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcc
Confidence 99999999998888899999999999999999999955 9999999999999999999999999998753221 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH--HHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA--EALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
....||..|+|||++.+..++.++||||||+++|||++|+.||....... ......+..+........
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------- 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----------
Confidence 34568999999999999999999999999999999999999995321110 001111111111111110
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCC
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPT 777 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPs 777 (804)
.+......+.+++.+||+.||++||+
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCC
Confidence 11122356778999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.51 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=200.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||+|+||.||+|+...++. .+|+|++..........+.+|+.++.+++|+||+++++.+..+...++|+|
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~---~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGE---LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCe---EEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45667899999999999999765433 799999876545556678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++..+.... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 999999999998777889999999999999999999954 99999999999999999999999999998653221 12
Q ss_pred cccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 HTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....++..|+|||.+. ...++.++||||||++++||++|+.|+........... ... ..+......
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~---~~~~~~~~~ 232 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSK---SNFQPPKLK 232 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eec---CCCCCCCCc
Confidence 23345788999999884 34578899999999999999999999854322111000 000 000001110
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
........+.+++.+||+.+|++||++++|++.|
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112346788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=305.96 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=199.3
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCcc-----------ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCcccee
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMAS-----------MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLL 578 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~-----------~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~ 578 (804)
...+.+.++||+|+||.||++...... .....||+|.+.... ......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 345567789999999999998764321 112358999987542 33456799999999999999999999
Q ss_pred eEEeCCCceEEEEeecCCCcHHHhhcCCC------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDL------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 579 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
+++......++||||+++++|.+++.... .+++..++.++.|+++||.|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999985431 357888999999999999999955 999999999999
Q ss_pred EEcCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc--CCCCCCcchhHH
Q 047263 647 LLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC--CRRNVDMEVNEA 723 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt--G~~p~~~~~~~~ 723 (804)
++++++.+||+|||++..+..... .......++..|+|||.+....++.++||||||++++||++ +..|+.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976533221 11222345678999999988899999999999999999998 455665433221
Q ss_pred HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.+ ......+..... .... .........+.+++.+|++.+|++||+|.+|++.|+.
T Consensus 241 --~~-~~~~~~~~~~~~-~~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VI-ENTGEFFRNQGR-QIYL-----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HH-HHHHHhhhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11 101111111100 0000 0011123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.53 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=200.3
Q ss_pred hhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||+|+..... .....+++|.+.... ....+++.+|+.+++.++||||+++++.+.+.+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 34678999999999999864321 122468888887543 234567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC------------------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEE
Q 047263 592 EFLSNGTLASFLFGD------------------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIL 647 (804)
||+.+++|.+++... ..+++..++.++.|++.||.|||+. +++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 999999999998532 2467888999999999999999954 9999999999999
Q ss_pred EcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHH
Q 047263 648 LDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEA 725 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~ 725 (804)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.|+.......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-- 237 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-- 237 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 999999999999999865332221 1222345678999999988889999999999999999998 888886543221
Q ss_pred HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 726 LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 726 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+... ...... .. ........+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 238 -~~~~----~~~~~~-----~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -LFNL----LKTGYR-----ME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHH----HhCCCC-----CC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111 111110 00 011223568899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.68 Aligned_cols=256 Identities=20% Similarity=0.305 Sum_probs=202.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||.||+|+....+. .+|||++... ..+....+.+|+++++.++||||+++++++.+.+..+++
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRK---PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCC---EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 3456789999999999999765443 7999987532 223345789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 591 YEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
+||+++++|.+++.. ...++......++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988852 34578889999999999999999955 99999999999999999999999999988654
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... .. ..... .
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~-~~----~~~~~-----~- 225 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC-QK----IEQCD-----Y- 225 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH-HH----HhcCC-----C-
Confidence 3221 12234578899999999888899999999999999999999999865432211111 10 00100 0
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
...........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00111233467889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=297.63 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=195.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.||+|+||.||+|...++. .+|+|.+..... +....|.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKT----PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCc----EEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 36899999999999875432 699999875433 3345689999999999999999999999999999999999999
Q ss_pred CcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccc
Q 047263 597 GTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675 (804)
Q Consensus 597 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (804)
++|.+++... ..+++..+..++.+++.+|.|||+. +++|+||||+||++++++.+||+|||++.............
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 9999998654 4578999999999999999999954 99999999999999999999999999987543222222222
Q ss_pred ccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 676 ~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
..++..|+|||++.+..++.++||||||+++|||++ |..||......... .. ...+... ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~----~~~~~~~---------~~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQ----VEKGYRM---------SCPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH----HHcCCCC---------CCCC
Confidence 334567999999998899999999999999999998 88888654322111 00 1111000 0011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
.....+.+++.+|++.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.69 Aligned_cols=249 Identities=23% Similarity=0.278 Sum_probs=193.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||+|+....+ +.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+....++||
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTH---ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 34578999999999999876543 479999986432 234567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
||+++|+|.+++.....+++.....++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999999888888999999999999999999995 4999999999999999999999999999764321100
Q ss_pred ---------------------------------------------CccccccCCCccccccccccCCCCccchhhHHHHH
Q 047263 671 ---------------------------------------------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVL 705 (804)
Q Consensus 671 ---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvl 705 (804)
.......||..|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123468999999999998899999999999999
Q ss_pred HHHHHcCCCCCCcchhHHHHH-HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 047263 706 LLEIICCRRNVDMEVNEAEAL-LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIW--CIQEDPSLRPTMRKVT 782 (804)
Q Consensus 706 l~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPsm~eVl 782 (804)
+|||++|+.||.......... +..+ .... . .. .......++.+++.+ |+..+|..||++.+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~------~~~~----~--~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINW------ENTL----H--IP--PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHcc------cccc----C--CC--CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999997654332111 1000 0000 0 00 001122345556655 6677788899999997
Q ss_pred H
Q 047263 783 Q 783 (804)
Q Consensus 783 ~ 783 (804)
+
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.80 Aligned_cols=237 Identities=26% Similarity=0.370 Sum_probs=191.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++...++. .||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGR---LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCC---EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 368999999999999875443 79999987432 23455677888888776 699999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTT 153 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcc
Confidence 99999999998888899999999999999999999954 9999999999999999999999999998753221 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . . ....+.. . .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~-~----~i~~~~~---~-------~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL--F-E----AILNDEV---V-------YP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--H-H----HHhcCCC---C-------CC
Confidence 345689999999999999999999999999999999999999976543221 1 0 0111100 0 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
......+.+++.+|++.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123467889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=307.46 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=202.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccc-------------cceeEEEEEccccc-cccHHHHHHHHHHhcccccCCcccee
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASM-------------YQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLL 578 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~-------------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~ 578 (804)
.+.+.++||+|+||.||++....... ....||+|.+.... ....++|.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 45667899999999999998764332 22468999987543 34466899999999999999999999
Q ss_pred eEEeCCCceEEEEeecCCCcHHHhhcCCC-----------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEE
Q 047263 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDL-----------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 579 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIL 647 (804)
+++..+...++++||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 99999999999999999999999997654 688999999999999999999955 9999999999999
Q ss_pred EcCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc--CCCCCCcchhHHH
Q 047263 648 LDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC--CRRNVDMEVNEAE 724 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt--G~~p~~~~~~~~~ 724 (804)
++.++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ +..|+.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~- 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ- 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence 99999999999999976533221 22233446778999999988889999999999999999998 566665432211
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
. .......+.......... .......++.+++.+|++.+|++|||+.+|++.|+.
T Consensus 242 -~-~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 -V-IENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -H-HHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 111111111111110000 111223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.18 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=194.8
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEe-CCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCD-DGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~Ey~~ 595 (804)
+.||+|+||.||+|...+.......+|+|++.... .+..+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999976554455679999986432 344568899999999999999999999875 4556889999999
Q ss_pred CCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC---C
Q 047263 596 NGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS---Q 671 (804)
Q Consensus 596 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~---~ 671 (804)
+++|.+++... ..+.+..+..++.||++||.|||+. +++||||||+|||+++++.+||+|||+++.+..... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999754 4567788899999999999999954 999999999999999999999999999976533211 1
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCC-CCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR-NVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||.+....++.++||||||+++|||++|.. |+....... +.... ..+... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~----~~~~~~-----~~-- 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL----LQGRRL-----LQ-- 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----hcCCCC-----CC--
Confidence 1122345678999999988899999999999999999999654 444322111 11111 011000 00
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
.......+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 224 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 --PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0112346888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=298.70 Aligned_cols=249 Identities=27% Similarity=0.360 Sum_probs=195.4
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
+||+|+||.||+|...... .+..||+|.+..... ...++|.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999875332 233699999875433 334679999999999999999999998854 5789999999999
Q ss_pred cHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc--c
Q 047263 598 TLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH--T 674 (804)
Q Consensus 598 sL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--~ 674 (804)
+|.+++.. ...+++..+++++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....+..... .
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999975 45789999999999999999999965 999999999999999999999999999986543322211 1
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
...++..|+|||.+....++.++||||||+++|||++ |..|+......... . ....+... ..+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~----~~~~~~~~---------~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---S----FIEQGKRL---------DCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH---H----HHHCCCCC---------CCC
Confidence 1223568999999988889999999999999999996 99998654332211 1 11111110 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12345777899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.81 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=201.7
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
+...++.+.++||+|+||.||+|...++. .+|+|.+.... ...+.|.+|+.++++++|+||+++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~----~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHT----KVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCc----eEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 44566778899999999999999876433 69999987543 34567899999999999999999999874 45789
Q ss_pred EEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 589 LVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
+++||+++++|.+++... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999999999998653 467899999999999999999995 499999999999999999999999999998654
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
...........++..|+|||.+....++.++||||||++++||++ |+.||........ . .. ........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~-~~----~~~~~~~~--- 223 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--I-QN----LERGYRMP--- 223 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--H-HH----HHcCCCCC---
Confidence 322222223345678999999998889999999999999999999 9999865432211 1 00 01110000
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.......++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011123568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.97 Aligned_cols=248 Identities=27% Similarity=0.292 Sum_probs=195.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
...+.||+|+||.||++.....+ ..||+|++.... ......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCC---ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 34578999999999999876443 379999986432 122345788999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++|+|.+++... ..+++.....++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999999888643 4688999999999999999999955 99999999999999999999999999998653221
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ......... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~----------~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKED----------Q 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhc----------c
Confidence 2223468899999999998899999999999999999999999997643321110 000000000 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
..........+.+++..|++.||.+|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 011122445678899999999999999 8888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.57 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=194.9
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++....+. .||+|.++... ....+.+..|..++..+ +||||+++++++.+....++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRR---IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCC---EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 368999999999999875443 79999987532 23345688999999888 799999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT 153 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcc
Confidence 99999999998888899999999999999999999954 9999999999999999999999999998743221 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH--HHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA--EALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
....||..|+|||++.+..++.++|||||||++|||++|+.||+...... ......+..+...+.... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C---
Confidence 34578999999999999999999999999999999999999996432111 011111111111111110 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCC------HHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPT------MRKVT 782 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPs------m~eVl 782 (804)
+......+.+++.+||+.||.+||+ +++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 1112346788999999999999997 66765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.23 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=202.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
...+.+.||+|+||.||+|...... .....+|+|.+.... .....++.+|+.+++.++|+||+++++++.+....++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 4445678999999999999886433 334579999987543 2345578999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCC----------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeec
Q 047263 590 VYEFLSNGTLASFLFGD----------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Df 659 (804)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCc
Confidence 99999999999998642 236788999999999999999995 49999999999999999999999999
Q ss_pred CcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 660 GLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 660 gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
|+++....... .......++..|+|||.+....++.++||||||+++|||++ |..|+......... ... ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~----~~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFV----ID 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHH----hc
Confidence 99986543322 12233446788999999988889999999999999999998 88888654332211 111 11
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
+..... +......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 237 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111000 11124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.00 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=203.7
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
....+.+.||+|+||.||+|...+.......|+||...... .+..+.|.+|+.++++++|+||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 34456788999999999999876543334569999987654 3455689999999999999999999999875 557899
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|||+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999764 4589999999999999999999954 99999999999999999999999999998654432
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
........++..|+|||.+....++.++||||||++++||++ |..||.......... .. ..+.. . ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~~----~~~~~--~---~~ 229 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG---RI----ENGER--L---PM 229 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HH----HcCCc--C---CC
Confidence 222222334568999999988889999999999999999996 999986554322111 00 01100 0 00
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.......+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 230 ----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 230 ----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11223568889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=298.65 Aligned_cols=250 Identities=28% Similarity=0.397 Sum_probs=197.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||+|++|.||++...... .+|+|++... ....+.|.+|+.+++.++|+|++++++++. ....+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~----~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTT----KVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCc----eEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 3556778999999999999876543 4899988653 234567899999999999999999999875 456889999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999754 3478999999999999999999955 899999999999999999999999999986543322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ . ... ..+...
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~-~~~----~~~~~~-------- 222 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--L-EQV----ERGYRM-------- 222 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-HHH----HcCCCC--------
Confidence 22222345678999999998899999999999999999999 8888865433211 1 111 111000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.........+.+++.+|++.+|++||++++|++.|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.06 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=202.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 588 (804)
...+.+.||+|+||.||++.... .......+|+|.++... ....+.+.+|+.+++++ +|+||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 34567899999999999997532 12234579999987543 23346789999999999 7999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 589 LVYEFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
+||||+++|+|.+++.... .+++.++..++.+++.||.|||+. +++|+||||+|||++.++.++++|||+++...
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997543 379999999999999999999955 99999999999999999999999999998654
Q ss_pred cCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 667 LDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 667 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
..... ......++..|+|||.+....++.++||||||+++|||++ |..|+........ .... ...+...
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~----~~~~~~~--- 263 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKL----IKEGYRM--- 263 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHH----HHcCCcC---
Confidence 33221 1122345678999999999899999999999999999998 8888865432211 1010 1111100
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
........++.+++.+|++.+|++||++.||++.|+.+
T Consensus 264 ------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 ------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=301.92 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=201.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCcc-ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
...+.++||+|+||.||+|+....+ ...+.||+|.+.... ....+++.+|+.++..++|+||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEE
Confidence 3445688999999999999865333 223458999987532 34456789999999999999999999999754 57899
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+||+++|+|.+++... ..+++..++.++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 9999999999999764 5689999999999999999999954 99999999999999999999999999998764322
Q ss_pred CCc-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 670 SQT-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 670 ~~~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+........ .... ..+....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~~~~----- 231 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLL----EKGERLP----- 231 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCCcCC-----
Confidence 211 112234668999999998899999999999999999998 8888865433221 1111 1110000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
........+.+++..|++.||++||++.++++.|+.+...+
T Consensus 232 ----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 ----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01122346788999999999999999999999998775544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=320.44 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=200.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||+++....+ ..||+|++.... ....+.+.+|++++..++|+||+++++++.+++..++||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTG---QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCC---CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 45678999999999999987543 379999987432 234567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC--
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-- 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-- 669 (804)
||+++++|.+++.....+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999888889999999999999999999995 599999999999999999999999999998654332
Q ss_pred --------------------------CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH
Q 047263 670 --------------------------SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA 723 (804)
Q Consensus 670 --------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~ 723 (804)
........||..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112234568999999999999999999999999999999999999997654322
Q ss_pred HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 047263 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPT-MRKVTQM 784 (804)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~eVl~~ 784 (804)
.... .... ...+..+ . .......+.+++.+|++ +|.+||+ ++++++.
T Consensus 238 ~~~~-------i~~~-~~~~~~p---~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNK-------IINW-KESLRFP---P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH-------Hhcc-CCcccCC---C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1100 0000 0000000 0 01134567788999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.94 Aligned_cols=242 Identities=26% Similarity=0.319 Sum_probs=194.8
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||++.....+. .+|+|.+.... ......+..|.+++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDE---LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCC---EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 368999999999999865443 79999987532 23445677888888877 799999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....+++.....++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTT 153 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcc
Confidence 99999999998888899999999999999999999954 9999999999999999999999999998753221 1222
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......... . ....... . .+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---~----~i~~~~~---~-------~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---Q----SILEDEV---R-------YP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---H----HHHcCCC---C-------CC
Confidence 3356899999999999999999999999999999999999999755432111 0 0111100 0 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTM-----RKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~ 783 (804)
......+.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1223567889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.16 Aligned_cols=241 Identities=27% Similarity=0.313 Sum_probs=191.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcc-cccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQ-THHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+|....... .||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQ---FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCC---EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 368999999999999875443 79999987532 2334556677777775 4899999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|.+++.....+++.+...++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKT 153 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCce
Confidence 99999999998777889999999999999999999954 9999999999999999999999999998753221 1222
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ . ... .... .. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~-~~i----~~~~------~~----~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--F-QSI----RMDN------PC----YP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--H-HHH----HhCC------CC----CC
Confidence 345689999999999998999999999999999999999999975533211 1 100 0000 00 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMR-KVT 782 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 782 (804)
......+.+++.+||+.+|++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11234677899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.30 Aligned_cols=243 Identities=23% Similarity=0.387 Sum_probs=190.9
Q ss_pred HhhCCCcceeEEEeeecCccc----cceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASM----YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+|....... ...++++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998754322 2346888888765555567889999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC--------EEEeecCcccc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN--------ARISDFGLAKL 664 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~--------~kl~Dfgla~~ 664 (804)
+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999764 4578999999999999999999954 9999999999999987765 58999998865
Q ss_pred cccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCC-CCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCR-RNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+........... . ... ..
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~-~~~-~~ 223 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------Y-EDR-HQ 223 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------H-Hcc-cc
Confidence 432 223457788999999986 45789999999999999999995 44443222211110 0 000 00
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
+ +.....++.+++..||+.+|++|||+++|++.|+
T Consensus 224 -----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -----L----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----C----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 1112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.86 Aligned_cols=201 Identities=26% Similarity=0.323 Sum_probs=172.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||++.....+ ..+|+|++.... ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTG---HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCC---CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 34578999999999999876543 379999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
||+++|+|.+++.....+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999888889999999999999999999995 4999999999999999999999999999875432110
Q ss_pred ---------------------------------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCC
Q 047263 671 ---------------------------------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVD 717 (804)
Q Consensus 671 ---------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~ 717 (804)
.......||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123468999999999999999999999999999999999999997
Q ss_pred cchh
Q 047263 718 MEVN 721 (804)
Q Consensus 718 ~~~~ 721 (804)
....
T Consensus 238 ~~~~ 241 (363)
T cd05628 238 SETP 241 (363)
T ss_pred CCCH
Confidence 6543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=315.49 Aligned_cols=260 Identities=25% Similarity=0.284 Sum_probs=196.3
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC-----ceE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL-----NRL 588 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 588 (804)
..++||+|+||.||++.....+ ..||+|++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDG---KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCC---CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4578999999999999876443 379999986532 234467889999999999999999999998776 789
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+|+||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 57888887778899999999999999999999954 9999999999999999999999999999865443
Q ss_pred CCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH-HHH---------------HH
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTD---------------WA 731 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~---------------~~ 731 (804)
.........++..|+|||.+.+. .++.++|||||||+++||++|+.||.......... +.. ..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 33333445678899999998764 57899999999999999999999997654322110 000 00
Q ss_pred HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......... ................++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 237 RAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000000 00000000001112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.02 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=202.9
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCcc----ccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCC
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMAS----MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG 584 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 584 (804)
...+.+.++||+|+||.||+++..... .....+|+|.+.... ....+++..|++++..+ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345667889999999999999764321 223469999997532 34456788999999999 799999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE
Q 047263 585 LNRLLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl 648 (804)
...++||||+++|+|.+++... ..+++.++++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 9999999999999999999653 2478899999999999999999954 99999999999999
Q ss_pred cCCCCEEEeecCcccccccCCCCc-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHH
Q 047263 649 DDYYNARISDFGLAKLLLLDQSQT-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEAL 726 (804)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~ 726 (804)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999987653222111 111224568999999998899999999999999999998 778876443221111
Q ss_pred HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
. ....... .........+.+++.+|++.+|++||+|.+|++.|+.+.+.
T Consensus 254 ~-------~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 L-------LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred H-------HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 0 1111100 01112245777899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.23 Aligned_cols=250 Identities=32% Similarity=0.453 Sum_probs=202.9
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccccc-HHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.||+|+||.||++...........+++|.+....... .+++.+|++.+..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999987642234579999998654333 67899999999999999999999999999999999999999
Q ss_pred CcHHHhhcCC---------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 597 GTLASFLFGD---------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 597 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 778999999999999999999995 5999999999999999999999999999987654
Q ss_pred CCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 668 DQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 668 ~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
... .......++..|+|||.+....++.++||||+|++++||++ |..|+........ . . ....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~-~----~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--L-E----YLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--H-H----HHHcCCC-----
Confidence 321 22333456889999999988899999999999999999999 5888876532211 0 1 0111100
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
.........++.+++.+|++.+|++||++.++++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=309.67 Aligned_cols=241 Identities=26% Similarity=0.323 Sum_probs=191.8
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++....+ ..||+|.++... ....+.+..|..++... +|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG---EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 46999999999999987544 379999987532 23345567777777654 899999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....+++.....++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRA 153 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCce
Confidence 99999999998878889999999999999999999954 999999999999999999999999999874321 12223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||++.+..++.++||||||+++|||++|+.||........ . . ...... ... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~--~-~----~~~~~~------~~~----~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL--F-E----SIRVDT------PHY----P 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--H-H----HHHhCC------CCC----C
Confidence 446689999999999999999999999999999999999999975543211 1 1 011110 000 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMR-KVT 782 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 782 (804)
.....++.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234677899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=300.97 Aligned_cols=243 Identities=28% Similarity=0.336 Sum_probs=192.3
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
||+|+||+||++.....+ ..+|+|++.... .+..+.+..|+++++.++|+||+++.+++..+...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATG---KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCC---cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 799999999999876543 379999986432 22345678899999999999999999999999999999999999
Q ss_pred CcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 597 GTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 597 gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++..+..... .
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~ 153 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-K 153 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-c
Confidence 999988743 35688999999999999999999954 999999999999999999999999999976543222 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ..+.. ... .... .
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~--------~~~----~~~~--~ 219 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--------RIL----NDSV--T 219 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH--------hhc----ccCC--C
Confidence 2345689999999999999999999999999999999999999975432211 11100 000 0000 1
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
........+.+++..|++.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1122345678899999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=316.91 Aligned_cols=251 Identities=18% Similarity=0.207 Sum_probs=196.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
.+.+.++||+|+||.||+++....+. .+|+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQ---VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCC---EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34556789999999999998875443 79999986421 2334567899999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++... .++......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999998653 577888889999999999999954 99999999999999999999999999998654333
Q ss_pred CCccccccCCCccccccccccC----CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNM----PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~----~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
........||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ . ........ .+..
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~-----~~i~~~~~-~~~~ 268 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--Y-----SKIMDHKN-SLTF 268 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH--H-----HHHHcCCC-cCCC
Confidence 3233446789999999998653 478899999999999999999999976543211 0 00111100 0000
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSL--RPTMRKVTQ 783 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~ 783 (804)
.........+.+++..||+.+|.+ ||++.++++
T Consensus 269 -----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 269 -----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 011123457788999999999988 999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=296.57 Aligned_cols=247 Identities=26% Similarity=0.334 Sum_probs=199.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||+++....+. .+++|.+... .....+++.+|++++++++|+||+++++++.+....++|||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCc---EEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 345789999999999999875543 7999988632 23456678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++.+....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 99999999999764 5678899999999999999999954 99999999999999999999999999988654322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......++..|+|||++.+..++.++||||||++++||++|+.|+........ . .. ...+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~----~~~~~~~~-------- 220 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL--I-LK----IIRGVFPP-------- 220 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--H-HH----HHcCCCCC--------
Confidence 222334578899999999999999999999999999999999999975542211 1 10 11111111
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
........+.+++.+|++.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=298.48 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=200.2
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
......+.++||+|+||.||++...... .+++|.+... ....+.|.+|+.+++.++|+||+++++++.+ ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~----~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHT----KVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCc----cEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 3445567789999999999999865433 5999988753 2345678999999999999999999999887 77899
Q ss_pred EEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 590 VYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
+|||+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++..+..
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999999753 4578889999999999999999954 999999999999999999999999999976543
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
..........++..|+|||++....++.++||||||++++|+++ |+.|+........ .... ..+...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~~~----- 222 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL----ERGYRM----- 222 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----hCCCCC-----
Confidence 22222222345678999999998889999999999999999999 8888865432211 1111 111000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.........+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.01 Aligned_cols=253 Identities=28% Similarity=0.377 Sum_probs=196.4
Q ss_pred hhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|++|.||+|...... .....|++|...... ......|..|+.+++.++|+||+++++++.+....++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 34578999999999999986411 134579999887443 333457999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCC-------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC---CEEEeecCc
Q 047263 592 EFLSNGTLASFLFGDL-------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY---NARISDFGL 661 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfgl 661 (804)
||+++++|.+++.... .+++..+++++.||+.||.|||+. +++|+||||+||+++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999996542 478999999999999999999955 899999999999998654 589999999
Q ss_pred ccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 662 AKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 662 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
++.+...... .......+..|+|||++.+..++.++|||||||++|||++ |..||......... .... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~~~~---~~~~ 239 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---EFVT---GGGR 239 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH---cCCc
Confidence 9865322111 1112223567999999999999999999999999999997 88888754332211 1010 0000
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
. .........+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 ~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 L----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 011122356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.07 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=191.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|+....+ ..+|+|++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNG---KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCC---CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 445688999999999999986443 3799999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+. ++|.+++.. ...++...+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SH 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-Cc
Confidence 996 577776654 35678889999999999999999954 9999999999999999999999999998754221 22
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc---C---------
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE---G--------- 738 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~--------- 738 (804)
......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......... +.. ....... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LER-IFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHH-HHHHhCCCChhhccchhhcc
Confidence 2234557899999998865 45789999999999999999999999754322111 100 0000000 0
Q ss_pred --ccccee---cchhhh-cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 --ITEALV---EFDIEA-LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 --~~~~~~---~~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+... ...+.. .........+.+++..|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000000 000011246778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.82 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=200.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 588 (804)
++...++||+|+||.||+++... +...+..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 34556789999999999998642 22334579999987543 33456799999999999999999999998775 5678
Q ss_pred EEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999654 4679999999999999999999955 999999999999999999999999999987643
Q ss_pred CCCC--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH--------HHHHHHHHhhhc
Q 047263 668 DQSQ--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA--------LLTDWAYDCYCE 737 (804)
Q Consensus 668 ~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~--------~l~~~~~~~~~~ 737 (804)
.... ......++..|+|||++.+..++.++||||||+++|||++++.|.......... ...........+
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 3221 122344677899999998888999999999999999999987664322111000 000000000111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
+.. ..........+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 242 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 GKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred Ccc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 100 000112346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=296.88 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=200.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
...+.+.||+|+||.||++... +..||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++|||
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hccceeeeecCCCceEEEEEec-----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 3456788999999999999865 23699999986543 56789999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999997654 689999999999999999999955 999999999999999999999999999986522111
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
....+..|+|||.+....++.++||||||++++||++ |..|+....... +.... ..+....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~~------- 219 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKGYRME------- 219 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcCCCCC-------
Confidence 2234568999999998899999999999999999997 888886543221 11111 1110000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
........+.+++.+|++.+|++||++++++++|+.+
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112245788899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.90 Aligned_cols=249 Identities=22% Similarity=0.254 Sum_probs=197.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||+++....+. .+|+|++.... .+..+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGD---IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCC---EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 456789999999999998765443 79999987532 234567889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++|+|.+++... ..+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999775 6789999999999999999999954 999999999999999999999999999987644333
Q ss_pred CccccccCCCccccccccc------cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 671 QTHTAIRGTKGYVAPEWFR------NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~------~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.......||..|+|||++. ...++.++||||||+++|||++|+.||........ .. . .... ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~----~-i~~~--~~~~ 228 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--YN----N-IMNF--QRFL 228 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--HH----H-HHcC--CCcc
Confidence 3333456899999999986 45678999999999999999999999975543221 00 0 0010 0000
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. .........+.+++..|++ +|.+||++.++++
T Consensus 229 ~~----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KF----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 0011234567788888997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.68 Aligned_cols=240 Identities=27% Similarity=0.300 Sum_probs=192.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccC-CccceeeEEeCCCceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHK-NLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV 590 (804)
.+.+.||+|+||.||+|+....+. .+|+|++.... ....+.+..|.+++..++|+ +|+++++++.+.+..++|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDE---LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCC---EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 456789999999999999765443 79999987432 23456788899999999765 688899999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~ 155 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-G 155 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-C
Confidence 99999999999998888889999999999999999999954 9999999999999999999999999998743211 1
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||..|+|||++.+..++.++|||||||++|||++|+.||......... ... .+... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~i----~~~~~----~----- 219 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QSI----MEHNV----S----- 219 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH----HcCCC----C-----
Confidence 2233456899999999999999999999999999999999999999765432211 001 11100 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
.+......+.+++.+|++.||.+||+.
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 -YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011123467789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=301.65 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=203.9
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCcc-ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeC-CCce
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNR 587 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 587 (804)
...+.+.+.||+|+||.||+|...... .....|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 344556788999999999999986522 224479999887542 3445678999999999999999999998866 5778
Q ss_pred EEEEeecCCCcHHHhhcCC--------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeec
Q 047263 588 LLVYEFLSNGTLASFLFGD--------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Df 659 (804)
++++||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643 4578999999999999999999954 9999999999999999999999999
Q ss_pred CcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 660 GLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 660 gla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
|+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.|+....... +..+. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL----KD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH----Hc
Confidence 999865433221 1122345678999999998899999999999999999999 999987543322 11111 11
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+.. + . ........+.+++.+|++.+|++|||+.+|++.|+.+.+
T Consensus 235 ~~~--~-----~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYR--L-----A--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCC--C-----C--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 100 0 0 011123467899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=312.24 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=204.3
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCCc
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGT 598 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 598 (804)
.||+|.||+||-|+..+.+. .+|||.+.....+..+-+.+|+.+-+.++|+|||+++|.+.++...-+.||.++|||
T Consensus 582 VLGKGTYG~VYA~RD~~tqv---rIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQV---RIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeecccccee---EEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 59999999999999876544 799999988777777889999999999999999999999999999999999999999
Q ss_pred HHHhhcCC-CCC--ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcccccccCCCCccc
Q 047263 599 LASFLFGD-LKP--GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 599 L~~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
|.++|... .++ ++.+.-.+.+||++||.|||+. .|||||||-+|||++. .|.+||+|||-++.+.. -.....
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 99999765 455 6778889999999999999976 9999999999999975 78899999999987532 233445
Q ss_pred cccCCCccccccccccC--CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 675 AIRGTKGYVAPEWFRNM--PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~--~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
++-||..|||||++..+ .|..++|||||||.+.||.||++||............ -+ -......-
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--------VG------myKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--------VG------MYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--------hc------ceecCCCC
Confidence 67799999999999755 5889999999999999999999999765544322211 11 11122334
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+.+..++...++++|+.++|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 5566788999999999999999999999885
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=302.67 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=200.0
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
...+.+.++||+|+||.||+|...+ .......||+|.+..... .....+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3445567899999999999997653 222345799998864332 2344688999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCC----------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEe
Q 047263 588 LLVYEFLSNGTLASFLFGD----------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARIS 657 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~ 657 (804)
++||||+++|+|.+++... ..+++....+++.|++.||.|||+. +++||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999642 2345677889999999999999954 99999999999999999999999
Q ss_pred ecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhh
Q 047263 658 DFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 658 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 735 (804)
|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+........ . .. .
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~--~-~~----~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--L-KF----V 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-HH----H
Confidence 99999865332221 1222334678999999998899999999999999999999 6777764432211 1 10 0
Q ss_pred hcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 736 CEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
..+.... ........+.+++.+|++.+|++|||+.++++.|+...
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1110000 01112357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.02 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=190.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.||+|+||.||+|+...+. ....+++|+++.... .....|.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY-TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCC-CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 36899999999999876432 344699999875432 3345788999999999999999999999999999999999999
Q ss_pred CcHHHhhcCC-----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 597 GTLASFLFGD-----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 597 gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+|.+++... ...++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999999643 2456778889999999999999954 9999999999999999999999999999754322211
Q ss_pred -ccccccCCCccccccccccC-------CCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 672 -THTAIRGTKGYVAPEWFRNM-------PITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 672 -~~~~~~gt~~y~aPE~l~~~-------~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
......++..|+|||++... .++.++||||||+++|||++ |+.||........... . ..+. ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~---~~~~-~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---T---VREQ-QLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---H---hhcc-cCC
Confidence 11234467889999998642 35789999999999999996 9999865433221110 0 0011 111
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
+..+.... .....+.+++..|+ .+|++|||+.||++.|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 12234667888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.35 Aligned_cols=238 Identities=26% Similarity=0.284 Sum_probs=188.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHH-HhcccccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVN-VIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++....+ +.||+|++.... ....+++..|.. +++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG---KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 36899999999999986544 379999986432 122334455544 56789999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....+++.....++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~ 153 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTT 153 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcc
Confidence 99999999998888899999999999999999999955 999999999999999999999999999875322 22233
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ .. . ...... . . .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~----~-i~~~~~----~--~----~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM--YD----N-ILNKPL----R--L----K 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH--HH----H-HHcCCC----C--C----C
Confidence 345689999999999999999999999999999999999999975432211 00 0 001100 0 0 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMR 779 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~ 779 (804)
......+.+++.+|++.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11245678899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.78 Aligned_cols=255 Identities=28% Similarity=0.386 Sum_probs=209.1
Q ss_pred HHhhCCCcceeEEEeeec-CccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIG-MASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~-~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.++||+|+||+||||.+- .+...+.+||||.+.... .+...++.+|+..|.++.||||+||+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 568999999999999874 444556799999997543 456789999999999999999999999998766 88999999
Q ss_pred CCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 595 SNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 595 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+.|+|.++++.+ ..+.-+..+.|..|||+||.|||++ +++||||-.+|||+.+-..+||.|||+++.+..+.....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999754 6788999999999999999999966 999999999999999999999999999998876554433
Q ss_pred cc-ccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 674 TA-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 674 ~~-~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.. ..-.+.|||-|.+....++.++|||||||.+||++| |..|.+....++...+. ....+-.
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e~geRLs 920 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------EKGERLS 920 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------hccccCC
Confidence 32 223567999999999999999999999999999998 77787765444333221 1111122
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.+......++.++..||..|+..||+++++...+.++...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 3344556788899999999999999999998888765443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=297.67 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=200.9
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.++||+|+||.||++..... ..++||.+.... ...+++.+|+.++++++|+||+++++++.+....++||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~----~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGT----TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCC----ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 3445678899999999999987543 259999987542 34567999999999999999999999999989999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999764 4688999999999999999999965 89999999999999999999999999998764322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.........+..|+|||.+.+..++.++||||||++++||++ |+.|+....... .+ ... ..+... .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~-~~~----~~~~~~-----~- 224 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VL-EQV----ERGYRM-----P- 224 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-HHH----HcCCCC-----C-
Confidence 222222334568999999998899999999999999999999 898886543221 11 111 011000 0
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
........+.+++.+|++.+|++||++.++++.|+.
T Consensus 225 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 ---RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001113568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=297.67 Aligned_cols=249 Identities=22% Similarity=0.245 Sum_probs=198.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-----cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-----QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
...+.||+|++|.||++.....+ .++++|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~---~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTG---RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccceecCCCceEEEEEEEcCCC---cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 34678999999999999876443 379999876432 1234568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|+||+++++|.+++.....+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998877889999999999999999999965 99999999999999999999999999997653322
Q ss_pred CCcc--ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 670 SQTH--TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 670 ~~~~--~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.... ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......... . ........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~----~~~~~~~~------ 226 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF--K----IATQPTNP------ 226 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH--H----HhccCCCC------
Confidence 1111 23457789999999999889999999999999999999999986542221110 0 00000000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
..+......+.+++.+|++.+|++|||+.++++.
T Consensus 227 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 ---QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111234467889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.70 Aligned_cols=249 Identities=21% Similarity=0.222 Sum_probs=195.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||+++....+. .||||++.... ....+.+.+|+.++..++|+||+++++++.++...++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGH---IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCC---EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 345789999999999999865443 79999997432 233456889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999998888899999999999999999999955 9999999999999999999999999998754321100
Q ss_pred -------------------------------------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCC
Q 047263 672 -------------------------------------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR 714 (804)
Q Consensus 672 -------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~ 714 (804)
......||+.|+|||++....++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112458999999999999999999999999999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 047263 715 NVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPT---MRKVTQ 783 (804)
Q Consensus 715 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~ 783 (804)
||.......... . . .... ..+..+ ........+.+++.+|+. +|.+|++ +.++++
T Consensus 238 Pf~~~~~~~~~~--~-i----~~~~-~~~~~~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQETYR--K-I----INWK-ETLQFP-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHHHHHH--H-H----HcCC-CccCCC-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 997654322110 0 0 0000 000000 001123456678888886 8999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=301.99 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=204.7
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
....+.+.++||+|+||.||++.....+. .+|+|.+.... ....+.+++|+++++.++|+||+++++++.+....+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~---~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGT---VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCc---EEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34456678999999999999998865443 68998876432 334568999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+||||+++++|.+++.....+++.....++.+++.+|.|||+. .+++|+||||+||++++++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999999999998777889999999999999999999952 37999999999999999999999999998754221
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-----HHHHHHHHHHhhhcCcccce
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-----EALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~ 743 (804)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+.........+.
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1223468899999999988899999999999999999999999997554321 111111111111110
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
............+.+++.+|++.||++||++.||+++.
T Consensus 230 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 ----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00001112345688899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.18 Aligned_cols=244 Identities=24% Similarity=0.306 Sum_probs=192.1
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++....+. .+|+|.+.... ....+.+..|+.++.++ +|+||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQ---IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCC---EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 368999999999999875543 79999997532 23345688999999888 699999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT 153 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCce
Confidence 99999999998878899999999999999999999954 9999999999999999999999999998753221 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||++.+..++.++||||||+++|||++|+.||......................... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence 34568999999999999999999999999999999999999996432211111111111111111100 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
......+.+++.+||+.||++||++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1123457789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=302.75 Aligned_cols=261 Identities=24% Similarity=0.284 Sum_probs=189.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhccc---ccCCccceeeEEe-----C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQT---HHKNLVRLLGFCD-----D 583 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~ 583 (804)
+.+.++||+|+||.||+++..... +..||+|++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCC--CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 445678999999999999874321 3369999886432 22234556677766655 6999999999885 3
Q ss_pred CCceEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
....++|+||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 5898888653 4578999999999999999999954 999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHHHHhhhcCc-
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWAYDCYCEGI- 739 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~- 739 (804)
++..... .......|+..|+|||.+....++.++||||||+++|||++|+.||......... .+.........+..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9865332 2233456899999999998889999999999999999999999999765432211 11110000000000
Q ss_pred -----ccceecch----hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 -----TEALVEFD----IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 -----~~~~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........ ... ........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000 000 00112356678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.18 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=202.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCc-cccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeC--CCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA-SMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~-~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 589 (804)
..+.+.||+|+||.||+++.... ...+..+|||.+...... ..++|.+|+++++.++|+||+++++++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 44668899999999999987533 233557999999765433 46789999999999999999999999877 567899
Q ss_pred EEeecCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999997654 689999999999999999999954 9999999999999999999999999999876422
Q ss_pred CCC--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH--------HHHHHHHhhhcC
Q 047263 669 QSQ--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL--------LTDWAYDCYCEG 738 (804)
Q Consensus 669 ~~~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~--------l~~~~~~~~~~~ 738 (804)
... ......++..|++||.+.+..++.++||||||++++||++|+.|+.......... ............
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 211 1112234567999999988899999999999999999999998875432211000 000000000011
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
. ..........++.+++.+|++.+|++||+|.||+++|+.+
T Consensus 243 ~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 E---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred C---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0 0001112235788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=291.19 Aligned_cols=269 Identities=24% Similarity=0.285 Sum_probs=203.0
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeC-----CCceEE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-----GLNRLL 589 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~l 589 (804)
.+.||+|+||.|.+++....+ +.||||++....+ -..+...+|+.+++.++|+||+.+++.+.. -+..|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~---~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTG---EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred cccccCcceeeEEEEEEcCCC---CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 467999999999999987655 4899999984433 345677899999999999999999998854 356799
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC-
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD- 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~- 668 (804)
|+|+| .-+|...++.++.++......++.||++||+|+| +.+|+||||||+|+|++.+...||+|||+|+.....
T Consensus 104 V~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred ehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999 4599999988888999999999999999999999 459999999999999999999999999999986433
Q ss_pred CCCccccccCCCccccccccc-cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH-----------------
Q 047263 669 QSQTHTAIRGTKGYVAPEWFR-NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW----------------- 730 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~-~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~----------------- 730 (804)
.....+....|..|.|||.+. ...|+.+.||||.|||+.||++|++-|.+........+...
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 123345677899999999874 56899999999999999999999999876654322111110
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCccCCCCC
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVVEVLDPP 795 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~~~~~pp 795 (804)
++.+...... ..........+ ......++|+.+||..||.+|+|++|.++ -|+..-+..+.|
T Consensus 260 ar~yi~slp~--~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 260 ARPYIKSLPQ--IPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHhCCC--CCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 1111110000 00000000001 22356788999999999999999999875 345444444333
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=299.16 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=200.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccH--HHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV--KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~--~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||+||+++...... .+|+|.+........ .....|+.++++++|+||+++++++.+....++|||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQ---KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTE---EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCe---EEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 356789999999999999886554 799999986543322 234569999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++..+..++.||++||.+||+. +++|+||||+||++++++.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~ 154 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNEN 154 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999998778889999999999999999999965 9999999999999999999999999999764 222334
Q ss_pred cccccCCCccccccccc-cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFR-NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~-~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||++. +...+.++||||+|+++++|++|+.|+................ ...... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-------~~~~~~---~~~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL-------KRPLPS---SSQ 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH-------HTHHHH---HTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc-------cccccc---ccc
Confidence 44566889999999998 8889999999999999999999999998652221111110000 000000 000
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++..||+.||++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011268889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.19 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=190.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC-----ceEEEE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL-----NRLLVY 591 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~ 591 (804)
.+.+|.|+||.||+|++.... .+||||+.....+. -..|+.+|+++.|||||+++-++.... ...|||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~---~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETE---EEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred eEEEeecccceEEEEEEcCCC---ceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 357999999999999998663 48999998754332 246899999999999999999885432 234899
Q ss_pred eecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-CCEEEeecCcccccc
Q 047263 592 EFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLLL 666 (804)
Q Consensus 592 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfgla~~~~ 666 (804)
|||+. +|...++. +..++...+.-+..||++||.|||+ .+|+||||||+|+|+|.+ |.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 88888864 5778888888999999999999995 599999999999999965 999999999999875
Q ss_pred cCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH-----Hhhh----
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY-----DCYC---- 736 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~---- 736 (804)
..+.. ..+.-|.-|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.++.......+..-+. +...
T Consensus 178 ~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 KGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred cCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 54433 33445788999998875 579999999999999999999999998765443221111110 0000
Q ss_pred ---cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 737 ---EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 737 ---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+....++...............++++++.++++.+|.+|.+..|++.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111111111122334567889999999999999999998874
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=310.18 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=198.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeC-CCc
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD-GLN 586 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 586 (804)
..+.+.+.||+|+||.||+|.... ....++.||||++.... ....+.+..|+.++.++ +|+||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 456678899999999999997532 22335579999997532 23456788999999999 78999999998865 456
Q ss_pred eEEEEeecCCCcHHHhhcCC------------------------------------------------------------
Q 047263 587 RLLVYEFLSNGTLASFLFGD------------------------------------------------------------ 606 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 606 (804)
.++++||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999998542
Q ss_pred -------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-CccccccC
Q 047263 607 -------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS-QTHTAIRG 678 (804)
Q Consensus 607 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g 678 (804)
..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1356778889999999999999954 999999999999999999999999999986533221 11222345
Q ss_pred CCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHH
Q 047263 679 TKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKL 757 (804)
Q Consensus 679 t~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 757 (804)
+..|+|||.+.+..++.++||||||+++|||++ |..|+........ .. ....++..... . ....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~~~~-----~----~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTRMRA-----P----DYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCCCCC-----C----CCCC
Confidence 678999999998899999999999999999997 8888764322111 10 01111111000 0 0122
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 758 ARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 758 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.39 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=206.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCc-eEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN-RLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-~~l 589 (804)
.+...+++|+|+||.++..+.+.+.. .+++|++... .....+...+|+.++++++|||||.+.+.+.+++. .+|
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~---~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDK---LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCc---eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 35677899999999999888775554 7999998643 33344567899999999999999999999999988 899
Q ss_pred EEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 590 VYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||+|++||+|.+.|.+. ..+++++..+++.|++.|+.|||+. +|+|||||+.||+++.+..+||.|||+|+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999765 4568888999999999999999955 999999999999999999999999999998865
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
+.. ......||+.||.||.+.+.+|..|+||||+||++|||++-+++|.......-. ..+......
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li-----------~ki~~~~~~-- 224 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI-----------LKINRGLYS-- 224 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH-----------HHHhhccCC--
Confidence 542 345577999999999999999999999999999999999999999866433211 111111111
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
..+..++.++..++..|++.+|+.||++.+++.+
T Consensus 225 ---Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 ---PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1233456788889999999999999999999865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=283.67 Aligned_cols=272 Identities=22% Similarity=0.206 Sum_probs=200.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-cHH-HHHHHHHHhcccccCCccceeeEEe--CCCceEEEEe
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVK-EFKTEVNVIGQTHHKNLVRLLGFCD--DGLNRLLVYE 592 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-~~~-~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~E 592 (804)
.++|++|.||.||+|+.+...+ .||+|+++...++ +.. .-.+||.++.+.+|||||.+..+.. +-+..|||||
T Consensus 81 lnrI~EGtyGiVYRakdk~t~e---IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDE---IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HhhcccCcceeEEEeccCCcce---eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 4689999999999999875544 8999999854321 111 2478999999999999999998774 3467999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||++ +|..++... +.+...+..-++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||+|+.++.. ..
T Consensus 158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LK 232 (419)
T ss_pred HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cc
Confidence 9987 888888764 5788889999999999999999955 9999999999999999999999999999987653 34
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch---
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD--- 747 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~--- 747 (804)
..+...-|..|.|||.+.+ ..|++..|+||+|||+.||+++++.|.+..+..+...+-.......+.+...+....
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 4566677999999998865 579999999999999999999999987765543222111111111111222111111
Q ss_pred -----------hhhcccHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCCC
Q 047263 748 -----------IEALNDKK-KLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797 (804)
Q Consensus 748 -----------~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~P 797 (804)
++..+... ..+.-.++....+..||.+|-|++|.++- +-..+.+.|..|
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P 373 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDP 373 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCCh
Confidence 11111111 23556677788899999999999987753 123444444433
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.37 Aligned_cols=243 Identities=23% Similarity=0.289 Sum_probs=189.8
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHh---cccccCCccceeeEEeCCCceEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVI---GQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l---~~l~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.||+|+||.||++.....+ ..||||++.... ....+.+..|++++ +.++||||+++++++.+.+..++
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTG---ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 4578999999999999876543 379999987432 22334566665554 56789999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++++|..++.. ..+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 9999999999988854 5689999999999999999999954 9999999999999999999999999998753221
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........|+..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. .......
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~~-----i~~~~~~-------- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FDS-----IVNDEVR-------- 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhCCCC--------
Confidence 2223346689999999999999999999999999999999999999976543221 100 0011000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.+......+.+++.+||+.||.+|| ++.++++
T Consensus 220 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 --YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0111235677899999999999999 4566554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.79 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=202.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|.....+ ..+|+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDG---RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCC---CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 446788999999999999987443 37999988632 223356789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 591 YEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
|||+++++|.+++.. ...+++.++..++.++++||.|||+. +++|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998853 34578999999999999999999954 99999999999999999999999999987653
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... . ....+..
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~----~~~~~~~------ 225 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-K----KIEKCDY------ 225 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHH-h----hhhcCCC------
Confidence 3221 12334578899999999988899999999999999999999999865432211111 0 0011100
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
...........+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus 226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00111133457889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.04 Aligned_cols=252 Identities=21% Similarity=0.259 Sum_probs=199.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.+.||+|+||.||+++....+. .+|+|.++.........+++|+.+++.++||||+++++.+.+.+..++|+|
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGE---LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCc---EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 45677899999999999998765443 799999876544555678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++.+...++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ...
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 999999999998888899999999999999999999965 9999999999999999999999999998765322 222
Q ss_pred cccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 HTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....|+..|+|||++. ...++.++|||||||++|||++|..|+............ ...... .....
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~~~~~~----~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------TKSNFQ----PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------hccCCC----CCccc
Confidence 23456889999999874 456889999999999999999999998644322111100 000000 00000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. .......+.+++.+|++.+|++||++++|++
T Consensus 233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 1112346788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.24 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=193.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
..||+|+||.||+|+...++ ..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~---~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQ---VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred EEEecCCceEEEEeEecCCC---cEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 47999999999999876543 379999987665566778999999999999999999999999999999999999999
Q ss_pred cHHHhhcCC-CCC--ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcccccccCCCCcc
Q 047263 598 TLASFLFGD-LKP--GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 598 sL~~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+|.+++... ..+ ++..+..++.||+.||.|||+ .+|+||||||+||+++. ++.++|+|||++....... ...
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~ 166 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCT 166 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-Ccc
Confidence 999999754 344 788888999999999999995 49999999999999976 6799999999987653222 122
Q ss_pred ccccCCCccccccccccC--CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 674 TAIRGTKGYVAPEWFRNM--PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~--~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
....++..|+|||++... .++.++||||||+++|||++|+.|+........... . ...... ...
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~---~-----~~~~~~------~~~ 232 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---K-----VGMFKI------HPE 232 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---h-----hhhhcc------CCC
Confidence 234578899999998654 378999999999999999999999864332211110 0 000000 000
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+.....++.+++.+||+.+|++|||+.+|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11123456788999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.35 Aligned_cols=241 Identities=29% Similarity=0.442 Sum_probs=190.4
Q ss_pred HhhCCCcceeEEEeeecCcc-------ccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 518 EELGKGAFGVVYKGAIGMAS-------MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~-------~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.||+|+||.||+|...... .....+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999987544 11235788877654332 6789999999999999999999999988 778999
Q ss_pred EeecCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-------CEEEeecCcc
Q 047263 591 YEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-------NARISDFGLA 662 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-------~~kl~Dfgla 662 (804)
+||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998665 78999999999999999999995 4999999999999999887 7999999999
Q ss_pred cccccCCCCccccccCCCccccccccccC--CCCccchhhHHHHHHHHHHcC-CCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNM--PITVKVDVYSFGVLLLEIICC-RRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~~DV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
..... .....++..|+|||++... .++.++||||||+++|||++| ..|+.......... . +...
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~--~-----~~~~- 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER--F-----YQDQ- 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH--H-----HhcC-
Confidence 86432 2223456789999999876 789999999999999999995 66665432211110 0 0000
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
... .......+.+++.+|++.+|++||++.+|++.|+
T Consensus 223 -~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 -HRL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CCC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0011167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.76 Aligned_cols=239 Identities=25% Similarity=0.299 Sum_probs=199.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 590 (804)
.|.++||+|.||+|+++..+..++ .+|||.+++.. .+..+..+.|.+++... +||.|++++.++...++.++|
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e---~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNE---YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCc---EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 467899999999999999987655 78999997643 35567788898888887 499999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+.||++ -++.+...+++.....++..|+.||.|||++ +|||||||.+|||||.+|.+||+||||++.-.. ..
T Consensus 448 mey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~g 522 (694)
T KOG0694|consen 448 MEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-QG 522 (694)
T ss_pred EEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC-CC
Confidence 999999993 3444567899999999999999999999976 999999999999999999999999999986432 23
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
....+.+||+.|||||++.+..|+.++|.|||||+|||||.|..||..+.+++...- ++. ...
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds---------------I~~--d~~ 585 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS---------------IVN--DEV 585 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---------------Hhc--CCC
Confidence 456779999999999999999999999999999999999999999997766542110 000 011
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
.++.-.+.+.+.++.+.+..+|++|--+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2333445677788899999999999866
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.53 Aligned_cols=240 Identities=26% Similarity=0.300 Sum_probs=191.9
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 590 (804)
.+.+.||+|+||.||+++....+ ..+|+|.+.... ....+.+..|..++..+ +|++|+++++++.+.+..++|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 35678999999999999886544 379999987532 22344567788887777 689999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~ 155 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-G 155 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC-C
Confidence 99999999999998888899999999999999999999954 9999999999999999999999999998753221 1
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ... .+...
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~-~~i----~~~~~---------- 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--F-QSI----MEHNV---------- 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--H-HHH----HhCCC----------
Confidence 223345689999999999999999999999999999999999999976543221 1 111 11100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
..+.....++.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.02 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=198.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.++||+|+||.||+++....+ ..+|+|.+.... ....+++.+|++++.+++||||+++++++.+++..++|+||
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSG---LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCC---eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 35678999999999999876544 368888876432 23345688999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|.+++.....+++.....++.||++||.|||+. .+++|+||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence 99999999998888889999999999999999999962 38999999999999999999999999998754321 12
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC-cc------------
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG-IT------------ 740 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-~~------------ 740 (804)
....++..|+|||.+.+..++.++||||||++++||++|+.|+...................... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 33467889999999988889999999999999999999999986543221111000000000000 00
Q ss_pred --------cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 741 --------EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 741 --------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
+.+................+.+++.+|++.+|++||++.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000001123468899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.36 Aligned_cols=265 Identities=27% Similarity=0.356 Sum_probs=204.7
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCcc----ccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEe
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMAS----MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCD 582 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 582 (804)
+....+.+.+.||+|+||.||++...... .....+|+|.+.... ....+++.+|+.++.++ +|+||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34445667889999999999999753221 223468999887532 33457899999999999 7999999999999
Q ss_pred CCCceEEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 583 DGLNRLLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 583 ~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
++...++++||+++|+|.+++... ..+++..+..++.||++||.|||+. +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 999999999999999999998642 2467888999999999999999954 999999999999
Q ss_pred EEcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHH
Q 047263 647 LLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAE 724 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~ 724 (804)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999865432211 1122234567999999999999999999999999999998 7788765432221
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
.. ......... ........+.+++.+|++.+|.+||++.|+++.|+.+....
T Consensus 246 ~~-------~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 FK-------LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HH-------HHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 011111000 01122356888999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.49 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=197.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||++...... ..+++|.+.....+..+.+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETG---VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCC---eEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 345678999999999999886543 37899998765556667899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|..++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999999998865 45689999999999999999999965 99999999999999999999999999987643221 22
Q ss_pred cccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 673 HTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....++..|+|||++. ...++.++|||||||++|||++|+.|+........ ..... ......+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~-----~~~~~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-----KSEPPTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHh-----hcCCCCCC---
Confidence 23345788999999984 44678899999999999999999999875432211 11100 00000000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233577899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.59 Aligned_cols=244 Identities=26% Similarity=0.339 Sum_probs=190.5
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
||+|+||.||++.....+. .+|+|++.... ....+.+..|++++++++||||+++++++.++...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGK---MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCc---EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 7999999999998875443 79999986421 12234566799999999999999999999999999999999999
Q ss_pred CcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 597 GTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 597 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++...... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~ 152 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTIT 152 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceee
Confidence 9999888643 4578889999999999999999954 9999999999999999999999999998765322 2223
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...|+..|+|||++.+..++.++||||+||++|||++|+.||.......... .......... ... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~-----~~~-----~~~ 220 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDE-----VKF-----EHQ 220 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhccc-----ccc-----ccc
Confidence 3568899999999998889999999999999999999999986543221110 0000000000 000 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....++.+++..||+.||++||++.|+++
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 23446788999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.82 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=199.9
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcc--cc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCc--eE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN--RL 588 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~--~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~--~~ 588 (804)
.|.++||+|.|-+||||..... +++||-..++ .. .....+.|..|+++|+.|+|+||++++.++.+... ..
T Consensus 43 k~~evLGrGafKtVYka~De~~---giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEE---GIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeecccccc---chhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 4677899999999999987543 4467654443 22 23345789999999999999999999999987766 77
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~ 667 (804)
+|+|.|..|+|..|+++.+.++......|+.||++||.|||.+ .++|||||||.+||+|+. .|.+||+|+|||...+.
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999999999999999999999999999999999998 899999999999999985 68999999999998654
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
... ....||+.|||||... ..|++.+||||||+.++||+|+..|+..-..... ++.....|+...-+..
T Consensus 199 s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 199 SHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVTSGIKPAALSK- 267 (632)
T ss_pred ccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHHcCCCHHHhhc-
Confidence 322 2378999999999988 6899999999999999999999999875544322 3333334433221111
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
-...++.++|..|+.. .++|||+.|++.
T Consensus 268 -------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 -------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1123677899999999 999999999985
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=313.64 Aligned_cols=251 Identities=19% Similarity=0.227 Sum_probs=193.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++...++. .+|+|.+... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQK---VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCC---EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 4456789999999999999875543 7999988642 123345688999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++... .++......++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999999644 578888999999999999999954 999999999999999999999999999987643333
Q ss_pred CccccccCCCccccccccccC----CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 671 QTHTAIRGTKGYVAPEWFRNM----PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~----~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.......||+.|+|||++... .++.++||||+||++|||++|+.||........ ... ...... .+
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--~~~-----i~~~~~-~~--- 266 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--YSK-----IMDHKN-SL--- 266 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhCCc-cc---
Confidence 233456799999999998754 378899999999999999999999976543211 100 001000 00
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSL--RPTMRKVTQM 784 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 784 (804)
.. .........+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~~--p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NF--PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC--CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 011122445667888888765544 8899998765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.62 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=197.5
Q ss_pred hhhHHhhCCCcceeEEEeeecC-------------ccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGM-------------ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLG 579 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~-------------~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g 579 (804)
+.+.++||+|+||.||++.... .......+|+|.+.... ....++|.+|+.+++.++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4567889999999999985432 11223468999997542 334568999999999999999999999
Q ss_pred EEeCCCceEEEEeecCCCcHHHhhcCCC-----------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE
Q 047263 580 FCDDGLNRLLVYEFLSNGTLASFLFGDL-----------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648 (804)
Q Consensus 580 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl 648 (804)
++.++...++||||+++++|.+++.... .+++.....++.|++.||+|||+. +++|+||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 9999999999999999999999986532 356778999999999999999965 99999999999999
Q ss_pred cCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc--CCCCCCcchhHHHH
Q 047263 649 DDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC--CRRNVDMEVNEAEA 725 (804)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt--G~~p~~~~~~~~~~ 725 (804)
++++.++|+|||+++.+..... .......++..|++||......++.++||||||+++|||++ |..|+.......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~-- 241 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-- 241 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--
Confidence 9999999999999986533221 11222334678999999888889999999999999999998 667775432221
Q ss_pred HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 726 LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 726 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.. ....+............ ........+.+++.+||+.||++||+|.+|++.|+.
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VI-ENTGEFFRDQGRQVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-HHHHHHHhhccccccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 10111111110000000 011123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=309.04 Aligned_cols=241 Identities=24% Similarity=0.242 Sum_probs=189.3
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHH-HHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEV-NVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++...++. .+|+|.+.... .....++..|. .+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEK---FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCC---EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 368999999999998865543 79999986432 12233444444 456788999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|.+++.....+.......++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~ 153 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTT 153 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCc
Confidence 99999999998877888888899999999999999954 9999999999999999999999999999753221 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ . ... ...... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-~~i----~~~~~~----------~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--Y-DNI----LNKPLQ----------LK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--H-HHH----HhCCcC----------CC
Confidence 345689999999999999999999999999999999999999975443221 0 000 011000 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
......+.+++.+|++.+|.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 12234677899999999999999887543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=316.08 Aligned_cols=200 Identities=25% Similarity=0.297 Sum_probs=170.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.++||+|+||.||+|+....+. .+|+|++.... ....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKA---LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCC---EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 45789999999999998765443 79999987432 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC---
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ--- 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~--- 669 (804)
|+++|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998877888999999999999999999954 99999999999999999999999999975332100
Q ss_pred -------------------------------------------CCccccccCCCccccccccccCCCCccchhhHHHHHH
Q 047263 670 -------------------------------------------SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706 (804)
Q Consensus 670 -------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll 706 (804)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001224689999999999999999999999999999
Q ss_pred HHHHcCCCCCCcchh
Q 047263 707 LEIICCRRNVDMEVN 721 (804)
Q Consensus 707 ~elltG~~p~~~~~~ 721 (804)
|||++|+.||.....
T Consensus 239 ~elltG~~Pf~~~~~ 253 (382)
T cd05625 239 YEMLVGQPPFLAQTP 253 (382)
T ss_pred HHHHhCCCCCCCCCH
Confidence 999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=309.97 Aligned_cols=239 Identities=27% Similarity=0.289 Sum_probs=189.0
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHH-HhcccccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVN-VIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++...++ ..+|+|++.... ....+++..|.. +++.++||||+++++.+.+++..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG---KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 36899999999999876543 379999986432 223344555554 56779999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|..++.....+++.....++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~ 153 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTT 153 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCc
Confidence 99999999998888899999999999999999999954 999999999999999999999999999875322 12223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||........ . ........ . . .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~-----~~~~~~~~----~--~----~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM--Y-----DNILHKPL----V--L----R 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--H-----HHHHcCCc----c--C----C
Confidence 345689999999999999999999999999999999999999975432211 1 00111100 0 0 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~e 780 (804)
......+.+++..|++.+|.+||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 112346778999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=307.97 Aligned_cols=238 Identities=25% Similarity=0.253 Sum_probs=187.8
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHH-HhcccccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVN-VIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+++....+. .+|+|.+.... ....+++..|.. +++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGS---FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCC---EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 368999999999999865443 79999986432 122334555544 67889999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|..++.....+.......++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETT 153 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcc
Confidence 99999999998878888999999999999999999954 9999999999999999999999999998753221 2223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||........ . .. ...... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-~~----i~~~~~----------~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM--Y-DN----ILHKPL----------QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH--H-HH----HhcCCC----------CCC
Confidence 345689999999999998999999999999999999999999976532211 0 00 001100 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMR 779 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~ 779 (804)
......+.+++.+|++.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12244678899999999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.31 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=198.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||.||++..... ......+|+|.+.... .+..++|.+|+.++++++|+||+++++++.++...+++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 44567899999999999986431 1234579999987543 33456799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCC----------------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE
Q 047263 591 YEFLSNGTLASFLFGD----------------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl 648 (804)
+||+++|+|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 9999999999999632 2357788899999999999999954 99999999999999
Q ss_pred cCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHH
Q 047263 649 DDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEAL 726 (804)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~ 726 (804)
++++.++|+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~-- 241 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-- 241 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999876433221 11122234567999999998899999999999999999997 7778754332211
Q ss_pred HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
+ . ....+.... .......++.+++.+|++.+|++|||+.||++.|++
T Consensus 242 ~-~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 I-Y----YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-H----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 0 111111100 011223578889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.30 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=200.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecC----ccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCc
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM----ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~----~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 586 (804)
...+.++||+|+||.||+++... .......+|+|.+.... .....++..|+.+++++ +|+||+++++++.+...
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 34467899999999999997532 11223468999987532 33456788999999999 69999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 587 RLLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
.++++||+++|+|.+++... ..+++....+++.||+.||.|||+. +++||||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcC
Confidence 99999999999999999643 3477888999999999999999954 9999999999999999
Q ss_pred CCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHH
Q 047263 651 YYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLT 728 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~ 728 (804)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.........
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--- 246 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF--- 246 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH---
Confidence 999999999999865432211 1112234467999999998899999999999999999999 78887644322111
Q ss_pred HHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 729 DWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
. ........ + ........+.+++.+|++.+|++||++.++++.|+++..
T Consensus 247 ~----~~~~~~~~---~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 K----LLREGHRM---D------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred H----HHHcCCCC---C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1 01111100 0 011223467789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.62 Aligned_cols=250 Identities=20% Similarity=0.205 Sum_probs=192.6
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||+++....+ ..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+++..++||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTN---ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCC---CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 45678999999999999876543 379999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC--
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-- 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-- 669 (804)
||+++|+|.+++.....++......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999998888888999999999999999999955 99999999999999999999999999975331100
Q ss_pred ----------------------------------------CCccccccCCCccccccccccCCCCccchhhHHHHHHHHH
Q 047263 670 ----------------------------------------SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709 (804)
Q Consensus 670 ----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~el 709 (804)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134689999999999999999999999999999999
Q ss_pred HcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 047263 710 ICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRP---TMRKVTQM 784 (804)
Q Consensus 710 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---sm~eVl~~ 784 (804)
++|+.||........... . ..+.. ....+ ........+.+++.+|+ .+|.+|+ ++.++++-
T Consensus 238 l~G~~Pf~~~~~~~~~~~---i-~~~~~----~~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLK---V-INWET----TLHIP-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHH---H-hccCc----cccCC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999976543321110 0 00000 00000 00112234555666655 5999999 78888743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.47 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=200.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||+++...+. ..+++|.+..... .+++.+|++++++++|+||+++++++.++...++++||
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETG---QVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCC---cEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 456788999999999999987643 3799999875432 67899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 999999999975 45779999999999999999999965 999999999999999999999999999987543221 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+........... ........+ ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~-------~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKPPPTL-------SD 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCCCCCC-------Cc
Confidence 2334578899999999998999999999999999999999999875433221110 000000000 01
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+|++.+|++|||+.||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1123356888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.21 Aligned_cols=248 Identities=26% Similarity=0.320 Sum_probs=198.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.++||+|++|.||+|+....+ ..+++|.+........+.+.+|+.+++.++|+||+++++.+..+.+.++||||+
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCC---cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 34567999999999999865443 379999987655555677899999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++++|.+++.. ..+++.++..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~ 174 (296)
T cd06654 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (296)
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccC
Confidence 99999999854 4578999999999999999999954 999999999999999999999999999876433221 123
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...++..|+|||.+.+..++.++||||||+++|||++|+.||........... ..... ...+ ....
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~------~~~~~-~~~~-------~~~~ 240 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNG-TPEL-------QNPE 240 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH------HhcCC-CCCC-------CCcc
Confidence 34578899999999988899999999999999999999999976543221110 00011 0000 0112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.....+.+++.+|++.+|++||++.+|++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 233567889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.63 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=187.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
++||+|+||.||+|....+ .....+++|.+.... .+....|.+|+..++.++|+||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 3699999999999976543 334568999876432 23456788999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCC-----CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 597 GTLASFLFGDL-----KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 597 gsL~~~l~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
|+|.+++.... ..++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999996542 235777889999999999999955 999999999999999999999999999875322211
Q ss_pred CccccccCCCcccccccccc-------CCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 671 QTHTAIRGTKGYVAPEWFRN-------MPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~-------~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
.......++..|+|||++.. ..++.++||||||+++|||++ |..|+....... .+. ....+. ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~----~~~~~~-~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLK----QVVREQ-DIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH----HHhhcc-Ccc
Confidence 11122345678999998743 356789999999999999999 677775443221 111 001111 111
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
+..+.. .......+.+++..|+ .||++||++++|+++|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 1123345566777788 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.35 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=198.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+...+.||+|+||.||+|.....+ ..||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTK---EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCC---eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 4455678999999999999876443 379999887432 334567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.. ..+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++|+|||++..+.... .
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-h
Confidence 99999999999854 567899999999999999999995 499999999999999999999999999997654322 1
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......++..|+|||.+.+..++.++||||||++++||++|+.|+.......... . ....... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~~~~~---------~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPKNSPP---------T 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhcCCCC---------C
Confidence 2223457889999999999899999999999999999999999986443221110 0 0011100 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
........+.+++.+|++.+|++||+|.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111234567889999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.87 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=197.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.+.||+|+||.||++....+. .+|+|.+.... ....+|.+|++++++++|+|++++++++.+....++|+||
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~----~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKR----KVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCC----eEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 345678999999999999875432 58999887432 2346789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++... ..+++..+..++.+++.+|+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999764 4578999999999999999999965 89999999999999999999999999987653322222
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.|+....... .+ . ...++. ....+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~-~----~~~~~~--~~~~~----- 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VV-E----TINAGF--RLYKP----- 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HH-H----HHhCCC--CCCCC-----
Confidence 222334578999999998899999999999999999998 888886543221 11 0 011110 00011
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
......+.+++.+||+.+|++||++.+|++.|.
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112357889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.38 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=193.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||+|+||.||+++..... ..+|+|.+... .....++|.+|++++++++||||+++++++...+..++|+||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTR---RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCC---cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35678999999999999876443 37999998643 234456799999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|..+. .+++.....++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 81 MDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 9999997653 467888899999999999999955 9999999999999999999999999999765322 22
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....++..|+|||.+.+..++.++||||||+++|||++|+.||......................... ....
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--------VLPV 222 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--------CCCC
Confidence 33568899999999999899999999999999999999999986532211100000000001111000 0011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.....++.+++.+|++.+|++||+++++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1233467889999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.90 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=199.2
Q ss_pred hHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
..+.||+|+||.||+|+..... .....+++|.+...... ..+++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4567999999999999975432 22346999988754333 45679999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCC---------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 593 FLSNGTLASFLFGDL---------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 593 y~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997654 689999999999999999999955 99999999999999999999999999987
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
..............++..|+|||.+.+..++.++||||||++++||++ |..||....... .+ . ....+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~-~----~~~~~~~~~ 238 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VL-N----RLQAGKLEL 238 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HH-H----HHHcCCcCC
Confidence 543332222333445678999999988889999999999999999999 677775332211 11 0 011111110
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
. ........+.+++.+|++.+|++||++.+++++|+
T Consensus 239 ~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 P--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 01122357888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=314.68 Aligned_cols=249 Identities=23% Similarity=0.246 Sum_probs=193.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||++.....+. .||||++.... .+..+.+++|++++++++||||+++++++.+....++||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGK---IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCC---EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 345789999999999998765443 79999986421 234567889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++|+|.+++.....+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999999888888999999999999999999995 49999999999999999999999999999643211000
Q ss_pred ----------------------------------------------ccccccCCCccccccccccCCCCccchhhHHHHH
Q 047263 672 ----------------------------------------------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVL 705 (804)
Q Consensus 672 ----------------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvl 705 (804)
......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012458999999999999899999999999999
Q ss_pred HHHHHcCCCCCCcchhHHHH-HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCC---CCHHHH
Q 047263 706 LLEIICCRRNVDMEVNEAEA-LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLR---PTMRKV 781 (804)
Q Consensus 706 l~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Psm~eV 781 (804)
+|||++|+.||......... .+..+ . ..+..+ . ......++.+++..|++ +|.+| |++.++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~-----~----~~~~~p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINW-----R----ETLYFP---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHcc-----C----CccCCC---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999765432211 11000 0 000000 0 11123456778888887 66654 699888
Q ss_pred HHH
Q 047263 782 TQM 784 (804)
Q Consensus 782 l~~ 784 (804)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.32 Aligned_cols=241 Identities=27% Similarity=0.297 Sum_probs=192.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 589 (804)
+++.+.||+|+||.||+++...++. .||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDE---LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCC---EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 3567789999999999998765443 79999987432 234456788888888875 5778889999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++.++..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999999998888899999999999999999999954 99999999999999999999999999987532221
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......||..|+|||++.+..++.++||||||+++|||++|+.||........ . ... .+...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~-~~i----~~~~~--------- 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--F-QSI----MEHNV--------- 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--H-HHH----HhCCC---------
Confidence 222345689999999999999999999999999999999999999976543211 1 101 01100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0011223467889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=329.31 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=198.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||+|+....+ ..||+|++..... ...+.|.+|++++++++||||+++++++.+++..++||
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg---~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCS---RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCC---cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 45678999999999999876543 3799999875322 23457899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-----------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecC
Q 047263 592 EFLSNGTLASFLFGD-----------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFG 660 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg 660 (804)
||+++|+|.+++... ...++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998531 2345677889999999999999954 99999999999999999999999999
Q ss_pred cccccccCCC-----------------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH
Q 047263 661 LAKLLLLDQS-----------------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA 723 (804)
Q Consensus 661 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~ 723 (804)
+++....... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01123468999999999999999999999999999999999999997543221
Q ss_pred HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCcc
Q 047263 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRP-TMRKVTQMLEGVVE 790 (804)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~Le~~~~ 790 (804)
... . . .+..+. ...........+.+++.+|++.||++|| +++++++.|+...+
T Consensus 239 i~~------~---~----~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISY------R---D----VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh------h---h----hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 100 0 0 000000 0000112335677899999999999995 67888888877544
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=277.83 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=199.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc--------cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCce
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--------QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--------~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 587 (804)
++.||.|..++|-+...+.++. +.|+|++.... .+..++-..|+.+++++ -||+|+.+.++++.+...
T Consensus 22 keilgrgvss~vrRci~k~t~~---e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGK---EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred HHHhcccchhhhhhhhhccccc---ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 5689999999999988876554 68888885321 12234567899999998 599999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++|+|.|+.|.|.++|.....+++....+|+.|+..|+.|||. .+|+||||||+|||+|++.++||+|||++..+.
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~- 174 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE- 174 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC-
Confidence 9999999999999999999999999999999999999999995 599999999999999999999999999998754
Q ss_pred CCCCccccccCCCcccccccccc------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRN------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
........+||++|+|||.++. ..|+..+|+|+.|||+|.|+.|.+||.....- + ..+...++..+
T Consensus 175 -~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm----l---MLR~ImeGkyq 246 (411)
T KOG0599|consen 175 -PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM----L---MLRMIMEGKYQ 246 (411)
T ss_pred -CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH----H---HHHHHHhcccc
Confidence 4556677899999999999864 35788999999999999999999998643221 1 11112222111
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+ ....-.+......+++.+||+.||.+|.|.+|+++
T Consensus 247 -F-----~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 -F-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -c-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0 11111233456788999999999999999999874
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=290.53 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=195.4
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
++||+|+||.||++....+. .|++|++...... ..++|.+|+.++++++|+||+++++++.+....++|+||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~----~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNT----EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCC----cEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 46999999999999986532 6999998754333 456899999999999999999999999999999999999999
Q ss_pred CcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc-c
Q 047263 597 GTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH-T 674 (804)
Q Consensus 597 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~ 674 (804)
++|.+++.. ...+++.....++.+++.+|.|||+. +++||||||+||+++.++.+||+|||++........... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999999965 35678899999999999999999955 999999999999999999999999999986532111111 1
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....+..|+|||.+.+..++.++||||||+++|||++ |..|+........... . .... .. ...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~----~~~~--~~-------~~~ 217 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---I----ESGY--RM-------PAP 217 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---H----hcCC--CC-------CCC
Confidence 2223567999999988899999999999999999999 7777755432211110 0 0100 00 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
......+.+++.+|++.+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 122457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=293.22 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=202.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||++....... .+++|.+........+.+.+|++++++++|+||+++++++.++...+++|||
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGE---LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCC---EEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 3456789999999999999865443 6999998865555677899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++... ..++......++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999999999776 7889999999999999999999955 99999999999999999999999999987654321 12
Q ss_pred cccccCCCccccccccccC---CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 HTAIRGTKGYVAPEWFRNM---PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~---~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....++..|+|||.+... .++.++||||||++++||++|+.|+........... . .... +....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~----~~~~----~~~~~-- 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--I----SKSN----FPPPK-- 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--H----Hhcc----CCCcc--
Confidence 2335678899999999776 889999999999999999999999875443221110 0 0010 00000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..........+.+++.+|++.+|.+||++++|+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.85 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=194.2
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEe-CCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD-DGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||++... +..+++|..+.. ...+.|.+|+.++++++|+|++++++++. ++...++++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-----CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 3456688999999999999765 235899988643 33567899999999999999999999764 556789999
Q ss_pred eecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999997543 478999999999999999999954 99999999999999999999999999987543211
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.....+..|+|||++....++.++||||||+++|||++ |+.|+....... +.... ..+....
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~~------ 219 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYKMD------ 219 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCCCCC------
Confidence 22234568999999998899999999999999999998 888876432211 11111 0111100
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 220 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 ---APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0112245678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.49 Aligned_cols=253 Identities=18% Similarity=0.208 Sum_probs=194.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
..+.+.+.||+|+||.||+++...... .+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.++...+
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRK---VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCc---EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 344556789999999999999875544 79999986421 233456789999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+||||+++|+|.+++... .++...+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999998654 578888889999999999999954 9999999999999999999999999999876433
Q ss_pred CCCccccccCCCccccccccccC----CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNM----PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~----~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.........||+.|+|||++... .++.++|||||||++|||++|+.||......... ........ .+
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~-~~- 266 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------SKIMNHKN-SL- 266 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC-cc-
Confidence 33333456799999999998754 3789999999999999999999999765432110 00111100 00
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSL--RPTMRKVTQM 784 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 784 (804)
. . .........+.+++..|++.++.+ ||++++|++.
T Consensus 267 ~--~--~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 T--F--PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred c--C--CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 0 011123456778889999854443 7899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=321.16 Aligned_cols=250 Identities=24% Similarity=0.272 Sum_probs=196.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCC-----
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL----- 585 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----- 585 (804)
.+.+.+.||+|+||.||+++....+ +.||||++... .......+.+|+..+..++|+||++++..+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDG---EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCC---CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4456788999999999999876543 37999998643 2344567889999999999999999988774332
Q ss_pred ---ceEEEEeecCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEee
Q 047263 586 ---NRLLVYEFLSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658 (804)
Q Consensus 586 ---~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~D 658 (804)
..++||||+++|+|.++|... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEe
Confidence 257999999999999998642 457888899999999999999995 4999999999999999999999999
Q ss_pred cCcccccccCC-CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 659 FGLAKLLLLDQ-SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 659 fgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
||+++.+.... ........||..|+|||++.+..++.++||||||+++|||++|+.||........ + . . ...
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~--~-~---~-~~~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--M-H---K-TLA 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--H-H---H-Hhc
Confidence 99998654322 2223446789999999999999999999999999999999999999975533211 1 0 0 111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
+.... .+......+.+++.+||+.+|.+||++.++++.
T Consensus 260 ~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11110 011234568889999999999999999998753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=285.08 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=197.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-c-cHHHHHHHHHHhcccccCC-ccceeeEEeCCC-----
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-D-GVKEFKTEVNVIGQTHHKN-LVRLLGFCDDGL----- 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~-~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~----- 585 (804)
+...++||+|.||+||+|+....+ ..||+|++.-..+ + .-....+|+.++++++|+| |+++++++...+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g---~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTG---KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCC---CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 344578999999999999987655 3799999976533 2 2234689999999999999 999999997776
Q ss_pred -ceEEEEeecCCCcHHHhhcCCC----CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecC
Q 047263 586 -NRLLVYEFLSNGTLASFLFGDL----KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFG 660 (804)
Q Consensus 586 -~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg 660 (804)
..+||+||++. +|.+++.... .++...+..++.||++||+|||++ +|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78899999965 8999987543 456678899999999999999955 99999999999999999999999999
Q ss_pred cccccccCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhh---h
Q 047263 661 LAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCY---C 736 (804)
Q Consensus 661 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~---~ 736 (804)
+|+.+... ....+...+|..|.|||++.+. .|+...||||+|||+.||++++.-|....+..... .+.+.. .
T Consensus 166 lAra~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLGTPN 241 (323)
T ss_pred hHHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcCCCC
Confidence 99965432 3335566789999999998765 79999999999999999999998887765532211 111111 1
Q ss_pred cCcccce---ecch--hhhcc-cH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 737 EGITEAL---VEFD--IEALN-DK-------KKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 737 ~~~~~~~---~~~~--~~~~~-~~-------~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
+.....+ .+.. ..... .. .......+++.+|++.+|.+|.|+..+++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111 0111 00000 00 011367889999999999999999999876
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=294.40 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=193.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCC------Cc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG------LN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~------~~ 586 (804)
+.+.+.||+|+||.||+|.....+. .+|+|++... .....++..|+.++.++ +|+||+++++++.+. ..
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~---~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQ---LAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCc---EEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4556789999999999998865543 7999998654 34456788999999998 799999999998653 45
Q ss_pred eEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 587 RLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 78999999999999999753 4678999999999999999999965 999999999999999999999999999986
Q ss_pred cccCCCCccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
..... .......|+..|+|||++. ...++.++||||||+++|||++|+.|+........... . . ...
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~---~---~-~~~ 232 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---I---P-RNP 232 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---H---h-cCC
Confidence 53222 2233456888999999986 34578899999999999999999999865433221111 0 0 010
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ........+.+++.+||+.+|.+|||+.+|++
T Consensus 233 ~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0001 01112346788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=305.33 Aligned_cols=250 Identities=26% Similarity=0.326 Sum_probs=205.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
...|+||+|.||.|++|.+.....+.+.||||.+...... ....|.+|+.+|.+|+|+|+++|+|...+ ....||+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3568999999999999999988888889999999865443 67789999999999999999999999988 778899999
Q ss_pred cCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
++.|||.+.|++. ..+-......++.|||.|+.||. ++++|||||..+|+||-..-.+||+||||.+.+...+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999999873 34556677899999999999999 559999999999999999999999999999987654432
Q ss_pred cc--ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcC-CCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 672 TH--TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICC-RRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 672 ~~--~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.. ....-...|.|||.++...|+.++|||+|||.||||+|+ ..||-....... | +.+|...
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI--L--------------~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI--L--------------KNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH--H--------------Hhccccc
Confidence 21 112235689999999999999999999999999999994 567655433211 1 1112222
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
+-.......+++++++..||..+|.+|||+..|.+.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 223455678899999999999999999999999743
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=277.46 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=198.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcc--ccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
.+.+.++||+|.|+.||+...... ++.+|+|.+. .......+++.+|+++-+.|+||||++++....+....+||
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~t---g~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccc---hHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456678999999999999876543 3357777664 22345678899999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc---CCCCEEEeecCccccccc
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLAKLLLL 667 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfgla~~~~~ 667 (804)
+|+|.|+.|..-+-.+...++...-..+.||+++|.|+|.. +|||||+||+|+||- ..-.+|++|||++..+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999999987776555667777889999999999999955 999999999999994 34458999999999876
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.........||++|||||+++..+++..+|||+.|||||-||.|..||..+.... .+ +++...-.+.+
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------ly----e~I~~g~yd~~ 232 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LY----EQIKAGAYDYP 232 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HH----HHHhccccCCC
Confidence 4445556779999999999999999999999999999999999999998743321 11 11112122221
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
...-....++..+|+.+||..||.+|.|+.|.+
T Consensus 233 --~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 --SPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred --CcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 111223345677899999999999999998865
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=294.13 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=195.6
Q ss_pred hhCCCcceeEEEeeecCcc---ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 519 ELGKGAFGVVYKGAIGMAS---MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~---~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.||+|+||.||+|+..+.. ...+.+++|.+.... .....+|.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6899999999999876422 223468999886533 244667899999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCC-------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-----CEEEeecCcc
Q 047263 595 SNGTLASFLFGD-------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-----NARISDFGLA 662 (804)
Q Consensus 595 ~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-----~~kl~Dfgla 662 (804)
++++|.+++... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.+. .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999642 346788999999999999999995 4899999999999999877 8999999999
Q ss_pred cccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcc
Q 047263 663 KLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGIT 740 (804)
Q Consensus 663 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (804)
+....... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+........ . ... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--~-~~~----~~~~- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--L-QHV----TAGG- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--H-HHH----hcCC-
Confidence 76533221 11222345678999999999999999999999999999998 8988864432211 1 100 0110
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.. .........+.+++.+||+.+|++||++.+|+++|++
T Consensus 231 -~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -RL-------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -cc-------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0111234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.44 Aligned_cols=258 Identities=28% Similarity=0.388 Sum_probs=202.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccc-cceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASM-YQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
...+.+.||+|+||.||+|.....+. ....+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 34567889999999999998764332 244689998875432 345678999999999999999999999987 788999
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+||+++|+|.+++... ..+++.....++.||++||+|||+ .+++|+||||+||++++++.+||+|||+++.+....
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999764 468999999999999999999996 499999999999999999999999999998764322
Q ss_pred CCcc-ccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 670 SQTH-TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 670 ~~~~-~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.... ....++..|+|||.+....++.++||||||++++|+++ |+.|++........ .. ...+.. ...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~~--~~~-- 232 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---DL----LEKGER--LPQ-- 232 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH----HhCCCC--CCC--
Confidence 2111 11223567999999988899999999999999999998 99998765432211 11 111100 000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+......+.+++..|+..+|.+||++.++++.|+.+..
T Consensus 233 -----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 -----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122457789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.76 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=193.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|.....+. .||+|++..... .....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTEN---LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCC---eEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 3456789999999999998765433 799999874332 234467889999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++ +|.+++... ..+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 9986 777777554 4578889999999999999999955 99999999999999999999999999997543222 1
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HHhhhcCcccc
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YDCYCEGITEA 742 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~~~ 742 (804)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... +...... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 237 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN--DE 237 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch--hh
Confidence 2223457889999998865 46889999999999999999999999765433221111000 0000000 00
Q ss_pred eecchhhhc-------ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEAL-------NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+...... ........+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 00112346788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=296.68 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=198.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||+|+||.||+|+....+. .+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGA---LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCc---eEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 35577899999999999998865443 799999887656667789999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++++|..++.. ...+++..+..++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 9999999988754 45689999999999999999999954 9999999999999999999999999998754221 12
Q ss_pred ccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 672 THTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
......++..|+|||++. ...++.++||||||+++|||++|+.|+........ ... .........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~-----~~~~~~~~~--- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK-----IAKSEPPTL--- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHH-----HhcCCCccC---
Confidence 223345788999999984 34578899999999999999999999865432211 101 001100000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+||+.+|++||++++|++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011123346788999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.56 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=197.0
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---------ccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
+.+.||+|++|.||+|.....+ ..+|+|.+..... +..+.+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSG---ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccceeecCCCeEEEEEEecCCC---cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4568999999999999876443 3799998864322 123568899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.++++||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999998878889999999999999999999954 99999999999999999999999999998764
Q ss_pred cCCC-----CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 667 LDQS-----QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 667 ~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. . .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~-----~-~~~~~~~ 230 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IF-----K-IGENASP 230 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HH-----H-HhccCCC
Confidence 2211 111234578899999999988999999999999999999999999975432211 00 0 0011000
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+||+.+|.+||++.+|++
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 ---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011123457788999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=293.28 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=199.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.+.||.|++|.||+|+....+ ..+++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCC---eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 356688999999999999986543 379999986543 3445678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++... .+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...... ..
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 99999999999765 789999999999999999999954 89999999999999999999999999998764332 22
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+.......... .........+..
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-------~~~~~~~~~~~~------- 220 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-------LIPKNNPPSLEG------- 220 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-------HhhhcCCCCCcc-------
Confidence 233457889999999998889999999999999999999999987543221100 001111111110
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+.+++.+|++.+|++||+++++++
T Consensus 221 -~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 -NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 013446788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=292.90 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=196.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC------ce
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------NR 587 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 587 (804)
+.+.||+|+||.||+|........++.+|||++.... ....+++.+|+.+++.++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 5678999999999999987655556689999987532 334567899999999999999999999886542 23
Q ss_pred EEEEeecCCCcHHHhhcCC------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 588 LLVYEFLSNGTLASFLFGD------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
++++||+++|+|.+++... ..+++....+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 7899999999999887422 2467888999999999999999954 999999999999999999999999999
Q ss_pred ccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 662 AKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 662 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
++....... .......++..|++||.+....++.++||||||+++|||++ |+.|+........ ..... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~----~~~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLI----KGN 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHH----cCC
Confidence 986543221 11222335678999999998899999999999999999999 7788764432211 11110 110
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
. +. ........+.+++.+|++.+|++||++.++++.|+++
T Consensus 233 ~--~~-------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R--LK-------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c--CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 0112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=297.90 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=198.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
+.++||.|++|.||+|.....+ ..|++|.+........+.+.+|+.+++.++|+||+++++++.++...++|+||++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATG---QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCC---cEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 4567999999999999875443 3799999876555556788999999999999999999999999999999999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccc
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (804)
+++|.+++.. ..+++.++..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 100 ~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 174 (296)
T cd06655 100 GGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (296)
T ss_pred CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCC
Confidence 9999998864 4689999999999999999999955 999999999999999999999999999876543222 1233
Q ss_pred ccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHH
Q 047263 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKK 755 (804)
Q Consensus 676 ~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (804)
..++..|+|||.+.+..++.++||||||+++|||++|+.||........... . . ......+. ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~---~-~~~~~~~~-------~~~~ 240 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---I---A-TNGTPELQ-------NPEK 240 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H---H-hcCCcccC-------Cccc
Confidence 4578899999999988899999999999999999999999976544322111 0 0 00000000 1112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 756 KLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 756 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+.+++.+||+.+|++||++.+|++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2346778999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=310.99 Aligned_cols=262 Identities=20% Similarity=0.210 Sum_probs=197.2
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.+.||+|+||.||++...+. .....|++|.+... +.+.+|++++++++|+||+++++++......++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~-~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCC-ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3456678999999999999976433 23557999988643 23568999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
|++. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++........
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9986 68888887778899999999999999999999955 999999999999999999999999999976543322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-HHHHHHHHHHhhhcCccc--------
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-EALLTDWAYDCYCEGITE-------- 741 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~-------- 741 (804)
.......||..|+|||++....++.++|||||||++|||++|+.||....... ...+.. +.........+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccchh
Confidence 22234568999999999999999999999999999999999999986543211 111111 00000000000
Q ss_pred ---c---ee---cc--hhhh-cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 742 ---A---LV---EF--DIEA-LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 742 ---~---~~---~~--~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
. .. .. .... .........+.+++.+|++.||++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00 00 0000 0001123467788999999999999999999865
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.13 Aligned_cols=262 Identities=24% Similarity=0.275 Sum_probs=197.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||.||++.....+. .+|+|++..... ...+.+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQ---IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCC---EEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 456789999999999999865433 799998864322 234578899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|..+......+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 999999999887777789999999999999999999954 99999999999999999999999999998654332 22
Q ss_pred cccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc---------ccc
Q 047263 673 HTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI---------TEA 742 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~~~ 742 (804)
.....++..|+|||++.+ ..++.++||||||++++||++|+.|+..........-.......+.+.. ...
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 333457889999998865 4578899999999999999999988865433211000000000000000 000
Q ss_pred eecchhhh-----cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEA-----LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........ .........+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.43 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=198.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|++|.||+++....+ ..||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATG---QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCC---CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 445678999999999999875443 37999999765555566789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 999999999854 4578889999999999999999955 999999999999999999999999999876533221 22
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||........... ....+ .......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~--------~~~~~~~ 238 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPELQNP 238 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC--------CCCCCCc
Confidence 334578899999999998899999999999999999999999965432211000 00000 0000011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+.+++.+|++.+|++||++.+|++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 223356778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=291.86 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=197.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc----------ccccHHHHHHHHHHhcc-cccCCccceeeEEeC
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV----------IQDGVKEFKTEVNVIGQ-THHKNLVRLLGFCDD 583 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~----------~~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~ 583 (804)
.+.+.||+|+||.||+|....+. +..+|+|.+... ......++..|+.++.+ ++|+||+++++++.+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~--~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNG--QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCC--CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 45678999999999999987622 237999987532 12234567788888865 799999999999999
Q ss_pred CCceEEEEeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeec
Q 047263 584 GLNRLLVYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Df 659 (804)
+...+++|||+++++|.+++.. ...+++..+++++.|++.||.|||+. .+++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988742 35678889999999999999999952 47999999999999999999999999
Q ss_pred CcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 660 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .. ..+..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---~~----~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---TK----IVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---HH----Hhhcc
Confidence 9998654332 334456888999999999888999999999999999999999998654322111 00 00111
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
.. + .........+.+++.+|++.||++||++.||..+|+
T Consensus 230 ~~----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YE----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CC----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 10 0 001122356788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=291.45 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=186.6
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
+||+|+||.||+|....+.. ...+++|.+.... .+..+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTG-VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCC-cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 69999999999998654432 3356777776433 334568999999999999999999999999999999999999999
Q ss_pred cHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-CCc
Q 047263 598 TLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-SQT 672 (804)
Q Consensus 598 sL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~~ 672 (804)
+|.+++... ....+.....++.||++||.|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999753 2345667789999999999999954 89999999999999999999999999986422111 112
Q ss_pred cccccCCCcccccccccc-------CCCCccchhhHHHHHHHHHHcC-CCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 673 HTAIRGTKGYVAPEWFRN-------MPITVKVDVYSFGVLLLEIICC-RRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~-------~~~s~~~DV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....... .+.. ...+. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~----~~~~~-~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNH----VIKDQ-QVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHhhc-ccccC
Confidence 233457889999998753 2457899999999999999975 55665432211 1111 11111 11112
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
++.... .....+.+++..|+ .+|++||++++|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 221111 12346677888899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=289.65 Aligned_cols=251 Identities=31% Similarity=0.490 Sum_probs=200.5
Q ss_pred hHHhhCCCcceeEEEeeecCcc-ccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.||+|+||.||+++..... .....+|+|.+...... ..+.+..|++++..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999987543 22357999999765433 567899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCC--CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGDLK--PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999976544 89999999999999999999954 9999999999999999999999999999876543222
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||.+.+..++.++||||+|++++||++ |..|+......... ... ......
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~----~~~~~~--------- 223 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL---EYL----KKGYRL--------- 223 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----hcCCCC---------
Confidence 2212336789999999988889999999999999999998 77777643222111 111 111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
........++.+++.+|++.+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111345788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.54 Aligned_cols=246 Identities=27% Similarity=0.299 Sum_probs=194.2
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
..+.||+|+||.||++.....+ +.+|+|++..... +..+.+..|+.++++++|+|++++++.+.+++..++|||
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCC---ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4567999999999999887544 3799999864321 223457889999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 99999999998643 457889999999999999999995 499999999999999999999999999987543221
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ....... .....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-----~~~~~-------- 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-----KEVQE-------- 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-----hhhhh--------
Confidence 22234689999999999999999999999999999999999999975432111 1110000 00000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
.........+.+++..||+.||++||| ++|+++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 -EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011122345778999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=297.70 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=198.1
Q ss_pred hHHhhCCCcceeEEEeeecCccc-cceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASM-YQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.||+|+||.||+|+....+. ....+|+|.+..... ....++.+|+.+++.++|+||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 45689999999999998754332 234689998875432 2344789999999999999999999998754 56799999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC-
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ- 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 671 (804)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.+......
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 9999999998764 4678999999999999999999954 9999999999999999999999999999865432221
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......... ... ..+. ....
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~--~~~~----- 232 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLL----EKGE--RLPQ----- 232 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HCCC--CCCC-----
Confidence 1122335678999999999999999999999999999997 88888654322211 111 0110 0000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.......+.+++..|+..+|++||++.++++.|+.+.+.
T Consensus 233 --~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 --PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011234677899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=296.18 Aligned_cols=264 Identities=24% Similarity=0.271 Sum_probs=202.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|++|.||+|....++. .|++|++.... ....+.+.+|++++++++|+||+++++++.+++..++|+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGE---IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCc---EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 3456789999999999999875543 79999986432 334567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||++++.+..++.....+++..+..++.+|+.||.|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9999988888777667789999999999999999999965 9999999999999999999999999999876544332
Q ss_pred ccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh--------hh-cCccc
Q 047263 672 THTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC--------YC-EGITE 741 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~-~~~~~ 741 (804)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+.................. +. +....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 33445678899999999887 8899999999999999999999998754332211110000000 00 00000
Q ss_pred --ceecc----hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 --ALVEF----DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 --~~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
++... ............++.+++.+||+.+|++||++++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0001111122577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=300.24 Aligned_cols=260 Identities=17% Similarity=0.171 Sum_probs=192.1
Q ss_pred hHHhhCCC--cceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 516 FKEELGKG--AFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 516 f~~~LG~G--~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.++||+| +|++||++....+++ .||+|++.... ....+.+++|+++++.++||||+++++++..++..++|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGE---YVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCc---EEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 56789999 788999998875544 79999987532 233456788999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999999653 4588999999999999999999954 99999999999999999999999998654432111
Q ss_pred CC------ccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhh-----
Q 047263 670 SQ------THTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC----- 736 (804)
Q Consensus 670 ~~------~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~----- 736 (804)
.. ......++..|+|||++.+ ..++.++|||||||+++||++|+.||........ .. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LL-EKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HH-HHhcCCccccccc
Confidence 10 0112345678999999875 4689999999999999999999999975432211 00 00000000
Q ss_pred -----cC---------cccceecch------------hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 737 -----EG---------ITEALVEFD------------IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 737 -----~~---------~~~~~~~~~------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+. ......+.. ............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000000000 000011123457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=294.10 Aligned_cols=247 Identities=25% Similarity=0.270 Sum_probs=193.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
..+.||+|+||+||++...... ..+|+|.+.... ......+.+|+++++.++|+||+++.+.+..++..++|||
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATG---KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCC---cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3467999999999999886543 379999986432 1223457889999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--
Confidence 99999999888643 468999999999999999999995 49999999999999999999999999998754321
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......|+..|+|||.+.+..++.++|+||||+++|||++|..||........... ..........
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~~---------- 222 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETEE---------- 222 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhcccc----------
Confidence 122334689999999999988999999999999999999999999976543221111 0000001000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
.........+.+++..|++.||++||+ +.+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011122345678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.94 Aligned_cols=251 Identities=19% Similarity=0.189 Sum_probs=192.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||+++....+. .+|+|.+.... ....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTER---IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCC---EEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 456789999999999998875443 79999986421 223455889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999976 4678899999999999999999995 4999999999999999999999999999986644333
Q ss_pred CccccccCCCcccccccccc-----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 671 QTHTAIRGTKGYVAPEWFRN-----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~-----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
.......|+..|+|||++.. ..++.++||||||+++|||++|+.||.......... ....... .+ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~--~~-~ 228 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEE--RF-Q 228 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCC--cc-c
Confidence 33334568999999999875 467889999999999999999999997543321110 0000000 00 0
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSL--RPTMRKVTQ 783 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~ 783 (804)
... .......++.+++.+|+..++++ |++++++++
T Consensus 229 --~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 --FPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred --CCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 000 00112456777888888765544 567888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.04 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=198.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+...++||+|+||.||+|+..... ..+|+|.+.... ....+.+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCC---EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 445678999999999999876543 379999886432 3445678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 9999999999864 4678888999999999999999954 999999999999999999999999999976543221 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+........... ...... ...
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~~~---------~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------IPKNNP---------PTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------hhcCCC---------CCC
Confidence 2234578889999999988899999999999999999999999875433211100 000000 111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22345678899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.93 Aligned_cols=252 Identities=20% Similarity=0.188 Sum_probs=190.9
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||+++....+. .+|+|.+... .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQ---VYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCC---EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 456789999999999999875443 7999998642 1233456889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999975 45788999999999999999999954 999999999999999999999999999876543333
Q ss_pred CccccccCCCcccccccccc-----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 671 QTHTAIRGTKGYVAPEWFRN-----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~-----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ..........+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~~~~~ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKEHFQFPP 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCCCcccCCC
Confidence 23333568999999999863 457889999999999999999999997543221100 0000000000000
Q ss_pred chhhhcccHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQ--EDPSLRPTMRKVTQM 784 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~--~dP~~RPsm~eVl~~ 784 (804)
. .......+.+++.+|+. .++..||++.++++-
T Consensus 232 -----~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 -----D-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----c-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 01123455666666554 444558899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=295.64 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=196.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
..||+|+||.||++...... ..+|||++........+.+.+|+..++.++|+||+++++.+..++..++||||++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTG---KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hcccCCCCeEEEEEEECCCC---CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 56999999999999876443 379999987655555677899999999999999999999999999999999999999
Q ss_pred cHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccccc
Q 047263 598 TLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677 (804)
Q Consensus 598 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 677 (804)
+|.+++.. ..+++.....++.||+.||.|||+. +|+||||||+||++++++.++|+|||++....... .......
T Consensus 105 ~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~ 179 (292)
T cd06658 105 ALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLV 179 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceee
Confidence 99998854 4688999999999999999999954 99999999999999999999999999987643322 2223355
Q ss_pred CCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHH
Q 047263 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKL 757 (804)
Q Consensus 678 gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 757 (804)
++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ........+ .. .....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~-----~~--~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------IRDNLPPRV-----KD--SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcCCCcc-----cc--ccccC
Confidence 78899999999888899999999999999999999999875433221100 001111100 00 11233
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 758 ARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 758 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
..+..++..|++.+|.+|||++++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 467788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.82 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=199.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||++...... ..+|+|.+........+.|..|++++++++|+||+++++.+.++...++||||
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETG---LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCC---cEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 566789999999999999886543 37999998765555667899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++... ..+++.....++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QK 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc-cc
Confidence 9999999998764 5689999999999999999999965 99999999999999999999999999987643222 22
Q ss_pred cccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 673 HTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ +.. ........+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~-----~~~~~~~~~~--- 229 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLK-----ILKSEPPTLD--- 229 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHH-----HhcCCCCCcC---
Confidence 23345788999999874 34577899999999999999999999875433211 111 0011100000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
........+.+++..||+.+|++||++.+|++-
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 ----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011223467789999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=294.33 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=197.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||+|+....+ ..+|+|++.... ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETG---QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCC---cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 45678999999999999986543 379999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|..++.....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 999999999887777899999999999999999999964 999999999999999999999999999987543221 2
Q ss_pred cccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh--------hhc-Ccccc
Q 047263 673 HTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC--------YCE-GITEA 742 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~-~~~~~ 742 (804)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||.................. +.. .....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223456788999999875 56789999999999999999999999755432211110000000 000 00000
Q ss_pred eecchhhhccc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEALND-----KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+....... ......+.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000001 112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=289.44 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=197.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.++||+|+||.||+++....+ ..+++|.+... .....+.+.+|+.+++.++|+||+++++.+.++...+++|||
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSD---QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCC---ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 35678999999999999876543 37999988643 234456788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
+++++|.+++.. ...++......++.||+.||.|||+. +++|+||||+||++++++.++++|||++...... ..
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~ 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc-cc
Confidence 999999998864 34578889999999999999999955 9999999999999999999999999999765332 22
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......++..|+|||++.+..++.++||||||+++++|++|+.||.......... . ...+....+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~~-------- 220 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------K-VCQGSYKPL-------- 220 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------H-HhcCCCCCC--------
Confidence 2233567889999999998899999999999999999999999997543321100 0 111111100
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......+.+++.+||+.+|++||++.+|+..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=298.80 Aligned_cols=196 Identities=20% Similarity=0.329 Sum_probs=158.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC--CCceEEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~Ey~ 594 (804)
.++||+|+||.||+|+..+.. ..+.+|+|.+... .....+.+|+.++++++||||+++++.+.+ +...++++||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~-~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCC-CCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 358999999999999876432 2457999998753 223457889999999999999999998854 45678999998
Q ss_pred CCCcHHHhhcCC---------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE----cCCCCEEEeecCc
Q 047263 595 SNGTLASFLFGD---------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGL 661 (804)
Q Consensus 595 ~~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfgl 661 (804)
.+ +|.+++... ..+++.....++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 777776421 2477888999999999999999955 99999999999999 4567899999999
Q ss_pred ccccccCCC--CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcc
Q 047263 662 AKLLLLDQS--QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDME 719 (804)
Q Consensus 662 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~ 719 (804)
++.+..... .......+|..|+|||++.+ ..++.++||||+||+++||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 987543221 12234568999999999876 45899999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.46 Aligned_cols=245 Identities=27% Similarity=0.332 Sum_probs=197.0
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-----cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-----QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
..+.||+|++|.||+|.....+. .+++|.+.... .+..+.+.+|+.+++.++|+||+++++++.++...+++
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGD---FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCc---EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 45679999999999999864433 79999886432 23456799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+||+++++|.+++.....+++..+..++.||++||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999998777789999999999999999999955 99999999999999999999999999988653322
Q ss_pred CccccccCCCccccccccccCC-CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~-~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......++..|++||.+.... ++.++|+||||+++++|++|+.||........ ..... .......
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~----~~~~~~~------- 222 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIG----RSKELPP------- 222 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHH----hcccCCC-------
Confidence 223455788999999987766 89999999999999999999999865432111 10000 0000000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+|++.+|++||++.++++
T Consensus 223 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 --IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01122356778999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=302.80 Aligned_cols=252 Identities=20% Similarity=0.199 Sum_probs=191.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||+++....+. .+|+|.+.... ....+.|.+|+.++..++|+||+++++++.+....++||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADK---VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCC---EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 456789999999999999875543 79999986421 223445889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++|+|.+++.. ...+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999976 4678899999999999999999995 4999999999999999999999999999976543333
Q ss_pred CccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 671 QTHTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
.......||..|+|||++. ...++.++|||||||++|||++|+.||.......... . ...... ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~-i~~~~~-~~~- 228 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------K-IMNHKE-RFQ- 228 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------H-HhCCCc-ccc-
Confidence 3333456899999999986 3467899999999999999999999997553322110 0 001100 000
Q ss_pred chhhhcccHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQE--DPSLRPTMRKVTQM 784 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPsm~eVl~~ 784 (804)
... ........+.+++.+|+.. ++..||++.++++.
T Consensus 229 --~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --FPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --CCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 0011234566677776654 44447899988755
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.41 Aligned_cols=241 Identities=26% Similarity=0.282 Sum_probs=186.7
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc---ccCCccceeeEEeCCCceEEEEee
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT---HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
||+|+||.||+++....+. .||+|++.... ......+..|..++.+. +||||++++..+.+....++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRR---IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCC---EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999998865443 79999986432 12233455666666655 699999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|.+++.....+++.....++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTT 153 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCc
Confidence 99999999998888899999999999999999999955 9999999999999999999999999998753222 2223
Q ss_pred ccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 674 TAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
....||..|+|||.+.+. .++.++|||||||++|||++|+.||........ . .....+.. .+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--~-----~~i~~~~~-~~-----~--- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--Y-----RNIAFGKV-RF-----P--- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--H-----HHHHcCCC-CC-----C---
Confidence 345689999999998754 478999999999999999999999976533211 1 00111100 00 0
Q ss_pred cHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRP----TMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RP----sm~eVl~ 783 (804)
.......+.+++.+||+.||.+|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 011234677899999999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.86 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=196.9
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
..+||+|+||.||++.....+ ..+|+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSG---RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCC---CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 347999999999999876443 37999998755445566788999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
++|..++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... ......
T Consensus 103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 999998754 5678999999999999999999954 99999999999999999999999999987553322 222335
Q ss_pred cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHH
Q 047263 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (804)
.++..|+|||++.+..++.++||||||++++||++|+.||.......... . .......... .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--~-----~~~~~~~~~~-------~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK--R-----LRDSPPPKLK-------NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-----HhccCCCCcc-------ccCCC
Confidence 68899999999998899999999999999999999999987543322110 0 0011000000 01112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 757 LARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
...+.+++.+|++.+|++||++++|++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3457789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.18 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=195.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc------cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI------QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
..+.||+|+||.||+|....+ ..+|+|.+.... .+..+.+.+|++++++++|+||+++++++.+....++
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQG----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred ccceEeccCCeEEEEEEEcCC----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 356799999999999986433 369999886432 1223568899999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
++||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999998777889999999999999999999955 89999999999999999999999999987643211
Q ss_pred -----CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 670 -----SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 670 -----~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
........++..|+|||.+.+..++.++||||||++++||++|..||............. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~-- 229 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-----AHRGLMPR-- 229 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-----hccCCCCC--
Confidence 111223457889999999999889999999999999999999999997543222111000 00011111
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+|++.+|++||++.++++
T Consensus 230 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 -------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11123456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.06 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=196.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC-CCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~ 591 (804)
.+.+.||+|++|.||+++...++. .+++|++.... ....+.+.+|++++++++|+|++++++.+.. +...+++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGK---QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCc---EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 456789999999999999865543 79999986432 3345678999999999999999999998764 44578999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++++|.+++... ..+++.++..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999753 4578999999999999999999955 99999999999999999999999999998664322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ... ...+...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~-~~~~~~~-------- 220 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYR-IIEGKLP-------- 220 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHhcCCC--------
Confidence 223345678899999999999999999999999999999999999875432211 001 1111110
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.........+.+++.+|++.+|++||++.++++.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0112234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.56 Aligned_cols=250 Identities=27% Similarity=0.315 Sum_probs=208.3
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccc-cCCccceeeEEeCCCce
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 587 (804)
..+.+.++||+|.||.||+++.+.++. .+|+|.+.+... .....+.+|+.+|+++. |||||.+.+.+++....
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~---~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGK---EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCc---eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345667899999999999999886543 799999975433 23468999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC----CCCEEEeecCccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD----YYNARISDFGLAK 663 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~----~~~~kl~Dfgla~ 663 (804)
++|||++.+|.|.+.+... .+++.....++.||+.++.|||+ .+|+||||||+|+|+.. ++.+|++|||++.
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999766 48899999999999999999995 59999999999999953 3579999999999
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
.... .......+||+.|+|||++....++..+||||.|+++|.|++|..||........... ...+..
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~~--- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGDF--- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCCC---
Confidence 8654 5556678899999999999999999999999999999999999999987765443221 111111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......-....+.+.+++..++..||.+|+|+.++++
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1122222334667888999999999999999999998
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.05 Aligned_cols=260 Identities=23% Similarity=0.268 Sum_probs=192.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||+|+....+ ..||+|++.... ....+.+.+|+.++++++|+||+++++++.++...++|+|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTG---QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred eEeeEecccCceEEEEEEECCCC---cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 34578999999999999976443 379999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC---CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|++ ++|.+++... ..+++..+..++.||++||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 6888887542 5678999999999999999999954 99999999999999999999999999997653221
Q ss_pred CCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc-------
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE------- 741 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 741 (804)
.......++..|+|||.+.+. .++.++||||||++++||++|+.|+..........-.........+....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 222334568899999988654 57899999999999999999999997654322110000000000000000
Q ss_pred ------ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ------ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......... .......++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 00112456778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.62 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=198.3
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.||+|+||.||+|....++. .+++|.+..... ...+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGE---LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCc---EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 45789999999999998765433 799999875443 3567899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|.+++.....+++..+..++.++++||.|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999998877789999999999999999999954 999999999999999999999999999987644332221
Q ss_pred c---cccCCCccccccccccCC---CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 674 T---AIRGTKGYVAPEWFRNMP---ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 674 ~---~~~gt~~y~aPE~l~~~~---~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
. ...++..|+|||++.... ++.++||||||++++||++|+.||.......... ... .......+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~-----~~~-~~~~~~~~---- 227 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM-----FHV-GAGHKPPI---- 227 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH-----HHH-hcCCCCCC----
Confidence 1 345788999999998766 8899999999999999999999996543211110 000 00100000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. ........+.+++.+|++.+|++||++.+++.
T Consensus 228 -~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 -P--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -C--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 01112455678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.21 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=199.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||+|++|.||++.....+. .+++|++.... ....+++.+|++++++++|+||+++++.+..+...++++||
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGK---IMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCc---EEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 467899999999999999875433 79999887543 34456789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++... ..++.....+++.|++.||.|||+ ..+++|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 9999999999765 778889999999999999999995 159999999999999999999999999998765322211
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
...++..|+|||.+.+..++.++||||||+++++|++|+.|+........... ..... ....... ...
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~~--------~~~ 225 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQY-IVNEPPP--------RLP 225 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH-HHHHH-HhcCCCC--------CCC
Confidence 15678899999999999999999999999999999999999865432111111 11100 0111000 001
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++..|++.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1114456889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.83 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=194.9
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc----------ccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ----------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~----------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
.+.||+|+||.||+|+....+ ..+|+|++..... ...+.+..|+.+++.++|+|++++++++...+.
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTG---EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred cceecccCceEEEEEeecCCC---ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 467999999999999876443 3799998753211 113467889999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.++|+||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||+++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998878889999999999999999999964 99999999999999999999999999997653
Q ss_pred cCCCC-ccccccCCCccccccccccCC--CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 667 LDQSQ-THTAIRGTKGYVAPEWFRNMP--ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 667 ~~~~~-~~~~~~gt~~y~aPE~l~~~~--~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
..... ......++..|+|||.+.... ++.++||||||++++||++|..|+........ + ..........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~-- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--M----FKLGNKRSAP-- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--H----HHhhccccCC--
Confidence 32211 123345788999999987654 88999999999999999999999864322211 0 0000010000
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.............+.+++..|++.+|++||++.+|++
T Consensus 232 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 ---PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ---cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0011111223467888999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=312.12 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=184.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCC--------C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--------L 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--------~ 585 (804)
+.+.++||+|+||.||+|+....+. .||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~---~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSE---KVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCC---EEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4456789999999999999865443 79999886431 2345799999999999999999876322 2
Q ss_pred ceEEEEeecCCCcHHHhhc----CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecC
Q 047263 586 NRLLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFG 660 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfg 660 (804)
..++||||+++ +|.+++. ....+++.....++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999985 6666553 346788999999999999999999954 999999999999999654 69999999
Q ss_pred cccccccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH-HHHHH----HHh
Q 047263 661 LAKLLLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTDWA----YDC 734 (804)
Q Consensus 661 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~~~----~~~ 734 (804)
+++.+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.......... ..... ...
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 998654322 2234567899999998865 468999999999999999999999997654322110 00000 000
Q ss_pred h-------hcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 735 Y-------CEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 735 ~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
+ .+-....+....+....+.....++.+++.+||+.||.+|||+.|++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 00000000011111111112345788999999999999999999987
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=303.18 Aligned_cols=189 Identities=24% Similarity=0.324 Sum_probs=159.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.+.||+|+||.||+|+...... .||+|..... ....|+.++++++|+||+++++++.+....++|+|
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPD---PVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCc---eEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34566789999999999999865433 7899975432 23568999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+. ++|.+++.. ...+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--AP 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc--Cc
Confidence 995 577777754 46789999999999999999999955 999999999999999999999999999975322 12
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCC
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223456899999999999999999999999999999999876654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.22 Aligned_cols=248 Identities=23% Similarity=0.281 Sum_probs=199.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||.++..... ..+++|++... .....+++.+|++++++++|+||+++++++.+....+++||
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDD---SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCC---cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 45678999999999998876443 37999987643 24456678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999999764 4678999999999999999999954 899999999999999999999999999986543332
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .... .+....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~-~~~~~~-------- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKIV-QGNYTP-------- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-cCCCCC--------
Confidence 233456789999999998888999999999999999999999998754332211 0100 111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
........+.+++.+|++.+|++||++.++++.+
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0112345678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=315.73 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=187.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc------cCCccceeeEEeCC-Cc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH------HKNLVRLLGFCDDG-LN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~------h~niv~l~g~~~~~-~~ 586 (804)
+.+.++||+|+||.||++.....+ ..||||+++... ...+++..|+.++.+++ |.+++++++++..+ .+
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRK---EYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCC---eEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 455678999999999999876543 379999986432 23344566666666664 45688999988654 56
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC--------------
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-------------- 652 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-------------- 652 (804)
.++|||++ +++|.+++.....+++..+..|+.||+.||.|||.+ .+|+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 78999987 678999988878899999999999999999999952 4899999999999998765
Q ss_pred --CEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH
Q 047263 653 --NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW 730 (804)
Q Consensus 653 --~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 730 (804)
.+||+|||.+... ........||..|+|||++.+..++.++|||||||++|||++|+.||+.........+...
T Consensus 284 ~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 284 PCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CceEEECCCCccccC----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4999999987542 2223456789999999999999999999999999999999999999976543322111110
Q ss_pred H---------HH--------hhhc-Ccccceecch-h------hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 731 A---------YD--------CYCE-GITEALVEFD-I------EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 731 ~---------~~--------~~~~-~~~~~~~~~~-~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. .. .+.. +......+.. . ...........+.+|+.+||+.||.+|||++|+++
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0 00 0000 0000000000 0 00000112346779999999999999999999986
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=308.44 Aligned_cols=200 Identities=26% Similarity=0.316 Sum_probs=172.3
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.||+|+||.||++.....+. .+|+|++.... ....+.+.+|+.++.+++|+||+++++.+.++...++|||
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGH---IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCC---EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 45789999999999999875443 79999986422 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC--
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS-- 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-- 670 (804)
|+++|+|.+++.....+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999999999888889999999999999999999995 4999999999999999999999999999875422110
Q ss_pred --------------------------------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCc
Q 047263 671 --------------------------------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM 718 (804)
Q Consensus 671 --------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~ 718 (804)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001234689999999999999999999999999999999999999976
Q ss_pred chh
Q 047263 719 EVN 721 (804)
Q Consensus 719 ~~~ 721 (804)
...
T Consensus 239 ~~~ 241 (360)
T cd05627 239 ETP 241 (360)
T ss_pred CCH
Confidence 544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.30 Aligned_cols=246 Identities=22% Similarity=0.264 Sum_probs=189.3
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-----cccHHHHHHHHHHhcccccCCccceeeEEeC--CCceE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-----QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRL 588 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 588 (804)
..+.||+|+||.||++.....+ ..+++|++.... .+..+.+.+|+.++++++|+||+++++++.+ +...+
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTG---RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCC---cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 4578999999999999876543 379999876322 1234568899999999999999999998865 35678
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+++||+++++|.+++.....+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 999999999999999877778999999999999999999995 49999999999999999999999999998765321
Q ss_pred C--CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 669 Q--SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 669 ~--~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
. ........++..|+|||.+.+..++.++||||||+++|||++|+.||......... ........ .+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~~-----~~ 228 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQPT-----NP 228 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCCC-----CC
Confidence 1 11122345788999999999888999999999999999999999998754222110 00000000 01
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. .+......+..++ +|+..+|++||+++||++
T Consensus 229 ~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 Q----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 1111223444454 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.39 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=195.6
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-----cHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-----GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
.+.+.||+|++|.||+|.....+ ..|++|++...... ....+..|++++++++|+||+++++++.++...++
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETG---RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCC---cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 34568999999999999976543 37999999754322 23457789999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
||||+ +++|.+++.... .+++..+..++.||++||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 99999 899999998765 789999999999999999999955 9999999999999999999999999999875432
Q ss_pred CCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC---------
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG--------- 738 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 738 (804)
. .......++..|+|||.+.+ ..++.++||||||++++||++|..++........ +.. ........
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 N-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGK-IFEALGTPTEENWPGVT 231 (298)
T ss_pred C-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHH-HHHHcCCCchhhhhhcc
Confidence 2 22223345778999998854 4678999999999999999999877765432211 000 00000000
Q ss_pred cccceecchhhh-----cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 739 ITEALVEFDIEA-----LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 739 ~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
............ .........+.+++.+|++.+|++|||+.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 0011234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=289.32 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=195.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+++.+.||+|+||.||++.....+ ..+|+|.+... .......+.+|+.++++++|+||+++++.+...+..++|+|
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTG---VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCC---cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 456789999999999999886443 37999988643 23345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC---CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|+++++|..++... ..+++..+..++.+++.||.|||+. .+++|+||||+||+++.++.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998763 3789999999999999999999952 48999999999999999999999999998765321
Q ss_pred CCccccccCCCccccccccccCC------CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMP------ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~------~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||........... . .....+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~-~~~~~~~~~-- 228 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---L-SAIVDGDPP-- 228 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---H-HHHhhcCCC--
Confidence 222345778999999986543 47899999999999999999999865422211100 0 000011100
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+|++.+|++||++.+++.
T Consensus 229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 -------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 011224566788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.61 Aligned_cols=189 Identities=26% Similarity=0.301 Sum_probs=161.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.+.||+|+||.||++...... +.||||... ...+.+|++++++++|+||+++++++..+...++|||++
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~---~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYP---QRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCC---CEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 34578999999999999987543 379999643 234578999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC-c
Q 047263 595 SNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-T 672 (804)
Q Consensus 595 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~-~ 672 (804)
. ++|.+++... ..+++.+++.|+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 5 6888887654 5689999999999999999999954 9999999999999999999999999999865432221 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCC
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
.....||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 23456899999999999999999999999999999999988654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.12 Aligned_cols=196 Identities=21% Similarity=0.333 Sum_probs=158.1
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEe--CCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD--DGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~Ey~~ 595 (804)
.+||+|+||.||+|+..++. ....+|+|++... .....+.+|++++++++||||+++++++. .+...++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCC-ccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 47999999999999976543 2457999998753 23346788999999999999999999884 3566789999987
Q ss_pred CCcHHHhhcC---------CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE----cCCCCEEEeecCcc
Q 047263 596 NGTLASFLFG---------DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLA 662 (804)
Q Consensus 596 ~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfgla 662 (804)
+ +|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 67666632 12467888999999999999999954 99999999999999 56778999999999
Q ss_pred cccccCCC--CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcch
Q 047263 663 KLLLLDQS--QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEV 720 (804)
Q Consensus 663 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~ 720 (804)
+....... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 87543222 12234567899999999876 458899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.18 Aligned_cols=260 Identities=23% Similarity=0.245 Sum_probs=191.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC------C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------L 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~ 585 (804)
+.+.+.||+|+||.||++...... ..||||++.... ....+.+.+|+.+++.++|+||+++++++... .
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCC---cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 445678999999999999876443 379999987532 23446788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++||||+++ +|...+. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 56999999975 6666664 3477888999999999999999954 9999999999999999999999999999864
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH-HHH---------------
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTD--------------- 729 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~--------------- 729 (804)
.. ........++..|+|||++.+..++.++|||||||++|||++|+.||.......... +..
T Consensus 177 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 32 222234568999999999999999999999999999999999999997554321100 000
Q ss_pred HHHHhhhcCcc------cceecchh---hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 730 WAYDCYCEGIT------EALVEFDI---EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 730 ~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......+... ..+..... ...........+.+++.+|++.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 00000000 000011123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=303.83 Aligned_cols=260 Identities=23% Similarity=0.254 Sum_probs=190.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC------C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------L 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~ 585 (804)
+.+.+.||+|+||.||++.....+ ..+|||++.... ....+.+.+|+.+++.++|+||+++++++... .
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCC---ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 344678999999999999875443 379999987532 23346788999999999999999999988543 3
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 46899999975 5666664 3478888999999999999999954 9999999999999999999999999999864
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH--HH--------------H
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL--LT--------------D 729 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~--l~--------------~ 729 (804)
.. ........+|..|+|||++.+..++.++||||||+++|||++|+.||.......... +. .
T Consensus 170 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 32 222334568999999999999999999999999999999999999997543221100 00 0
Q ss_pred HHHHhhhcCcc-cce------ecchh--hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 730 WAYDCYCEGIT-EAL------VEFDI--EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 730 ~~~~~~~~~~~-~~~------~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
........... ..+ .+... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 000 00000 000111224567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=303.89 Aligned_cols=260 Identities=24% Similarity=0.259 Sum_probs=190.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCC------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------ 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 585 (804)
+.+.+.||+|+||.||++.....+ ..+|+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLG---INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCC---ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 445678999999999999876443 37999998643 2234567889999999999999999999986443
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 46999999976 5655553 3477888899999999999999955 9999999999999999999999999999754
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH----------------HHH
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL----------------LTD 729 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~----------------l~~ 729 (804)
.. ........+|..|+|||.+.+..++.++||||||+++|||++|+.||.......... +..
T Consensus 174 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 22 222334568899999999999999999999999999999999999997553221100 000
Q ss_pred HHHHhhhcCc-c-----cceecch-h--hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 730 WAYDCYCEGI-T-----EALVEFD-I--EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 730 ~~~~~~~~~~-~-----~~~~~~~-~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......... . .++.... . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 0 0000000 0 000011123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.66 Aligned_cols=260 Identities=23% Similarity=0.260 Sum_probs=188.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhccc---ccCCccceeeEEeC-----C
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQT---HHKNLVRLLGFCDD-----G 584 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~-----~ 584 (804)
.+.++||+|+||.||++.....+. .+|+|.+..... .....+.+|+.+++.+ +|+||+++++++.. .
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGH---FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCc---EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 456789999999999999875543 799998864321 2233456677766655 69999999998854 3
Q ss_pred CceEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 585 LNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
...++++||+++ +|.+++... ..+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 457899999985 888888653 3478999999999999999999955 9999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHHH----Hhhhc
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWAY----DCYCE 737 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~----~~~~~ 737 (804)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||......... .+..... ..+..
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 865322 2223345788999999999889999999999999999999999998655332211 1100000 00000
Q ss_pred Cc--ccceecch-h--hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GI--TEALVEFD-I--EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~--~~~~~~~~-~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ........ . ...........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000 0 00001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.07 Aligned_cols=262 Identities=20% Similarity=0.246 Sum_probs=193.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|.....+ ..||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTD---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCC---cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 345678999999999999876543 379999986432 2334567889999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|++ ++|.+++.. ...+++.....++.||++||.|||+ .+++|+||||+||++++++.+||+|||++....... .
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 997 588888765 3567889999999999999999995 499999999999999999999999999997543222 1
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HHhhhc-Cccc
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YDCYCE-GITE 741 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~-~~~~ 741 (804)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... +..... ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 2223446889999998865 45788999999999999999999999765432211100000 000000 0000
Q ss_pred ceecchhhh----cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFDIEA----LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+.... .........+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 000112346788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=287.46 Aligned_cols=246 Identities=22% Similarity=0.255 Sum_probs=192.0
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-----cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-----QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRL 588 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 588 (804)
..+.||+|+||.||+|.....+ ..|++|++.... .+..+.+.+|+.++++++|+||+++++++.+. ...+
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTG---RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCC---cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 4578999999999999886544 379999875321 12345788999999999999999999988764 4577
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+++||+++++|.+++.....+++....+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999999998777788999999999999999999955 8999999999999999999999999999865322
Q ss_pred CC--CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 669 QS--QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 669 ~~--~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ... .....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~-------- 225 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFK----IATQP-------- 225 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHH----HhcCC--------
Confidence 11 112334578899999999888899999999999999999999999865422211 100 00000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+......+.+++.+|+. +|++||++++|++
T Consensus 226 -~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111123344567778888885 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=285.31 Aligned_cols=243 Identities=29% Similarity=0.433 Sum_probs=192.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||++... +..+|+|..... ...+.+.+|+.++++++|+|++++++++.++ ..+++|||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEYT-----GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred ceeeeeeccCCCCceEecccC-----CCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 456788999999999998743 235899998653 2346789999999999999999999998765 47999999
Q ss_pred cCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 9999999999754 3578999999999999999999954 9999999999999999999999999998754221
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......+..|+|||.+.+..++.++||||||++++||++ |+.||......... .. ...+... .
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~~~---~----- 217 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK---EC----VEKGYRM---E----- 217 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH---HH----HhCCCCC---C-----
Confidence 112233567999999998899999999999999999998 88888654332211 10 1111100 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
........+.+++.+|++.+|++||++.+|++.|++
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011234567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=287.58 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=196.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc------cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI------QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
..+.||+|++|.||++....++ ..+|+|.+.... .+..+.+..|+.++++++|+||+++++++.+.+..++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~---~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccceecCcCceEEEEEEEcCCC---cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 3467999999999999875443 379999886432 1235678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~~ 668 (804)
|+||+++++|.+++.....+++.....++.||+.||.|||+. +++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999998878889999999999999999999955 999999999999998776 5999999999766433
Q ss_pred CCC---ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 669 QSQ---THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 669 ~~~---~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
... ......++..|+|||.+.+..++.++||||+|+++++|++|+.|+........... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~------ 228 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATT------ 228 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccCC------
Confidence 211 12234578899999999888899999999999999999999999864332111111 000000000
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+......+.+++.+|++.+|++||++.++++
T Consensus 229 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112234467888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=288.36 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=197.4
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
-+.||+|++|.||++.....+ ..+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTG---RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred ceEeccCCCeEEEEEEECCCC---CEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 358999999999999876443 37999988755445566789999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........ .....
T Consensus 101 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 175 (285)
T cd06648 101 GALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSL 175 (285)
T ss_pred CCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccc
Confidence 999999976 5688999999999999999999955 999999999999999999999999998876533222 22334
Q ss_pred cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHH
Q 047263 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (804)
.|+..|+|||.+.+..++.++||||||++++||++|+.|+......... . ........... .....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~----~~~~~~~~~~~-------~~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---K----RIRDNLPPKLK-------NLHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---H----HHHhcCCCCCc-------ccccC
Confidence 5788999999998888999999999999999999999998654322110 0 01111111110 01113
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 757 LARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+.+++.+|++.+|++||++.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=294.29 Aligned_cols=248 Identities=23% Similarity=0.244 Sum_probs=196.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|++|.||++.....+ ..+|+|.+..... ...+.+..|+++++.++|+||+++++.+.++...++||
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTG---KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCC---cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 34568999999999999887543 3799999875432 24567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+.+++|.+++... ..+++..+..++.|+++||.|||. .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 567899999999999999999995 499999999999999999999999999987543211
Q ss_pred CC----------------------------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchh
Q 047263 670 SQ----------------------------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVN 721 (804)
Q Consensus 670 ~~----------------------------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~ 721 (804)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11123578899999999988899999999999999999999999975543
Q ss_pred HHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 047263 722 EAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPT----MRKVTQ 783 (804)
Q Consensus 722 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----m~eVl~ 783 (804)
... +.. .. .. .............+.+++.+|++.+|++||+ +++++.
T Consensus 238 ~~~--~~~----~~-~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET--FSN----IL-KK--------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH--HHH----Hh-cC--------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 221 100 00 00 0000011114567889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=278.30 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=206.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.++||+|+||.|||+..+..+ ..+|||++.- ....+++..|+.++++...+++|+++|.+......++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG---~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESG---HVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccC---cEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 346789999999999999987554 4899999875 45688999999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|..|++.+++.. ++.+.+.++..++...++||+|||.- .-+|||||..||||+.+|.+|++|||.+..+.. .-.+
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAK 185 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAK 185 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHh
Confidence 999999999975 57889999999999999999999965 779999999999999999999999999987643 2334
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
..+..||+-|||||+++.-.|+.++||||+|+...||.-|++|+....+-.. +.---..+...-..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------IFMIPT~PPPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------IFMIPTKPPPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------eEeccCCCCCCCCC
Confidence 5567899999999999999999999999999999999999999865432110 00000111112223
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+...+.++-+++..||-+.|++|-|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 4566788999999999999999999877654
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.00 Aligned_cols=253 Identities=19% Similarity=0.234 Sum_probs=198.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||++...... ..|++|.+.... ....+.+.+|+.+++.++|+||+++++.+..+...++||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCC---cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 34678999999999999886543 379999886542 233457889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC--
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-- 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-- 669 (804)
||+++++|.+++.....+++.....++.++++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999998878889999999999999999999954 99999999999999999999999999987421100
Q ss_pred ------------CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 670 ------------SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 670 ------------~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
........++..|+|||.+....++.++||||||+++|||++|..||....... .+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~~-----~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQ-----VIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHh
Confidence 001112356789999999988889999999999999999999999987543221 1110 000
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
+. ...+. ........+.+++.+|++.+|++||++.++.++|+.
T Consensus 231 ~~---~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DD---IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cc---cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 00000 001234567899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=284.82 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=197.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.+|+++...++. .+++|++... .....+++.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGK---QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCC---EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 456789999999999998865433 7999998642 23345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++... ..+++....+++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 99999999998654 3568889999999999999999954 99999999999999999999999999998653322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......++..|+|||++.+..++.++||||||++++||++|+.|+........ . .... .+...
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~----~~~~-~~~~~--------- 219 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--V----LKII-RGSYP--------- 219 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--H----HHHh-cCCCC---------
Confidence 112234578899999999988999999999999999999999999875433211 1 1101 11100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+|++.+|++||+|.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 011223456888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=284.98 Aligned_cols=252 Identities=28% Similarity=0.347 Sum_probs=203.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||+|++|.||+++....+ ..+++|++..... ...+++.+|+..+.+++|+||+++++++......++|+||
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~---~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTG---KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCC---cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 45678999999999999987543 3799999876543 4467899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|.+++.....++...+..++.|+++||.|||+. .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~ 157 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-C 157 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-c
Confidence 99999999998878899999999999999999999951 59999999999999999999999999999876433222 2
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+.... ...... ....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~--------~~~~ 225 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPPP--------SLPA 225 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCCC--------CCCc
Confidence 2445788999999999999999999999999999999999998765421111111111 011110 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
......+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1144678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=287.26 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=196.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccc---cCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+|.....+ ..+++|.+... .....+++.+|+.++++++ |+|++++++++.++...++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTG---RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCC---cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 345678999999999999986443 37999988643 2344567889999999986 9999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++++|.+++... .+++.....++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999998654 788999999999999999999955 99999999999999999999999999998764433
Q ss_pred CCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.|+........... .... ....+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~ 222 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------IPKS-----KPPRL 222 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------cccC-----CCCCC
Confidence 22334468889999998865 4578999999999999999999999975432211000 0000 00111
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
. .......+.+++.+|++.+|++||++.++++.
T Consensus 223 ~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 E---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred C---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 11134568889999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=278.56 Aligned_cols=266 Identities=24% Similarity=0.303 Sum_probs=209.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
++.+.||+|.-|+||.+.+.... ...|+|++.+.. .+.....+.|.+||+.+.||.++.|++.++.++..+|+|
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~---~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTN---CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCC---ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45789999999999999998654 379999997643 334456789999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC-
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD- 668 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~- 668 (804)
|||+||+|..+++++ +.++...+..++.+|+-||+||| ..|||+|||||+||||.++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999764 67889999999999999999999 569999999999999999999999999988543110
Q ss_pred -------------------------------C-C----------------------CccccccCCCccccccccccCCCC
Q 047263 669 -------------------------------Q-S----------------------QTHTAIRGTKGYVAPEWFRNMPIT 694 (804)
Q Consensus 669 -------------------------------~-~----------------------~~~~~~~gt~~y~aPE~l~~~~~s 694 (804)
. . ......+||-.|+|||++++...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 011124588999999999999999
Q ss_pred ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCC
Q 047263 695 VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSL 774 (804)
Q Consensus 695 ~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 774 (804)
.++|.|+|||++||||.|..||.+....+... .++...+.-......+..+.+||...|.+||++
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999998765543211 111112221222245667889999999999999
Q ss_pred CCC----HHHHHH--HhhcC----ccCCCCC-CCCCCc
Q 047263 775 RPT----MRKVTQ--MLEGV----VEVLDPP-CPCPFT 801 (804)
Q Consensus 775 RPs----m~eVl~--~Le~~----~~~~~pp-~P~~~~ 801 (804)
|-- +.||-+ .++++ +....|| .|.+..
T Consensus 379 Rlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d 416 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD 416 (459)
T ss_pred hhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence 998 777753 34443 3334454 376654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=285.93 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=197.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||+|....++ ..+++|++.... ....+.+.+|+.++++++|+||+++++++.++...++|+|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETG---ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCC---ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 45678999999999999986543 379999987543 2335678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+ +++|.+++.. ...+++.++..++.||++||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 9999999864 45689999999999999999999954 9999999999999999999999999999876543332
Q ss_pred ccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc-----------
Q 047263 672 THTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI----------- 739 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------- 739 (804)
......++..|+|||.+.+. .++.++||||+|++++||++|..++........ + ...........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ--L-AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH--H-HHHHHHcCCCChHHHhhccCcc
Confidence 33445688899999998654 468999999999999999999877754432211 0 00100000000
Q ss_pred -ccceecc-----hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 740 -TEALVEF-----DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 740 -~~~~~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
...+... .... ...+....+.+++.+|++.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0000 001223788899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=289.88 Aligned_cols=248 Identities=24% Similarity=0.291 Sum_probs=190.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEe-----CCCceE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCD-----DGLNRL 588 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~ 588 (804)
.+.+.||+|+||.||+++....+. .+|+|.+... .....++.+|+.++..+ +|+||+++++++. .+...+
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~---~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGS---KAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCc---eeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 446789999999999999865443 7999987643 22345688899999999 6999999999884 445689
Q ss_pred EEEeecCCCcHHHhhc----CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 589 LVYEFLSNGTLASFLF----GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
+||||+++++|.+++. ....+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999998875 235678889999999999999999954 999999999999999999999999999876
Q ss_pred cccCCCCccccccCCCcccccccccc-----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRN-----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
..... .......|+..|+|||++.. ..++.++||||||+++|||++|+.|+........ +.. .....
T Consensus 174 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~-----~~~~~ 245 (286)
T cd06638 174 LTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFK-----IPRNP 245 (286)
T ss_pred cccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hhh-----ccccC
Confidence 53322 12233458899999998853 4578899999999999999999999875432211 100 00000
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
...+.. .......+.+++.+|++.+|++||++.||++.
T Consensus 246 ~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000100 11123468889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=291.60 Aligned_cols=255 Identities=25% Similarity=0.271 Sum_probs=197.6
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
+..+...+.||+|+||.||+++...++. .+|+|++.... .+..+++..|++++++++|+|++++++++.++...
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNE---VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCc---EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 3445567789999999999999865443 79999986432 23345788999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 588 LLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
++||||+.+ +|.+++.. ...+++.++..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 999999975 77776643 56689999999999999999999955 99999999999999999999999999987542
Q ss_pred cCCCCccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
. .....++..|+|||++. ...++.++||||||+++|||++|+.|+........ +.... ..+.
T Consensus 177 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~----~~~~---- 241 (317)
T cd06635 177 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----QNES---- 241 (317)
T ss_pred C-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHH----hccC----
Confidence 2 22345788999999873 45788999999999999999999999865432211 10100 0110
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
...........+.+++.+|++.+|.+||++.+|++.+-.....+
T Consensus 242 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 242 -----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 00111123456788999999999999999999998665444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=288.23 Aligned_cols=258 Identities=22% Similarity=0.232 Sum_probs=196.8
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEEEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLLVY 591 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 591 (804)
+.++||+|++|.||+|+....+ ..+|+|++.... ....+.+.+|++++++++|+|++++++++.+. ...++|+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTG---ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCC---eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 4578999999999999987543 379999998653 33456788999999999999999999999888 8899999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++ +|.+++... ..+++..++.++.||++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99985 888888665 5789999999999999999999965 999999999999999999999999999987654433
Q ss_pred CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc---Ccccc----
Q 047263 671 QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE---GITEA---- 742 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~---- 742 (804)
.......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........... ....... .....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhccccccc
Confidence 23333456788999997764 4678999999999999999999999876543321110 1000000 00000
Q ss_pred ----------eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 ----------LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ----------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+.......+...+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000011111112567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=321.61 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=192.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeC--CCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 588 (804)
.+.+.++||+|+||.||+++..... ..+|+|.+... .......|..|+.++++++|||||++++++.+ ....+
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg---~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCC---eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4556788999999999999987544 37888988643 23345678999999999999999999998854 45689
Q ss_pred EEEeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhcc----CCCeeecCCCCCcEEEcC----------
Q 047263 589 LVYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEEC----STQIIHCDIKPQNILLDD---------- 650 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivH~dlkp~NILl~~---------- 650 (804)
|||||+++|+|.++|.. ...+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999999864 256899999999999999999999642 146999999999999964
Q ss_pred -------CCCEEEeecCcccccccCCCCccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchh
Q 047263 651 -------YYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVN 721 (804)
Q Consensus 651 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~ 721 (804)
...+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2348999999998653221 2234568999999999854 4588999999999999999999999975432
Q ss_pred HHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 722 EAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 722 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... .+ ....... ... .......+.+|+..||+.+|.+||++.+++.
T Consensus 249 ~~q-li-----~~lk~~p-----~lp-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQ-LI-----SELKRGP-----DLP-----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHH-HH-----HHHhcCC-----CCC-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 11 0011110 000 0112356788999999999999999999983
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=285.56 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=197.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.++||+|+||.||+|...... ..+|+|...... ....+.+.+|+..+.+++|+||+++++++.++...++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCC---cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 3456678999999999999875443 379999876432 234567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.. ..+++.....++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||++..+.... .
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence 99999999999864 4678999999999999999999954 99999999999999999999999999987653321 1
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......++..|+|||.+.+..++.++||||||++++||++|..|+........... ........
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~--------- 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-------IPKNNPPT--------- 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-------HhcCCCCC---------
Confidence 12234578899999999988899999999999999999999999865432211100 00110000
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
........+.+++.+|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111234567789999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=290.22 Aligned_cols=250 Identities=26% Similarity=0.318 Sum_probs=198.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.+.||+|+||.||++....+. ..+++|.+........+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATG---QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCC---CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3445678999999999999865443 3699999875444556778999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.. ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred cCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 9999999999864 3578899999999999999999955 999999999999999999999999998876533222 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
.....++..|+|||.+....++.++||||||+++||+++|+.||........... ....+ . .....
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~-~-------~~~~~ 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-T-------PELQN 237 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC-C-------CCCCC
Confidence 2334578899999999888899999999999999999999999975433211000 00000 0 00001
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11233567789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=291.97 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=194.9
Q ss_pred CHHHHHHHHhh--hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEE
Q 047263 505 TYKDLEAATNG--FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFC 581 (804)
Q Consensus 505 ~~~~l~~at~~--f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 581 (804)
++.++.+++.+ +.+.||+|+||.||++....++. .+|+|.+... .....++.+|+.++.++ +|+|++++++++
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~---~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGS---LAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCC---EEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 33444444443 45689999999999998865443 7999988653 22345678899999998 899999999998
Q ss_pred eCC-----CceEEEEeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC
Q 047263 582 DDG-----LNRLLVYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652 (804)
Q Consensus 582 ~~~-----~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~ 652 (804)
... ...++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 643 357999999999999998853 45688999999999999999999965 999999999999999999
Q ss_pred CEEEeecCcccccccCCCCccccccCCCccccccccccC-----CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHH
Q 047263 653 NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM-----PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL 727 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l 727 (804)
.+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.|+........ +
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~ 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L 242 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H
Confidence 999999999886533221 12234578899999998643 368899999999999999999999865432211 1
Q ss_pred HHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 728 TDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ........+.. ..+....+.+++.+|++.+|++||++.++++
T Consensus 243 ~~-----~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FK-----IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH-----HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 01111111111 1123346889999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=286.85 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=199.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|++|.||++...... ..+++|.+..... ..+.+.+|+++++.++|+|++++++++......++|+||
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATG---KEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCC---cEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 345678999999999999987433 3799999875433 467789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SK 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-hh
Confidence 99999999998776 88999999999999999999995 599999999999999999999999999987543222 12
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
.....++..|++||.+.+..++.++||||||+++|||++|+.|+.......... . . . ........ .
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~-~---~-~~~~~~~~-------~ 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--L-I---T-TKGIPPLK-------N 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-H---H-hcCCCCCc-------c
Confidence 233457789999999998889999999999999999999999987543322111 0 0 0 01000000 0
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+|++.+|.+||++.+|++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113356888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=289.38 Aligned_cols=244 Identities=25% Similarity=0.298 Sum_probs=192.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|+....+. .||+|++.... .+..+++.+|+++++.++||||+++++++.+++..++|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNE---VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 4556789999999999999865433 79999886432 23345788999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+||+. |+|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 46666654 346789999999999999999999954 9999999999999999999999999998754321
Q ss_pred CCccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 670 SQTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+.......... ...... .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~~~-~------ 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQND-S------ 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhcCC-C------
Confidence 2345778999999874 4568899999999999999999999986543222110 000000 0
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
...........+.+++.+||+.+|++||++.+|+..
T Consensus 232 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011112244578899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=290.32 Aligned_cols=259 Identities=20% Similarity=0.230 Sum_probs=191.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||.||+++....+. .+++|++.... ......+.+|++++++++|+||+++++++.+....++|+|
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~---~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCc---EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 456789999999999999865443 79999886432 2234567889999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++ +|.+++.. ...+++.....++.||++||.|||+. +++||||||+||+++.++.+||+|||+++...... .
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~ 154 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R 154 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence 9975 77777654 46789999999999999999999955 99999999999999999999999999998653322 2
Q ss_pred ccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH----------HHHhhhcCcc
Q 047263 672 THTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW----------AYDCYCEGIT 740 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~----------~~~~~~~~~~ 740 (804)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......... +... .+........
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChHHhHHhhhccc
Confidence 22334568899999998764 4789999999999999999999886443222111 1000 0000000000
Q ss_pred cceecchhhh-----cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 EALVEFDIEA-----LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 ~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ..... .........+.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccc-CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00000 001123467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=285.23 Aligned_cols=252 Identities=27% Similarity=0.356 Sum_probs=199.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||.|+||.||+|....++ ..+++|++.... ....+.+.+|++.++.++|+||+++++.+.++...++|+||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNN---EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCC---cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 45678999999999999876543 379999986432 23567899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC---CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++++|.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999754 4588999999999999999999954 999999999999999999999999999987654332
Q ss_pred C---ccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 671 Q---THTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 671 ~---~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
. ......++..|+|||.+... .++.++||||||++++||++|+.|+....... ...... ......+..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~-----~~~~~~~~~- 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL-----QNDPPSLET- 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh-----cCCCCCcCC-
Confidence 2 22334578899999998776 78999999999999999999999997543321 111100 010000000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..........+.+++..|++.||++||++++|++
T Consensus 230 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 ---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001133467789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=283.44 Aligned_cols=250 Identities=26% Similarity=0.325 Sum_probs=197.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeC--CCceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 590 (804)
.+.+.||.|+||.||++.....+ ..+++|.+... .....+.+..|+.+++.++|+||+++++++.. +...+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDG---KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCC---CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 35578999999999999876543 37899988642 23345678899999999999999999998754 4567899
Q ss_pred EeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhcc--CCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 591 YEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEEC--STQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
|||+++++|.+++.. ...+++...+.++.+|+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999864 367889999999999999999999432 45899999999999999999999999999987
Q ss_pred cccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
...... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+....... +.... ..+...
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~--- 228 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKI----KEGKFR--- 228 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHH----hcCCCC---
Confidence 643322 1233467889999999998889999999999999999999999997654221 11111 111111
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.........+.+++.+|++.+|++||++.+|++.
T Consensus 229 ------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112334678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=293.24 Aligned_cols=240 Identities=26% Similarity=0.315 Sum_probs=196.4
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.||.|+||.||-+......+ .||||++.-... +..+++..|+..+.+++|||+|.+.|++..+...+|||||
T Consensus 31 LrEIGHGSFGAVYfArd~~n~e---vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSE---VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHhcCCccceeEEeeccCccc---eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4689999999999998765544 899999974433 3356789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|-| |-.|+|.- ++.+-..++..|+.+.+.||+|||+ .+.||||||..||||++.|.+|++|||.+.+.. .
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----P 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----P 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcC-----c
Confidence 964 77777753 4677888999999999999999995 499999999999999999999999999987643 2
Q ss_pred cccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 HTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
...+.||+.|||||++. .+.|+-++||||+||...||.-.++|......-. -.+....+ ..+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIAQN---------esP 243 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN---------ESP 243 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHHhc---------CCC
Confidence 34577999999999884 5789999999999999999999998865432111 11111111 112
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+.+..+..++..||++-|.+|||.+++++
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2335678889999999999999999999988765
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=281.68 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=195.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||++...... ..+|+|.+... ..+..+.+.+|++++++++|+||+++++.+..+...++|+|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQ---KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCC---cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 45678999999999999876543 47999998643 23345679999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-CCEEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~ 669 (804)
|+++++|.+++... ..+++..+.+++.+++++|.|||+. +++|+||+|+||+++++ +.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999763 4578999999999999999999965 99999999999999865 457999999998654322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......++..|+|||.+....++.++||||||+++++|++|+.|+........ . ... . .+....+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~-~~~---~-~~~~~~~------ 221 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--V-LKI---M-SGTFAPI------ 221 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--H-HHH---H-hcCCCCC------
Confidence 22234578899999999988899999999999999999999999875533211 1 100 0 1111111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 222 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ---SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1113456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=286.88 Aligned_cols=252 Identities=27% Similarity=0.335 Sum_probs=194.5
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E 592 (804)
+.++||.|++|.||++.....+ ..+|+|.+..... ....++.+|++++++++|+||+++++++.+. ...++|||
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTG---MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred EEEEeccCCceEEEEEEECCCC---eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 4568999999999999986543 3799999875332 3456789999999999999999999988553 46899999
Q ss_pred ecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 593 FLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 593 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
|+++++|.+++.. ...++......++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988753 35578889999999999999999965 9999999999999999999999999998754322
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH--HHHHHHHHHHHhhhcCcccceecc
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE--AEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ....+..+.. ......+.+.
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 231 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELKDE 231 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhhccC
Confidence 1 12345678899999999999999999999999999999999999765321 1111111111 1011111110
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..........+.+++.+||+.+|++|||+.||++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 ---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0111223567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=279.34 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=200.8
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
..+.||+|++|.||++....++ ..+++|++.....+..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTG---KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred eeeeeccCCceEEEEEEECCCC---cEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4568999999999999987543 3799999987655566789999999999999999999999999999999999999
Q ss_pred CCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 596 NGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 596 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
+++|.+++... ..+++..+..++.+++.+|.|||+ .+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999999776 678999999999999999999995 5999999999999999999999999999987544322 33
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...++..|++||.+....++.++||||||+++++|++|+.|+........... . .......+.. ..
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~----~~~~~~~~~~-------~~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---I----ATNGPPGLRN-------PE 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---H----HhcCCCCcCc-------cc
Confidence 45678899999999888899999999999999999999999875532211110 0 0010111110 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+.+++.+|++.+|++|||+.++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12457888999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=284.66 Aligned_cols=243 Identities=22% Similarity=0.213 Sum_probs=186.4
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHh---cccccCCccceeeEEeCCCceEEEEe
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVI---GQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.||+|+||.||++.....+ ..+|+|.+..... .....+.+|..++ ...+|+||+.+++++..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCC---cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 3899999999999876543 3799998864321 1223344444433 34479999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++..+..+++.....++.|++.||.|||+. +++|+||||+|||+++++.++|+|||++...... .
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~ 151 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc---C
Confidence 999999999998888899999999999999999999954 9999999999999999999999999998754322 1
Q ss_pred cccccCCCccccccccc-cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFR-NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~-~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....|+..|+|||.+. +..++.++||||||++++||++|+.||..........+.... .. ... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----~~-----~~~----~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----LT-----VNV----E 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-----hc-----CCc----C
Confidence 22345899999999886 456899999999999999999999999654322211111100 00 000 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQM 784 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 784 (804)
.......++.+++..|++.||++|| +++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112345778899999999999999 59998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=296.74 Aligned_cols=258 Identities=22% Similarity=0.253 Sum_probs=188.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCC------C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------L 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~ 585 (804)
+...+.||+|+||.||++.....+ ..||||++..... ...+.+.+|+.++++++|+||+++++++... .
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCC---CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 445678999999999999876543 3799999875322 2345678999999999999999999987543 4
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++++|++ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 568999987 778988775 45688999999999999999999955 9999999999999999999999999999864
Q ss_pred ccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHH-------HHhhh
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWA-------YDCYC 736 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~-------~~~~~ 736 (804)
.. ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||........ ..+.... .....
T Consensus 169 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 169 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred CC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 32 2234568999999999876 5788999999999999999999999865432211 0000000 00000
Q ss_pred cCcc----c---ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 737 EGIT----E---ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 737 ~~~~----~---~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.... . .......... .......+.+++.+|++.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0 0000000000 00012346789999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=287.70 Aligned_cols=261 Identities=20% Similarity=0.248 Sum_probs=190.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||+|+||.||+|.....+. .+++|++..... .....+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQ---LVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCc---EEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 346789999999999998765443 799999865432 3334678899999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+. ++|.+++.. ...+.+.....++.||+.||.|||+. +++|+||||+||+++.++++||+|||+++...... ..
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 96 566666543 35677888899999999999999954 99999999999999999999999999997543221 12
Q ss_pred cccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh---------hh--cCcc
Q 047263 673 HTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC---------YC--EGIT 740 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~---------~~--~~~~ 740 (804)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||+............+.... .. ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2334468899999998754 5788999999999999999999999755432221111111000 00 0000
Q ss_pred cceecch----hh-hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 EALVEFD----IE-ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 ~~~~~~~----~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....... .. ..........+.+++.+|++.||.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 00 0000112356778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=282.94 Aligned_cols=243 Identities=23% Similarity=0.265 Sum_probs=194.6
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
||.|++|.||+++....+ ..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+.++...++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN---RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCC---cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 699999999999986533 379999986432 23456799999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
++|.+++.....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99999998877889999999999999999999954 99999999999999999999999999998754322 22334
Q ss_pred cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHH
Q 047263 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (804)
.++..|++||.+....++.++|+||||+++|||++|..|+.....+....... ...+. .....+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~--------~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-----ILKGN--------GKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH-----HhccC--------CCCCCCccc
Confidence 57889999999988889999999999999999999999997654221111100 00000 000111112
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 757 LARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
...+.+++..||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=288.32 Aligned_cols=241 Identities=25% Similarity=0.251 Sum_probs=196.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|++|.||++...... +.+|+|.+.... .+..+.+.+|++++++++||||+++++++.++...++||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSG---KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35678999999999999987543 379999886432 233567889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.....++...+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999999998888899999999999999999999964 9999999999999999999999999999875433
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||.+.+...+.++||||||++++||++|+.|+........ . . ....+.. .
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~----~~~~~~~------~---- 216 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI--Y-E----KILEGKV------R---- 216 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H----HHhcCCc------c----
Confidence 2334578899999999888899999999999999999999999875542211 0 0 0001100 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVT 782 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl 782 (804)
.+......+.+++.+||+.+|.+|| +++|++
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0111245778899999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=284.73 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=197.6
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
||+|+||.||+++....+ ..+++|.+..... ...+.+.+|++++++++|+||+++++.+.++...++++||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG---DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCC---CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 689999999999987543 3799999865432 4456789999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC------
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS------ 670 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~------ 670 (804)
++|.+++.....+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99999998777889999999999999999999965 999999999999999999999999999876433211
Q ss_pred -CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 -QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 -~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|++||.+.....+.++||||||++++||++|..|+.......... . ...+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~-----~~~~~~----~~--- 220 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ--N-----ILNGKI----EW--- 220 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-----HhcCCc----CC---
Confidence 12233457789999999988889999999999999999999999987654332110 0 001100 00
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
.........+..++.+|++.+|++|||+.+|.+.|+
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 -PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000012467789999999999999999977777775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=285.16 Aligned_cols=262 Identities=19% Similarity=0.194 Sum_probs=194.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 589 (804)
+.+.+.||+|+||.||+|+....+ ..+++|+++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTG---EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCC---cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 456789999999999999986543 3799999874322 2234577899999999999999999998777 88999
Q ss_pred EEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
|+||+++ +|.+++... ..+++.....++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..+...
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999985 898888654 4589999999999999999999955 9999999999999999999999999999876433
Q ss_pred CCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHH-------HHHhhhc--
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDW-------AYDCYCE-- 737 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~-------~~~~~~~-- 737 (804)
. .......++..|+|||.+.+. .++.++|+||||++++||++|+.||........ ..+... .+..+.+
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 2 222334467889999988754 468999999999999999999999875543221 111000 0000000
Q ss_pred ----CcccceecchhhhcccHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 ----GITEALVEFDIEALNDKK-KLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ----~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..........+....... ....+.+++..|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111111111 2556788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.35 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=193.2
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.++||.|++|.||+|....++ ..|++|++.... ....+.+.+|++++++++|+|++++++++.++...+++|||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTG---EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCC---CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 4678999999999999986543 379999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
++ ++|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 95 68999987654 789999999999999999999954 99999999999999999999999999997643221 1
Q ss_pred ccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHH-------HHHhhh--cCcc
Q 047263 672 THTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDW-------AYDCYC--EGIT 740 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~-------~~~~~~--~~~~ 740 (804)
......++..|+|||++.+. .++.++||||||+++|||++|+.||......... ..... .+.... .+..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 12223467889999988654 5789999999999999999999998655332210 00000 000000 0000
Q ss_pred cceecch--hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 EALVEFD--IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 ~~~~~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+.... ............+.+++.+|++.+|++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000001122357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=286.16 Aligned_cols=257 Identities=23% Similarity=0.224 Sum_probs=200.4
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.||+|++|.||+++.......+..+|||.+.... ....+.+.+|+.++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 4578999999999999876544455689999886432 22345688999999999 599999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++++|.+++.....+++.....++.|++++|.|||+ .+++|+||||+||+++.++.++|+|||+++.+.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 9999999999999877788999999999999999999995 4999999999999999999999999999886544333
Q ss_pred CccccccCCCccccccccccCC--CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMP--ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~--~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......++..|+|||.+.+.. .+.++||||||++++||++|..|+......... ........... ..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~-------~~- 230 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKSK-------PP- 230 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHccC-------CC-
Confidence 2233345788999999987655 788999999999999999999998543211100 01011100000 00
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.+......+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 231 ---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 231 ---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111234677899999999999999999998888663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=283.81 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=195.9
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
..+||+|+||.||++.....+. .+|+|++..........+.+|+.+++.++|+||+++++++.+++..++||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGK---LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCe---EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3689999999999998865433 7999998755445566789999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... ......
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 999998754 4578999999999999999999965 99999999999999999999999999987653322 122335
Q ss_pred cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHH
Q 047263 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (804)
.++..|+|||.+....++.++||||||++++||++|..|+........... . .......+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~----~~~~~~~~~~-------~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---I----RDNLPPKLKN-------LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H----HhhCCcccCC-------cccC
Confidence 578899999999888899999999999999999999999865433211110 0 0111110000 0112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 757 LARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 345778899999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=285.28 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=190.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.||.|++|.||+|+....+ ..++||++.... ....+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred eeeeecCCCceEEEEEEECCCC---CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4568999999999999886543 379999886432 22345788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
+. ++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 96 688888864 35678999999999999999999954 99999999999999999999999999987653221 1
Q ss_pred ccccccCCCccccccccccCC-CCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHH-------HHhhhc-----
Q 047263 672 THTAIRGTKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWA-------YDCYCE----- 737 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~-~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~-------~~~~~~----- 737 (804)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||......... ...... +.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 222334678899999886644 688999999999999999999998654332110 000000 000000
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.............. .......+.+++.+|++.||++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 0112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=279.85 Aligned_cols=245 Identities=23% Similarity=0.251 Sum_probs=190.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHH-hcccccCCccceeeEEeCCCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNV-IGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.||+|+||.||+|.....+. .+|+|.+.... ......+..|..+ ....+|+|++++++++.+++..++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGD---YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCC---eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 468999999999998865433 79999986432 1222334445444 4456899999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||+++.... .
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999999998878889999999999999999999954 999999999999999999999999999875432 2
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ... ...+... . .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~-----~~~~~~~----~--~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FDN-----ILSRRIN----W--PEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHH-----HHhcccC----C--CCccc
Confidence 234578899999999888899999999999999999999999975433211 100 0011000 0 00011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
......+.+++.+|++.+|++||++.++.+.|+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123457889999999999999998877766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=283.52 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=193.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCC------c
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGL------N 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~------~ 586 (804)
+.+.+.||+|++|.||+|+....+ ..+++|.+.... ...+++.+|+.+++++ +|+||+++++++.+.. .
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTG---QLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCC---cEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 445688999999999999986543 379999887543 2446789999999999 6999999999996644 4
Q ss_pred eEEEEeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 587 RLLVYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
.++||||+++++|.+++.. +..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 8999999999999999864 3578899999999999999999995 49999999999999999999999999998
Q ss_pred cccccCCCCccccccCCCcccccccccc-----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRN-----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
...... ........++..|+|||.+.. ..++.++||||||++++||++|+.||........ +.. ...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~-----~~~ 232 (275)
T cd06608 161 AQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK-----IPR 232 (275)
T ss_pred eecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH-----hhc
Confidence 764322 222233457889999998753 3467899999999999999999999964322211 111 011
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+ .........+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 111224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=282.57 Aligned_cols=246 Identities=27% Similarity=0.300 Sum_probs=198.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||++.....+. .+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKK---MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCc---EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 356789999999999998765433 79999987432 244678999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.....+++.....++.||++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 9999999999998777889999999999999999999965 89999999999999999999999999988654322
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+..........+.. .... . ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~--~--------~~~ 220 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET--A--------DVL 220 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc--c--------ccc
Confidence 2233557889999999998889999999999999999999999987654321111111 0000 0 001
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTM--RKVT 782 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm--~eVl 782 (804)
.+......+.+++.+|++.+|.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111223678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=286.30 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=191.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||+|++|.||+|+....+ ..+|+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTG---QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCC---cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 34578999999999999976443 3799999865332 2234577899999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+.+ +|.+++... ..+++.....++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 985 899888654 4678899999999999999999954 99999999999999999999999999987532211 11
Q ss_pred cccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc---Cccc-------
Q 047263 673 HTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE---GITE------- 741 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~------- 741 (804)
.....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........... ..+..... ....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH--KIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH--HHHHhcCCCChhhhhhhhhccc
Confidence 222346788999998865 4688999999999999999999999865432111110 01110000 0000
Q ss_pred -------ceecchhhhc-ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 -------ALVEFDIEAL-NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 -------~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+... ........+.+++..|++.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 01111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.64 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=190.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeC------CCc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD------GLN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~ 586 (804)
+.+.+.||+|+||.||+|+..... +.+|+|.+... .....++..|+.++.++ +|+||+++++++.. ...
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~---~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTG---QLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCC---cEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 345678999999999999986543 37999988653 23345788899999998 79999999999853 457
Q ss_pred eEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 587 RLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
.+++|||+++|+|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.++|+|||++..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 89999999999999999653 4577888899999999999999954 999999999999999999999999999876
Q ss_pred cccCCCCccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
..... .......++..|+|||.+. ...++.++||||||+++|||++|+.||........... .....
T Consensus 171 ~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~~~~ 242 (282)
T cd06636 171 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNP 242 (282)
T ss_pred hhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-------HhhCC
Confidence 43221 1223355788999999885 34678899999999999999999999965432211100 00000
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. ...........+.+++.+||+.||.+||++.||++
T Consensus 243 ~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 P--------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C--------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00011123457889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=283.53 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=190.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.++||+|+||.||+++....+ ..+|+|++.... ......+.+|+.++.++. |+||+++++++.++...+++|||
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSG---TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCC---CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4678999999999999876543 479999987432 234567889999999996 99999999999999999999999
Q ss_pred cCCCcHHHh---hc--CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 594 LSNGTLASF---LF--GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 594 ~~~gsL~~~---l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+.. +|.++ +. ....+++....+++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++.+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 44443 22 236688999999999999999999952 48999999999999999999999999999765322
Q ss_pred CCCccccccCCCccccccccccC---CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNM---PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~---~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
. ......++..|+|||.+... .++.++||||||++++||++|+.||........ . ..+.. .+..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~-~~~~----- 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-Q----LTQVV-KGDP----- 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH-H----Hhhhc-CCCC-----
Confidence 1 22333578899999999766 689999999999999999999999865431111 0 00100 0100
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
+.+...........+.+++.+|++.+|++|||+.+|++.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112345678899999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=282.17 Aligned_cols=259 Identities=20% Similarity=0.211 Sum_probs=189.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccc-cCCccceeeEEeCC--CceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDG--LNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV 590 (804)
.+.++||+|+||.||+|+....+. .+|+|++..... ........|+.++.++. |+|++++++++.+. +..++|
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~---~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGK---YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCc---EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 346789999999999998765433 799999875322 22234457888888885 99999999999887 889999
Q ss_pred EeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+||++ ++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99997 477777765 45789999999999999999999965 9999999999999999 999999999998653322
Q ss_pred CCccccccCCCccccccccc-cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHH-------HHHhhhcCcc
Q 047263 670 SQTHTAIRGTKGYVAPEWFR-NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDW-------AYDCYCEGIT 740 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~-~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~-------~~~~~~~~~~ 740 (804)
......++..|+|||.+. +..++.++|||||||++|||++|..||......... ..... ..........
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 122345788999999764 456788999999999999999999999765432210 00000 0000000000
Q ss_pred cceecchhhh----cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 EALVEFDIEA----LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 ~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+.... .........+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 001123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.46 Aligned_cols=247 Identities=28% Similarity=0.336 Sum_probs=200.4
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEEEEe
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLLVYE 592 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E 592 (804)
.+.||+|++|.||+|.....+ ..+++|++..... ...+.+.+|++.+++++|+||+++++.+.+. ...++++|
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTG---ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred eeEeeecCceEEEEEEECCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 467999999999999987543 3799999875432 4567899999999999999999999999988 88999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC-
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ- 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 671 (804)
|+++++|.+++.....+++..+..++.+++++|.|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 999999999998877899999999999999999999964 9999999999999999999999999999876443321
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......++..|+|||.+.....+.++||||||+++++|++|+.|+......... ........... .
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~---------~ 224 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-----LYKIGSSGEPP---------E 224 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHhccccCCCc---------C
Confidence 123355788999999998888999999999999999999999999765411111 01100000000 1
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+......+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.28 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=187.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHH-hcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNV-IGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||+++....+ ..||+|++.... .+...++..|+.. ++.++|+||+++++++.++...+++||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTG---TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCC---cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 34578999999999999986543 379999987543 2233455556664 566789999999999999999999999
Q ss_pred ecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 593 FLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 593 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
|++ |+|.+++.. ...+++..+..++.||+.||.|||++ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 678777643 34678999999999999999999952 38999999999999999999999999999865322
Q ss_pred CCCccccccCCCcccccccccc----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRN----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+......... +... ..+....+
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~-----~~~~~~~~- 228 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-LKQV-----VEEPSPQL- 228 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-HHHH-----HhcCCCCC-
Confidence 12223457889999998864 45688999999999999999999998643221111 1000 01111111
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+|++.+|++||++.+|++
T Consensus 229 -------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 -------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123456888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=281.16 Aligned_cols=242 Identities=28% Similarity=0.314 Sum_probs=190.6
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
||+|+||+||++.....+. .+++|.+.... ....+.+..|++++++++||||+++++.+...+..++|+||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGK---MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCc---EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 6999999999998765433 79999886432 22345678899999999999999999999999999999999999
Q ss_pred CcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 597 GTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 597 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~ 152 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIK 152 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccc
Confidence 99999997654 688999999999999999999954 999999999999999999999999999876533 22223
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
...++..|+|||.+.+..++.++||||||+++++|++|+.||........ ..+. ...... .....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~------~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--------RRTLEM------AVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--------hccccc------cccCC
Confidence 34577899999999888899999999999999999999999865433111 1110 000000 00011
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
......+.+++.+||+.+|++|| +..+++.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 12245678899999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=279.68 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=195.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||++....++. .+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+....++|+|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSE---HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCc---eEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 356789999999999999876544 68999986431 2345678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC-EEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN-ARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~-~kl~Dfgla~~~~~~~ 669 (804)
|+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||++++++. +||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999998654 3578999999999999999999954 9999999999999998754 6999999998654322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......|+..|+|||++....++.++||||||++++||++|..|+........ ..... .+.....
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~~~------ 222 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKIC-QGYFAPI------ 222 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh-cccCCCC------
Confidence 222334578899999999888899999999999999999999999865432211 11111 1111000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+|++.+|++|||+.+|++
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122346888999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.73 Aligned_cols=278 Identities=22% Similarity=0.299 Sum_probs=198.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCC-----Cce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-----LNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 587 (804)
+.+.++||+|+||.||+|+....+ ..||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTG---VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCC---CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 345678999999999999876443 379999986432 23445688999999999999999999987544 357
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++|+||+.+ +|.+++. ...+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999975 7877774 45688999999999999999999955 999999999999999999999999999986533
Q ss_pred CCCC--ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc---cc
Q 047263 668 DQSQ--THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI---TE 741 (804)
Q Consensus 668 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~ 741 (804)
.... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... .......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCHHHHH
Confidence 2211 1223467889999998754 568899999999999999999999986543221100 0000000000 00
Q ss_pred ceecch---------hhhc-----ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCccC-CCCC--CCCCCcc
Q 047263 742 ALVEFD---------IEAL-----NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM--LEGVVEV-LDPP--CPCPFTV 802 (804)
Q Consensus 742 ~~~~~~---------~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--Le~~~~~-~~pp--~P~~~~~ 802 (804)
.+.... .... .......++.+++.+||+.+|++|||+.++++. ++..... ..|. .|++|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 315 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDF 315 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhh
Confidence 000000 0000 001124568899999999999999999999886 6554432 2333 3555543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=290.19 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=194.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhccc-ccCCccceeeEEeCC--Cc
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG--LN 586 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~--~~ 586 (804)
..+.+.+.||+|+||.||+|....++ ..+|+|++... .......+..|+.+++++ +|+||+++++++... ..
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTK---EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCC---eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 34566789999999999999876443 37999988542 123345677899999999 999999999998653 46
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.++||||++ ++|..++... .+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 799999997 5999988765 778999999999999999999954 99999999999999999999999999998764
Q ss_pred cCCC----CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHH-------HH
Q 047263 667 LDQS----QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWA-------YD 733 (804)
Q Consensus 667 ~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~-------~~ 733 (804)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3322 12233567889999998754 56789999999999999999999998654332110 000000 00
Q ss_pred hhhcCcccceec----c---hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 734 CYCEGITEALVE----F---DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 734 ~~~~~~~~~~~~----~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.+.......+.+ . .... ........+.+++.+|++.+|++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000 0 0000 001134678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=284.84 Aligned_cols=260 Identities=23% Similarity=0.247 Sum_probs=192.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC-----
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL----- 585 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----- 585 (804)
.+.+.+.||+|+||.||+|+....+ ..||+|++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTG---ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCC---cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3455788999999999999987544 379999986432 223456788999999999999999999987655
Q ss_pred -----ceEEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeec
Q 047263 586 -----NRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659 (804)
Q Consensus 586 -----~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Df 659 (804)
..++|+||+++ +|.+.+.. ...+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999987 66666654 35689999999999999999999965 9999999999999999999999999
Q ss_pred CcccccccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 660 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
|++...............++..|+|||.+.+ ..++.++||||||++++||++|+.|+........... ........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~---~~~~~~~~ 237 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL---ISRLCGSP 237 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCC
Confidence 9998764433222233345778999998864 4578999999999999999999999975433221111 00100000
Q ss_pred cc---ccee--------c------chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 IT---EALV--------E------FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ~~---~~~~--------~------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ..+. + ...... .......+.+++.+||+.+|++||++.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred Chhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 0 000000 0012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=305.81 Aligned_cols=267 Identities=19% Similarity=0.272 Sum_probs=183.4
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccc----------------eeEEEEEccccccccHHHHHHHHHHhcccccCCcc
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQ----------------VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~----------------~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv 575 (804)
..+.+.++||+|+||.||++..+...... ..++.|++.. .......+.+|+.++++++|+||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcC
Confidence 44666789999999999998764322100 0011122211 122345688999999999999999
Q ss_pred ceeeEEeCCCceEEEEeecCCCcHHHhhcCC-----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGD-----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 576 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
++++++.+.+..++|+|++. ++|.+++... ..........|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 4666666432 2233556778999999999999954 9999999999999999
Q ss_pred CCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCC-CcchhHHHHHHHH
Q 047263 651 YYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV-DMEVNEAEALLTD 729 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~-~~~~~~~~~~l~~ 729 (804)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++ ..........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 999999999999876543333334467899999999999999999999999999999999988543 2222111111111
Q ss_pred HHHHh--hhcCccc---ceecc----hhh-------h-cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 730 WAYDC--YCEGITE---ALVEF----DIE-------A-LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 730 ~~~~~--~~~~~~~---~~~~~----~~~-------~-~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..... ..+.... .+.+. ... . .........+.+++.+||+.||.+|||+.|+++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11000 0000000 00000 000 0 000011234567788999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=276.49 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=200.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||+++....+. .+++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGD---FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCc---EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 356789999999999998765443 799999976543 455689999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-D 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-c
Confidence 99999999999887889999999999999999999995 4999999999999999999999999999987543222 1
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
.....++..|+|||...+..++.++|||++|+++++|++|+.|+......... . ... ...... .
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-~-----~~~-~~~~~~---------~ 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-F-----RIV-QDDHPP---------L 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-H-----HHh-ccCCCC---------C
Confidence 23345788999999998888899999999999999999999998754322111 0 000 010000 1
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+|++.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122457788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=286.43 Aligned_cols=262 Identities=18% Similarity=0.158 Sum_probs=183.8
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccH-----------HHHHHHHHHhcccccCCccceeeE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV-----------KEFKTEVNVIGQTHHKNLVRLLGF 580 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~-----------~~f~~E~~~l~~l~h~niv~l~g~ 580 (804)
..+.+.++||+|+||.||+|....+......+++|.......... .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 345567899999999999999876533233566665432211110 112234445667789999999997
Q ss_pred EeCCC----ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEE
Q 047263 581 CDDGL----NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656 (804)
Q Consensus 581 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl 656 (804)
+.... ..++++|+... ++.+.+......++.....|+.|+++||.|||+. +|+||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence 65443 34677777643 5666665545567888899999999999999954 9999999999999999999999
Q ss_pred eecCcccccccCCC------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH
Q 047263 657 SDFGLAKLLLLDQS------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW 730 (804)
Q Consensus 657 ~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 730 (804)
+|||+++.+..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||.......... ..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~--~~ 245 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI--HA 245 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH--HH
Confidence 99999987643221 11223468999999999999999999999999999999999999997653221110 00
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
....+.. .+...... .......+.+++..|++.+|++||++.++++.|+
T Consensus 246 ~~~~~~~----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIK----RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHH----Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000000 01101000 0112356888999999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=281.55 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=193.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.++||+|++|.||+|+...++ ..+|||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTG---EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCC---eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 34678999999999999986544 3799999875432 2346678899999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC---CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++ +|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 985 888887643 4578999999999999999999954 99999999999999999999999999997653321
Q ss_pred CccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHH-------HHhhhcC--c
Q 047263 671 QTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWA-------YDCYCEG--I 739 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~-------~~~~~~~--~ 739 (804)
.......++..|++||.+.+. .++.++||||||+++|||++|+.||......... .+.... ++.+... .
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 122234568889999988654 5788999999999999999999998755432211 000000 0000000 0
Q ss_pred ccce---ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 TEAL---VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ~~~~---~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... .+... ..........+.+++.+|++.+|.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00000 0001122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=283.57 Aligned_cols=249 Identities=25% Similarity=0.294 Sum_probs=193.5
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
...++...+.||+|+||.||+|+....+ ..+++|++... .....+++.+|+++++.++|+|++++++++.+...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCC---cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 3344455678999999999999986543 37999988632 22344578899999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 587 RLLVYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
.++|+||+. |+|.+++. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999999997 57777664 345678999999999999999999954 9999999999999999999999999998764
Q ss_pred ccCCCCccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
.. .....++..|+|||.+. ...++.++||||||++++||++|+.|+.......... ... .+..
T Consensus 166 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~-----~~~~-- 231 (308)
T cd06634 166 AP-----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA-----QNES-- 231 (308)
T ss_pred cC-----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHh-----hcCC--
Confidence 32 22345788999999874 3567889999999999999999999986543221111 100 1100
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
...........+.+++.+||+.+|++||++.+|++..
T Consensus 232 ------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 ------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0011122345678899999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=281.25 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=196.1
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc--cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
..+.||+|++|.||+++...++ ..+++|++...... ....+..|+.++++++|+||+++++++.++...++|+||
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTG---EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred cceeeecCCCceEEEEEcCCCC---cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 4567999999999999986443 37999998754322 456788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++ +|.+++.. ...+++..+..++.+|+.||.|||+. +++|+||||+||++++++.++|+|||.+....... ..
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 975 88887765 36789999999999999999999965 99999999999999999999999999998765433 12
Q ss_pred cccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc---Ccccceec---
Q 047263 673 HTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE---GITEALVE--- 745 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~--- 745 (804)
.....++..|+|||.+.+. .++.++||||||+++++|++|+.||........... ..+.... .....+..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhh
Confidence 2334577889999998776 789999999999999999999999865543221100 0000000 00000000
Q ss_pred --------chh--hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 746 --------FDI--EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 746 --------~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... ..........++.+++..||+.||.+||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00011224578899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=288.42 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=202.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.++...||.|+||.|||++.+..+ ...|-|.+.....+..+.|+-|+++|+...||+||+|++.+..++..+|+.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~---~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETK---LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccch---hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345678999999999999987543 35677888877778889999999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|.||-.+.++-. ...++..++.-++.|++.||.|||++ .|||||||..|||++-+|.++|+|||.+-.... ..+.
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 999999988754 56789999999999999999999954 999999999999999999999999999865322 2334
Q ss_pred cccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 673 HTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
...+.||+.|||||+.. ..+|+.++|||||||.|.||.-+.+|-....+- ..+.. ..... ..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllK----iaKSe-PP------ 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAKSE-PP------ 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHH----HhhcC-CC------
Confidence 55678999999999874 568999999999999999999999886543221 11111 01111 11
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.-..+......+.++..+||..||..||++.++++
T Consensus 254 -TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 -TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11234456677889999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=286.69 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=191.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLL 589 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 589 (804)
.+.++||+|++|.||+|+.... ..+..+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567899999999999998652 124479999998632 33446778899999999999999999999888 78999
Q ss_pred EEeecCCCcHHHhhcCC-----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC----CCCEEEeecC
Q 047263 590 VYEFLSNGTLASFLFGD-----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD----YYNARISDFG 660 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~----~~~~kl~Dfg 660 (804)
||||+++ +|.+++... ..++......++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999986 566655321 3578888999999999999999954 9999999999999999 9999999999
Q ss_pred cccccccCCC--CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-------HHHHHHH
Q 047263 661 LAKLLLLDQS--QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-------EALLTDW 730 (804)
Q Consensus 661 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-------~~~l~~~ 730 (804)
++..+..... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||....... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987543222 12223457888999998765 457899999999999999999999986543321 0000000
Q ss_pred HHHhhh-----------c--Cccc---ceec-----chhhhcccH--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 731 AYDCYC-----------E--GITE---ALVE-----FDIEALNDK--KKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 731 ~~~~~~-----------~--~~~~---~~~~-----~~~~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+. + .... .... ..+...... ....++.+++.+|++.||++|||+.|+++
T Consensus 238 -~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 -FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred -HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0 0000 0000 000000001 23356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=284.65 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=190.4
Q ss_pred HHhhCCC--cceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 517 KEELGKG--AFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 517 ~~~LG~G--~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.++||+| +||+||+++....+ ..||+|.+... ..+..+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTG---TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCC---cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 3567777 88999999875443 37999998643 22345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 99999999998754 457888889999999999999995 4999999999999999999999999986543322111
Q ss_pred Cc------cccccCCCccccccccccC--CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh--------
Q 047263 671 QT------HTAIRGTKGYVAPEWFRNM--PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC-------- 734 (804)
Q Consensus 671 ~~------~~~~~gt~~y~aPE~l~~~--~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------- 734 (804)
.. .....++..|+|||++.+. .++.++||||||++++||++|+.||......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML-LQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH-HHHhcCCCCCCccccc
Confidence 11 0112245679999999763 4789999999999999999999999754322110 00000000
Q ss_pred --------------hhcCc---------ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 735 --------------YCEGI---------TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 735 --------------~~~~~---------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+. ....................+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 00011111111122345577899999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=289.62 Aligned_cols=270 Identities=22% Similarity=0.260 Sum_probs=202.6
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC-----ce
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL-----NR 587 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~ 587 (804)
.+.+.||+|++|.||+++....+ ..+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTG---RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCC---cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 45678999999999999976543 379999987643 334567899999999999999999999998775 78
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
+++|||++ ++|.+++.....+++..+..++.+|+.||.|||+. +|+|+||||+|||++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999998 48999998777899999999999999999999954 999999999999999999999999999987644
Q ss_pred CCC--CccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc-------
Q 047263 668 DQS--QTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE------- 737 (804)
Q Consensus 668 ~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 737 (804)
... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||....................+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 321 122334578889999999887 8899999999999999999999999765432211100000000000
Q ss_pred -Ccccceecc-hhh-----hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCccC
Q 047263 738 -GITEALVEF-DIE-----ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM--LEGVVEV 791 (804)
Q Consensus 738 -~~~~~~~~~-~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--Le~~~~~ 791 (804)
......... ... ..........+.+++.+||+.+|++||+++++++. ++++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000000000 000 00011134567899999999999999999999974 6655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=276.49 Aligned_cols=244 Identities=25% Similarity=0.300 Sum_probs=198.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|++|.||+++....+ ..+++|++.... .....++.+|+++++.++|+||+++++++.+....++|+|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDN---QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCC---CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 34678999999999999876443 379999987432 2345578899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 593 FLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 593 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
|+++++|.+++.. ...+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999865 3567899999999999999999995 49999999999999999999999999999876443
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......++..|++||.+.+..++.++|+||||++++||++|+.|+......... .. ...+....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~~----~~~~~~~~------ 220 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---YK----VQRGKYPP------ 220 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH----HhcCCCCC------
Confidence 222345788999999999999999999999999999999999999765432211 10 11111111
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+|++.+|++||++.++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=289.63 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=196.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC-----Cce
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-----LNR 587 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 587 (804)
...+.||+|+||.||+++....+ ..||||++.... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETN---EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCC---CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 34568999999999999876443 479999987532 23345678899999999999999999988654 347
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++|+||+. ++|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 68999998878899999999999999999999954 999999999999999999999999999986543
Q ss_pred CCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH--------HhhhcC
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY--------DCYCEG 738 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~ 738 (804)
.. .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||................ ......
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 22 22234457889999998764 468899999999999999999999996543221111000000 000000
Q ss_pred ccccee-------cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCc
Q 047263 739 ITEALV-------EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM--LEGVV 789 (804)
Q Consensus 739 ~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--Le~~~ 789 (804)
...... ...... .......++.+++.+|++.+|++|||++++++- ++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 240 KARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000 000000 011234678899999999999999999999866 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=289.92 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=194.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC----CCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD----GLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 587 (804)
+.+.+.||+|++|.||++.....+. .||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~---~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGK---KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCC---EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3445789999999999998775443 79999987532 2345677889999999999999999998753 3567
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++|+||+. ++|.+++.....+++.....++.||++||.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999996 68999998777899999999999999999999965 999999999999999999999999999976543
Q ss_pred CCCC---ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HHhh
Q 047263 668 DQSQ---THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YDCY 735 (804)
Q Consensus 668 ~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~ 735 (804)
.... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||............... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2221 1223467889999998865 46889999999999999999999999654332111000000 0000
Q ss_pred hcCcccceec-chhhhcc-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 736 CEGITEALVE-FDIEALN-----DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 736 ~~~~~~~~~~-~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......... ....... .......+.+++.+|++.+|++||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000 0000000 1123567899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=276.99 Aligned_cols=247 Identities=21% Similarity=0.241 Sum_probs=193.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-----ccccHHHHHHHHHHhcccccCCccceeeEEeCC--Cce
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-----IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNR 587 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 587 (804)
.+.+.||+|+||.||+|.....+ ..+++|.+... ..+..+.+++|++++++++|+||+++++++.+. ...
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTG---RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCC---CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 45678999999999999876543 37999987421 123456789999999999999999999998664 457
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++++||+++++|.+++.....+++....+++.||+.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999998777788999999999999999999955 999999999999999999999999999986532
Q ss_pred CC--CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 668 DQ--SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 668 ~~--~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
.. ........++..|+|||.+.+..++.++||||||++++||++|+.||........ ... ......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~~~~------ 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFK----IATQPT------ 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHH----HHcCCC------
Confidence 11 1112234578899999999988899999999999999999999999865422211 101 000100
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+......+.+++.+|++ +|.+||+..+++.
T Consensus 227 ---~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ---KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 011122344678889999998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=281.65 Aligned_cols=257 Identities=25% Similarity=0.315 Sum_probs=189.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|++|.||+|+....+ +.+++|++.... ....+.+.+|++++++++|+||+++++++.++...++|||
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCC---cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 44678999999999999986543 379999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~ 669 (804)
|++ ++|.+++.... ..++.....++.||+.||+|||+. +++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 996 57877775443 346778889999999999999954 9999999999999985 567999999999765332
Q ss_pred CCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC---cccc---
Q 047263 670 SQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG---ITEA--- 742 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~--- 742 (804)
........++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... . ........ ....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--K-IFRILGTPNEETWPGVTS 233 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhCCCChhhcccccc
Confidence 112233456789999998865 467899999999999999999999997553322111 0 00000000 0000
Q ss_pred e----------ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 L----------VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~----------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+ ..... .........++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 0001123456788999999999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=280.23 Aligned_cols=253 Identities=22% Similarity=0.218 Sum_probs=195.6
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
.+.+.||+|+||.||++....+...+..+|+|.+.... ....+++.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 34578999999999999875444445679999986432 12345688999999999 59999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|+||+++++|.+++.....+++.....++.|+++||.|||+. +++||||+|+|||+++++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999998878888999999999999999999954 99999999999999999999999999998754433
Q ss_pred CCccccccCCCccccccccccC--CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNM--PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~--~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
........|+..|+|||.+... .++.++||||||+++|||++|+.|+........ ............ .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~-------~- 229 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-------P- 229 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC-------C-
Confidence 3333345688899999998753 467899999999999999999999864322110 001111100000 0
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
..+......+.+++.+|++.+|++|| ++.+++.
T Consensus 230 ---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00112335677899999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=283.63 Aligned_cols=263 Identities=22% Similarity=0.260 Sum_probs=190.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------ 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 585 (804)
+.+.++||+|+||.||+++....+ ..+|||++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~---~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTK---QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCC---cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 445678999999999999876543 379999886432 222345678999999999999999999986654
Q ss_pred --ceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 586 --NRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 586 --~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
..++||||+.+ +|.+.+... ..+++.+...++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 777777544 4689999999999999999999965 9999999999999999999999999999
Q ss_pred cccccCCCC---ccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 663 KLLLLDQSQ---THTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 663 ~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
......... ......++..|+|||.+.+. .++.++||||||++++||++|+.|+......................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 865432221 12234567889999988654 47889999999999999999999987654432211111111000000
Q ss_pred ccccee-----c----ch------hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 ITEALV-----E----FD------IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ~~~~~~-----~----~~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...... + .. ............+.+++.+|++.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 0 00 000000112345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=279.26 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=193.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||+|+....+. .++||++..... .......+|+..+++++ |+||+++++++.++...++|||
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGE---LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCc---EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 356789999999999999875543 799999875432 22234567899999999 9999999999999999999999
Q ss_pred ecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 889999887654 789999999999999999999965 99999999999999999999999999998653221
Q ss_pred CccccccCCCccccccccc-cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH-HHH---------HHHHhhhcCc
Q 047263 671 QTHTAIRGTKGYVAPEWFR-NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTD---------WAYDCYCEGI 739 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~-~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~---------~~~~~~~~~~ 739 (804)
......++..|+|||.+. ...++.++||||||++++||++|+.||.......... ... |.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223345788999999874 4568999999999999999999999886553322110 000 0000000000
Q ss_pred ccce----ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 740 TEAL----VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 740 ~~~~----~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.... ....+.... ......+.+++.+|++.+|++||+++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 000000000 1114678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=288.71 Aligned_cols=260 Identities=23% Similarity=0.233 Sum_probs=191.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCC------C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------L 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~ 585 (804)
+...+.||+|+||.||++.....+ ..+|+|++... .....+++.+|+.++++++|+||+++++++... .
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTG---QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCC---CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 344578999999999999876543 37999998643 223345678899999999999999999988543 3
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++||||+.+ +|.+.+... ++......++.|++.||.|||.. +++||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 56999999964 888887544 78889999999999999999954 9999999999999999999999999999865
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHH-----------H----
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLT-----------D---- 729 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~-----------~---- 729 (804)
... .......++..|+|||.+.+..++.++||||||+++++|++|+.||......... .+. .
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 169 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 322 2223345788999999999999999999999999999999999998654321100 000 0
Q ss_pred HHHHhhhcCcc------cceecc----hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 730 WAYDCYCEGIT------EALVEF----DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 730 ~~~~~~~~~~~------~~~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
........... .++... .............+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 000000 00000011235667899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=287.66 Aligned_cols=267 Identities=21% Similarity=0.253 Sum_probs=192.4
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC------CceE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------LNRL 588 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 588 (804)
.+.||+|+||.||+|+....+ ..+|+|++.... ....+.+.+|+.+++.++|+||+++++++... ...+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTG---EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCC---cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 467999999999999876443 379999986432 22345688999999999999999999998654 3468
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+|+||+.. +|..++ ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 97 lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 97 LVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred EEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 99999974 777665 24578999999999999999999955 899999999999999999999999999875422
Q ss_pred CCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HHhhhcCc
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YDCYCEGI 739 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 739 (804)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... .....+..
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 1223456788999999876 46889999999999999999999999765322111000000 00000000
Q ss_pred ccceec-------chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhhcCccCCCCCCC
Q 047263 740 TEALVE-------FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT--QMLEGVVEVLDPPCP 797 (804)
Q Consensus 740 ~~~~~~-------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl--~~Le~~~~~~~pp~P 797 (804)
...... ..... ........+.+++.+||+.||++||++++++ ..++...+..+.+.|
T Consensus 247 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~ 312 (342)
T cd07879 247 AKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQ 312 (342)
T ss_pred hHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCC
Confidence 000000 00000 0001234678999999999999999999999 447777665444433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=276.40 Aligned_cols=246 Identities=20% Similarity=0.316 Sum_probs=203.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|.|..|-.++.--. ++.||||++.+..- -...++++|++-|+.++|||||+|+.+......+|||+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFT---GekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcc---cceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45567899999999988876533 44899999986533 23457889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE-cCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL-DDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl-~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|.-.+|+|.+||-++ ..+.+....++..||+.||.|+|+ ..+|||||||+||.+ .+-|-+||.|||++-.+. .
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--P 171 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC--C
Confidence 999999999998654 678899999999999999999995 499999999999987 567889999999998764 3
Q ss_pred CCccccccCCCccccccccccCCCC-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPIT-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.+...+.+|+..|-|||++.+..|+ +++||||+|||||-|++|+.||......+.. ..++|-.
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCK- 235 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCK- 235 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhccc-
Confidence 5566778999999999999999887 6899999999999999999999765433211 1122211
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
..-+.....++.+||..||+.||++|.+.+||+..
T Consensus 236 -YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 -YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 11234566789999999999999999999999753
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=281.12 Aligned_cols=257 Identities=20% Similarity=0.226 Sum_probs=188.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccc-cCCccceeeEEeCCCc-----
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLN----- 586 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~----- 586 (804)
...+.||+|+||.||+|.....+. .||+|+...... ...+.+.+|+.+++.++ |+||+++++++.....
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~---~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGK---LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCc---EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 345789999999999999865443 799998764322 23457888999999994 6999999999877665
Q ss_pred eEEEEeecCCCcHHHhhcCC-----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecC
Q 047263 587 RLLVYEFLSNGTLASFLFGD-----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFG 660 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfg 660 (804)
.++||||+++ +|.+++... ..+++.....++.||++||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 788887532 3578999999999999999999954 9999999999999998 8999999999
Q ss_pred cccccccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 661 LAKLLLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 661 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
++..+..... ......++..|+|||++.+ ..++.++||||||+++|||++|..||......... . ... .......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~-~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-L-HIF-KLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-H-HHH-HHhCCCC
Confidence 9876532211 1122345788999998865 46789999999999999999999998654332211 0 000 0000000
Q ss_pred ---ccce------------ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 ---TEAL------------VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ---~~~~------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ...... ........++.+++.+|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000000 001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=289.53 Aligned_cols=199 Identities=29% Similarity=0.404 Sum_probs=169.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cC-----CccceeeEEeCCCc
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HK-----NLVRLLGFCDDGLN 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~-----niv~l~g~~~~~~~ 586 (804)
++.+.+.||+|.||.|-|+.....+ +.||||+++.. ..-.++-..|+.+|..|+ |. |+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~---e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTG---EIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCC---cEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 5667889999999999999887544 48999999875 334456688999999997 43 89999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC--CCCEEEeecCcc
Q 047263 587 RLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD--YYNARISDFGLA 662 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~--~~~~kl~Dfgla 662 (804)
.+||+|.+. -+|.++|+.+ ..++......|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.+
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 999999885 4999999876 4577889999999999999999965 9999999999999964 347999999999
Q ss_pred cccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA 723 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~ 723 (804)
... .+....+.-+.-|.|||++.+.+|+.+.||||||||+.||++|.+-|.++.+..
T Consensus 339 c~~----~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 339 CFE----SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred ccc----CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 863 222335667889999999999999999999999999999999988776665443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=283.30 Aligned_cols=263 Identities=23% Similarity=0.252 Sum_probs=190.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 589 (804)
+.+.+.||+|+||.||+|+....+ ..||+|++..... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSG---EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCC---cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 345678999999999999986543 3799999864322 2233567899999999999999999998765 46899
Q ss_pred EEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
||||+.+ +|.+++.. ...+++..+..++.||++||.|||+. +++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 78887764 36789999999999999999999965 9999999999999999999999999999876432
Q ss_pred CCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH-HHHH-------HHHhhhcCc
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTDW-------AYDCYCEGI 739 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~~~~ 739 (804)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +... .+.......
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 2 22223345778999999865 567899999999999999999999997554332111 1000 000000000
Q ss_pred c-cc--eecchhhh--cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 740 T-EA--LVEFDIEA--LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 740 ~-~~--~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
. .. +....... .........+.+++..|++.||++|||++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00 00000000 0001124567789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=279.30 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=192.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccc--cccccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS--VIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~--~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 589 (804)
.+...++||+||...|||+...+.. .+|+|++.. ...+...-|.+|+..|.+|+ |.+||+|++|-..+..+||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~----iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQ----IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCc----chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4566789999999999999876554 478887753 33455678999999999995 9999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCC--ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 590 VYEFLSNGTLASFLFGDLKP--GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||||- .-+|.++|...... +| .+..+..|++.++.++|++ +|||.||||.|+|+-+ |.+||+|||.|..+..
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99985 45999999876433 35 7778899999999999987 9999999999999865 5899999999998776
Q ss_pred CCCC-ccccccCCCccccccccccC-----------CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhh
Q 047263 668 DQSQ-THTAIRGTKGYVAPEWFRNM-----------PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 668 ~~~~-~~~~~~gt~~y~aPE~l~~~-----------~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (804)
+... ......||..||+||.+... ..+.++||||+|||||+|+.|+.||...... |+.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-------~aK--- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-------IAK--- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------HHH---
Confidence 5543 34457899999999988532 2567899999999999999999999743221 111
Q ss_pred hcCcccceecchhhhcc-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 736 CEGITEALVEFDIEALN-DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 736 ~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
...+.++...-.+ ....-.++++++..||+.||.+||++-++++-
T Consensus 582 ----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 ----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1122222211111 11111238999999999999999999998753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=277.77 Aligned_cols=242 Identities=21% Similarity=0.221 Sum_probs=186.3
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHH---HhcccccCCccceeeEEeCCCceEEEEe
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVN---VIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.||+|+||.||++.....+ +.||+|.+..... .....+..|.. .+...+|+||+++++++.+.+..++|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCC---CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 3899999999999876443 3799998864321 11223444443 3444579999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|..++.....+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++..+... .
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~ 151 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---C
Confidence 999999999998888899999999999999999999964 8999999999999999999999999998754322 1
Q ss_pred cccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.||............. . ... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~---~~~------~~~~~--- 218 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M---TLT------MAVEL--- 218 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H---hhc------cCCCC---
Confidence 2234688999999998754 68999999999999999999999997653221111100 0 000 00001
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.......+.+++.+|++.+|.+|| ++.++++
T Consensus 219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111245788899999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=285.38 Aligned_cols=257 Identities=20% Similarity=0.233 Sum_probs=192.9
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccccc--------------HHHHHHHHHHhcccccCCccceeeEEe
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG--------------VKEFKTEVNVIGQTHHKNLVRLLGFCD 582 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~--------------~~~f~~E~~~l~~l~h~niv~l~g~~~ 582 (804)
.+.||+|+||.||+|.....+ +.||||++....... ...+.+|+++++.++|+||+++++++.
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTG---KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV 90 (335)
T ss_pred hhcccCCCceeEEEEEECCCC---CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence 467999999999999876443 379999886432211 124778999999999999999999999
Q ss_pred CCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 583 DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 583 ~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
.++..++||||+. |+|.+++.....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 91 EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999997 69999998777889999999999999999999954 9999999999999999999999999999
Q ss_pred cccccCC-------------CCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHH
Q 047263 663 KLLLLDQ-------------SQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT 728 (804)
Q Consensus 663 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 728 (804)
....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--- 243 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL--- 243 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 8654111 1111223457789999998764 4689999999999999999999998765433211
Q ss_pred HHHHHhhhcCccc---c------------eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 729 DWAYDCYCEGITE---A------------LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 729 ~~~~~~~~~~~~~---~------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
............. . ........ ........+.+++.+|++.+|++||+++|++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111111000000 0 00000000 011124568899999999999999999999864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.37 Aligned_cols=241 Identities=26% Similarity=0.325 Sum_probs=188.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.++||+|+||.||+|+....+ ..+++|++.... ....+.+.+|+++++.++|+|++++++++.+....++||||
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTN---EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred ceeeccCCCeEEEEEEECCCC---cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 357999999999999876443 379999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+. |+|.+++.. ...+++..+..++.||+.+|.|||+. +++|+||+|+||++++++.+||+|||++.... .
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 96 467776654 45689999999999999999999954 99999999999999999999999999986422 1
Q ss_pred cccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 HTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....++..|+|||++. ...++.++||||||++++||++|..|+.......... ....... ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~~-~~------- 239 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNDS-PT------- 239 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCC-CC-------
Confidence 22346788999999984 4568899999999999999999999986543222111 0000110 00
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.........+.+++.+|++.+|.+||++.+++..
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123457889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.79 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=198.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.||.|+||.||++....++ ..+++|++..... ...+++.+|+++++.++|+|++++++.+.++...++|+||
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDG---KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCC---cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4567999999999999986543 3799999875432 4566789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 594 LSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 594 ~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999763 6789999999999999999999965 99999999999999999999999999998754432
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+....++.++||||+|+++++|++|+.|+....... .... ........+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~-----~~~~~~~~~------ 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LALK-----ILKGQYPPI------ 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHHH-----HhcCCCCCC------
Confidence 22233467889999999988889999999999999999999999986553221 1100 111111111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+......+.+++.+|++.+|++||++.++++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123356788999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=303.96 Aligned_cols=261 Identities=27% Similarity=0.342 Sum_probs=204.4
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeecCcccc----ceeEEEEEcccccc-ccHHHHHHHHHHhccc-ccCCccceeeEEeC
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIGMASMY----QVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD 583 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~~~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 583 (804)
......+.+.||+|.||.|++|........ ...||||.++.... ...+.++.|+++++.+ +|+||+.++|+|.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 333334566999999999999987533322 56799999986443 4567899999999999 69999999999999
Q ss_pred CCceEEEEeecCCCcHHHhhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEE
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGDL----------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIL 647 (804)
....++|.||+..|+|.++|+..+ .++....+.++.|||.|++||++ .+++||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEE
Confidence 999999999999999999998655 37778899999999999999995 48999999999999
Q ss_pred EcCCCCEEEeecCcccccccCCCCcccccc--CCCccccccccccCCCCccchhhHHHHHHHHHHcCC-CCCCcchhHHH
Q 047263 648 LDDYYNARISDFGLAKLLLLDQSQTHTAIR--GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR-RNVDMEVNEAE 724 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~-~p~~~~~~~~~ 724 (804)
+.++..+||+|||+++.............. -...|||||.+....|+.++|||||||+||||+|.. .|+.......
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~- 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE- 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-
Confidence 999999999999999965443333222222 245699999999999999999999999999999955 4443311111
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.. . +...++.. ...+.....++++++..||+.+|++||++.++++.|+..
T Consensus 530 ~l-~----~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 EL-L----EFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HH-H----HHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 1 11222211 112233456788999999999999999999999999884
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=278.99 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=198.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV 590 (804)
.+.+.||+|++|.||+++...++ ..+++|.+... ..+..+.+.+|++++++++ |+||+++++++.+++..++|
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETN---KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCC---CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 35578999999999999987543 37999988642 2234567889999999998 99999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999998888899999999999999999999965 999999999999999999999999999986543221
Q ss_pred -------------------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH
Q 047263 671 -------------------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA 731 (804)
Q Consensus 671 -------------------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 731 (804)
.......++..|+|||.+....++.++||||||++++++++|+.|+........ +.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~-~ 234 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--FQK-I 234 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHH-H
Confidence 122234578899999999888899999999999999999999999875542111 100 0
Q ss_pred HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 047263 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTM----RKVTQ 783 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm----~eVl~ 783 (804)
... ....+......+.+++.+|++.+|++||++ +++++
T Consensus 235 ----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 ----LKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----Hhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000 000111224568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=277.98 Aligned_cols=258 Identities=16% Similarity=0.142 Sum_probs=189.6
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+|.|+++.||++.. .+..+|||++... ..+..+.+..|+++++.++|+||+++++++.+.+..+++|||
T Consensus 6 i~~~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhHhhcCCceEEEEEecC-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 344556666666666544 2347999998753 344567899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 594 LSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
+++++|.+++... ..+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999999999753 4578888999999999999999965 999999999999999999999999998875432211
Q ss_pred -----CccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc----C-
Q 047263 671 -----QTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE----G- 738 (804)
Q Consensus 671 -----~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----~- 738 (804)
.......++..|+|||.+.. ..++.++||||||++++||++|+.||........ .+ ......... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LL-EKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHhccCccccccCc
Confidence 11223446778999999865 3588999999999999999999999975432211 11 100000000 0
Q ss_pred ------cccc----eec----chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 ------ITEA----LVE----FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ------~~~~----~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ..+ .............++.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000 00111112233467889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=285.10 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=202.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|.|++|..|+....+. .||||.+.+..- ...+.+.+|+.+|..++|||||+++.+.......|+|||
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~---~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGT---EVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCc---eEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 456789999999999999876644 799999976432 334568999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+.+|.+.++|..+..+.......+..|+.++++|||.+ .|+|||||++||||+.+.++||+|||++..+. ....
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~ 210 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLM 210 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--cccc
Confidence 999999999999988888888899999999999999954 99999999999999999999999999998764 4455
Q ss_pred cccccCCCccccccccccCCCC-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPIT-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
....+|++.|.|||++.+..+. +++|+||+|++||-|+.|..||+...-.. ..+..+....+-
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------------Lr~rvl~gk~rI- 274 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------------LRPRVLRGKYRI- 274 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------------ccchheeeeecc-
Confidence 6678899999999999988765 79999999999999999999998653211 001111111111
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+.....++-++++.++-.+|.+|+++.+|.+
T Consensus 275 -p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 275 -PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1223456778889999999999999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=271.62 Aligned_cols=239 Identities=21% Similarity=0.227 Sum_probs=183.2
Q ss_pred hHHh--hCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEE--LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~--LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+. ||+|+||.||++.....+ ..+|+|.+........ |+.....+ +|+||+++++.+..++..++|||
T Consensus 18 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 18 IVKKLKLIDGKFGKVSVLKHKPTQ---KLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred cccceeecCCCceEEEEEEEcCCC---cEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 3444 599999999999876554 3688888764321111 22222212 79999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++++|.+++.....+++..+..++.||++||.|||+. +++||||||+||+++.++ .++|+|||++......
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999999999998877899999999999999999999955 899999999999999988 9999999998764322
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
....++..|+|||++.+..++.++||||||++++||++|+.|+....... .....+... ..... .
T Consensus 164 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-----~~~~~-------~ 228 (267)
T PHA03390 164 --SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR-----QQKKL-------P 228 (267)
T ss_pred --ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh-----hcccC-------C
Confidence 22457889999999999899999999999999999999999997443221 111111110 00000 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPT-MRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~eVl~ 783 (804)
........+.+++.+||+.+|.+||+ ++++++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11134457888999999999999995 688763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.78 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=189.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|++|.||+|+....+ ..+|||++.... .....++..|+.++.+.+ |+||+++++++.++...+++||
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTG---HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCC---eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 45678999999999999987543 379999987532 233455677777776665 9999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+.+ +|.+++.. ...+++..+..++.+|++||.|||+. .+|+||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-- 169 (296)
T cd06618 95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-- 169 (296)
T ss_pred ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--
Confidence 9864 67666654 45788999999999999999999952 489999999999999999999999999987653322
Q ss_pred ccccccCCCccccccccccCC----CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 672 THTAIRGTKGYVAPEWFRNMP----ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~----~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||.......+ .+.. ..... ...+..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~~-~~~~~~-- 241 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTK----ILQEE-PPSLPP-- 241 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHH----HhcCC-CCCCCC--
Confidence 122334678999999987553 78899999999999999999999865322211 1111 01111 000000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
......++.+++.+|++.+|++||++.++++.
T Consensus 242 -----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00234568889999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=274.32 Aligned_cols=257 Identities=25% Similarity=0.286 Sum_probs=189.6
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhccc---ccCCccceeeEEeCCCc----
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQT---HHKNLVRLLGFCDDGLN---- 586 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~---- 586 (804)
+.+.||+|+||.||+|+....+ ..+|+|++..... .....+.+|+.++.++ +|+||+++++++.+...
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTG---RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred EEEEecccCceEEEEEEECCCC---CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 4568999999999999987533 3799999974322 2234566777776655 69999999999988776
Q ss_pred -eEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 587 -RLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 587 -~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
.+++|||+.+ +|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 888888653 3589999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhh-------
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC------- 736 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~------- 736 (804)
...... ......++..|+|||.+.+..++.++||||||++++||++|..|+........ +.........
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence 753322 12233468889999999998999999999999999999999988876543221 1111100000
Q ss_pred cCc---ccceecch--hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 737 EGI---TEALVEFD--IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 737 ~~~---~~~~~~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... ...+.... ............+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 00000000 000011123467789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.92 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=195.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.||+|++|.||+|+....+. .+++|.+.... ....+.+..|+.++++++|+||+++++++.+....++|+||
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGE---IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred eehcccccCcceEEEeeecCCCc---EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 45689999999999999875443 79999987643 33346788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
++ ++|.+++... ..+++..+..++.++++||.|||+. +++||||+|+||++++++.++|+|||++........ .
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 98 5899999776 5789999999999999999999965 999999999999999999999999999986543222 2
Q ss_pred cccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHH-------HHHHhhhc-----C
Q 047263 673 HTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTD-------WAYDCYCE-----G 738 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~-------~~~~~~~~-----~ 738 (804)
.....++..|+|||.+.+. .++.++||||||++++||++|+.|+......... .... ..+....+ .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233456789999998766 8899999999999999999999988655432110 0000 00000000 0
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
............ ........+.+++..|++.+|++||++++|+.
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 00112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=258.11 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=202.5
Q ss_pred cccCHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeE
Q 047263 502 HCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGF 580 (804)
Q Consensus 502 ~~~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~ 580 (804)
.+-+|+|+-+-| .+.||+|+|+.|--.+.-..+ .++|||++.+..........+|++++.+.+ |+||+.|+.+
T Consensus 71 ~~g~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~---~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief 144 (463)
T KOG0607|consen 71 LSGKFEDMYKLT---SELLGEGAYASVQTCVSIQTG---KEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF 144 (463)
T ss_pred ccchHHHHHHhH---HHHhcCccceeeeeeeeeccc---hhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH
Confidence 344566766665 578999999999887755433 379999999887777888999999999985 9999999999
Q ss_pred EeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC---EEEe
Q 047263 581 CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN---ARIS 657 (804)
Q Consensus 581 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~---~kl~ 657 (804)
|+++...|||||-|.||+|..+|.+++.+++.+..++..+|+.||.|||. ++|.||||||+|||-.+... +||+
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 99999999999999999999999999999999999999999999999995 59999999999999975543 7999
Q ss_pred ecCcccccccCC--C----CccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH---
Q 047263 658 DFGLAKLLLLDQ--S----QTHTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA--- 723 (804)
Q Consensus 658 Dfgla~~~~~~~--~----~~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~--- 723 (804)
||.+..-..... + ....+..|+..|||||+.. ...|+.+.|.||+|||||-||+|..||.......
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 998875432221 1 1223456888999999863 3468899999999999999999999996653321
Q ss_pred -----HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 724 -----EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 724 -----~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...-.....+...++..+ +.+. .-...+.+..+++...+..++.+|-++.+++.
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYe-FPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYE-FPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCc-CChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111112222111 1111 11122445566777778899999999888875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=311.03 Aligned_cols=245 Identities=27% Similarity=0.332 Sum_probs=197.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
..||.|.||.||-+...+.++ ..|+|.+.... ....+...+|+.++..++|||+|+++|+-.+.+..+|.||||+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGe---llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGE---LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred cccCCcceeeeEEeecCCccc---hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence 469999999999999876654 78888886332 3455678899999999999999999999999999999999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC---c
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ---T 672 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~---~ 672 (804)
+|+|.+.+......++.....+..|++.|++|||++ +||||||||.||+|+.+|-+|++|||.|..+...... .
T Consensus 1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999999999888888888888899999999999976 9999999999999999999999999999987554211 2
Q ss_pred cccccCCCccccccccccC---CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHH-hhhcCcccceecchh
Q 047263 673 HTAIRGTKGYVAPEWFRNM---PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD-CYCEGITEALVEFDI 748 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~---~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~ 748 (804)
.....||+.|||||++.+. ...-+.||||+|||++||+||++||..-..+ |+.- +...+...+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~Pq------ 1461 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHKPQ------ 1461 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCCCC------
Confidence 2346799999999999654 3456899999999999999999999754332 1110 011111111
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.+.....+-.+++.+|++.||++|-++.|+++.
T Consensus 1462 ---~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 ---IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 122255667789999999999999888777653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.34 Aligned_cols=262 Identities=20% Similarity=0.207 Sum_probs=189.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCC---------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--------- 584 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--------- 584 (804)
+.+.+.||+|+||.||+|.....+ ..||+|++.....+..+.+.+|++++++++|+||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~---~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCD---KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCC---cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 445678999999999999886543 37999998765556667889999999999999999999876543
Q ss_pred -----CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEEee
Q 047263 585 -----LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISD 658 (804)
Q Consensus 585 -----~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl~D 658 (804)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+. +++||||||+||+++ +++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 588888854 4678999999999999999999965 999999999999997 456789999
Q ss_pred cCcccccccCCCC--ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH----
Q 047263 659 FGLAKLLLLDQSQ--THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA---- 731 (804)
Q Consensus 659 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~---- 731 (804)
||++..+...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999765322111 1122346888999997654 56888999999999999999999999755432211100000
Q ss_pred ----HHhhhcCcccceecchhhhcc-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 732 ----YDCYCEGITEALVEFDIEALN-----DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 732 ----~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..................... ......++.+++..|++.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000000000000 0112356788999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=279.68 Aligned_cols=262 Identities=23% Similarity=0.243 Sum_probs=188.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCC------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------ 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 585 (804)
+.+.++||+|+||.||+|+....+. .+++|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGR---VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCc---EEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 3456789999999999999765443 699998864322 22345788999999999999999999875443
Q ss_pred --ceEEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 586 --NRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 586 --~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
..++|+||+.. +|...+.. ...+++..+..++.|+++||.|||. .+++|+||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 35899999976 56666654 4578999999999999999999995 49999999999999999999999999999
Q ss_pred cccccCCCC----------ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH
Q 047263 663 KLLLLDQSQ----------THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA 731 (804)
Q Consensus 663 ~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 731 (804)
+........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 865432211 1122346788999998765 45889999999999999999999998755433211110000
Q ss_pred HHhhhcCc------cccee----c----chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 732 YDCYCEGI------TEALV----E----FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 732 ~~~~~~~~------~~~~~----~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+.. ..... . ..... ........+.+++.+|++.+|++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 00000 0 00000 00112256889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=259.29 Aligned_cols=280 Identities=21% Similarity=0.252 Sum_probs=197.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccc-cceeEEEEEcccccc-cc-HHHHHHHHHHhcccccCCccceeeEEeC-CCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASM-YQVPVAVKKLHSVIQ-DG-VKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~-~~~~vavK~~~~~~~-~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l 589 (804)
++...+||+|.||.|||++..+... ....+|+|+++.... .+ -...-+|+.+++.++|+||+.+..++.. +...+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 3456789999999999996654432 234799999985422 12 2345689999999999999999998877 788899
Q ss_pred EEeecCCCcHHHhhcCC-----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC----CCEEEeecC
Q 047263 590 VYEFLSNGTLASFLFGD-----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY----YNARISDFG 660 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~----~~~kl~Dfg 660 (804)
++||.+. +|..+|+.+ +.++......|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999987 677777532 4567788899999999999999965 99999999999999877 999999999
Q ss_pred cccccccCCC--CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH------HHHHHH
Q 047263 661 LAKLLLLDQS--QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA------LLTDWA 731 (804)
Q Consensus 661 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~------~l~~~~ 731 (804)
+++++...-. .....+.-|..|.|||.+.+ ..|+.+.|||+.|||+.||++-.+.|......... .....+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 9999865332 23344567899999998876 57999999999999999999998877554322110 011111
Q ss_pred HHhh---hcCcc----------cceecchhhhcccH---HH-------HHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 732 YDCY---CEGIT----------EALVEFDIEALNDK---KK-------LARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 732 ~~~~---~~~~~----------~~~~~~~~~~~~~~---~~-------~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.+.+ .+... ..+.+.......+. .. ....++|...+|+.||.+|.|.++.++-. -.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF 340 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YF 340 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-cc
Confidence 1111 00000 01111111111110 00 12256788889999999999999877643 23
Q ss_pred ccCCCCCCCC
Q 047263 789 VEVLDPPCPC 798 (804)
Q Consensus 789 ~~~~~pp~P~ 798 (804)
.+-+.||.|.
T Consensus 341 ~~d~lpp~pt 350 (438)
T KOG0666|consen 341 TEDPLPPLPT 350 (438)
T ss_pred ccCCCCCCcc
Confidence 4455566664
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=270.10 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=189.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||+++...........++|..... ......++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 34567899999999999987654332222333333221 1223345778999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 592 EFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 592 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++ +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998853 35689999999999999999999954 9999999999999975 5699999999876533
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. .......++..|+|||.+....++.++|+||||+++++|++|..|+........ . . . ...+...
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~-~---~-~~~~~~~------ 223 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--V-L---R-IVEGPTP------ 223 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--H-H---H-HHcCCCC------
Confidence 22 222334578899999999888899999999999999999999999864432111 0 0 0 0111111
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+|++.+|++||++.++++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 012233457888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=267.65 Aligned_cols=237 Identities=28% Similarity=0.293 Sum_probs=192.4
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
||+|+||.||++.....+ ..+++|.+..... .....+..|+.++++++|+||+++++.+..+...++||||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG---KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCC---cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 699999999999886533 3799998865322 2455789999999999999999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
++|.+++.....+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 9999999887788999999999999999999996 499999999999999999999999999998654322 223345
Q ss_pred cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHH
Q 047263 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKK 756 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (804)
.++..|++||...+...+.++|+||||++++||++|+.|+....... .. ... ... . .. .+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~-~~~----~~~---~---~~----~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IY-EKI----LKD---P---LR----FPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HH-HHH----hcC---C---CC----CCCCC
Confidence 67889999999988889999999999999999999999996554311 11 100 000 0 00 01111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 047263 757 LARFVMVAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 757 ~~~l~~l~~~Cl~~dP~~RPsm~e 780 (804)
...+.+++.+|+..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 456788999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=297.21 Aligned_cols=249 Identities=29% Similarity=0.401 Sum_probs=186.2
Q ss_pred hhhH--HhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeC-------
Q 047263 514 NGFK--EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD------- 583 (804)
Q Consensus 514 ~~f~--~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------- 583 (804)
.+|. +.||+||||.|||++.+-++. .+|||++.... .+......+|+..+++|+|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr---~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGR---EYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccch---hhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3454 479999999999999876544 79999997543 3445678899999999999999999765211
Q ss_pred --------------------------------------------------------------------------------
Q 047263 584 -------------------------------------------------------------------------------- 583 (804)
Q Consensus 584 -------------------------------------------------------------------------------- 583 (804)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CceEEEEeecCCCcHHHhhcCCCCC-ChhhHHHHHHHHHHHHHHhhh
Q 047263 584 ------------------------G--------LNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHE 630 (804)
Q Consensus 584 ------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~gL~yLH~ 630 (804)
+ ...||=||||+.-+|.+++..+... .-...+++..+|+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1136789999998888888766544 466788999999999999996
Q ss_pred ccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc------c-----------CCCCccccccCCCccccccccccC--
Q 047263 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL------L-----------DQSQTHTAIRGTKGYVAPEWFRNM-- 691 (804)
Q Consensus 631 ~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~l~~~-- 691 (804)
. +||||||||.||+||++..+||+|||++.... . ......+...||.-|+|||.+.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 5 89999999999999999999999999998721 0 011234557799999999999765
Q ss_pred -CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHcccc
Q 047263 692 -PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQE 770 (804)
Q Consensus 692 -~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~ 770 (804)
.|+.|+|+||+||||+||+. ||....+... .+ ..++.+....- .....++...-.+++.+++++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~-iL-----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS-IL-----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHH-HH-----HhcccCCCCCC------cccccccchHHHHHHHHHhcC
Confidence 49999999999999999984 4655443321 11 11122211111 112223444556799999999
Q ss_pred CCCCCCCHHHHHH
Q 047263 771 DPSLRPTMRKVTQ 783 (804)
Q Consensus 771 dP~~RPsm~eVl~ 783 (804)
||.+|||+.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=271.99 Aligned_cols=239 Identities=26% Similarity=0.280 Sum_probs=192.0
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
-+.||+|+||.||-.+....++ .+|.|++.+.. .+++.-..+|-.++.+++.+.||.+--.++..+..+||+..
T Consensus 190 ~RvlGkGGFGEV~acqvraTGK---MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGK---MYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eEEEecccccceeEEEEecchh---hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 3579999999999988876654 78888886432 23445578899999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|.||+|.-+|.... .++++....++.+|+.||++||.. +||.|||||+|||||+.|+++|+|+|+|..+.. .+
T Consensus 267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--g~ 341 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--GK 341 (591)
T ss_pred ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC--CC
Confidence 99999999998654 778899999999999999999955 999999999999999999999999999987643 33
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||.+|||||++++..|+...|.||+||+||||+.|+.||....+.... .+.. .+... ..
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr------------r~~~~--~~ 407 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR------------RTLED--PE 407 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH------------HHhcc--hh
Confidence 334448999999999999999999999999999999999999999755443221 1111 00000 11
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPT 777 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs 777 (804)
..+..-++++..+...-|+.||.+|--
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 122334456666777778999998853
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=280.15 Aligned_cols=263 Identities=22% Similarity=0.239 Sum_probs=189.9
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhccc-ccCCccceeeEEeCC----Cce
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG----LNR 587 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~----~~~ 587 (804)
.+.+.||+|+||.||++...... .+..+|+|++..... ...+.+.+|+++++++ +|+||+++++.+... ...
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCC-cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 34578999999999999986541 134799999874322 2345688899999999 599999999975432 456
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++++||+. ++|.+++.....+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++.+..
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 78888886 68999998888899999999999999999999954 999999999999999999999999999986543
Q ss_pred CCCC---ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-------------HHHHH
Q 047263 668 DQSQ---THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-------------LLTDW 730 (804)
Q Consensus 668 ~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-------------~l~~~ 730 (804)
.... ......|+..|+|||.+.+ ..++.++||||||+++++|++|+.||......... .+...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 1223468899999998765 46899999999999999999999998754322100 00000
Q ss_pred HHHhhhcC--cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 731 AYDCYCEG--ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 731 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........ ............ ........+.+++.+|++.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 000000000000 00112356889999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=253.89 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=191.5
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+...||.|..|.|+|...+..+. .+|||.+.... .+..+.+...+.++.+-+ +|.||+.+|||..+...++.||.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~---iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGH---IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hHHhhcCCCccceEEEEEcccce---EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 56789999999999999876543 79999997643 344566777787777665 99999999999999999999998
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|.. -++++|+. ...+++...-++...+.+||.||.+. .+|+|||+||+|||+|+.|++|++|||++..+- ++..
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSkA 247 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSKA 247 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceee--cccc
Confidence 853 45555543 34567777779999999999999874 699999999999999999999999999998653 4555
Q ss_pred cccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 HTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.+...|-+.|||||.+. ...|+.++||||||+.++||.||..|+.....+.+..- . + + +.... .+.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-k-v---l-n~ePP-----~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-K-V---L-NEEPP-----LLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-H-H---H-hcCCC-----CCC
Confidence 66677889999999985 34789999999999999999999999987544432211 1 1 1 11111 111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ..-+..+.+++..||++|+.+||...++++
T Consensus 317 ~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 113456788999999999999999887764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=279.41 Aligned_cols=265 Identities=23% Similarity=0.255 Sum_probs=190.4
Q ss_pred HHHHHHHhhh--HHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEe
Q 047263 507 KDLEAATNGF--KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCD 582 (804)
Q Consensus 507 ~~l~~at~~f--~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 582 (804)
.++...+++| .+.||+|+||.||++.....+ ..||+|++.... ....+.+.+|+.++.+++|+||+++++++.
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG---LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCC---eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3444444444 467999999999999876443 479999987532 223456888999999999999999999885
Q ss_pred CC------CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEE
Q 047263 583 DG------LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656 (804)
Q Consensus 583 ~~------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl 656 (804)
.. ...+++++++ +++|.+++.. ..+++..+..++.||++||.|||+. +++||||||+||++++++.+||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 43 3467888876 7899888754 4689999999999999999999965 9999999999999999999999
Q ss_pred eecCcccccccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHH----
Q 047263 657 SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDW---- 730 (804)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~---- 730 (804)
+|||++..... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||......... .+...
T Consensus 162 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 162 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred ecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999875422 2233457889999998866 56889999999999999999999998644322110 00000
Q ss_pred ---HHHhhhcCcccce-------ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 731 ---AYDCYCEGITEAL-------VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 731 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
............. ...... .........+.+++.+|++.+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000 000000 0000124567899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=280.31 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=192.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC------c
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------N 586 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 586 (804)
.+.+.||+|+||.||++.....+ ..||||++.... ....+.+.+|+.++++++|+||+++++++..+. .
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 18 RDLKQVGSGAYGTVCSALDRRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred EEEEEeeecCCeEEEEEEECCCC---cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 34568999999999999876443 379999986432 223456889999999999999999999986553 3
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.++||||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999998 6799888854 5688999999999999999999954 99999999999999999999999999997643
Q ss_pred cCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH-HHHHH---HHhhhcCcc-
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTDWA---YDCYCEGIT- 740 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~~~---~~~~~~~~~- 740 (804)
. ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||.......... ..... ...+.+...
T Consensus 170 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 170 S----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred c----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 2 1223456889999999876 458899999999999999999999997543221100 00000 000000000
Q ss_pred ---c-------ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhhcCccCC
Q 047263 741 ---E-------ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT--QMLEGVVEVL 792 (804)
Q Consensus 741 ---~-------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl--~~Le~~~~~~ 792 (804)
. ........ .........+.+++.+|++.||++|||+.+++ ..++...+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred hhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 0 00000000 00011234578999999999999999999998 4555544443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=258.33 Aligned_cols=239 Identities=27% Similarity=0.278 Sum_probs=195.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
.+|.+.||+|.||+|...+-+..++ .+|+|++++... +...+-..|-++++..+||.+..+.-.+...++.++|
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k---~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGK---LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCc---eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3578999999999999988765544 799999976432 3345567899999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+.||.|.-+|.+.+.+++.....+...|+.||.||| +.+||.||||.+|.|||.+|++||+|||+++.- ....
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKYG 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc-cccc
Confidence 999999999999998889999999999999999999999 459999999999999999999999999999853 2345
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
....+.+||+.|+|||++....|..++|.|.+||++|||++|+.||.....+.-..+.- .+.+
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl----------~ed~------- 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL----------MEDL------- 385 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH----------hhhc-------
Confidence 66778999999999999999999999999999999999999999998654432111110 0111
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP 776 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP 776 (804)
..+.....+...|....|.+||.+|-
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11222233455566667899999995
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=281.99 Aligned_cols=255 Identities=23% Similarity=0.285 Sum_probs=189.6
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCc------e
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN------R 587 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 587 (804)
+.+.||+|++|.||+|+...++. .+|+|++.... ....+.+.+|+.++++++|+||+++++++...+. .
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGR---KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCc---EEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 45689999999999999875443 79999986432 2334567889999999999999999998866654 8
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||++.....
T Consensus 96 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 9999998 5699998865 5689999999999999999999954 999999999999999999999999999986532
Q ss_pred CCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHH---HhhhcCcc--
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAY---DCYCEGIT-- 740 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~---~~~~~~~~-- 740 (804)
. .....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ..+..... ..+.++..
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred c----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 2 233457888999999865 3678999999999999999999999865433211 00000000 00000000
Q ss_pred --cceec-------chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 --EALVE-------FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 --~~~~~-------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+.. ...... .......+.+++.+|++.+|++|||+.+|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 000000 0112567889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=275.33 Aligned_cols=258 Identities=23% Similarity=0.279 Sum_probs=188.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeC-CCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~ 591 (804)
.+.+.||+|+||.||++.....+. .+|+|++... .....+.+..|++++.+++||||+++++++.. ....++++
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQLTGQ---NVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred EEEEeecccCCeEEEEEEECCCCC---EEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 345789999999999998765433 7999987542 22345678899999999999999999998865 56789999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+ +++|.+++.. ..+++.....++.|+++||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 998 5689888854 4567888889999999999999954 999999999999999999999999999875322
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHH-------HHhhhcCcccc
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWA-------YDCYCEGITEA 742 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~-------~~~~~~~~~~~ 742 (804)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||......... .+.... ......+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 1123456788999998865 57899999999999999999999998654432111 110000 00000000000
Q ss_pred e-ecchhhhccc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 743 L-VEFDIEALND-----KKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 743 ~-~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
+ .........+ ......+.+++.+|++.+|++||++++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000001 1123678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=280.92 Aligned_cols=198 Identities=30% Similarity=0.416 Sum_probs=169.1
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCC------ceEE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------NRLL 589 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 589 (804)
.+.||+|+||.||+|+.+.. ++.||||.+..... ...+....|++++++++|+|||++++.-++.. ...+
T Consensus 18 ~e~LG~Ga~g~V~rgrnket---G~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKET---GRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred hhhhcCCccceeeeeccccc---ccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 57899999999999997644 44899999986443 23445789999999999999999999876544 4689
Q ss_pred EEeecCCCcHHHhhcCC---CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc--CCCC--EEEeecCcc
Q 047263 590 VYEFLSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD--DYYN--ARISDFGLA 662 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~--~~~~--~kl~Dfgla 662 (804)
|||||.+|||...|.+. ..+++.+.+.+..+++.||.|||++ +|+||||||.||++- ++|+ .||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999764 4578999999999999999999977 999999999999994 3444 599999999
Q ss_pred cccccCCCCccccccCCCccccccccc-cCCCCccchhhHHHHHHHHHHcCCCCCCcchhH
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFR-NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE 722 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~ 722 (804)
+.+.. ........||..|++||... .+.|+..+|.|||||++||++||..||......
T Consensus 172 rel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 97643 33667788999999999998 488999999999999999999999999765443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=264.85 Aligned_cols=244 Identities=28% Similarity=0.305 Sum_probs=198.0
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCC
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG 584 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 584 (804)
+..+..+|...||+|+||.|..+..+...+ .+|||++++.. ....+--+.|-++|+.. +-|.++.++.++...
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdE---LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDE---LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcch---hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 344446899999999999999998775544 79999997543 23344456788888877 577899999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
++.|+||||+.+|+|--++++-.++.+.....+|..||-||-+|| +++|+.||||.+|||||.+|++||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999999999988888999999999999999999999 55999999999999999999999999999985
Q ss_pred cccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
- .-......+.+||+.|+|||.+...+|...+|.|||||+||||+.|..||+.+.+++-... +.+.
T Consensus 500 n-i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a-----------I~eh-- 565 (683)
T KOG0696|consen 500 N-IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA-----------IMEH-- 565 (683)
T ss_pred c-ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-----------HHHc--
Confidence 2 2234455678999999999999999999999999999999999999999998876542111 0111
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCC
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRP 776 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 776 (804)
...++...+.+...+...-+.+.|.+|-
T Consensus 566 ----nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ----NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1122334455666677777888888874
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-31 Score=257.15 Aligned_cols=261 Identities=26% Similarity=0.312 Sum_probs=198.8
Q ss_pred cccccCHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhccc-ccCCccce
Q 047263 500 NLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HHKNLVRL 577 (804)
Q Consensus 500 ~~~~~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l 577 (804)
....|+-.+|+. ..+||.|.||+|+|-..+..+ +.+|||+++.... ...+++..|.+...+- ++||||++
T Consensus 57 ~~~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk~sg---~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 57 HLHTFTSDNLQD-----LGEIGNGAFGTVNKMLHKPSG---KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred cccccccchHHH-----HHHhcCCcchhhhhhhcCccC---cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 355666666664 358999999999998876544 4899999986544 4556788888766555 79999999
Q ss_pred eeEEeCCCceEEEEeecCCCcHHHhhc-----CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC
Q 047263 578 LGFCDDGLNRLLVYEFLSNGTLASFLF-----GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652 (804)
Q Consensus 578 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~ 652 (804)
+|.+..+...++.||.|.- ||+.+-+ .+..+++...-+|......||.||.+. ..|||||+||+||||+..|
T Consensus 129 yGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G 205 (361)
T KOG1006|consen 129 YGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHG 205 (361)
T ss_pred hhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCC
Confidence 9999999999999999964 6665432 346678888888999999999999874 6899999999999999999
Q ss_pred CEEEeecCcccccccCCCCccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH
Q 047263 653 NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW 730 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 730 (804)
.+||+|||.+..+.. +...+.-.|-..|||||.+.. ..|+.++||||+|+.|+|+.||+.|+.......+.. ..
T Consensus 206 ~vKLCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql-~~- 281 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL-CQ- 281 (361)
T ss_pred CEeeecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH-HH-
Confidence 999999999976532 333344567788999999953 358999999999999999999999987654422211 11
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+....+.. .....+....+..++-.|+.+|.++||...++.+
T Consensus 282 ----Vv~gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 282 ----VVIGDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----HHcCCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11222222211 1223345678889999999999999999988754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.86 Aligned_cols=222 Identities=21% Similarity=0.137 Sum_probs=176.5
Q ss_pred CcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCCcHHHh
Q 047263 523 GAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASF 602 (804)
Q Consensus 523 G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 602 (804)
|.+|.||+++...++. .+|+|++.... ++..|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~---~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQ---TFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCc---EEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999875544 79999987532 234455555566799999999999999999999999999999999
Q ss_pred hcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCcc
Q 047263 603 LFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682 (804)
Q Consensus 603 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 682 (804)
+.....+++.....++.|++.||.|||+. +++||||||+||+++.++.++++|||.+..+... .....++..|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 98777889999999999999999999954 9999999999999999999999999987654321 1223456789
Q ss_pred ccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHH
Q 047263 683 VAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVM 762 (804)
Q Consensus 683 ~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 762 (804)
+|||.+....++.++||||+|+++|||++|+.++........ .. ....+ +......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~-----~~~~~----~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH-----TTLNI----PEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc-----cccCC----cccCCHHHHH
Confidence 999999888899999999999999999999987643211100 00 00001 1112356788
Q ss_pred HHHHccccCCCCCCCHHH
Q 047263 763 VAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 763 l~~~Cl~~dP~~RPsm~e 780 (804)
++.+|++.||++||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=277.99 Aligned_cols=237 Identities=26% Similarity=0.292 Sum_probs=190.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.|...+|.|+|+.|-++....... ..++|++... ..+-.+|+.++... +|+||+++.+.+.++.+.++|||
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~---~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQ---EPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hccccccCCCCccceeeeecccccc---chhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4566779999999999988765544 6889998764 22335677666555 79999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE-cCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL-DDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl-~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
.+.++-|.+.+....... .++..|+.+|+.++.|||++ +++||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999999988887666555 77888999999999999965 99999999999999 58999999999999876543
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
....+-|..|.|||++....+++++|+||||++||+||+|+.|+....... ... . .+.. ..
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-ei~-~------------~i~~----~~ 530 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-EIH-T------------RIQM----PK 530 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-HHH-H------------hhcC----Cc
Confidence 333456889999999999999999999999999999999999997553331 111 0 0001 11
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+....+|+.+||+.||.+||+|.++..
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11344567788999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=254.69 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=199.7
Q ss_pred hhHHhhCCCcceeEEEeeecCcccc--ceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeC-CCceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMY--QVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~--~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV 590 (804)
..+..+-+|.||.||+|.+.+.+.. .+.|.+|.++.. ++-....+..|...+..+.|||+..+.+.+.+ ....+.+
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 3456799999999999988654422 345777777643 23345578899999999999999999998855 4667899
Q ss_pred EeecCCCcHHHhhc-----C---CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 591 YEFLSNGTLASFLF-----G---DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~-----~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
|.++.-|+|..+|. + .+.++-.+...++.|++.|++|||.+ ++||.||..+|.++|+..++||+|=.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence 99999999999997 2 24556677889999999999999954 9999999999999999999999999999
Q ss_pred cccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcc
Q 047263 663 KLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGIT 740 (804)
Q Consensus 663 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (804)
+.+...+.. ..........||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+-.. ++++|
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-------ylkdG-- 514 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-------YLKDG-- 514 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-------HHhcc--
Confidence 976543322 2233445678999999999999999999999999999998 667766554443211 11222
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.+-..+.+...++..++.-||...|++||++++++.-|.+
T Consensus 515 -------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 515 -------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1222345567789999999999999999999999998865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=260.69 Aligned_cols=254 Identities=25% Similarity=0.289 Sum_probs=194.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---c----ccHHHHHHHHHHhcccccCCccceeeEE-eCCC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---Q----DGVKEFKTEVNVIGQTHHKNLVRLLGFC-DDGL 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~----~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~ 585 (804)
+-+...||+|||+.|||+..-... +.||||+-.-.. . .-.+...+|..+-+.|.||.||++++++ .+.+
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~Eq---RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQ---RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchh---heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 344578999999999999875443 368888754211 1 1123467899999999999999999998 4566
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc---CCCCEEEeecCcc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLA 662 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfgla 662 (804)
..+-|+||++|.+|+-+|+.++.+++.+...|+.||+.||.||.+. +.+|||-||||.||||. .-|.+||.|||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 7889999999999999999999999999999999999999999988 89999999999999994 4578999999999
Q ss_pred cccccCCCC------ccccccCCCcccccccccc----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH
Q 047263 663 KLLLLDQSQ------THTAIRGTKGYVAPEWFRN----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY 732 (804)
Q Consensus 663 ~~~~~~~~~------~~~~~~gt~~y~aPE~l~~----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 732 (804)
+++..+... ......||..|++||.+-- ..++.|+||||.|||+|+.+.|+.||.......+-+....+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI- 699 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI- 699 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch-
Confidence 998654432 2334679999999998743 35789999999999999999999999876544321110000
Q ss_pred HhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
+...-+.+. ..+....+...++.+||+..-++|....++.
T Consensus 700 ------lkAtEVqFP----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 700 ------LKATEVQFP----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ------hcceeccCC----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 000001111 1112234667799999999999998776654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=257.48 Aligned_cols=239 Identities=27% Similarity=0.298 Sum_probs=192.9
Q ss_pred cceeEEEeeecCccccceeEEEEEcccccccc-HHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCCcHHHh
Q 047263 524 AFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASF 602 (804)
Q Consensus 524 ~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 602 (804)
+||.||+++....+ ..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTG---KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999987533 379999998654444 68899999999999999999999999999999999999999999999
Q ss_pred hcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCcc
Q 047263 603 LFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682 (804)
Q Consensus 603 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 682 (804)
+.....+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 98766689999999999999999999965 99999999999999999999999999998764332 33345578899
Q ss_pred ccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHH
Q 047263 683 VAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVM 762 (804)
Q Consensus 683 ~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 762 (804)
++||.+....++.++|||+||+++++|++|..|+....... ...... ........ ........++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~----~~~~~~~~-------~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKI----GKPKPPFP-------PPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH----hccCCCCc-------cccccCCHHHHH
Confidence 99999998889999999999999999999999987532111 111111 01100000 000003457889
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 047263 763 VAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 763 l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=293.46 Aligned_cols=143 Identities=29% Similarity=0.357 Sum_probs=127.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.++||+|+||.||+|.....+ ..||||++.... ....+.+..|+.+++.++|+||+++++.+......+|||
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNS---KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCC---cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 35678999999999999987543 379999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
||+.+++|.+++.....+++...+.|+.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998777889999999999999999999954 99999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=285.18 Aligned_cols=204 Identities=24% Similarity=0.273 Sum_probs=181.6
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
...+.+.+.||+|+||.|..++.+.... .+|+|++.+. .......|.+|..+|..-+.+=|+.++-.|.++.+.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~---VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEK---VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeecccc---chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 3445678899999999999999876554 7899999863 234456799999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
|||||||+||+|..+|.....++......++..|.-||.-|| +.|+|||||||+|||||..|++||+|||-+..+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999999988778999999999999999999999 56999999999999999999999999999988877
Q ss_pred CCCCccccccCCCccccccccc----c-CCCCccchhhHHHHHHHHHHcCCCCCCcch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFR----N-MPITVKVDVYSFGVLLLEIICCRRNVDMEV 720 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~ 720 (804)
+..-.....+||+.|++||+++ + +.|....|.||+||++|||+.|..||..+.
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 7766677788999999999995 2 578899999999999999999999998653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=261.03 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=188.5
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.||.|-||+||-|+.+..+ +.||||.+.+. ..+...+.++|+.++++++||.||.+.-.|+..+..++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktG---rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTG---RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccC---ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 467999999999999987554 47999999753 2355678999999999999999999999999999999999999
Q ss_pred CCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCcccccccCCC
Q 047263 595 SNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 595 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~~ 670 (804)
.|.=|.-+|.. +.+++...-..++.||+.||.|||.. +|+|+||||+||||.+ --.+||+|||+|+.++...
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 66555555543 46778888888999999999999954 9999999999999964 3469999999999875433
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
-.....||+.|+|||+++++.|...-|+||.|||+|--|+|-.||.....-.+.+.. + ......
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--A-------------aFMyPp 785 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--A-------------AFMYPP 785 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc--c-------------ccccCC
Confidence 344578999999999999999999999999999999999999999754322221110 0 011111
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eV 781 (804)
..-.+.....++++...||..-++|-|..+-
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 1122334556677777777777778776543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=243.29 Aligned_cols=244 Identities=23% Similarity=0.230 Sum_probs=188.0
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeC----CCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD----GLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~E 592 (804)
++||-|-.|.|-....+..++ .+|+|.+... ...++|+++-... .|+|||.++++++. ....++|||
T Consensus 68 qvLG~GinGkV~~C~~k~T~e---kfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQE---KFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEEEeccchh---hhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 689999999999888765544 7999998753 2336677776665 59999999998854 355689999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc---CCCCEEEeecCccccccc
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLAKLLLL 667 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfgla~~~~~ 667 (804)
.|+||.|...+.++ ..+++.+.-.|+.||+.|+.||| +.+|.||||||+|+|.. .|..+||+|||+|+....
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 99999999999866 45889999999999999999999 55999999999999996 455689999999996432
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....+.+-|+.|.|||++....|+...|+||+||++|-||+|-+||.........- -.. .++......+
T Consensus 217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp---gMk----~rI~~gqy~F- 286 (400)
T KOG0604|consen 217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMK----RRIRTGQYEF- 286 (400)
T ss_pred --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh---hHH----hHhhccCccC-
Confidence 334455667999999999999999999999999999999999999997665422100 000 1111111111
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....-...++...+++...|..+|.+|-|+++++.
T Consensus 287 -P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 287 -PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11112234566778888899999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=271.03 Aligned_cols=257 Identities=21% Similarity=0.215 Sum_probs=173.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCc-------------cccceeEEEEEccccccccHHH--------------HHHHHHHh
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA-------------SMYQVPVAVKKLHSVIQDGVKE--------------FKTEVNVI 566 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~-------------~~~~~~vavK~~~~~~~~~~~~--------------f~~E~~~l 566 (804)
+.+.++||+|+||.||+|..... ...++.||||++........++ +..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 34467899999999999975221 1234579999987543322233 34467777
Q ss_pred cccccCCc-----cceeeEEeC--------CCceEEEEeecCCCcHHHhhcCC------------------------CCC
Q 047263 567 GQTHHKNL-----VRLLGFCDD--------GLNRLLVYEFLSNGTLASFLFGD------------------------LKP 609 (804)
Q Consensus 567 ~~l~h~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~------------------------~~l 609 (804)
.+++|.++ ++++++|.. ....+|||||+++++|.++|+.. ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766654 678888753 35689999999999999998642 123
Q ss_pred ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCccccccccc
Q 047263 610 GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689 (804)
Q Consensus 610 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 689 (804)
+|..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 5677889999999999999954 8999999999999999999999999999765432222222233478999999875
Q ss_pred cCCC----------------------CccchhhHHHHHHHHHHcCCC-CCCcchhHH------HHHHHHHHHHhhhcCcc
Q 047263 690 NMPI----------------------TVKVDVYSFGVLLLEIICCRR-NVDMEVNEA------EALLTDWAYDCYCEGIT 740 (804)
Q Consensus 690 ~~~~----------------------s~~~DV~S~Gvll~elltG~~-p~~~~~~~~------~~~l~~~~~~~~~~~~~ 740 (804)
.... ..+.||||+||+++||++|.. |+....... ...+.. |+.....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~r~~~~~-- 459 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--WRMYKGQ-- 459 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--HHhhccc--
Confidence 3221 134799999999999999875 554221111 011111 1111111
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDP---SLRPTMRKVTQ 783 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPsm~eVl~ 783 (804)
..+... .........+++..++..+| .+|+|++|+++
T Consensus 460 --~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 --KYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred --CCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111 11123567788888888765 68999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=278.44 Aligned_cols=262 Identities=20% Similarity=0.174 Sum_probs=165.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCc-cccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeE------EeCCCc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA-SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGF------CDDGLN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~------~~~~~~ 586 (804)
+.+.++||+|+||.||+|+...+ ...+..||+|++..... .+.+..| .+....+.+++.++.. +.++..
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 34567899999999999998754 12234799999864321 1111222 1122222222222221 345678
Q ss_pred eEEEEeecCCCcHHHhhcCCCCC--------------------ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKP--------------------GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l--------------------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
.++||||+.+++|.+++...... ....+..++.||+.||.|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 89999999999999998643210 1223457899999999999954 999999999999
Q ss_pred EEcC-CCCEEEeecCcccccccCCCCccccccCCCccccccccccC----------------------CCCccchhhHHH
Q 047263 647 LLDD-YYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM----------------------PITVKVDVYSFG 703 (804)
Q Consensus 647 Ll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~~~DV~S~G 703 (804)
|+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 68999999999987654444444556789999999965321 234567999999
Q ss_pred HHHHHHHcCCCCCCcchhHHHHHHHHH--HHHhhhcCcccceecchhhhcc--cHHHHHHHHHHHHHccccCCCCCCCHH
Q 047263 704 VLLLEIICCRRNVDMEVNEAEALLTDW--AYDCYCEGITEALVEFDIEALN--DKKKLARFVMVAIWCIQEDPSLRPTMR 779 (804)
Q Consensus 704 vll~elltG~~p~~~~~~~~~~~l~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 779 (804)
|+||||+++..+.+.........+... ....+....... ......... .........+|+.+||+.||++|||+.
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 999999998766543321111111000 000010000000 000000000 000122345899999999999999999
Q ss_pred HHHH
Q 047263 780 KVTQ 783 (804)
Q Consensus 780 eVl~ 783 (804)
++++
T Consensus 446 e~L~ 449 (566)
T PLN03225 446 AALA 449 (566)
T ss_pred HHhC
Confidence 9986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=270.39 Aligned_cols=249 Identities=24% Similarity=0.299 Sum_probs=201.4
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEe-----CCCc
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCD-----DGLN 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~-----~~~~ 586 (804)
+..|.+.||.|.+|.|||++....+. ..|+|++... ....++...|.++++.+ .|||++.++|++. .++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~---~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQ---LAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCc---eeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34567899999999999998775543 6888887754 44556778899999888 6999999999884 3577
Q ss_pred eEEEEeecCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 587 RLLVYEFLSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
++||||||.+||..|+++. ...+.|..+..|++.++.|+.+||.. .++|||||-.||||++++.+|+.|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 8999999999999999975 46788999999999999999999954 999999999999999999999999999987
Q ss_pred cccCCCCccccccCCCccccccccccC-----CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNM-----PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
+.... ....+..||+.|||||++... .|+.++|+||+|++..||.-|.+|+....+-...
T Consensus 173 ldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------------- 237 (953)
T KOG0587|consen 173 LDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------------- 237 (953)
T ss_pred eeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh--------------
Confidence 64332 234456799999999999643 5778999999999999999999998755432211
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+......+.....++.+++..||.+|-+.||++.++++
T Consensus 238 F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11112223333446678899999999999999999999988764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-29 Score=260.50 Aligned_cols=237 Identities=23% Similarity=0.241 Sum_probs=194.9
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccc---cccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS---VIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
..||-|+||.|=..+...... ..|+|.+++ ...+..++...|-.+|.+.+.+.||+++..+.+....||+||-|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~---~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKA---TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhcccCccceEEEEEecccch---HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 459999999999888765432 356666643 34455677889999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
-||.|...|.++..++......++..+.+|+.||| +++||+|||||+|.+||.+|-+||.|||+|+.+. ...+.-
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~KTw 577 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGRKTW 577 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc--cCCcee
Confidence 99999999999999999999999999999999999 5599999999999999999999999999999864 455667
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
+++||+.|.|||++.++..+.++|.||+|+++|||++|++||....+-..-.+ ...++.. -..+.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILkGid~--------i~~Pr 642 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILKGIDK--------IEFPR 642 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHhhhhh--------hhccc
Confidence 78999999999999999999999999999999999999999987765432211 1111111 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCC
Q 047263 755 KKLARFVMVAIWCIQEDPSLRPT 777 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RPs 777 (804)
.......+++.+....+|.+|--
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhc
Confidence 23345566777777899999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=249.09 Aligned_cols=268 Identities=21% Similarity=0.292 Sum_probs=201.1
Q ss_pred cCHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc--C----Cccce
Q 047263 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH--K----NLVRL 577 (804)
Q Consensus 504 ~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h--~----niv~l 577 (804)
|...|.....+.+.+.+|+|.||.|-+...... ...||||+++... +..+.-+-|+++++++.+ | -+|.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~---~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRET---KEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCC---CceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 445566667777889999999999999877654 4589999998763 334556889999999942 2 26778
Q ss_pred eeEEeCCCceEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc------
Q 047263 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD------ 649 (804)
Q Consensus 578 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~------ 649 (804)
.+++.-.++.++|+|.+ |-|+.++|..+ ..++...+..|+.|++++++|||+. +++|-||||+|||+.
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence 88899999999999987 55999999876 4567889999999999999999954 999999999999993
Q ss_pred --------------CCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCC
Q 047263 650 --------------DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRN 715 (804)
Q Consensus 650 --------------~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p 715 (804)
++..+||+|||-|+... +.......|..|.|||++.+-.++..+||||+||||.|+.+|...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 13358999999998643 233566789999999999999999999999999999999999988
Q ss_pred CCcchhHHHHHHHHHHHH--------------hhhcCcc-----------cceecc----hhhhcccHHHHHHHHHHHHH
Q 047263 716 VDMEVNEAEALLTDWAYD--------------CYCEGIT-----------EALVEF----DIEALNDKKKLARFVMVAIW 766 (804)
Q Consensus 716 ~~~~~~~~~~~l~~~~~~--------------~~~~~~~-----------~~~~~~----~~~~~~~~~~~~~l~~l~~~ 766 (804)
|......+...+++.+.. ....+.. ....+. ...-.....+..+|.+|+..
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 865543332222221111 1111100 000000 00111234566789999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 047263 767 CIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 767 Cl~~dP~~RPsm~eVl~ 783 (804)
+|..||.+|+|+.|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=236.67 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=189.0
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc-ccc-HHHHHHHHHHhcccccCCccceeeEEeC--------CCc
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDG-VKEFKTEVNVIGQTHHKNLVRLLGFCDD--------GLN 586 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~~~ 586 (804)
..+||+|.||.||+++.+++++ .||+|+.-... ..+ -..-.+|+.++..++|+|++.++..|.. ...
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~k---kvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGK---KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccc---hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 4579999999999998876654 58887764321 112 2235789999999999999999998843 234
Q ss_pred eEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
.+||+++++. +|.-+|... .+++..++.+++.++..||.|+|. ..|+|||+|+.|+|++.++.+||+|||+++.+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 7999999987 788888665 788999999999999999999994 49999999999999999999999999999876
Q ss_pred ccCCC---CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 666 LLDQS---QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 666 ~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
..... ...+...-|..|.+||.+.+ +.++++.|||.-|||+.||.++.+.+....+.....+..........+...
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 43322 12233445899999998865 579999999999999999999998887765544333322211111111000
Q ss_pred ceecch---------hh-hcc--cHHH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFD---------IE-ALN--DKKK------LARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~---------~~-~~~--~~~~------~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...... +. ... -.+. ..+.++++..++..||.+|++..+++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 000000 00 000 0011 135678888899999999999988763
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=216.90 Aligned_cols=194 Identities=24% Similarity=0.353 Sum_probs=161.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.++||+|.||+||||+..+..+ .||+|+.+-.. +..-....+|+-+++.++|+|||++++..-.++..-+|+|||
T Consensus 7 mekigegtygtvfkarn~~t~e---ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred HHhhcCCcceeeEecccCCccc---eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4789999999999999876544 89999986432 222345688999999999999999999999999999999999
Q ss_pred CCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 595 SNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 595 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
.. .|.++... +..++.+....++.|+++||.|+|.+ ++.||||||+|.|++.+|+.|++|||+++.++..- +..
T Consensus 84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 64 67776643 46788889999999999999999954 99999999999999999999999999999875432 222
Q ss_pred ccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCc
Q 047263 674 TAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDM 718 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~ 718 (804)
....-|..|.+|.++.+. -|++..|+||-|||+.|+....+|...
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 334468899999998764 689999999999999999986666543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=221.77 Aligned_cols=102 Identities=37% Similarity=0.627 Sum_probs=75.3
Q ss_pred CCeEEEeecCCCCCC---CCcEEEEecCCCeEEeCCCCceEeec-cCCCCc--eeEEEEccCcCEEEEecCCcccccccc
Q 047263 76 QKTIVWFANGDSPAA---SGTKVELTADQGLVLTSPQGRELWKS-DPIIGT--VAYGLMNDTGNFVLLSDNTNKLWESFN 149 (804)
Q Consensus 76 ~~t~vWvANr~~Pv~---~~s~l~~~~~G~L~l~~~~~~~vWst-~~~~~~--~~~a~l~d~GNlVl~~~~~~~lWQSFd 149 (804)
++||||+|||++|+. ...+|.|+.||+|+|+|.+++++|++ ++.+.+ ...|.|+|+|||||++..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 479999999999993 34799999999999999999999999 555443 679999999999999999999999999
Q ss_pred CCcccccCCcccCCC------ceEEecCCCCCCC
Q 047263 150 NPTDTMLPSQIFDNG------QFLSSKQSDGNFS 177 (804)
Q Consensus 150 ~PTDTlLpg~~l~~~------~~L~S~~s~~dps 177 (804)
|||||+||+|+|+.+ ..|+||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999998763 3599999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=267.50 Aligned_cols=238 Identities=29% Similarity=0.370 Sum_probs=182.2
Q ss_pred HHhhCCCccee-EEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEeec
Q 047263 517 KEELGKGAFGV-VYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~-Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.+|.|.-|+ ||+|... +++||||++-. +......+|+..++.- +|||||++++.-.+....|+..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-----~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-----GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-----CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35689998875 6999875 34799999864 2334557899998887 6999999999989999999999999
Q ss_pred CCCcHHHhhcCC-CCC---ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-----CCCEEEeecCccccc
Q 047263 595 SNGTLASFLFGD-LKP---GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-----YYNARISDFGLAKLL 665 (804)
Q Consensus 595 ~~gsL~~~l~~~-~~l---~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-----~~~~kl~Dfgla~~~ 665 (804)
.. +|.+++... ... .-...+.+..|+++||++|| +.+||||||||+||||+. ..+++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 999999874 111 11234678899999999999 569999999999999975 257899999999988
Q ss_pred ccCCCC--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcC-CCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 666 LLDQSQ--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICC-RRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 666 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
..+... ......||.+|+|||.+....-+.++||||+|||+|+.++| ..||.........++.. +....+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------ccceee
Confidence 655432 23456799999999999998888999999999999999998 78887654433222211 000111
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
+.. ..+. +..+||.+|++++|..||++.+|+
T Consensus 735 L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 LEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 110 0111 677899999999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=237.25 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=192.5
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.||+|+|.+|-.+.+..... .+|+|++++. ..+...-.+.|-.++.+. +||.+|.++.++..+.+.++|.
T Consensus 254 ll~vigrgsyakvl~~~~~~t~q---iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQ---IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred eeeeecCcchhhhhheehcccce---eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 45789999999999998875544 6888887642 234445567777777776 7999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++|+|--++.+..+++++....+...|.-||.|||+. +|+.||||.+|||||..|++|+.|+|+.+.- .....
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~-l~~gd 406 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-LGPGD 406 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-CCCCc
Confidence 9999999999999999999999999999999999999965 9999999999999999999999999999853 23455
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-HHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-EALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
...+.+||+.|+|||.+++..|.-.+|.|++||+++||+.|+.||+....+. +....++..+...+.... .
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------i 478 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------I 478 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------c
Confidence 5677899999999999999999999999999999999999999997653221 222222333322222111 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP 776 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP 776 (804)
+...+.+...+...-+.+||.+|-
T Consensus 479 --prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 --PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --cceeehhhHHHHHHhhcCCcHHhc
Confidence 111223444566667888888773
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=219.55 Aligned_cols=198 Identities=28% Similarity=0.373 Sum_probs=162.8
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.++||+|++|.|-+-++...+ ...|+|++.... .+..++...|+.+..+- .+|.+|.++|........++.||.|
T Consensus 51 i~elGrGayG~vekmrh~~sg---~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSG---TIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhcCCccchhhheeeccCC---eEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 468999999999887776544 379999997543 34445677788776655 7999999999999999999999999
Q ss_pred CCCcHHHhh----cCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 595 SNGTLASFL----FGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 595 ~~gsL~~~l----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
.- ||+.+- .....+++...-+|+..|.+||.|||++ ..++|||+||+|||++.+|++||+|||.+..+.. +
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d--S 202 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD--S 202 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh--h
Confidence 65 776653 4567888999999999999999999985 6899999999999999999999999999986532 2
Q ss_pred CccccccCCCccccccccc----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhH
Q 047263 671 QTHTAIRGTKGYVAPEWFR----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE 722 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~ 722 (804)
-..+...|-..|||||.+. ...|+.|+||||+|+.+.||.+++.|++.....
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 2223345777899999885 347999999999999999999999998866443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=227.17 Aligned_cols=210 Identities=34% Similarity=0.525 Sum_probs=182.0
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCCc
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGT 598 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gs 598 (804)
||+|.+|.||++....++ ..+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG---KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCC---cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999987533 37999999865332 35679999999999999999999999999999999999999999
Q ss_pred HHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcccccccCCCCccccc
Q 047263 599 LASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 599 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
|.+++... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 99999765 5788999999999999999999965 9999999999999999 89999999999986543221 12334
Q ss_pred cCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHH
Q 047263 677 RGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKK 755 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (804)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999999877 888999999999999998
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 756 KLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 756 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=247.77 Aligned_cols=199 Identities=25% Similarity=0.321 Sum_probs=170.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.||-|+||.|.++.-.+.. ..+|.|.+++.. .......++|..||+....+=||+|+-.|.+.+.+|+||||+
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~---~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTR---ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecchh---hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence 35999999999998765443 368999887543 344567899999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc-------
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL------- 667 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~------- 667 (804)
+||++-.+|.+...+.+.....++..+..|+++.| +.+.|||||||+|||||.+|++||.||||+.-++=
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999999999999999999999999999999 56999999999999999999999999999865420
Q ss_pred --C-----CC-----------C----------------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCC
Q 047263 668 --D-----QS-----------Q----------------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713 (804)
Q Consensus 668 --~-----~~-----------~----------------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~ 713 (804)
. ++ . ......||..|+|||++....++...|.||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 0 00 0 001135999999999999999999999999999999999999
Q ss_pred CCCCcchhH
Q 047263 714 RNVDMEVNE 722 (804)
Q Consensus 714 ~p~~~~~~~ 722 (804)
.||....+.
T Consensus 869 ~pf~~~tp~ 877 (1034)
T KOG0608|consen 869 PPFLADTPG 877 (1034)
T ss_pred CCccCCCCC
Confidence 999766543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=233.27 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=195.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccc--cHHHHHHHHHHhcccccCCccceeeEEeCCC-----ceEE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL-----NRLL 589 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 589 (804)
.+.||-|+||.||....+.++ +.|+.|++...... ..+.+.+|+.++.-++|.|++..++...-.. ++|+
T Consensus 58 DRPIGYGAFGVVWsVTDPRdg---rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSG---KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCcccccceeEEEeccCCCCc---cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 356999999999998876443 47999999865432 3467889999999999999999998764432 4578
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
++|.|.. +|.+++-..+.++-....-+..||++||+|||. .+|.||||||.|.|++.|...||+|||+++.-..++
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8888854 888888888889999999999999999999995 499999999999999999999999999999877777
Q ss_pred CCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHH-H-------HHHHhhhcCcc
Q 047263 670 SQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT-D-------WAYDCYCEGIT 740 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~-~-------~~~~~~~~~~~ 740 (804)
...++...-|..|.|||.+.+ +.|+.+.||||.|||+.||+-.+..|....+-....+. + .+.+..+|+..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 777777778999999999976 47999999999999999999888777554332221111 1 11222333322
Q ss_pred cceecchh-----hh---ccc-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 741 EALVEFDI-----EA---LND-KKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 741 ~~~~~~~~-----~~---~~~-~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
..++.... .. ..+ ...-.+.+++...++..+|++|.+..+.+.-+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 22211111 00 000 11122344566678899999999888876544
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=204.82 Aligned_cols=107 Identities=31% Similarity=0.514 Sum_probs=97.5
Q ss_pred eeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEEeCCCCceEeeccCCC-C
Q 047263 43 SWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPII-G 121 (804)
Q Consensus 43 ~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l~~~~~~~vWst~~~~-~ 121 (804)
+|+|++|.|++|||.+.... .++.+|||.+.+ +++||.||++.|....+.|.|+.||+|+|.|.+|.++|+|++.. .
T Consensus 9 ~l~s~~~~f~~G~~~~~~q~-~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~ 86 (116)
T cd00028 9 TLVSSGSLFELGFFKLIMQS-RDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVN 86 (116)
T ss_pred EEEeCCCcEEEecccCCCCC-CeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccCCC
Confidence 89999999999999987654 378999999887 88999999999977778999999999999999999999999876 4
Q ss_pred ceeEEEEccCcCEEEEecCCccccccccCC
Q 047263 122 TVAYGLMNDTGNFVLLSDNTNKLWESFNNP 151 (804)
Q Consensus 122 ~~~~a~l~d~GNlVl~~~~~~~lWQSFd~P 151 (804)
...+|+|+|+|||||++.++.+||||||||
T Consensus 87 ~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 87 GNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=224.72 Aligned_cols=197 Identities=31% Similarity=0.428 Sum_probs=171.8
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.+.||+|++|.||++.....+. .+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGE---LVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCc---EEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 45679999999999999875333 7999999865444 5678999999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCC-CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 595 SNGTLASFLFGDLK-PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 595 ~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
++++|.+++..... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999999987666 89999999999999999999965 999999999999999999999999999987654432223
Q ss_pred ccccCCCcccccccc-ccCCCCccchhhHHHHHHHHHHcCCCCCCc
Q 047263 674 TAIRGTKGYVAPEWF-RNMPITVKVDVYSFGVLLLEIICCRRNVDM 718 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l-~~~~~s~~~DV~S~Gvll~elltG~~p~~~ 718 (804)
....++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=196.91 Aligned_cols=105 Identities=31% Similarity=0.538 Sum_probs=95.8
Q ss_pred eeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEEeCCCCceEeeccCC-CC
Q 047263 43 SWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPI-IG 121 (804)
Q Consensus 43 ~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l~~~~~~~vWst~~~-~~ 121 (804)
.|+|++|.|++|||.+.... ++.+|||++.+ +++||+|||+.|+..++.|.++.||+|+|.|.+|.++|+|++. ..
T Consensus 9 ~l~s~~~~f~~G~~~~~~q~--dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~ 85 (114)
T smart00108 9 TLVSGNSLFELGFFTLIMQN--DYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGAN 85 (114)
T ss_pred EEecCCCcEeeeccccCCCC--CEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCCC
Confidence 89999999999999986653 78999999887 8899999999998777899999999999999999999999986 45
Q ss_pred ceeEEEEccCcCEEEEecCCccccccccC
Q 047263 122 TVAYGLMNDTGNFVLLSDNTNKLWESFNN 150 (804)
Q Consensus 122 ~~~~a~l~d~GNlVl~~~~~~~lWQSFd~ 150 (804)
+..+++|+|+|||||++..+.+|||||||
T Consensus 86 ~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 86 GNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 56789999999999999989999999997
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=236.44 Aligned_cols=192 Identities=24% Similarity=0.328 Sum_probs=164.6
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--------ccHHHHHHHHHHhcccc---cCCccceeeEEeCCC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------DGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDGL 585 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~ 585 (804)
.+.+|+|+||.|..++.+... ..|+||.+.+... ...-..-.|+.+|..++ |+||++++.+|++++
T Consensus 566 lq~lG~GAyGkV~lai~K~n~---~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENN---YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred eeeccccccceEEEeeecccc---eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 457999999999999987653 3789998865311 11123557999999997 999999999999999
Q ss_pred ceEEEEeecC-CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 586 NRLLVYEFLS-NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 586 ~~~lV~Ey~~-~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
..||++|-.. +-+|.+++..+..+++.+...|.+||+.|+++||++ +|||||||-+||.++.+|-+||+|||.+..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999874 568999999999999999999999999999999965 999999999999999999999999999876
Q ss_pred cccCCCCccccccCCCccccccccccCCCC-ccchhhHHHHHHHHHHcCCCCCC
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPIT-VKVDVYSFGVLLLEIICCRRNVD 717 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~~DV~S~Gvll~elltG~~p~~ 717 (804)
.. +.....++||.+|.|||++.+.+|- ..-|||++|++||.++....|+.
T Consensus 720 ~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 43 2334457899999999999998875 45799999999999998888864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=204.63 Aligned_cols=256 Identities=18% Similarity=0.282 Sum_probs=184.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeCCC--ceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGL--NRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~l 589 (804)
.+++.+++|+|.|+.||.|..-.+.+ .++||.++.. ..+.+++|+.++..|. ||||+++++...+.. ..-|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~e---K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNE---KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCc---eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35667899999999999998654433 6999999865 4467889999999997 999999999987654 4569
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~~ 668 (804)
|+||+.+.+...+- .+++...+...+.++++||.|+| +.||.|||+||.|+++|. .-..+|+|+|+|......
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999987765544 45667778889999999999999 569999999999999996 456899999999987543
Q ss_pred CCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHH-----------HHHHHHhhh
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL-----------TDWAYDCYC 736 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l-----------~~~~~~~~~ 736 (804)
... .....+..|-.||.+-. ..|+-.-|+|||||+|.+|+..+.||.......+..+ ..+.... .
T Consensus 187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY-~ 263 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY-Q 263 (338)
T ss_pred cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH-c
Confidence 322 22234566888998864 4678899999999999999999999855433222111 1111110 0
Q ss_pred cCcccceec-------c----hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 737 EGITEALVE-------F----DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 737 ~~~~~~~~~-------~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
-.+..++-+ . .+......-...+.++++...|..|-++|||+.|.+.
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 001111111 0 0011111112356778888889999999999998763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-25 Score=239.51 Aligned_cols=248 Identities=22% Similarity=0.260 Sum_probs=201.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
...++|.|.||.|||++.....+ ..|+|.++-......+-.++|+-+++..+|+|||.++|.+......++.|||+.
T Consensus 19 llqrvgsgTygdvyKaRd~~s~e---laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGE---LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred heeeecCCcccchhhhcccccCc---hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 45689999999999999875544 789999887666777788899999999999999999999999999999999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccc
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (804)
+|+|.+.-+....+++.++...++...+|++||| +.+-+|||||-.|||+++.|.+|++|||.+..+.. .-.+...
T Consensus 96 ggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~Krks 171 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAKRKS 171 (829)
T ss_pred CCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh-hhhhhhc
Confidence 9999999998899999999999999999999999 55889999999999999999999999999876532 2334556
Q ss_pred ccCCCcccccccc---ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 676 IRGTKGYVAPEWF---RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 676 ~~gt~~y~aPE~l---~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
+.||+.|||||+. +.+.|.+++|||+.|+...|+---..|.....+.....++. ....++. ....
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-----------kS~~qpp-~lkD 239 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-----------KSGFQPP-TLKD 239 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-----------ccCCCCC-cccC
Confidence 7799999999987 45679999999999999999987777754443332222211 1111111 1112
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
.....+.+.+++..|+..+|++||+.+.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 334566788899999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=217.00 Aligned_cols=253 Identities=24% Similarity=0.271 Sum_probs=182.4
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC------CceEEE
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------LNRLLV 590 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV 590 (804)
.+|.|.- .|--+. +...+++||+|++.... ....+.-.+|...+..++|+||++++.++.-. .+.|+|
T Consensus 24 p~~~g~~-~v~~a~---D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAF---DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred ccCCCCc-eEEecc---hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 4566655 333332 23445589999986432 23445668999999999999999999998433 456899
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||||. .+|...+. ..++-.+...|..|++.|++||| +.+|+||||||+||++..+..+||.|||+++.-. ..
T Consensus 100 ~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~--~~ 171 (369)
T KOG0665|consen 100 MELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED--TD 171 (369)
T ss_pred HHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccC--cc
Confidence 99996 48887775 55677788899999999999999 5599999999999999999999999999998633 23
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH----------------HHHHHHHHHh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE----------------ALLTDWAYDC 734 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~----------------~~l~~~~~~~ 734 (804)
...+.+..|.-|.|||++-+..+.+.+||||.||++.||++|+.-|.+...-.. ..+...+...
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 456677889999999999988899999999999999999999987764432110 0111111111
Q ss_pred hhcCc-------ccceecchh--hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 735 YCEGI-------TEALVEFDI--EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 735 ~~~~~-------~~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..... .+.+.|... ....+......+.+++.+||..+|++|-++.++++
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11110 011111111 11112234456778999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=207.26 Aligned_cols=250 Identities=18% Similarity=0.274 Sum_probs=183.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeE-EeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGF-CDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~ 591 (804)
+.+.+.||+|.||.+-.+..+.... .+++|-+... ....++|.+|..---.| .|.||+.-+.. |...+..++++
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t---~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKT---RIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCce---EEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 5677899999999999998876544 7888888754 34567899998876666 59999988774 55666778999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc--CCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD--DYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~ 669 (804)
||++.|+|..-+.. ..+.+....+++.|++.||.||| ++++||||||.+|||+- +..++||+|||+.+..+.
T Consensus 102 E~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred ccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 99999999998854 45677888999999999999999 55999999999999993 455899999999875422
Q ss_pred CCccccccCCCccccccccccC-----CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNM-----PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~-----~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.......+..|.+||..... ...+.+|||.||++++.++||+.||......... -|.|..|..+....+.
T Consensus 176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRKNPALP 250 (378)
T ss_pred --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcccCccCc
Confidence 22223346679999977432 3467899999999999999999999744333332 2344445455443222
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
+.. ..-.+.+.++..+-+.+++++|=-+.++.++
T Consensus 251 ~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 251 KKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hhh------cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 211 1123456667777788999998555554443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=258.35 Aligned_cols=194 Identities=16% Similarity=0.208 Sum_probs=137.9
Q ss_pred cccc-CCccceeeEE-------eCCCceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeee
Q 047263 568 QTHH-KNLVRLLGFC-------DDGLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIH 638 (804)
Q Consensus 568 ~l~h-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 638 (804)
.++| +||++++++| .+....++++||+ +++|.++|... ..+++.+++.++.||++||.|||+ .+|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 4456 6888888877 3334567888987 55999999753 568999999999999999999995 49999
Q ss_pred cCCCCCcEEEcC-------------------CCCEEEeecCcccccccCCC---------------CccccccCCCcccc
Q 047263 639 CDIKPQNILLDD-------------------YYNARISDFGLAKLLLLDQS---------------QTHTAIRGTKGYVA 684 (804)
Q Consensus 639 ~dlkp~NILl~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y~a 684 (804)
|||||+||||+. ++.+|++|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44556666666653211000 00112357888999
Q ss_pred ccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHH
Q 047263 685 PEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVA 764 (804)
Q Consensus 685 PE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 764 (804)
||++.+..++.++|||||||+||||++|..|+...... ..... .. ..... ..........++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~-----~~----~~~~~-----~~~~~~~~~~~~ 245 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLR-----HR----VLPPQ-----ILLNWPKEASFC 245 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHH-----Hh----hcChh-----hhhcCHHHHHHH
Confidence 99999999999999999999999999988876432111 10000 00 00000 011223456788
Q ss_pred HHccccCCCCCCCHHHHHH
Q 047263 765 IWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 765 ~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+||+++|.+||+|.||++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 8999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=214.61 Aligned_cols=142 Identities=29% Similarity=0.379 Sum_probs=113.8
Q ss_pred ccccCHHHHHH-HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-----c---
Q 047263 501 LHCFTYKDLEA-ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-----H--- 571 (804)
Q Consensus 501 ~~~~~~~~l~~-at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----h--- 571 (804)
.+...+-|.-. +.+...++||=|.|++||.+....... -||+|+.+.. +.-.+.-..||++|++++ |
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r---~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKR---YVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeeccCCe---EEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34444445554 667778899999999999998876554 7999998753 333445688999999883 3
Q ss_pred CCccceeeEEe----CCCceEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCc
Q 047263 572 KNLVRLLGFCD----DGLNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQN 645 (804)
Q Consensus 572 ~niv~l~g~~~----~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 645 (804)
..||+|+++|. .+.+.+||+|+. |-+|..+|... +.++.....+|+.||+.||.|||.+| +|||-||||+|
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN 218 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN 218 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence 36999999994 567899999998 45777777654 66888999999999999999999975 99999999999
Q ss_pred EEEc
Q 047263 646 ILLD 649 (804)
Q Consensus 646 ILl~ 649 (804)
|||.
T Consensus 219 vLl~ 222 (590)
T KOG1290|consen 219 VLLC 222 (590)
T ss_pred eeee
Confidence 9993
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=201.54 Aligned_cols=166 Identities=20% Similarity=0.147 Sum_probs=124.9
Q ss_pred CcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcccc
Q 047263 597 GTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675 (804)
Q Consensus 597 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 675 (804)
|+|.+++.. +..+++.+++.|+.||++||.|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999976 45699999999999999999999965 3 999999999999999 99988653321
Q ss_pred ccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHH
Q 047263 676 IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKK 755 (804)
Q Consensus 676 ~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (804)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+........ .+...... ....... .......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~-----~~~~~~~---~~~~~~~ 134 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNG-----MPADDPR---DRSNLES 134 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHH-----hccCCcc---ccccHHH
Confidence 2578999999999999999999999999999999999999865432211 11111110 0000000 0000111
Q ss_pred HH--HHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 756 KL--ARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 756 ~~--~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.. .++.+++.+|++.+|.+||++.++++.+..+
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22 2689999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=217.07 Aligned_cols=208 Identities=22% Similarity=0.251 Sum_probs=170.2
Q ss_pred ccCHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc------cCCccc
Q 047263 503 CFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH------HKNLVR 576 (804)
Q Consensus 503 ~~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~------h~niv~ 576 (804)
.+.+.|+....+.+..-.|+|-|++|-+|...... ..||||++... +-..+.=+.|+++|++|+ .-|.++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~---~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARG---QEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCC---CeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35567788888888888999999999999876443 38999999865 333445578999999995 348999
Q ss_pred eeeEEeCCCceEEEEeecCCCcHHHhhcC---CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-C
Q 047263 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFG---DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-Y 652 (804)
Q Consensus 577 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-~ 652 (804)
++..|...++++||+|-+ ..+|.+.|+. +..+.......++.|++-||..|.. .+|+|.||||+|||+++. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcc
Confidence 999999999999999976 4589999874 3456677888999999999999994 599999999999999875 4
Q ss_pred CEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchh
Q 047263 653 NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVN 721 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~ 721 (804)
.+||+|||.|...... ..+.+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+...
T Consensus 575 iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 575 ILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eeeeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 5799999999765332 22233345679999999999999999999999999999999998876544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=210.48 Aligned_cols=197 Identities=23% Similarity=0.312 Sum_probs=160.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEeecC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
.++||+|.|++||++.+.........||+|.+.... ......+|++++..+ -+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 468999999999999887532234579999997643 334578999999999 49999999999999999999999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcccccccCC-----
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLDQ----- 669 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~----- 669 (804)
+-...++.. .++...+..++..+++||.++|. .+||||||||+|+|.+. .++-.|.|||++.......
T Consensus 119 H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 119 HDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred ccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 999888885 45678889999999999999995 59999999999999984 6778999999997221000
Q ss_pred --------C------------------------------CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHH
Q 047263 670 --------S------------------------------QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEII 710 (804)
Q Consensus 670 --------~------------------------------~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~ell 710 (804)
. .......||+||.|||++.. ..-++++||||-|||++.++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0 00112349999999999864 46788999999999999999
Q ss_pred cCCCCCCcchh
Q 047263 711 CCRRNVDMEVN 721 (804)
Q Consensus 711 tG~~p~~~~~~ 721 (804)
+++.||.....
T Consensus 273 s~~~PFf~a~d 283 (418)
T KOG1167|consen 273 SRRYPFFKAKD 283 (418)
T ss_pred ccccccccCcc
Confidence 99999965543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-22 Score=191.25 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=188.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcc--ccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
-++..+|.+...|..|+|++.... +++|++. .......++|.+|.-.++-+.||||+.++|.|....+..++.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd-----ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND-----IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc-----hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 356678999999999999997554 5556654 233344578999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEe--ecCccccccc
Q 047263 592 EFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARIS--DFGLAKLLLL 667 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~--Dfgla~~~~~ 667 (804)
.||+.|||...|++.. ..+-.+..+++.+||+|++|||.- .+-|.---|....+++|++.+++|+ |--++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf---- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee----
Confidence 9999999999998764 357788999999999999999975 3334455688999999999988874 322221
Q ss_pred CCCCccccccCCCccccccccccCCCC---ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPIT---VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s---~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
......-.+.||+||.++.++.+ .++|+|||.+++|||.|...||..-.+-+.... ...|++...
T Consensus 342 ----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------ialeglrv~-- 409 (448)
T KOG0195|consen 342 ----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------IALEGLRVH-- 409 (448)
T ss_pred ----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------hhhcccccc--
Confidence 11112236789999999877655 478999999999999999999976554332211 111222211
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
.++-.+..+.+++.-|+.+||.+||.+..|+-+||+++
T Consensus 410 -------ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 -------IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 12223446777888899999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-21 Score=204.32 Aligned_cols=162 Identities=20% Similarity=0.108 Sum_probs=123.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-----ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-----IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
+.+.+.||+|+||+||+|...... +..+|||++... .....+.|.+|++++++++|+|++..+.. ....+
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDP--GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCC--CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 445678999999999999876421 235799987532 12235569999999999999999864432 24679
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCC-CCCcEEEcCCCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDI-KPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-kp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
|||||+++++|.... .. ....++.+++++|.|||+. +|+|||| ||+|||++.++++||+|||+++.+..
T Consensus 95 LVmE~~~G~~L~~~~-~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 95 LVRGWTEGVPLHLAR-PH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEEccCCCCHHHhC-cc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999999997321 11 1246788999999999954 9999999 99999999999999999999997754
Q ss_pred CCCCc-------cccccCCCcccccccccc
Q 047263 668 DQSQT-------HTAIRGTKGYVAPEWFRN 690 (804)
Q Consensus 668 ~~~~~-------~~~~~gt~~y~aPE~l~~ 690 (804)
..... .....++..|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 33111 134567888999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5e-19 Score=191.15 Aligned_cols=260 Identities=19% Similarity=0.202 Sum_probs=187.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc----CCccceeeEE-eCCCce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH----KNLVRLLGFC-DDGLNR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h----~niv~l~g~~-~~~~~~ 587 (804)
.+.+.++||+|+||.||++...... ...+|+|............+..|+.++..+++ +++.+++... ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 3446789999999999999976554 33578887765433322367888888888873 5889999888 577788
Q ss_pred EEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-----CCEEEeecC
Q 047263 588 LLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-----YNARISDFG 660 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-----~~~kl~Dfg 660 (804)
++||+.. +.+|.++.... ..++..+.++|+.|++.+|.+||+. +++||||||+|+++... -.+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999976 67999987433 6789999999999999999999954 99999999999999754 358999999
Q ss_pred ccc--ccccCCCC------c-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHH
Q 047263 661 LAK--LLLLDQSQ------T-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDW 730 (804)
Q Consensus 661 la~--~~~~~~~~------~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~ 730 (804)
+++ .+...... . ....+||..|.++....+...+.+.|+||++.++.|++.|..||........ ..+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 999 43222211 1 2235699999999999999999999999999999999999999854432211 111110
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.. .. .... .......+ +.++..-+-..+..++|....+...|+.....
T Consensus 253 ~~----~~----~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PR----KL----LTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hh----hh----cccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00 00 0000 11112223 33333334457899999999999998775544
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=163.02 Aligned_cols=88 Identities=28% Similarity=0.673 Sum_probs=75.7
Q ss_pred cEEEeeeccceeeeeeeccccCcceeEEEEEeeCCcEEEEecCCCCCCCCCeeEEEecCccccccccccCCCCCCCCCCc
Q 047263 226 YMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDICKASFVSTGSGTCGFNSV 305 (804)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~y~~~~~~~~~~~W~~~~~~p~~~Cd~~~~~~~~g~CG~~g~ 305 (804)
+.+.++.+.++.++++... +.+.++|++||.+|++++|.|.+ .+++|.++|++|.|+||+ |+.||+||+
T Consensus 23 ~~~~fv~~~~e~~~t~~~~--~~s~~~r~~ld~~G~l~~~~w~~---~~~~W~~~~~~p~d~Cd~------y~~CG~~g~ 91 (110)
T PF00954_consen 23 YNYSFVSNNEEVYYTYSLS--NSSVLSRLVLDSDGQLQRYIWNE---STQSWSVFWSAPKDQCDV------YGFCGPNGI 91 (110)
T ss_pred eEEEEEECCCeEEEEEecC--CCceEEEEEEeeeeEEEEEEEec---CCCcEEEEEEecccCCCC------ccccCCccE
Confidence 3466777888888887764 45689999999999999999964 467899999999999999 999999999
Q ss_pred cccCCCCCccccCCCCccCC
Q 047263 306 CRLNNRRPICECPRGYTLID 325 (804)
Q Consensus 306 C~~~~~~~~C~C~~Gf~~~~ 325 (804)
|+.+ ..|.|+||+||+|++
T Consensus 92 C~~~-~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 92 CNSN-NSPKCSCLPGFEPKN 110 (110)
T ss_pred eCCC-CCCceECCCCcCCCc
Confidence 9864 478999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=213.80 Aligned_cols=253 Identities=20% Similarity=0.233 Sum_probs=186.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcc----c-ccccc-HHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH----S-VIQDG-VKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~----~-~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
.+.+|.|.+|.|+..+.....+ ..+.|... . ..... ...+..|+-+-..++|+|++..+..+.+.....-+
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~---~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLK---SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred cceeeecccCceEEEEecCCCc---cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 4579999999777766544332 12222221 1 11111 11256677788889999999988888777777777
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||++. +|..++.....+.-.++..+..|+..|+.|||+. +|.|||+|++|++++.++.+||+|||.+..+..+..
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999999 9999998877888899999999999999999955 999999999999999999999999999988765444
Q ss_pred ---CccccccCCCccccccccccCCCCcc-chhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 671 ---QTHTAIRGTKGYVAPEWFRNMPITVK-VDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 671 ---~~~~~~~gt~~y~aPE~l~~~~~s~~-~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.......|+..|+|||.+....|.+. .||||.|+++..|++|+.||........... ......+....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--------~~~~~~~~~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--------TNNYSDQRNIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------hhccccccccc
Confidence 34455778999999999999999875 8999999999999999999865544322110 00001111111
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.....-......+...++.++|+.+|.+|-||++|++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11111122334567789999999999999999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-18 Score=187.39 Aligned_cols=254 Identities=29% Similarity=0.344 Sum_probs=193.6
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc---cHHHHHHHHHHhcccccC-CccceeeEEeCCCceEEEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD---GVKEFKTEVNVIGQTHHK-NLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~ 591 (804)
..+.||.|.||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++...+......++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred eEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 4567899999999999886 35888888754432 367899999999999988 7999999997777789999
Q ss_pred eecCCCcHHHhhcCCC---CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecCccccccc
Q 047263 592 EFLSNGTLASFLFGDL---KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLL 667 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~ 667 (804)
||+.+++|.+++.... .+.......++.|++.++.|+|+. +++|||+||+||+++..+ .+++.|||.++.+..
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999997776654 688899999999999999999965 899999999999999988 799999999986544
Q ss_pred CCCC-----ccccccCCCcccccccccc---CCCCccchhhHHHHHHHHHHcCCCCCCcchhH--HHHHHHHHHHHhhhc
Q 047263 668 DQSQ-----THTAIRGTKGYVAPEWFRN---MPITVKVDVYSFGVLLLEIICCRRNVDMEVNE--AEALLTDWAYDCYCE 737 (804)
Q Consensus 668 ~~~~-----~~~~~~gt~~y~aPE~l~~---~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~ 737 (804)
.... ......|+..|++||.+.. ...+...|+|++|++++++++|..|+...... .... ..... .
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~----~ 229 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIIL----E 229 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH-HHHHH----h
Confidence 3322 2356779999999999987 57889999999999999999999997655431 1111 11111 1
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.... .................+.+++..|+..+|..|.++.+....
T Consensus 230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1110 000000000002223567788888999999999999887653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.3e-19 Score=194.03 Aligned_cols=216 Identities=27% Similarity=0.433 Sum_probs=164.1
Q ss_pred hcccccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCC
Q 047263 566 IGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQ 644 (804)
Q Consensus 566 l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~ 644 (804)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ...++|.....++.+|++||.|||.. .-.+|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4678999999999999999999999999999999999986 57889999999999999999999964 22399999999
Q ss_pred cEEEcCCCCEEEeecCcccccccC-CCCccccccCCCccccccccccC-------CCCccchhhHHHHHHHHHHcCCCCC
Q 047263 645 NILLDDYYNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPEWFRNM-------PITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 645 NILl~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-------~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
|.++|..+.+||+|||+....... .........-..-|.|||.++.. ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998875321 11112222234579999999763 2577899999999999999999999
Q ss_pred CcchhHHHH-HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 717 DMEVNEAEA-LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 717 ~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+........ .+...+. . .......+.+.... +....+..++..||..+|.+||++.+|-..++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVK----K-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHH----h-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 875433221 1111111 1 11112222222111 333478899999999999999999999998876544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.4e-18 Score=170.17 Aligned_cols=257 Identities=19% Similarity=0.251 Sum_probs=188.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.++||+|.||..+.|+.--. +++||||-....+ ...++..|.+..+.| ..++|...+-|-.++.+-.||+|.
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~n---ne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYN---NEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred eeccccccCcceeeeccccccc---CceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3568999999999999987644 3489999876532 335677888888887 578999999998999999999998
Q ss_pred cCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-----CCEEEeecCccccccc
Q 047263 594 LSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-----YNARISDFGLAKLLLL 667 (804)
Q Consensus 594 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-----~~~kl~Dfgla~~~~~ 667 (804)
. |-||.|+.. ...+++..+...+|.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+.+..
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 7 668888774 467889999999999999999999965 99999999999999633 3478999999998876
Q ss_pred CCCCc------cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 668 DQSQT------HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 668 ~~~~~------~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
..... .....||.+||+-....++..+.+.|.=|+|-++++.|-|..||..-..+.... -++ +-+..+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~----kYe--KIGe~K 255 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE----KYE--KIGETK 255 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH----HHH--Hhcccc
Confidence 55433 334569999999999999999999999999999999999999997654332111 011 112222
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
+......-...-++++...++.+.+ .+-.+-|...-+...+..++
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHH
Confidence 2222222222344455555555543 23344466665555544443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-18 Score=168.71 Aligned_cols=138 Identities=15% Similarity=0.116 Sum_probs=106.4
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccc--c-------HH-----------------HHHHHHHHhccccc
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--G-------VK-----------------EFKTEVNVIGQTHH 571 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~f~~E~~~l~~l~h 571 (804)
+.||+|++|.||+|...+ +++||||+++..... . .. ....|++.+.++.+
T Consensus 3 ~~ig~G~~~~Vy~a~~~~----g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 78 (190)
T cd05147 3 GCISTGKEANVYHATTAN----GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT 78 (190)
T ss_pred CccccccceEEEEEECCC----CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 579999999999998863 337999999653211 1 01 12359999999988
Q ss_pred CCccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHh-hhccCCCeeecCCCCCcEEEcC
Q 047263 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYL-HEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 572 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlkp~NILl~~ 650 (804)
+++.....+.. ...+|||||++++++...+.....++......++.|++.+|.|+ |+ .+|+||||||+|||++
T Consensus 79 ~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 79 AGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 87754443322 23389999999988766544456788889999999999999999 64 4999999999999998
Q ss_pred CCCEEEeecCccccc
Q 047263 651 YYNARISDFGLAKLL 665 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~ 665 (804)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=161.61 Aligned_cols=203 Identities=20% Similarity=0.213 Sum_probs=165.7
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc-CCccceeeEEeCCCceEE
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH-KNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~l 589 (804)
...+...++||.|+||.+|.|..-..++ .||||..+.... ..++..|..+.+.|++ ..|..+..+..+...-.|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge---~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGE---EVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCc---eEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3445677899999999999998765444 799999875432 3467788899998875 578888888899999999
Q ss_pred EEeecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCccccc
Q 047263 590 VYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLL 665 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~ 665 (804)
|||.. +-||.++.. ....++..+.+-++-|++.-++|+|.. +.+||||||+|.|+.- ...+.++|||+++.+
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99987 668888774 457788899999999999999999955 9999999999999963 456899999999987
Q ss_pred ccCCCCc------cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH
Q 047263 666 LLDQSQT------HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE 722 (804)
Q Consensus 666 ~~~~~~~------~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~ 722 (804)
....... .....||.+|.+-....+...+.+.|+=|+|.+|..+.-|..||..-...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 6544332 23456899999988777778889999999999999999999999766443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-18 Score=171.46 Aligned_cols=172 Identities=12% Similarity=0.056 Sum_probs=128.4
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHH---------HHHHHHHHhcccccCCccceee
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK---------EFKTEVNVIGQTHHKNLVRLLG 579 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~---------~f~~E~~~l~~l~h~niv~l~g 579 (804)
+.+..+...+.+|.|+||.||.... +. ..+|||.+........+ .+.+|+..+.+++|++|..+..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~----~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DY----GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CC----CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 3444455567899999999998544 22 25999999754332222 2678999999999999999999
Q ss_pred EEeCC--------CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC
Q 047263 580 FCDDG--------LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY 651 (804)
Q Consensus 580 ~~~~~--------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~ 651 (804)
++... ...+|+|||++|.+|.++.. ++ .....+++.+|..+|+. +++|||+||+||+++.+
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~----~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----IS----EDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh----cc----HHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 86533 35789999999999988742 22 13466999999999965 99999999999999998
Q ss_pred CCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHH
Q 047263 652 YNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710 (804)
Q Consensus 652 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ell 710 (804)
+ ++|+|||.......+... ..+.....+..++|+|+||+.+.-+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988754211111 01233445667999999999988765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-18 Score=198.11 Aligned_cols=250 Identities=23% Similarity=0.249 Sum_probs=177.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHH--hcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNV--IGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
..+.+.||.++|=+|.|++.+.+ .|+||.+.+.. .-..+.|.++++- ...++|||.+.+.-.-..+...|||
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG-----~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREG-----LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCc-----eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHH
Confidence 34678899999999999988755 37888875433 3334445444433 4556899999998887777778899
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc--cC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL--LD 668 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~--~~ 668 (804)
-+|..+ +|.|.|..+.-+...+..-|+.|++.||..+|+ .+|+|||||.+|||++.-.=+.|+||.-.+..- .+
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 999876 899998777777778888899999999999995 499999999999999998889999998766432 11
Q ss_pred CCCcc----ccccCCCccccccccccC----------C-CCccchhhHHHHHHHHHHcC-CCCCCcchhHHHHHHHHHHH
Q 047263 669 QSQTH----TAIRGTKGYVAPEWFRNM----------P-ITVKVDVYSFGVLLLEIICC-RRNVDMEVNEAEALLTDWAY 732 (804)
Q Consensus 669 ~~~~~----~~~~gt~~y~aPE~l~~~----------~-~s~~~DV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~ 732 (804)
..... .+.+.-.+|+|||.+-.. . .+++.||||.||++.||++- +++|...+--.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a--------- 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA--------- 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh---------
Confidence 11111 112233479999977431 2 67889999999999999985 66665432111
Q ss_pred HhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
++.+. .......++.. +...+.++++.|++.||++|-++++.++.-.++
T Consensus 247 --Yr~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 --YRSGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --HhccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11110 00000000111 112577899999999999999999999875443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=163.37 Aligned_cols=141 Identities=17% Similarity=0.112 Sum_probs=109.2
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccccc--------------------------HHHHHHHHHHhcccc
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG--------------------------VKEFKTEVNVIGQTH 570 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~f~~E~~~l~~l~ 570 (804)
.+.||+|++|.||+|...+ ++.||||.+....... ...+..|.+.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~----g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTGD----GEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcCC----CCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 3579999999999998762 3479999987542110 112467899999999
Q ss_pred cCCccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 571 h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
|+++.....+... ..+|||||++++++.........++......++.+++.++.+||+. .+|+||||||+||+++
T Consensus 78 ~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~- 152 (190)
T cd05145 78 EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH- 152 (190)
T ss_pred hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-
Confidence 9987655544433 3489999999886554433345667788899999999999999961 4999999999999999
Q ss_pred CCCEEEeecCcccccc
Q 047263 651 YYNARISDFGLAKLLL 666 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~~ 666 (804)
+++++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.4e-18 Score=184.89 Aligned_cols=189 Identities=25% Similarity=0.237 Sum_probs=158.8
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+|+|.||.|+...--.+...+...|.|.+.+... ......+.|..++...+ ||.+|+++-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999998765444444445677777754322 11125677888888887 99999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI 676 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 676 (804)
|.|...+......+..........++-++.++|+ .+|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 9999999888888888888888999999999995 49999999999999999999999999999875332222
Q ss_pred cCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCc
Q 047263 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM 718 (804)
Q Consensus 677 ~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~ 718 (804)
+||..|||||++. ....++|-||||++++||++|-.||..
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8899999999998 568899999999999999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=155.26 Aligned_cols=183 Identities=17% Similarity=0.064 Sum_probs=134.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccc----cHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD----GVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~----~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 591 (804)
...|++|+||+||.+..+ ..+++.+.+.....- ..+.|.+|++++++++ |+++++++++ +..+++|
T Consensus 7 ~~~l~~~~f~~v~~~~~~-----~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGG-----ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ceeecCCCcceEEEeecC-----CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 357999999999965442 235777777654331 1225789999999995 5889999886 4579999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCC-CCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDI-KPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-kp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+.+.+|...+.. ....++.+++++|.++|+. +|+|||| ||+|||++.++.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999998765421 1245778999999999965 9999999 79999999999999999999985433221
Q ss_pred C----c--------cccccCCCccccccccccC-CCC-ccchhhHHHHHHHHHHcCCCCCCc
Q 047263 671 Q----T--------HTAIRGTKGYVAPEWFRNM-PIT-VKVDVYSFGVLLLEIICCRRNVDM 718 (804)
Q Consensus 671 ~----~--------~~~~~gt~~y~aPE~l~~~-~~s-~~~DV~S~Gvll~elltG~~p~~~ 718 (804)
. . ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 0112256778888754432 333 567889999999999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=157.28 Aligned_cols=134 Identities=19% Similarity=0.197 Sum_probs=103.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-----ccCCccceeeEEeCCC---c-eE
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-----HHKNLVRLLGFCDDGL---N-RL 588 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~ 588 (804)
+.||+|+||.||. .+... ..+||++........+++.+|+.+++.+ .||||++++|+++++. . ..
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~----~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDA----QRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred ceecCCCceEEEE--CCCCc----CeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 5799999999996 33222 2468888754444567899999999999 5799999999998764 3 33
Q ss_pred EEEee--cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHH-HHhhhccCCCeeecCCCCCcEEEcC----CCCEEEeecCc
Q 047263 589 LVYEF--LSNGTLASFLFGDLKPGWSRRTDIAFGIARGL-LYLHEECSTQIIHCDIKPQNILLDD----YYNARISDFGL 661 (804)
Q Consensus 589 lV~Ey--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~dlkp~NILl~~----~~~~kl~Dfgl 661 (804)
+|+|| +.+++|.+++.+. .++.. ..++.+++.++ +|||++ +|+||||||+|||++. +.+++|+||+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5589999999654 34444 45677888777 999965 9999999999999974 34799999554
Q ss_pred cc
Q 047263 662 AK 663 (804)
Q Consensus 662 a~ 663 (804)
+.
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=163.31 Aligned_cols=271 Identities=24% Similarity=0.277 Sum_probs=172.5
Q ss_pred CCCCCCCCCcccccccccCHHHHHHHHhhhHHhhCCCcceeEEEeeecCcccc---------------------------
Q 047263 487 NSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMY--------------------------- 539 (804)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~--------------------------- 539 (804)
.++.+.+++....-...|+++|.+ |.+.||+|.-..||.+.+..++..
T Consensus 137 ~ks~~whDei~~r~dskFtiddye-----iG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~ 211 (598)
T KOG4158|consen 137 LKSTEWHDEIPNRIDSKFTIDDYE-----IGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVS 211 (598)
T ss_pred hhccCCCCcCcchhhcccchhhhc-----ccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCccc
Confidence 334455666666666678887754 788999999999999887652211
Q ss_pred -----ceeEEEEEcccccccc-----HHHHHHHH--------------HHhcc--------cccCCccceeeEEeC----
Q 047263 540 -----QVPVAVKKLHSVIQDG-----VKEFKTEV--------------NVIGQ--------THHKNLVRLLGFCDD---- 583 (804)
Q Consensus 540 -----~~~vavK~~~~~~~~~-----~~~f~~E~--------------~~l~~--------l~h~niv~l~g~~~~---- 583 (804)
.-+.|||.+.....+. .+...+|. ...+. -+|||||++.++|.+
T Consensus 212 ~p~~~aFPLAiKmMfN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~ 291 (598)
T KOG4158|consen 212 KPAQKAFPLAIKMMFNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKV 291 (598)
T ss_pred CccccccchHHHHhcccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhcc
Confidence 0135566654322111 11111221 11122 259999999998744
Q ss_pred -----------------------CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecC
Q 047263 584 -----------------------GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCD 640 (804)
Q Consensus 584 -----------------------~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~d 640 (804)
+...|+||.-.+. +|..+|..+.. +...+.-|+.|+++|+.|||.+ +|.|||
T Consensus 292 lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~-s~r~~~~~laQlLEav~hL~~h---gvAhRD 366 (598)
T KOG4158|consen 292 LPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR-SYRTGRVILAQLLEAVTHLHKH---GVAHRD 366 (598)
T ss_pred CCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC-chHHHHHHHHHHHHHHHHHHHc---cchhhc
Confidence 2345788876644 88888865443 4455666888999999999966 999999
Q ss_pred CCCCcEEE--cCCCC--EEEeecCcccccccCC-----CCccccccCCCccccccccccCC------CCccchhhHHHHH
Q 047263 641 IKPQNILL--DDYYN--ARISDFGLAKLLLLDQ-----SQTHTAIRGTKGYVAPEWFRNMP------ITVKVDVYSFGVL 705 (804)
Q Consensus 641 lkp~NILl--~~~~~--~kl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~------~s~~~DV~S~Gvl 705 (804)
+|++|||+ |+|+. ..|+|||.+.-..... ........|...-||||+....+ --.|+|.|+.|.+
T Consensus 367 lKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Gal 446 (598)
T KOG4158|consen 367 LKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGAL 446 (598)
T ss_pred ccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhh
Confidence 99999998 45544 5789999875432211 11122344777899999886432 1358999999999
Q ss_pred HHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 706 LLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 706 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
.||++....||....+ ..+.... +.+.....+ +......+.+++..-++.||++||+..-..
T Consensus 447 aYEIfg~~NPFY~rGe---m~L~~r~---Yqe~qLPal---------p~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 447 AYEIFGRSNPFYKRGE---MLLDTRT---YQESQLPAL---------PSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred HHHHhccCCcccccch---heechhh---hhhhhCCCC---------cccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 9999999999976321 1111110 111111111 111223466778888999999999875433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-16 Score=159.61 Aligned_cols=227 Identities=21% Similarity=0.245 Sum_probs=144.4
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccc----------cCCccceeeEEe-
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTH----------HKNLVRLLGFCD- 582 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~----------h~niv~l~g~~~- 582 (804)
.+.||.|+++.||.++.... ++++|+|.+... .....+++++|.-.+..+. |-.++..++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t---~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVET---GEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEETTEEEEEEEETTT---TEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred ccccccCCceEEEEEEEccC---CceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 35799999999999998654 448999998533 2345677888876666643 222222222221
Q ss_pred C--------C---C-----ceEEEEeecCCCcHHHhhc---CCC----CCChhhHHHHHHHHHHHHHHhhhccCCCeeec
Q 047263 583 D--------G---L-----NRLLVYEFLSNGTLASFLF---GDL----KPGWSRRTDIAFGIARGLLYLHEECSTQIIHC 639 (804)
Q Consensus 583 ~--------~---~-----~~~lV~Ey~~~gsL~~~l~---~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 639 (804)
. . . ..+++|+-+ .++|.+++. ... .+....++.+..|+++.+++||.. +++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1 1 1 235677766 458877753 221 123445677789999999999965 99999
Q ss_pred CCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCcccccccccc--------CCCCccchhhHHHHHHHHHHc
Q 047263 640 DIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN--------MPITVKVDVYSFGVLLLEIIC 711 (804)
Q Consensus 640 dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~~DV~S~Gvll~ellt 711 (804)
||+|+|++++.+|.++|+||+.....+. .......+..|.+||.... ..++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987765322 1111334578999997643 257889999999999999999
Q ss_pred CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCC
Q 047263 712 CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLR 775 (804)
Q Consensus 712 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 775 (804)
++.|++.......... .-.... +..+.+..|+..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986644321100 111233 566778889999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=182.97 Aligned_cols=197 Identities=21% Similarity=0.220 Sum_probs=156.0
Q ss_pred HHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc---cCCccceeeEEeCC
Q 047263 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDG 584 (804)
Q Consensus 508 ~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~ 584 (804)
++...+..+.+.||+|+||+||+|...+ +..||+|.-+.... -+|.--.+++.+|+ -+-|..+...+.-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~----~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN----GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC----CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3333445567889999999999999876 33799999875422 22332333333443 23455555555667
Q ss_pred CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-------CCCCEEEe
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-------DYYNARIS 657 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-------~~~~~kl~ 657 (804)
+..+||+||.+-|+|.+++...+.++|.....++.|+++.+.+||.. +|||+||||+|.||. +...++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 78899999999999999999889999999999999999999999965 999999999999993 34568999
Q ss_pred ecCcccccccC-CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCC
Q 047263 658 DFGLAKLLLLD-QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR 714 (804)
Q Consensus 658 Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~ 714 (804)
|||.+..+..- +.......++|-.+-.+|...+++.+-++|-|.+..+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999766432 2335556778999999999999999999999999999999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.9e-17 Score=173.57 Aligned_cols=120 Identities=32% Similarity=0.454 Sum_probs=107.3
Q ss_pred ceEEEEeecCCCcHHHhhcCC---CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 586 NRLLVYEFLSNGTLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
..++.|+++...+|.++|.++ ...++...+.++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999765 345788899999999999999 38999999999999999999999999999
Q ss_pred cccccCC-----CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc
Q 047263 663 KLLLLDQ-----SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC 711 (804)
Q Consensus 663 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt 711 (804)
....... ...++...||..||+||.+.+..|+.|+||||+|+||+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8776554 445667789999999999999999999999999999999996
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=154.16 Aligned_cols=140 Identities=18% Similarity=0.171 Sum_probs=106.4
Q ss_pred hhHHhhCCCcceeEEEee-ecCccccceeEEEEEccccccc------------------------cHHHHHHHHHHhccc
Q 047263 515 GFKEELGKGAFGVVYKGA-IGMASMYQVPVAVKKLHSVIQD------------------------GVKEFKTEVNVIGQT 569 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~-~~~~~~~~~~vavK~~~~~~~~------------------------~~~~f~~E~~~l~~l 569 (804)
.+.+.||+|++|.||+|. .... ++.||+|++...... ....+..|+..+.++
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~---g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGS---GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCC---CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356789999999999998 3222 347999998743210 112356899999999
Q ss_pred ccCC--ccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCC-eeecCCCCCcE
Q 047263 570 HHKN--LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQ-IIHCDIKPQNI 646 (804)
Q Consensus 570 ~h~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlkp~NI 646 (804)
.+.. +.+++++ ...++||||+++.+|...+.............++.||+.++.+||+. + ++||||||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 7633 3444443 23589999999999877664444555566789999999999999965 8 99999999999
Q ss_pred EEcCCCCEEEeecCccccc
Q 047263 647 LLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~ 665 (804)
+++ +++++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=151.23 Aligned_cols=134 Identities=19% Similarity=0.256 Sum_probs=111.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccc--------cHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--------GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~--------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
+.||+|++|.||+|.... ..+++|+....... ....+..|++++..++|+++.....++.+....++
T Consensus 2 ~~l~~G~~~~vy~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG-----IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFII 76 (211)
T ss_pred cccccCceEEEEEEeeCC-----CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence 468999999999998632 25888876532211 12357889999999999999888888878888999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
+|||+++++|.+++..... .+..++.+++.+|.+||+. +++|+|++|+|||++ ++.++|+|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999999864322 7889999999999999955 999999999999999 78999999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.5e-15 Score=169.54 Aligned_cols=131 Identities=18% Similarity=0.259 Sum_probs=107.6
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEc-cccc-------cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKL-HSVI-------QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~-~~~~-------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
.+.||+|+||.||+|...... +++|+. .... ....+.+.+|++++..++|++++....++.+....+
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-----~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-----AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-----ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 578999999999999875442 333332 1110 012346889999999999999999888888888889
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
+||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999884 4678999999999999965 99999999999999 677999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.4e-15 Score=146.96 Aligned_cols=130 Identities=20% Similarity=0.272 Sum_probs=105.4
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEcccccc--------ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
.||+|++|.||+|.... ..+++|....... .....+.+|++++..++|+++.....++.+....++|
T Consensus 1 ~ig~G~~~~vy~~~~~~-----~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-----LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeecCC-----ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 38999999999998532 3588888643211 1135678899999999998876666666677778999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
|||+++++|.+++..... .++.+++++|.+||+. +++|+|++|+||+++ ++.++++|||++..
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999998754321 8899999999999954 999999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=145.35 Aligned_cols=135 Identities=18% Similarity=0.140 Sum_probs=104.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc----------------------ccHHHHHHHHHHhccccc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ----------------------DGVKEFKTEVNVIGQTHH 571 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~f~~E~~~l~~l~h 571 (804)
+.+.+.||+|+||.||++...+ ++.||||++..... .....+..|+.++..+.|
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPD----GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhcCCccccCcceEEEEEEcCC----CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 4556789999999999998753 33699998653210 011236778888998888
Q ss_pred C--CccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc
Q 047263 572 K--NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD 649 (804)
Q Consensus 572 ~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~ 649 (804)
+ .+.+.++. ...++||||+++++|...... .....++.+++.++.++|+. +++|+||||+||+++
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 7 44444442 345899999999999876531 34567889999999999964 999999999999999
Q ss_pred CCCCEEEeecCccccc
Q 047263 650 DYYNARISDFGLAKLL 665 (804)
Q Consensus 650 ~~~~~kl~Dfgla~~~ 665 (804)
+++.++|+|||++..+
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5e-14 Score=161.38 Aligned_cols=204 Identities=22% Similarity=0.229 Sum_probs=134.8
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
.+.|..|+||.||..+.+... +.+|+|.-+.... .++ ++.....|.+|
T Consensus 88 IklisngAygavylvrh~~tr---qrfa~kiNkq~li-----lRn---ilt~a~npfvv--------------------- 135 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETR---QRFAMKINKQNLI-----LRN---ILTFAGNPFVV--------------------- 135 (1205)
T ss_pred eEeeccCCCCceeeeeccccc---cchhhcccccchh-----hhc---cccccCCccee---------------------
Confidence 467899999999998776433 3677743222100 000 22222233222
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-------
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ------- 669 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~------- 669 (804)
|+-...++....++... +.+++||| +.+|+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 gDc~tllk~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 136 GDCATLLKNIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred chhhhhcccCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 44445554434443332 78899999 5699999999999999999999999999987632110
Q ss_pred -------CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 670 -------SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 670 -------~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
.......+||+.|+|||++....|...+|.|++|+|+||.+-|+.||..+.+++-..........|.|+
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~---- 280 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE---- 280 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc----
Confidence 112234579999999999999999999999999999999999999999886554211110000011111
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCC
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPT 777 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 777 (804)
......+..+++.+.|+.+|.+|--
T Consensus 281 ----------dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 281 ----------DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ----------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1122345666777889999999953
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.7e-13 Score=128.93 Aligned_cols=134 Identities=23% Similarity=0.175 Sum_probs=113.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc--CCccceeeEEeCCCceEEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH--KNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.||+|.++.||++.... ..+++|....... ...+..|+..+..++| .++++++++....+..++++||+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-----~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-----EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred ceecccccccceEEEEecC-----CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 3579999999999998754 2589999865433 5678999999999987 59999999998888999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
+++.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.+++.||+.+..
T Consensus 76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98877654 5567788899999999999975445799999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.4e-13 Score=132.98 Aligned_cols=137 Identities=21% Similarity=0.227 Sum_probs=94.5
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccc--cHHHH----------------------HHHHHHhcccccC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEF----------------------KTEVNVIGQTHHK 572 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~--~~~~f----------------------~~E~~~l~~l~h~ 572 (804)
.+.||+|+||.||+|...+ +++||||.+...... ....+ ..|...+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~----~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDGD----GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECCC----CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 4679999999999998763 337999987643211 11111 3455555555443
Q ss_pred C--ccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 573 N--LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 573 n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
. +.+.+++ ...++||||++++.+........... .....++.+++.++.++|.+ .+|+|+||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-
Confidence 2 4444433 24689999999954322111111111 66788999999999999951 5999999999999999
Q ss_pred CCCEEEeecCccccc
Q 047263 651 YYNARISDFGLAKLL 665 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~ 665 (804)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-12 Score=134.07 Aligned_cols=134 Identities=16% Similarity=0.103 Sum_probs=102.3
Q ss_pred HhhC-CCcceeEEEeeecCccccceeEEEEEccccc-------------cccHHHHHHHHHHhcccccCCc--cceeeEE
Q 047263 518 EELG-KGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-------------QDGVKEFKTEVNVIGQTHHKNL--VRLLGFC 581 (804)
Q Consensus 518 ~~LG-~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-------------~~~~~~f~~E~~~l~~l~h~ni--v~l~g~~ 581 (804)
..|| .|+.|+||+...... .++||++.... ......+.+|++++.+++|++| ++.+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~-----~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGV-----NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeCCc-----eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 4687 899999999877522 58888775310 1223457889999999998875 7777765
Q ss_pred eCCCc----eEEEEeecCC-CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEE
Q 047263 582 DDGLN----RLLVYEFLSN-GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656 (804)
Q Consensus 582 ~~~~~----~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl 656 (804)
..... .++|+||+++ .+|.+++... .++. ..+.+|+++|.+||+. +|+|+||||+|||++.++.++|
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 43322 2599999997 6899888543 3332 3467899999999965 9999999999999999889999
Q ss_pred eecCcccc
Q 047263 657 SDFGLAKL 664 (804)
Q Consensus 657 ~Dfgla~~ 664 (804)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-14 Score=163.50 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=184.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 591 (804)
++.+.||+|.|+.|-......+. ...+|+|.+.... .........|..+-..+. |+|++++++...+....+++.
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~--~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDP--ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccchhhhhhhcCCC--cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 44566999999999877664333 2357777776543 222334455777777776 999999999999999999999
Q ss_pred eecCCCcHHHhh-cCCC-CCChhhHHHHHHHHHHHHHHhh-hccCCCeeecCCCCCcEEEcCCC-CEEEeecCccccccc
Q 047263 592 EFLSNGTLASFL-FGDL-KPGWSRRTDIAFGIARGLLYLH-EECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLL 667 (804)
Q Consensus 592 Ey~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~ 667 (804)
||..++++.+.+ .... ..+.........|+..++.|+| +. ++.|+||||+|.+++..+ ..+++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999988 5444 5667777889999999999999 54 899999999999999999 999999999998766
Q ss_pred --CCCCccccccC-CCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 668 --DQSQTHTAIRG-TKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 668 --~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
..........| +..|+|||...+. -..+..|+||.|+++.-+++|..|++.......... .| .+....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~-----~~~~~~-- 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SW-----KSNKGR-- 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-ee-----cccccc--
Confidence 23344455667 9999999999875 446789999999999999999999876544321110 11 111000
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
.. ............++...++..+|..|.+.+++.
T Consensus 250 ~~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FT----QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cc----cCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 001111223455667777889999999988764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=137.65 Aligned_cols=198 Identities=20% Similarity=0.244 Sum_probs=137.9
Q ss_pred HHHhcccccCCccceeeEEeCC-----CceEEEEeecCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhccC
Q 047263 563 VNVIGQTHHKNLVRLLGFCDDG-----LNRLLVYEFLSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEECS 633 (804)
Q Consensus 563 ~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~ 633 (804)
..-+-++-|.|||+++.|..+. .+..++.|||..|+|..+|++. ..+......+|+.||..||.|||.. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3444556799999999998543 4578999999999999999753 4566777789999999999999976 8
Q ss_pred CCeeecCCCCCcEEEcCCCCEEEeecCcccc---cccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHH
Q 047263 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKL---LLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710 (804)
Q Consensus 634 ~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~---~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ell 710 (804)
+.|+|+++..+.|++..++-+||.--.-... .............+.++|.+||+-.....+.++|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999888853211110 0000011112234678999999988888889999999999999998
Q ss_pred cCCCCCCcchhHH--HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 711 CCRRNVDMEVNEA--EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 711 tG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
-+..-........ +.... .....+-+. .-..++..|++.+|.+||+|.+++
T Consensus 277 ilEiq~tnseS~~~~ee~ia---------~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA---------NVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HheeccCCCcceeehhhhhh---------hheeeccCc------------cccCcCcccccCCCCCCcchhhhh
Confidence 8765422111110 10000 000000000 112356779999999999998875
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-12 Score=102.53 Aligned_cols=57 Identities=23% Similarity=0.462 Sum_probs=49.6
Q ss_pred cceEEeecCCCCCCcccc-cCcCChhhHHHHhcCCCceeeEeec---CCceeeeecCCCCC
Q 047263 354 YDFEVITNTDWPTSDYQL-LTPFTEEGCRQSCLHDCMCAVAIFR---SGDMCWKKKLPLSN 410 (804)
Q Consensus 354 ~~f~~~~~~~~~~~~~~~-~~~~~~~~C~~~Cl~nCsC~a~~y~---~g~~c~~~~~~l~~ 410 (804)
++|+++++|++|++.... ..++++++|++.||+||||+||+|. +|.+|++|.+.|.|
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 479999999999886544 3679999999999999999999997 46789999987765
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.9e-11 Score=135.14 Aligned_cols=138 Identities=22% Similarity=0.234 Sum_probs=96.4
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccH----------------------------------------HH
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV----------------------------------------KE 558 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~ 558 (804)
.||.|++|.||+|++.++. .||||+.+....+.. -.
T Consensus 124 plasaSigQVh~A~l~~G~----~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGK----EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred ceeeeehhheEEEEecCCC----EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 5999999999999997654 699999865321110 02
Q ss_pred HHHHHHHhcccc----cCCccceeeEE-eCCCceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHH-HHHHhhhc
Q 047263 559 FKTEVNVIGQTH----HKNLVRLLGFC-DDGLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIAR-GLLYLHEE 631 (804)
Q Consensus 559 f~~E~~~l~~l~----h~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~-gL~yLH~~ 631 (804)
|..|.+.+.+++ |.+-+.+-..+ ......+|||||++|++|.++.... ... .+.+++..+++ .+..+|+.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 444555555542 33333333333 2345679999999999998876432 111 34567777766 46778854
Q ss_pred cCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 632 ~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
+++|+|+||.||++++++++++.|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.4e-11 Score=101.68 Aligned_cols=72 Identities=21% Similarity=0.421 Sum_probs=59.8
Q ss_pred cceEEeecCCCCCCcccccCcCChhhHHHHhcCCCceeeEeecC-CceeeeecCCCCCCccccCCCCcceeecc
Q 047263 354 YDFEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRS-GDMCWKKKLPLSNGRFDANLNGKALIKIR 426 (804)
Q Consensus 354 ~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~y~~-g~~c~~~~~~l~~~~~~~~~~~~~~lkl~ 426 (804)
++|+.++++++|+..+.. .++++++|++.||+||+|.||+|.. +.+|++|...+.+.+.........|||++
T Consensus 12 ~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 569999999999876655 7889999999999999999999974 45699999988887764444577888873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.9e-11 Score=129.50 Aligned_cols=254 Identities=22% Similarity=0.203 Sum_probs=177.5
Q ss_pred HHHHHHHhhhHHhhCC--CcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhccc-ccCCccceeeEE
Q 047263 507 KDLEAATNGFKEELGK--GAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQT-HHKNLVRLLGFC 581 (804)
Q Consensus 507 ~~l~~at~~f~~~LG~--G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 581 (804)
.+..+....+.+.+|. |.+|.||++.... ......+|+|+-+.... .....=++|+...+++ .|+|.++....+
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 3445555667788999 9999999998733 23344788888543322 2222224566666666 499999988899
Q ss_pred eCCCceEEEEeecCCCcHHHhhcCCCC-CChhhHHHHHHHHHH----HHHHhhhccCCCeeecCCCCCcEEEcCC-CCEE
Q 047263 582 DDGLNRLLVYEFLSNGTLASFLFGDLK-PGWSRRTDIAFGIAR----GLLYLHEECSTQIIHCDIKPQNILLDDY-YNAR 655 (804)
Q Consensus 582 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~dlkp~NILl~~~-~~~k 655 (804)
++.+..++-+|++. .+|..+.+.... ++....+.+..+..+ |+.++| +..++|-|+||.||++.++ ...+
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceee
Confidence 99999999999886 688888766543 566667777777777 999999 5699999999999999999 8899
Q ss_pred EeecCcccccccCCC----CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH
Q 047263 656 ISDFGLAKLLLLDQS----QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA 731 (804)
Q Consensus 656 l~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 731 (804)
+.|||+...+..... .......|...|++||..++ .++...|+|++|.+++|..++.......... .|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W- 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SW- 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc-
Confidence 999999988765442 11223357778999998865 5788999999999999999887654432110 01
Q ss_pred HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
....... +.......-..++..++..+++++|..|++.+.+.
T Consensus 336 -~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 -SQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -ccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0000100 11111111123444477889999999999876654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.4e-10 Score=109.45 Aligned_cols=129 Identities=19% Similarity=0.131 Sum_probs=94.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCcc-ceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV-RLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.|+.|.++.||++... +..+++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++
T Consensus 4 ~~l~~G~~~~vy~~~~~-----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC-----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 45889999999998864 22599998765422 223467889999988765554 454443 3346899999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc--CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC--STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
.++.+. ......++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 887643 0112346779999999999652 22369999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-09 Score=119.98 Aligned_cols=161 Identities=16% Similarity=0.196 Sum_probs=119.3
Q ss_pred eEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHH
Q 047263 542 PVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGI 621 (804)
Q Consensus 542 ~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i 621 (804)
+|.|...+...........+-++.++.++||||++++...+.+...|||+|-+. .|..++... +.....-.++||
T Consensus 39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCLGLFQI 113 (690)
T ss_pred ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHHHHHHH
Confidence 677777665544444557788899999999999999999999999999999875 455555422 244455678899
Q ss_pred HHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhH
Q 047263 622 ARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYS 701 (804)
Q Consensus 622 a~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S 701 (804)
+.||.|||+. .+++|++|..+.|++++.|+.||++|.+......-.. ......--..|..|+.+.... -..|.|-
T Consensus 114 l~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~ 188 (690)
T KOG1243|consen 114 LAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWG 188 (690)
T ss_pred HHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhh
Confidence 9999999975 4899999999999999999999999998865322111 011111223466666443221 4579999
Q ss_pred HHHHHHHHHcC
Q 047263 702 FGVLLLEIICC 712 (804)
Q Consensus 702 ~Gvll~elltG 712 (804)
||++++|++.|
T Consensus 189 Lg~li~el~ng 199 (690)
T KOG1243|consen 189 LGCLIEELFNG 199 (690)
T ss_pred HHHHHHHHhCc
Confidence 99999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.2e-10 Score=127.18 Aligned_cols=141 Identities=16% Similarity=0.097 Sum_probs=87.3
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccccc----------------------------------HH------
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG----------------------------------VK------ 557 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~------ 557 (804)
+.||+|++|.||+|+++++ ++.||||+.+....+. .+
T Consensus 125 ~PlasaSiaQVh~A~l~~~---G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~El 201 (537)
T PRK04750 125 KPLASASIAQVHFARLKDN---GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDEL 201 (537)
T ss_pred hhhcCCCccEEEEEEECCC---CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhh
Confidence 3699999999999999863 2369999997532110 11
Q ss_pred HHHHHHHHhcccc----cCCccceeeEEeC-CCceEEEEeecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHH-HHHhhh
Q 047263 558 EFKTEVNVIGQTH----HKNLVRLLGFCDD-GLNRLLVYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARG-LLYLHE 630 (804)
Q Consensus 558 ~f~~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~g-L~yLH~ 630 (804)
+|..|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.|.++-. .....+ +..++...++. +..++
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVEVFFTQVF- 277 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHHHHHHHHH-
Confidence 1334444444432 3333333333322 456789999999999987521 111111 11222222211 12222
Q ss_pred ccCCCeeecCCCCCcEEEcCCC----CEEEeecCccccccc
Q 047263 631 ECSTQIIHCDIKPQNILLDDYY----NARISDFGLAKLLLL 667 (804)
Q Consensus 631 ~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfgla~~~~~ 667 (804)
..+++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34999999999999999888 999999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.3e-09 Score=101.06 Aligned_cols=140 Identities=15% Similarity=0.204 Sum_probs=97.5
Q ss_pred HhhCCCcceeEEEeeecCcc---ccceeEEEEEcccccc----------------------ccHHHHH----HHHHHhcc
Q 047263 518 EELGKGAFGVVYKGAIGMAS---MYQVPVAVKKLHSVIQ----------------------DGVKEFK----TEVNVIGQ 568 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~---~~~~~vavK~~~~~~~----------------------~~~~~f~----~E~~~l~~ 568 (804)
..||.|.-+.||.|.-.++. .....+|||..+.... ...+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 36899999999999754320 0234699998852110 0012233 78999988
Q ss_pred ccc--CCccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHh-hhccCCCeeecCCCCCc
Q 047263 569 THH--KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYL-HEECSTQIIHCDIKPQN 645 (804)
Q Consensus 569 l~h--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlkp~N 645 (804)
+.. -++.+++++ ...+|||||+.+..+..-.-....++..+...+..+++.+|..| |+ .+++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 854 466667654 56789999998754422221222344455677889999999999 74 499999999999
Q ss_pred EEEcCCCCEEEeecCccccc
Q 047263 646 ILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 646 ILl~~~~~~kl~Dfgla~~~ 665 (804)
||+++ +.+.|+|||.+...
T Consensus 156 IL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC-CcEEEEECCCceeC
Confidence 99974 68999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-09 Score=90.42 Aligned_cols=65 Identities=14% Similarity=0.132 Sum_probs=53.7
Q ss_pred ceEEeecCCCCCCcccccCcCChhhHHHHhcC---CCceeeEeecC-CceeeeecCCC-CCCccccCCCCcceee
Q 047263 355 DFEVITNTDWPTSDYQLLTPFTEEGCRQSCLH---DCMCAVAIFRS-GDMCWKKKLPL-SNGRFDANLNGKALIK 424 (804)
Q Consensus 355 ~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~y~~-g~~c~~~~~~l-~~~~~~~~~~~~~~lk 424 (804)
.|+++.++++|++.. +++++|++.|++ ||||+||+|.. +.+|++|...+ .+.+...+.+.++|+|
T Consensus 10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 499999999998754 689999999999 99999999963 45799999988 7777666556677775
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-08 Score=104.30 Aligned_cols=142 Identities=19% Similarity=0.240 Sum_probs=108.6
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhccccc--CCccceeeEEeCCC---ceEEEE
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHH--KNLVRLLGFCDDGL---NRLLVY 591 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lV~ 591 (804)
+.|+.|..+.||++...++ ..+++|....... .....+..|.++++.+++ .++.+++.+..+.. ..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g----~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGG----RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCC----cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 4589999999999987542 3589998765322 134578899999999976 44677888876643 568999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc---------------------------------------
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC--------------------------------------- 632 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 632 (804)
||+++.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988776532 34667778888888888888888421
Q ss_pred --------------CCCeeecCCCCCcEEEcC--CCCEEEeecCcccc
Q 047263 633 --------------STQIIHCDIKPQNILLDD--YYNARISDFGLAKL 664 (804)
Q Consensus 633 --------------~~~ivH~dlkp~NILl~~--~~~~kl~Dfgla~~ 664 (804)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.7e-08 Score=94.20 Aligned_cols=130 Identities=22% Similarity=0.306 Sum_probs=100.8
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEcccc-cc-----c--cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQ-----D--GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~-----~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
.+.+|+-..+|.+...+. ++++|.-... .. + ..+...+|+.++.+++--.|.-..-+..+.....|+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-----~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-----PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred hhhCCcceeEEeeeccCc-----ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence 578899999998855321 3444443211 11 1 123467899999999877777777788888999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
|||+++..|.+.|... +..++..|-.-+.-||.. +|+|+||.++||++.... +.++||||+..
T Consensus 78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999998654 467788888889999955 999999999999998774 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.1e-09 Score=118.44 Aligned_cols=245 Identities=20% Similarity=0.189 Sum_probs=167.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHH--HHHHHHhccc-ccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEF--KTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f--~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 591 (804)
++...||.|.|+.|++..... .....+++|.+.........+. ..|+.+...+ .|.++++....+....+.++=-
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~--~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRP--EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeeeecC--CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 345679999999999877441 2233688888765433222221 2344444444 5888888888888888888999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-CCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~ 670 (804)
||++++++...+.-...++...++++..|++.++.++| ++.++|+|+||+||++..+ +.-++.||+.+..+...
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 99999999888855667788899999999999999999 5699999999999999876 78899999998642111
Q ss_pred CccccccCCCcc-ccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGY-VAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y-~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......+..| .+++......+-.+.|+||||.-+.|.+++..-...... | .....+...
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~--~~i~~~~~p-------- 481 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S--LTIRSGDTP-------- 481 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c--eeeeccccc--------
Confidence 11111122233 366666777889999999999999999998754321110 0 000111111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.... ....+..++..+..+++..||.+.+...+.+.
T Consensus 482 ~~~~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 482 NLPG--LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CCCc--hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111 11445556666888999999999887766543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.3e-07 Score=102.04 Aligned_cols=168 Identities=21% Similarity=0.258 Sum_probs=127.8
Q ss_pred cceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEe----CCCceEEEEeecCC-Cc
Q 047263 524 AFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD----DGLNRLLVYEFLSN-GT 598 (804)
Q Consensus 524 ~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~Ey~~~-gs 598 (804)
.-.+.||+....++. .+++|++.....+....-..-++.++++.|.|+|++...+. .+..++|||+|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~---~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGN---AYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCc---eeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 345678988765544 68899995443333333456688899999999999999875 45678999999986 57
Q ss_pred HHHhhcCC---------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 599 LASFLFGD---------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 599 L~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
|.++-+.. ...++...+.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 77665422 2345788899999999999999955 88889999999999999999999998887
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCC
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRN 715 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p 715 (804)
.+..+.. |-+ .--.+-|.=.||.+++.|.||...
T Consensus 442 vl~~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 6544331 111 113467999999999999999755
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.3e-08 Score=91.17 Aligned_cols=140 Identities=21% Similarity=0.255 Sum_probs=102.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcc-ccc-------cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVI-------QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~-~~~-------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
...|-||+-+.|+++.... +...||.-. +.. +-..+..++|++.+.+++--.|.-..-++.+...-.
T Consensus 12 l~likQGAEArv~~~~~~G-----e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~ 86 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSG-----EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ 86 (229)
T ss_pred ceeeeccceeeEeeeccCC-----ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence 3568899999999987652 234454432 211 112346789999999998767776677788888889
Q ss_pred EEEeecCC-CcHHHhhcCC-CCCChhhH-HHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC---CEEEeecCcc
Q 047263 589 LVYEFLSN-GTLASFLFGD-LKPGWSRR-TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY---NARISDFGLA 662 (804)
Q Consensus 589 lV~Ey~~~-gsL~~~l~~~-~~l~~~~~-~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfgla 662 (804)
|+|||+++ .++.+++... ........ ..++..|-+.+.-||.. +|+|+||..+||+|..++ .+.++|||++
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence 99999987 4788888654 22233333 68889999999999955 999999999999996544 3589999998
Q ss_pred cc
Q 047263 663 KL 664 (804)
Q Consensus 663 ~~ 664 (804)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.3e-09 Score=118.92 Aligned_cols=193 Identities=21% Similarity=0.198 Sum_probs=135.7
Q ss_pred ccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc
Q 047263 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD 649 (804)
Q Consensus 570 ~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~ 649 (804)
+||-+++..--+.-....+|+++|..+++|...|+.....+..-....+..+.+.++|||. ..+.|+|++|.|++..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhc
Confidence 4455555554455677889999999999999999877666655555666678889999994 4689999999999999
Q ss_pred CCCCEEEeecCcccccccC------------------------------CCCccccccCCCccccccccccCCCCccchh
Q 047263 650 DYYNARISDFGLAKLLLLD------------------------------QSQTHTAIRGTKGYVAPEWFRNMPITVKVDV 699 (804)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV 699 (804)
.++..+++||+.......- .........+|..|.+||.+.+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 9999999999843322100 0011223458999999999999999999999
Q ss_pred hHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHH
Q 047263 700 YSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMR 779 (804)
Q Consensus 700 ~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 779 (804)
|++|++++|.++|..||......... +++........ ....+...+...++..-+..+|.+|-.|.
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f-----------~ni~~~~~~~p---~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIF-----------ENILNRDIPWP---EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhh-----------hccccCCCCCC---CCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999999999876544321 11111111100 11122233455566666778888887665
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.6e-07 Score=84.71 Aligned_cols=77 Identities=21% Similarity=0.356 Sum_probs=59.5
Q ss_pred EEEEecCCCeEEeCCC-CceEeeccCCCC--ceeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEec
Q 047263 94 KVELTADQGLVLTSPQ-GRELWKSDPIIG--TVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSK 170 (804)
Q Consensus 94 ~l~~~~~G~L~l~~~~-~~~vWst~~~~~--~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~ 170 (804)
.+.+..||+||+.+.. +.++|++++... ....+.|+++|||||++.++.++|+|=.
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t--------------------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT--------------------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc---------------------
Confidence 3445578999999765 589999997532 2357899999999999988889999811
Q ss_pred CCCCCCCCCceEEEecCCCceEEEe
Q 047263 171 QSDGNFSKGRFRFELNSNGNLVLTT 195 (804)
Q Consensus 171 ~s~~dps~G~~~~~~~~~g~~~~~~ 195 (804)
....|.|.+.|+++|+++++.
T Consensus 82 ----~~~~~~~~~~L~ddGnlvl~~ 102 (114)
T smart00108 82 ----TGANGNYVLVLLDDGNLVIYD 102 (114)
T ss_pred ----cCCCCceEEEEeCCCCEEEEC
Confidence 013567899999999998863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.7e-07 Score=94.93 Aligned_cols=120 Identities=15% Similarity=0.071 Sum_probs=89.5
Q ss_pred eEEEEEccccccc-cH----------HHHHHHHHHhcccccCC--ccceeeEEeC-----CCceEEEEeecCCC-cHHHh
Q 047263 542 PVAVKKLHSVIQD-GV----------KEFKTEVNVIGQTHHKN--LVRLLGFCDD-----GLNRLLVYEFLSNG-TLASF 602 (804)
Q Consensus 542 ~vavK~~~~~~~~-~~----------~~f~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~lV~Ey~~~g-sL~~~ 602 (804)
.+.||+....... .. ..+.+|...+.+++..+ .+.++++.+. ....+||+|++++- +|.++
T Consensus 47 ~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~ 126 (268)
T PRK15123 47 SYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDY 126 (268)
T ss_pred EEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHH
Confidence 6889977543211 11 13788999998885443 4455666643 23578999999986 89998
Q ss_pred hcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-------CCCEEEeecCcccc
Q 047263 603 LFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-------YYNARISDFGLAKL 664 (804)
Q Consensus 603 l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-------~~~~kl~Dfgla~~ 664 (804)
+.. ....+...+..++.++++.+.-||+. +|+|+|++++|||++. +..+.++||+.+..
T Consensus 127 ~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 127 CADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 853 23445667789999999999999965 9999999999999975 46789999998753
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.6e-07 Score=83.53 Aligned_cols=85 Identities=21% Similarity=0.359 Sum_probs=63.5
Q ss_pred EEec-CCCeEEeCCC-CceEeeccCCC--CceeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEecC
Q 047263 96 ELTA-DQGLVLTSPQ-GRELWKSDPII--GTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQ 171 (804)
Q Consensus 96 ~~~~-~G~L~l~~~~-~~~vWst~~~~--~~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~~ 171 (804)
.+.. ||+||+++.. ++++|++|+.. .....+.|+++|||||.+.++.++|||=-.
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~--------------------- 83 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT--------------------- 83 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc---------------------
Confidence 3454 8999998754 58999999764 344678999999999999888999998210
Q ss_pred CCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCccccc
Q 047263 172 SDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESK 211 (804)
Q Consensus 172 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 211 (804)
.+.+.+.+.|+++|+++++..+ ..+.|.+.
T Consensus 84 ----~~~~~~~~~L~ddGnlvl~~~~------~~~~W~Sf 113 (116)
T cd00028 84 ----RVNGNYVLVLLDDGNLVLYDSD------GNFLWQSF 113 (116)
T ss_pred ----CCCCceEEEEeCCCCEEEECCC------CCEEEcCC
Confidence 0257789999999999986432 24566553
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.7e-06 Score=87.01 Aligned_cols=105 Identities=21% Similarity=0.225 Sum_probs=85.5
Q ss_pred HHHHHHHHHhcccc--cCCccceeeEEeCCC----ceEEEEeecCCC-cHHHhhcCCCCCChhhHHHHHHHHHHHHHHhh
Q 047263 557 KEFKTEVNVIGQTH--HKNLVRLLGFCDDGL----NRLLVYEFLSNG-TLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629 (804)
Q Consensus 557 ~~f~~E~~~l~~l~--h~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH 629 (804)
....+|...+..++ .-...+.+++.+... ..+||+|++++. +|.+++......+...+..++.++++.+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35678888888775 345667777775532 358999999984 89999977555777788999999999999999
Q ss_pred hccCCCeeecCCCCCcEEEcCCC---CEEEeecCcccc
Q 047263 630 EECSTQIIHCDIKPQNILLDDYY---NARISDFGLAKL 664 (804)
Q Consensus 630 ~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfgla~~ 664 (804)
+. +|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 136 ~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 66 999999999999998876 789999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.7e-06 Score=84.88 Aligned_cols=125 Identities=22% Similarity=0.199 Sum_probs=80.0
Q ss_pred eEEEeeecCccccceeEEEEEccccc--------------c------------ccHHHHHHHHHHhcccccC--Ccccee
Q 047263 527 VVYKGAIGMASMYQVPVAVKKLHSVI--------------Q------------DGVKEFKTEVNVIGQTHHK--NLVRLL 578 (804)
Q Consensus 527 ~Vykg~~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~f~~E~~~l~~l~h~--niv~l~ 578 (804)
.||.|...++. .+|||...... . ......++|.+.|.++..- ++.+++
T Consensus 1 ~Vy~~~~~~~~----~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDPDGE----EVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEECTTE----EEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECCCCC----EEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 37888776544 59999875210 0 0012357899999999765 566776
Q ss_pred eEEeCCCceEEEEeecC--CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHh-hhccCCCeeecCCCCCcEEEcCCCCEE
Q 047263 579 GFCDDGLNRLLVYEFLS--NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYL-HEECSTQIIHCDIKPQNILLDDYYNAR 655 (804)
Q Consensus 579 g~~~~~~~~~lV~Ey~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlkp~NILl~~~~~~k 655 (804)
.+- ...|||||++ +..+..+.... ++......++.+++..+..+ | ..+|+|+||.+.|||++++ .+.
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEE
T ss_pred EEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEE
Confidence 553 4579999999 65554433211 11445667788888866654 6 4599999999999999988 999
Q ss_pred EeecCccccc
Q 047263 656 ISDFGLAKLL 665 (804)
Q Consensus 656 l~Dfgla~~~ 665 (804)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.4e-06 Score=88.91 Aligned_cols=260 Identities=15% Similarity=0.094 Sum_probs=149.9
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEE-------eCCCceE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFC-------DDGLNRL 588 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~-------~~~~~~~ 588 (804)
.+.||+|+-+.+|-.---.+ .+-|+..........+- ++.|... .||-+-.-+.+= ......-
T Consensus 16 gr~LgqGgea~ly~l~e~~d------~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD------QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CccccCCccceeeecchhhc------hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 46799999999996321111 23355544333222222 2223333 455332211110 1122245
Q ss_pred EEEeecCCC-cHHHhhcC------CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 589 LVYEFLSNG-TLASFLFG------DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 589 lV~Ey~~~g-sL~~~l~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
++|..+++. .+..+..- -...+|...++.+..+|.+.+-||+. +.+-+|++++|+|+++++.+.+.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 677776654 23333321 13457999999999999999999976 889999999999999999999998665
Q ss_pred ccccccCCCCccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcC-CCCCCcchhHH--HHHHH-HHHH
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICC-RRNVDMEVNEA--EALLT-DWAY 732 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG-~~p~~~~~~~~--~~~l~-~~~~ 732 (804)
.... ..........|...|++||... +..-+...|-|.+|+++++++.| +.|+....... ..-+. ..+.
T Consensus 164 fqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 164 FQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 4432 2334444567889999999765 33456789999999999999998 78876542111 00000 0000
Q ss_pred HhhhcCcccceecchhhhcccHHH-HHHHHHHHHHcccc--CCCCCCCHHHHHHHhhcCcc
Q 047263 733 DCYCEGITEALVEFDIEALNDKKK-LARFVMVAIWCIQE--DPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~--dP~~RPsm~eVl~~Le~~~~ 790 (804)
-.+........-........+.+. ...+.-+..+|+.. ++.-|||.+..+..|..+.+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 000000000000000001111111 13344456667754 36789999999988876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=79.64 Aligned_cols=136 Identities=15% Similarity=0.097 Sum_probs=101.5
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccc------cccHHHHHHHHHHhcccccC--CccceeeEEe-C----CCc
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI------QDGVKEFKTEVNVIGQTHHK--NLVRLLGFCD-D----GLN 586 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~------~~~~~~f~~E~~~l~~l~h~--niv~l~g~~~-~----~~~ 586 (804)
-|+||.+.|++-.+... .+-+|+-.... .-....|.+|+..+.+++.. ++.++. ++. . .-.
T Consensus 26 ~~rgG~SgV~r~~~~g~-----~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-----KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEeCCc-----EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 36689999998766432 48888876321 22566899999999999533 355555 332 1 123
Q ss_pred eEEEEeecCC-CcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC--EEEeecCc
Q 047263 587 RLLVYEFLSN-GTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN--ARISDFGL 661 (804)
Q Consensus 587 ~~lV~Ey~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~--~kl~Dfgl 661 (804)
.+||+|-+++ -+|.+++... ...+...+..++.+|++.+.-||+. ++.|+|+.+.||+++.++. ++++||.-
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 5799997764 5899998653 3457778889999999999999965 9999999999999986666 89999976
Q ss_pred ccc
Q 047263 662 AKL 664 (804)
Q Consensus 662 a~~ 664 (804)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.2e-07 Score=102.76 Aligned_cols=149 Identities=17% Similarity=0.227 Sum_probs=97.9
Q ss_pred HHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC--------ccccccCCCcccccccccc
Q 047263 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ--------THTAIRGTKGYVAPEWFRN 690 (804)
Q Consensus 619 ~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~ 690 (804)
.+++.|+.|+|. +..+||++|.|++|.+++++..||+.|+.+......... ...-......|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 456699999997 468999999999999999999999999988754331110 0011123457999999999
Q ss_pred CCCCccchhhHHHHHHHHHHcCCCC-CCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccc
Q 047263 691 MPITVKVDVYSFGVLLLEIICCRRN-VDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQ 769 (804)
Q Consensus 691 ~~~s~~~DV~S~Gvll~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 769 (804)
..-+.++|+||+|+++|-+..|+.+ +........... . . ..+..-......+...++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-----~----~----~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-----S----R----NLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-----h----h----cccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999955544 332211111100 0 0 000000001112333455555666789
Q ss_pred cCCCCCCCHHHHH
Q 047263 770 EDPSLRPTMRKVT 782 (804)
Q Consensus 770 ~dP~~RPsm~eVl 782 (804)
.++..||++.++.
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999887664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-05 Score=80.25 Aligned_cols=135 Identities=16% Similarity=0.120 Sum_probs=91.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc----------------------ccHHHHHHHHHHhccccc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ----------------------DGVKEFKTEVNVIGQTHH 571 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~f~~E~~~l~~l~h 571 (804)
+.+.++||.|.-+.||.|..+.+. ++|||-=+.... -.....++|.+.|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~----~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGR----KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECCCCC----EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 346688999999999999987554 588875431100 011234678888888865
Q ss_pred C--CccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc
Q 047263 572 K--NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD 649 (804)
Q Consensus 572 ~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~ 649 (804)
. .+.+.+++ +.-.+||||+++-.|...- ++-.....|+..|++-+.-+- ..+|+|+|+.+-||+++
T Consensus 169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~ 236 (304)
T COG0478 169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVT 236 (304)
T ss_pred cCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEe
Confidence 5 66666644 4567999999986654332 122233334444444443333 24899999999999999
Q ss_pred CCCCEEEeecCcccc
Q 047263 650 DYYNARISDFGLAKL 664 (804)
Q Consensus 650 ~~~~~kl~Dfgla~~ 664 (804)
++|.+.++||-.+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999987754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.1e-05 Score=91.07 Aligned_cols=138 Identities=18% Similarity=0.230 Sum_probs=88.2
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEcccccccc------------------------------HH----------H
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG------------------------------VK----------E 558 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~ 558 (804)
-|+.++-|.||+|++.++. .||||+.+....+. .+ .
T Consensus 132 PiAsASIaQVH~A~L~sG~----~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 132 PIASASIAQVHRAVLKSGE----EVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred chhhhhHhhheeEEecCCC----EEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 5899999999999998754 69999987532211 01 1
Q ss_pred HHHHHHHhcccc-----cCCccceeeEEeCCCceEEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHH-HHhhhc
Q 047263 559 FKTEVNVIGQTH-----HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGL-LYLHEE 631 (804)
Q Consensus 559 f~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL-~yLH~~ 631 (804)
+..|..-+.+++ .+++.-..-|.+-.....|+|||++|-.+.+...- ....+ +..++..++++. ..+-
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~~-- 282 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHHH--
Confidence 233433333331 22222222222335678999999999999888522 23344 233333333321 1111
Q ss_pred cCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 632 ~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
..+++|.|.+|.||+++.++++.+.|||+...+.
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2389999999999999999999999999997654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.11 E-value=7e-06 Score=68.27 Aligned_cols=58 Identities=22% Similarity=0.448 Sum_probs=46.4
Q ss_pred ceEEeecCCCCCCcccccCcCChhhHHHHhcC-CCceeeEeecC-Cceeeeec-CCCCCCc
Q 047263 355 DFEVITNTDWPTSDYQLLTPFTEEGCRQSCLH-DCMCAVAIFRS-GDMCWKKK-LPLSNGR 412 (804)
Q Consensus 355 ~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~y~~-g~~c~~~~-~~l~~~~ 412 (804)
.|..++++.+++.........++++|++.|++ +|+|.|+.|.. +..|++|. ..+.+..
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 59999999998655443466799999999999 99999999974 55799988 5555544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.7e-05 Score=75.63 Aligned_cols=136 Identities=14% Similarity=0.193 Sum_probs=83.9
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC--ccceeeEEeCCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN--LVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
+.||+|..+.||+.. +. ..++|...... ......+|.+++..+..-. +.+.+++..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~---~~----~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TG----KWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec---CC----CEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 468999999999831 11 36778776532 3345688999998886443 4778888888888889999999
Q ss_pred CCc-HHHhh---------------------cCC--CCCChhhHHH-HHH----------HHHH-HHHHhhhc-cCCCeee
Q 047263 596 NGT-LASFL---------------------FGD--LKPGWSRRTD-IAF----------GIAR-GLLYLHEE-CSTQIIH 638 (804)
Q Consensus 596 ~gs-L~~~l---------------------~~~--~~l~~~~~~~-i~~----------~ia~-gL~yLH~~-~~~~ivH 638 (804)
|.. +...+ +.- .......+.. +.. .+.+ ...+|... ....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 22111 110 0111111000 000 0111 11222111 1345789
Q ss_pred cCCCCCcEEEcCCCCEEEeecCccc
Q 047263 639 CDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 639 ~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.4e-05 Score=77.02 Aligned_cols=102 Identities=24% Similarity=0.356 Sum_probs=83.3
Q ss_pred HHHHHHhccccc-CCccceeeEEeCCCceEEEEeecCCCcHHHh---hcCCCCCChhhHHHHHHHHHHHHHHhhhccCCC
Q 047263 560 KTEVNVIGQTHH-KNLVRLLGFCDDGLNRLLVYEFLSNGTLASF---LFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQ 635 (804)
Q Consensus 560 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 635 (804)
..|.-+++.+++ +++.+++|+|- .++|.||...+++... +..-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888876 59999999993 4789999997765421 222235689999999999999999999865566
Q ss_pred eeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 636 IIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 636 ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999877643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00011 Score=65.92 Aligned_cols=99 Identities=24% Similarity=0.405 Sum_probs=64.0
Q ss_pred eeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEee-cCCCCCCCCcEEEEecCCCeEEeCCCCceEeeccCCCC
Q 047263 43 SWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFA-NGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPIIG 121 (804)
Q Consensus 43 ~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvA-Nr~~Pv~~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~ 121 (804)
.+.+.+|.+.|-|-..++ |-| |.. ..+++|.. +...+......+.|..||||||+|..++++|+|... .
T Consensus 13 p~~~~s~~~~L~l~~dGn------Lvl-~~~--~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~-p 82 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN------LVL-YDS--NGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDY-P 82 (114)
T ss_dssp EEEECETTEEEEEETTSE------EEE-EET--TTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTS-S
T ss_pred ccccccccccceECCCCe------EEE-EcC--CCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCC-C
Confidence 444545788888754322 434 332 25779999 433333356789999999999999999999999433 3
Q ss_pred ceeEEEEcc--CcCEEEEecCCccccccccCCc
Q 047263 122 TVAYGLMND--TGNFVLLSDNTNKLWESFNNPT 152 (804)
Q Consensus 122 ~~~~a~l~d--~GNlVl~~~~~~~lWQSFd~PT 152 (804)
..+.+..++ .||++ ......+.|.|=+.|+
T Consensus 83 tdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 83 TDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp S-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred ccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 445566666 88888 7666788898866663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.85 E-value=7.1e-05 Score=74.15 Aligned_cols=68 Identities=24% Similarity=0.285 Sum_probs=53.1
Q ss_pred CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
...+|+|||++|..|.+... ++. .++..+++++.-||+. |++|+|.+|+|++++++ .+++.||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 34568999999988876542 111 3556778889999965 99999999999999865 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=72.11 Aligned_cols=135 Identities=20% Similarity=0.213 Sum_probs=86.3
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHH---------H---------------HHHHHHHhcccc--cC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK---------E---------------FKTEVNVIGQTH--HK 572 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~---------~---------------f~~E~~~l~~l~--h~ 572 (804)
.|+.|.-..||+|...++. .+|||+.........+ . ...|..-|.++. +-
T Consensus 55 ~istGKEA~Vy~a~~~~~~----~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 55 CISTGKEANVYLAETGDGR----YVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eecCCcceEEEeeccCCCc----eEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4788888999998764443 5999998643221110 1 234555555552 33
Q ss_pred CccceeeEEeCCCceEEEEeecCCCcH-HHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC
Q 047263 573 NLVRLLGFCDDGLNRLLVYEFLSNGTL-ASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY 651 (804)
Q Consensus 573 niv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~ 651 (804)
.+.+.+++. +-.|||||+....+ .-.|.. ..+.......+..++++.+.-|-. ..++||+||..-|||+. +
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence 444445443 34799999975421 112211 122222456666777777777764 24899999999999999 8
Q ss_pred CCEEEeecCccccc
Q 047263 652 YNARISDFGLAKLL 665 (804)
Q Consensus 652 ~~~kl~Dfgla~~~ 665 (804)
+.+.|+|++.+...
T Consensus 203 ~~p~iID~~QaV~~ 216 (268)
T COG1718 203 GEPYIIDVSQAVTI 216 (268)
T ss_pred CeEEEEECcccccc
Confidence 89999999988754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00013 Score=82.20 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=87.7
Q ss_pred hhH-HhhCCCcceeEEEeeecCccccceeEEEEEcccccccc-------------------------------HH-----
Q 047263 515 GFK-EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-------------------------------VK----- 557 (804)
Q Consensus 515 ~f~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~----- 557 (804)
.|. +.||.-+.|.||+|+++++. .||||.-+...++. .+
T Consensus 163 ~f~~~piaaASlaQVhrA~L~~G~----~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 163 EFDEEPIAAASLAQVHRARLKNGE----DVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred hcCcchhhhcchhheEEEEecCCC----EEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 344 45999999999999998744 59999986533221 00
Q ss_pred -HHHHHHHHhccc----ccCC------ccceeeEEeCCCceEEEEeecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHH
Q 047263 558 -EFKTEVNVIGQT----HHKN------LVRLLGFCDDGLNRLLVYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGL 625 (804)
Q Consensus 558 -~f~~E~~~l~~l----~h~n------iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL 625 (804)
+|..|.+-..+. .|-+ |.+++- .-...+.|+||||+|..+.+.-. .+..++-.....-+.+...-+
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ 316 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH
Confidence 133343333222 3444 223322 22357899999999988877643 123333333333333322222
Q ss_pred HHhhhccCCCeeecCCCCCcEEEcC----CCCEEEeecCcccccc
Q 047263 626 LYLHEECSTQIIHCDIKPQNILLDD----YYNARISDFGLAKLLL 666 (804)
Q Consensus 626 ~yLH~~~~~~ivH~dlkp~NILl~~----~~~~kl~Dfgla~~~~ 666 (804)
-+- .|.+|+|=+|.||++.. ++++.+-|||+...+.
T Consensus 317 If~-----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFK-----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHh-----cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 232 38999999999999983 6789999999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=6.4e-06 Score=91.33 Aligned_cols=183 Identities=19% Similarity=0.133 Sum_probs=129.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC-ccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN-LVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~Ey 593 (804)
.|-...+++.+++++|.+-...+. ..++.+... ....-++++|.+++||| .++.++-+..+...+++++|
T Consensus 245 ~~fh~fvK~altknpKkRptaekl----L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKL----LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhh----eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 344567889999999876433221 223333321 34467899999999999 78888888888888999999
Q ss_pred cCCC-cHHH-hhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNG-TLAS-FLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~g-sL~~-~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
+..+ +-.. .......+...+...+...-++++++||+. .-+|+| ||+..+ +..+..||+....+....
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9887 2211 111112233334455666777899999953 347888 777665 578999999887654432
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCC
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
......++..++|||+.....+..+.|+|+.|+-..++.-|..|-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 445567899999999999999999999999998777777776654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00032 Score=72.63 Aligned_cols=136 Identities=15% Similarity=0.052 Sum_probs=82.6
Q ss_pred hCCCcc-eeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEeecCCC
Q 047263 520 LGKGAF-GVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 520 LG~G~f-G~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
|..|.. ..||+..... ..+.+|+..... ..+...|+++++.+. +-.+.+++++...++..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~~-----~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-----PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCCC-----CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444444 7789876532 258888876542 335667888888774 455667888877767789999999998
Q ss_pred cHHHhh-------------------cCCC--CCC----hhhHHHHHH--------------------HHHHHHHHhhhc-
Q 047263 598 TLASFL-------------------FGDL--KPG----WSRRTDIAF--------------------GIARGLLYLHEE- 631 (804)
Q Consensus 598 sL~~~l-------------------~~~~--~l~----~~~~~~i~~--------------------~ia~gL~yLH~~- 631 (804)
+|.... +.-. ... ...+..... .+...+..|-..
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 876432 1100 000 000000000 011111222111
Q ss_pred ---cCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 632 ---CSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 632 ---~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
....++|+|+.|.|||++++....|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13458999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00021 Score=73.07 Aligned_cols=139 Identities=22% Similarity=0.180 Sum_probs=82.8
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccC--CccceeeEEeC---CCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHK--NLVRLLGFCDD---GLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~--niv~l~g~~~~---~~~~~lV~E 592 (804)
+.|+.|..+.||+....++ .+++|..... .....+..|..++..+... .+.+++.+... ....+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~~~-----~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDG-----RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEETTS-----EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCc-----EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 3578899999999987652 5899987654 4456778888888888544 35677765432 234689999
Q ss_pred ecCCCcHHH----------------hhc---CC----CCCChhh---------HHHH------------HHHHHH-HHHH
Q 047263 593 FLSNGTLAS----------------FLF---GD----LKPGWSR---------RTDI------------AFGIAR-GLLY 627 (804)
Q Consensus 593 y~~~gsL~~----------------~l~---~~----~~l~~~~---------~~~i------------~~~ia~-gL~y 627 (804)
++++..+.. .+. .. ....+.. .... ...+.+ .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988877 110 11 1111100 0000 112222 3333
Q ss_pred hhhc----cCCCeeecCCCCCcEEEc-CCCCEEEeecCccc
Q 047263 628 LHEE----CSTQIIHCDIKPQNILLD-DYYNARISDFGLAK 663 (804)
Q Consensus 628 LH~~----~~~~ivH~dlkp~NILl~-~~~~~kl~Dfgla~ 663 (804)
+++. ....++|+|+.+.||+++ +++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3321 245799999999999999 66667799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00093 Score=81.51 Aligned_cols=81 Identities=14% Similarity=0.265 Sum_probs=56.9
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccc-cCCc--cceeeEEeCC---CceEEE
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTH-HKNL--VRLLGFCDDG---LNRLLV 590 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV 590 (804)
++++.|.+..+|+.....+.. ...+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. ...++|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~-~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGS-VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEeCCCCcCceEEEEECCCCc-ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 468899999999977654321 1246777764322 223456889999999985 6654 8888888764 467899
Q ss_pred EeecCCCcH
Q 047263 591 YEFLSNGTL 599 (804)
Q Consensus 591 ~Ey~~~gsL 599 (804)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0023 Score=68.23 Aligned_cols=75 Identities=9% Similarity=0.009 Sum_probs=54.3
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc---CCccceeeEEeCC---CceEEEE
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH---KNLVRLLGFCDDG---LNRLLVY 591 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lV~ 591 (804)
+.||.|..+.||+....++ .+++|..+. ......|..|.+.++.+.. ..+.++++.+..+ +..+|||
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-----~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-----NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eecCCccceeEEEEEcCCC-----CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 4699999999999765433 256666432 1123578899999988853 4788999888543 6689999
Q ss_pred eecCCCcH
Q 047263 592 EFLSNGTL 599 (804)
Q Consensus 592 Ey~~~gsL 599 (804)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998764
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0003 Score=57.64 Aligned_cols=51 Identities=22% Similarity=0.443 Sum_probs=39.7
Q ss_pred eEEeecCCCCCCcccccCcCChhhHHHHhcCCCceeeEeecC-CceeeeecC
Q 047263 356 FEVITNTDWPTSDYQLLTPFTEEGCRQSCLHDCMCAVAIFRS-GDMCWKKKL 406 (804)
Q Consensus 356 f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~y~~-g~~c~~~~~ 406 (804)
|..++++++++.++......+.++|++.|+.+|+|.||.|+. ...|+++..
T Consensus 6 ~~~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 6 FRQGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred ccccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 444567777776665555679999999999999999999963 345998775
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0027 Score=60.28 Aligned_cols=129 Identities=19% Similarity=0.285 Sum_probs=85.8
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
..+.|++|.+|.||+|..... .+|+|.-... .....+..|++++..++-.++..=+-.+-+ .++.|||+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-----~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~ 95 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-----EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYID 95 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-----eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhc
Confidence 356899999999999987644 5888887653 345678899999998886665543332222 234599999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCC-CCcEEEcCCCCEEEeecCcccc
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIK-PQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk-p~NILl~~~~~~kl~Dfgla~~ 664 (804)
|-.|.+.-... + .+-...+++. +|.-+ ..+|-|+.|. |..++|..+..+.|+||.-|..
T Consensus 96 G~~L~~~~~~~---~----rk~l~~vlE~-a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG---D----RKHLLRVLEK-AYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc---c----HHHHHHHHHH-HHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887665321 1 1222334444 33333 3488898887 4555555555999999998873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0017 Score=66.78 Aligned_cols=73 Identities=15% Similarity=0.187 Sum_probs=45.0
Q ss_pred HhhCCCcce-eEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccC---CccceeeEEeCCC---ceEEE
Q 047263 518 EELGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHK---NLVRLLGFCDDGL---NRLLV 590 (804)
Q Consensus 518 ~~LG~G~fG-~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~~~~---~~~lV 590 (804)
+.|+.|+.. .||+.. . .+++|.... ......+..|.+.+..+... .+.++++.....+ ..+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~----~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG----D----DMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC----C----ceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 346766666 488741 1 366776553 22345788899999887532 3455555443322 34889
Q ss_pred EeecCCCcHH
Q 047263 591 YEFLSNGTLA 600 (804)
Q Consensus 591 ~Ey~~~gsL~ 600 (804)
||+++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.005 Score=60.99 Aligned_cols=127 Identities=18% Similarity=0.221 Sum_probs=85.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc----------------cccHHHHHHHHHHhcccc------cCCcc
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----------------QDGVKEFKTEVNVIGQTH------HKNLV 575 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----------------~~~~~~f~~E~~~l~~l~------h~niv 575 (804)
..||+|+.=.||.- +.+. ...||+..... ....+++.+|+.....+. +.+|.
T Consensus 7 ~~i~~G~~R~cy~H--P~dp----~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDP----NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEEC--CCCC----CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 46899999999963 3333 36777776543 123456677777666665 88999
Q ss_pred ceeeEEeCCCceEEEEeecCC------CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc
Q 047263 576 RLLGFCDDGLNRLLVYEFLSN------GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD 649 (804)
Q Consensus 576 ~l~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~ 649 (804)
+++|+.+.+...-+|+|.+.+ -+|.+++.... ++. ...+.+. +-..||-+. .|+.+|++|+||++.
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEE
Confidence 999999999999999998743 35777774432 333 3333333 334455533 799999999999995
Q ss_pred CC--C--CEEEee
Q 047263 650 DY--Y--NARISD 658 (804)
Q Consensus 650 ~~--~--~~kl~D 658 (804)
.+ + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0076 Score=66.25 Aligned_cols=76 Identities=17% Similarity=0.217 Sum_probs=52.3
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc-------cccHHHHHHHHHHhcccc---cCCccceeeEEeCCCce
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-------QDGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-------~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 587 (804)
+.||.|.+..||+....++. +.++||.-.... .-....+..|.+.|..+. ..++.+++.+ +....
T Consensus 32 ~elggGn~N~VyrV~~~~g~---~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGG---KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred eEcCCCceEEEEEEEeCCCC---eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 46999999999999986543 258999854211 113445677777777763 2456777766 44568
Q ss_pred EEEEeecCCCc
Q 047263 588 LLVYEFLSNGT 598 (804)
Q Consensus 588 ~lV~Ey~~~gs 598 (804)
++||||+++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 89999998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0031 Score=75.37 Aligned_cols=196 Identities=19% Similarity=0.165 Sum_probs=134.6
Q ss_pred HHHHHHHhcccccCCccceeeEEeCCCce----EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCC
Q 047263 559 FKTEVNVIGQTHHKNLVRLLGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634 (804)
Q Consensus 559 f~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 634 (804)
...|...+.++.|+|+++++.|..+.... .+..|++..-++...+..-...+....+.+..++.+|+.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 45577788888999999999998665443 34567888888999988888888999999999999999999965
Q ss_pred CeeecCCCCC---cEEEcCCCCEEEe--ecCcccccccCCCCccccccCCCccccccccccCCCCc--cchhhHHHHHHH
Q 047263 635 QIIHCDIKPQ---NILLDDYYNARIS--DFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITV--KVDVYSFGVLLL 707 (804)
Q Consensus 635 ~ivH~dlkp~---NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~--~~DV~S~Gvll~ 707 (804)
...|.-+..+ +.-.+.++...++ ||+.++.+...... ....-+..+.++|......+.. ..|+|.+|.++.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 3444444333 3444556666666 88887765332221 1122344677888776665554 479999999999
Q ss_pred HHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 047263 708 EIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQML 785 (804)
Q Consensus 708 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 785 (804)
.+..|..+....... ..+.+ .. .. ..+......|+..++++|++..+++...
T Consensus 384 ~~~~~~~i~~~~~~~------------------~~~l~----~~-~~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVP------------------VSLLD----VL-ST---SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhcCcccccccch------------------hhhhc----cc-cc---hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999887653321110 01111 00 10 1455677789999999999999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0064 Score=63.40 Aligned_cols=134 Identities=12% Similarity=0.102 Sum_probs=75.1
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCc-cceeeEEeCCCceEEEEeecCCCc
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL-VRLLGFCDDGLNRLLVYEFLSNGT 598 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 598 (804)
+..|-...+|+.... +..+++|..........-...+|.++++.+....+ .+++.... ..+|+||++|..
T Consensus 4 ~~~G~tn~~y~~~~~-----~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEHP-----GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEeC-----CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 556778889987632 12577887654322211134678888888864433 44454432 368999999876
Q ss_pred HHHh-----------------hcCCC----CCChhhH-HHHHHH---------HHHHHHHhhhc-----cCCCeeecCCC
Q 047263 599 LASF-----------------LFGDL----KPGWSRR-TDIAFG---------IARGLLYLHEE-----CSTQIIHCDIK 642 (804)
Q Consensus 599 L~~~-----------------l~~~~----~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivH~dlk 642 (804)
+... |+... .++...+ .....+ +.+.+..+... ....++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5421 11111 1111111 111111 11112212111 13468999999
Q ss_pred CCcEEEcCCCCEEEeecCccc
Q 047263 643 PQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 643 p~NILl~~~~~~kl~Dfgla~ 663 (804)
|.||++++++ +.|+||..+.
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cCcEEEeCCC-CEEEeccccC
Confidence 9999999876 7899998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0048 Score=65.83 Aligned_cols=137 Identities=15% Similarity=0.148 Sum_probs=82.1
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC--ccceeeEE------eCCCceEEE
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN--LVRLLGFC------DDGLNRLLV 590 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV 590 (804)
.|..|....+|+....++ .+++|+... ........|++++..+++.. +.+++... ..++..++|
T Consensus 21 ~i~~G~~n~~y~v~~~~~-----~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 21 GISAGIENTNYFVTTDSG-----RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred cccCccccceEEEEeCCC-----cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 577787788998765432 488888764 22345666777777775432 44544421 223456899
Q ss_pred EeecCCCcHHH----hh----------cC---C--------CCCChhhHH----------HHHHHHHHHHHHhhh----c
Q 047263 591 YEFLSNGTLAS----FL----------FG---D--------LKPGWSRRT----------DIAFGIARGLLYLHE----E 631 (804)
Q Consensus 591 ~Ey~~~gsL~~----~l----------~~---~--------~~l~~~~~~----------~i~~~ia~gL~yLH~----~ 631 (804)
+||++|..+.. .. +. . ....|.... .....+...+.++.+ .
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99999876532 00 10 0 001222111 111123344455543 1
Q ss_pred cCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 632 ~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
....++|+|++|.||+++++..+.|.||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 24579999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0079 Score=61.75 Aligned_cols=138 Identities=17% Similarity=0.199 Sum_probs=76.7
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC-ccceeeEEeCCCceEEEEeecCCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN-LVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
.|..|-...+|+....++ ....+++|........ .-.-..|+.++..+...+ ..++++... ..++|||+++.
T Consensus 5 ~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 5 RFTGGITNKLVKVSNKED--NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EcCCcccceEEEEEcCCC--CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 467788889998875531 0124778876543221 122346888888875433 344444432 24799999987
Q ss_pred cHHHh--------------h---cCC---C--------CCC-hhhHHHHHH----------------------HHHHHHH
Q 047263 598 TLASF--------------L---FGD---L--------KPG-WSRRTDIAF----------------------GIARGLL 626 (804)
Q Consensus 598 sL~~~--------------l---~~~---~--------~l~-~~~~~~i~~----------------------~ia~gL~ 626 (804)
++... | +.. . ... |.....+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65321 1 110 0 011 222111111 1111111
Q ss_pred Hh----hhc-cCCCeeecCCCCCcEEEcC-CCCEEEeecCccc
Q 047263 627 YL----HEE-CSTQIIHCDIKPQNILLDD-YYNARISDFGLAK 663 (804)
Q Consensus 627 yL----H~~-~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~ 663 (804)
.| ... ....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22 111 1346999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.01 Score=58.42 Aligned_cols=134 Identities=25% Similarity=0.329 Sum_probs=92.0
Q ss_pred cccccCHHHHHHHHhhhHHhhCCCcc-eeEEEeeecCccccceeEEEEEcccc-----------cc----------ccHH
Q 047263 500 NLHCFTYKDLEAATNGFKEELGKGAF-GVVYKGAIGMASMYQVPVAVKKLHSV-----------IQ----------DGVK 557 (804)
Q Consensus 500 ~~~~~~~~~l~~at~~f~~~LG~G~f-G~Vykg~~~~~~~~~~~vavK~~~~~-----------~~----------~~~~ 557 (804)
.+..|+... +...|.+.||.|.- |.|||.++... .+|+|.+... .. ....
T Consensus 28 KL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I~g~-----~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 99 (207)
T PF13095_consen 28 KLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEIDGR-----IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYAD 99 (207)
T ss_pred CcCCcCCCC---CcEeeeeecCCCCceeEEEEEEECCe-----EEEEEEeeccccCCCccccccccccccccchhhhhcC
Confidence 355666632 56678899999999 99999998643 6999993210 00 1122
Q ss_pred HHHHHHHHhcccc---cCCc--cceeeEEeCC------------------CceEEEEeecCCCcHHHhhcCCCCCChhhH
Q 047263 558 EFKTEVNVIGQTH---HKNL--VRLLGFCDDG------------------LNRLLVYEFLSNGTLASFLFGDLKPGWSRR 614 (804)
Q Consensus 558 ~f~~E~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~ 614 (804)
-|..|.+...+|+ +.++ |+.+|+..-. ..+.||.||++... ...
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~ 166 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ 166 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc
Confidence 4889999998885 4456 9999987211 11247777776533 122
Q ss_pred HHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 615 TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 615 ~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
.+-+.+|.+-|..+| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 334556777788889 459999999999985 4588999854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.027 Score=60.28 Aligned_cols=140 Identities=22% Similarity=0.245 Sum_probs=79.4
Q ss_pred hhCCCcceeEEEeeecCc---cccceeEEEEEccccccccHHHHHHHHHHhcccccCCc-cceeeEEeCCCceEEEEeec
Q 047263 519 ELGKGAFGVVYKGAIGMA---SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL-VRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~---~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~ 594 (804)
.|..|-...+|+.....+ ...+..+++|....... .......|.+++..+....+ .++++++.+ .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 355666678898876432 01123578888654322 22344677777777753333 455555542 3589999
Q ss_pred CCCcHHHh-h----------------cCC-CCC--------C--hhhHHHH--------------------------HHH
Q 047263 595 SNGTLASF-L----------------FGD-LKP--------G--WSRRTDI--------------------------AFG 620 (804)
Q Consensus 595 ~~gsL~~~-l----------------~~~-~~l--------~--~~~~~~i--------------------------~~~ 620 (804)
+|..+... + +.. ... . |....++ ...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88766431 0 110 000 0 1111110 112
Q ss_pred HHHHHHHhhh------ccCCCeeecCCCCCcEEEcCC----CCEEEeecCccc
Q 047263 621 IARGLLYLHE------ECSTQIIHCDIKPQNILLDDY----YNARISDFGLAK 663 (804)
Q Consensus 621 ia~gL~yLH~------~~~~~ivH~dlkp~NILl~~~----~~~kl~Dfgla~ 663 (804)
+.+-+..|.. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2222333432 135678999999999999985 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.062 Score=57.99 Aligned_cols=31 Identities=26% Similarity=0.364 Sum_probs=26.6
Q ss_pred CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 633 STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
..+++|+|+++.||+++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999976556899999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.054 Score=57.15 Aligned_cols=72 Identities=18% Similarity=0.240 Sum_probs=44.3
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc---ccCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT---HHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.|+.|....+|+... + +..+.||.-.. .....|..|.+-|+.| .-..+.+++++....+..+||+||+
T Consensus 23 ~~v~GG~i~~a~~~~~-~----~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 23 EPVSGGDINEAYRLDT-D----GGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEE--SSSSEEEEEET-T----S-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred EecCCCChhheEEEEC-C----CccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3588888899998762 2 22688998763 2334577777777777 3556888999887777889999999
Q ss_pred CCC
Q 047263 595 SNG 597 (804)
Q Consensus 595 ~~g 597 (804)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.033 Score=54.85 Aligned_cols=138 Identities=18% Similarity=0.204 Sum_probs=88.0
Q ss_pred eEEEEEccccccc-cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHH
Q 047263 542 PVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG 620 (804)
Q Consensus 542 ~vavK~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ 620 (804)
+..+|++....-. ...-|+.+.+++++++ .|+++..- .+...-++.|+|..-.. . -..++..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~-~~N~i~a 149 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------N-FSNFITA 149 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------c-hhHHHHH
Confidence 4677888765444 4566788899988885 45666522 33344588898854211 0 1112222
Q ss_pred HHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhh
Q 047263 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVY 700 (804)
Q Consensus 621 ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~ 700 (804)
=++.|.-.|.+ +.+.+|+|-.|+||+-|+.|.+||.|=+.... + +..|.--| ....++++.+-
T Consensus 150 gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~------~-------~V~~vN~~---Y~~lT~~aE~~ 212 (308)
T PF07387_consen 150 GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE------N-------QVNMVNIE---YESLTQEAEVK 212 (308)
T ss_pred hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh------h-------eeeEEeee---ccccChHHHHH
Confidence 24567778866 78999999999999999999999999764421 0 11122211 12456778888
Q ss_pred HHHHHHHHHHcCC
Q 047263 701 SFGVLLLEIICCR 713 (804)
Q Consensus 701 S~Gvll~elltG~ 713 (804)
+|=.-+++++...
T Consensus 213 ~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 213 VFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHH
Confidence 8877788877544
|
The function of this family is unknown. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.11 Score=55.85 Aligned_cols=139 Identities=14% Similarity=0.189 Sum_probs=78.9
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccC--CccceeeEE------eCCCceEE
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHK--NLVRLLGFC------DDGLNRLL 589 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~--niv~l~g~~------~~~~~~~l 589 (804)
+.++.|....+|+....++ .+++|+..... ...+...|.+++..|... ++.+++... ...+..++
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-----~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-----RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred cccCCccccceEEEEeCCC-----cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 3467777788998765432 36778765421 123445566666666422 244444422 22345689
Q ss_pred EEeecCCCcHHH-----------h---hcCC-C-----------CCChhhHH------------HHHHHHHHHHHHhhh-
Q 047263 590 VYEFLSNGTLAS-----------F---LFGD-L-----------KPGWSRRT------------DIAFGIARGLLYLHE- 630 (804)
Q Consensus 590 V~Ey~~~gsL~~-----------~---l~~~-~-----------~l~~~~~~------------~i~~~ia~gL~yLH~- 630 (804)
++||++|..+.. . ++.. . ...|.... .....+.+.+.++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 999998854321 1 1110 0 01122110 011123344555542
Q ss_pred ---ccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 631 ---ECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 631 ---~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
....+++|+|+++.||++++++...|.||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 225689999999999999988767899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.086 Score=57.45 Aligned_cols=141 Identities=19% Similarity=0.183 Sum_probs=80.2
Q ss_pred hhCCCcceeEEEeeecCcc-ccceeEEEEEccccccccHHHHHHHHHHhcccccCCcc-ceeeEEeCCCceEEEEeecCC
Q 047263 519 ELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV-RLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
.|-.|-.-.+|+.....+. .....+++|........... -.+|..++..+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 3445677788987654321 12246888877654332222 26788888888654444 556665433 58999987
Q ss_pred CcHHHh-----------------hcCCC----C-C-ChhhHHHHHHH-----------------HHHHHHHhhh-----c
Q 047263 597 GTLASF-----------------LFGDL----K-P-GWSRRTDIAFG-----------------IARGLLYLHE-----E 631 (804)
Q Consensus 597 gsL~~~-----------------l~~~~----~-l-~~~~~~~i~~~-----------------ia~gL~yLH~-----~ 631 (804)
.+|... ++... . . .|.+..++..+ +...+..|.+ .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 11111 0 1 12222222211 1112222221 1
Q ss_pred cCCCeeecCCCCCcEEEcC-CCCEEEeecCcccc
Q 047263 632 CSTQIIHCDIKPQNILLDD-YYNARISDFGLAKL 664 (804)
Q Consensus 632 ~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~ 664 (804)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 57899999988763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.15 Score=53.59 Aligned_cols=31 Identities=32% Similarity=0.562 Sum_probs=25.8
Q ss_pred CCeeecCCCCCcEEEcCCCCE-EEeecCcccc
Q 047263 634 TQIIHCDIKPQNILLDDYYNA-RISDFGLAKL 664 (804)
Q Consensus 634 ~~ivH~dlkp~NILl~~~~~~-kl~Dfgla~~ 664 (804)
..++|+|+++.|||+++++++ -|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 458999999999999975664 6999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.3 Score=53.77 Aligned_cols=79 Identities=16% Similarity=0.182 Sum_probs=49.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-------ccHHHHHHHHHHhcccc---cCCccceeeEEeCCCce
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-------DGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 587 (804)
+.||.|....||+..... + .++||+-..... .....-..|.+.|+.+. ..++.+++.++.+ ..
T Consensus 38 ~eiggGn~N~VyrV~~~~-~----svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~ 110 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSSS-G----SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MA 110 (418)
T ss_pred EEcCCCceeeEEEEEcCC-c----cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CC
Confidence 568999999999976532 1 488988762211 12222233455555443 3578889888874 46
Q ss_pred EEEEeecCC--CcHHHhh
Q 047263 588 LLVYEFLSN--GTLASFL 603 (804)
Q Consensus 588 ~lV~Ey~~~--gsL~~~l 603 (804)
+++|||+++ ..+.+-|
T Consensus 111 vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 111 LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEEeecCCcceehhhhh
Confidence 788999976 3454443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.19 Score=53.44 Aligned_cols=111 Identities=23% Similarity=0.382 Sum_probs=68.0
Q ss_pred ccHHHHHHHHHHhcccc--cCCccceeeEEeCCC--ceEEEEeecCCCcHHH------------------hhc---C---
Q 047263 554 DGVKEFKTEVNVIGQTH--HKNLVRLLGFCDDGL--NRLLVYEFLSNGTLAS------------------FLF---G--- 605 (804)
Q Consensus 554 ~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~------------------~l~---~--- 605 (804)
.......+|.++|+.+. -....+.+++|.++. ..+.||+|.++..+.. +|. .
T Consensus 63 ~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida 142 (321)
T COG3173 63 ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDA 142 (321)
T ss_pred hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCC
Confidence 33445567777777774 345666777887766 6699999998833222 221 0
Q ss_pred -C-------------CCCChhhHHHHHH--------HHHHHHHHhhhcc-----CCCeeecCCCCCcEEEcCCCCEEEee
Q 047263 606 -D-------------LKPGWSRRTDIAF--------GIARGLLYLHEEC-----STQIIHCDIKPQNILLDDYYNARISD 658 (804)
Q Consensus 606 -~-------------~~l~~~~~~~i~~--------~ia~gL~yLH~~~-----~~~ivH~dlkp~NILl~~~~~~kl~D 658 (804)
. +...|...++.+. ....-..+|++.. ...++|+|+++.||+++.+...=|.|
T Consensus 143 ~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlD 222 (321)
T COG3173 143 AGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLD 222 (321)
T ss_pred cCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEe
Confidence 0 0001222221110 2233345555432 35699999999999999988899999
Q ss_pred cCcccc
Q 047263 659 FGLAKL 664 (804)
Q Consensus 659 fgla~~ 664 (804)
|+++..
T Consensus 223 we~~~l 228 (321)
T COG3173 223 WELATL 228 (321)
T ss_pred cccccc
Confidence 999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.19 Score=54.39 Aligned_cols=141 Identities=17% Similarity=0.244 Sum_probs=78.1
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCcc-ceeeEEeCCCceEEEEeecCCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV-RLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
.|..|---.+|+............+++|.......... .-.+|..+++.+...++. ++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 35556677788876543321122578887765433221 225788888888655553 566665322 589999776
Q ss_pred cHHH-------hh----------cCCC-----CC-ChhhHHHHHHHH----------------------HHHHHHhhhc-
Q 047263 598 TLAS-------FL----------FGDL-----KP-GWSRRTDIAFGI----------------------ARGLLYLHEE- 631 (804)
Q Consensus 598 sL~~-------~l----------~~~~-----~l-~~~~~~~i~~~i----------------------a~gL~yLH~~- 631 (804)
.|.. .+ +... .. -|....++..++ .+-+..+.+.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 01 1111 01 133222222111 1112222111
Q ss_pred ----cCCCeeecCCCCCcEEEcC-CCCEEEeecCcccc
Q 047263 632 ----CSTQIIHCDIKPQNILLDD-YYNARISDFGLAKL 664 (804)
Q Consensus 632 ----~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~ 664 (804)
...-.+|+|+.+.|||+++ ++.++++||..+..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1234799999999999975 57899999998753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.26 Score=53.28 Aligned_cols=81 Identities=17% Similarity=0.124 Sum_probs=47.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-------ccHHHHHHHHHHhcccc--cC-CccceeeEEeCCCce
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-------DGVKEFKTEVNVIGQTH--HK-NLVRLLGFCDDGLNR 587 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~--h~-niv~l~g~~~~~~~~ 587 (804)
++||.|....||++..+.+. ..|+||.-..... -......-|.+.|.... .| .+.+++. .+....
T Consensus 1 ~EigdGnlN~VfrV~~~~g~---~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~ 75 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGD---RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMA 75 (370)
T ss_pred CcCCCCceEEEEEEEcCCCC---eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccc
Confidence 36899999999999975332 2588988753211 11223345556665442 34 3444443 355566
Q ss_pred EEEEeecCCC-cHHHhh
Q 047263 588 LLVYEFLSNG-TLASFL 603 (804)
Q Consensus 588 ~lV~Ey~~~g-sL~~~l 603 (804)
.+|||+++.. .|.+.|
T Consensus 76 ~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 76 VTVMEDLSHHKIARKGL 92 (370)
T ss_pred eehHhhCccchHHHHHH
Confidence 7999998653 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.013 Score=71.82 Aligned_cols=156 Identities=11% Similarity=-0.049 Sum_probs=108.6
Q ss_pred HHHHHHhcccccCCccceeeEEe--CCCceEEEEeecCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhcc-
Q 047263 560 KTEVNVIGQTHHKNLVRLLGFCD--DGLNRLLVYEFLSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEEC- 632 (804)
Q Consensus 560 ~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~- 632 (804)
..|....+...|+++.....-.. +..+.+.+++|+..|.+.+.|-++ ..++.........+......-+|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 44555566678888777665443 334568899999999999988643 22222222222222244444444332
Q ss_pred -CCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc
Q 047263 633 -STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC 711 (804)
Q Consensus 633 -~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt 711 (804)
+.-.+|+++|+-|.+|..+.++|+.++|+.+.. ...........+++-|+.|+....-.++.++|+|..|+.+|++-.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 334789999999999999999999999999832 222233344556778999998888889999999999999999988
Q ss_pred CCCCC
Q 047263 712 CRRNV 716 (804)
Q Consensus 712 G~~p~ 716 (804)
|..++
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.34 Score=52.00 Aligned_cols=32 Identities=19% Similarity=0.324 Sum_probs=28.6
Q ss_pred CCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
..+++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.16 Score=51.18 Aligned_cols=31 Identities=29% Similarity=0.470 Sum_probs=21.9
Q ss_pred CCeeecCCCCCcEEE-cCCCCEEEeecCcccc
Q 047263 634 TQIIHCDIKPQNILL-DDYYNARISDFGLAKL 664 (804)
Q Consensus 634 ~~ivH~dlkp~NILl-~~~~~~kl~Dfgla~~ 664 (804)
..+.|+|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458899999999999 8899999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 804 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-124
Identities = 121/299 (40%), Positives = 177/299 (59%), Gaps = 17/299 (5%)
Query: 500 NLHCFTYKDLEAATNGFKEE--LGKGAFGVVYKGAIGMASMYQVPVAVKKL-HSVIQDGV 556
L F+ ++L+ A++ F + LG+G FG VYKG + ++ VAVK+L Q G
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL----VAVKRLKEERTQGGE 71
Query: 557 KEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG----WS 612
+F+TEV +I H+NL+RL GFC RLLVY +++NG++AS L + W
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 613 RRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672
+R IA G ARGL YLH+ C +IIH D+K NILLD+ + A + DFGLAKL+ D T
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDT 189
Query: 673 H--TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM--EVNEAEALLT 728
H TA+RGT G++APE+ + K DV+ +GV+LLE+I +R D+ N+ + +L
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 729 DWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787
DW E EALV+ D++ +++ + + VA+ C Q P RP M +V +MLEG
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-117
Identities = 108/314 (34%), Positives = 164/314 (52%), Gaps = 20/314 (6%)
Query: 488 SQVPSHDGVVETNLHCFTYKDLEAATNGFKEE--LGKGAFGVVYKGAI--GMASMYQVPV 543
+ S +V + DLE ATN F + +G G FG VYKG + G V
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA------KV 66
Query: 544 AVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL 603
A+K+ G++EF+TE+ + H +LV L+GFCD+ +L+Y+++ NG L L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 604 FGDLKPG----WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659
+G P W +R +I G ARGL YLH IIH D+K NILLD+ + +I+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 660 GLAKLLLLDQSQTH--TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVD 717
G++K + QTH T ++GT GY+ PE+F +T K DVYSFGV+L E++C R +
Sbjct: 184 GISKKGT-ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 718 MEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPT 777
+ L +WA + + G E +V+ ++ + L +F A+ C+ RP+
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 778 MRKVTQMLEGVVEV 791
M V LE + +
Sbjct: 303 MGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-114
Identities = 114/313 (36%), Positives = 161/313 (51%), Gaps = 33/313 (10%)
Query: 496 VVETNLHCFTYKDLEAATNGFKEE--------LGKGAFGVVYKGAIGMASMYQVPVAVKK 547
V +T H F++ +L+ TN F E +G+G FGVVYKG + VAVKK
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----NTTVAVKK 61
Query: 548 LHSVIQD----GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL 603
L +++ ++F E+ V+ + H+NLV LLGF DG + LVY ++ NG+L L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 604 FGDLKPG---WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFG 660
W R IA G A G+ +LHE IH DIK NILLD+ + A+ISDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 661 LAKLLLLDQSQTH--TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDM 718
LA+ QT + I GT Y+APE R IT K D+YSFGV+LLEII VD
Sbjct: 179 LARASEKFA-QTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 719 EVNEAEALLTDWAYDCYCEGITEALVEFDIEALND--KKKLARFVMVAIWCIQEDPSLRP 776
+ LL D + E + + ++ + +ND + VA C+ E + RP
Sbjct: 237 --HREPQLLLDIKEEIEDEE--KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 777 TMRKVTQMLEGVV 789
++KV Q+L+ +
Sbjct: 293 DIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-71
Identities = 71/315 (22%), Positives = 122/315 (38%), Gaps = 32/315 (10%)
Query: 504 FTYKDLEAATNGFK--EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT 561
++L + + E +G FG V+K + VAVK + + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKA-----QLLNEYVAVKIFPIQDKQS-WQNEY 67
Query: 562 EVNVIGQTHHKNLVRLLGFCDDGLN----RLLVYEFLSNGTLASFLFGDLKPGWSRRTDI 617
EV + H+N+++ +G G + L+ F G+L+ FL + W+ I
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126
Query: 618 AFGIARGLLYLHEECSTQ-------IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670
A +ARGL YLHE+ I H DIK +N+LL + A I+DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 671 QTHT-AIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE 724
T GT+ Y+APE +++D+Y+ G++L E+ D V+E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 725 ALLTDWAYDCYCEGITEALVEFD------IEALNDKKKLARFVMVAIWCIQEDPSLRPTM 778
+ + +V + +A C D R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 779 RKVTQMLEGVVEVLD 793
V + + + + +
Sbjct: 307 GCVGERITQMQRLTN 321
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 9e-60
Identities = 75/298 (25%), Positives = 131/298 (43%), Gaps = 44/298 (14%)
Query: 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQ-VPVAVKKLHSVIQDGVKEFKTEVN 564
YK++E +E +G+GAFGVV K ++ VA+K++ S + K F E+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKA------KWRAKDVAIKQIES--ESERKAFIVELR 53
Query: 565 VIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG---WSRRTDIAFGI 621
+ + +H N+V+L G C + + LV E+ G+L + L G +
Sbjct: 54 QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
++G+ YLH +IH D+KP N+LL +I DFG A D T +G+
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSA 167
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR---RNVDMEVNEAEALLTDWAYDCYCE 737
++APE F + K DV+S+G++L E+I R + +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH--------N 219
Query: 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795
G L++ + + + L C +DPS RP+M ++ +++ ++
Sbjct: 220 GTRPPLIKNLPKPI---ESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 7e-59
Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 52/305 (17%)
Query: 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQ-VPVAVKKLHS--VIQDGVKEFKTE 562
+ DL KE++G G+FG V++ + VAVK L + V EF E
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRA------EWHGSDVAVKILMEQDFHAERVNEFLRE 84
Query: 563 VNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAF 619
V ++ + H N+V +G N +V E+LS G+L L + RR +A+
Sbjct: 85 VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
+A+G+ YLH + I+H ++K N+L+D Y ++ DFGL++L + + GT
Sbjct: 145 DVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGT 202
Query: 680 KGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
++APE R+ P K DVYSFGV+L E+ ++ + +
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ----------------PW----GNL 242
Query: 740 TEALVEFDIEALNDK---------KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
A V + K ++A ++ W +P RP+ + +L +++
Sbjct: 243 NPAQVVAAV-GFKCKRLEIPRNLNPQVAA-IIEGCW--TNEPWKRPSFATIMDLLRPLIK 298
Query: 791 VLDPP 795
PP
Sbjct: 299 SAVPP 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-57
Identities = 73/330 (22%), Positives = 121/330 (36%), Gaps = 47/330 (14%)
Query: 504 FTYKDLEAATNGFK--EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT 561
+ + K E +G+G +G VYKG S+ + PVAVK + + F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKG-----SLDERPVAVKVFSF--ANR-QNFIN 54
Query: 562 EVNV--IGQTHHKNLVRLLGFC-----DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR 614
E N+ + H N+ R + D + LLV E+ NG+L +L W
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSS 113
Query: 615 TDIAFGIARGLLYLHEECST------QIIHCDIKPQNILLDDYYNARISDFGLAKLL--- 665
+A + RGL YLH E I H D+ +N+L+ + ISDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 666 ----LLDQSQTHTAIRGTKGYVAPEWFRN-------MPITVKVDVYSFGVLLLEII--CC 712
++ + GT Y+APE +VD+Y+ G++ EI C
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 713 RRNVDMEVNEAEALLTDWAYDCYCEGITEALV-------EFDIEALNDKKKLARFVMVAI 765
V E + + + LV +F + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 766 WCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795
C +D R T + + + ++ + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-56
Identities = 67/306 (21%), Positives = 120/306 (39%), Gaps = 63/306 (20%)
Query: 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQV---PVAVKKLH-------SVIQDG 555
++E +++++GKG FG+V+KG VA+K L + + +
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKG------RLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 556 VKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRR 614
+EF+ EV ++ +H N+V+L G + +V EF+ G L L P WS +
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 615 TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-----YNARISDFGLAKLLLLDQ 669
+ IA G+ Y+ + I+H D++ NI L A+++DFGL++
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QS 179
Query: 670 SQTHTAIRGTKGYVAPEWF--RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL 727
+ + + G ++APE T K D YSF ++L I+
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG------------- 226
Query: 728 TDWAYDCYCEGITEALVEFDIEALNDKKKL-------ARFVMVAIWCIQEDPSLRPTMRK 780
+ + + ++F + + R V C DP RP
Sbjct: 227 ---PF----DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY 279
Query: 781 VTQMLE 786
+ + L
Sbjct: 280 IVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 7e-55
Identities = 76/305 (24%), Positives = 120/305 (39%), Gaps = 48/305 (15%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQ---VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHK 572
E LGKG FG K ++ + +K+L ++ + F EV V+ H
Sbjct: 14 HGEVLGKGCFGQAIKV------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEE 631
N+++ +G + E++ GTL + D + WS+R A IA G+ YLH
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-- 125
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH-------------TAIRG 678
S IIH D+ N L+ + N ++DFGLA+L++ +++Q + G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 679 TKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR---NVDMEVNEAEALLTDWAYDCY 735
++APE KVDV+SFG++L EII + L D Y
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-RTMDFGLNVRGFLDRY 243
Query: 736 C-EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794
C + + + C DP RP+ K+ LE + L
Sbjct: 244 CPPNCPPSFFP-----------------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286
Query: 795 PCPCP 799
P
Sbjct: 287 HLPLG 291
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 8e-55
Identities = 67/305 (21%), Positives = 120/305 (39%), Gaps = 62/305 (20%)
Query: 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEV 563
++ LE E +GKG FG VY G + VA++ + +D +K FK EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHG------RWHGEVAIRLIDIERDNEDQLKAFKREV 80
Query: 564 NVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIA 622
QT H+N+V +G C + ++ TL S + + ++ IA I
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL----LLLDQSQTHTAIRG 678
+G+ YLH + I+H D+K +N+ D+ I+DFGL + + G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 679 TKGYVAPEWFRNM---------PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTD 729
++APE R + P + DV++ G + E+
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE---------------- 240
Query: 730 WAYDCYCEGITEALVEF--------DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
W + + + + ++ + K+++ ++ +C + RPT K+
Sbjct: 241 WPF----KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKL 293
Query: 782 TQMLE 786
MLE
Sbjct: 294 MDMLE 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 8e-55
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
+ +G G+FG VYKG + VAVK L+ + ++ FK EV V+ +T H N
Sbjct: 28 VGQRIGSGSFGTVYKG------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
++ +G+ +V ++ +L L + K + DIA ARG+ YLH
Sbjct: 82 ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLL-LLDQSQTHTAIRGTKGYVAPEWFRN- 690
+ IIH D+K NI L + +I DFGLA S + G+ ++APE R
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 691 --MPITVKVDVYSFGVLLLEIICCR---RNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
P + + DVY+FG++L E++ + N +N + ++ E + +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQII---------EMVGRGSLS 244
Query: 746 FDIEALNDK--KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
D+ + K++ R + C+++ RP+ ++ +E
Sbjct: 245 PDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-54
Identities = 76/290 (26%), Positives = 108/290 (37%), Gaps = 50/290 (17%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH----SVIQDGVKEFKTEVNVIGQTHH 571
+E +G G FG VY+ VAVK I ++ + E + H
Sbjct: 11 LEEIIGIGGFGKVYRA-----FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
N++ L G C N LV EF G L L G + + A IARG+ YLH+E
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDE 124
Query: 632 CSTQIIHCDIKPQNILLDDYYNAR--------ISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
IIH D+K NIL+ I+DFGLA+ T + G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWM 181
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743
APE R + DV+S+GVLL E++ + GI
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV----------------PF----RGIDGLA 221
Query: 744 VEFDIEALNDKKKL-------ARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
V + + +K L F + C DP RP+ + L
Sbjct: 222 VAYGV--AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-53
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 51/295 (17%)
Query: 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQ-VPVAVKKLH--SVIQDGVKEFKTE 562
+K L F +L + G ++KG +Q + VK L ++F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKG------RWQGNDIVVKVLKVRDWSTRKSRDFNEE 57
Query: 563 VNVIGQTHHKNLVRLLGFCDD--GLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIA 618
+ H N++ +LG C + L+ ++ G+L + L + S+ A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
+ARG+ +LH I + +++++D+ ARIS + S
Sbjct: 118 LDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMY 170
Query: 679 TKGYVAPEWFRNMP---ITVKVDVYSFGVLLLEIICCR---RNVD-MEVNEAEALLTDWA 731
+VAPE + P D++SF VLL E++ ++ ME+ AL
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL----- 225
Query: 732 YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
EG+ + + KL + C+ EDP+ RP + +LE
Sbjct: 226 -----EGLRPTIPPGISPHV---SKLMK------ICMNEDPAKRPKFDMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-48
Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 32/302 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+++GKG +G V+ G VAVK + ++ +TE+ H+N++
Sbjct: 41 MVKQIGKGRYGEVWMG-----KWRGEKVAVKVFFT-TEEASWFRETEIYQTVLMRHENIL 94
Query: 576 RLLGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+ G L+ ++ NG+L +L +A+ GL +LH E
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 632 CSTQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH---TAIRGTKGYV 683
+ I H D+K +NIL+ I+D GLA + D ++ GTK Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 684 APE------WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA-YDCYC 736
PE + + D+YSFG++L E + R V E + D D
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 737 EGITEALVEFDI-----EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791
E + E + + + + L + + C +P+ R T +V + L + E
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
Query: 792 LD 793
D
Sbjct: 333 QD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-47
Identities = 70/299 (23%), Positives = 111/299 (37%), Gaps = 40/299 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNV--IGQTHHKN 573
E +GKG +G V++G S VAVK S +D K + E + H+N
Sbjct: 12 LLECVGKGRYGEVWRG-----SWQGENVAVKIFSS--RD-EKSWFRETELYNTVMLRHEN 63
Query: 574 LVRLLGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
++ + + L+ + G+L +L I IA GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 630 EECSTQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL-----LLDQSQTHTAIRGT 679
E I H D+K +NIL+ I+D GLA + LD GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV--GT 180
Query: 680 KGYVAPEWFRNMPITV------KVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD 733
K Y+APE +VD+++FG++L E + R + V + + D +
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVVPN 239
Query: 734 CYCEGITEALVEFD-----I-EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+V D I L + C ++PS R T ++ + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-46
Identities = 63/299 (21%), Positives = 110/299 (36%), Gaps = 40/299 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNV--IGQTHHKN 573
+E +GKG FG V++G VAVK S ++ + + E + H+N
Sbjct: 46 LQESIGKGRFGEVWRG-----KWRGEEVAVKIFSS--RE-ERSWFREAEIYQTVMLRHEN 97
Query: 574 LVRLLGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
++ + + LV ++ +G+L +L +A A GL +LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 630 EECSTQ-----IIHCDIKPQNILLDDYYNARISDFGLAKLL-----LLDQSQTHTAIRGT 679
E I H D+K +NIL+ I+D GLA +D + H GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GT 214
Query: 680 KGYVAPE------WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD 733
K Y+APE ++ + D+Y+ G++ E I R ++ + + D
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQLPYYDLVPS 273
Query: 734 CYCEGITEALVEFD-----I-EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+V I + L + C + + R T ++ + L
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 69/289 (23%), Positives = 121/289 (41%), Gaps = 33/289 (11%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
F ++LGKG FG V + VAVKKL ++ +++F+ E+ ++ H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 575 VRLLGFCDDGLNR--LLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLH 629
V+ G C R L+ E+L G+L +L + + I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH--IKLLQYTSQICKGMEYLG 131
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APE 686
+ + IH D+ +NIL+++ +I DFGL K+L D+ + + APE
Sbjct: 132 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFKVKEPGESPIFWYAPE 187
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
+V DV+SFGV+L E+ E ++ + + +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQMIVFHL-- 241
Query: 747 DIEALNDKKKLAR---------FVMVAIWCIQEDPSLRPTMRKVTQMLE 786
IE L + +L R +M W + + RP+ R + ++
Sbjct: 242 -IELLKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 33/289 (11%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
F ++LGKG FG V + VAVKKL ++ +++F+ E+ ++ H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 575 VRLLGFCDDGLNR--LLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLH 629
V+ G C R L+ E+L G+L +L + + I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH--IKLLQYTSQICKGMEYLG 162
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APE 686
+ + IH D+ +NIL+++ +I DFGL K+L D+ + + + APE
Sbjct: 163 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-YYKVKEPGESPIFWYAPE 218
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
+V DV+SFGV+L E+ E ++ + + +
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ----GQMIVFHL-- 272
Query: 747 DIEALNDKKKLAR---------FVMVAIWCIQEDPSLRPTMRKVTQMLE 786
IE L + +L R +M W + + RP+ R + ++
Sbjct: 273 -IELLKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-40
Identities = 64/284 (22%), Positives = 110/284 (38%), Gaps = 36/284 (12%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNL 574
E++G+G FG V+ G VAVK ++ D +F E ++ Q H N+
Sbjct: 118 LGEQIGRGNFGEVFSG---RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECS 633
VRL+G C +V E + G +FL + + A G+ YL +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK-- 232
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY----VAPEWFR 689
IH D+ +N L+ + +ISDFG+++ + A G + APE
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALN 288
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYC-EGITEALVEF 746
+ + DV+SFG+LL E + ++ + + C E +A+
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLPCPELCPDAVFR- 346
Query: 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
+M W +P RP+ + Q L+ + +
Sbjct: 347 --------------LMEQCW--AYEPGQRPSFSTIYQELQSIRK 374
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 36/290 (12%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+ +LGKG FG V + VAVK+L D ++F+ E+ ++ H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 575 VRLLGFCDDGLNR--LLVYEFLSNGTLASFLF---GDLKPGWSRRTDIAFGIARGLLYLH 629
V+ G + LV E+L +G L FL L SR + I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA--SRLLLYSSQICKGMEYLG 144
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APE 686
+ +H D+ +NIL++ + +I+DFGLAKLL LD+ + + + APE
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPE 200
Query: 687 WFRNMPITVKVDVYSFGVLLLEII-CCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
+ + + DV+SFGV+L E+ C ++ + C + + +
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM------GCERDVPALSRL- 253
Query: 746 FDIEALNDKKKLAR---------FVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+E L + ++L +M W P RP+ + L+
Sbjct: 254 --LELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 68/293 (23%), Positives = 121/293 (41%), Gaps = 33/293 (11%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKN 573
+LG+G FG V VAVK L + + + K E+ ++ +H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 574 LVRLLGFCDDGLNR--LLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHE 630
+V+ G C + L+ EFL +G+L +L K ++ A I +G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG- 143
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEW 687
S Q +H D+ +N+L++ + +I DFGL K + D+ +T V APE
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSPVFWYAPEC 200
Query: 688 FRNMPITVKVDVYSFGVLLLEII-CCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
+ DV+SFGV L E++ C + + + +T +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI------GPTHGQMTVTRL-- 252
Query: 747 DIEALNDKKKLAR---------FVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
+ L + K+L +M W + PS R + + + + E +++
Sbjct: 253 -VNTLKEGKRLPCPPNCPDEVYQLMRKCW--EFQPSNRTSFQNLIEGFEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-38
Identities = 78/276 (28%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
K +LG G +G VY+G + Y + VAVK L + V+EF E V+ + H NLV
Sbjct: 224 MKHKLGGGQYGEVYEG---VWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECS 633
+LLG C ++ EF++ G L +L + S +A I+ + YL ++
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
IH ++ +N L+ + + +++DFGL++L+ D H + + APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 694 TVKVDVYSFGVLLLEIICCRRNV--DMEVNEAEALLTDWAYDCYC-EGITEALVEFDIEA 750
++K DV++FGVLL EI + +++++ LL Y EG E + E
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPEGCPEKVYE----- 450
Query: 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+M A W Q +PS RP+ ++ Q E
Sbjct: 451 ----------LMRACW--QWNPSDRPSFAEIHQAFE 474
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 33/288 (11%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKN 573
+LG+G FG V VAVK L + +K E++++ +H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 574 LVRLLGFC--DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+++ G C + LV E++ G+L +L G ++ A I G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH-- 151
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWF 688
+ IH D+ +N+LLD+ +I DFGLAK + + V APE
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECL 209
Query: 689 RNMPITVKVDVYSFGVLLLEII-CCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747
+ DV+SFGV L E++ C + E + +T +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ------GQMTVLRL--- 260
Query: 748 IEALNDKKKLAR---------FVMVAIWCIQEDPSLRPTMRKVTQMLE 786
E L ++L R +M W + + S RPT + +L+
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILK 306
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNL 574
++ +G G G V G + + VPVA+K L + + ++F +E +++GQ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+RL G G ++V E++ NG+L +FL D + + + G+ G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRN 690
+H D+ +N+L+D ++SDFGL+++L D +T G K + APE
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT-TGGKIPIRWTAPEAIAF 228
Query: 691 MPITVKVDVYSFGVLLLEII 710
+ DV+SFGV++ E++
Sbjct: 229 RTFSSASDVWSFGVVMWEVL 248
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 41/275 (14%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQTHHKN 573
F E+G+G+F VYK G+ + V VA + + + + FK E ++ H N
Sbjct: 30 FDIEIGRGSFKTVYK---GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 574 LVRLLGFCDDGL---NRLLVY-EFLSNGTLASFL--FGDLKPG----WSRRTDIAFGIAR 623
+VR + + +++ E +++GTL ++L F +K W R+ I +
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILK 140
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
GL +LH + IIH D+K NI + + +I D GLA L ++ A+ GT +
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEF 196
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742
+APE + VDVY+FG+ +LE+ E A + +T
Sbjct: 197 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRR---------VTSG 245
Query: 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPT 777
+ + + ++ + CI+++ R +
Sbjct: 246 VKPASFDKVAI-PEVKEIIE---GCIRQNKDERYS 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKN 573
++ +G G FG VYKG + +VPVA+K L + + +F E ++GQ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
++RL G +++ E++ NG L FL D + + + GIA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
+H D+ +NIL++ ++SDFGL+++L D T+T G K + APE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-SGGKIPIRWTAPEAIS 223
Query: 690 NMPITVKVDVYSFGVLLLEII 710
T DV+SFG+++ E++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVM 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNL 574
+ +G G FG V G + + S ++ VA+K L + ++F E +++GQ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+RL G ++V E++ NG+L SFL D + + + GIA G+ YL +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRN 690
+H D+ +NIL++ ++SDFGL ++L D +T RG K + +PE
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT-RGGKIPIRWTSPEAIAY 224
Query: 691 MPITVKVDVYSFGVLLLEII 710
T DV+S+G++L E++
Sbjct: 225 RKFTSASDVWSYGIVLWEVM 244
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 516 FKEELGKGAFGVVYKG----AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH 571
F E LG+G F ++KG +++ V +K L ++ + F +++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAFGIARGLLYL 628
K+LV G C G +LV EF+ G+L ++L + W + ++A +A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNAR--------ISDFGLAKLLLLDQSQTHTAIRGTK 680
E +IH ++ +NILL + + +SD G++ +L + I
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-TVLPKDILQERIPWV- 184
Query: 681 GYVAPEWFRNMPI-TVKVDVYSFGVLLLEII 710
PE N + D +SFG L EI
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKN 573
+ LG GAFG VYKG I ++PVA+K+L + KE E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
+ RLLG C L+ + + G L ++ G + IA+G+ YL +
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
++H D+ +N+L+ + +I+DFGLAKLL ++ + H G K + A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 690 NMPITVKVDVYSFGVLLLEII 710
+ T + DV+S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-35
Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 32/284 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+ +LG+G FG V+ G VA+K L + F E V+ + H+ LV
Sbjct: 188 LEVKLGQGCFGEVWMGTW----NGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECS 633
+L + +V E++S G+L FL G+ D+A IA G+ Y+
Sbjct: 243 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-- 299
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+H D++ NIL+ + +++DFGLA+L+ ++ + + APE
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 694 TVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYC-EGITEALVEFDIEA 750
T+K DV+SFG+LL E+ R M E + Y C E+L +
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHD----- 412
Query: 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794
+M W +++P RPT + LE +P
Sbjct: 413 ----------LMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-35
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+++LG G FG V+ VAVK + V+ F E NV+ H LV
Sbjct: 192 LEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246
Query: 576 RLLGFC-DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEEC 632
+L + + ++ EF++ G+L FL D D + IA G+ ++ +
Sbjct: 247 KLHAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR- 303
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
IH D++ NIL+ +I+DFGLA+++ ++ +TA G K + APE
Sbjct: 304 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358
Query: 690 NMPITVKVDVYSFGVLLLEII 710
T+K DV+SFG+LL+EI+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIV 379
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQTHHK 572
E+LG G+FGVV +G S V VAVK L + + +F EVN + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 573 NLVRLLGFC-DDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHE 630
NL+RL G + +V E G+L L + A +A G+ YL
Sbjct: 82 NLIRLYGVVLTPPM--KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEW 687
+ + IH D+ +N+LL +I DFGL + L + K APE
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPES 195
Query: 688 FRNMPITVKVDVYSFGVLLLEII 710
+ + D + FGV L E+
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMF 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHSVIQD-GVKEFKTEVNVIGQTHHKN 573
+ LG G FG V+KG I ++PV +K + + + IG H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 574 LVRLLGFC-DDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+VRLLG C L LV ++L G+L + G + IA+G+ YL E
Sbjct: 77 IVRLLGLCPGSSL--QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWF 688
++H ++ +N+LL +++DFG+A LL D Q K + A E
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESI 189
Query: 689 RNMPITVKVDVYSFGVLLLEII 710
T + DV+S+GV + E++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELM 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
F +E+G G FG+V+ G + + VA+K + ++F E V+ + H LV
Sbjct: 12 FVQEIGSGQFGLVHLGYW----LNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLV 66
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
+L G C + LV EF+ +G L+ +L + + G+ YL E
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 123
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRNM 691
+IH D+ +N L+ + ++SDFG+ + +L DQ +T+ GTK V +PE F
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFS 180
Query: 692 PITVKVDVYSFGVLLLEII 710
+ K DV+SFGVL+ E+
Sbjct: 181 RYSSKSDVWSFGVLMWEVF 199
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-35
Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 32/284 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+ +LG+G FG V+ G VA+K L + F E V+ + H+ LV
Sbjct: 271 LEVKLGQGCFGEVWMGTW----NGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECS 633
+L + +V E++S G+L FL G+ D+A IA G+ Y+
Sbjct: 326 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-- 382
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+H D++ NIL+ + +++DFGLA+L+ ++ + + APE
Sbjct: 383 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 694 TVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYC-EGITEALVEFDIEA 750
T+K DV+SFG+LL E+ R M E + Y C E+L +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHD----- 495
Query: 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794
+M W +++P RPT + LE +P
Sbjct: 496 ----------LMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 64/197 (32%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNLVR 576
ELG G FG V KG M VAVK L + E E NV+ Q + +VR
Sbjct: 24 ELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
++G C+ + +LV E G L +L + ++ ++ G+ YL E
Sbjct: 83 MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRNMPI 693
+H D+ +N+LL + A+ISDFGL+K L D++ + A K V APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYKF 197
Query: 694 TVKVDVYSFGVLLLEII 710
+ K DV+SFGVL+ E
Sbjct: 198 SSKSDVWSFGVLMWEAF 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNLV 575
ELG G FG V +G Q+ VA+K L + +E E ++ Q + +V
Sbjct: 15 DIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECST 634
RL+G C +LV E G L FL G + S ++ ++ G+ YL E+
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRNM 691
+H D+ +N+LL + + A+ISDFGL+K L D S +TA K + APE
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFR 188
Query: 692 PITVKVDVYSFGVLLLEII 710
+ + DV+S+GV + E +
Sbjct: 189 KFSSRSDVWSYGVTMWEAL 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMY--QVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN 573
+ELG G FGVV G + Q VAVK + EF E + + H
Sbjct: 12 LLKELGSGQFGVVKLG------KWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPK 64
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
LV+ G C +V E++SNG L ++L S+ ++ + + G+ +L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH- 123
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
Q IH D+ +N L+D ++SDFG+ + +L DQ + + GTK V APE F
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFH 178
Query: 690 NMPITVKVDVYSFGVLLLEII 710
+ K DV++FG+L+ E+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVF 199
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMY--QVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN 573
F +ELG G FGVV G + Q VA+K + EF E V+ H+
Sbjct: 28 FLKELGTGQFGVVKYG------KWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEK 80
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
LV+L G C ++ E+++NG L ++L + + ++ + + YL +
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK- 139
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
Q +H D+ +N L++D ++SDFGL++ +L D+ +T+ G+K V PE
Sbjct: 140 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLM 194
Query: 690 NMPITVKVDVYSFGVLLLEII 710
+ K D+++FGVL+ EI
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIY 215
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 36/279 (12%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
K +LG G +G VY+G + Y + VAVK L + V+EF E V+ + H NLV
Sbjct: 17 MKHKLGGGQYGEVYEG---VWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECS 633
+LLG C ++ EF++ G L +L + S +A I+ + YL
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 129
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRN 690
IH D+ +N L+ + + +++DFGL++L+ D +TA G K + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAY 186
Query: 691 MPITVKVDVYSFGVLLLEIICCRRNV--DMEVNEAEALLTDWAYDCYC-EGITEALVEFD 747
++K DV++FGVLL EI + +++++ LL Y EG E + E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPEGCPEKVYE-- 243
Query: 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+M A W Q +PS RP+ ++ Q E
Sbjct: 244 -------------LMRACW--QWNPSDRPSFAEIHQAFE 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 46/200 (23%), Positives = 84/200 (42%), Gaps = 12/200 (6%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNL 574
LG+G FG VY+G ++ VAVK D ++F +E ++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
V+L+G ++ ++ E G L +L + I + + YL
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRN 690
+H DI +NIL+ ++ DFGL++ + + + + T+ + +PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMSPESINF 188
Query: 691 MPITVKVDVYSFGVLLLEII 710
T DV+ F V + EI+
Sbjct: 189 RRFTTASDVWMFAVCMWEIL 208
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-34
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQ-VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+ +GKG FG V G Y+ VAVK + + + F E +V+ Q H NL
Sbjct: 197 LLQTIGKGEFGDVMLG------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 248
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEE 631
V+LLG + L +V E+++ G+L +L + + + + YL
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+H D+ +N+L+ + A++SDFGL K Q ++ T APE R
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 361
Query: 692 PITVKVDVYSFGVLLLEII 710
+ K DV+SFG+LL EI
Sbjct: 362 KFSTKSDVWSFGILLWEIY 380
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-34
Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 56/288 (19%)
Query: 516 FKEELGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKN 573
K+ LG GA G +VY+G VAVK++ + EV ++ + H N
Sbjct: 28 PKDVLGHGAEGTIVYRG-----MFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPN 79
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR----GLLYLH 629
++R D + + E L TL ++ + ++ + + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 630 EECSTQIIHCDIKPQNILL-----DDYYNARISDFGLAKLLLLDQS--QTHTAIRGTKGY 682
S I+H D+KP NIL+ A ISDFGL K L + + + + GT+G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 683 VAPEWFR---NMPITVKVDVYSFGVLLLEIICCRR-----NVDMEVNEAEALLTDWAYDC 734
+APE T VD++S G + +I ++ + N LL + D
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---LLGACSLD- 248
Query: 735 YCEGITEALVEFDIEALNDKKKLAR-FVMVAIWCIQEDPSLRPTMRKV 781
+ + +AR + I DP RP+ + V
Sbjct: 249 ------------CLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHV 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKN 573
+ LG GAFG VYKG I ++PVA+K+L E E V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEEC 632
+ RLLG C L+ + + G L ++ G + IA+G+ YL +
Sbjct: 79 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
++H D+ +N+L+ + +I+DFGLAKLL ++ + H G K + A E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 690 NMPITVKVDVYSFGVLLLEII 710
+ T + DV+S+GV + E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQ-VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN 573
K ELG+GAFG V+ ++ + VAVK L K+F+ E ++ H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-----------FGDLKPGWSRRT-----DI 617
+V+ G C DG ++V+E++ +G L FL G + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ---SQTHT 674
A IA G++YL S +H D+ +N L+ +I DFG+++ + HT
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 675 A--IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
IR PE T + DV+SFGV+L EI
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNL 574
+G+G FG V++G + VA+K + D V+ +F E + Q H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
V+L+G + ++ E + G L SFL + A+ ++ L YL +
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRN 690
+ +H DI +N+L+ ++ DFGL++ + + T+ K + APE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINF 191
Query: 691 MPITVKVDVYSFGVLLLEII 710
T DV+ FGV + EI+
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNL 574
F E +G+G FG VY G + ++ AVK L+ + G V +F TE ++ H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 575 VRLLGFC-DDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
+ LLG C + L+V ++ +G L +F+ P +A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--- 145
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
S + +H D+ +N +LD+ + +++DFGLA+ + + + G K V A E +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 690 NMPITVKVDVYSFGVLLLEII 710
T K DV+SFGVLL E++
Sbjct: 206 TQKFTTKSDVWSFGVLLWELM 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNL 574
F E +G+G FG VY G + ++ AVK L+ + G V +F TE ++ H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 575 VRLLGFC-DDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
+ LLG C + L+V ++ +G L +F+ P +A+G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--- 209
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
S + +H D+ +N +LD+ + +++DFGLA+ + + + G K V A E +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 690 NMPITVKVDVYSFGVLLLEII 710
T K DV+SFGVLL E++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNL 574
+GKG FGVVY G + ++ A+K L + + V+ F E ++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 575 VRLLGFCDDGLNRLL-VYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEEC 632
+ L+G + ++ +G L F+ P +ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG------YVAPE 686
+ +H D+ +N +LD+ + +++DFGLA+ + + + +++ + + A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTALE 198
Query: 687 WFRNMPITVKVDVYSFGVLLLEII 710
+ T K DV+SFGVLL E++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKN 573
+ LG+G FG V +G + + VAVK + Q ++EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 574 LVRLLGFCDDG-----LNRLLVYEFLSNGTLASFL------FGDLKPGWSRRTDIAFGIA 622
++RLLG C + +++ F+ G L ++L G IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
G+ YL + +H D+ +N +L D ++DFGL+K + + R K
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIAKMP 212
Query: 683 V---APEWFRNMPITVKVDVYSFGVLLLEII 710
V A E + T K DV++FGV + EI
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM-YQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHK 572
ELG+G+FG+VY+G A G+ + VA+K ++ EF E +V+ + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL----------FGDLKPGWSRRTDIAFGIA 622
++VRLLG G L++ E ++ G L S+L P S+ +A IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
G+ YL+ + + +H D+ +N ++ + + +I DFG+ + D +T +G KG
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 201
Query: 683 V-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ +PE ++ T DV+SFGV+L EI
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
E LG G FG V+ G VAVK L F E N++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 576 RLLGFC-DDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
RL + + ++ E++ NG+L FL +K ++ D+A IA G+ ++ E
Sbjct: 72 RLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFR 689
IH D++ NIL+ D + +I+DFGLA+L+ ++ +TA G K + APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAIN 183
Query: 690 NMPITVKVDVYSFGVLLLEII 710
T+K DV+SFG+LL EI+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIV 204
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-33
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQTHHKNLV 575
ELG G FG V +G M Q+ VA+K L + +E E ++ Q + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECST 634
RL+G C +LV E G L FL G + S ++ ++ G+ YL E+
Sbjct: 400 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRNM 691
+H ++ +N+LL + + A+ISDFGL+K L D S +TA K + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFR 514
Query: 692 PITVKVDVYSFGVLLLEII 710
+ + DV+S+GV + E +
Sbjct: 515 KFSSRSDVWSYGVTMWEAL 533
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQ-VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+ +GKG FG V G Y+ VAVK + + + F E +V+ Q H NL
Sbjct: 25 LLQTIGKGEFGDVMLG------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 76
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEE 631
V+LLG + L +V E+++ G+L +L + + + + YL
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 134
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
+H D+ +N+L+ + A++SDFGL K Q ++ T APE R
Sbjct: 135 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 189
Query: 692 PITVKVDVYSFGVLLLEII 710
+ K DV+SFG+LL EI
Sbjct: 190 KFSTKSDVWSFGILLWEIY 208
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 60/299 (20%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
LG+GAFG V K A A+KK+ ++ + +EV ++ +H+ +V
Sbjct: 10 EIAVLGQGAFGQVVK-ARNALD--SRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 576 RLLGFCDDGLNRL-------------LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA 622
R + N + + E+ NGTL + +++ D + +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLF 122
Query: 623 R----GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL------------- 665
R L Y+H + IIH D+KP NI +D+ N +I DFGLAK +
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 666 -LLDQSQTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEA 723
+AI GT YVA E K+D+YS G++ E + + ME
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-MIYPFSTGMERVN- 236
Query: 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLAR-FVMVAIWCIQEDPSLRPTMRKV 781
+L + +EF + ++K K+ + + I DP+ RP R +
Sbjct: 237 --ILKK---------LRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTL 281
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQ-VPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN 573
K ELG+GAFG V+ + + VAVK L + ++F+ E ++ H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL----------FGDLKPGWSRRT-----DIA 618
+VR G C +G L+V+E++ +G L FL G +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
+A G++YL +H D+ +N L+ +I DFG+++ D T G
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVG 217
Query: 679 TKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ + PE T + DV+SFGV+L EI
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 34/217 (15%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKK--LHSVIQDGVKEFKTEVNVIGQT 569
+G G++G K G I + K+ S+ + + +EVN++ +
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKI---------LVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 570 HHKNLVRLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPG--------WSRRTDIAF 619
H N+VR D L +V E+ G LAS + K +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMT 118
Query: 620 GIARGLLYLHE--ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
+ L H + ++H D+KP N+ LD N ++ DFGLA++L D S T +
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR 714
GT Y++PE M K D++S G LL E+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIG 567
D E NG + LGKG +G+VY G QV +A+K++ + E+ +
Sbjct: 18 DYEYDENGDRVVLGKGTYGIVYAG---RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARG 624
HKN+V+ LG + + E + G+L++ L P I F I G
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
L YLH+ QI+H DIK N+L++ Y +ISDFG +K L T T GT Y+
Sbjct: 135 LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYM 190
Query: 684 APEWFRNMPI--TVKVDVYSFGVLLLE 708
APE P D++S G ++E
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIE 217
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 79/320 (24%), Positives = 115/320 (35%), Gaps = 69/320 (21%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQ-VPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHK 572
LG GAFG VY+G GM + + VAVK L V + +F E +I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL-------FGDLKPGWSRRTDIAFGIARGL 625
N+VR +G L R ++ E ++ G L SFL +A IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNAR---ISDFGLAKLLLLDQSQTHTAIRGTKGY 682
YL IH DI +N LL R I DFG+A+ D + +G
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247
Query: 683 V-----APEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737
+ PE F T K D +SFGVLL EI
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF-----------------------SLGY 284
Query: 738 ----GITEALVEFDIEALNDKKKLAR---------FVMVAIWCIQEDPSLRPTMRKVTQM 784
+ V +E + ++ +M W Q P RP + +
Sbjct: 285 MPYPSKSNQEV---LEFVTSGGRMDPPKNCPGPVYRIMTQCW--QHQPEDRPNFAIILER 339
Query: 785 LEGVV---EVLDPPCPCPFT 801
+E +V++ P +
Sbjct: 340 IEYCTQDPDVINTALPIEYG 359
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 68/213 (31%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQ-VPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHK 572
LG GAFG VY+G GM + + VAVK L V + +F E +I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL-------FGDLKPGWSRRTDIAFGIARGL 625
N+VR +G L R ++ E ++ G L SFL +A IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNAR---ISDFGLAKLLLLDQSQTHTAIRGTKGY 682
YL IH DI +N LL R I DFG+A+ D + +G
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 206
Query: 683 V-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ PE F T K D +SFGVLL EI
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 22/212 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQTHHKN 573
LGKG FG V + + V VAVK K + ++EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 574 LVRLLGFCDDGLNR------LLVYEFLSNGTLASFLFGDLKPGWSRR------TDIAFGI 621
+ +L+G + +++ F+ +G L +FL I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG 681
A G+ YL S IH D+ +N +L + ++DFGL++ + + +K
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCASKL 201
Query: 682 YV---APEWFRNMPITVKVDVYSFGVLLLEII 710
V A E + TV DV++FGV + EI+
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 56/296 (18%), Positives = 100/296 (33%), Gaps = 54/296 (18%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKL-HSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+ LG+G FGVV++ + A+K++ + ++ EV + + H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCN---YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 577 LLGFCDDGLN---------RLLVY---EFLSNGTLASFLF---GDLKPGWSRRTDIAFGI 621
+ ++ +Y + L ++ + S I I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL-----------LLDQS 670
A + +LH S ++H D+KP NI ++ DFGL + +
Sbjct: 128 AEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW 730
HT GTK Y++PE + KVD++S G++L E + + ME
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE-LLYPFSTQMERVR-------- 235
Query: 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+F V + P RP ++E
Sbjct: 236 TLTDVRNL------KFPPLFTQKYPCEYVMVQ---DMLSPSPMERPE---AINIIE 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQ-VPVAVKKLH-SVIQDGVKEFKTEVNVIGQ-THH 571
F + LG GAFG V + A G+ + VAVK L S + +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL-------------FGDLKPGWSRRT--- 615
N+V LLG C G L++ E+ G L +FL ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 616 --DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
++ +A+G+ +L S IH D+ +NILL +I DFGLA+ D
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDS 199
Query: 674 TAIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ + APE N T + DV+S+G+ L E+
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM-YQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQ-THH 571
F + LG GAFG V + A G+ + VAVK L + D + +E+ ++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--------------FGDLKPGWSRRTDI 617
+N+V LLG C G L++ E+ G L +FL +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
+ +A+G+ +L S IH D+ +N+LL + + A+I DFGLA+ D I
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIV 222
Query: 678 GTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ APE + TV+ DV+S+G+LL EI
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 60/275 (21%), Positives = 115/275 (41%), Gaps = 29/275 (10%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVI-QDGVKEFKTEVNVIGQTHHKNL 574
+++G+G F VY+ + VPVA+KK + ++ + E++++ Q +H N+
Sbjct: 38 KKIGRGQFSEVYRA---ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 575 VRLLGFCDDGLNRLLVY-EFLSNGTLASFL--FGDLKPGWSRRT--DIAFGIARGLLYLH 629
++ + N L + E G L+ + F K RT + L ++H
Sbjct: 95 IKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
+++H DIKP N+ + ++ D GL + + H+ + GT Y++PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 209
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749
K D++S G LL E+ + + +L C+ I + +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---------CKKIEQCDYP-PLP 259
Query: 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784
+ + ++L + V CI DP RP + V +
Sbjct: 260 SDHYSEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHKNL 574
+G+G FG V++G + VA+K + D V+ +F E + Q H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFL-FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
V+L+G + ++ E + G L SFL + A+ ++ L YL S
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV---APEWFRN 690
+ +H DI +N+L+ ++ DFGL++ + + T+ K + APE
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINF 566
Query: 691 MPITVKVDVYSFGVLLLEII 710
T DV+ FGV + EI+
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQ-VPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHK 572
F EELG+ FG VYKG G A Q VA+K L +EF+ E + + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL-----FGDLKPGWSRRT-----------D 616
N+V LLG +++ + S+G L FL D+ RT
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD---QSQTH 673
+ IA G+ YL S ++H D+ +N+L+ D N +ISD GL + + + +
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 674 TA--IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+ IR APE ++ D++S+GV+L E+
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 59/282 (20%), Positives = 104/282 (36%), Gaps = 51/282 (18%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E +G G FG V+K A +K+ ++ ++ + EV + + H N+V
Sbjct: 17 ELIGSGGFGQVFK-AKHRID--GKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVHY 69
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLF--------GDLKPGWSRRT----------DIAF 619
G D S+ + LF G L+ +R ++
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
I +G+ Y+H S ++I+ D+KP NI L D +I DFGL L T +GT
Sbjct: 130 QITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRTRSKGT 184
Query: 680 KGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
Y++PE + +VD+Y+ G++L E++ E TD +
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF----ETSKFFTDLRDGIISDIF 240
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
+ ++ + + P RP ++
Sbjct: 241 DKKEKTL-LQ----------------KLLSKKPEDRPNTSEI 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM---YQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQ-T 569
+ LG+GAFG V A+G+ V VAVK L + + + +E+ ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR--------------- 614
HKN++ LLG C ++ E+ S G L +L PG
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 615 -TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ D +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 674 TAIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ T G + APE + T + DV+SFGVL+ EI
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM---YQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQ-T 569
+ LG+G FG V A+G+ V VAVK L + + + +E+ ++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR--------------- 614
HKN++ LLG C ++ E+ S G L +L PG
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 615 -TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ D +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 257
Query: 674 TAIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ T G + APE + T + DV+SFGVL+ EI
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 54/282 (19%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQTHHKNL- 574
+++G G V++ + Q+ A+K L + ++ E+ + + +
Sbjct: 34 KQIGSGGSSKVFQV---LNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 575 -VRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+RL + +V E N L S+L + P + + + +H+
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQH 146
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH-TAIRGTKGYVAPEWFRN 690
I+H D+KP N L+ D ++ DFG+A + D + + GT Y+ PE ++
Sbjct: 147 ---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 691 MP-----------ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
M I+ K DV+S G +L + + +N+ L I
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA----------I 252
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
+ E + + + K L + C++ DP R ++ ++
Sbjct: 253 IDPNHEIEFPDIPE-KDLQDVLK---CCLKRDPKQRISIPEL 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM-YQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQ-THH 571
F + LG GAFG V A G++ + VAVK L + +E+ ++ Q H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL------FGDLKPGWSRR----------- 614
+N+V LLG C L++E+ G L ++L F + + + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 615 ------TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
A+ +A+G+ +L +H D+ +N+L+ +I DFGLA+ D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR----D 221
Query: 669 QSQTHTAIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ + APE T+K DV+S+G+LL EI
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM-YQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHK 572
+ LG+G FG V K A + VAVK L + +++ +E NV+ Q +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL------------------FGDLKPGWSRR 614
++++L G C LL+ E+ G+L FL L R
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 615 ------TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
A+ I++G+ YL +++H D+ +NIL+ + +ISDFGL++ D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 669 QSQTHTAIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ + ++ ++G + A E + T + DV+SFGVLL EI+
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 53/282 (18%), Positives = 105/282 (37%), Gaps = 49/282 (17%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKK--LHSVIQDGVKEFKTEVNVIGQT 569
+++G+G+FG G +K+ + + +E + EV V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQ---------YVIKEINISRMSSKEREESRREVAVLANM 80
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLY 627
H N+V+ ++ + +V ++ G L + + D I L +
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW 687
+H+ +I+H DIK QNI L ++ DFG+A++L I GT Y++PE
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196
Query: 688 FRNMPITVKVDVYSFGVLLLEIICCRR---NVDMEVNEAEALLTDWAYDCYCEGITEALV 744
N P K D+++ G +L E+ + M + + ++
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------------------KNLVLKII 238
Query: 745 EFDIEALNDK--KKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784
++ L V + +P RP++ + +
Sbjct: 239 SGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILEK 277
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM---YQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQ-T 569
+ LG+GAFG V AIG+ VAVK L + + + +E+ ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL------------FGDLKPGWSRR--- 614
HKN++ LLG C ++ E+ S G L +L P
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 615 -TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ D
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 245
Query: 674 TAIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ T G + APE + T + DV+SFGVLL EI
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 56/282 (19%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIG--QTHHKN 573
+++G G V++ + Q+ A+K L + ++ E+ + Q H
Sbjct: 15 KQIGSGGSSKVFQV---LNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
++RL + +V E N L S+L + P + + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQH 127
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH-TAIRGTKGYVAPEWFRN 690
I+H D+KP N L+ D ++ DFG+A + D + + GT Y+ PE ++
Sbjct: 128 ---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 691 MP-----------ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
M I+ K DV+S G +L + + +N+ L I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA----------I 233
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
+ E + +K L + C++ DP R ++ ++
Sbjct: 234 IDPNHEIEFPD-IPEKDLQDVLK---CCLKRDPKQRISIPEL 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM-YQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQ-THH 571
+ LG+GAFG V + A G+ VAVK L + +E+ ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 572 KNLVRLLGFC-DDGLNRLLVYEFLSNGTLASFL-----------FGDLKPGWSRRT---- 615
N+V LLG C G +++ EF G L+++L T
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 616 -DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674
+F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ D +
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203
Query: 675 AIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+R + APE + T++ DV+SFGVLL EI
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 73/304 (24%), Positives = 107/304 (35%), Gaps = 67/304 (22%)
Query: 516 FKEELGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKN 573
++ LG G+ G VV++G S PVAVK++ D E+ ++ ++ H N
Sbjct: 19 SEKILGYGSSGTVVFQG-----SFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPN 70
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLA-------SFLFGDLKPGWSRRTDIAFGIARGLL 626
++R + E L N L + IA G+
Sbjct: 71 VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 627 YLHEECSTQIIHCDIKPQNILLD-------------DYYNARISDFGLAKLLLLDQSQTH 673
+LH S +IIH D+KPQNIL+ + ISDFGL K L QS
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 674 TAIR---GTKGYVAPE-------WFRNMPITVKVDVYSFGVLLLEIICCRR-----NVDM 718
T + GT G+ APE +T +D++S G + I+ +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 719 EVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLAR-FVMVAIWCIQEDPSLRPT 777
E N + + L E A + I DP RPT
Sbjct: 247 ESNIIRGIFS--------------LDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPT 289
Query: 778 MRKV 781
KV
Sbjct: 290 AMKV 293
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 65/308 (21%), Positives = 114/308 (37%), Gaps = 57/308 (18%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
F ++LG+G F V G+ + A+K++ Q +E + E ++ +H N++
Sbjct: 33 FIQKLGEGGFSYVDL-VEGLHDGHFY--ALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 576 RLLGFCDDGLNR----LLVYEFLSNGTLASFL--FGDLKPGWSRRT--DIAFGIARGLLY 627
RL+ +C L+ F GTL + + D + + GI RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR--------GT 679
+H + H D+KP NILL D + D G + + A+ T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 680 KGYVAPEWF---RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC 736
Y APE F + I + DV+S G +L ++ DM + +++
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-------- 258
Query: 737 EGITEALVEFDIEALNDKKKL-------ARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789
A+ ++ + + + + DP RP + + +
Sbjct: 259 -------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ----L 301
Query: 790 EVLDPPCP 797
E L PP P
Sbjct: 302 EALQPPAP 309
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 60/197 (30%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKE-FKTEVNVIGQTHHKNLVR 576
LGKG FG VY A S + + A+K L + + GV+ + EV + H N++R
Sbjct: 17 LGKGKFGNVYL-AREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L G+ D L+ E+ GT+ L + +A L Y H S
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--YITELANALSYCH---SK 128
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
++IH DIKP+N+LL +I+DFG + S+ GT Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLC-GTLDYLPPEMIEGRMHD 185
Query: 695 VKVDVYSFGVLLLEIIC 711
KVD++S GVL E +
Sbjct: 186 EKVDLWSLGVLCYEFLV 202
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL-HSVIQDGVKEFKTEVNVIGQ-THHKN 573
F++ +G+G FG V K I ++ A+K++ +D ++F E+ V+ + HH N
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFL-----------FGDLKPGWSRRT-----DI 617
++ LLG C+ L E+ +G L FL F S +
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR 677
A +ARG+ YL Q IH D+ +NIL+ + Y A+I+DFGL++ ++
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVK 197
Query: 678 GTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
T G + A E T DV+S+GVLL EI+
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 53/282 (18%), Positives = 108/282 (38%), Gaps = 43/282 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQTHHKNL- 574
+++G G V++ + Q+ A+K L + ++ E+ + + +
Sbjct: 62 KQIGSGGSSKVFQV---LNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 575 -VRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+RL + +V E N L S+L + P + + + +H+
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIHQH 174
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH-TAIRGTKGYVAPEWFRN 690
I+H D+KP N L+ D ++ DFG+A + D + + G Y+ PE ++
Sbjct: 175 ---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 691 MP-----------ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
M I+ K DV+S G +L + + +N+ L I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA----------I 280
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
+ E + + + K L + C++ DP R ++ ++
Sbjct: 281 IDPNHEIEFPDIPE-KDLQDVLK---CCLKRDPKQRISIPEL 318
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 43/251 (17%), Positives = 77/251 (30%), Gaps = 33/251 (13%)
Query: 480 FFVYNKKNSQVPSHDGVVETNLHCFTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMY 539
F + K +P+ E L LG+GAF VY+ G +
Sbjct: 44 TFEWQCK---LPAIKPKTEFQLGSKLVY--------VHHLLGEGAFAQVYEATQGDLNDA 92
Query: 540 QV--PVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597
+ +K + + + ++ +LV E S G
Sbjct: 93 KNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 598 TLASFLFGDLKPGWSRRT-----DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652
TL + + A + + +H +IIH DIKP N +L + +
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGF 209
Query: 653 NA-----------RISDFGLAK-LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVY 700
+ D G + + L + TA T G+ E N P ++D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 701 SFGVLLLEIIC 711
+ ++
Sbjct: 270 GVAATVYCMLF 280
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 16/197 (8%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKE-FKTEVNVIGQTHHKNLVR 576
LGKG FG VY A + + + A+K L + ++GV+ + E+ + H N++R
Sbjct: 22 LGKGKFGNVYL-AREKQNKFIM--ALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
+ + D L+ EF G L L G S +A L Y H
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT--FMEELADALHYCH---ER 133
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
++IH DIKP+N+L+ +I+DFG + + T GT Y+ PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRTMC-GTLDYLPPEMIEGKTHD 190
Query: 695 VKVDVYSFGVLLLEIIC 711
KVD++ GVL E +
Sbjct: 191 EKVDLWCAGVLCYEFLV 207
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 38/220 (17%)
Query: 516 FKEELGKGAFGVVYKG---AIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHH 571
+ LG+GA V++G G A+K + V E V+ + +H
Sbjct: 13 LSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 572 KNLVRLLGFCDDGLNRL--LVYEFLSNGTLASFLFGDLKPGWSRR------TDIAFGIAR 623
KN+V+L ++ R L+ EF G+L + L +P + + +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVG 123
Query: 624 GLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
G+ +L E I+H +IKP NI+ D +++DFG A+ L+ + ++ GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVSLYGT 178
Query: 680 KGYVAPE--------WFRNMPITVKVDVYSFGVLLLEIIC 711
+ Y+ P+ VD++S GV
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASM-YQVPVAVKKLHSVIQDGVK-EFKTEVNVIGQTHHK 572
+ ++G+GAFG V++ A G+ VAVK L ++ +F+ E ++ + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFL-------------------FGDLKPGWSR 613
N+V+LLG C G L++E+++ G L FL PG
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 614 RT-----DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
+ IA +A G+ YL + +H D+ +N L+ + +I+DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR----N 223
Query: 669 QSQTHTAIRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+ PE T + DV+++GV+L EI
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 65/214 (30%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 516 FKEELGKGAFGVVYKG---AIGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQTHH 571
KE LG G FG V + G VA+K+ + +E + E+ ++ + +H
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGE------QVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71
Query: 572 KNLVRLLGFCDD------GLNRLLVYEFLSNGTLASFL-----FGDLKPGWSRRTDIAFG 620
N+V D LL E+ G L +L LK G R +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT--LLSD 129
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLAKLLLLDQSQTHTAIR 677
I+ L YLHE +IIH D+KP+NI+L +I D G AK L +
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV- 184
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC 711
GT Y+APE TV VD +SFG L E I
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQV-------PVAVKKLHSVIQDG---VKEFKTEVNVIG 567
++LG G GM+++Y VA+K + ++ +K F+ EV+
Sbjct: 17 DKLGGG----------GMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLY 627
Q H+N+V ++ ++ LV E++ TL+ ++ + I G+ +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-AIRGTKGYVAPE 686
H+ +I+H DIKPQNIL+D +I DFG+AK L + S T T + GT Y +PE
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPE 182
Query: 687 WFRNMPITVKVDVYSFGVLLLEII 710
+ D+YS G++L E++
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEML 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQ-THHKN 573
+ELG+G F VV + I ++ A K K QD E E+ V+
Sbjct: 34 SKELGRGKFAVVRQ-CISKST--GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR--TDIAFGIARGLLYLHEE 631
++ L ++ +L+ E+ + G + S +L S + I G+ YLH
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 632 CSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
I+H D+KPQNILL + +I DFG+++ + + I GT Y+APE
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEIL 205
Query: 689 RNMPITVKVDVYSFGVLL 706
PIT D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 14/197 (7%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKE-FKTEVNVIGQTHHKNLVR 576
LGKG F ++ + A K + +++ +E E+++ H+++V
Sbjct: 49 LGKGGFAKCFE-ISDADTKEVF--AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEECST 634
GF +D +V E +L L +R I G YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--YLRQIVLGCQYLH---RN 160
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
++IH D+K N+ L++ +I DFGLA + D + + GT Y+APE +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 695 VKVDVYSFGVLLLEIIC 711
+VDV+S G ++ ++
Sbjct: 220 FEVDVWSIGCIMYTLLV 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 52/199 (26%), Positives = 80/199 (40%), Gaps = 20/199 (10%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
+ +G+G+FG V++ AVKK+ ++ E E+ +V
Sbjct: 63 QPRVGRGSFGEVHRM---KDKQTGFQCAVKKVR--LEVFRVE---ELVACAGLSSPRIVP 114
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L G +G + E L G+L + G L + GL YLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY--YLGQALEGLEYLHTR--- 169
Query: 635 QIIHCDIKPQNILLDDY-YNARISDFGLAKLLLLDQSQTHTA----IRGTKGYVAPEWFR 689
+I+H D+K N+LL A + DFG A L D I GT+ ++APE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 690 NMPITVKVDVYSFGVLLLE 708
P KVD++S ++L
Sbjct: 230 GKPCDAKVDIWSSCCMMLH 248
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 15/198 (7%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKE-FKTEVNVIGQTHHKNLVR 576
LGKG+F VY+ A + + +V A+K + ++ + G+ + + EV + Q H +++
Sbjct: 19 LGKGSFAGVYR-AESIHTGLEV--AIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
L + +D LV E NG + +L +R I G+LYLH S
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLH---S 130
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
I+H D+ N+LL N +I+DFGLA L + + +T + GT Y++PE
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 694 TVKVDVYSFGVLLLEIIC 711
++ DV+S G + ++
Sbjct: 190 GLESDVWSLGCMFYTLLI 207
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 14/197 (7%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKE-FKTEVNVIGQTHHKNLVR 576
LGKG F ++ + A K + +++ +E E+++ H+++V
Sbjct: 23 LGKGGFAKCFE-ISDADTKEVF--AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 79
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEECST 634
GF +D +V E +L L +R I G YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY--YLRQIVLGCQYLH---RN 134
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
++IH D+K N+ L++ +I DFGLA + D + + GT Y+APE +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 695 VKVDVYSFGVLLLEIIC 711
+VDV+S G ++ ++
Sbjct: 194 FEVDVWSIGCIMYTLLV 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 53/203 (26%), Positives = 81/203 (39%), Gaps = 19/203 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQDGVKEFKTEVNVIGQTH 570
E +GKG F VV + I + AVK K S ++ K E ++
Sbjct: 28 LCEVIGKGPFSVVRR-CINRET--GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRR--TDIAFGIARGLL 626
H ++V LL +V+EF+ L + D +S + I L
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 627 YLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
Y H IIH D+KP +LL ++ ++ FG+A L + GT ++
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 684 APEWFRNMPITVKVDVYSFGVLL 706
APE + P VDV+ GV+L
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 42/208 (20%), Positives = 83/208 (39%), Gaps = 40/208 (19%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
E+LG+G FG+V++ + +S + K + D K E++++ H+N++
Sbjct: 9 IAEDLGRGEFGIVHR-CVETSS--KKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTL---------------ASFLFGDLKPGWSRRTDIAFG 620
L + ++++EF+S +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV---------HQ----- 110
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLLLDQSQTHTAIRG 678
+ L +LH S I H DI+P+NI+ ++ +I +FG A+ L +
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFT 165
Query: 679 TKGYVAPEWFRNMPITVKVDVYSFGVLL 706
Y APE ++ ++ D++S G L+
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 38/220 (17%)
Query: 516 FKEELGKGAFGVVYKG---AIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHH 571
+ LG+GA V++G G A+K + V E V+ + +H
Sbjct: 13 LSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 572 KNLVRLLGFCDDGLNRL--LVYEFLSNGTLASFLFGDLKPGWSRR------TDIAFGIAR 623
KN+V+L ++ R L+ EF G+L + L +P + + +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVG 123
Query: 624 GLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
G+ +L E I+H +IKP NI+ D +++DFG A+ L D Q + GT
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GT 178
Query: 680 KGYVAPE--------WFRNMPITVKVDVYSFGVLLLEIIC 711
+ Y+ P+ VD++S GV
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 27/236 (11%)
Query: 485 KKNSQVPSHDGVVETNLHCFTYKDLEAATNGFK------EELGKGAFGVVYKGAIGMASM 538
++ +D E + + +E EELG GAFGVV++ + A+
Sbjct: 18 YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR-CVEKAT- 75
Query: 539 YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGT 598
K +++ K E++++ Q HH L+ L +D +L+ EFLS G
Sbjct: 76 -GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 599 L------ASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652
L + + + R GL ++H I+H DIKP+NI+ +
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQ-----ACEGLKHMH---EHSIVHLDIKPENIMCETKK 186
Query: 653 NAR--ISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
+ I DFGLA L+ + T + APE P+ D+++ GVL
Sbjct: 187 ASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 46/215 (21%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH------SVIQDGVKEFKTEVNVIGQT 569
EELG G F +V K ++ + A K + S +E + EV+++ Q
Sbjct: 16 IGEELGSGQFAIVKK-CREKST--GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRT 615
H N++ L ++ + +L+ E +S G L A+
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ--------- 123
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAKLLLLDQSQ 671
I G+ YLH + +I H D+KP+NI+L + ++ DFGLA + +
Sbjct: 124 -----ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGV 173
Query: 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
I GT +VAPE P+ ++ D++S GV+
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 19/199 (9%)
Query: 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
E LG G FG V+K A+ + +A K + + +E K E++V+ Q H NL
Sbjct: 92 SKTEILGGGRFGQVHK-CEETAT--GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFG---DLKPGWSRR--TDIAFGIARGLLYLH 629
++L + + +LV E++ G LF D + I G+ ++H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW 687
I+H D+KP+NIL + +I DFGLA+ + GT ++APE
Sbjct: 205 ---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR--RYKPREKLKVNFGTPEFLAPEV 259
Query: 688 FRNMPITVKVDVYSFGVLL 706
++ D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 46/215 (21%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQDGVKE-FKTEVNVIGQT 569
EELG G F +V K ++ + A K + + + +E + EV+++ Q
Sbjct: 16 IGEELGSGQFAIVKK-CREKST--GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRT 615
H N++ L ++ + +L+ E +S G L A+
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ--------- 123
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAKLLLLDQSQ 671
I G+ YLH + +I H D+KP+NI+L + ++ DFGLA + +
Sbjct: 124 -----ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGV 173
Query: 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
I GT +VAPE P+ ++ D++S GV+
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 46/215 (21%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQDGVKE-FKTEVNVIGQT 569
EELG G F +V K + A K +L S + +E + EVN++ +
Sbjct: 9 MGEELGSGQFAIVRK-CRQKGT--GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRT 615
H N++ L ++ + +L+ E +S G L A+ +
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL---------KQ 116
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAKLLLLDQSQ 671
I G+ YLH S +I H D+KP+NI+L ++ DFG+A + +
Sbjct: 117 -----ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGN 166
Query: 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
I GT +VAPE P+ ++ D++S GV+
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 65/312 (20%), Positives = 117/312 (37%), Gaps = 52/312 (16%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLV 575
+ L +G F VY+ A + S + A+K+L S ++ + EV + + + H N+V
Sbjct: 33 RRVLAEGGFAFVYE-AQDVGSGREY--ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 576 RLLGFC-------DDGLNRLLVYEFLSNGTLASFLF-----GDLKPGWSRRTDIAFGIAR 623
+ D G L+ L G L FL G L + I + R
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCR 147
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAI------- 676
+ ++H IIH D+K +N+LL + ++ DFG A + + +A
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 677 ----RGTKGYVAPE---WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTD 729
T Y PE + N PI K D+++ G +L +C R++
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL-LCFRQH-------------- 251
Query: 730 WAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789
++ +G +V + F + +Q +P R ++ +V L+ +
Sbjct: 252 -PFE---DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307
Query: 790 EVLDPPCPCPFT 801
+ P T
Sbjct: 308 AARNVNPKSPIT 319
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 44/210 (20%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
KE++G G++ V + I A+ + AVK +I ++ E+ ++ + H N+
Sbjct: 26 VKEDIGVGSYSVCKR-CIHKAT--NMEFAVK----IIDKSKRDPTEEIEILLRYGQHPNI 78
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAFG 620
+ L DDG +V E + G L AS + T
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------FT----- 124
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAKLLLLDQSQTHTAI 676
I + + YLH + ++H D+KP NIL + + RI DFG AK L + T
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
T +VAPE D++S GVLL
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 46/215 (21%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK------KLHSVIQDGVKEFKTEVNVIGQT 569
EELG G F VV K ++ + A K S ++ + EV+++ +
Sbjct: 15 TGEELGSGQFAVVKK-CREKST--GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRT 615
H N++ L ++ + +L+ E ++ G L A+ +
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL---------KQ 122
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAKLLLLDQSQ 671
I G+ YLH S QI H D+KP+NI+L +I DFGLA + D
Sbjct: 123 -----ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGN 172
Query: 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
I GT +VAPE P+ ++ D++S GV+
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 18/198 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
++G+G+ G+V A S VAVK + Q + EV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCL-AREKHS--GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 578 LG--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEEC 632
+ L ++ EFL G L + IA + + L YLH
Sbjct: 108 YKSYLVGEEL--WVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLH--- 158
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
+ +IH DIK +ILL ++SDFG + D + + + GT ++APE
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217
Query: 693 ITVKVDVYSFGVLLLEII 710
+VD++S G++++E++
Sbjct: 218 YATEVDIWSLGIMVIEMV 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 37/219 (16%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH-----------------SVIQDGVKEFKTE 562
L +G F + + A+KK I+ +FK E
Sbjct: 39 LNQGKFNKII-----LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 563 VNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTD---- 616
+ +I ++ + G + ++YE++ N ++ F F L ++
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 617 --IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674
I + Y+H E I H D+KP NIL+D ++SDFG ++ + +
Sbjct: 154 KCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKG 209
Query: 675 AIRGTKGYVAPEWFRNMPITV--KVDVYSFGVLLLEIIC 711
+ RGT ++ PE+F N KVD++S G+ L +
Sbjct: 210 S-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/209 (24%), Positives = 76/209 (36%), Gaps = 36/209 (17%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQ- 568
LG G++G V+K G + AVK+ S + EV +
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRL---------YAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 569 THHKNLVRLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGW----SRRTDIAFGIA 622
H VRL + + G L L E +L G ++
Sbjct: 114 GQHPCCVRLEQAWEEGG--ILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTL 167
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
L +LH S ++H D+KP NI L ++ DFGL L + G Y
Sbjct: 168 LALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRY 222
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEIIC 711
+APE + DV+S G+ +LE+ C
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVAC 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
EELG GAFGVV++ A+ A K + + + + + E+ + H LV
Sbjct: 161 IHEELGTGAFGVVHR-VTERAT--GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAF---GIARGLLYLHE 630
L +D +++YEF+S G L F + ++ + + + +GL ++H
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 272
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARI--SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
+H D+KP+NI+ + + DFGL L D Q+ GT + APE
Sbjct: 273 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVA 328
Query: 689 RNMPITVKVDVYSFGVLL 706
P+ D++S GVL
Sbjct: 329 EGKPVGYYTDMWSVGVLS 346
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 49/201 (24%), Positives = 76/201 (37%), Gaps = 23/201 (11%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQV----PVAVKKLHSVIQDG---VKEFKTEVNVIGQTH 570
+G+G G VY+ VA+K + + + E G+
Sbjct: 40 RLVGRGGMGDVYEA-------EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ 92
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYL 628
++V + F + + ++ LA+ L G L P R I I L
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP--PRAVAIVRQIGSALDAA 150
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-AIRGTKGYVAPEW 687
H H D+KP+NIL+ A + DFG+A D+ T GT Y+APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPER 206
Query: 688 FRNMPITVKVDVYSFGVLLLE 708
F T + D+Y+ +L E
Sbjct: 207 FSESHATYRADIYALTCVLYE 227
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 36/241 (14%), Positives = 71/241 (29%), Gaps = 58/241 (24%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH------SVIQDGVKE------------- 558
LG+ + A + V + S +KE
Sbjct: 79 TVLGQEDPYAYLE-ATDQET--GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 559 ---------FKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLLVYEFLSN------GTLAS 601
F +++ K ++R+ D L+R +Y + + L S
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 602 FLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661
R + + R L LH ++H ++P +I+LD ++ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 662 AKLLLLDQSQTHTAIRGTKGYVAPEWF-----------RNMPITVKVDVYSFGVLLLEII 710
+ ++G+ PE R +T D ++ G+++ I
Sbjct: 253 LV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 711 C 711
C
Sbjct: 308 C 308
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 18/198 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E++G+GA G VY A+ +A+ VA+++++ Q + E+ V+ + + N+V
Sbjct: 26 EKIGQGASGTVYT-AMDVAT--GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 578 LG--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEEC 632
L D L +V E+L+ G+L + IA + L +LH
Sbjct: 83 LDSYLVGDEL--WVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
S Q+IH DIK NILL + +++DFG + +QS+ T + GT ++APE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 693 ITVKVDVYSFGVLLLEII 710
KVD++S G++ +E+I
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/221 (23%), Positives = 88/221 (39%), Gaps = 52/221 (23%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK---------KLHSVIQDGVKEFKTEVNVI 566
KE LG+G VV + I + AVK +Q+ + EV+++
Sbjct: 21 PKEILGRGVSSVVRR-CIHKPT--CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 567 GQ-THHKNLVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGW 611
+ + H N+++L + LV++ + G L +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM------- 130
Query: 612 SRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671
R + + LH I+H D+KP+NILLDD N +++DFG + LD +
Sbjct: 131 --RA-----LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGE 178
Query: 672 THTAIRGTKGYVAPEWFRNMPITV------KVDVYSFGVLL 706
+ GT Y+APE +VD++S GV++
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK---KLHSVIQDGVKEFKTEVNVIGQTHHK 572
+ LGKG+FG V + AVK K + + EV ++ Q H
Sbjct: 30 GQRVLGKGSFGEVIL-CKDKIT--GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDL--KPGWSRRT--DIAFGIARGLLYL 628
N+++L F +D LV E + G LF ++ + +S I + G+ Y+
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 629 HEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
H +I+H D+KP+N+LL N RI DFGL+ + S+ GT Y+AP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST--HFEASKKMKDKIGTAYYIAP 197
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIIC 711
E K DV+S GV+L ++
Sbjct: 198 EVLHG-TYDEKCDVWSTGVILYILLS 222
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV-KEFKTEVNVIGQTHHKNLVR 576
ELG G GVV+K S + +A K +H I+ + + E+ V+ + + +V
Sbjct: 39 SELGAGNGGVVFK-VSHKPS--GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 577 LLG-FCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
G F DG + E + G+L L G + + ++ + +GL YL E+
Sbjct: 96 FYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREKH- 151
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+I+H D+KP NIL++ ++ DFG++ L S ++ + GT+ Y++PE +
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 694 TVKVDVYSFGVLLLEI 709
+V+ D++S G+ L+E+
Sbjct: 208 SVQSDIWSMGLSLVEM 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 41/210 (19%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
KEELGKGAF VV + + + + A K ++ + ++ + E + + H N
Sbjct: 10 VKEELGKGAFSVVRR-CVHKTT--GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAF 619
+VRL + LV++ ++ G L AS +
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI---------QQ---- 113
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA---RISDFGLAKLLLLDQSQTHTAI 676
I + Y H S I+H ++KP+N+LL +++DFGLA + + S+
Sbjct: 114 -ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 167
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
GT GY++PE + P + VD+++ GV+L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQTHHKN 573
++LG GA+G V + V A+K + SV + EV V+ H N
Sbjct: 41 RVKKLGSGAYGEVLL-CRDKVT--HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDL--KPGWSRRT--DIAFGIARGLLYLH 629
+++L F +D N LV E G L F ++ + ++ I + G+ YLH
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 630 EECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
I+H D+KP+N+LL + +I DFGL+ + + + GT Y+APE
Sbjct: 154 ---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA--VFENQKKMKERLGTAYYIAPE 208
Query: 687 WFRNMPITVKVDVYSFGVLLLEIIC 711
R K DV+S GV+L ++
Sbjct: 209 VLRK-KYDEKCDVWSIGVILFILLA 232
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 40/208 (19%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
F E LG GAF V+ + A+K + + E+ V+ + H+N+V
Sbjct: 13 FMEVLGSGAFSEVFL-VKQRLT--GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAFGI 621
L + + LV + +S G L AS + + +
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI---------QQ-----V 115
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
+ YLH I+H D+KP+N+L ++ I+DFGL+K+ TA G
Sbjct: 116 LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-G 169
Query: 679 TKGYVAPEWFRNMPITVKVDVYSFGVLL 706
T GYVAPE P + VD +S GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 42/210 (20%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
LGKG+FG V K + Q AVK ++ S EV ++ + H N
Sbjct: 26 IVCMLGKGSFGEVLK-CKDRIT--QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAF 619
+++L +D + +V E + G L A+ + +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII---------KQ---- 129
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAI 676
+ G+ Y+H+ I+H D+KP+NILL + + +I DFGL+ Q+
Sbjct: 130 -VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDR 183
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
GT Y+APE R K DV+S GV+L
Sbjct: 184 IGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 41/200 (20%), Positives = 70/200 (35%), Gaps = 35/200 (17%)
Query: 592 EFLSNGTLASFL---FGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648
+ L ++ I IA + +LH + ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFF 197
Query: 649 DDYYNARISDFGLAKLL-----------LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKV 697
++ DFGL + + THT GTK Y++PE + KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 698 DVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKL 757
D++S G++L E + + ME ++TD +F + +
Sbjct: 258 DIFSLGLILFE-LLYSFSTQMERVR---IITD-----VRNL------KFPLLFTQKYPQE 302
Query: 758 ARFVMVAIWCIQEDPSLRPT 777
V + P+ RP
Sbjct: 303 HMMVQ---DMLSPSPTERPE 319
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQV-------PVAVKKLHSVIQDG---VKEFKTEVNVIG 567
E LG G GM+ ++ VAVK L + + F+ E
Sbjct: 18 EILGFG----------GMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 568 QTHHKNLVRLL--GFCDDGLNRL--LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR 623
+H +V + G + L +V E++ TL + + R ++ +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ-THT-AIRGTKG 681
L + H+ IIH D+KP NI++ ++ DFG+A+ + + T T A+ GT
Sbjct: 128 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 682 YVAPEWFRNMPITVKVDVYSFGVLLLEII 710
Y++PE R + + DVYS G +L E++
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 26/234 (11%), Positives = 52/234 (22%), Gaps = 49/234 (20%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFKTEVNVIGQTHHK 572
E L G VV+ + A+K + ++ + +
Sbjct: 66 LVEPLRVGDRSVVFL-VRDVER--LEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 573 NLVRLLGFC--------------------------DDGLNRLLVYEFLSNGTLASF--LF 604
+ N LL+ S L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL 181
Query: 605 GDLKPGWSRRTDIAFG-----IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659
+ +A + R L S ++H P N+ + + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWF--RNMPITVKVDVYSFGVLLLEIIC 711
+ A Y E+ T ++ + G+ + + C
Sbjct: 239 SALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK--KLHSVIQDGVKEFKTEVNVIGQTHHKN 573
LGKG+FG V K + Q AVK S EV ++ + H N
Sbjct: 26 IVCMLGKGSFGEVLK-CKDRIT--QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT-------DIAFGIARGLL 626
+++L +D + +V E + G L F ++ R+ I + G+
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGEL----FDEII---KRKRFSEHDAARIIKQVFSGIT 135
Query: 627 YLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
Y+H I+H D+KP+NILL + + +I DFGL+ Q+ GT Y+
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYI 190
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEIIC 711
APE R K DV+S GV+L ++
Sbjct: 191 APEVLRG-TYDEKCDVWSAGVILYILLS 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-26
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 40/210 (19%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL--HSVIQDGVKEFKTEVNVIGQTHHKN 573
EELGKGAF VV + + + + A + + ++ + E + H N
Sbjct: 15 LFEELGKGAFSVVRR-CVKVLA--GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAF 619
+VRL + + L+++ ++ G L AS +
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI---------QQ---- 118
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAI 676
I +L+ H ++H ++KP+N+LL +++DFGLA + +Q
Sbjct: 119 -ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
GT GY++PE R P VD+++ GV+L
Sbjct: 175 -GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
KEELGKGAF VV + + + + A K ++ + ++ + E + + H N
Sbjct: 33 VKEELGKGAFSVVRR-CVHKTT--GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDL--KPGWSRR--TDIAFGIARGLLYLH 629
+VRL + LV++ ++ G L F D+ + +S + I + Y H
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 630 EECSTQIIHCDIKPQNILLDDYYNA---RISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
S I+H ++KP+N+LL +++DFGLA + + S+ GT GY++PE
Sbjct: 146 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLSPE 200
Query: 687 WFRNMPITVKVDVYSFGVLL 706
+ P + VD+++ GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 45/208 (21%), Positives = 81/208 (38%), Gaps = 40/208 (19%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+ +G+G++G V A+ + ++ A KK+ + V FK E+ ++ H N++
Sbjct: 13 LENTIGRGSWGEVKI-AVQKGT--RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAFGI 621
RL +D + LV E + G L A+ + + +
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM---------KD-----V 115
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
+ Y H + H D+KP+N L ++ DFGLA + G
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKVG 170
Query: 679 TKGYVAPEWFRNMPITVKVDVYSFGVLL 706
T YV+P+ + D +S GV++
Sbjct: 171 TPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 51/220 (23%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHS---VIQDGVKEFKTEVNVIG 567
K+ +G+G VV + + A+ AVK +++ + + E +++
Sbjct: 98 PKDVIGRGVSSVVRR-CVHRAT--GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 568 Q-THHKNLVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWS 612
Q H +++ L+ + LV++ + G L +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-------- 206
Query: 613 RRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672
R+ + + +LH + I+H D+KP+NILLDD R+SDFG + L+ +
Sbjct: 207 -RS-----LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC--HLEPGEK 255
Query: 673 HTAIRGTKGYVAPEWFRNMPITV------KVDVYSFGVLL 706
+ GT GY+APE + +VD+++ GV+L
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNL 574
FK +LG GAFG V+ +S + +K ++ Q +++ + E+ V+ H N+
Sbjct: 26 FKRKLGSGAFGDVHL-VEERSS--GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRR--------TDIAFGIARGLL 626
+++ +D N +V E G L + +R ++ + L
Sbjct: 83 IKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 627 YLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
Y H + ++H D+KP+NIL + +I DFGLA+ L + T GT Y+
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE--LFKSDEHSTNAAGTALYM 193
Query: 684 APEWFRNMPITVKVDVYSFGVLL 706
APE F+ +T K D++S GV++
Sbjct: 194 APEVFKR-DVTFKCDIWSAGVVM 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 60/248 (24%), Positives = 90/248 (36%), Gaps = 58/248 (23%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQDGVKEFKTEVNVIGQTH 570
K +G+G++GVV AI + + A+K K+ + V+ KTEV ++ + H
Sbjct: 30 LKGAIGQGSYGVVRV-AIENQT--RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTL------------------------------A 600
H N+ RL +D LV E G L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 601 SFLFGDLKPGWSRRTDIAFG----------IARGLLYLHEECSTQIIHCDIKPQNILL-- 648
G+ D I L YLH + I H DIKP+N L
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFST 203
Query: 649 DDYYNARISDFGLAKLLLLDQSQTHTAIR---GTKGYVAPEWFRNM--PITVKVDVYSFG 703
+ + ++ DFGL+K + + + GT +VAPE K D +S G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 704 VLLLEIIC 711
VLL ++
Sbjct: 264 VLLHLLLM 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVR 576
E++GKG+FG V+K I + Q VA+K + +D +++ + E+ V+ Q + +
Sbjct: 28 EKIGKGSFGEVFK-GIDNRT--QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEECS 633
G ++ E+L G+ L +PG T IA I +GL YLH S
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 137
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+ IH DIK N+LL ++ +++DFG+A L Q + +T + GT ++APE +
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 196
Query: 694 TVKVDVYSFGVLLLEII 710
K D++S G+ +E+
Sbjct: 197 DSKADIWSLGITAIELA 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 32/209 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQV-----PVAVKKLHSVI-QDGVKEFKTEVNVIGQTHH 571
+ G G +Y PV +K L + E + + H
Sbjct: 86 GCIAHGGLGWIYLA-------LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 572 KNLVRLLGFCDDGLNRL-----LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLL 626
++V++ F + +V E++ +L L + I L
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA--IAYLLEILPALS 196
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-AIRGTKGYVAP 685
YLH +++ D+KP+NI+L + ++ D G + + GT G+ AP
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTE-EQLKLIDLGAVSRI------NSFGYLYGTPGFQAP 246
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRR 714
E R P TV D+Y+ G L +
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 49/291 (16%), Positives = 97/291 (33%), Gaps = 65/291 (22%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKK--LHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
E++G G FG V+K + + A+K+ + EV H ++
Sbjct: 17 EKIGSGEFGSVFKC---VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 575 VRLLG-FCDDGLNRLLVY-EFLSNGTLASFLFGDLKPGW----SRRTDIAFGIARGLLYL 628
VR + +D + +L+ E+ + G+LA + + + + D+ + RGL Y+
Sbjct: 74 VRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 629 HEECSTQIIHCDIKPQNILLD-------------------DYYNARISDFGLAKLLLLDQ 669
H ++H DIKP NI + + +I D G + Q
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 670 SQTHTAIRGTKGYVAPE-WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT 728
+ G ++A E N K D+++ + ++
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE--------PLPRNGD 235
Query: 729 DWAYDCYCEGITEALVEFDIEALNDK--KKLARFVMVAIWCIQEDPSLRPT 777
W + + + + ++ + I DP RP+
Sbjct: 236 QWH----------EIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS 273
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 23/199 (11%)
Query: 516 FKEELGKGAFGVVYKGA-IGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
+ ELG+GA +VY+ G Y + V K K +TE+ V+ + H N+
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNI 110
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDL--KPGWSRR--TDIAFGIARGLLYLHE 630
++L + LV E ++ G L F + K +S R D I + YLH
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLH- 165
Query: 631 ECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW 687
I+H D+KP+N+L +I+DFGL+K++ + + GT GY APE
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPEI 221
Query: 688 FRNMPITVKVDVYSFGVLL 706
R +VD++S G++
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 7e-25
Identities = 33/238 (13%), Positives = 65/238 (27%), Gaps = 53/238 (22%)
Query: 518 EELGKGAFGVVYKG---AIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEV-------- 563
LG+ + G V + + + +K+ K EV
Sbjct: 84 TVLGQEDPYAYLEATDQETG------ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 564 -----------------NVIGQTHHKNLVRLLGFCDDG--LNRLLVYEFL--SNGTLASF 602
+++ K ++R+ D L+R +Y + + T
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 603 LFGDLK----PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658
L R + + R L LH ++H ++P +I+LD ++
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254
Query: 659 FGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP-----ITVKVDVYSFGVLLLEIIC 711
F A +T D ++ G+ + I C
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 44/209 (21%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQ-THHKNL 574
+ LG+G+F + K + S AVK +I ++ + E+ + H N+
Sbjct: 16 DKPLGEGSFSICRK-CVHKKS--NQAFAVK----IISKRMEANTQKEITALKLCEGHPNI 68
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAFG 620
V+L D L+ LV E L+ G L AS++ R
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM---------RK----- 114
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIR 677
+ + ++H ++H D+KP+N+L +D +I DFG A+L D T
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
T Y APE D++S GV+L
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 58/264 (21%), Positives = 100/264 (37%), Gaps = 66/264 (25%)
Query: 486 KNSQVPSHDG----VVETNLHCFTYKDLEAATNG-----------FKEELGKGAFGVVYK 530
K + P ++ + + F + DL + LG GA G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 531 GAIGMASMYQVPVAVKKLH--------SVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD 582
A + VA++ + + D +TE+ ++ + +H ++++ F D
Sbjct: 154 -AFERKT--CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210
Query: 583 DGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAFGIARGLLYL 628
+ +V E + G L F + + YL
Sbjct: 211 AE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------------MLLAVQYL 255
Query: 629 HEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
HE IIH D+KP+N+LL ++ +I+DFG +K +L + S T GT Y+AP
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-GTPTYLAP 310
Query: 686 EWFRNM---PITVKVDVYSFGVLL 706
E ++ VD +S GV+L
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL-------------HSVIQDGVKEFKTE 562
+LG GA+G V A+K + + I+ +E E
Sbjct: 40 KVRKLGSGAYGEVLL-CKEKNG--HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 563 VNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT------- 615
++++ H N+++L +D LV EF G L F + +R
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQII---NRHKFDECDAA 149
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQT 672
+I I G+ YLH I+H DIKP+NILL + N +I DFGL+ +
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS--FFSKDYK 204
Query: 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC 711
GT Y+APE + K DV+S GV++ ++C
Sbjct: 205 LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVP----VAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HH 571
E+G+GA+G V K M P +AVK++ S + K+ +++V+ ++
Sbjct: 28 GEIGRGAYGSVNK-------MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 572 KNLVRLLG-FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD------IAFGIARG 624
+V+ G +G + + E + + + F + I +
Sbjct: 81 PYIVQFYGALFREG-DCWICMELM-STSFDKFY-KYVYSVLDDVIPEEILGKITLATVKA 137
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVA 684
L +L E +IIH DIKP NILLD N ++ DFG++ L+ ++T A G + Y+A
Sbjct: 138 LNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMA 193
Query: 685 PE----WFRNMPITVKVDVYSFGVLLLEI 709
PE V+ DV+S G+ L E+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 18/198 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E+LG+G++G VYK + VA+K++ ++ ++E E++++ Q ++V+
Sbjct: 35 EKLGEGSYGSVYKA---IHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 578 LG--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEEC 632
G F + L +V E+ G+++ + L+ +IA +GL YLH
Sbjct: 90 YGSYFKNTDL--WIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLH--- 142
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
+ IH DIK NILL+ +A+++DFG+A L ++ +T I GT ++APE + +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 693 ITVKVDVYSFGVLLLEII 710
D++S G+ +E+
Sbjct: 202 YNCVADIWSLGITAIEMA 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
ELG GAFG VYK A + A K + + ++ ++++ E+ ++ H +V+L
Sbjct: 25 GELGDGAFGKVYK-AKNKET--GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 578 LG--FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARGLLYLHEEC 632
LG + D L ++ EF G + + + I + L +LH +
Sbjct: 82 LGAYYHDGKL--WIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-----W 687
+IIH D+K N+L+ + R++DFG++ L + + I GT ++APE
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCET 193
Query: 688 FRNMPITVKVDVYSFGVLLLEII 710
++ P K D++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 44/215 (20%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVP----VAVKKLHSVIQDGV-KEFKTEVNVIGQT-HH 571
ELG+GA+GVV K M VP +AVK++ + + K ++++ +T
Sbjct: 13 MELGRGAYGVVEK-------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 572 KNLVRLLG-------------FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIA 618
V G D L++ T+ + G IA
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK----------IA 115
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
I + L +LH + +IH D+KP N+L++ ++ DFG++ L+D G
Sbjct: 116 VSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-G 171
Query: 679 TKGYVAPE----WFRNMPITVKVDVYSFGVLLLEI 709
K Y+APE +VK D++S G+ ++E+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 51/219 (23%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--------SVIQDGVKEFKTEVNVIG 567
+ LG GA G V A + VA+K + + D +TE+ ++
Sbjct: 14 MSKTLGSGACGEVKL-AFERKT--CKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSR 613
+ +H ++++ F D + +V E + G L F
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYF--------- 120
Query: 614 RTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQS 670
+ + YLH IIH D+KP+N+LL ++ +I+DFG +K +L + S
Sbjct: 121 YQ-----MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETS 171
Query: 671 QTHTAIRGTKGYVAPE---WFRNMPITVKVDVYSFGVLL 706
T GT Y+APE VD +S GV+L
Sbjct: 172 LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVR 576
E +G G +G VYK + + A+K + V D +E K E+N++ + HH+N+
Sbjct: 30 ELVGNGTYGQVYK-GRHVKT--GQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 577 LLG-----FCDDGLNRL-LVYEFLSNGTLASFLFGDL-KPGWSRRTD---IAF---GIAR 623
G ++L LV EF G++ DL K IA+ I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-----DLIKNTKGNTLKEEWIAYICREILR 140
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
GL +LH+ ++IH DIK QN+LL + ++ DFG++ L + +T I GT ++
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 196
Query: 684 APE-----WFRNMPITVKVDVYSFGVLLLEII 710
APE + K D++S G+ +E+
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 42/213 (19%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQTHHK 572
LG+G FG V+ K +Y A KKL + G + E ++ + H +
Sbjct: 193 LGRGGFGEVFACQMKAT---GKLY----ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 573 NLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLK---PGWSRRTDIAFGIAR----- 623
+V L + + L LV + NG GD++ F R
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIM-NG-------GDIRYHIYNVDEDNPG-FQEPRAIFYT 295
Query: 624 -----GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
GL +LH+ II+ D+KP+N+LLDD N RISD GLA L Q++T G
Sbjct: 296 AQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-G 351
Query: 679 TKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC 711
T G++APE VD ++ GV L E+I
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLV 575
K+ LG G G V + + A+K ++ D + + EV+ Q + ++V
Sbjct: 34 KQVLGLGVNGKVLE-CFHRRT--GQKCALK----LLYD-SPKARQEVDHHWQASGGPHIV 85
Query: 576 RLLGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGWSRR--TDIAFGIARGLLYLH 629
+L ++ + L++ E + G L S + ++ R +I I + +LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 630 EECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
S I H D+KP+N+L + +++DFG AK Q+ T T YVAPE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPC-YTPYYVAPE 199
Query: 687 WFRNMPITVKVDVYSFGVLL 706
D++S GV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVR 576
E +G GA VV + + VA+K+++ Q + E E+ + Q HH N+V
Sbjct: 21 EVIGSGATAVVQAA---YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 577 LLG-FCDDGLNRL-LVYEFLSNGTLA-----SFLFGDLKPGWSRRTDIAF---GIARGLL 626
F + L LV + LS G++ G+ K G + IA + GL
Sbjct: 78 YYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIR----GTKGY 682
YLH+ IH D+K NILL + + +I+DFG++ L T +R GT +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 683 VAPEWF-RNMPITVKVDVYSFGVLLLEII 710
+APE + K D++SFG+ +E+
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 67/210 (31%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQTHHK 572
LGKG FG V + MY A KKL + G E ++ + + +
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMY----ACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 573 NLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR-------- 623
+V L + + + L LV + NG GDLK F AR
Sbjct: 245 FVVSL-AYAYETKDALCLVLTLM-NG-------GDLKFHIYHMGQAGFPEARAVFYAAEI 295
Query: 624 --GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKG 681
GL LH E +I++ D+KP+NILLDD+ + RISD GLA + Q+ + GT G
Sbjct: 296 CCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVG 350
Query: 682 YVAPEWFRNMPITVKVDVYSFGVLLLEIIC 711
Y+APE +N T D ++ G LL E+I
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 4e-22
Identities = 52/313 (16%), Positives = 92/313 (29%), Gaps = 69/313 (22%)
Query: 518 EELGKGA--FGVVYKGAIGMASMYQVP----VAVKK--LHSVIQDGVKEFKTEVNVIGQT 569
+GKG V P V V++ L + + V + E++V
Sbjct: 31 TVIGKGFEDLMTVNLA-------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 570 HHKNLVRLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAF---GIARG 624
+H N+V F D N L +V F++ G+ L IA+ G+ +
Sbjct: 84 NHPNIVPYRATFIAD--NELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKA 140
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV- 683
L Y+H +H +K +IL+ +S ++ + K V
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 684 -----APEWFRNMPI--TVKVDVYSFGVLLLEII-------------------------- 710
+PE + K D+YS G+ E+
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 711 --CCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLAR----FVMVA 764
+ + + T D + + + FV
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ- 316
Query: 765 IWCIQEDPSLRPT 777
C+Q +P RP+
Sbjct: 317 --CLQRNPDARPS 327
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 49/219 (22%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLV 575
++ LG+GA V I + + AVK + EV ++ Q H+N++
Sbjct: 18 EDVLGEGAHARVQT-CINLIT--SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTL--------------ASFLFGDLKPGWSRRTDIAFGI 621
L+ F ++ LV+E + G++ AS + D +
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD--------------V 120
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIR- 677
A L +LH + I H D+KP+NIL + +I DF L + L+ + +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 678 -----GTKGYVAPEWFRNMPITVK-----VDVYSFGVLL 706
G+ Y+APE D++S GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-22
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 39/209 (18%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+ LG G G V + + Q A+K ++QD + + EV + + + ++
Sbjct: 66 TSQVLGLGINGKVLQ-IFNKRT--QEKFALK----MLQD-CPKARREVELHWRASQCPHI 117
Query: 575 VRLLGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG---------- 620
VR++ ++ L+V E L G L F + R D AF
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRI----QDRGDQAFTEREASEIMKS 169
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIR 677
I + YLH S I H D+KP+N+L +++DFG AK + T
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 224
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLL 706
T YVAPE D++S GV++
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTH-HKNLV 575
E+G G G V+K +AVK++ S ++ K +++V+ ++H +V
Sbjct: 31 GEMGSGTCGQVWKM---RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 576 RLLG-FCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD------IAFGIARGLLYL 628
+ G F + + + E + LK + I + L YL
Sbjct: 88 QCFGTFITNT-DVFIAMELMGTCAE------KLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-- 686
E+ +IH D+KP NILLD+ ++ DFG++ L+ D+++ +A G Y+APE
Sbjct: 141 KEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERI 196
Query: 687 ---WFRNMPITVKVDVYSFGVLLLEI 709
++ DV+S G+ L+E+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 31/206 (15%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQTHHKNL 574
E+G G+FG VY A + + VA+KK+ + ++ EV + + H N
Sbjct: 60 REIGHGSFGAVYF-ARDVRN--SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 575 VRLLG--FCDDGLNRLLVYEFLSNG--TLASFLFGDLKPGWSRRTDIAF---GIARGLLY 627
++ G + LV E+ L L+ IA G +GL Y
Sbjct: 117 IQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAY 169
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE- 686
LH S +IH D+K NILL + ++ DFG A ++ + ++ + GT ++APE
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEV 221
Query: 687 --WFRNMPITVKVDVYSFGVLLLEII 710
KVDV+S G+ +E+
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELA 247
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKL--HSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+ +GKG F V K A + + VA+K + + +++ EV ++ +H N+V
Sbjct: 21 KTIGKGNFAKV-KLARHILT--GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFG-IARGLLYLHEEC 632
+L + L+ E+ S G + +L G +K +R F I + Y H++
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK---FRQIVSAVQYCHQKR 134
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
I+H D+K +N+LLD N +I+DFG + + + G Y APE F+
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQGKK 189
Query: 693 IT-VKVDVYSFGVLLLEIIC 711
+VDV+S GV+L ++
Sbjct: 190 YDGPEVDVWSLGVILYTLVS 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKL------HSVIQDGVKEFKTEVNVIGQTHH 571
LG G FG VY G+ +PVA+K + EV ++ +
Sbjct: 49 PLLGSGGFGSVY---SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 572 K--NLVRLLGFCDDGLNRLLVYEFLSN-GTLASFLF--GDLKPGWSRRTDIAFG-IARGL 625
++RLL + + + +L+ E L F+ G L+ +R F + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF---FWQVLEAV 162
Query: 626 LYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVA 684
+ H + ++H DIK +NIL+D + ++ DFG LL + GT+ Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTDFD-GTRVYSP 216
Query: 685 PEWFRNMPIT-VKVDVYSFGVLLLEIIC 711
PEW R V+S G+LL +++C
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQD-GVKEFKTEVN----VIG 567
LGKG FG V+ G ++ VA+K ++ EV V
Sbjct: 37 PLLGKGGFGTVF---AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGT-LASFLF--GDLKPGWSRRTDIAFG-IAR 623
H ++RLL + + +LV E L ++ G L G SR FG +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF---FGQVVA 150
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
+ + H S ++H DIK +NIL+D A++ DFG LL GT+ Y
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFD-GTRVY 204
Query: 683 VAPEWFRNMPIT-VKVDVYSFGVLLLEIIC 711
PEW + V+S G+LL +++C
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVK--------KLHSVIQDGVKEFKTEVNVIGQT 569
LG GAFG V+ + V VK + + + + E+ ++ +
Sbjct: 30 SPLGSGAFGFVW---TAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF------GDLKPGWSRRTDIAFG-IA 622
H N++++L ++ LV E +G LF L + F +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYI---FRQLV 140
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
+ YL IIH DIK +NI++ + + ++ DFG A L + +T GT Y
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTIEY 195
Query: 683 VAPEWFRNMP-ITVKVDVYSFGVLLLEIIC 711
APE P +++++S GV L ++
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 51/221 (23%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT-EVNVIGQTHHKNLVR 576
+ +G G+FGVVY+ A S VA+KK V+QD K FK E+ ++ + H N+VR
Sbjct: 60 KVIGNGSFGVVYQ-AKLCDS--GELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVR 111
Query: 577 LLGF--------CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI--------AFG 620
L F + LN LV +++ T+ + + + +
Sbjct: 112 LRYFFYSSGEKKDEVYLN--LVLDYVPE-TVYRVA----RHYSRAKQTLPVIYVKLYMYQ 164
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGT 679
+ R L Y+H S I H DIKPQN+LLD D ++ DFG AK L+ +
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS------ 215
Query: 680 KGYV------APEW-FRNMPITVKVDVYSFGVLLLEIICCR 713
Y+ APE F T +DV+S G +L E++ +
Sbjct: 216 --YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
F + LG+G+F V + + Y + + ++K H + ++ V E +V+ + H
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKI-LEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG------IARGLLYL 628
V+L D + NG L ++ D I L YL
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL----LKYIRK--IGSFDETCTRFYTAEIVSALEYL 146
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA-IRGTKGYVAPEW 687
H IIH D+KP+NILL++ + +I+DFG AK+L + Q GT YV+PE
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 688 FRNMPITVKVDVYSFGVLLLEIIC 711
D+++ G ++ +++
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVA 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LG+GA+G V + + + + VAVK + D + K E+ + +H+N+V+
Sbjct: 15 LGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFG-IARGLLYLHEECSTQ 635
G +G + L E+ S G L + + ++R F + G++YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF---FHQLMAGVVYLH---GIG 125
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT--HTAIRGTKGYVAPEWFRNMPI 693
I H DIKP+N+LLD+ N +ISDFGLA + + + + GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 694 T-VKVDVYSFGVLLLEIIC 711
VDV+S G++L ++
Sbjct: 185 HAEPVDVWSCGIVLTAMLA 203
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 520 LGKGAFGVVYKG-AIGMASMYQVPVAVKKL--HSVIQ-DGVKEFKTEVNV---IGQTHHK 572
+G+G FG VY MY A+K L + G E + +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMY----AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 573 NLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+V + + ++L + + ++ G L L + A I GL ++H
Sbjct: 253 FIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-WFRN 690
+++ D+KP NILLD++ + RISD GLA + + H ++ GT GY+APE +
Sbjct: 312 ---FVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASV-GTHGYMAPEVLQKG 365
Query: 691 MPITVKVDVYSFGVLLLEIIC 711
+ D +S G +L +++
Sbjct: 366 VAYDSSADWFSLGCMLFKLLR 386
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT----EVNVIGQTHHKN 573
G+G FG V ++ + VA+KK VIQD F+ + + HH N
Sbjct: 29 RMAGQGTFGTVQL-GKEKST--GMSVAIKK---VIQD--PRFRNRELQIMQDLAVLHHPN 80
Query: 574 LVRLL---------GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI------- 617
+V+L D LN +V E++ + TL + + R+
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLN--VVMEYVPD-TLHRC----CRNYYRRQVAPPPILIKV 133
Query: 618 -AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA-RISDFGLAKLLLLDQSQTHTA 675
F + R + LH S + H DIKP N+L+++ ++ DFG AK L +
Sbjct: 134 FLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-- 190
Query: 676 IRGTKGYVAPEWFRNMPI-------TVKVDVYSFGVLLLEII 710
Y+ ++R + T VD++S G + E++
Sbjct: 191 ------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 520 LGKGAFG----VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
LGKG FG V K Y + + +KK V +D V TE V+ + H L
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 576 RLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L + +RL V E+ + G L L + R I L YLH E +
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN- 269
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+++ D+K +N++LD + +I+DFGL K + D + T GT Y+APE +
Sbjct: 270 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 327
Query: 695 VKVDVYSFGVLLLEIICCR 713
VD + GV++ E++C R
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 517 KEELGKGAFGVVY-----------------KGAIGMASMYQVPVAVKKLHSVIQDGVKEF 559
K+E+GKG++GVV K + + + + ++
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 560 ------KTEVNVIGQTHHKNLVRLLGFCDDGLNRLL--VYEFLSNGTLASFLF-GDLKPG 610
E+ ++ + H N+V+L+ DD L V+E ++ G + L
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 611 WSRR--TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
+R D+ GI YLH +IIH DIKP N+L+ + + +I+DFG++
Sbjct: 138 QARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 669 QSQTHTAIRGTKGYVAPEWFRNMPITV---KVDVYSFGVLLLEIIC 711
+ + GT ++APE +DV++ GV L +
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 48/219 (21%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT-EVNVIGQTHHKNLVR 576
+ +G G+FGVV++ A + S VA+KK V+QD K FK E+ ++ H N+V
Sbjct: 46 KVIGNGSFGVVFQ-AKLVESD---EVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVD 96
Query: 577 LLGF-----CDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDI--------AFGIA 622
L F L LV E++ T+ + + + + +
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RHYAKLKQTMPMLLIKLYMYQLL 151
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKG 681
R L Y+H S I H DIKPQN+LLD ++ DFG AK+L+ +
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS-------- 200
Query: 682 YV------APEW-FRNMPITVKVDVYSFGVLLLEIICCR 713
Y+ APE F T +D++S G ++ E++ +
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 36/212 (16%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
LG+G++G V + S AVK KL I +G K E+ ++ + HKN+
Sbjct: 13 LGEGSYGKVK---EVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNV 68
Query: 575 VRLLGFCDDGLNR--LLVYEFLSNGTLASFLF-----GDLKPGWSRRTDIAFG-IARGLL 626
++L+ + + +V E+ G + + F + GL
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGY---FCQLIDGLE 123
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL--LLDQSQTHTAIRGTKGYVA 684
YLH S I+H DIKP N+LL +IS G+A+ L T+ +G+ +
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQP 179
Query: 685 PEWFRNM-----PITVKVDVYSFGVLLLEIIC 711
PE + KVD++S GV L I
Sbjct: 180 PEIANGLDTFSGF---KVDIWSAGVTLYNITT 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNLVRLL 578
LG+GA+G V + + + + VAVK + D + K E+ + +H+N+V+
Sbjct: 15 LGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 579 GFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFG-IARGLLYLHEECSTQ 635
G +G + L E+ S G L + + ++R F + G++YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF---FHQLMAGVVYLH---GIG 125
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT--HTAIRGTKGYVAPEWFRNMPI 693
I H DIKP+N+LLD+ N +ISDFGLA + + + + GT YVAPE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 694 T-VKVDVYSFGVLLLEIIC 711
VDV+S G++L ++
Sbjct: 185 HAEPVDVWSCGIVLTAMLA 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 36/212 (16%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+GKG+FG V MY + + K V ++ V+ E+ ++ H LV
Sbjct: 23 IGKGSFGKVCIVQKNDT---KKMYAMKY-MNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 576 RLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR--------GL 625
L F D+ + +V + L G L L + + L
Sbjct: 79 NLWYSFQDEE--DMFMVVDLLLGGDLRYHL--------QQNVHFKEETVKLFICELVMAL 128
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
YL + +IIH D+KP NILLD++ + I+DF +A +L + T + GTK Y+AP
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYMAP 183
Query: 686 EWFRNMPI---TVKVDVYSFGVLLLEIICCRR 714
E F + + VD +S GV E++ RR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 520 LGKGAFG----VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
LGKG FG V K Y + + ++K + +D V TE V+ T H L
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKI-LRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 576 RLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L + +RL V E+ + G L L + R I L YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+++ DIK +N++LD + +I+DFGL K + D + T GT Y+APE +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 183
Query: 695 VKVDVYSFGVLLLEIICCR 713
VD + GV++ E++C R
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 41/214 (19%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+G+GAFG V K A ++ + + + K + + F+ E +V+ K +
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKI-LNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 576 RLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG----------IAR 623
L F DD N L LV ++ G L + L + + +
Sbjct: 138 TLHYAFQDD--NNLYLVMDYYVGGDLLTLL---------SKFEDRLPEEMARFYLAEMVI 186
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGY 682
+ +H +H DIKP NIL+D + R++DFG L+ D + Q+ A+ GT Y
Sbjct: 187 AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242
Query: 683 VAPEWFRNMPITVK-----VDVYSFGVLLLEIIC 711
++PE + M D +S GV + E++
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 18/199 (9%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVK---KLHSVIQDGVKEFKTEVNVIGQTHHKNLVR 576
LG G FG V IG + VAVK + D V + K E+ + H ++++
Sbjct: 19 LGVGTFGKVK---IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFG-IARGLLYLHEECS 633
L + +V E++S G L ++ G ++ +RR F I + Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL---FQQILSAVDYCH---R 129
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
++H D+KP+N+LLD + NA+I+DFGL+ ++ D T+ G+ Y APE
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISGRLY 187
Query: 694 T-VKVDVYSFGVLLLEIIC 711
+VD++S GV+L ++C
Sbjct: 188 AGPEVDIWSCGVILYALLC 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKL--HSVIQDGVKEFKTEVNVIGQTHHKN 573
LG+G+FG V+ +Y A+K L ++ K E +++ + +H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLY----AMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 574 LVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG----------IA 622
+V+L + +L L+ +FL G L F L ++ F +A
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDL----FTRL------SKEVMFTEEDVKFYLAELA 136
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
L +LH S II+ D+KP+NILLD+ + +++DFGL+K + + + ++ GT Y
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEY 192
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
+APE T D +SFGVL+ E++
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
LG G+FG V K + + Y + + + K V ++ E ++ + LV
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKI-LDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIAR---GLLYLHE 630
+L D N +V E+++ G + S L G +R F A+ YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-----FYAAQIVLTFEYLH- 158
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
S +I+ D+KP+N+L+D +++DFG AK + +T T + GT +APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILS 212
Query: 691 MPITVKVDVYSFGVLLLEIIC 711
VD ++ GVL+ E+
Sbjct: 213 KGYNKAVDWWALGVLIYEMAA 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+G+GAFG V K +Y + + + K + + F E +++ + +V
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 576 RLLG-FCDDGLNRL-LVYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIAR---GLLYLH 629
+L F DD L +V E++ G L + + D+ W+R F A L +H
Sbjct: 133 QLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWAR-----FYTAEVVLALDAIH 185
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPEWF 688
S IH D+KP N+LLD + +++DFG + + + TA+ GT Y++PE
Sbjct: 186 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241
Query: 689 RNMPITVK----VDVYSFGVLLLEIIC 711
++ D +S GV L E++
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 2e-17
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 520 LGKGAFGVV----YKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
LGKG+FG V KG +Y V + +KK + D V+ E V+ L
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKI-LKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+L C ++RL V E+++ G L + + A IA GL +L +
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-- 461
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
II+ D+K N++LD + +I+DFG+ K + D T T GT Y+APE P
Sbjct: 462 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPY 519
Query: 694 TVKVDVYSFGVLLLEIICCR 713
VD ++FGVLL E++ +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ 539
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 41/215 (19%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQTHHK 572
+G+GAF V K +Y A+K + + + V F+ E +V+ +
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVY----AMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 573 NLVRLL-GFCDDGLNRL-LVYEFLSNGTLASFL--FGD-LKPGWSRRTDIAFGIAR---G 624
+ +L F D+ N L LV E+ G L + L FG+ + +R F +A
Sbjct: 122 WITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR-----FYLAEIVMA 174
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYV 683
+ +H +H DIKP NILLD + R++DFG L D + ++ A+ GT Y+
Sbjct: 175 IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYL 230
Query: 684 APEWFRNMPITVKVDVY-------SFGVLLLEIIC 711
+PE + + Y + GV E+
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 41/209 (19%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKL--HSVIQDG-VKEFKTEVNVIGQTHHK 572
LG G+FG V+ + A+K L V++ V+ E ++ H
Sbjct: 14 LGTGSFGRVHLIRSRHN-------GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG----------IA 622
++R+ G D ++ +++ G L S L R++ F +
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---------RKSQR-FPNPVAKFYAAEVC 116
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGY 682
L YLH S II+ D+KP+NILLD + +I+DFG AK T+T + GT Y
Sbjct: 117 LALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-LCGTPDY 169
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEIIC 711
+APE P +D +SFG+L+ E++
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 520 LGKGAFG----VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+G+G++ V K +Y + V VKK + + +TE +V Q ++H L
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
V L C +RL V E+++ G L + K + I+ L YLHE
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-- 129
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
II+ D+K N+LLD + +++D+G+ K L T T GT Y+APE R
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDY 187
Query: 694 TVKVDVYSFGVLLLEIICCR 713
VD ++ GVL+ E++ R
Sbjct: 188 GFSVDWWALGVLMFEMMAGR 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-17
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQDGVKEFKTEVNVIGQTHHKNL 574
LG G FG V +G + VAVK K+ S+ D V + + E+ + H ++
Sbjct: 24 LGVGTFGKVK---VGKHELTGHKVAVKILNRQKIRSL--DVVGKIRREIQNLKLFRHPHI 78
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRT--DIAFGIARGLLYLHE 630
++L + +V E++S G L ++ G L SRR I G+ Y H
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH- 133
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
++H D+KP+N+LLD + NA+I+DFGL+ ++ D T+ G+ Y APE
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISG 189
Query: 691 MP-ITVKVDVYSFGVLLLEIIC 711
+VD++S GV+L ++C
Sbjct: 190 RLYAGPEVDIWSSGVILYALLC 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 520 LGKGAFGVV----YKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
LGKG+FG V KG +Y V + +KK + D V+ E V+ L
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKI-LKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+L C ++RL V E+++ G L + + A IA GL +L +
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-- 140
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
II+ D+K N++LD + +I+DFG+ K + D T T GT Y+APE P
Sbjct: 141 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPY 198
Query: 694 TVKVDVYSFGVLLLEIICCR 713
VD ++FGVLL E++ +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 520 LGKGAFG----VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+G+G++ V K +Y + V VKK + + +TE +V Q ++H L
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRV-VKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
V L C +RL V E+++ G L + K + I+ L YLHE
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-- 172
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
II+ D+K N+LLD + +++D+G+ K L T T GT Y+APE R
Sbjct: 173 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDY 230
Query: 694 TVKVDVYSFGVLLLEIICCR 713
VD ++ GVL+ E++ R
Sbjct: 231 GFSVDWWALGVLMFEMMAGR 250
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKL--HSVIQDG--VKEFKTEVNVIGQTHH 571
LGKG +G V+ ++ A+K L ++++ K E N++ + H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIF----AMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 572 KNLVRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR------- 623
+V L+ + +L L+ E+LS G L F L+ + F
Sbjct: 81 PFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLE------REGIFMEDTACFYLAE 129
Query: 624 ---GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
L +LH++ II+ D+KP+NI+L+ + +++DFGL K + D + THT GT
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTI 185
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
Y+APE VD +S G L+ +++
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 46/206 (22%), Positives = 77/206 (37%), Gaps = 54/206 (26%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+ LG G G V + + Q A+K ++QD + + EV + + + ++
Sbjct: 22 TSQVLGLGINGKVLQ-IFNKRT--QEKFALK----MLQD-CPKARREVELHWRASQCPHI 73
Query: 575 VRLLGFCDDGLNR----LLVYEFLSNGTLASFLFGD--LKPGWSRRT-----DIAFGIAR 623
VR++ ++ L+V E L G L F G T +I I
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGEL----F-SRIQDRGDQAFTEREASEIMKSIGE 128
Query: 624 GLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
+ YLH S I H D+KP+N+L +++DFG AK +
Sbjct: 129 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------GE 173
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLL 706
Y D++S GV++
Sbjct: 174 KY-----------DKSCDMWSLGVIM 188
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKL--HSVIQDGVKE-FKTEVNVIGQTHHKNLVR 576
LG+G+FG V + Q VA+K + + + + + E++ + H ++++
Sbjct: 17 LGEGSFGKVK---LATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFG-IARGLLYLHEECS 633
L + ++V E+ + G L ++ + RR F I + Y H
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRF---FQQIICAIEYCH---R 126
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+I+H D+KP+N+LLDD N +I+DFGL+ ++ D + T+ G+ Y APE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYAAPEVINGKLY 184
Query: 694 T-VKVDVYSFGVLLLEIIC 711
+VDV+S G++L ++
Sbjct: 185 AGPEVDVWSCGIVLYVMLV 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 22/198 (11%), Positives = 44/198 (22%), Gaps = 47/198 (23%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQV----PVAVKKLHSVI---QDGVKEFKTEVNVIGQTH 570
G ++ VA+ + D ++E + + +
Sbjct: 37 IFHGGVPPLQFWQA-------LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHE 630
+ R+L L+V E++ G+L P +A H
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP--VGAIRAMQSLAAAADAAHR 147
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
+ P + +S G L +
Sbjct: 148 A---GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA---- 179
Query: 691 MPITVKVDVYSFGVLLLE 708
+ D+ G L
Sbjct: 180 ---NPQDDIRGIGASLYA 194
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 520 LGKGAFGVV----YKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
LGKG+FG V +K + + +KK ++ D V+ E V+ H L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+ L V E+L+ G L + K SR T A I GL +LH +
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-- 137
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
I++ D+K NILLD + +I+DFG+ K +L ++T+T GT Y+APE
Sbjct: 138 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKY 195
Query: 694 TVKVDVYSFGVLLLEIICCR 713
VD +SFGVLL E++ +
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
LGKG+FG V K +Y V V +KK + D V+ TE ++ +H L
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKV-LKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+L C +RL V EF++ G L + + +R A I L++LH++
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK-- 143
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
II+ D+K N+LLD + +++DFG+ K + + T T GT Y+APE + M
Sbjct: 144 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQEMLY 201
Query: 694 TVKVDVYSFGVLLLEIICCR 713
VD ++ GVLL E++C
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 22/202 (10%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKL--HSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
+G G FGV + + + VAVK + + I + V+ E+ H N+VR
Sbjct: 28 IGSGNFGVAR---LMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRF 81
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFG-IARGLLYLHEECST 634
+ ++ E+ S G L + G +R F + G+ Y H S
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF---FQQLLSGVSYCH---SM 135
Query: 635 QIIHCDIKPQNILLDD--YYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
QI H D+K +N LLD +I DFG +K +L SQ + + GT Y+APE
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQE 193
Query: 693 IT-VKVDVYSFGVLLLEIICCR 713
DV+S GV L ++
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGA 215
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 40/219 (18%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT---EVNVI-------- 566
+LG G F V+ A M + VA+K +++ + E+ ++
Sbjct: 25 RKLGWGHFSTVWL-AKDMVN--NTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 567 ---GQTHHKNLVRLLG-FCDDGLNRL---LVYEFLSNGTLASFLFGDLKPGWSRRT--DI 617
++++LL F G N + +V+E L L + + G I
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQI 136
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDD------YYNARISDFGLAKLLLLDQSQ 671
+ + GL Y+H C IIH DIKP+N+L++ +I+D G A +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
+T T+ Y +PE P D++S L+ E+I
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 30/158 (18%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT---EVNVIG 567
++G+G++GVV+K G I VA+KK S +K K E+ ++
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQI---------VAIKKFLESEDDPVIK--KIALREIRMLK 57
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAFGIARG 624
Q H NLV LL LV+E+ + T+ L + + I + +
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKS--ITWQTLQA 114
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662
+ + H IH D+KP+NIL+ + ++ DFG A
Sbjct: 115 VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 41/209 (19%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLVR 576
+LG+G + V++ + V VK L V + K+ K E+ ++ N++
Sbjct: 42 RKLGRGKYSEVFEA---INITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIIT 95
Query: 577 LLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTD-----IAFGIARGLLYLH 629
L D LV+E ++N D K + TD + I + L Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNT--------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 630 EECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
S I+H D+KP N+++D ++ R+ D+GLA+ Q VA +F
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--------RVASRYF 196
Query: 689 R-------NMPITVKVDVYSFGVLLLEII 710
+ +D++S G +L +I
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMI 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 30/158 (18%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT---EVNVIG 567
+G+G++G+V K G I VA+KK S VK K E+ ++
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRI---------VAIKKFLESDDDKMVK--KIAMREIKLLK 79
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAFGIARG 624
Q H+NLV LL C LV+EF+ + T+ L L ++ F I G
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQK--YLFQIING 136
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662
+ + H S IIH DIKP+NIL+ ++ DFG A
Sbjct: 137 IGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 46/243 (18%), Positives = 84/243 (34%), Gaps = 69/243 (28%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT-EVNVIGQTHHKNLVR 576
+ LG G+FG+V + + S A+KK V+QD +K E++++ H N+++
Sbjct: 13 KTLGTGSFGIVCE-VFDIES--GKRFALKK---VLQD--PRYKNRELDIMKVLDHVNIIK 64
Query: 577 LL-GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG--------------- 620
L+ F G + + +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 621 -------------------------IARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNA 654
+ R + ++H S I H DIKPQN+L++
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181
Query: 655 RISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLL 707
++ DFG AK L+ + Y+ ++R T +D++S G +
Sbjct: 182 KLCDFGSAKKLIPSEPSVA--------YICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 708 EII 710
E+I
Sbjct: 234 ELI 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 56/225 (24%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE--FKT---------EVNVI 566
+ G++G V + + PVA+K++ + + DG E+ ++
Sbjct: 28 RFISSGSYGAVCA-GVDSEGI---PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 567 GQTHHKNLVRLLG----FCDDGLNRL-LVYEFLSNGTLASFLFGDL----KPGWSRRTD- 616
HH N++ L F + +++L LV E + T DL +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RT-------DLAQVIHDQRIVISPQ 134
Query: 617 ----IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672
+ I GL LH ++H D+ P NILL D + I DF LA+ D ++T
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 673 HTAIRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLLEII 710
YV W+R T VD++S G ++ E+
Sbjct: 192 --------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLVRL 577
+G GA G+V A + VA+KKL Q+ + E+ ++ +HKN++ L
Sbjct: 33 IGSGAQGIVCA-AYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 578 L-----GFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
L + + +V E + L + +L R + + + + G+ +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDH--ERMSYLLYQMLCGIKHLH-- 144
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR-- 689
S IIH D+KP NI++ +I DFGLA+ T YV ++R
Sbjct: 145 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--------PYVVTRYYRAP 195
Query: 690 ----NMPITVKVDVYSFGVLLLEII 710
M VD++S G ++ E+I
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMI 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+GKG+FG V K Y V V ++K + + K +E NV+ + H L
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKV-LQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 575 VRLLGFCDDGLNRL-LVYEFLSNGTLASFLFGDL-----KPGWSRRTDIAF---GIARGL 625
V L F ++L V +++ NG G+L + F IA L
Sbjct: 102 VGLH-FSFQTADKLYFVLDYI-NG-------GELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
YLH S I++ D+KP+NILLD + ++DFGL K + S T T GT Y+AP
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAP 208
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCR 713
E P VD + G +L E++
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 43/167 (25%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDGVKE-FKT----EVNVI 566
+ LG+G F VYK I VA+KK+ + K+ E+ ++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQI---------VAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 567 GQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA---- 622
+ H N++ LL N LV++F+ DL+ + + +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET---------DLE-VIIKDNSLVLTPSHIKA 116
Query: 623 ------RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
+GL YLH I+H D+KP N+LLD+ +++DFGLAK
Sbjct: 117 YMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
+G GA+G V AI S VA+KKL Q + + E+ ++ H+N++
Sbjct: 30 THVGSGAYGSVCS-AIDKRS--GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 576 RLL-----GFCDDGLNRL-LVYEFLSNGT-LASFLFGDLKPGWSRRTDIAFGIARGLLYL 628
LL LV F+ T L + + + + + +GL Y+
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSE--EKIQYLVYQMLKGLKYI 142
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
H S ++H D+KP N+ +++ +I DFGLA+ D T GYV W+
Sbjct: 143 H---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT--------GYVVTRWY 189
Query: 689 R-------NMPITVKVDVYSFGVLLLEII 710
R M VD++S G ++ E++
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 35/172 (20%), Positives = 67/172 (38%), Gaps = 40/172 (23%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT-EVNVIGQTHHKNLV 575
++G+G +G VYK A A+K++ G+ E+ ++ + H N++
Sbjct: 26 GCKVGRGTYGHVYK-AKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVI 81
Query: 576 RLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLK-------PGWSRRTDIAFGIA---- 622
L F ++ L++++ + DL + + +
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH---------DLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 623 ------RGLLYLHEECSTQIIHCDIKPQNILLDDYYNAR----ISDFGLAKL 664
G+ YLH + ++H D+KP NIL+ R I+D G A+L
Sbjct: 133 LLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 48/215 (22%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEF----KTEVNVI------G 567
+ +GKG+FG V K A VA+K ++++ K F E+ ++
Sbjct: 103 KVIGKGSFGQVVK-AYDHKV--HQHVALK----MVRN-EKRFHRQAAEEIRILEHLRKQD 154
Query: 568 QTHHKNLVRLLGFCDD-----------GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD 616
+ + N++ +L +N +YE + F ++
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRK------- 204
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLLLDQSQTHT 674
A I + L LH+ +IIHCD+KP+NILL + ++ DFG + + Q
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVY 257
Query: 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEI 709
++ Y APE + +D++S G +L E+
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
+ +G GA G+V A VA+KKL Q+ + E+ ++ +HKN++
Sbjct: 68 KPIGSGAQGIVCA-AYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 576 RLL-----GFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
LL + + LV E + + L + +L R + + + + G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDH--ERMSYLLYQMLCGIKHLH 181
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
S IIH D+KP NI++ +I DFGLA+ T YV ++R
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--------PYVVTRYYR 230
Query: 690 ------NMPITVKVDVYSFGVLLLEII 710
M VD++S G ++ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMV 257
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 34/212 (16%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGV-----------KEFKTEVNV 565
E+G+GA+G V+K A + + + VA+K++ ++G+ + +
Sbjct: 17 AEIGEGAYGKVFK-ARDLKNGGRF-VALKRVRVQTGEEGMPLSTIREVAVLRHLE----- 69
Query: 566 IGQTHHKNLVRLL----GFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRT--DIA 618
H N+VRL D +L LV+E + L ++L +PG T D+
Sbjct: 70 --TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
F + RGL +LH S +++H D+KPQNIL+ +++DFGLA++ + T +
Sbjct: 127 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 181
Query: 679 TKGYVAPEWFRNMPITVKVDVYSFGVLLLEII 710
T Y APE VD++S G + E+
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 31/159 (19%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT---EVNVIGQTHHKNL 574
++LG+G + VYKG + VA+K++ ++G T EV+++ H N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNL---VALKEIRLEHEEGAP--CTAIREVSLLKDLKHANI 62
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA----------RG 624
V L + LV+E+L DLK + + RG
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK---------DLK-QYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
L Y H +++H D+KPQN+L+++ +++DFGLA+
Sbjct: 113 LAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 28/159 (17%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDGVKEFKT---EVNVIGQ 568
E+LG G + VYK G VA+K++ ++G T E++++ +
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVY---------VALKEVKLDSEEGTP--STAIREISLMKE 59
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSN---GTLASFLFGDLKPGWSRRT--DIAFGIAR 623
H+N+VRL LV+EF+ N + S G+ G + + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662
GL + H +I+H D+KPQN+L++ ++ DFGLA
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 50/198 (25%), Positives = 77/198 (38%), Gaps = 52/198 (26%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT----EVNV- 565
E+G GA+G VYK G VA+K + G EV +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHF---------VALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 566 --IGQTHHKNLVRLL----GFCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIA 618
+ H N+VRL+ D ++ LV+E + DL+ +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---------DLRTYLDKAPPPG 116
Query: 619 FGIA----------RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
RGL +LH + I+H D+KP+NIL+ +++DFGLA++
Sbjct: 117 LPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 669 QSQTHTAIRGTKGYVAPE 686
+ T + T Y APE
Sbjct: 174 MALTPVVV--TLWYRAPE 189
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT---EVNVIG 567
E++G+G +G V+K I VA+K++ +GV + E+ ++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEI---------VALKRVRLDDDDEGVP--SSALREICLLK 56
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA----- 622
+ HKN+VRL LV+EF DLK + +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ---------DLK-KYFDSCNGDLDPEIVKSF 106
Query: 623 -----RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL-DQSQTHTAI 676
+GL + H S ++H D+KPQN+L++ ++++FGLA+ + + + +
Sbjct: 107 LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 677 RGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRR 714
T Y P+ + + +D++S G + E+ R
Sbjct: 164 --TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 55/246 (22%), Positives = 96/246 (39%), Gaps = 78/246 (31%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV------------KEFKTEV 563
++LGKGA+G+V+K +I + VAVKK+ Q+ E
Sbjct: 13 LVKKLGKGAYGIVWK-SIDRRT--GEVVAVKKIFDAFQNSTDAQRTFREIMILTELS--- 66
Query: 564 NVIGQTHHKNLVRLLG-FCDDGLNRL-LVYEF-------------LSNGTLASFLFGDLK 608
H+N+V LL D + LV+++ L ++
Sbjct: 67 ------GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117
Query: 609 PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
+ + + YLH S ++H D+KP NILL+ + +++DFGL++ +
Sbjct: 118 ------------LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 669 QSQTHTAIRGTK--------------GYVAPEWFR-------NMPITVKVDVYSFGVLLL 707
+ T+ YVA W+R + T +D++S G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 708 EIICCR 713
EI+C +
Sbjct: 223 EILCGK 228
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 27/158 (17%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT---EVNVIG 567
E++G+G +GVVYK G + VA+KK+ +GV T E++++
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEV---------VALKKIRLDTETEGVP--STAIREISLLK 57
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGL 625
+ +H N+V+LL LV+EFL L F+ G F + +GL
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
+ H S +++H D+KPQN+L++ +++DFGLA+
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 34/163 (20%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT---EVNVIG 567
+LG+G +G VYK VA+K++ ++GV T EV+++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNET---------VAIKRIRLEHEEEGVP--GTAIREVSLLK 88
Query: 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGL 625
+ H+N++ L L++E+ N L ++ D P S R + + G+
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGV 145
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNAR-----ISDFGLAK 663
+ H S + +H D+KPQN+LL + I DFGLA+
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 43/165 (26%)
Query: 518 EELGKGAFGVVYK-----GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT---EVNVIGQ 568
E++G+G +GVVYK G I VA+K++ +G+ T E++++ +
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRI---------VALKRIRLDAEDEGIP--STAIREISLLKE 75
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA------ 622
HH N+V L+ LV+EF+ DLK +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK---------DLK-KVLDENKTGLQDSQIKIYL 125
Query: 623 ----RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
RG+ + H +I+H D+KPQN+L++ +++DFGLA+
Sbjct: 126 YQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 47/253 (18%), Positives = 95/253 (37%), Gaps = 64/253 (25%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNL 574
K +G+G++G VY A + + VA+KK++ + +D + + E+ ++ + +
Sbjct: 31 KHLIGRGSYGYVYL-AYDKNT--EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 575 VRLLG-FCDDGLNRL----LVYEFL---------SNGTLASFLFGDLKPGWSRRTD---- 616
+RL D L + +V E + L T+
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFL---------------TEEHIK 132
Query: 617 -IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675
I + + G ++H + IIH D+KP N LL+ + ++ DFGLA+ + ++
Sbjct: 133 TILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 676 IRGTK---------------GYVAPEWFR-------NMPITVKVDVYSFGVLLLEIICCR 713
+V W+R T +D++S G + E++
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 714 RNVDMEVNEAEAL 726
++ + L
Sbjct: 250 QSHINDPTNRFPL 262
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 42/217 (19%)
Query: 520 LGKGAFGVVY----KGAIGMASMYQVPVAVKKLH--SVIQ--DGVKEFKTEVNVIGQT-H 570
LG GA+G V+ +Y A+K L +++Q + +TE V+
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLY----AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 571 HKNLVRLLG-FCDDGLNRL-LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR----- 623
LV L F + +L L+ ++++ G L + L F
Sbjct: 118 SPFLVTLHYAFQTET--KLHLILDYINGGELFTHL----------SQRERFTEHEVQIYV 165
Query: 624 -----GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRG 678
L +LH II+ DIK +NILLD + ++DFGL+K + D+++ G
Sbjct: 166 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 679 TKGYVAPEWFRNMPI--TVKVDVYSFGVLLLEIICCR 713
T Y+AP+ R VD +S GVL+ E++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 61/222 (27%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
+G GA+G V A + + VAVKKL Q + +T E+ ++ H+N++
Sbjct: 35 SPVGSGAYGSVCA-AFDTKT--GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 576 RLL----------GFCD----------DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT 615
LL F D D LN ++ + L++ + ++
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQ---------- 140
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675
I RGL Y+H S IIH D+KP N+ +++ +I DFGLA+ T
Sbjct: 141 -----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMT--- 187
Query: 676 IRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLLEII 710
GYVA W+R M VD++S G ++ E++
Sbjct: 188 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 52/225 (23%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKN 573
K LG+GA+GVV A + VA+KK+ + +T E+ ++ H+N
Sbjct: 15 LKSLLGEGAYGVVCS-ATHKPT--GEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 574 LVRLLG-FCDDGLNRL----LVYEF--------LSNGTLASFLFGDLKPGWSRRTD---- 616
++ + D ++ E +S L +D
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML---------------SDDHIQ 115
Query: 617 -IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675
+ R + LH + +IH D+KP N+L++ + ++ DFGLA+++ +
Sbjct: 116 YFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 676 IRGTK---GYVAPEWFR-------NMPITVKVDVYSFGVLLLEII 710
+VA W+R + + +DV+S G +L E+
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 29/158 (18%)
Query: 518 EELGKGAFGVVYK-----GAIGMASMYQVPVAVKKLH-SVIQDGVKEFKT---EVNVIGQ 568
E++G+G +GVVYK G A+KK+ +G+ T E++++ +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGET---------FALKKIRLEKEDEGIP--STTIREISILKE 56
Query: 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI---AFGIARGL 625
H N+V+L +LV+E L L L D+ G + G+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL--DVCEGGLESVTAKSFLLQLLNGI 113
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
Y H +++H D+KPQN+L++ +I+DFGLA+
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 46/242 (19%), Positives = 94/242 (38%), Gaps = 69/242 (28%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNL 574
+ +G G++G V + A + VA+KK+ V +D + + E+ ++ + +H ++
Sbjct: 58 RHLIGTGSYGHVCE-AYDKLE--KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 575 VRLLGFC----DDGLNRL-LVYEFL---------SNGTLA-----SFLFGDLKPGWSRRT 615
V++L + + L +V E + L + L+
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN---------- 164
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675
+ G+ Y+H S I+H D+KP N L++ + ++ DFGLA+ + ++
Sbjct: 165 -----LLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 676 IRGTK--------------------GYVAPEWFR-------NMPITVKVDVYSFGVLLLE 708
+ G+V W+R T +DV+S G + E
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 709 II 710
++
Sbjct: 277 LL 278
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 42/212 (19%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEF----KTEVNVI------G 567
+GKG+FG V K A Q VA+K +I++ K F + EV ++
Sbjct: 60 SLIGKGSFGQVVK-AYDRVE--QEWVAIK----IIKN-KKAFLNQAQIEVRLLELMNKHD 111
Query: 568 QTHHKNLVRLLGF-------CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIA 618
+V L C LV+E LS L L G S A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFA 163
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA--RISDFGLAKLLLLDQSQTHTAI 676
+ LL+L IIHCD+KP+NILL + + +I DFG + Q
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQY 218
Query: 677 RGTKGYVAPEWFRNMPITVKVDVYSFGVLLLE 708
++ Y +PE MP + +D++S G +L+E
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 61/222 (27%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
+ +G GA+G V A+ + VA+KKL+ Q + + E+ ++ H+N++
Sbjct: 31 QPVGSGAYGAVCS-AVDGRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 576 RLL----------GFCD----------DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT 615
LL F D D L +L+ +E L + ++
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLMKHEKLGEDRIQFLVYQ---------- 136
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675
+ +GL Y+H + IIH D+KP N+ +++ +I DFGLA+ D T
Sbjct: 137 -----MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT--- 183
Query: 676 IRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLLEII 710
GYV W+R M T VD++S G ++ E+I
Sbjct: 184 -----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 54/174 (31%)
Query: 518 EELGKGAFGVVYK------GAIGMASMYQVPVAVKKLHSVIQDGVKE-FKT----EVNVI 566
++G+G FG V+K G VA+KK V+ + KE F E+ ++
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQK---------VALKK---VLMENEKEGFPITALREIKIL 70
Query: 567 GQTHHKNLVRLLGFCDDGLNRL--------LVYEFLSNGTLASFLFGDLKPGWSRRTDIA 618
H+N+V L+ C + LV++F + DL G +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH---------DLA-GLLSNVLVK 120
Query: 619 FGIA----------RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662
F ++ GL Y+H +I+H D+K N+L+ +++DFGLA
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.1 bits (170), Expect = 3e-13
Identities = 42/253 (16%), Positives = 66/253 (26%), Gaps = 28/253 (11%)
Query: 21 TFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLF--LLSIWYAKIPQKT 78
+ +LSA Q LSPN F D N + ++W A Q
Sbjct: 9 FNGVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQG-DGNLVIQDNGATVWVANEQQPF 64
Query: 79 IVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPIIGT------VAYGLMNDTG 132
+ A + G L R +W +D T + ++ D G
Sbjct: 65 SSTIPLRNKKA----PLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDG 120
Query: 133 NFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLV 192
N VL+ + S + G L G G + +GNLV
Sbjct: 121 NIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGNLV 177
Query: 193 LTTVNLPSDYTNEPYYESKTNGSSNQLVFNQSGYMYILQEYDQRFALTRRVETSASNFYY 252
+ + T G Q ++ Y A+ T
Sbjct: 178 A------YGPNGAATWNAGTQGKGAVRAVFQGDGNLVV--YGAGNAVLWHSHTGGHA-SA 228
Query: 253 RATINFDGVFTQY 265
+ +G
Sbjct: 229 VLRLQANGSIAIL 241
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 8e-05
Identities = 26/221 (11%), Positives = 47/221 (21%), Gaps = 39/221 (17%)
Query: 14 LLLQPFLTFAQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAK 73
L + + S + L +G+ N + + A
Sbjct: 85 AFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAI 144
Query: 74 IPQK--TIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDT 131
G A +K+ D LV P G W + +
Sbjct: 145 DSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGD 204
Query: 132 GNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNL 191
GN V+ LW S L +NG++
Sbjct: 205 GNLVVYGAGNAVLWHS--------------------------HTGGHASAVLRLQANGSI 238
Query: 192 VLTTVNLPSDYTNEPYYESKTN---GSSNQLVFNQSGYMYI 229
+ +P + + + + I
Sbjct: 239 AI--------LDEKPVWARFGFQPTYRHIRKINPDQKPIDI 271
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 59/223 (26%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
+G+GA+G+V A + +V VA+KK+ S + +T E+ ++ + H+N++
Sbjct: 33 SYIGEGAYGMVCS-AYDNLN--KVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 576 RLL---------GFCD----------DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD 616
+ D D L +LL + LSN + FL+
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICYFLYQ----------- 136
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH--T 674
I RGL Y+H S ++H D+KP N+LL+ + +I DFGLA++ D T T
Sbjct: 137 ----ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 675 AIRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLLEII 710
YVA W+R + T +D++S G +L E++
Sbjct: 190 ------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 12/100 (12%)
Query: 616 DIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA 675
+F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ + D
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DY 249
Query: 676 IRGTKGYV-----APEWFRNMPITVKVDVYSFGVLLLEII 710
+R + APE + T++ DV+SFGVLL EI
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 12/153 (7%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQV-PVAVKKLHSVIQDG-VKEFKTEVNVIGQ-THH 571
+ LG+GAFG V + A G+ VAVK L + +E+ ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 572 KNLVRLLGFC-DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHE 630
N+V LLG C G +++ EF G L+++L S+R + +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663
+ I D+K + + ++ S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 48/225 (21%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKT--EVNVIGQTHHKNLV 575
+ LG G G+V+ A+ VA+KK+ V+ D E+ +I + H N+V
Sbjct: 17 KPLGCGGNGLVFS-AVDNDC--DKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 576 RLL-------------GFCDDGLNRL-LVYEFLS---NGTLASFLFGDLKPGWSRRTDIA 618
++ LN + +V E++ L G L
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLE--EHARLFM 126
Query: 619 FGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLLLLDQSQTH--TA 675
+ + RGL Y+H S ++H D+KP N+ ++ +I DFGLA+++ S +
Sbjct: 127 YQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS- 182
Query: 676 IRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLLEIICCR 713
+ +W+R T +D+++ G + E++ +
Sbjct: 183 -----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 64/231 (27%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEF----KTEVNVI------G 567
LG+G FG V + + A + VA+K +I++ V ++ + E+NV+
Sbjct: 25 GNLGEGTFGKVVE-CLDHAR-GKSQVALK----IIRN-VGKYREAARLEINVLKKIKEKD 77
Query: 568 QTHHKNLVRLLGFCDD-----------GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD 616
+ + V + + + G N +EFL + ++
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPYPLPHVRH------- 127
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA-------------------RIS 657
+A+ + L +LHE Q+ H D+KP+NIL + R++
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 658 DFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLE 708
DFG A + HT I T+ Y PE + DV+S G +L E
Sbjct: 185 DFGSA----TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 70/236 (29%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEF----KTEVNVIGQ----- 568
++G G FG V + + + AVK V+++ +K++ K E +++ +
Sbjct: 41 RKMGDGTFGRVLL-CQHIDN--KKYYAVK----VVRN-IKKYTRSAKIEADILKKIQNDD 92
Query: 569 THHKNLVRLLGFCDD-----------GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDI 617
++ N+V+ G G + +YE ++ F D+K
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNGFHIEDIKL-------Y 142
Query: 618 AFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA----------------------- 654
I + L YL + + H D+KP+NILLDD Y
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 655 --RISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLE 708
++ DFG A +S H +I T+ Y APE N+ V D++SFG +L E
Sbjct: 200 GIKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 64/231 (27%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEF----KTEVNVIGQ----- 568
+ LG+GAFG V + I + + VAVK ++++ V + ++E+ V+
Sbjct: 20 DTLGEGAFGKVVE-CIDHKAGGRH-VAVK----IVKN-VDRYCEAARSEIQVLEHLNTTD 72
Query: 569 -THHKNLVRLLGFCDD-----------GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTD 616
V++L + + GL+ Y+F+ F ++
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLPFRLDHIRK------- 122
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA-------------------RIS 657
+A+ I + + +LH ++ H D+KP+NIL ++
Sbjct: 123 MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 658 DFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLE 708
DFG A + H+ + T+ Y APE + + DV+S G +L+E
Sbjct: 180 DFGSA----TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 2e-10
Identities = 71/451 (15%), Positives = 143/451 (31%), Gaps = 140/451 (31%)
Query: 395 FRSGDM--CWKKKLPLSNGRFDANLNGKALIKIRKGNLPPTSPDFPRPNVKNNQKKDQEN 452
F +G+ +K L + F N + K + D P+ + K++ ++
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDV------------QDMPKSILS---KEEIDH 53
Query: 453 LIILGSVLLGGSVFFNCLLVGALCLCFFFVYNKKNSQVPSH-DGVVETNLHCFTYKDLEA 511
+I+ + G F LL +K+ V + V+ N YK L +
Sbjct: 54 IIMSKDAVSGTLRLFWTLL------------SKQEEMVQKFVEEVLRIN-----YKFLMS 96
Query: 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQ---------VPVAVK------KLHSVIQDGV 556
K E + M MY V K + + ++ +
Sbjct: 97 P---IKTE---------QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 557 KEFKTEVNVI-------GQT--------HHKNLVRL--------LGFCDDGLNRLLVYEF 593
E + NV+ G+T +K ++ L C+ L E
Sbjct: 145 LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL---EM 201
Query: 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN 653
L L + P W+ R+D + I + + E + + ++L + N
Sbjct: 202 LQK------LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 654 ARISD-FGL-AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC 711
A+ + F L K+LL T R +T + + + L+
Sbjct: 256 AKAWNAFNLSCKILLT-----------T---------RFKQVTDFLSAATTTHISLD--- 292
Query: 712 CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL-NDKKKLARFVMVAIW-CIQ 769
++ + +E ++LL + ++ + L + + I I+
Sbjct: 293 -HHSMTLTPDEVKSLLLKY-------------LDCRPQDLPREVLTTNPRRLSIIAESIR 338
Query: 770 EDPS-----LRPTMRKVTQMLEGVVEVLDPP 795
+ + K+T ++E + VL+P
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 58.8 bits (141), Expect = 1e-09
Identities = 39/253 (15%), Positives = 69/253 (27%), Gaps = 35/253 (13%)
Query: 34 SLSASQNSSSWLSP-----NGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSP 88
LS + L F F S D N L ++ + + W +N
Sbjct: 6 GLSHEGSHPQTLHAAQSLELSSFRFTMQS-DCN-----LVLFDSDVRV----WASNTAGA 55
Query: 89 AASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMN-DTGNFVLLSDNTNKLWES 147
+G + L +D LV+ + Q W S Y L+ + S
Sbjct: 56 --TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTS 113
Query: 148 FNNPTDTMLPSQIFDNGQ-----FLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDY 202
+ + + +R + ++ NLVL
Sbjct: 114 NKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLF-------D 166
Query: 203 TNEPYYESKTNGSSN--QLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDG 260
++ + + T G + V +G M + + S S Y + D
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVLQPNGRMDV---LTNQNIAVWTSGNSRSAGRYVFVLQPDR 223
Query: 261 VFTQYQHPKNSTG 273
Y +TG
Sbjct: 224 NLAIYGGALWTTG 236
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 30/143 (20%), Positives = 47/143 (32%), Gaps = 55/143 (38%)
Query: 617 IAFGIARGLLYLHEECSTQIIHCDIKPQNILL--DDYY---------------------- 652
I + +GL YLH +C +IIH DIKP+NILL ++ Y
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 653 -------------------------NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEW 687
+I+D G A + + T T+ Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQTRQYRSLEV 264
Query: 688 FRNMPITVKVDVYSFGVLLLEII 710
D++S + E+
Sbjct: 265 LIGSGYNTPADIWSTACMAFELA 287
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 2e-08
Identities = 29/193 (15%), Positives = 52/193 (26%), Gaps = 55/193 (28%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--------SVIQDGVKEFKTEVNV---- 565
E++G+G FG V++ PVA+K + Q +E E+ +
Sbjct: 26 EKIGEGVFGEVFQ-----TIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80
Query: 566 -----IGQTHHKNLVRLL------------------------GFCDDGLNRL------LV 590
+ + L G +D + +V
Sbjct: 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140
Query: 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650
EF G + L + I + L + H D+ N+LL
Sbjct: 141 LEFEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKK 197
Query: 651 YYNARISDFGLAK 663
++ K
Sbjct: 198 TSLKKLHYTLNGK 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 16/171 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
+G+G+FGV+++G + + QV + + S E++T + G T + +
Sbjct: 16 RRIGEGSFGVIFEG-TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNV 71
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECSTQ 635
F +GL+ +LV + L G L +S +T A + + +H
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKS 126
Query: 636 IIHCDIKPQNILLDDYYNAR-----ISDFGLAKLLLLDQSQTHTAIRGTKG 681
+++ DIKP N L+ + + DFG+ K ++ H R K
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 5e-07
Identities = 28/121 (23%), Positives = 44/121 (36%), Gaps = 19/121 (15%)
Query: 29 ITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSP 88
+T G L A Q+ + F D N L ++ W +N
Sbjct: 4 LTNGEGLYAGQSLD-----VEPYHFIMQE-DCN-----LVLYDHSTSV----WASNTGIL 48
Query: 89 AASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWES 147
G K L +D V+ +GR LW S + G Y L + + GN V+ + +W +
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---SDIWST 105
Query: 148 F 148
Sbjct: 106 G 106
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 1e-04
Identities = 22/124 (17%), Positives = 34/124 (27%), Gaps = 22/124 (17%)
Query: 153 DTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT 212
+ + + GQ L + F + + NLVL + + S T
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLY-------DHSTSVWASNT 45
Query: 213 NGSSN---QLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPK 269
+ V G + YD + N Y + DG Y
Sbjct: 46 GILGKKGCKAVLQSDGNFVV---YDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSDI 102
Query: 270 NSTG 273
STG
Sbjct: 103 WSTG 106
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 14/169 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
++G G+FG +Y G +A+ +V + ++ + + E K ++ + +
Sbjct: 15 RKIGSGSFGDIYLG-TDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--IPTI 70
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECSTQ 635
+G ++V E L G LF +S +T +A + + Y+H S
Sbjct: 71 RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKN 125
Query: 636 IIHCDIKPQNILLDDYYNA---RISDFGLAKLLLLDQSQTHTAIRGTKG 681
IH D+KP N L+ I DFGLAK ++ H R K
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 23/126 (18%), Positives = 34/126 (26%), Gaps = 21/126 (16%)
Query: 153 DTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT 212
+ +L Q L + G + + + NLV + S T
Sbjct: 3 NVLLSGQTLHADHSLQA---------GAYTLTIQNKCNLVKY-------QNGRQIWASNT 46
Query: 213 NGSSNQ--LVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKN 270
+ + L G + I YD N Y + DG F Y
Sbjct: 47 DRRGSGCRLTLLSDGNLVI---YDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPVLW 103
Query: 271 STGNEG 276
S G G
Sbjct: 104 SLGPNG 109
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 41/176 (23%), Positives = 70/176 (39%), Gaps = 26/176 (14%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVK-----KLHSVIQDGVKEFKTEVNVIGQTHHK 572
+++G G FG + G + + VA+K + + +K + G
Sbjct: 15 KKIGCGNFGELRLG-KNLYT--NEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG----- 66
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHE 630
+ ++ F G +V E L G LF +S +T IA + + Y+H
Sbjct: 67 -IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH- 122
Query: 631 ECSTQIIHCDIKPQNILLDDYYNAR-----ISDFGLAKLLLLDQSQTHTAIRGTKG 681
S +I+ D+KP+N L+ N I DF LAK + +++ H R K
Sbjct: 123 --SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 33/167 (19%), Positives = 63/167 (37%), Gaps = 30/167 (17%)
Query: 520 LGKGAFGVVYKGA-----IGMASMYQVPVAVK------KLHSVIQDGVKEFKT-EVNVIG 567
+ G++Y+ A + + ++K +L + + K +VN
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 568 QTHHKNLV---RLLGF-CDDGLNRLLVYEFLSNGT-LASFLFGDLKPGWSRRTDIAFGIA 622
+ + L+ +GF R LV L G L S L K S R+ +A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS--VLQVA 165
Query: 623 RGLL----YLHEECSTQIIHCDIKPQNILLDDYYNARI--SDFGLAK 663
LL +LH + +H ++ +NI +D +++ + +G A
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-06
Identities = 22/125 (17%), Positives = 39/125 (31%), Gaps = 22/125 (17%)
Query: 151 PTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYES 210
+ + Q+ L++ + + + NLVL Y + ++S
Sbjct: 5 TNNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVL--------YGGKYGWQS 47
Query: 211 KTNGSSNQ--LVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHP 268
T+G+ L N G + I D F +S+ Y + DG Y
Sbjct: 48 NTHGNGEHCFLRLNHKGELII---KDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGPA 104
Query: 269 KNSTG 273
T
Sbjct: 105 IFETS 109
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 18/97 (18%), Positives = 28/97 (28%), Gaps = 8/97 (8%)
Query: 41 SSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTAD 100
S L +G H L D L+ W +N + L
Sbjct: 11 SGQVLYGDGRLTAKNHQLVMQGDCNLVLYGG------KYGWQSNTHG-NGEHCFLRLNHK 63
Query: 101 QGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVL 136
L++ + +W S Y L + D G V+
Sbjct: 64 GELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-06
Identities = 27/128 (21%), Positives = 44/128 (34%), Gaps = 26/128 (20%)
Query: 152 TDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESK 211
+D + D G L+ G + F + ++ NLVL N + S
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLY-------DNNRAVWASG 44
Query: 212 TNGSSN--QLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPK 269
TNG ++ L G + I Y A+ T+ N Y + D Y
Sbjct: 45 TNGKASGCVLKMQNDGNLVI---YSGSRAIWAS-NTNRQNGNYYLILQRDRNVVIY---- 96
Query: 270 NSTGNEGW 277
+++ N W
Sbjct: 97 DNSNNAIW 104
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 8e-06
Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 18/123 (14%)
Query: 29 ITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSP 88
+ G L + + G + F + D N L ++ +A+G +
Sbjct: 4 LNSGHQLDTGGSLA-----EGGYLFIIQN-DCN-----LVLYDNNRA-----VWASGTNG 47
Query: 89 AASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWES 147
ASG +++ D LV+ S R +W S+ Y L + N V+ ++ N +W +
Sbjct: 48 KASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
Query: 148 FNN 150
N
Sbjct: 107 HTN 109
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 14/169 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
++G G+FG +Y G + + +V + ++ + + + E K + G T + +
Sbjct: 13 RKIGSGSFGEIYLG-TNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG---IPNV 68
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIARGLLYLHEECSTQ 635
F +G +LV + L G LF S +T +A + + ++H +
Sbjct: 69 RWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 636 IIHCDIKPQNILLDDYYNAR---ISDFGLAKLLLLDQSQTHTAIRGTKG 681
+H DIKP N L+ A I DFGLAK + H R K
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 23/121 (19%), Positives = 35/121 (28%), Gaps = 13/121 (10%)
Query: 158 SQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSSN 217
+ + G + + S F + + NLVL Y ++S T+G
Sbjct: 2 NNVLLTGDVIHTDNQ---LSYESAAFVMQGDCNLVL--------YNEAGGFQSNTHGRGV 50
Query: 218 --QLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNE 275
L N G + I + Y AT+ D T Y ST
Sbjct: 51 DCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGPAIWSTPAA 110
Query: 276 G 276
Sbjct: 111 A 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 23/125 (18%), Positives = 39/125 (31%), Gaps = 19/125 (15%)
Query: 151 PTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYES 210
+ + SQ+ + L++ + + + NLVLT + +ES
Sbjct: 5 VRNVLFSSQVMYDNAQLAT---------RDYSLVMRDDCNLVLTKGS-----KTNIVWES 50
Query: 211 KTNGSSNQ--LVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHP 268
T+G + SG + I D R T Y + +G Y
Sbjct: 51 GTSGRGQHCFMRLGHSGELDI---TDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA 107
Query: 269 KNSTG 273
ST
Sbjct: 108 VWSTA 112
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 21/122 (17%), Positives = 41/122 (33%), Gaps = 17/122 (13%)
Query: 34 SLSASQ--NSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAAS 91
SLS+ + L + D N ++ + P +A+ S
Sbjct: 3 SLSSPNSLFTGHSLEVGPSYRLIMQG-DCN-----FVLYDSGKPV-----WASNTGGLGS 51
Query: 92 GTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWESFNN 150
G ++ L + LV+ R +W++ Y L + N V+ +W + +
Sbjct: 52 GCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG---PVVWATGSG 108
Query: 151 PT 152
P
Sbjct: 109 PA 110
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 32/167 (19%), Positives = 65/167 (38%), Gaps = 30/167 (17%)
Query: 520 LGKGAFGVVYKGAI--GMASMYQVPVAVKKL---HSVIQDGVKEFKT--EVNVIGQTHHK 572
+G+G FG +Y + + P VK + + +K ++ + I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 573 NLVRLLGFC----------DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIA 622
++ LG + R ++ + G+ ++ +SR+T ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKT--VLQLS 158
Query: 623 RGLL----YLHEECSTQIIHCDIKPQNILLDDYYNARI--SDFGLAK 663
+L Y+HE +H DIK N+LL+ ++ D+GLA
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 32/164 (19%), Positives = 60/164 (36%), Gaps = 27/164 (16%)
Query: 520 LGKGAFGVVYKGAIGMASMYQVPVAVK---KLHSVIQDGVKEFKT--EVNVIGQTHHKNL 574
+G G FG++Y VK + + + +K ++ + + I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 575 VRLLGF----------CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRT--DIAFGIA 622
+ LG R +V E L G + + + T + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRML 161
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNAR---ISDFGLAK 663
L Y+H + +H DIK N+LL Y N ++D+GL+
Sbjct: 162 DVLEYIH---ENEYVHGDIKAANLLL-GYKNPDQVYLADYGLSY 201
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 4e-04
Identities = 23/122 (18%), Positives = 38/122 (31%), Gaps = 20/122 (16%)
Query: 152 TDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESK 211
T+ +L Q D L + G F + + NLVL N S+ N
Sbjct: 3 TNYLLSGQTLDTEGHLKN---------GDFDLVMQDDCNLVLYNGNWQSNTAN------- 46
Query: 212 TNGSSNQLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNS 271
NG +L G + I + + + + Y A ++ DG +
Sbjct: 47 -NGRDCKLTLTDYGELVI---KNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFK 102
Query: 272 TG 273
Sbjct: 103 ID 104
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 16/133 (12%), Positives = 40/133 (30%), Gaps = 28/133 (21%)
Query: 63 DLFLLSIWYAKIPQKTIVWFANGDSPAASGT-KVELTADQGLVLTSPQGRELWKSDPI-I 120
+ + S + + + + + + + D LVL +W ++ +
Sbjct: 1 NNIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTGGL 59
Query: 121 GTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGR 180
G ++ G V++++ +W QS G
Sbjct: 60 GNGCRAVLQPDGVLVVITNENVTVW-------------------------QSPVAGKAGH 94
Query: 181 FRFELNSNGNLVL 193
+ L + N+V+
Sbjct: 95 YVLVLQPDRNVVI 107
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 7e-04
Identities = 22/120 (18%), Positives = 40/120 (33%), Gaps = 20/120 (16%)
Query: 29 ITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSP 88
+ G +LS + + NG + F D N L ++ P +A
Sbjct: 4 LYSGETLSPGEFLN-----NGRYVFIMQE-DCN-----LVLYDVDKPI-----WATNTGG 47
Query: 89 AASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWES 147
+ + +D LV+ SP+ +W S+ Y + N V+ W +
Sbjct: 48 LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYG---TARWAT 104
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 804 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.81 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.81 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.78 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.75 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.67 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.6 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.59 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.59 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.54 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.53 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.51 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.48 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.48 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.35 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.28 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.22 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.21 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.19 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.11 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.0 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.99 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.98 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.83 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.76 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.11 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.11 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.92 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.82 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.6 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.02 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.41 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.28 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.23 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.89 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.41 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.99 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 88.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.63 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 86.88 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.04 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 81.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.33 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=434.17 Aligned_cols=268 Identities=24% Similarity=0.326 Sum_probs=214.5
Q ss_pred CHHHHHHHHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEE
Q 047263 505 TYKDLEAATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFC 581 (804)
Q Consensus 505 ~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~ 581 (804)
.+.|+..++..|.++||+|+||+||+|++.. ....++.||||+++... ....++|.+|+.++++++|||||+++|+|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3344555566788999999999999999743 22345689999997543 34567899999999999999999999999
Q ss_pred eCCCceEEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCc
Q 047263 582 DDGLNRLLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQN 645 (804)
Q Consensus 582 ~~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 645 (804)
.++...+||||||++|+|.++|... ..++|.++++|+.|||+||+|||+. +|+||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence 9999999999999999999999643 3578999999999999999999965 99999999999
Q ss_pred EEEcCCCCEEEeecCcccccccCC-CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHH
Q 047263 646 ILLDDYYNARISDFGLAKLLLLDQ-SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEA 723 (804)
Q Consensus 646 ILl~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~ 723 (804)
|||++++++||+|||+++.+.... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.......
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998764433 233445679999999999999999999999999999999999 889997654322
Q ss_pred HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
+... ...+.... .+......+.+|+.+||+.||++||||.||++.|+...++
T Consensus 256 ---~~~~----i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 256 ---VVEM----IRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp ---HHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred ---HHHH----HHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 1111 11221110 1112345688999999999999999999999999976543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=433.41 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=205.2
Q ss_pred hhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||.||+|++.. ....++.||||+++....+..++|.+|++++++++|||||+++|+|.++...+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 356789999999999998753 233456899999987767777899999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC---------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEe
Q 047263 593 FLSNGTLASFLFGD---------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARIS 657 (804)
Q Consensus 593 y~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~ 657 (804)
||++|+|.++|+.. ..++|.++++|+.|||+||.|||+. +|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 99999999999753 3588999999999999999999965 99999999999999999999999
Q ss_pred ecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhh
Q 047263 658 DFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 658 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 735 (804)
|||+++.+..... .......||+.|||||++.+..++.++|||||||+||||+| |+.||........ ...+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i---- 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDCI---- 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHHH----
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHHH----
Confidence 9999987644332 23345679999999999999999999999999999999999 8999976543221 1111
Q ss_pred hcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 736 CEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
..+.... .+.....++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 274 ~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111100 1112345688999999999999999999999999998765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=432.23 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=210.6
Q ss_pred hhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.++||+|+||.||+|++.. ....++.||||+++....+..++|.+|++++++++|||||+++|+|.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3467889999999999998753 22345689999998776677789999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEee
Q 047263 592 EFLSNGTLASFLFGD-------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~D 658 (804)
|||++|+|.++|+.. ..++|.++++|+.|||+||.|||+. +|+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 999999999999643 4689999999999999999999965 999999999999999999999999
Q ss_pred cCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhh
Q 047263 659 FGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYC 736 (804)
Q Consensus 659 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 736 (804)
||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||....... +...+ .
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i----~ 244 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI----T 244 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHH----H
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----H
Confidence 9999876443322 2334568999999999999999999999999999999999 899997654322 11111 1
Q ss_pred cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 737 EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.+.... .+.....++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 245 ~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 QGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111110 1112345788999999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=423.10 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=199.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||+||+|++.. .||||.++.. ..+..++|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECC------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467889999999999998642 4899998643 23456789999999999999999999999865 56899999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-C
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-S 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~ 670 (804)
||++|+|.++|... ..++|.++.+|+.|||+||.|||+. +|+||||||+||||++++++||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999754 6799999999999999999999965 99999999999999999999999999998764322 2
Q ss_pred CccccccCCCcccccccccc---CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 671 QTHTAIRGTKGYVAPEWFRN---MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~---~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......||+.|||||++.+ .+++.++|||||||+||||+||+.||........ +.. ....+. ..+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~----~~~~~~----~~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIF----MVGRGY----ASPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHH----HHHTTC----CCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHH----HHhcCC----CCCC
Confidence 33455689999999999864 4689999999999999999999999975433221 111 111111 1111
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.. .........+.+++.+||+.||++||||.||++.|+.+..
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 0111234578889999999999999999999999987643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=403.47 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=197.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeC----CCceE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD----GLNRL 588 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 588 (804)
.|.++||+|+||.||+|.....+ +.||+|++... .....+.|.+|++++++++|||||++++++.+ +...+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC---eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 35678999999999999987544 47999999643 23445679999999999999999999999864 35579
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfgla~~~~~ 667 (804)
||||||++|+|.++|.....+++..+..++.||+.||.|||++ ..+|+||||||+||||+ .++.+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 9999999999999999888999999999999999999999965 23499999999999998 48999999999998532
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
........||+.|||||++.+ .++.++|||||||++|||+||+.||........ + ......+... ..
T Consensus 184 --~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~----~~~i~~~~~~----~~ 250 (290)
T 3fpq_A 184 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVKP----AS 250 (290)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCCC----GG
T ss_pred --CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--H----HHHHHcCCCC----CC
Confidence 233445789999999999875 699999999999999999999999965432211 1 1111121111 11
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... ....++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~----~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 11235788999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=407.84 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=205.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+|+....+ +.||||++........+.+.+|+.++++++|||||++++++.+++..||||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSG---KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEeecCcCeEEEEEEECCCC---CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 345678999999999999987544 37999999765555566789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|.+++.. ..+++.+...++.||+.||.|||+. +|+||||||+||||+.++++||+|||+++.+... ....
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 227 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRR 227 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCCB
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC-CCcc
Confidence 999999999965 5689999999999999999999965 9999999999999999999999999999876433 2334
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||+.|||||++.+..|+.++|||||||++|||++|+.||......... . ...+.....+.. .
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~----~i~~~~~~~~~~-------~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----MIRDNLPPRLKN-------L 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H----HHHHSSCCCCSC-------G
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H----HHHcCCCCCCCc-------c
Confidence 5678999999999999999999999999999999999999999765432211 1 111111111111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....++.+++.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122456788999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=406.03 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=197.0
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC----ceEEEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL----NRLLVY 591 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 591 (804)
+.++||+|+||+||+|++. ++.||||++..... ....+..|+..+.+++|||||+++++|.+++ ..+|||
T Consensus 7 L~~~iG~G~fG~Vy~~~~~-----g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEECSSSEEEEEEET-----TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEC-----CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4678999999999999874 34799999975322 2223445777778899999999999997654 579999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc-----CCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC-----STQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
|||++|+|.++|+. ..++|..+.+++.|+++||+|||+++ .++|+||||||+||||++++++||+|||+++...
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999965 46899999999999999999999652 3589999999999999999999999999998764
Q ss_pred cCCCC---ccccccCCCccccccccccC------CCCccchhhHHHHHHHHHHcCCCCCCcchhHHH---------HHHH
Q 047263 667 LDQSQ---THTAIRGTKGYVAPEWFRNM------PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE---------ALLT 728 (804)
Q Consensus 667 ~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~---------~~l~ 728 (804)
..... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+........ ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 43322 22345799999999999754 467899999999999999999877643221100 0000
Q ss_pred HHHHHhhhcCcccceecchhh-hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 729 DWAYDCYCEGITEALVEFDIE-ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
. ......++ ..++.+. .....+....+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 240 ~-~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 240 E-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp H-HHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0 11111111 1111111 12233566788999999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=414.93 Aligned_cols=265 Identities=26% Similarity=0.350 Sum_probs=210.6
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEcccccc-ccHHHHHHHHHHhccccc-CCccceeeEEeCC
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHH-KNLVRLLGFCDDG 584 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~ 584 (804)
+....+.+.++||+|+||.||+|...... ...+.||||++..... ...++|.+|++++.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 33445566789999999999999876432 2345799999975433 345679999999999965 8999999999764
Q ss_pred -CceEEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEE
Q 047263 585 -LNRLLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 585 -~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIL 647 (804)
...+||||||++|+|.++|+.. ..++|.++..++.|||+||.|||+. +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 5689999999999999999642 3478999999999999999999965 9999999999999
Q ss_pred EcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHH
Q 047263 648 LDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEA 725 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~ 725 (804)
|++++.+||+|||+|+.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||........
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 999999999999999976544332 3345678999999999999999999999999999999998 8999975432211
Q ss_pred HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 726 LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 726 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
+. ....++..... +.....++.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 297 -~~----~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 -FC----RRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -HH----HHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HH----HHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11 11112211111 111235688899999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=406.22 Aligned_cols=249 Identities=22% Similarity=0.210 Sum_probs=200.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.++||+|+||.||+|+....+ +.||||+++.... +.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g---~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTG---FQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EeCcEeccCCCeEEEEEEECCCC---CEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 34568999999999999987544 4799999975321 246999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecCcccccccCCCC--
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLLDQSQ-- 671 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~~~-- 671 (804)
++|+|.++|.....+++.+...++.||+.||.|||+ .+|+||||||+||||+.++ ++||+|||+++.+..+...
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999999999888889999999999999999999995 4999999999999999987 6999999999976543321
Q ss_pred --ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 672 --THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 672 --~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......||+.|||||++.+..++.++|||||||++|||++|+.||........ +.. + ...... .
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~-i---~~~~~~-------~- 275 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLK-I---ASEPPP-------I- 275 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHH-H---HHSCCG-------G-
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHH-H---HcCCCC-------c-
Confidence 22345799999999999999999999999999999999999999975433211 000 0 001100 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
...+......+.+++.+||+.||.+|||+.|+++.|...
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011122345788899999999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=405.28 Aligned_cols=247 Identities=20% Similarity=0.281 Sum_probs=196.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||+|+....+ +.||||++... .....+.|.+|+.++++++|||||++++++.+++..||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDG---RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp EEEEEEC------CEEEEEETTTC---CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 456789999999999999986544 37999999643 2344567999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++|+|.++|... ..+++.+...|+.||+.||.|||+. +|+||||||+||||++++.+||+|||+++.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 999999999999644 4568889999999999999999965 9999999999999999999999999999875322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|||||++.+..|+.++|||||||+||||++|+.||........ + .... .+....
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~----~~i~-~~~~~~------- 244 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL--V----LKII-SGSFPP------- 244 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H----HHHH-HTCCCC-------
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--H----HHHH-cCCCCC-------
Confidence 1223446799999999999999999999999999999999999999986543321 1 1111 111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......++.+|+.+||+.||++|||++|+++
T Consensus 245 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 --VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01123456888999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=396.93 Aligned_cols=245 Identities=22% Similarity=0.257 Sum_probs=205.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||+||+++....++ .||||++... .....+.+.+|++++++++|||||++++++.+++..|||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSR---EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCC---EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECCCCC---EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5567899999999999999875543 7999999743 234567899999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.++|.....+++.+...++.||+.||.|||+. +|+||||||+||||++++.+||+|||+++.+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999998888999999999999999999999965 999999999999999999999999999998754332
Q ss_pred -CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 -QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 -~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......+||+.|||||++.+..++.++||||+||++|||++|+.||........ + ..+ ..+.. . .
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~-~~i----~~~~~----~--~- 253 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI--F-AKI----IKLEY----D--F- 253 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHH----HHTCC----C--C-
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHH----HcCCC----C--C-
Confidence 334567899999999999999999999999999999999999999976543221 1 111 11110 0 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eV 781 (804)
+.....++.+++.+||+.||++|||++|+
T Consensus 254 ---p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 254 ---PEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp ---CTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred ---CcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 11123467889999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=408.65 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=205.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+|+....+ +.||||++........+.+.+|+.++++++|||||++++++.+++..||||||
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSG---KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeeEeccCcCcEEEEEEECCCC---CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 445678999999999999987554 37999999765555667789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
|++|+|.+++.. ..+++.++..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+... ....
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~ 304 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRR 304 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCB
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC-Cccc
Confidence 999999999964 4689999999999999999999965 9999999999999999999999999999876433 2334
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||+.|||||++.+..|+.++|||||||++|||++|+.||......... . .........+.. .
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~----~i~~~~~~~~~~-------~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----MIRDNLPPRLKN-------L 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H----HHHHSCCCCCSC-------T
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H----HHHcCCCCCCcc-------c
Confidence 5678999999999999999999999999999999999999999765433211 1 111111111111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+.+|+.+||+.||++|||+.|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122356788999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=394.50 Aligned_cols=249 Identities=22% Similarity=0.235 Sum_probs=198.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||+||+++...+...++.||||.+.... ......+.+|++++++++|||||++++++.+++..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 566789999999999999876555556689999996532 223446889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++|+|.++|.....+++.+...++.||+.||.|||+. +|+||||||+|||+++++++||+|||+|+..... ..
T Consensus 106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 181 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EK 181 (304)
T ss_dssp CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC------C
T ss_pred EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC-Cc
Confidence 9999999999999888999999999999999999999965 9999999999999999999999999999865332 23
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......||+.|||||++.+..++.++||||+||++|||++|+.||......... ..+ ..... . .
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~i----~~~~~----~--~--- 245 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMI----LKAKL----G--M--- 245 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCCC----C--C---
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---HHH----HcCCC----C--C---
Confidence 344578999999999999999999999999999999999999999865433211 111 11110 0 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
+.....++.+++.+||+.||++||| ++|+++
T Consensus 246 -p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 -PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112356788999999999999998 467663
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=382.55 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=189.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||.||+++....+ +.||||++.... ....+.+.+|++++++++|||||++++++.+++..+||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTG---QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTC---CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 556789999999999999876543 479999996432 23456799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+ +|+|.+++..+..+++.+...++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+.... .
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~ 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--G 165 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC--C
Confidence 9999 689999998888999999999999999999999965 999999999999999999999999999986533 2
Q ss_pred CccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......||+.|||||++.+..+ +.++||||+||++|||++|+.||........ . . ....+... .
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~--~-~----~i~~~~~~------~- 231 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL--F-K----NISNGVYT------L- 231 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-H----HHHHTCCC------C-
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH--H-H----HHHcCCCC------C-
Confidence 23345679999999999998886 5799999999999999999999976543221 1 1 11111110 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+.....++.+++.+||+.||++|||++|+++
T Consensus 232 ---p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 ---PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112356788999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=378.93 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=183.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCC-------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------- 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------- 585 (804)
+.+.+.||+|+||.||+|+...++ +.||||++.... ....+.+.+|+.++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDD---CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTC---CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEeeEEecCCCeEEEEEEECCCC---CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 445678999999999999986544 379999997433 334567999999999999999999999986544
Q ss_pred -----ceEEEEeecCCCcHHHhhcCCCCC---ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEe
Q 047263 586 -----NRLLVYEFLSNGTLASFLFGDLKP---GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARIS 657 (804)
Q Consensus 586 -----~~~lV~Ey~~~gsL~~~l~~~~~l---~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~ 657 (804)
..++||||+++|+|.+++.....+ .+...+.|+.||++||.|||+. +|+||||||+||||+.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999876544 4556789999999999999965 99999999999999999999999
Q ss_pred ecCcccccccCCCC-----------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH
Q 047263 658 DFGLAKLLLLDQSQ-----------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL 726 (804)
Q Consensus 658 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~ 726 (804)
|||+|+.+...... ......||+.|||||++.+..++.++|||||||++|||++ ||....... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~-~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV-RT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH-HH
Confidence 99999876543221 1234579999999999999999999999999999999996 665432211 11
Q ss_pred HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+. ........ .. .......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~-----~~~~~~~p-----~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LT-----DVRNLKFP-----PL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-----HHHTTCCC-----HH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-----HHhcCCCC-----CC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 01111110 00 1122345567999999999999999999986
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=362.00 Aligned_cols=227 Identities=20% Similarity=0.301 Sum_probs=182.1
Q ss_pred hhccCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCC-----CcEEEE
Q 047263 23 AQTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAAS-----GTKVEL 97 (804)
Q Consensus 23 ~~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~-----~s~l~~ 97 (804)
+++.|+|++|++|++++ +|+|++|+||||||++ + + +|| |+ |.+ |||+|||++|+.+ ++.|+|
T Consensus 11 ~~~~~~l~~g~~l~~~~---~l~S~~g~F~lgf~~~--~-~-~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l 77 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQGD--G-N-LVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPL 77 (276)
T ss_dssp CTTSSEECTTEEBCTTC---EEECTTSSEEEEECTT--S-C-EEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCS
T ss_pred cccCCEecCCCEecCCC---EEEcCCCcEEEEEECC--C-C-eEE---EC--CCC-eEEECCCCCCcCCcccccceEEEE
Confidence 45679999999999754 9999999999999943 2 3 566 76 777 9999999999965 678999
Q ss_pred ecCCCeEE--eCCCCceEeeccCCC------CceeEEEEccCcCEEEEecCCccccccccCCcccccCCcc----cCCCc
Q 047263 98 TADQGLVL--TSPQGRELWKSDPII------GTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQI----FDNGQ 165 (804)
Q Consensus 98 ~~~G~L~l--~~~~~~~vWst~~~~------~~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~----l~~~~ 165 (804)
+.||+|+| .|++|++||+|+++. ..+++|+|+|+|||||++ +.+|||| |||||+||||+ |..++
T Consensus 78 ~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 78 AFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp EEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred eCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCc
Confidence 99999999 788899999999764 345789999999999998 7899999 99999999999 77788
Q ss_pred eEEecCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCCCCC-cceeeeccccEEEeeeccceeeeeeecc
Q 047263 166 FLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSS-NQLVFNQSGYMYILQEYDQRFALTRRVE 244 (804)
Q Consensus 166 ~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (804)
.| ++.+||++|.|+++++++|+++++. .. ..+||++++++.. ..+.+...|.+.+.+.++..++.+....
T Consensus 154 ~L---~S~~dps~G~fsl~l~~dGnlvLy~--~~----~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~~ 224 (276)
T 3m7h_A 154 EL---VQGVVYGAGASKLVFQGDGNLVAYG--PN----GAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGG 224 (276)
T ss_dssp EE---CTTCEEEETTEEEEECTTSCEEEEC--TT----SSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCTT
T ss_pred cc---ccCCCCCCceEEEeecCCceEEEEe--CC----CeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCCC
Confidence 88 5688999999999999999877642 11 3789999888654 3445666777766655544555554321
Q ss_pred ccCcceeEEEEEeeCCcEEEEecCCCCCCCCCeeEEEecCc
Q 047263 245 TSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPD 285 (804)
Q Consensus 245 ~~~~~~~~r~~l~~dG~l~~y~~~~~~~~~~~W~~~~~~p~ 285 (804)
...+|++|+.||++++|.| ...|..++.+|+
T Consensus 225 ----~~~~rl~Ld~dGnLvly~~------~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 225 ----HASAVLRLQANGSIAILDE------KPVWARFGFQPT 255 (276)
T ss_dssp ----CTTCEEEECTTSCEEEEEE------EEEEESSSCCTT
T ss_pred ----CCCEEEEEcCCccEEEEcC------CCeEEccCccCC
Confidence 2248999999999999998 134777777665
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=376.98 Aligned_cols=263 Identities=20% Similarity=0.281 Sum_probs=198.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC------CC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD------GL 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~ 585 (804)
+.+.++||+|+||.||+|+....+ +.||||++.... ....+.+.+|+.+|++++|||||++++++.. ..
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTG---QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred eEEEEEEecccCeEEEEEEECCCC---CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 456789999999999999987544 479999997532 2345678899999999999999999998753 46
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..|||||||+ |+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999996 78999999889999999999999999999999965 9999999999999999999999999999876
Q ss_pred ccCC---CCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 666 LLDQ---SQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 666 ~~~~---~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
.... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.........................
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4322 2334567899999999998775 56899999999999999999999997664433211111000000000000
Q ss_pred ceecch---------hhhcccH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFD---------IEALNDK-----KKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~---------~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...... ....... ....++.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000000 12356788999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=366.33 Aligned_cols=286 Identities=41% Similarity=0.708 Sum_probs=238.2
Q ss_pred cccccCHHHHHHHHhhh--HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccc
Q 047263 500 NLHCFTYKDLEAATNGF--KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVR 576 (804)
Q Consensus 500 ~~~~~~~~~l~~at~~f--~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~ 576 (804)
....|++.++..++++| .+.||+|+||.||+|...++ ..||||++..... .....+.+|++++++++||||++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG----TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSS----CCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCC----CEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 35678999999888766 46899999999999986543 3699999975432 22346899999999999999999
Q ss_pred eeeEEeCCCceEEEEeecCCCcHHHhhcCCC----CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC
Q 047263 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDL----KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652 (804)
Q Consensus 577 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~ 652 (804)
+++++.+....++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 9999999999999999999999999997643 489999999999999999999976556999999999999999999
Q ss_pred CEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH--HHHHHHHH
Q 047263 653 NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE--AEALLTDW 730 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~--~~~~l~~~ 730 (804)
.+||+|||+++..............||..|+|||.+.+..++.++||||||+++|||++|+.||+..... .......+
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999999877555555555667999999999999889999999999999999999999999743321 12233344
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
......+.....+.+..............+.+++.+||+.||.+|||+.||+++|++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 44445555566666666666777888999999999999999999999999999998743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=363.61 Aligned_cols=272 Identities=35% Similarity=0.632 Sum_probs=227.0
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
+.+.||+|+||.||+|+..+ +..||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRD----GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTT----CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred ccceeecCCCeeEEEEEECC----CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 35689999999999999653 33699999987666677889999999999999999999999999999999999999
Q ss_pred CCcHHHhhcCCC----CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-C
Q 047263 596 NGTLASFLFGDL----KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-S 670 (804)
Q Consensus 596 ~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~ 670 (804)
+|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999997643 588999999999999999999965 99999999999999999999999999998654322 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||.............|.......+......+.....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc
Confidence 22334568999999999998899999999999999999999999997654433223333443334444455555555555
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~p 794 (804)
.........+.+++.+||+.||++|||+.||++.|+.+..+..+
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 56677888999999999999999999999999999998776554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=368.51 Aligned_cols=200 Identities=20% Similarity=0.315 Sum_probs=168.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||+||+|+.+.....++.||||++... .....+.+|++++..+ +||||+++++++.+.++.+||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 45567899999999999987544344568999998753 3455688999999988 69999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-CCEEEeecCcccccccCCC-
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfgla~~~~~~~~- 670 (804)
|+++|+|.+++. .+++.+...++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999994 588999999999999999999965 99999999999999876 7999999999986532211
Q ss_pred --------------------------CccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchh
Q 047263 671 --------------------------QTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVN 721 (804)
Q Consensus 671 --------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~ 721 (804)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 112345799999999999775 589999999999999999999999965443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.85 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=209.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||++.....+. .||+|++........+.|.+|++++++++||||+++++++.++...++||||
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~---~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGE---VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCC---EEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeccceecCCCCEEEEEEEECCCCc---EEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3456789999999999999875443 7999998776667778899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++|+|.+++.. ...+++.++..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999986 57789999999999999999999965 99999999999999999999999999998764332211
Q ss_pred -------------cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 673 -------------HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 673 -------------~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------------- 232 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------------- 232 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------------
Confidence 124568999999999999999999999999999999999998876432211000
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
...................+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 233 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 -GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00000000001111223467889999999999999999999999998876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=382.88 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=204.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+++....+. .||+|++........+.+.+|+.+|+.++|||||++++++.++...+|||||
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~---~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGN---NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCC---EEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCC---EEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4567899999999999999875543 7999999766555667889999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC--CCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY--YNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~--~~~kl~Dfgla~~~~~~~~ 670 (804)
|++|+|.++|.. ...+++.+...++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.+.. .
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--K 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--T
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC--C
Confidence 999999999865 46789999999999999999999965 99999999999999854 8999999999987643 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|||||++.+..++.++||||+||++|||++|+.||.......... .+ ..... .+...
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~---~i----~~~~~-~~~~~---- 378 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NV----KSCDW-NMDDS---- 378 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HH----HTTCC-CCCSG----
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HH----HhCCC-CCCcc----
Confidence 33445679999999999999999999999999999999999999997654432111 01 11100 00000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+|+.+||+.||.+|||+.|+++
T Consensus 379 -~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 -AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112356788999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=379.50 Aligned_cols=246 Identities=20% Similarity=0.212 Sum_probs=196.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHH---HHHHHHhcccccCCccceeeEEeCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEF---KTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f---~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
+.+.+.||+|+||.||+++....+ +.||||++.... .+....+ +.++.+++.++|||||++++++.+.+..
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg---~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred eEEEEEEecccCeEEEEEEECCCC---CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 345678999999999999987554 389999996421 1222333 4456777888999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||||||++||+|.++|.....+++.....++.||+.||.|||+ .+|+||||||+||||+.+|++||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999999999988899999999999999999999995 5999999999999999999999999999987643
Q ss_pred CCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
. .....+||+.|||||++.. ..|+.++|+||+||+||||++|+.||..........+..... ....
T Consensus 345 ~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~~~------ 411 (689)
T 3v5w_A 345 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TMAV------ 411 (689)
T ss_dssp C---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HCCC------
T ss_pred C---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CCCC------
Confidence 2 2345689999999999964 579999999999999999999999997643322111111110 1100
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVT 782 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl 782 (804)
..+.....++.+|+.+||+.||.+|++ ++||+
T Consensus 412 ----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 412 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 011122456788999999999999998 67775
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=353.36 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=210.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||+|+||.||+|.....+..+..||||++... .....+.|.+|+.++++++||||+++++++.++...++||||
T Consensus 52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 131 (325)
T 3kul_A 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131 (325)
T ss_dssp EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence 3456799999999999999766666667999999764 334456799999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (325)
T 3kul_A 132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208 (325)
T ss_dssp CTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence 9999999999754 6789999999999999999999965 99999999999999999999999999998765433222
Q ss_pred --cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 --HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 --~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......... . ...+...
T Consensus 209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~----~~~~~~~-------- 273 (325)
T 3kul_A 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS---S----VEEGYRL-------- 273 (325)
T ss_dssp EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH---H----HHTTCCC--------
T ss_pred eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH---H----HHcCCCC--------
Confidence 222345778999999999999999999999999999999 999986554332111 0 1111000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp 795 (804)
.........+.+++.+||+.||.+|||+.+|+++|+.+.+.+...
T Consensus 274 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 274 -PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred -CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 011123457889999999999999999999999999987765443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=351.05 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=198.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||+|+.. +..||||++.... ....++|.+|++++++++||||+++++++.+....++||
T Consensus 39 y~i~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEWH-----GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ceeeeEeecCCCeEEEEEEEC-----CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 445678999999999999763 3369999987543 334567999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCC---CChhhHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 592 EFLSNGTLASFLFGDLK---PGWSRRTDIAFGIARGLLYLHEECSTQ--IIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
||+++|+|.+++..... +++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999987643 89999999999999999999965 6 9999999999999999999999999998543
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.. ........||..|+|||.+.+..++.++||||||+++|||++|+.||........... .. .......
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---~~---~~~~~~~---- 259 (309)
T 3p86_A 191 ST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VG---FKCKRLE---- 259 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---HH---HSCCCCC----
T ss_pred cc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---hcCCCCC----
Confidence 22 2223445689999999999999999999999999999999999999976543321110 00 0000000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCCCC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPC 798 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~P~ 798 (804)
........+.+++.+||+.||.+|||+.+|++.|+.+.+...||.++
T Consensus 260 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 260 -----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred -----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 11122346788999999999999999999999999988776666554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=360.47 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=198.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||+|+.......+..||||++.... ....++|.+|+.++++++||||+++++++.+....++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3445678999999999999887544456689999997542 345568999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++|+|.+++... ..+++.++..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999765 4689999999999999999999965 999999999999999999999999999987654332
Q ss_pred Ccc--ccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 671 QTH--TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 671 ~~~--~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .. ...+.. .
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~~----i~~~~~----~-- 269 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---KA----VDEGYR----L-- 269 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---HH----HHTTEE----C--
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcCCC----C--
Confidence 221 12235678999999999999999999999999999998 99998755432211 11 111100 0
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.........+.+++.+||+.||.+||++.+|+++|+.+...
T Consensus 270 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 ---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 01112345788999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=354.03 Aligned_cols=260 Identities=26% Similarity=0.359 Sum_probs=209.2
Q ss_pred hhhHHhhCCCcceeEEEeeecC----ccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGM----ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~----~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 587 (804)
+.+.+.||+|+||.||+|+... ....+..||||++.... ....+.+.+|+.+++++ +||||+++++++.+....
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 162 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence 4456789999999999998642 22345679999997543 34456799999999999 899999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC
Q 047263 588 LLVYEFLSNGTLASFLFGDL----------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY 651 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~ 651 (804)
++||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|||++.+
T Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239 (370)
T ss_dssp EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence 99999999999999997542 478899999999999999999965 99999999999999999
Q ss_pred CCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHH
Q 047263 652 YNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTD 729 (804)
Q Consensus 652 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~ 729 (804)
+.+||+|||+++....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||......... .
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~---~ 316 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---K 316 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H
Confidence 9999999999986543322 22333457889999999999999999999999999999999 99998754332211 1
Q ss_pred HHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 730 WAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
. ...+... .........+.+++.+||+.||.+||++.||++.|+.++.+.
T Consensus 317 ~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 317 L----LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp H----HHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H----HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111110 011123457888999999999999999999999999887643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=342.05 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=208.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||++.....+ ..||+|++.... ....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILN---IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCC---CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 445678999999999999876543 379999985432 23456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999998888899999999999999999999965 999999999999999999999999999987654443
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......... ....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~------~~~~ 234 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDSVP------NVTT 234 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSCCC------CHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhccCC------Ccch
Confidence 4444567899999999999999999999999999999999999999765433211 011111110 0011
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCccCCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP-TMRKVTQMLEGVVEVLDPP 795 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~Le~~~~~~~pp 795 (804)
.........+.+++.+|++.||.+|| +++++.+.|+.+..-....
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 11122345788899999999999999 9999999999877655443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.63 Aligned_cols=261 Identities=21% Similarity=0.276 Sum_probs=212.5
Q ss_pred cccCHHHHHHHHhhh------------HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc
Q 047263 502 HCFTYKDLEAATNGF------------KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT 569 (804)
Q Consensus 502 ~~~~~~~l~~at~~f------------~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l 569 (804)
..+++++++.++... .++||+|+||.||+|+....+ +.||||++........+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g---~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG---RQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCC---cEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 568899999888642 347999999999999986443 37999999876666778899999999999
Q ss_pred ccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc
Q 047263 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD 649 (804)
Q Consensus 570 ~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~ 649 (804)
+||||+++++++......++||||+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 999999999999999999999999999999999864 5689999999999999999999965 999999999999999
Q ss_pred CCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHH
Q 047263 650 DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTD 729 (804)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 729 (804)
.++.+||+|||++....... .......||..|+|||++.+..++.++||||||+++|||++|+.||......... .
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---K 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H
T ss_pred CCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 99999999999998754322 2234567899999999999999999999999999999999999999765432211 1
Q ss_pred HHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 730 WAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
. ........+.. .......+.+++.+||+.||++|||+.++++-
T Consensus 252 ~----~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 R----LRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H----HHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H----HhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11111111100 11123467889999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.90 Aligned_cols=278 Identities=39% Similarity=0.620 Sum_probs=220.3
Q ss_pred cccccCHHHHHHHHhhhHH--------hhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhc
Q 047263 500 NLHCFTYKDLEAATNGFKE--------ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIG 567 (804)
Q Consensus 500 ~~~~~~~~~l~~at~~f~~--------~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~ 567 (804)
..+.|++.++..++.+|.+ .||+|+||.||+|... +..||||++.... .+..+.+.+|+.+++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----CceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 4578999999999999874 4999999999999863 2369999986432 334678999999999
Q ss_pred ccccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcC---CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCC
Q 047263 568 QTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG---DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQ 644 (804)
Q Consensus 568 ~l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~ 644 (804)
+++||||+++++++.+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~ 162 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA 162 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHH
Confidence 99999999999999999999999999999999999864 35689999999999999999999965 9999999999
Q ss_pred cEEEcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH
Q 047263 645 NILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA 723 (804)
Q Consensus 645 NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~ 723 (804)
||+++.++.+||+|||+++........ ......|+..|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 999999999999999999865432222 2234568999999998875 58899999999999999999999997543321
Q ss_pred HHHHHHHHHHhhh-cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 724 EALLTDWAYDCYC-EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 724 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
. +..+...... ........+... ..........+.+++.+||+.+|.+|||+.+|++.|+++.
T Consensus 242 ~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 L--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp B--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred H--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 0 0000000000 011111111111 1234566788999999999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.94 Aligned_cols=247 Identities=25% Similarity=0.321 Sum_probs=203.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.++||+|+||.||++.....+ +.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 23 ~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMDVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp CCCEEEEEETTEEEEEEEBTTTC---CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeeeccCCCeEEEEEEECCCC---cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 34578999999999999875443 379999997665666778999999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 174 (297)
T 3fxz_A 100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRS 174 (297)
T ss_dssp TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBC
T ss_pred CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccC
Confidence 999999999654 688999999999999999999965 99999999999999999999999999998654332 2334
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccH
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (804)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||............ ...... .+. ...
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~~-~~~-------~~~ 240 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTP-ELQ-------NPE 240 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCSC-CCS-------CGG
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCC-CCC-------Ccc
Confidence 567899999999999999999999999999999999999999765433221110 011110 000 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 755 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 23356788999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=348.73 Aligned_cols=267 Identities=24% Similarity=0.370 Sum_probs=205.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC--CCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 589 (804)
.+.+.++||+|+||.||+++... ....+..||||++........+.|.+|+.++++++||||+++++++.. ....++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 44567889999999999998532 223456899999987666667889999999999999999999999854 356899
Q ss_pred EEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999999765 4589999999999999999999965 9999999999999999999999999999876433
Q ss_pred CC--CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHH---------HHHHHHhhhc
Q 047263 669 QS--QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL---------TDWAYDCYCE 737 (804)
Q Consensus 669 ~~--~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l---------~~~~~~~~~~ 737 (804)
.. .......++..|+|||.+.+..++.++||||||+++|||++|..|+........... ..........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 22 122334467789999999999999999999999999999999998865432211100 0001111111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
+.. ..........+.+++.+||+.||++|||+.||++.|+.+.+-
T Consensus 248 ~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 248 NGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 100 011122345788999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.43 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=208.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.+.||+|+||.||++....+ ..||+|++.... ...+++.+|+.++.+++||||+++++++.++...++|||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQ----YDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred heeeeeeeccCCCceEEEEEecCc----eeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 445678899999999999987643 259999997543 345779999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999999764 4589999999999999999999965 9999999999999999999999999999876544333
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||.+.+..++.++||||||++++||++ |+.||........... ...+.. ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~--~~~----- 226 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-------VSQGHR--LYR----- 226 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTTCC--CCC-----
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-------HHcCCC--CCC-----
Confidence 3344556778999999999899999999999999999999 9999876543321110 011110 000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
+......+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111234688899999999999999999999999988764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=347.39 Aligned_cols=267 Identities=27% Similarity=0.356 Sum_probs=202.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC----ceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL----NRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 589 (804)
+.+.++||+|+||.||+|+.. +..||||++.... .....+..|+.++++++||||+++++++.+.. ..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhheecccCceEEEEEEEC-----CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 345678999999999999875 2479999997542 33445677999999999999999999997754 3699
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc-------CCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC-------STQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ +.+|+||||||+|||++.++.+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 9999999999999965 45899999999999999999999431 229999999999999999999999999999
Q ss_pred cccccCCCC-ccccccCCCcccccccccc-----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH----------H
Q 047263 663 KLLLLDQSQ-THTAIRGTKGYVAPEWFRN-----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA----------L 726 (804)
Q Consensus 663 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~----------~ 726 (804)
+.+...... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 876543322 2334578999999999976 35567899999999999999999998654221100 0
Q ss_pred HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
................+ . ...........+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVL-R---DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHTTSCCCCCC-C---GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCc-c---ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111111111111111 0 1112234566799999999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=335.65 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=206.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||++....+. .||+|++.... ...+++.+|++++++++||||+++++++.++...++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKD----KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTE----EEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ceeeheecCCCccEEEEEEecCCC----eEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 445678999999999999986433 59999997543 3457799999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999999654 5689999999999999999999965 99999999999999999999999999998764433333
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......... .. ...+... .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~~----~~~~~~~---------~ 227 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---ED----ISTGFRL---------Y 227 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH----HHTTCCC---------C
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH----HhcCccC---------C
Confidence 344556788999999999999999999999999999999 89998765433211 10 1111000 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.+......+.+++.+||+.||++||++.++++.|+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 011123568889999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=366.21 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=209.3
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||+|+||.||+|+.... +..||||.+... ....++|.+|+.++++++||||++++++|.+....+||||
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGG---TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HceeeeEecCCCCeEEEEEEEcCC---CeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 345678999999999999998753 347999999764 3356789999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999975 35688999999999999999999965 999999999999999999999999999987644333
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+....++.++||||||+++|||++ |+.|+......... ... ..+..
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~~--------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELL----EKDYR--------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHH----HTTCC---------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCCC---------
Confidence 33334456788999999999999999999999999999999 88888754432211 111 11110
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
..........+.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 001112345788899999999999999999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=339.41 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=195.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||+|...........||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 4456788999999999999987655556679999987543 334567999999999999999999999985 46789999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999999755 4689999999999999999999965 999999999999999999999999999987654433
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......+++.|+|||.+....++.++||||||+++|||++ |..||......... ... ..+....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i----~~~~~~~------- 237 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENGERLP------- 237 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----HTTCCCC-------
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHH----HcCCCCC-------
Confidence 33344456789999999998899999999999999999997 88998755432211 111 1111000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
........+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 238 --MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111234567889999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.61 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=202.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|+||.||+|.....+ ..||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTG---REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 345678999999999999886443 379999986532 344567889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||++...... .
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--G 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--C
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--C
Confidence 9999999999998888899999999999999999999965 9999999999999999999999999999865432 3
Q ss_pred ccccccCCCccccccccccCCCC-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPIT-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|+|||.+.+..++ .++||||||+++|||++|+.||.......... . ...+...
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~----i~~~~~~--------- 232 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE---R----VLRGKYR--------- 232 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H----HHHCCCC---------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH---H----HHhCCCC---------
Confidence 34556799999999999888775 79999999999999999999998654332111 0 1111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+......+.+++.+||+.||.+|||++|+++
T Consensus 233 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01112346778999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=361.98 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=206.4
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
...+.++||+|+||.||+|....+ ..||||++.... ...++|.+|+.++++++||||+++++++. ....++|||
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTT----EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HeEEEEEcccCCceEEEEEEECCc----cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 345678899999999999998643 369999998643 45788999999999999999999999986 567899999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999754 3678899999999999999999965 999999999999999999999999999987643222
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+....++.++||||||+++|||++ |+.||......... ... ..+.. .
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i----~~~~~--~------ 404 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RAL----ERGYR--M------ 404 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH----HHTCC--C------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCCC--C------
Confidence 22233446788999999998999999999999999999999 99999755432211 111 11100 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
..+......+.+++.+||+.||++|||+.+|+++|+.+....
T Consensus 405 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 001123457889999999999999999999999999986543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.44 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=204.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||+|+||.||++....+ ..||+|++.... ...+++.+|++++.+++|+||+++++++.+....++|||
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTT----EEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCC----CeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 344568899999999999987643 359999998543 345779999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999999976 46789999999999999999999965 9999999999999999999999999999876443333
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+...
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------~~~~~~~--------- 240 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------IAQGLRL--------- 240 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTTCCC---------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-------HhcccCC---------
Confidence 3334456788999999998899999999999999999998 9999876543321110 1111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.........+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0011123568889999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=348.99 Aligned_cols=261 Identities=28% Similarity=0.368 Sum_probs=207.0
Q ss_pred HHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
..+.+.+.||+|+||.||+|+... ....+..||||++... ..+...++.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 344567889999999999999653 2234557999999754 2345567899999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCC-------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC---CEEEee
Q 047263 589 LVYEFLSNGTLASFLFGD-------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY---NARISD 658 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~---~~kl~D 658 (804)
+||||+++|+|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999643 3578999999999999999999965 999999999999999554 599999
Q ss_pred cCcccccccCC-CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhh
Q 047263 659 FGLAKLLLLDQ-SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYC 736 (804)
Q Consensus 659 fgla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 736 (804)
||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......... .. ..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~~----i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EF----VT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HH----HH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HH
Confidence 99998653322 233344567899999999999999999999999999999998 99998765433211 11 11
Q ss_pred cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 737 EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.+.... ........+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 301 ~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111000 0112234678899999999999999999999999887643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.45 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=200.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCcc-ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|+||.||+|+....+ ....+||+|++.... ....++|.+|+.++++++||||+++++++.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 445678999999999999975433 334568999986432 355678999999999999999999999998754 78999
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.......
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 99999999999976 46789999999999999999999965 999999999999999999999999999987654332
Q ss_pred C-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 671 Q-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 671 ~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........... . ..+..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~----~~~~~-------- 237 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---L----EKGER-------- 237 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H----HTTCC--------
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH---H----HcCCC--------
Confidence 2 2233456889999999999999999999999999999999 9999976543321111 1 01110
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
..........+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 238 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 -LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00111233468889999999999999999999999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.62 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=205.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCc-e
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLN-R 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~-~ 587 (804)
.+.+.++||+|+||.||+|+... ....++.||||++.... ....+.+.+|++++.++ +||||+++++++.+... .
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 34456789999999999998643 33445689999997643 33456799999999999 79999999999987654 8
Q ss_pred EEEEeecCCCcHHHhhcCCCC-----------------------------------------------------------
Q 047263 588 LLVYEFLSNGTLASFLFGDLK----------------------------------------------------------- 608 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 608 (804)
++||||+++|+|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999976532
Q ss_pred -------CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-CccccccCCC
Q 047263 609 -------PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTK 680 (804)
Q Consensus 609 -------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~ 680 (804)
+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .......||.
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 78899999999999999999965 999999999999999999999999999986543322 2233456788
Q ss_pred ccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHH
Q 047263 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLAR 759 (804)
Q Consensus 681 ~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 759 (804)
.|+|||++.+..++.++||||||+++|||++ |+.||......... .. ....+..... .......
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~----~~~~~~~~~~---------~~~~~~~ 324 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR----RLKEGTRMRA---------PDYTTPE 324 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HH----HHHHTCCCCC---------CTTCCHH
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HH----HHHcCCCCCC---------CCCCCHH
Confidence 9999999999999999999999999999998 99999755332211 01 1111111100 1112346
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 760 FVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 760 l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+.+++..||+.||.+|||+.||++.|+.+++
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 7889999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.38 Aligned_cols=266 Identities=27% Similarity=0.338 Sum_probs=212.8
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCc----cccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCC
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMA----SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGL 585 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~----~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 585 (804)
..+.+.++||+|+||.||+|+.... ......||||++.... ....+++.+|+++++++ +||||+++++++.++.
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 3455678999999999999986432 1334579999997543 34457799999999999 9999999999999999
Q ss_pred ceEEEEeecCCCcHHHhhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDL----------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD 649 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~ 649 (804)
..++||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 9999999999999999997543 488999999999999999999965 999999999999999
Q ss_pred CCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHH
Q 047263 650 DYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALL 727 (804)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l 727 (804)
+++.+||+|||+++....... .......+|..|+|||++.+..++.++||||||++++||++ |+.|+.........
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~-- 303 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-- 303 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 999999999999987643322 22334557889999999999999999999999999999999 99998755432211
Q ss_pred HHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCC
Q 047263 728 TDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPC 796 (804)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~ 796 (804)
. ....+..... .......+.+++.+||+.||++|||+.||++.|+.+........
T Consensus 304 -~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 304 -K----LLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp -H----HHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred -H----HHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1 1111111100 11223568889999999999999999999999999876654443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=342.50 Aligned_cols=260 Identities=24% Similarity=0.345 Sum_probs=207.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|+..... ..+..||||.+.... ....+.|.+|+.++++++||||+++++++.++...++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 345678999999999999986422 234579999997543 34456799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCC------------------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 591 YEFLSNGTLASFLFGD------------------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
|||+++|+|.+++... ..+++.+++.++.||++||.|||+. +|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 9999999999999753 5688999999999999999999965 999999999999
Q ss_pred EEcCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHH
Q 047263 647 LLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAE 724 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~ 724 (804)
|++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 999999999999999987543322 22334567889999999999899999999999999999999 9999875543221
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
. . ....+..... .......+.+++.+||+.||++||++.+|++.|+.+.+-.
T Consensus 286 ~---~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 286 I---Y----YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H---H----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred H---H----HHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 1 1111111110 1122356888999999999999999999999999887643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=353.29 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=203.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|+...++ ..||||.+..... +..++|.+|+.++++++||||+++++++.++...++|||
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADN---TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEeeEeccCCCCeEEEEEEecCC---eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 445688999999999999987443 3799999875432 334578999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999754 4688999999999999999999965 9999999999999999999999999999864322111
Q ss_pred c-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 672 T-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 672 ~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
. .....++..|+|||.+....++.++||||||+++|||++ |+.|+......... .. ...+... .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~~----~~~~~~~--~----- 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EF----VEKGGRL--P----- 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---HH----HHTTCCC--C-----
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcCCCC--C-----
Confidence 1 112234678999999998899999999999999999998 99998765433211 11 1111100 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.+......+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 336 --~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 336 --CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 011123467889999999999999999999999988753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.87 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=203.4
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccc----cceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASM----YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
.+.+.+.||+|+||.||+|+....+. ....||+|.+........+.+.+|+.++++++||||+++++++.+++..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 44567889999999999998865432 13469999998766677788999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCC-CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC--------EEEeec
Q 047263 589 LVYEFLSNGTLASFLFGDLK-PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN--------ARISDF 659 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~--------~kl~Df 659 (804)
+||||+++|+|.+++..... +++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+||
T Consensus 89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999986644 89999999999999999999965 9999999999999998887 999999
Q ss_pred CcccccccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 660 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
|++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|..|+........... . ....
T Consensus 166 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~---~---~~~~ 234 (289)
T 4fvq_A 166 GISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ---F---YEDR 234 (289)
T ss_dssp CSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---H---HHTT
T ss_pred cccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH---H---hhcc
Confidence 99875421 223457889999999987 7799999999999999999996655543322211110 0 0000
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
..+. ......+.+++.+||+.||++|||+.++++.|+.+..-.
T Consensus 235 --~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 235 --HQLP---------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp --CCCC---------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred --CCCC---------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0000 011235778999999999999999999999999887643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.87 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=202.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc------ccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
+.+.+.||+|+||.||+++....+ ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTG---LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCC---CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456788999999999999987544 3799999875332 1357899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC----CEEEeecCccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY----NARISDFGLAK 663 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfgla~ 663 (804)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999998888899999999999999999999965 999999999999998776 79999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
..... .......||+.|+|||++.+..++.++||||||+++|||++|..||........ +.. .....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~~-----i~~~~---- 234 (361)
T 2yab_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN-----ITAVS---- 234 (361)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH-----HHTTC----
T ss_pred EcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhcC----
Confidence 75432 233456799999999999999999999999999999999999999976543321 100 00110
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ..........+.+++..||+.||.+|||+.|+++
T Consensus 235 ~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YDFD--EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCC--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCC--chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0000112356788999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=338.57 Aligned_cols=246 Identities=25% Similarity=0.266 Sum_probs=202.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++....+ +.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 345678999999999999986544 37999999753 234567789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-C
Confidence 99999999999998888899999999999999999999965 9999999999999999999999999999854322 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... . .+.. .
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i---~-~~~~---~------ 223 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---ELI---L-MEEI---R------ 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH---H-HCCC---C------
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---HHH---H-cCCC---C------
Confidence 2344567999999999999999999999999999999999999999765432211 000 0 1100 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.+......+.+++.+||+.||.+|| +++||++
T Consensus 224 -~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0112235678899999999999999 8999865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.04 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=203.6
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc------ccHHHHHHHHHHhcccccCCccceeeEEeCCC
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL 585 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 585 (804)
..+.+.+.||+|+||.||++.....+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEeceEEeeCCCeEEEEEEECCCC---cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34566788999999999999987544 3799999865322 24678999999999999999999999999999
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC----CEEEeecCc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY----NARISDFGL 661 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfgl 661 (804)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999998888899999999999999999999965 999999999999999887 799999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... . .. ... .
T Consensus 165 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~-~~----~~~-~ 234 (326)
T 2y0a_A 165 AHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA--N-VS----AVN-Y 234 (326)
T ss_dssp CEECCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH--H-HH----HTC-C
T ss_pred CeECCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--H-HH----hcC-C
Confidence 9875432 22344568999999999999999999999999999999999999997654322111 0 00 000 0
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 EFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCH-----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCc-----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000112356788999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=357.11 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=201.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+|....+ ..||||++.... ...++|.+|+.++++++||||+++++++.+ ...++||||
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTT----EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ceeeeeecCCCCeEEEEEEECCC----ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 44567899999999999998653 259999998643 345789999999999999999999999976 678999999
Q ss_pred cCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999743 5689999999999999999999965 9999999999999999999999999999876543333
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||.+....++.++||||||+++|||++ |+.|+......... .. ...+...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~----i~~~~~~--------- 400 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQ----VERGYRM--------- 400 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HH----HHTTCCC---------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcCCCC---------
Confidence 3334456789999999999999999999999999999999 89998755432211 11 1111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~p 794 (804)
..+......+.+++.+||+.||++|||+++|++.|+.+.....|
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 01112345788899999999999999999999999998765443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.21 Aligned_cols=256 Identities=27% Similarity=0.368 Sum_probs=209.9
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.+.||+|+||.||+|.....+ ..||+|.+... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGT---EEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCC---EEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34455678999999999999987543 47999999754 345678999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999753 5589999999999999999999976 99999999999999999999999999998765544
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
........++..|+|||.+.+..++.++||||||+++|||++ |..|+........... . ......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~----~~~~~~------- 231 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---L----EKDYRM------- 231 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---H----HTTCCC-------
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H----hccCCC-------
Confidence 444445567889999999999999999999999999999999 8888875543321111 1 011000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.........+.+++.+|++.||.+|||+.+|+++|+.+.+
T Consensus 232 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 232 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 0111223578899999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.68 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=195.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcc--cccCCccceeeEEeC----CCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ--THHKNLVRLLGFCDD----GLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~----~~~~ 587 (804)
+.+.+.||+|+||.||+|+.. +..||||++... ..+.+..|.+++.. ++||||+++++++.+ ....
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSWQ-----GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEET-----TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred EEEEEeeccCCCcEEEEEEEC-----CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 445678999999999999873 336999998753 34555666666655 799999999998654 3457
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc-----CCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC-----STQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
++||||+++|+|.+++. ...+++..+++++.||+.||.|||... +.+|+||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 89999999999999995 457899999999999999999999321 349999999999999999999999999999
Q ss_pred cccccCCCCc---cccccCCCccccccccccC------CCCccchhhHHHHHHHHHHcC----------CCCCCcchhHH
Q 047263 663 KLLLLDQSQT---HTAIRGTKGYVAPEWFRNM------PITVKVDVYSFGVLLLEIICC----------RRNVDMEVNEA 723 (804)
Q Consensus 663 ~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~s~~~DV~S~Gvll~elltG----------~~p~~~~~~~~ 723 (804)
+......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8654433221 2334789999999999876 455799999999999999999 77775432211
Q ss_pred HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
... ...............+ ............+.+++.+||+.||++|||+.+|++.|+++
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSF-EDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCH-HHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cch-hhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 100 0000000111111111 11112334667899999999999999999999999999865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=332.86 Aligned_cols=269 Identities=16% Similarity=0.162 Sum_probs=209.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.+.||+|+||.||+|+.... +..||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTT---TEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECCC---CcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 34567899999999999997544 3479999986432 334578899999999 79999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC-----EEEeecCcccccc
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN-----ARISDFGLAKLLL 666 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~-----~kl~Dfgla~~~~ 666 (804)
|+ +++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999864 468999999999999999999995 49999999999999987776 9999999998765
Q ss_pred cCCCC------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcc
Q 047263 667 LDQSQ------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGIT 740 (804)
Q Consensus 667 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (804)
..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43321 234456899999999999999999999999999999999999999764322111111111000000000
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCCCCCC
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPCPF 800 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~P~~~ 800 (804)
.. ........+.+++.+||+.||++||++.+|++.|+.+.+-.......++
T Consensus 243 ~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 293 (298)
T 1csn_A 243 RE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 293 (298)
T ss_dssp HH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred HH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcc
Confidence 00 0011235788999999999999999999999999998776555444443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=331.84 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=203.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.+.||+|+||.||+|+.......+..||+|.+.... ....+.|.+|+.++++++||||+++++++.+ ...++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 345678999999999999987665556679999997642 3456789999999999999999999999865 45689999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++++|.+++... ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999999754 5589999999999999999999965 9999999999999999999999999999876544433
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... . ..+....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---~----~~~~~~~-------- 234 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---L----EKGDRLP-------- 234 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---H----HHTCCCC--------
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---H----hcCCCCC--------
Confidence 3444567889999999998999999999999999999998 9999865433221110 1 0110000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
........+.+++.+||+.||++||++.|+++.|+.+.+
T Consensus 235 -~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 235 -KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 011123568889999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=336.39 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=207.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||++..... ...+..||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 44567899999999999987432 2334579999997543 34457899999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCC------------------------CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 591 YEFLSNGTLASFLFGDLK------------------------PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
|||+++++|.+++..... +++..++.++.||++||.|||+. +|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 999999999999976433 78889999999999999999965 999999999999
Q ss_pred EEcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHH
Q 047263 647 LLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAE 724 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~ 724 (804)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999876433222 2233456788999999999899999999999999999999 9999876543321
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
... ...+.... ........+.+++.+||+.||.+||++.+|++.|+.+.+
T Consensus 262 ~~~-------~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 262 FNL-------LKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHH-------HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-------hhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 11111100 111234578899999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=339.60 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=193.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCce---
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR--- 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 587 (804)
.+.+.+.||+|+||.||+|...........||||++... .....+.+.+|++++++++||||+++++++.+....
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 445678899999999999998765544457999999754 234567899999999999999999999999887665
Q ss_pred ---EEEEeecCCCcHHHhhcCC------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEee
Q 047263 588 ---LLVYEFLSNGTLASFLFGD------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658 (804)
Q Consensus 588 ---~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~D 658 (804)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 9999999999999999643 2588999999999999999999965 999999999999999999999999
Q ss_pred cCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhh
Q 047263 659 FGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYC 736 (804)
Q Consensus 659 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 736 (804)
||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ..
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-------~~ 253 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY-------LI 253 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HH
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH-------Hh
Confidence 999987543322 22233456788999999999999999999999999999999 8999876543321110 01
Q ss_pred cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 737 EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
.+... .........+.+++.+||+.||++|||+.++++.|+++++-+
T Consensus 254 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 254 GGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11100 011123357889999999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=341.19 Aligned_cols=268 Identities=15% Similarity=0.158 Sum_probs=201.3
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-----------cHHHHHHHHHHhcccccCCccceeeEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-----------GVKEFKTEVNVIGQTHHKNLVRLLGFC 581 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-----------~~~~f~~E~~~l~~l~h~niv~l~g~~ 581 (804)
.+.+.+.||+|+||.||+|........+..+|||+....... ..+.+.+|+..+..++|+||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 345678899999999999998765455668999998754321 122466788899999999999999999
Q ss_pred eC----CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC--CEE
Q 047263 582 DD----GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY--NAR 655 (804)
Q Consensus 582 ~~----~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~--~~k 655 (804)
.+ ....++||||+ +++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+|
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence 77 77889999999 999999998877899999999999999999999965 999999999999999877 999
Q ss_pred EeecCcccccccCCC------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHH
Q 047263 656 ISDFGLAKLLLLDQS------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTD 729 (804)
Q Consensus 656 l~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 729 (804)
|+|||+++.+..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-- 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ-- 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH--
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH--
Confidence 999999987643321 112445789999999999999999999999999999999999999965322221111
Q ss_pred HHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 730 WAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.............+.. ..........+.+++.+||+.||++||++++|++.|+.+..
T Consensus 272 ~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLDELPQSVLK----WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHTTTHHHHH----HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhcccccHHHHh----hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0111111111110000 00001234578899999999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=353.56 Aligned_cols=249 Identities=20% Similarity=0.198 Sum_probs=199.3
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.++||+|+||.||+++....+ +.||+|++.... ....+.+.+|+.++..++||||+++++++.++...+||||
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTT---EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEeCCCEEEEEEEEcCCC---cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3578999999999999987654 379999987421 1223348899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999987 57899999999999999999999965 9999999999999999999999999999876554444
Q ss_pred ccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHHHHhhhcCcccceec
Q 047263 672 THTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~ 745 (804)
......||+.|+|||++. ...++.++|||||||++|||++|+.||......... .+..... .+..
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------~~~~ 302 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---------RFQF 302 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---------HCCC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc---------cccC
Confidence 445568999999999987 567899999999999999999999999765433211 1100000 0000
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSL--RPTMRKVTQ 783 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~ 783 (804)
+.. .......+.+++.+||+.+|++ ||+++||++
T Consensus 303 p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 303 PTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred Ccc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 0112346778999999888887 999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.83 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=206.4
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCce-EEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR-LLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV~Ey~ 594 (804)
.++||+|+||.||+|...........+|+|.+..... ...+.|.+|+.++++++||||+++++++.+.+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4689999999999999876666666799999975433 4457899999999999999999999999876665 9999999
Q ss_pred CCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC---C
Q 047263 595 SNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ---S 670 (804)
Q Consensus 595 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~---~ 670 (804)
.+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999976 46688999999999999999999965 99999999999999999999999999998654322 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ +.... ......
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~----~~~~~~--------- 247 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFL----AQGRRL--------- 247 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHH----HTTCCC---------
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHh----hcCCCC---------
Confidence 223345678899999999999999999999999999999996666543322211 11111 011100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
.........+.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0011123568899999999999999999999999999766543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.05 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=197.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-------cHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-------GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
+.+.+.||+|+||.||+|+...++. .||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKS---VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCC---EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred ceehhccccCCceeEEEEEEcCCce---EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4456789999999999999865443 7999998643221 1267899999999999999999999997654
Q ss_pred eEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCC--eeecCCCCCcEEEcCCCC-----EEEee
Q 047263 587 RLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQ--IIHCDIKPQNILLDDYYN-----ARISD 658 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlkp~NILl~~~~~-----~kl~D 658 (804)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998888654 5789999999999999999999965 6 999999999999988776 99999
Q ss_pred cCcccccccCCCCccccccCCCcccccccc--ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhh
Q 047263 659 FGLAKLLLLDQSQTHTAIRGTKGYVAPEWF--RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC 736 (804)
Q Consensus 659 fgla~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (804)
||+++... .......||..|+|||.+ ....++.++||||||+++|||++|+.||............... .
T Consensus 173 fg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----~ 244 (287)
T 4f0f_A 173 FGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR----E 244 (287)
T ss_dssp CTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH----H
T ss_pred CCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh----c
Confidence 99997432 233446789999999998 4556789999999999999999999999755433221111100 1
Q ss_pred cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 737 EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
...... ........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 245 ~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EGLRPT---------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SCCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cCCCCC---------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 1112235788999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.01 Aligned_cols=257 Identities=18% Similarity=0.176 Sum_probs=202.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.+.||+|+||.||+|+.... ++.||||.+.... ..+.+.+|+++++++ +|+||+++++++.++...++||||
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYT---NEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTT---TEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEeeccCCceEEEEEECCC---CcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4567899999999999997544 3479999987532 234688999999999 999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC-----EEEeecCccccccc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN-----ARISDFGLAKLLLL 667 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~-----~kl~Dfgla~~~~~ 667 (804)
+ +++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++.+..
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 9999999976 46789999999999999999999965 9999999999999998887 99999999987644
Q ss_pred CCCC------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 668 DQSQ------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 668 ~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
.... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~--- 239 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT--- 239 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS---
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC---
Confidence 3322 1245679999999999999999999999999999999999999997643221111101000000000
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
..... ..... ++.+++..|++.||.+||++.+|++.|+.+.+
T Consensus 240 -----~~~~~-~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 240 -----PIEVL-CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp -----CHHHH-TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----CHHHH-hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 00000 00012 78899999999999999999999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=342.88 Aligned_cols=273 Identities=14% Similarity=0.157 Sum_probs=204.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccc--cceeEEEEEccccccccH-----------HHHHHHHHHhcccccCCccceee
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASM--YQVPVAVKKLHSVIQDGV-----------KEFKTEVNVIGQTHHKNLVRLLG 579 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~--~~~~vavK~~~~~~~~~~-----------~~f~~E~~~l~~l~h~niv~l~g 579 (804)
.+.+.++||+|+||.||+|....+.. .++.||||.+........ ..+..|+..+..++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 44567889999999999998875431 235799999875432111 12345666778889999999999
Q ss_pred EEeCC----CceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc--CCC
Q 047263 580 FCDDG----LNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD--DYY 652 (804)
Q Consensus 580 ~~~~~----~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~--~~~ 652 (804)
++.+. ...+|||||+ +++|.+++... ..+++..++.|+.||+.||.|||+. +|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 98765 4579999999 99999999765 6799999999999999999999965 999999999999999 889
Q ss_pred CEEEeecCcccccccCCCC------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH
Q 047263 653 NARISDFGLAKLLLLDQSQ------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL 726 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~ 726 (804)
.+||+|||+++.+...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876433221 1133459999999999999999999999999999999999999998543322111
Q ss_pred HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCC
Q 047263 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp 795 (804)
.......... ...+.+..+. ......++.+++..|++.+|.+||++.+|+++|+.+.+....+
T Consensus 272 --~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 272 --RDSKIRYREN-IASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp --HHHHHHHHHC-HHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred --HHHHHHhhhh-HHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1111111111 1111111110 0112356788999999999999999999999999877654433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=338.85 Aligned_cols=251 Identities=28% Similarity=0.394 Sum_probs=200.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.+.||+|+||.||+++....+. .||||++..... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCC---EEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeeEEecCCCEEEEEEEECCCCc---EEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3456789999999999998875443 799999864322 334568899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-CC
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-SQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~ 671 (804)
|+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999999888899999999999999999999965 99999999999999999999999999998764332 22
Q ss_pred ccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......... ..+. ..... ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~-----~~~~~--~~----- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWK-----EKKTY--LN----- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHHH-----TTCTT--ST-----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHh-----ccccc--CC-----
Confidence 3345679999999999987775 778999999999999999999997654322111 1110 11000 00
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 -~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011223567789999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.26 Aligned_cols=265 Identities=26% Similarity=0.355 Sum_probs=209.9
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCc----cccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCC
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMA----SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG 584 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~----~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 584 (804)
...+.+.+.||+|+||.||+|..... ...++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 34455678999999999999987531 1335579999997543 34456799999999999 899999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDL----------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl 648 (804)
...++||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997643 378999999999999999999965 99999999999999
Q ss_pred cCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHH
Q 047263 649 DDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEAL 726 (804)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~ 726 (804)
+.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH-
Confidence 9999999999999987643322 12233456788999999998899999999999999999999 99998755432211
Q ss_pred HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCC
Q 047263 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~p 794 (804)
... ..+.... ........+.+++.+||+.+|.+|||+.+|++.|+.+......
T Consensus 270 --~~~----~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 270 --KLL----KEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp --HHH----HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --HHH----hcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111 1111100 0112235688899999999999999999999999998766443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=329.80 Aligned_cols=254 Identities=30% Similarity=0.425 Sum_probs=204.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.+.||+|+||.||+|....+ ..||+|++... ....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred hhhheeeecCCCCeEEEEEEEcCC----cEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 345678899999999999987543 36999998754 3346789999999999999999999999864 56899999
Q ss_pred ecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999997643 689999999999999999999965 999999999999999999999999999987654333
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+.+..++.++||||||++++||++ |+.||........ . .. ...+...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~-~~----~~~~~~~-------- 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--I-QN----LERGYRM-------- 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H-HH----HHTTCCC--------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--H-HH----HhcccCC--------
Confidence 33334456788999999998899999999999999999999 8889875443221 1 11 1111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.........+.+++.+|++.||++|||+.+++++|+.+...
T Consensus 230 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 00112235788899999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.87 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=202.6
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
..+.+.+.||+|+||.||++.....+ ..||+|++.... ....+.+.+|+.++++++||||+++++++.++...++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44566788999999999999986543 379999996432 3345678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC---CCEEEeecCcccccc
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY---YNARISDFGLAKLLL 666 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfgla~~~~ 666 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++....
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999998888899999999999999999999965 99999999999999865 459999999998654
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .. ...+... ....
T Consensus 183 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~~----i~~~~~~-~~~~ 252 (362)
T 2bdw_A 183 DS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQ----IKAGAYD-YPSP 252 (362)
T ss_dssp TC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----HHHTCCC-CCTT
T ss_pred CC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HH----HHhCCCC-CCcc
Confidence 22 2234467999999999999999999999999999999999999999765432211 11 1111100 0000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.||++||++.++++
T Consensus 253 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 -----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00112356788999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=336.32 Aligned_cols=267 Identities=21% Similarity=0.266 Sum_probs=200.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCce---
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR--- 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 587 (804)
+.+.+.||+|+||.||+++.... ++.||||++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRD---HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCC---CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 44567899999999999997644 3479999997542 23345789999999999999999999998766544
Q ss_pred -EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 588 -LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 588 -~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 99999999999999998878899999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCC--CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 667 LDQS--QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 667 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.......... ........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~~---- 237 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPI---- 237 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCC----
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCCC----
Confidence 3322 22234568999999999999999999999999999999999999997654432111 11111110
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHhhcCccCCCCCCCCC
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMR-KVTQMLEGVVEVLDPPCPCP 799 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl~~Le~~~~~~~pp~P~~ 799 (804)
. ...........+.+++.+||+.||++||+.. ++.+.|..+....+|+.|..
T Consensus 238 ~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 238 P---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp C---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred C---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 0 0000111345688899999999999999554 55566666655555554443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=345.17 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=201.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
.+.+.++||+|+||.||++.....+ ..+|+|++.... ....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~---~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAG---QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTT---EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred CeEEEEEeccCCCeEEEEEEECCCC---cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4556788999999999999876543 479999986532 23456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc---CCCCEEEeecCccccccc
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLAKLLLL 667 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfgla~~~~~ 667 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ +++.+||+|||+++....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999999999888899999999999999999999965 999999999999998 568899999999986543
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
. ........||+.|+|||++.+..++.++||||+|+++|||++|+.||.......... ....+... +...
T Consensus 166 ~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~~-~~~~- 235 (444)
T 3soa_A 166 E-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ-------QIKAGAYD-FPSP- 235 (444)
T ss_dssp T-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHTCCC-CCTT-
T ss_pred C-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHhCCCC-CCcc-
Confidence 2 223345679999999999999999999999999999999999999997654332111 01111110 0000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++..||+.||.+|||+.|+++
T Consensus 236 ----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 ----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00112356788999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=343.27 Aligned_cols=259 Identities=24% Similarity=0.424 Sum_probs=195.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeC-CCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E 592 (804)
.+.+.||+|+||.||+|+..........||||.+.... ....++|.+|+.++++++||||+++++++.+ +...++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34578999999999999986554445679999987543 3456789999999999999999999998754 567899999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++|+|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999765 5678999999999999999999965 9999999999999999999999999999865433211
Q ss_pred ---ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 672 ---THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 672 ---~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+......... ... ..+.. ..
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~~----~~~~~--~~--- 316 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL----LQGRR--LL--- 316 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HHH----HTTCC--CC---
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HHH----HcCCC--CC---
Confidence 1233456788999999999999999999999999999999 56666543222111 001 11110 00
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
.+......+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 317 ----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 317 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01112346888999999999999999999999999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.22 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=194.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||+++.. +..||||++.. ....+.|.+|++++++++||||+++++++.+ ..++||||
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET-----TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred eeeeeEeecCCCceEEEEEEC-----CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 345678999999999999874 23699999975 3445789999999999999999999998874 58999999
Q ss_pred cCCCcHHHhhcCCC---CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC-EEEeecCcccccccCC
Q 047263 594 LSNGTLASFLFGDL---KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN-ARISDFGLAKLLLLDQ 669 (804)
Q Consensus 594 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~-~kl~Dfgla~~~~~~~ 669 (804)
+++|+|.+++.... .+++..++.++.||++||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999998664 3578889999999999999999743368999999999999998887 799999999764321
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||........... +. ...+.....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~------ 225 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WA-VHNGTRPPL------ 225 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH----HH-HHTTCCCCC------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH----HH-HhcCCCCCc------
Confidence 2234589999999999999999999999999999999999999975432221111 00 111111111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.......+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111234678899999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.53 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=208.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 588 (804)
.+.+.+.||+|+||.||+|.... ....+..||||++..... ...+.+.+|+.++.++ +||||+++++++.++...+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 34567889999999999998632 233456899999975432 3456799999999999 9999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCC------------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 589 LVYEFLSNGTLASFLFGDL------------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
+||||+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence 9999999999999997543 488999999999999999999965 9999999999999999
Q ss_pred CCCEEEeecCcccccccCCCCc-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHH
Q 047263 651 YYNARISDFGLAKLLLLDQSQT-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLT 728 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~ 728 (804)
++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||........ +.
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~ 258 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FY 258 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--HH
Confidence 9999999999998765433221 223456788999999999999999999999999999999 9999865432211 11
Q ss_pred HHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 729 DWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
... .+.... .........+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus 259 ~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 KMI----KEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHH----HHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHh----ccCCCC---------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111 111100 0011223578889999999999999999999999988654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.75 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=204.0
Q ss_pred hhhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 589 (804)
+.+.++||+|+||.||+++... +...+..||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 4556789999999999998532 23345689999997432 34567899999999999999999999999876 66899
Q ss_pred EEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 9999999999999954 46789999999999999999999965 9999999999999999999999999999876543
Q ss_pred CC--CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH--------HHHHHHHhhhcC
Q 047263 669 QS--QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL--------LTDWAYDCYCEG 738 (804)
Q Consensus 669 ~~--~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~--------l~~~~~~~~~~~ 738 (804)
.. .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ...........+
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 32 22334567888999999999999999999999999999999998864332111000 000000001111
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
.. ..........+.+++.+||+.||.+|||+.+++++|+.++
T Consensus 260 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 KR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00 0011223457889999999999999999999999999865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.40 Aligned_cols=270 Identities=25% Similarity=0.355 Sum_probs=206.9
Q ss_pred hhHHhhCCCcceeEEEeeec-CccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeC--CCceEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIG-MASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRLLV 590 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~-~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 590 (804)
.+.++||+|+||.||++... .....++.||||++.... .+..+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 45678999999999988653 223346689999997643 2445679999999999999999999999977 4567999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999754 489999999999999999999965 999999999999999999999999999987644322
Q ss_pred --CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHH--------HHHHHHhhhcCcc
Q 047263 671 --QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL--------TDWAYDCYCEGIT 740 (804)
Q Consensus 671 --~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l--------~~~~~~~~~~~~~ 740 (804)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ..........+.
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE- 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC-
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc-
Confidence 123345578889999999998999999999999999999999999875432211000 000000011110
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCCC
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCP 797 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~P 797 (804)
...........+.+++.+||+.||.+|||+.++++.|+.+.+...++.|
T Consensus 269 --------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 269 --------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred --------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 0111122345788999999999999999999999999998776554444
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=337.76 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=201.3
Q ss_pred hhHHhhCCCcceeEEEeeecCcc-ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||+|+....+ ....+||+|.+.... .+..+.+.+|+.++++++||||+++++++. +...++|+|
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 45678999999999999976443 334458889886432 233456788999999999999999999986 467899999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 99999999999765 5789999999999999999999965 9999999999999999999999999999976543322
Q ss_pred -ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 672 -THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 672 -~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... . ..+... ..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~----~~~~~~--~~---- 238 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---L----EKGERL--AQ---- 238 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH---H----HTTCBC--CC----
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH---H----HcCCCC--CC----
Confidence 2344567889999999999999999999999999999999 9999976543321111 1 111100 00
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 239 ---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 ---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00122356789999999999999999999999988754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.61 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=205.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||++....+ ..||+|++.... ...+++.+|++++++++||||+++++++.+....++||||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred eeeeeEecCCCceeEEEEEecCC----CeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 34567899999999999998643 369999998643 3457899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999764 5689999999999999999999965 99999999999999999999999999998654332222
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... . ....+... .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----~i~~~~~~---------~ 225 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---E----DISTGFRL---------Y 225 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTTCCC---------C
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---H----HHhcCCcC---------C
Confidence 333456788999999998899999999999999999999 89998765432211 1 01111100 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.+......+.+++.+|++.||++||++.++++.|+.+.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011123567889999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.18 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=201.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||+++...++ ..+|+|.+... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~---~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSK---KTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEeeeEEecCCCeEEEEEEECCCC---cEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 345678999999999999986544 37999998743 33456789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC--CCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD--YYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-- 157 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence 9999999999765 4789999999999999999999965 9999999999999987 789999999999875432
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +.. . ..... ... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~-i----~~~~~----~~~--~ 224 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IEN-I----MNAEY----TFD--E 224 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH-H----HHTCC----CCC--H
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--HHH-H----HcCCC----CCC--h
Confidence 233445689999999999998899999999999999999999999976543321 100 0 01100 000 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........++.+++.+||+.||.+|||+.|+++
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000112456889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.69 Aligned_cols=261 Identities=20% Similarity=0.213 Sum_probs=198.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||++.....+ ..||+|++..... ...+.+.+|+.++++++||||+++++++.++...++|
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRE---RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTT---EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCC---eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 445678999999999999876443 4799999975432 2346789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999998878899999999999999999999965 999999999999999999999999999987654433
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... . ........ . .
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~----~~~~~~~~----~---~ 255 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG---A----HINQAIPR----P---S 255 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH---H----HHHSCCCC----G---G
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH---H----HhccCCCC----c---c
Confidence 3344566899999999999999999999999999999999999999865433111 1 11111100 0 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCccCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP-TMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~Le~~~~~~~p 794 (804)
.........+.+++.+||+.||++|| +++++++.|+.......+
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 01112234678899999999999999 999999999987665543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.22 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=199.8
Q ss_pred hHHhhCCCcceeEEEeeecCcc-ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.||+|+||.||+|...... .....||||++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 4578999999999999876432 335579999997543 33456789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 128 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 9999999999764 6789999999999999999999965 99999999999999999999999999998764432221
Q ss_pred --cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 --HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 --~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... . ....+...
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~----~~~~~~~~-------- 269 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---K----AINDGFRL-------- 269 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTTCCC--------
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH---H----HHHCCCcC--------
Confidence 222345778999999999999999999999999999999 99998654332211 1 11111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.........+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 270 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 -PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00112335688899999999999999999999999886543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.93 Aligned_cols=251 Identities=22% Similarity=0.235 Sum_probs=199.9
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-----cccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-----QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
..+.+.+.||+|+||.||++.....+ +.||||++.... ....+.+.+|+.++++++||||+++++++.++..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETG---QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCC---CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45667789999999999999886544 379999986321 2246789999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC---EEEeec
Q 047263 587 RLLVYEFLSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN---ARISDF 659 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Df 659 (804)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998887542 3578999999999999999999965 9999999999999986654 999999
Q ss_pred CcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 660 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
|+++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..........+ ..+.
T Consensus 178 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i--------~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI--------IKGK 248 (351)
T ss_dssp TTCEECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHH--------HHTC
T ss_pred cceeEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHH--------HcCC
Confidence 999876432 2223445799999999999999999999999999999999999999986532211110 0110
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ..... .......+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 0112357788999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.76 Aligned_cols=265 Identities=20% Similarity=0.244 Sum_probs=205.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCC--ceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL--NRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV 590 (804)
+.+.+.||+|+||.||+|.....+ +.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred EEEEEEecCCCCeEEEEEEECCCC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 345678999999999999987543 379999997543 345677899999999999999999999997765 77999
Q ss_pred EeecCCCcHHHhhcCCC---CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE----cCCCCEEEeecCccc
Q 047263 591 YEFLSNGTLASFLFGDL---KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAK 663 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfgla~ 663 (804)
|||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997643 389999999999999999999965 99999999999999 778889999999998
Q ss_pred ccccCCCCccccccCCCccccccccc--------cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH--HHHHHHHHHH
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFR--------NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA--EALLTDWAYD 733 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~ 733 (804)
...... ......||..|+|||++. +..++.++||||||+++|||++|+.||....... ...+.. ...
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~ 241 (319)
T 4euu_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK-IIT 241 (319)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH-HHH
T ss_pred ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH-Hhc
Confidence 754322 233456899999999986 5788999999999999999999999996433211 111111 111
Q ss_pred hhhcCccccee-----------cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 734 CYCEGITEALV-----------EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 734 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.........+. ...............+.+++.+||+.||++|||+.|+++-...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 11111111000 0111122345667788999999999999999999999988764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.53 Aligned_cols=259 Identities=24% Similarity=0.426 Sum_probs=200.0
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEe-CCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCD-DGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~E 592 (804)
.+.+.||+|+||.||+|+..........+|+|.+.... ....+.+.+|+.++++++||||+++++++. ++...++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 45678999999999999987655556679999987543 344567999999999999999999999864 5567899999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 9999999999976 45688999999999999999999965 999999999999999999999999999986543321
Q ss_pred --CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCC-CCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 671 --QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR-RNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 671 --~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......+|..|+|||.+.+..++.++||||||++++||++|. .|+.......... .. ..+... .
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~----~~~~~~-~---- 252 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YL----LQGRRL-L---- 252 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HH----HTTCCC-C----
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HH----hcCCCC-C----
Confidence 1223345678899999999999999999999999999999955 4444332221110 00 011100 0
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
........+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 253 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 253 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 01112346888999999999999999999999999876644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.02 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=205.7
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCce
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 587 (804)
..+.+.+.||+|+||.||+|..... ...+..||||.+.... ....+.+.+|+.++.++ +||||+++++++.+....
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3445678899999999999987421 2235579999997532 23456799999999999 899999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCC-----------------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCC
Q 047263 588 LLVYEFLSNGTLASFLFGDL-----------------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQ 644 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~ 644 (804)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 99999999999999997643 268999999999999999999965 9999999999
Q ss_pred cEEEcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhH
Q 047263 645 NILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNE 722 (804)
Q Consensus 645 NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~ 722 (804)
|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999999999999999999876543322 2233457889999999999999999999999999999998 99998765332
Q ss_pred HHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 723 AEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.. +.. ....+... .........+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 282 ~~--~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 AN--FYK----LIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HH--HHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HH--HHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 111 11111110 01112245688899999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.34 Aligned_cols=249 Identities=25% Similarity=0.314 Sum_probs=202.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||+|.....+ ..+|+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATG---RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCEEEEEEEECCCC---CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 456688999999999999987544 37999998765555566899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC--CCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD--YYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 9999999999765 4789999999999999999999965 9999999999999974 578999999999875432
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||..|+|||++.+..++.++||||||+++|||++|+.||........ +.. .. ..... + . .
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~-i~----~~~~~-~-~----~ 271 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQN-VK----RCDWE-F-D----E 271 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH-HH----HCCCC-C-C----S
T ss_pred cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--HHH-HH----hCCCC-C-C----c
Confidence 223345689999999999999999999999999999999999999976543221 111 10 10000 0 0 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001122456789999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.76 Aligned_cols=251 Identities=28% Similarity=0.366 Sum_probs=191.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc----ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ----DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+|... +..+|||++..... +..+.+.+|+++++.++||||+++++++.++...++
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred eeeeeeeccCCCeEEEEEEEc-----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 345678999999999999874 23699999865322 335678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC--------CCCEEEeecCc
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD--------YYNARISDFGL 661 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~--------~~~~kl~Dfgl 661 (804)
||||+++++|.+++. ...+++..+..++.|+++||.|||+....+|+||||||+|||++. ++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999995 457899999999999999999999762223999999999999986 77899999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
+....... .....|+..|+|||.+.+..++.++||||||++++||++|+.||.......... .........
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~ 233 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAMNKLAL 233 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHTSCCCC
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhcCCCCC
Confidence 98654322 224568999999999999999999999999999999999999997654332111 001111110
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
. ........+.+++.+|++.||++|||+.|+++.|+.+
T Consensus 234 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 P---------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C---------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 1112235688999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=337.56 Aligned_cols=248 Identities=24% Similarity=0.313 Sum_probs=201.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||++.....+. .||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKK---MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCC---EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCC---EEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4456889999999999999875543 7999998643 234567889999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+.+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.. .
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--E 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT--T
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC--C
Confidence 99999999999999888899999999999999999999965 999999999999999999999999999987542 2
Q ss_pred CccccccCCCcccccccccc---CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 671 QTHTAIRGTKGYVAPEWFRN---MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~---~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+..... ....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~~------- 237 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTVV------- 237 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCCC-------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hccc-------
Confidence 33455679999999999964 458999999999999999999999997543322211111110 0000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPT-MRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~eVl~ 783 (804)
..+......+.+++.+||+.||.+||+ +++|.+
T Consensus 238 ---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011122457888999999999999998 777654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.92 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=197.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCc-----
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN----- 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~----- 586 (804)
+.+.+.||+|+||.||+|........+..||+|++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 44567899999999999988766555678999998743 23445679999999999999999999999977653
Q ss_pred eEEEEeecCCCcHHHhhc------CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecC
Q 047263 587 RLLVYEFLSNGTLASFLF------GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFG 660 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg 660 (804)
.++||||+++++|.+++. ....+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecC
Confidence 499999999999999983 34668999999999999999999995 499999999999999999999999999
Q ss_pred cccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 661 LAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 661 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......... .. ..+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---~~----~~~ 265 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD---YL----LHG 265 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HH----HTT
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---HH----HcC
Confidence 9987643322 22233456889999999999999999999999999999999 888886554332111 01 111
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
.... ........+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 266 ~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 266 HRLK---------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp CCCC---------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCC---------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1100 11122356889999999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=337.17 Aligned_cols=246 Identities=22% Similarity=0.271 Sum_probs=195.0
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
.+.||+|+||.||+|.....+ ..||+|++........+++.+|+.++++++||||+++++++.+....+|||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATG---LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTC---CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCC---cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 357999999999999886543 37999999876556677899999999999999999999999999999999999999
Q ss_pred CcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE--cCCCCEEEeecCcccccccCCCCcc
Q 047263 597 GTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL--DDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 597 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
++|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||+ +.++.+||+|||+++..... ...
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~ 245 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKL 245 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--ccc
Confidence 9999988654 4689999999999999999999965 99999999999999 56789999999999875432 223
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||+.|+|||++....++.++||||||+++|||++|+.||........ +.... .... . +.. ...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~----~~~~-~-~~~-----~~~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNIL----ACRW-D-LED-----EEF 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHH----HTCC-C-SCS-----GGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH----hccC-C-CCh-----hhh
Confidence 345689999999999999999999999999999999999999976543321 11111 0000 0 000 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+.+++.+||+.||.+|||+.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122457888999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.35 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=197.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+++....+ ..||||++... .....+.+..|..++..+ +||||+++++++.+....++
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~---~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETG---DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCC---CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 455788999999999999987544 37999999753 234456788999999988 79999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-N 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc-C
Confidence 999999999999998888899999999999999999999965 999999999999999999999999999985322 2
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ...+.. .
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---~----i~~~~~---~----- 242 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---A----ILNDEV---V----- 242 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H----HHHCCC---C-----
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH---H----HHcCCC---C-----
Confidence 233445679999999999999899999999999999999999999997664432110 0 011100 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTM------RKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm------~eVl~ 783 (804)
.+......+.+++.+||+.||.+||++ ++|++
T Consensus 243 --~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 --YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011123467889999999999999998 66653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=349.07 Aligned_cols=248 Identities=26% Similarity=0.343 Sum_probs=199.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC-ceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL-NRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~E 592 (804)
+.+.++||+|+||.||+|... +..||||.++... ..+.|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred eEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 345678999999999999875 2369999998642 4578999999999999999999999987665 7899999
Q ss_pred ecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++|+|.+++.... .+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999997643 368999999999999999999965 9999999999999999999999999999854221
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .. ...+...
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~----i~~~~~~-------- 405 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PR----VEKGYKM-------- 405 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HH----HHTTCCC--------
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcCCCC--------
Confidence 122356889999999999999999999999999999998 99998754332211 10 1111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
..+......+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 406 -~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 -DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01112345788899999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.97 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=179.0
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.||+|+||.||++.....+ +.||||++.. .....+.+|+.++..++ ||||+++++++.++...++||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSN---QAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTC---CEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCC---CEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 57999999999999987544 3799999874 34567789999999997 99999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC---CEEEeecCcccccccCCCCcc
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY---NARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~---~~kl~Dfgla~~~~~~~~~~~ 673 (804)
|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++..... ....
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~ 166 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPL 166 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCcc
Confidence 99999999888899999999999999999999965 999999999999997665 7999999999865332 2233
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||.+.+..++.++||||||+++|||++|+.||.....................+... + .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~-----~~~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-F-----EGEAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-C-----CSHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-C-----Ccccc
Confidence 44568999999999999999999999999999999999999997543221000000011111111110 0 00001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 123457889999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=338.61 Aligned_cols=266 Identities=26% Similarity=0.333 Sum_probs=208.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEe--CCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD--DGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 589 (804)
.+.+.++||+|+||.||+++... +...+..||||++........+.+.+|++++++++|+||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 34567789999999999998532 22345689999998766666778999999999999999999999886 4566889
Q ss_pred EEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 590 VYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999999999976 35689999999999999999999965 9999999999999999999999999999876433
Q ss_pred CCC--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHH--------HHHHHHhhhcC
Q 047263 669 QSQ--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL--------TDWAYDCYCEG 738 (804)
Q Consensus 669 ~~~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l--------~~~~~~~~~~~ 738 (804)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ..........+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 321 22334578889999999998999999999999999999999999865433211000 00000000011
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
. ...........+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 261 ~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 261 Q---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred c---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 011122234678899999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=362.12 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=200.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
++||+|+||.||+|...... .+..||||+++... ....++|.+|+.++++++|||||++++++.+ ...++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSS-CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCC-cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999765432 34579999997543 2346789999999999999999999999965 46889999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC--Ccc
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS--QTH 673 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~ 673 (804)
+|+|.+++.....+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999998888899999999999999999999965 999999999999999999999999999987654332 222
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
....+|..|+|||++.+..++.++||||||+++|||++ |+.||.......... ....+.... .
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i~~~~~~~---------~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------MLEKGERMG---------C 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTTCCCC---------C
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCCCC---------C
Confidence 33456788999999999999999999999999999998 999997654432111 111111110 1
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
+......+.+++..||+.||++||++.+|++.|+.+.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1123457889999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=360.24 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=206.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||+|+||.||+|....+ ..||||++.... ...++|.+|++++++++|+||+++++++.+ ...+||||
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTT----EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhheecccCCCeEEEEEEECCC----ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 345677899999999999998653 259999998643 345789999999999999999999999976 67899999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++|+|.++|... ..+++..++.|+.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999743 5689999999999999999999965 999999999999999999999999999987543222
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+....++.++||||||++||||++ |+.||......... .. ...+...
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~~----i~~~~~~-------- 483 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQ----VERGYRM-------- 483 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---HH----HHTTCCC--------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcCCCC--------
Confidence 22233446788999999999999999999999999999999 89998755332211 11 1111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCC
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~p 794 (804)
.........+.+++.+||+.||++|||+++|+++|+.+.....|
T Consensus 484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 00112345688899999999999999999999999998765433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=329.10 Aligned_cols=243 Identities=24% Similarity=0.281 Sum_probs=201.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++....+ +.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 345678999999999999986544 379999987532 24566788999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 9999999999999888889999999999999999999995 4999999999999999999999999999986432
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . ... .... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~---~i~-~~~~----~----- 221 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---E---KIL-NAEL----R----- 221 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H---HHH-HCCC----C-----
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H---HHH-hCCC----C-----
Confidence 233467999999999999999999999999999999999999999765432211 0 001 1110 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.+......+.+++.+||+.||.+|| ++++|++
T Consensus 222 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111235678899999999999999 8888873
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=342.96 Aligned_cols=248 Identities=19% Similarity=0.218 Sum_probs=198.3
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.++||+|+||.||+++....+. .+|+|++.... ....+.+.+|+.+++.++||||+++++++.++...+||||
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRK---VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCC---EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEcCCCEEEEEEEECCCCc---EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 45689999999999999875543 79999986421 2233458899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 150 ~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 150 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp CCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999999965 4688999999999999999999965 99999999999999999999999999998765443333
Q ss_pred cccccCCCccccccccccCC----CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 673 HTAIRGTKGYVAPEWFRNMP----ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~----~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.....||+.|+|||++.... ++.++|||||||++|||++|+.||.......... . + ..... .+..+.
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~-i----~~~~~-~~~~p~- 296 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--K-I----MNHKN-SLTFPD- 296 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H-H----HTHHH-HCCCCT-
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH--H-H----Hhccc-cccCCC-
Confidence 44677999999999998665 7899999999999999999999997654332111 0 0 00000 000000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSL--RPTMRKVTQ 783 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~ 783 (804)
.......+.+++.+||+.+|.+ ||+++||++
T Consensus 297 ----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 297 ----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ----cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0112356788999999999988 999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.47 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=198.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|.....+ ..||||++.... .+..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQ---QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 345678999999999999986544 379999986432 22345789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+ +|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 9999 789999998888899999999999999999999976 9999999999999999999999999999865432
Q ss_pred CccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ....+....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~~~~-- 224 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVNSCV-- 224 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCCSSC--
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHcCC--
Confidence 23344579999999999988776 789999999999999999999997543211 011110000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+......+.+++.+||+.||.+|||++|+++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0011122456788999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=331.30 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=191.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCc------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN------ 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------ 586 (804)
+.+.+.||+|+||.||+|+...++ +.||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDD---CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTC---CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred CceeeEecCCCCeEEEEEEEcCCC---cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 445678999999999999987443 379999997433 3355789999999999999999999999865432
Q ss_pred ---------------------------------------------------eEEEEeecCCCcHHHhhcCCCC---CChh
Q 047263 587 ---------------------------------------------------RLLVYEFLSNGTLASFLFGDLK---PGWS 612 (804)
Q Consensus 587 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~---l~~~ 612 (804)
.++||||+++++|.+++..... ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 7899999999999999987644 3455
Q ss_pred hHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-----------CccccccCCCc
Q 047263 613 RRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS-----------QTHTAIRGTKG 681 (804)
Q Consensus 613 ~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~ 681 (804)
.++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 6899999999999999965 999999999999999999999999999987654321 12234568999
Q ss_pred cccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHH
Q 047263 682 YVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFV 761 (804)
Q Consensus 682 y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 761 (804)
|+|||.+.+..++.++||||||+++|||++|..|+.... ... ......... .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----~~~-----~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----RII-----TDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----HHH-----HHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----HHH-----HHhhccCCC---------cccccCChhHH
Confidence 999999999999999999999999999999876642111 100 000111000 01122335668
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 047263 762 MVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 762 ~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+++.+||+.||++|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=322.40 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=203.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.+.||+|+||.||+|....... .+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRI---RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCC---EEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCc---EEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34556789999999999999875543 799999987666677889999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE---cCCCCEEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 999999999998888899999999999999999999965 99999999999999 78899999999999865432
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......||..|+|||.+.+. ++.++||||||++++||++|+.||.......... . ..++... ....
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~-----~~~~~~~-~~~~--- 229 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML--K-----IREGTFT-FPEK--- 229 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-----HHHCCCC-CCHH---
T ss_pred -cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH--H-----HHhCCCC-CCch---
Confidence 233445689999999998764 8999999999999999999999997654332111 0 1111100 0000
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+|++.||++|||+.++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 --DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00012357888999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=327.24 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=191.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--------------------------ccHHHHHHHHHHhc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------------------------DGVKEFKTEVNVIG 567 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~f~~E~~~l~ 567 (804)
+.+.+.||+|+||.||+|+....+ +.||||++..... ...+.+.+|+++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDN---TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTT---EEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred eEEEeEEeecCCEEEEEEEECCCC---cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 345678999999999999876543 4799999864321 12356899999999
Q ss_pred ccccCCccceeeEEeC--CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCc
Q 047263 568 QTHHKNLVRLLGFCDD--GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQN 645 (804)
Q Consensus 568 ~l~h~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 645 (804)
+++||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||++||.|||+. +|+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 9999999999999986 567899999999999988764 45789999999999999999999965 99999999999
Q ss_pred EEEcCCCCEEEeecCcccccccCCCCccccccCCCccccccccccCC---CCccchhhHHHHHHHHHHcCCCCCCcchhH
Q 047263 646 ILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP---ITVKVDVYSFGVLLLEIICCRRNVDMEVNE 722 (804)
Q Consensus 646 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~~DV~S~Gvll~elltG~~p~~~~~~~ 722 (804)
||++.++.+||+|||+++...... .......||..|+|||.+.+.. .+.++||||||+++|||++|+.||......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 999999999999999998754322 2233457899999999997665 478899999999999999999999765432
Q ss_pred HHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 723 AEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... .. ....... . + ........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~---~~----~~~~~~~-~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 CLH---SK----IKSQALE-F--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHH---HH----HHHCCCC-C--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHH---HH----HhcccCC-C--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 110 00 1111100 0 0 01112356888999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=328.07 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=188.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|.....+ +.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTG---VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ------------CEEEEEECSSSC---CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred eeEeeEECCCCCEEEEEEEECCCC---cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 456789999999999999876543 479999987543 2344678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 593 FLSNGTLASFLFGD------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 593 y~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
|++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999988642 4578999999999999999999965 99999999999999999999999999998754
Q ss_pred cCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhh---cCcccc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC---EGITEA 742 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~ 742 (804)
... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ...... +.....
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPNESLWPS 235 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCTTTCGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChhHhhh
Confidence 322 22334568999999999876 4689999999999999999999999976654322111 111000 000000
Q ss_pred ee-----------------cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LV-----------------EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~-----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ...............+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 000000011122357889999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.33 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=199.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC--CceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG--LNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 589 (804)
+.+.+.||+|+||.||+|+.. +..+|||++.... ....+.|.+|+.++++++||||+++++++.+. ...++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred hHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 345678999999999999975 3369999987542 34456799999999999999999999999887 78899
Q ss_pred EEeecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 590 VYEFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||||+++|+|.+++.... .+++..+..++.||++||.|||+. ...++||||||+||+++.++.++|.|||+.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999998765 489999999999999999999965 2229999999999999999999999998876422
Q ss_pred CCCCccccccCCCccccccccccCCCCc---cchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITV---KVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~---~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.....||+.|+|||.+.+...+. ++||||||+++|||++|+.||.......... ..........+
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~~- 232 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVALEGLRPTI- 232 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHHSCCCCCC-
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHhcCCCCCC-
Confidence 22345789999999998765544 7999999999999999999997654332111 11111111111
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.......+.+++..||+.||++|||++++++.|+.+.+
T Consensus 233 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 --------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11223468889999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=357.74 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=200.3
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
+||+|+||.||+|...... .+..||||+++... ....++|.+|+.++++++||||+++++++.+ +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSS-CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999876432 24579999997643 3456789999999999999999999999976 5689999999999
Q ss_pred cHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc--cc
Q 047263 598 TLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT--HT 674 (804)
Q Consensus 598 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~--~~ 674 (804)
+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999999754 5689999999999999999999965 99999999999999999999999999998764333221 12
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......... .. ...+... ..+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~----i~~~~~~---------~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AF----IEQGKRM---------ECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HH----HHTTCCC---------CCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HH----HHcCCCC---------CCC
Confidence 2345689999999999999999999999999999998 99999765433211 11 1111110 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
......+.+++..||+.+|++||++.+|++.|+.+...
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 12345788999999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=325.00 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=197.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||+|+....+ +.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeeeEecCCCCeEEEEEEECCCC---ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 345678999999999999987544 379999996432 233567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||++++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9998755555555567899999999999999999999965 9999999999999999999999999999875422 22
Q ss_pred ccccccCCCccccccccccCC-CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc---cee---
Q 047263 672 THTAIRGTKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE---ALV--- 744 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~-~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~--- 744 (804)
......||..|+|||.+.+.. ++.++||||||+++|||++|+.|+......... +.. ........... ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKR-IFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHH-HHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-HHHHhCCCChhhhhhhcccc
Confidence 334456899999999997765 799999999999999999999886444332211 111 11111000000 000
Q ss_pred cch---------hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 745 EFD---------IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 745 ~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+.. ............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000001123456789999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.46 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=195.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.++||+|+||.||+++....+ +.+|+|++.... .+..+.+..|..++.++ +||||+++++++.+....+|
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~---~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTD---RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 345678999999999999987554 379999997542 22334578899999887 89999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-P 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-T
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc-C
Confidence 999999999999998888899999999999999999999965 999999999999999999999999999985322 2
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH--HHHHHHHHHhhhcCcccceecch
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE--ALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........+........
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 280 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 280 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC------
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC------
Confidence 2334556799999999999999999999999999999999999999964322110 00001111111111100
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
.+......+.+++.+||+.||.+||++
T Consensus 281 ----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 ----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111234567889999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.53 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=201.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEe----CCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD----DGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~l 589 (804)
+.+.+.||+|+||.||+++....+ +.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDG---HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTC---CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCC---cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 456788999999999999976443 379999987655566778999999999999999999999986 3457889
Q ss_pred EEeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 590 VYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
|+||+++|+|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999874 46789999999999999999999965 9999999999999999999999999998764
Q ss_pred ccCCCC--------ccccccCCCccccccccccCC---CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh
Q 047263 666 LLDQSQ--------THTAIRGTKGYVAPEWFRNMP---ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC 734 (804)
Q Consensus 666 ~~~~~~--------~~~~~~gt~~y~aPE~l~~~~---~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 734 (804)
...... ......||..|+|||.+.... ++.++||||||+++|||++|+.||........... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-LA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-HH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-HH----
Confidence 321111 112345799999999987554 68999999999999999999999864322111110 00
Q ss_pred hhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
..... ...........+.+++.+||+.||.+|||+.+|++.|+.+....+
T Consensus 260 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 260 VQNQL---------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hhccC---------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 00100 000011223578899999999999999999999999998764433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.29 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=199.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCcc-ccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|+||.||+|.....+ ....+|++|.+... .....+++.+|+.++++++||||+++++++.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 445678999999999999975443 33445788888643 3456788999999999999999999999998764 88999
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 99999999999976 46789999999999999999999965 999999999999999999999999999987643322
Q ss_pred C-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 671 Q-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 671 ~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........... . ..+...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~----~~~~~~------- 238 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---L----EKGERL------- 238 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H----HTTCCC-------
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---H----HcCCCC-------
Confidence 2 2223456788999999999999999999999999999999 9999976544321111 1 011100
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.........+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 239 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 --PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 01111234678899999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=327.52 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=194.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||+++... +..||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQ----GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETT----SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhhccCCCCeEEEEEEECC----CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3456789999999999998754 3369999987432 223467899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++ +|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP-V 173 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-C
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC-c
Confidence 99985 777777654 5589999999999999999999965 9999999999999999999999999999875422 2
Q ss_pred CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc---c----
Q 047263 671 QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE---A---- 742 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~---- 742 (804)
.......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ........... .
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGTTS
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhhcc
Confidence 23344568999999999876 5689999999999999999999999976544321111 11111000000 0
Q ss_pred ---------eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 ---------LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ---------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
................++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000001112356789999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.13 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=206.2
Q ss_pred hhhHHhhCCCcceeEEEeeecC-ccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC--ceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGM-ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL--NRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~-~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV 590 (804)
+.+.+.||+|+||.||+++... ....+..||||++........+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 3456789999999999998532 22345689999998766666788999999999999999999999986654 78999
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999765 5689999999999999999999965 99999999999999999999999999998764433
Q ss_pred CC--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH---------HHHHHHHHhhhcC
Q 047263 670 SQ--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA---------LLTDWAYDCYCEG 738 (804)
Q Consensus 670 ~~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~---------~l~~~~~~~~~~~ 738 (804)
.. ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ............+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 21 122345677899999999888999999999999999999999887643221110 0000000111111
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.. ..........+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 280 ~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 280 GR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp CC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 00111234578899999999999999999999999988754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=328.66 Aligned_cols=248 Identities=22% Similarity=0.236 Sum_probs=191.5
Q ss_pred HHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhccc-ccCCccceeeEEeCC
Q 047263 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG 584 (804)
Q Consensus 508 ~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 584 (804)
++....+.+.++||+|+||+||+|+...++ +.||||++..... ....++..|+..+.++ +|+||+++++++.++
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDG---RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTS---CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCC---eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 444556667789999999999999987543 3799999864322 2333455565555555 899999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 585 LNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
...++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence 9999999999 6688888765 45689999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
..... .......||+.|+|||++.+ .++.++||||||+++|||++|..++....... ....+..
T Consensus 206 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~--- 269 (311)
T 3p1a_A 206 ELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ----------QLRQGYL--- 269 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH----------HHTTTCC---
T ss_pred ecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----------HHhccCC---
Confidence 65332 22344568999999999876 78999999999999999999987765432111 1111111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... .......+.+++.+||+.||++|||++|+++
T Consensus 270 -~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 -PPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Cccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 1122457889999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.55 Aligned_cols=268 Identities=22% Similarity=0.260 Sum_probs=195.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.||+|+||.||+++....+ ..||||++........+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITS---QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSC---CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ceecCCceEEEEEEEEcCCC---cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence 57999999999999876443 37999999876566678899999999885 799999999999999999999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC---EEEeecCcccccccCCC---
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLLLDQS--- 670 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Dfgla~~~~~~~~--- 670 (804)
++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 96 GSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 99999998888899999999999999999999965 9999999999999998776 99999999986542211
Q ss_pred ---CccccccCCCcccccccccc-----CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH--------HHHHHHHHHh
Q 047263 671 ---QTHTAIRGTKGYVAPEWFRN-----MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE--------ALLTDWAYDC 734 (804)
Q Consensus 671 ---~~~~~~~gt~~y~aPE~l~~-----~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~--------~~l~~~~~~~ 734 (804)
.......||..|+|||.+.. ..++.++||||||+++|||++|+.||........ ..........
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 11223458999999999875 5688999999999999999999999975432110 0000000111
Q ss_pred hhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCccCCCCCCC
Q 047263 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVVEVLDPPCP 797 (804)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~~~~~pp~P 797 (804)
...+... +.... .......+.+++.+||+.||.+|||+.|+++ .+.+.......|.|
T Consensus 253 i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~ 311 (316)
T 2ac3_A 253 IQEGKYE-FPDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTP 311 (316)
T ss_dssp HHHCCCC-CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----------
T ss_pred HhccCcc-cCchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCc
Confidence 1111100 00000 0112356889999999999999999999987 34444333333333
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.35 Aligned_cols=250 Identities=22% Similarity=0.233 Sum_probs=193.4
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
.+.+.+.||+|+||.||+++...+...+..||+|++.... ......+.+|+.++++++||||+++++++.++...+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 3456788999999999999886444456689999997542 233456889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 9999999999999998878889999999999999999999965 9999999999999999999999999999754322
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ + ... . .... .
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-~~i---~-~~~~----~--- 239 (327)
T 3a62_A 175 G-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--I-DKI---L-KCKL----N--- 239 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHH---H-HTCC----C---
T ss_pred C-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--H-HHH---H-hCCC----C---
Confidence 2 223345789999999999999999999999999999999999999976543221 1 001 0 1100 0
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.+......+.+++.+||+.||.+|| ++.++++
T Consensus 240 ---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 ---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0111235678899999999999999 6777764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.85 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=193.6
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
+....+.+.++||+|+||.||+|+... .+|+|++.... ....+.|.+|+.++++++|+||+++++++ ....
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 333445567899999999999997642 38999986432 34456799999999999999999999976 4567
Q ss_pred eEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 89999999999999999644 5689999999999999999999965 9999999999999999999999999999865
Q ss_pred ccCC-CCccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 666 LLDQ-SQTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 666 ~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
.... ........||..|+|||.+. ...++.++||||||+++|||++|+.||........ +..... .+...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG----RGSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH----HTSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc----ccccC
Confidence 4322 22234456899999999986 66788999999999999999999999976433221 111111 11110
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.... .........+.+++.+||+.+|.+|||+.+|+++|+.+.+
T Consensus 245 ----~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 ----PDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ----CCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----cchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0000 0111234578899999999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.98 Aligned_cols=245 Identities=27% Similarity=0.309 Sum_probs=200.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+++....+ +.||||++.... ....+.+..|..++..+ +||||+++++++.+....++
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 345678999999999999987543 479999997532 34556788899999877 99999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 171 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 171 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-
Confidence 999999999999998878899999999999999999999965 9999999999999999999999999999854322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+ ..... .
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i----~~~~~------~-- 236 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---HSI----RMDNP------F-- 236 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCCC------C--
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----HhCCC------C--
Confidence 22344567999999999999999999999999999999999999999765433211 101 11100 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMR-KVT 782 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 782 (804)
.+......+.+++.+||+.||++||++. +|+
T Consensus 237 --~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0111235678899999999999999997 664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.97 Aligned_cols=254 Identities=27% Similarity=0.356 Sum_probs=202.0
Q ss_pred hHH-hhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKE-ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~-~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+ .||+|+||.||+|...... .+..||||++..... ...+++.+|+.+++.++||||+++++++ +....++|||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hccCccccccCeeeEeeeecCCC-ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 445 8999999999999764332 345799999975432 3356899999999999999999999999 5677899999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 98 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred eCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 999999999998888899999999999999999999965 99999999999999999999999999998764433221
Q ss_pred --cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 673 --HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 673 --~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... . ....+....
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----~~~~~~~~~------- 240 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---A----MLEKGERMG------- 240 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H----HHHTTCCCC-------
T ss_pred cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---H----HHHcCCCCC-------
Confidence 222346788999999998889999999999999999999 99999765433211 1 111111110
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
........+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 241 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 241 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111234578899999999999999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=327.41 Aligned_cols=262 Identities=20% Similarity=0.298 Sum_probs=196.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|....++ ..||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDG---VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTC---CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcCCC---ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 455678999999999999876443 37999998742 234456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 591 YEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999863 46688999999999999999999965 99999999999999999999999999998654
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||........... . ..........
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~--- 258 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-K----KIEQCDYPPL--- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH-H----HHHTTCSCCC---
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH-H----HhhcccCCCC---
Confidence 322 222345689999999999999999999999999999999999999875432211111 1 0111111100
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp 795 (804)
........+.+++.+||+.||.+|||+.+|++.|+.+.....+|
T Consensus 259 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 259 -----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 01122356888999999999999999999999999987665444
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=335.43 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=186.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||+|+....+ +.||||++.... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQ---KPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCC---cEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 345678999999999999987543 379999997542 346788999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-- 204 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-- 204 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--
Confidence 99999999998888899999999999999999999965 9999999999999975 889999999999865332
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .+ ......... ....
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~-----~~i~~~~~~-~~~~---- 273 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MF-----RRILNCEYY-FISP---- 273 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HH-----HHHHTTCCC-CCTT----
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HH-----HHHHhCCCc-cCCc----
Confidence 223345689999999999999999999999999999999999999975543321 11 011111100 0000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.||++|||+.|+++
T Consensus 274 -~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123456788999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.76 Aligned_cols=271 Identities=24% Similarity=0.324 Sum_probs=199.2
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcc--cccCCccceeeEEeCC--
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ--THHKNLVRLLGFCDDG-- 584 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~-- 584 (804)
.....+.+.++||+|+||.||+|+.. +..||||++... ....+..|.+++.. ++||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34455667789999999999999875 347999998643 23344455555544 4999999999999877
Q ss_pred --CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc-----CCCeeecCCCCCcEEEcCCCCEEEe
Q 047263 585 --LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC-----STQIIHCDIKPQNILLDDYYNARIS 657 (804)
Q Consensus 585 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NILl~~~~~~kl~ 657 (804)
...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 6789999999999999999654 6899999999999999999999531 2289999999999999999999999
Q ss_pred ecCcccccccCCCCc---cccccCCCccccccccccCCCCcc------chhhHHHHHHHHHHcC----------CCCCCc
Q 047263 658 DFGLAKLLLLDQSQT---HTAIRGTKGYVAPEWFRNMPITVK------VDVYSFGVLLLEIICC----------RRNVDM 718 (804)
Q Consensus 658 Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~s~~------~DV~S~Gvll~elltG----------~~p~~~ 718 (804)
|||+++.+....... .....||..|+|||.+.+...+.+ +||||||+++|||++| ..|+..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998664333221 224568999999999987766655 9999999999999999 555543
Q ss_pred chhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 719 EVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 719 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
........ .. ......... .................+.+++.+||+.||.+|||+.+|++.|+.+.+..+
T Consensus 265 ~~~~~~~~-~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 265 LVPSDPSY-ED-MREIVCIKK---LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TSCSSCCH-HH-HHHHHTTSC---CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hcCCCCch-hh-hHHHHhhhc---cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 22111000 00 000000110 001111111223567789999999999999999999999999999877554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=331.63 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=196.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+++....+ +.||+|++.... ....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTD---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 345678999999999999987543 479999997542 23455688999999887 89999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 999999999999998878899999999999999999999965 9999999999999999999999999999853222
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH--HHHHHHHHhhhcCcccceecch
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA--LLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......+........
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 237 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 237 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------
Confidence 22344567999999999999999999999999999999999999999653211100 0000111111111100
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
.+......+.+++.+||+.||.+||++
T Consensus 238 ----~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 ----IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 011234567889999999999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.76 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=203.8
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc------ccHHHHHHHHHHhcccccCCccceeeEEeCCC
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL 585 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 585 (804)
..+.+.+.||+|+||.||++.....+ ..||+|.+..... ...+++.+|+.++++++||||+++++++.+..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCC---eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34566789999999999999987544 3799999865322 13678999999999999999999999999999
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC----CEEEeecCc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY----NARISDFGL 661 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfgl 661 (804)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999998888899999999999999999999965 999999999999999887 799999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
+...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. ......
T Consensus 166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-----i~~~~~- 235 (321)
T 2a2a_A 166 AHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN-----ITSVSY- 235 (321)
T ss_dssp CEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH-----HHTTCC-
T ss_pred ceecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HHH-----HHhccc-
Confidence 9875432 223345689999999999999999999999999999999999999976543321 100 001100
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. .... .......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~-~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DF-DEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC-CHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc-Chhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000 0112356788999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=332.57 Aligned_cols=243 Identities=21% Similarity=0.194 Sum_probs=201.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++....+ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEECCCC---CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 345678999999999999987543 379999986432 24567789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 99999999999998878899999999999999999999965 999999999999999999999999999986532
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|+|||++.+..++.++||||||+++|||++|+.||........ . .....+...
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~-----~~i~~~~~~--------- 256 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--Y-----EKIVSGKVR--------- 256 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-----HHHHHCCCC---------
T ss_pred -CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH--H-----HHHHcCCCC---------
Confidence 22345789999999999999999999999999999999999999976543221 1 011111110
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
.+......+.+++.+||+.||.+||+ +++|++
T Consensus 257 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01122356788999999999999998 888764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.28 Aligned_cols=252 Identities=27% Similarity=0.372 Sum_probs=202.1
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
.||+|+||.||+|...... .+..||||++.... ....+.+.+|++++++++||||+++++++ +.+..++||||++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred cccccCceeEEEeEeccCC-CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 7999999999999865332 24579999997643 34567799999999999999999999999 456789999999999
Q ss_pred cHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC--ccc
Q 047263 598 TLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ--THT 674 (804)
Q Consensus 598 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~ 674 (804)
+|.+++... ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||++......... ...
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 999999754 5689999999999999999999965 9999999999999999999999999999876433321 122
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
...+|..|+|||.+.+..++.++||||||+++|||++ |+.||......... .. ...+.... ..
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~----i~~~~~~~---------~~ 235 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AF----IEQGKRME---------CP 235 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HH----HHTTCCCC---------CC
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HH----HhcCCcCC---------CC
Confidence 3446889999999998899999999999999999998 99999765433211 11 11111100 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
......+.+++..||+.+|.+||++.+|++.|+.+..-
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 12345788899999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.98 Aligned_cols=250 Identities=22% Similarity=0.236 Sum_probs=189.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+++....+ +.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTK---ELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTC---CEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeccCCCEEEEEEEECCCC---cEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 456788999999999999987544 379999997543 2346688999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC--EEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN--ARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~--~kl~Dfgla~~~~~~~~~ 671 (804)
+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++.... ..
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HS 172 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc--cC
Confidence 99999999998878899999999999999999999965 9999999999999987765 99999999974322 22
Q ss_pred ccccccCCCccccccccccCCCCcc-chhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVK-VDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~-~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|+|||++.+..++.+ +||||||+++|||++|+.||.......... ....... .... .+
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~~-~~~~-~~------- 241 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRIL-SVKY-SI------- 241 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHHH-TTCC-CC-------
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHHh-cCCC-CC-------
Confidence 2334568999999999988887766 899999999999999999997543321100 0010100 0000 00
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000112356788999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=332.61 Aligned_cols=246 Identities=26% Similarity=0.292 Sum_probs=200.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+++.... ++.||+|++... .....+.+..|..++..+ +||||+++++++.+....++
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~---~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTE---EEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCC---CCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 44567899999999999998654 347999999753 234566788999999988 89999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD- 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-
Confidence 999999999999998878899999999999999999999965 9999999999999999999999999999853222
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|+|||++.+..++.++||||||+++|||++|+.||........ . .. .......
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~-~~----i~~~~~~-------- 239 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--F-QS----IMEHNVA-------- 239 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HH----HHHCCCC--------
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH--H-HH----HHhCCCC--------
Confidence 2234456799999999999999999999999999999999999999976543321 1 10 1111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
.+......+.+++.+||+.||.+||+ +++|++
T Consensus 240 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01123457888999999999999995 466653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.11 Aligned_cols=262 Identities=21% Similarity=0.240 Sum_probs=197.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||.||+++....+ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTG---QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEeeEEeecCCeEEEEEEeCCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 45678999999999999986543 3799999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence 999999999998888899999999999999999999965 99999999999999999999999999998754322 22
Q ss_pred cccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH--------HhhhcC-cccc
Q 047263 673 HTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY--------DCYCEG-ITEA 742 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~-~~~~ 742 (804)
.....||..|+|||.+.+ ..++.++||||||+++|||++|+.||................ ..+... ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 334568999999999876 678999999999999999999999997665443221111000 000000 0000
Q ss_pred eecchhhhcc-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEALN-----DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...+...... .......+.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 0123456889999999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=331.15 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=205.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhccc-ccCCccceeeEEeCCC-ce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGL-NR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~-~~ 587 (804)
.+.+.+.||+|+||.||+|+... ....+..||||++..... ...+.+.+|+.++.++ +||||+++++++.+.. ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 34556789999999999998643 223456899999975433 3456789999999999 7999999999987654 58
Q ss_pred EEEEeecCCCcHHHhhcCCCC----------------CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC
Q 047263 588 LLVYEFLSNGTLASFLFGDLK----------------PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY 651 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~ 651 (804)
++||||+++++|.+++..... +++..+..++.||++||.|||+. +|+||||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence 999999999999999976543 78899999999999999999965 99999999999999999
Q ss_pred CCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHH
Q 047263 652 YNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTD 729 (804)
Q Consensus 652 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~ 729 (804)
+.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........ +..
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~ 262 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR 262 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--HHH
Confidence 99999999999876443322 2234557889999999999999999999999999999998 9999865432211 101
Q ss_pred HHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 730 WAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
....+..... .......+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus 263 ----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 263 ----RLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ----HHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111111000 11123467889999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=346.39 Aligned_cols=247 Identities=26% Similarity=0.272 Sum_probs=192.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++....+ ..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATG---RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCC---CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 345678999999999999986544 37999999743 233456788999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-C
Confidence 99999999999998888899999999999999999999951 48999999999999999999999999999854322 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........... . .... ..
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---i---~~~~-~~--------- 367 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I---LMEE-IR--------- 367 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H---HHCC-CC---------
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---H---HhCC-CC---------
Confidence 234456799999999999999999999999999999999999999976543321110 0 0011 00
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 368 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 -FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111235678899999999999999 9999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.82 Aligned_cols=252 Identities=24% Similarity=0.244 Sum_probs=194.2
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-----ccccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-----IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
.+.+.+.||+|+||.||+++..... ..||+|++... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTR---AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred heeecceeeecCCeEEEEEEECCCC---ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 4566789999999999999876544 37999998643 234567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCC----------------------------------------CCCChhhHHHHHHHHHHHHHH
Q 047263 588 LLVYEFLSNGTLASFLFGD----------------------------------------LKPGWSRRTDIAFGIARGLLY 627 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~~ia~gL~y 627 (804)
++||||+++|+|.+++... ..+++..+..++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999998521 112456678899999999999
Q ss_pred hhhccCCCeeecCCCCCcEEEcCCC--CEEEeecCcccccccCCC---CccccccCCCcccccccccc--CCCCccchhh
Q 047263 628 LHEECSTQIIHCDIKPQNILLDDYY--NARISDFGLAKLLLLDQS---QTHTAIRGTKGYVAPEWFRN--MPITVKVDVY 700 (804)
Q Consensus 628 LH~~~~~~ivH~dlkp~NILl~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~ 700 (804)
||+. +|+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.+ ..++.++|||
T Consensus 184 LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9965 999999999999998766 899999999987643222 12345668999999999865 6789999999
Q ss_pred HHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHH
Q 047263 701 SFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 701 S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e 780 (804)
|||+++|||++|+.||.......... ......... .. .........+.+++.+||+.||.+||++.+
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~~~--~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKLCF--EN-----PNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCT--TS-----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHH------HHHhccccc--CC-----cccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 99999999999999997654332111 111111000 00 001112356788999999999999999999
Q ss_pred HHH
Q 047263 781 VTQ 783 (804)
Q Consensus 781 Vl~ 783 (804)
+++
T Consensus 328 ~l~ 330 (345)
T 3hko_A 328 ALQ 330 (345)
T ss_dssp HHH
T ss_pred Hhc
Confidence 986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.94 Aligned_cols=244 Identities=26% Similarity=0.338 Sum_probs=197.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||++....++. .||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCC---EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEccCCc---EEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 446789999999999998875543 79999986432 234567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++..... .
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---~ 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---S 162 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc---c
Confidence 999999999999887889999999999999999999995 4999999999999999999999999999865322 2
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||........... . ..... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~----~~~~~----------~ 225 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---I----SRVEF----------T 225 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---H----HHTCC----------C
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH---H----HhCCC----------C
Confidence 23345689999999999999999999999999999999999999976543321110 0 00000 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.+......+.+++.+||+.||.+|||+.||++-
T Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 011123467789999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.32 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=206.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
.+.+.+.||+|+||.||+|+... ....+..||||++..... .....|.+|+.++++++|+||+++++++.+....++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 34567889999999999998753 112345799999975432 345578999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCC----------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeec
Q 047263 590 VYEFLSNGTLASFLFGD----------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Df 659 (804)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence 99999999999999642 4568899999999999999999965 9999999999999999999999999
Q ss_pred CcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 660 GLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 660 gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......... . ...+
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~----~~~~ 255 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---R----FVME 255 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---H----HHHT
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---H----HHHc
Confidence 99986543322 12233456889999999999999999999999999999999 88888654332211 1 1111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+.... ........+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus 256 ~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11100 011233568889999999999999999999999988654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=334.31 Aligned_cols=265 Identities=15% Similarity=0.141 Sum_probs=203.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccc-----cceeEEEEEccccccccHHHHHHHHHHhcccccCCccc------------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASM-----YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVR------------ 576 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~-----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~------------ 576 (804)
+.+.+.||+|+||.||+|+...... .+..||+|.+... +.+.+|++++++++||||++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 4456889999999999999875311 2457999998753 46789999999999999988
Q ss_pred ---eeeEEeC-CCceEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 577 ---LLGFCDD-GLNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 577 ---l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 6677765 67889999999 99999999875 7899999999999999999999965 9999999999999999
Q ss_pred CC--CEEEeecCcccccccCCCC------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH
Q 047263 651 YY--NARISDFGLAKLLLLDQSQ------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE 722 (804)
Q Consensus 651 ~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~ 722 (804)
++ .+||+|||+++.+...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999876543221 123457899999999999999999999999999999999999999865422
Q ss_pred HHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 723 AEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
..... ... ..+... ...+...... .......+.+++.+||+.||++||++++|+++|+.+.+...
T Consensus 275 ~~~~~-~~~-~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 275 TEDIM-KQK-QKFVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHH-HHH-HHHHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHH-HHH-HhccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 21111 111 111111 1111111000 00123568889999999999999999999999999876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=329.63 Aligned_cols=257 Identities=27% Similarity=0.386 Sum_probs=202.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|+||.||+++...++. ...+++|++.... ....+.+.+|+++++++ +||||+++++++.+....++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTE-EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeecCCCceEEEEEEccCCc-ccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 4467889999999999999865432 2246999887532 33456789999999999 9999999999999999999999
Q ss_pred eecCCCcHHHhhcCCC----------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEE
Q 047263 592 EFLSNGTLASFLFGDL----------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNAR 655 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~k 655 (804)
||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEE
Confidence 9999999999997654 688999999999999999999965 999999999999999999999
Q ss_pred EeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHh
Q 047263 656 ISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDC 734 (804)
Q Consensus 656 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 734 (804)
|+|||+++.... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......... ..
T Consensus 183 L~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------~~ 253 (327)
T 1fvr_A 183 IADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------EK 253 (327)
T ss_dssp ECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HH
T ss_pred EcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH-------HH
Confidence 999999974322 112233456789999999998889999999999999999998 99999765432210 11
Q ss_pred hhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
...+... .........+.+++.+||+.||.+|||+.++++.|+.+.+-.
T Consensus 254 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 254 LPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111100 011122356888999999999999999999999998876544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.61 Aligned_cols=240 Identities=23% Similarity=0.286 Sum_probs=198.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--------ccHHHHHHHHHHhcccccCCccceeeEEeCCC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 585 (804)
+.+.+.||+|+||.||+|+....+ ..||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKN---KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTT---EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred eEEEeEEEecCCEEEEEEEECCCC---cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 344567999999999999876543 4799999875421 13345788999999999999999999999999
Q ss_pred ceEEEEeecCCC-cHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 586 NRLLVYEFLSNG-TLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 586 ~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
..++||||+.+| +|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999877 9999999888999999999999999999999965 999999999999999999999999999987
Q ss_pred cccCCCCccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
.... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ...
T Consensus 180 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~~~ 240 (335)
T 3dls_A 180 LERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------EAA 240 (335)
T ss_dssp CCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------TTC
T ss_pred CCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------hhc
Confidence 5432 22344668999999999988876 789999999999999999999997532110 000
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
... +......+.+++.+||+.||++|||+.++++-
T Consensus 241 ~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 IHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 11123467889999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.52 Aligned_cols=267 Identities=18% Similarity=0.196 Sum_probs=204.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEE-eCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFC-DDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~E 592 (804)
+.+.+.||+|+||.||+|+....+ +.||||++.... ..+++.+|+.+++.++|++++..+.++ .++...++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTT---EEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEccCCCeEEEEEEEcCCC---cEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 345678999999999999975443 479999986533 234688999999999998877777665 66677899999
Q ss_pred ecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE---cCCCCEEEeecCcccccccC
Q 047263 593 FLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 593 y~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfgla~~~~~~ 668 (804)
|+ +++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 999999997 356789999999999999999999965 99999999999999 58899999999999876543
Q ss_pred CCC------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCccc
Q 047263 669 QSQ------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITE 741 (804)
Q Consensus 669 ~~~------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~ 741 (804)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ ..+........ .....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-CCchH
Confidence 321 23445789999999999999999999999999999999999999975432111 11100000000 00000
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCCCCC
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPCP 799 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~P~~ 799 (804)
.........+.+++.+||+.||++|||+.+|++.|+.+......+...+
T Consensus 241 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~ 289 (296)
T 3uzp_A 241 ---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 289 (296)
T ss_dssp ---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCC
T ss_pred ---------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccc
Confidence 0001123568899999999999999999999999999876655544333
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=332.83 Aligned_cols=248 Identities=19% Similarity=0.260 Sum_probs=191.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhccccc--CCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHH--KNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||++.... +..||||++... ..+..+.+.+|+.++.+++| +||+++++++.++...++
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTT----SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeCC----CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3456789999999999998754 336999998643 23445779999999999976 999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||| +.+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999 56889999999888999999999999999999999965 999999999999997 5789999999998764433
Q ss_pred CC-ccccccCCCcccccccccc-----------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 670 SQ-THTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 670 ~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... .....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----~~~~~ 236 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-----AIIDP 236 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH-----HHHCT
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH-----HHhcC
Confidence 22 2334679999999999865 6789999999999999999999999975433211110 00000
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.... ..+......+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~---------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cccc---------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1000 0011112467889999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=334.31 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=205.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccc--cceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASM--YQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~--~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 588 (804)
.+.+.+.||+|+||.||+|.....+. ....||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+....+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 34556789999999999998754322 23469999997543 23456799999999999 8999999999999999999
Q ss_pred EEEeecCCCcHHHhhcC--------------CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCE
Q 047263 589 LVYEFLSNGTLASFLFG--------------DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNA 654 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~ 654 (804)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence 99999999999999964 23578999999999999999999965 99999999999999999999
Q ss_pred EEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHH
Q 047263 655 RISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAY 732 (804)
Q Consensus 655 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 732 (804)
||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........ +....
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~- 280 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYKLV- 280 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHHHH-
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHHHH-
Confidence 99999999876443322 2233456789999999999999999999999999999999 8888865432211 11111
Q ss_pred HhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
..+.... ........+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus 281 ---~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 281 ---KDGYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp ---HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hcCCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1111000 011123567889999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.24 Aligned_cols=261 Identities=23% Similarity=0.251 Sum_probs=195.8
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-----cccHHHHHHHHHHhcccc---cCCccceeeEEe
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-----QDGVKEFKTEVNVIGQTH---HKNLVRLLGFCD 582 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~ 582 (804)
...+.+.++||+|+||.||+|+....+ +.||||++.... ......+.+|+.++++++ ||||+++++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSG---HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTC---CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 345566789999999999999875443 379999986422 112345677777777765 999999999997
Q ss_pred CCC-----ceEEEEeecCCCcHHHhhcCCCC--CChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEE
Q 047263 583 DGL-----NRLLVYEFLSNGTLASFLFGDLK--PGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNAR 655 (804)
Q Consensus 583 ~~~-----~~~lV~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~k 655 (804)
... ..++||||+. ++|.+++..... +++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 655 4789999997 599999987644 89999999999999999999965 899999999999999999999
Q ss_pred EeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhh
Q 047263 656 ISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 656 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (804)
|+|||+++.... ........||..|+|||.+.+..++.++||||||+++|||++|+.||........... .....
T Consensus 161 l~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IFDLI 235 (308)
T ss_dssp ECSCSCTTTSTT--CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH---HHHHH
T ss_pred EeeCccccccCC--CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHh
Confidence 999999986532 2233456789999999999999999999999999999999999999976654332111 11111
Q ss_pred h---cCcc-ccee--cchh--h-----hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 736 C---EGIT-EALV--EFDI--E-----ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 736 ~---~~~~-~~~~--~~~~--~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. +... .... .... . .....+....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 0000 0000 0000 0 0001123467889999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.31 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=201.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|+....+ +.||||++.... .+..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTG---HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTC---CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 345678999999999999986443 379999996432 23456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-- 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 169 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence 9999999999999888889999999999999999999995 49999999999999999999999999999875432
Q ss_pred CccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ . .....+...
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~-----~~i~~~~~~-------- 234 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--F-----KKICDGIFY-------- 234 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--H-----HHHHTTCCC--------
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--H-----HHHhcCCcC--------
Confidence 23345679999999999988765 6899999999999999999999976543221 1 111111110
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+......+.+++.+||+.||.+|||+.||++
T Consensus 235 --~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01112346788999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=335.36 Aligned_cols=255 Identities=23% Similarity=0.236 Sum_probs=202.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 588 (804)
+.+.+.||+|+||.||+++...+...++.||||++.... ....+.+.+|+.++.++ +|+||+++++++.++...+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 455688999999999999986544456689999987432 23345678899999999 6999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+||||+++|+|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 9999999999999998878899999999999999999999965 9999999999999999999999999999876544
Q ss_pred CCCccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-HHHHHHHHHHhhhcCcccceec
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-EALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
.........||..|+|||++.+ ..++.++||||||+++|||++|+.||....... ...+.... . ....
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~-~~~~----- 283 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---L-KSEP----- 283 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---H-HCCC-----
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---h-ccCC-----
Confidence 4444455679999999999985 357899999999999999999999997543221 11111100 0 0000
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQML 785 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~L 785 (804)
.........+.+++.+||+.||.+|| ++.|+++..
T Consensus 284 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01112235678899999999999999 999998643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=338.83 Aligned_cols=248 Identities=21% Similarity=0.207 Sum_probs=197.2
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.||+|+||.||+++....+ +.||||++.... ....+.+.+|+.++..++|+||+++++++.+.+..+||||
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~---~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTG---QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 3568999999999999987544 379999997422 2233458899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++........
T Consensus 142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999764 5789999999999999999999965 9999999999999999999999999999876544433
Q ss_pred ccccccCCCccccccccc-------cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH-HHHHHHHHhhhcCcccce
Q 047263 672 THTAIRGTKGYVAPEWFR-------NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA-LLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~-------~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~ 743 (804)
......||+.|+|||++. ...++.++|||||||++|||++|+.||......... .+..+. . .+
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----~----~~ 289 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-----E----HL 289 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----H----HC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----c----Cc
Confidence 344567999999999987 457899999999999999999999999765433211 110000 0 00
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLR---PTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Psm~eVl~ 783 (804)
..+.. ......++.+++.+||+ +|.+| |+++||++
T Consensus 290 ~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 SLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00000 11123577889999999 99988 68999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.09 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=193.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||.||+++...+ ..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred hhhhhcccCCCEEEEEEEcCCC----CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4567899999999999987433 369999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++ +|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VR 155 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc-cc
Confidence 9985 898888754 6788999999999999999999965 9999999999999999999999999999865432 22
Q ss_pred ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc------ce-
Q 047263 672 THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE------AL- 743 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~~- 743 (804)
......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... . ........... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--R-IFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H-HHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHHCCCChhhchhhhccc
Confidence 2334568999999999875 458999999999999999999999997654332111 1 11111000000 00
Q ss_pred -ecchh-------hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 -VEFDI-------EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 -~~~~~-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+... ...........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00001123456789999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.03 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=201.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||++.....+. .||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCC---EEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCc---eEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3456789999999999998875443 79999986432 334567889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC---EEEeecCcccccccC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLLLD 668 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Dfgla~~~~~~ 668 (804)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 9999999999998888899999999999999999999965 9999999999999986655 99999999976543
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
........|+..|+|||.+.+..++.++||||||++++||++|+.||........... . ..+... ....
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~----~~~~~~-~~~~-- 229 (284)
T 3kk8_A 161 -SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ---I----KAGAYD-YPSP-- 229 (284)
T ss_dssp -SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H----HHTCCC-CCTT--
T ss_pred -CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH---H----Hhcccc-CCch--
Confidence 2223345689999999999999999999999999999999999999976543321110 0 111100 0000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.||++|||+.|+++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 ---EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112356788999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.41 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=200.4
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC-------
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD------- 583 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------- 583 (804)
...+.+.+.||+|+||.||+++....+ +.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDG---KTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTC---CEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCC---eEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 344556788999999999999986443 379999997543 356789999999999999999998854
Q ss_pred ---------CCceEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC
Q 047263 584 ---------GLNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652 (804)
Q Consensus 584 ---------~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~ 652 (804)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||+++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 44578999999999999999643 6789999999999999999999965 999999999999999999
Q ss_pred CEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH
Q 047263 653 NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY 732 (804)
Q Consensus 653 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 732 (804)
.+||+|||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|..|+...... .
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---------~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF---------F 228 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH---------H
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH---------H
Confidence 99999999998764332 233456899999999999999999999999999999999999886422110 0
Q ss_pred HhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCCC
Q 047263 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPC 796 (804)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp~ 796 (804)
.....+... ......+.+++.+||+.||.+|||+.|+++.|+.+...+....
T Consensus 229 ~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 229 TDLRDGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp HHHHTTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred HHhhccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 111111111 1122457789999999999999999999999998876655443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.41 Aligned_cols=265 Identities=16% Similarity=0.161 Sum_probs=198.7
Q ss_pred hhhHHhhCCC--cceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKG--AFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G--~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.++||+| +||.||+++....+ +.||||++.... .+..+.+.+|+.++++++||||+++++++.+++..++
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTG---EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCC---CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4456889999 99999999987543 379999997543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 590 VYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999765 6789999999999999999999965 999999999999999999999999999875432
Q ss_pred CCC------CccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH--HHHHHHHHh---
Q 047263 668 DQS------QTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA--LLTDWAYDC--- 734 (804)
Q Consensus 668 ~~~------~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~--~l~~~~~~~--- 734 (804)
... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+.......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 211 11223468899999999987 67999999999999999999999999654322110 000000000
Q ss_pred -------h---------hcCcccceecch--------hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 735 -------Y---------CEGITEALVEFD--------IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 735 -------~---------~~~~~~~~~~~~--------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
. .......+.... ............+.+++.+||+.||++|||++|+++-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 000000000000 0000111234568899999999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.39 Aligned_cols=251 Identities=29% Similarity=0.396 Sum_probs=202.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||++.....+ ..||||++.... ....+.+.+|+.+++.++||||+++++++.++...++|+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCC---cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3455678999999999999886543 379999986433 344577899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC-
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS- 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~- 670 (804)
||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999999998888899999999999999999999965 999999999999999999999999999986543321
Q ss_pred CccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......|+..|+|||.+.+..+ +.++||||||++++||++|+.||......... ...+ ...... . .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~-----~~~~~~-~-~---- 229 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-----KEKKTY-L-N---- 229 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHH-----HTTCTT-S-T----
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHh-----hhcccc-c-C----
Confidence 22344568999999999987765 77999999999999999999999765432211 1111 111000 0 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122346778999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=332.40 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=185.1
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEe--------C
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCD--------D 583 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~--------~ 583 (804)
.+.+.++||+|+||.||+++....+ +.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSG---REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred eEEEEEEEccCCceEEEEEEECCCC---cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3455688999999999999976443 379999987665566778999999999996 999999999983 3
Q ss_pred CCceEEEEeecCCCcHHHhhcC---CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecC
Q 047263 584 GLNRLLVYEFLSNGTLASFLFG---DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFG 660 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg 660 (804)
....++|+||+. |+|.+++.. ...+++..++.++.||+.||.|||+. ..+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 445789999996 799888864 46789999999999999999999965 1229999999999999999999999999
Q ss_pred cccccccCCCC-----------ccccccCCCcccccccc---ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH
Q 047263 661 LAKLLLLDQSQ-----------THTAIRGTKGYVAPEWF---RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL 726 (804)
Q Consensus 661 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~l---~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~ 726 (804)
+++........ ......||..|+|||.+ .+..++.++||||||+++|||++|+.||....... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~ 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--I 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--h
Confidence 99876432221 11234589999999998 56778999999999999999999999996432211 0
Q ss_pred HHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
+ .... .... .......+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 262 ~---------~~~~----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 V---------NGKY----SIPP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -------------C----CCCT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred h---------cCcc----cCCc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 0000 0000 0111234678999999999999999999999999876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.50 Aligned_cols=263 Identities=19% Similarity=0.205 Sum_probs=201.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEE-eCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFC-DDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||+|+....+ ..||||.+.... ..+++.+|+.+++.++|++++..+..+ .++...++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCC---ceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3456788999999999999876443 379999865432 223578899999999988877777766 6677789999
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE---cCCCCEEEeecCccccccc
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfgla~~~~~ 667 (804)
||+ +++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 9999999974 56789999999999999999999965 99999999999999 7899999999999987654
Q ss_pred CCC------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcc
Q 047263 668 DQS------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGIT 740 (804)
Q Consensus 668 ~~~------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~ 740 (804)
... .......||..|+|||.+.+..++.++||||||+++|||++|+.||........ ..+........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~- 238 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STP- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSC-
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-cch-
Confidence 332 122345789999999999999999999999999999999999999975432211 11100000000 000
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCC
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDP 794 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~p 794 (804)
.. .........+.+++.+||+.||++|||+.+|++.|+.+.+-...
T Consensus 239 -------~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 -------IE-VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -------HH-HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred -------hh-hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 00 00011235788999999999999999999999999987765443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.40 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=195.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC----CCceE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD----GLNRL 588 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 588 (804)
.+.++||+|+||.||+|...... ..||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~---~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCc---eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34567999999999999886544 379999986432 3445679999999999999999999998864 45689
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfgla~~~~~ 667 (804)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. ..+|+||||||+|||++ +++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999998878899999999999999999999965 12399999999999998 789999999999975432
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......|+..|+|||.+.+ .++.++||||||+++|||++|+.||.......... .....+... ..
T Consensus 185 ---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~----~~ 250 (290)
T 1t4h_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------RRVTSGVKP----AS 250 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH------HHHTTTCCC----GG
T ss_pred ---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH------HHHhccCCc----cc
Confidence 22334568999999998874 58999999999999999999999997543322111 111111111 01
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ......+.+++..||+.||.+|||+.++++
T Consensus 251 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 FD----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC----CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 111246888999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=326.06 Aligned_cols=259 Identities=26% Similarity=0.321 Sum_probs=197.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|+..........||||++.... .+..+.+.+|+.++++++||||+++++++.++. .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 455678999999999999876544445579999987532 344678999999999999999999999998765 8899
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+||+++++|.+++... ..+++..+..++.||++||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999764 5688999999999999999999965 99999999999999999999999999998764333
Q ss_pred CC--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 670 SQ--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 670 ~~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ + . .........
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~-~---~~~~~~~~~----- 244 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--L-H---KIDKEGERL----- 244 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H-H---HHHTSCCCC-----
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--H-H---HHHccCCCC-----
Confidence 21 1223457788999999998889999999999999999999 9999976543221 1 0 111111000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.........+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 245 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 ----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01112345788999999999999999999999999876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=331.93 Aligned_cols=263 Identities=28% Similarity=0.368 Sum_probs=202.2
Q ss_pred HHHHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCc
Q 047263 510 EAATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 510 ~~at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 586 (804)
....+.+.+.||+|+||.||+|+... ....+..||||++... ......++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 33445567899999999999998543 2234557999999743 23455679999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC-------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEE
Q 047263 587 RLLVYEFLSNGTLASFLFGD-------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARI 656 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl 656 (804)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999754 3478899999999999999999965 9999999999999984 456999
Q ss_pred eecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHh
Q 047263 657 SDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDC 734 (804)
Q Consensus 657 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 734 (804)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......... ...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~--- 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFV--- 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH---
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HHH---
Confidence 99999986543322 22334567889999999998899999999999999999998 88888755432211 111
Q ss_pred hhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 735 YCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
..+.... ........+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 259 -~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 -TSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -hcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1111100 0112234678899999999999999999999999887543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.38 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=196.7
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||++.....+ +.||||.+...... +.+|++++.++ +||||+++++++.++...++||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATN---MEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3455678999999999999986543 47999999754332 35678888877 7999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC----CCEEEeecCccccccc
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY----YNARISDFGLAKLLLL 667 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~----~~~kl~Dfgla~~~~~ 667 (804)
||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999999888899999999999999999999965 99999999999998543 3499999999987643
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.. .......||+.|+|||++.+..++.++||||||+++|||++|..||..........+.... ..+...
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~------ 241 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS------ 241 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC------
T ss_pred CC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc------
Confidence 32 2334467899999999998888999999999999999999999999754322211111111 111110
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
............+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011123456788999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.78 Aligned_cols=243 Identities=26% Similarity=0.275 Sum_probs=189.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHH-hcccccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNV-IGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+++....+ +.+|||++.... ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~---~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEE---VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTC---CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 456789999999999999987544 379999997543 2234456777776 577899999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 999999999999998878889999999999999999999965 9999999999999999999999999999864322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......... . ........ +
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~----~i~~~~~~-~------ 258 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---D----NILNKPLQ-L------ 258 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH---H----HHHHSCCC-C------
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---H----HHHhcccC-C------
Confidence 22344567999999999999999999999999999999999999999765433211 0 01111100 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e 780 (804)
.......+.+++.+||+.||.+||++.+
T Consensus 259 ---~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 259 ---KPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1112346788999999999999999854
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.77 Aligned_cols=252 Identities=19% Similarity=0.176 Sum_probs=198.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEccccccccHHHHHHHHHHhcccc---cCCccceeeEEeCCCce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 587 (804)
.+.+.++||+|+||.||+|.... ....+..||||++... ...++..|+.++..++ |+||+++++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 34456789999999999996432 1233457999999754 3456677777777665 99999999999999999
Q ss_pred EEEEeecCCCcHHHhhc-----CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-----------C
Q 047263 588 LLVYEFLSNGTLASFLF-----GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-----------Y 651 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-----------~ 651 (804)
++||||+++|+|.+++. ....+++..+..|+.||++||.|||+ .+|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999997 35678999999999999999999995 49999999999999998 8
Q ss_pred CCEEEeecCcccccccC-CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH
Q 047263 652 YNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW 730 (804)
Q Consensus 652 ~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 730 (804)
+.+||+|||+++.+... .........||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 99999999999765422 23334556799999999999999999999999999999999999999864422110
Q ss_pred HHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhhcCccC
Q 047263 731 AYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLR-PTMRKVTQMLEGVVEV 791 (804)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Psm~eVl~~Le~~~~~ 791 (804)
. ........ ...+.+.+++..|++.+|.+| |+++++.+.|+.+.+.
T Consensus 294 --------~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 --------K----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------E----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------e----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 00111111 123456678888999999988 6899999998876554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.38 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=203.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++....+ ..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNK---FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeheecCCCCeEEEEEEEcCCC---cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 445678999999999999986543 379999986432 23456789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--- 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence 9999999999999887889999999999999999999995 4999999999999999999999999999875432
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... . ...... .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~-~~~~~~------~--- 230 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------R-IVNVDL------K--- 230 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H-HHTTCC------C---
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------H-Hhcccc------C---
Confidence 22334568999999999999999999999999999999999999997654332111 0 001100 0
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCc
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVV 789 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~ 789 (804)
.+......+.+++.+|++.||.+||++.++++ .+....
T Consensus 231 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 231 -FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 01112356788999999999999999999985 454433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.61 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=200.1
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc------ccHHHHHHHHHHhcccccCCccceeeEEeCCC
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL 585 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 585 (804)
..+.+.+.||+|+||.||+++....+ ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTG---KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCC---CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 34566789999999999999987543 3799999864321 24678999999999999999999999999999
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC----CEEEeecCc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY----NARISDFGL 661 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfgl 661 (804)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+. +++||||||+||+++.++ .+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999999998878899999999999999999999965 999999999999998877 899999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 741 (804)
+....... ......++..|+|||.+.+..++.++||||||++++||++|+.||........ +.. ......
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-----~~~~~~- 228 (283)
T 3bhy_A 159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LTN-----ISAVNY- 228 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH-----HHTTCC-
T ss_pred ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HHH-----hHhccc-
Confidence 98654322 22345689999999999999999999999999999999999999976543221 100 001100
Q ss_pred ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ... ........+.+++.+||+.||++||++.++++
T Consensus 229 ~~-~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DF-DEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC-CHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-cch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 000 00112356788999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.40 Aligned_cols=244 Identities=25% Similarity=0.308 Sum_probs=195.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+...+.||+|+||.||+|+.... ++.||||++.... ....+.+.+|++++++++||||+++++++.++...++|
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccC---CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 44567899999999999987544 3479999986432 23346789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|||+. |+|.+++. ....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 99997 67877775 456789999999999999999999965 999999999999999999999999999986532
Q ss_pred CCccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 670 SQTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||........ + ....... .....
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~----~~~~~~~-~~~~~-- 274 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIAQNE-SPALQ-- 274 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHHSC-CCCCC--
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H----HHHHhcC-CCCCC--
Confidence 23456899999999984 56789999999999999999999999875533221 1 1111111 11110
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......+.+++.+||+.||++|||++++++.
T Consensus 275 ------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11123467789999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.62 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=194.3
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.++||+|+||.||++.....+ ..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSG---LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heeecceeccCCCeEEEEEEEccCC---ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4566789999999999999886543 379999987543 345678999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE---cCCCCEEEeecCcccc
Q 047263 592 EFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKL 664 (804)
Q Consensus 592 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfgla~~ 664 (804)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||++ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999854 36789999999999999999999965 99999999999999 4568899999999986
Q ss_pred cccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.... .......|+..|+|||.+. ..++.++||||||++++||++|+.||........... .. . .......
T Consensus 177 ~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~---~~--~-~~~~~~~- 246 (285)
T 3is5_A 177 FKSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK---AT--Y-KEPNYAV- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH--H-CCCCCCC-
T ss_pred cCCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh---hc--c-CCccccc-
Confidence 5432 2234456899999999886 4689999999999999999999999976543321110 00 0 0000000
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. .......+.+++.+||+.||++|||+.||++
T Consensus 247 ----~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ----E---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----c---cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0012346778999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=334.80 Aligned_cols=270 Identities=19% Similarity=0.229 Sum_probs=207.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCC--ceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL--NRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV 590 (804)
+.+.+.||+|+||.||+|.....+ ..||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred eEEEEEEEcCCCeEEEEEEECCCC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 345678999999999999987543 379999997543 345677889999999999999999999998765 67999
Q ss_pred EeecCCCcHHHhhcCCC---CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE----cCCCCEEEeecCccc
Q 047263 591 YEFLSNGTLASFLFGDL---KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGLAK 663 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfgla~ 663 (804)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997643 389999999999999999999965 99999999999999 778889999999998
Q ss_pred ccccCCCCccccccCCCcccccccccc--------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-HHHHHHHHHHh
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRN--------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-EALLTDWAYDC 734 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~ 734 (804)
..... .......||..|+|||++.. ..++.++||||||+++|||++|+.||....... ...........
T Consensus 165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 75432 22334568999999999865 567889999999999999999999996432211 11111111110
Q ss_pred hhcCccccee-----------cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 735 YCEGITEALV-----------EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 735 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
........+. ...............+.+++.+||+.||++||++.++++.++.+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0000000000 00111123356677888999999999999999999999999887653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.62 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=202.4
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.+.||+|+||.||+++....+ +.||+|.+........+.+.+|+.++++++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTG---KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCC---CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 34556788999999999999986443 379999998654445567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE---cCCCCEEEeecCcccccccC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfgla~~~~~~ 668 (804)
||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++ ++++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999999999998778899999999999999999999965 99999999999999 7889999999999975422
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ . .. ..++... ..
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~----i~~~~~~-~~---- 227 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--F-EK----IKEGYYE-FE---- 227 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-HH----HHHCCCC-CC----
T ss_pred --CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--H-HH----HHcCCCC-CC----
Confidence 223345689999999999999999999999999999999999999976543221 1 10 1111100 00
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcC
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGV 788 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~ 788 (804)
..........+.+++.+||+.||++|||+.++++ .+++.
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 -SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0001122356888999999999999999999986 44443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=326.08 Aligned_cols=272 Identities=23% Similarity=0.291 Sum_probs=206.6
Q ss_pred CHHHHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcc--cccCCccceeeEEe
Q 047263 505 TYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ--THHKNLVRLLGFCD 582 (804)
Q Consensus 505 ~~~~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~ 582 (804)
...+.....+.+.+.||+|+||.||+|+.. ++.||||++... ..+.+..|++++.. ++||||+++++++.
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEEc-----CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 334455566777889999999999999873 347999998743 44667788888877 79999999999998
Q ss_pred CCC----ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc-----CCCeeecCCCCCcEEEcCCCC
Q 047263 583 DGL----NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC-----STQIIHCDIKPQNILLDDYYN 653 (804)
Q Consensus 583 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NILl~~~~~ 653 (804)
+.. ..++||||+++|+|.+++.. ..+++..++.++.||+.||.|||... +.+|+||||||+|||++.+++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 876 78999999999999999965 46899999999999999999999321 249999999999999999999
Q ss_pred EEEeecCcccccccCCCC---ccccccCCCccccccccccC------CCCccchhhHHHHHHHHHHcC----------CC
Q 047263 654 ARISDFGLAKLLLLDQSQ---THTAIRGTKGYVAPEWFRNM------PITVKVDVYSFGVLLLEIICC----------RR 714 (804)
Q Consensus 654 ~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~~~DV~S~Gvll~elltG----------~~ 714 (804)
+||+|||++......... ......||..|+|||.+.+. .++.++||||||+++|||++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876443322 23445689999999999765 334789999999999999999 66
Q ss_pred CCCcchhHHHHHHHHHHHHhhhcCcccceecchhh-hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 715 NVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE-ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 715 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
||........ .... ......+... ..... .....+....+.+++.+||+.||++|||+.+|++.|+.+.+-
T Consensus 266 p~~~~~~~~~-~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 266 PYYDLVPSDP-SVEE-MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTTSCSSC-CHHH-HHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CccccCcCcc-cHHH-HHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 7654321110 0000 0111111111 11111 112345667899999999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.56 Aligned_cols=247 Identities=19% Similarity=0.271 Sum_probs=191.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccc--cCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTH--HKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||++.... +..||||++... ..+..+.+.+|+.++.+++ |+||+++++++..+...++
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC----CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4456789999999999998754 336999998643 2345578999999999996 5999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||| +.+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 67889999998888899999999999999999999954 999999999999995 5799999999998764333
Q ss_pred CC-ccccccCCCcccccccccc-----------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 670 SQ-THTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 670 ~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... +. .....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~----~~~~~ 283 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LH----AIIDP 283 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HH----HHHCT
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-HH----HHhCc
Confidence 22 2345679999999999865 46889999999999999999999999754322111 10 00111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+ +......+.+++.+||+.||.+|||+.||++
T Consensus 284 ~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 284 NHEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TSCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCC---------CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 100000 0111346788999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.89 Aligned_cols=259 Identities=23% Similarity=0.245 Sum_probs=197.3
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-----cCCccceeeEEeCCCce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-----HKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----h~niv~l~g~~~~~~~~ 587 (804)
.+.+.++||+|+||.||+++....+ ..||||++... ....+.+..|+.+++.++ ||||+++++++......
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNK---KYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCC---eEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 4455689999999999999986544 37999999753 334566788999998886 99999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---------------
Q 047263 588 LLVYEFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD--------------- 650 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~--------------- 650 (804)
++||||+ +++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 999999997653 588999999999999999999965 9999999999999975
Q ss_pred ----------CCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcch
Q 047263 651 ----------YYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEV 720 (804)
Q Consensus 651 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~ 720 (804)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78999999999986432 2334568999999999999999999999999999999999999997654
Q ss_pred hHHHHHHHHHHH---------HhhhcCcccceecc-----hhhhcccH---------------HHHHHHHHHHHHccccC
Q 047263 721 NEAEALLTDWAY---------DCYCEGITEALVEF-----DIEALNDK---------------KKLARFVMVAIWCIQED 771 (804)
Q Consensus 721 ~~~~~~l~~~~~---------~~~~~~~~~~~~~~-----~~~~~~~~---------------~~~~~l~~l~~~Cl~~d 771 (804)
............ ..........+... ........ .....+.+++.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 432211111000 00000000000000 00000000 01256779999999999
Q ss_pred CCCCCCHHHHHH
Q 047263 772 PSLRPTMRKVTQ 783 (804)
Q Consensus 772 P~~RPsm~eVl~ 783 (804)
|.+|||+.|+++
T Consensus 344 P~~Rpta~elL~ 355 (360)
T 3llt_A 344 PTLRPSPAELLK 355 (360)
T ss_dssp GGGSCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=334.63 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=200.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||++.....+ ..||+|++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceeeeeecCCCCeEEEEEEECCCC---cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345678999999999999987544 379999987542 3345679999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.....+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++...... .
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 186 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 999999999998888899999999999999999999962 27999999999999999999999999999765322 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHH---------Hhhhc------
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY---------DCYCE------ 737 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~------ 737 (804)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||................ .....
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 234568999999999999999999999999999999999999997654432211100000 00000
Q ss_pred --------Ccccceec----chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 --------GITEALVE----FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 --------~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+ ..............+.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000 00000001112456889999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.62 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=178.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||+|+....+ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTG---LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeeecCCCceEEEEEEEccCC---ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 34678999999999999876443 379999986432 233577999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++++|.+++... ..+++..+..++.||++||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 999999999999865 6789999999999999999999965 99999999999999999999999999998654322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ + . ..... +..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~----~~~~~---~~~--- 230 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L----N----KVVLA---DYE--- 230 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSS---CCC---
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H----H----HHhhc---ccC---
Confidence 222345689999999999998999999999999999999999999975432211 0 0 00000 000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+......+.+++.+||+.||++|||+.++++
T Consensus 231 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 -MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01122356788999999999999999999876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.52 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=197.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|+||.||+++....+. .||||++..... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGR---IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCC---EEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred heeeeEEeecCCEEEEEEEECCCCc---eEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4456789999999999999875443 799999864332 33456889999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-c
Confidence 9999999999988888899999999999999999999965 99999999999999999999999999998654322 2
Q ss_pred ccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HHhhhc-C---
Q 047263 672 THTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YDCYCE-G--- 738 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~-~--- 738 (804)
......|+..|+|||.+.+. .++.++||||||+++|||++|+.||............... ...+.. .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 23345689999999999775 7899999999999999999999999766543211110000 000000 0
Q ss_pred --cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 --ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+................+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000111100000011123467889999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.38 Aligned_cols=262 Identities=18% Similarity=0.222 Sum_probs=190.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||+++....+ ..||||++..... ...+.+.+|+.++++++||||+++++++.++...++||
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTN---ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTT---EEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEecCCeEEEEEEECCCC---ceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 345678999999999999876543 4799999974432 23456789999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-----CCCCEEEeecCcccccc
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-----DYYNARISDFGLAKLLL 666 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-----~~~~~kl~Dfgla~~~~ 666 (804)
||++ |+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ +++.+||+|||+++...
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9998 59999998888899999999999999999999965 999999999999994 45569999999998764
Q ss_pred cCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcc-----
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGIT----- 740 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----- 740 (804)
.. ........+|..|+|||++.+. .++.++||||||+++|||++|+.||........................
T Consensus 189 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Cc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 32 2223345679999999999774 5899999999999999999999999765443211110000000000000
Q ss_pred --------cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 --------EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 --------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...................+.+++.+||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000011112357789999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.17 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=201.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||++.....+. .+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKE---VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCC---EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCc---eEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 346789999999999999875543 79999986432 234567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.....+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 170 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc-c
Confidence 9999999999998878899999999999999999999965 99999999999999999999999999998754322 2
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... . ....... .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~-----~~~~~~~------~--- 234 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--R-----IKKNEYS------I--- 234 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H-----HHTTCCC------C---
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-----HhhccCC------C---
Confidence 2334568999999999999899999999999999999999999997654332111 0 1111000 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+||+.||++|||++++++
T Consensus 235 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 235 -PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1112346778999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=344.22 Aligned_cols=247 Identities=28% Similarity=0.293 Sum_probs=199.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||+++....+ ..||+|++... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34578999999999999987543 37999999643 2344567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~- 339 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 339 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence 9999999999997653 489999999999999999999965 9999999999999999999999999999875432
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.... .... .
T Consensus 340 -~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i----~~~~-~------- 406 (576)
T 2acx_A 340 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KEVP-E------- 406 (576)
T ss_dssp -CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH----HHCC-C-------
T ss_pred -ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh----hccc-c-------
Confidence 223445799999999999999999999999999999999999999976532111 1111111 0100 0
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.........+.+++.+||+.||.+|| +++||++
T Consensus 407 --~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 --EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01112235788899999999999999 7788863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.67 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=201.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.||+|+||.||++.....+. .+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKE---VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCC---EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCC---EEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 346789999999999999875543 79999986432 234567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
||+++++|.+++.....+++.++..++.||++||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence 9999999999998878899999999999999999999965 99999999999999999999999999998754322 2
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... . ....... .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~-----~~~~~~~------~--- 260 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--R-----IKKNEYS------I--- 260 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H-----HHHTCCC------C---
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH--H-----HhcCCCC------C---
Confidence 2344568999999999999999999999999999999999999997654332111 0 0011000 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+||+.||++|||+.|+++
T Consensus 261 -~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 -PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112346778999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=354.81 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=204.8
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
..+.+.+.||+|+||.||+|...........||||++.... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 34556788999999999999987655556689999987543 3345679999999999999999999999854 568999
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|||+++|+|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999999999754 4689999999999999999999965 99999999999999999999999999998765443
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
........+++.|+|||.+.+..++.++||||||+++|||++ |..||......... ... ..+....
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i----~~~~~~~------ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENGERLP------ 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH----HHTCCCC------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCCCCC------
Confidence 333344556789999999999999999999999999999997 88998765432211 111 1111000
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.+......+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus 613 ---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 ---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011223578889999999999999999999999988653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.94 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=186.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccc-cCCccceeeEEeCCC--ce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGL--NR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~--~~ 587 (804)
.+.+.+.||+|+||.||+|.....+ ..||||++.... ....+.+.+|+.++.+++ ||||+++++++...+ ..
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTG---EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTC---CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCC---CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3456688999999999999876544 379999986432 334567889999999997 999999999997544 68
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999998 689998865 4788999999999999999999965 999999999999999999999999999986532
Q ss_pred C--------------------CCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH
Q 047263 668 D--------------------QSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL 726 (804)
Q Consensus 668 ~--------------------~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~ 726 (804)
. .........||+.|+|||++.+ ..++.++|||||||+++||++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 1112334579999999999876 678999999999999999999999997654332111
Q ss_pred HHHHHHHhhh----cCc----------------------ccceecc----hhhhcccHHHHHHHHHHHHHccccCCCCCC
Q 047263 727 LTDWAYDCYC----EGI----------------------TEALVEF----DIEALNDKKKLARFVMVAIWCIQEDPSLRP 776 (804)
Q Consensus 727 l~~~~~~~~~----~~~----------------------~~~~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 776 (804)
.......... ... ...+... .............+.+++.+||+.||++||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 1000000000 000 0000000 000000001235688999999999999999
Q ss_pred CHHHHHHH
Q 047263 777 TMRKVTQM 784 (804)
Q Consensus 777 sm~eVl~~ 784 (804)
|++|+++-
T Consensus 322 t~~e~l~H 329 (388)
T 3oz6_A 322 SANDALKH 329 (388)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhCC
Confidence 99999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.54 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=192.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCC-CceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-LNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E 592 (804)
+.+.+.||+|+||.||++... +..||||.+... ...+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ceEEeEEecCCCceEEEEEEc-----CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 445678999999999999864 336999999753 3557899999999999999999999997554 57899999
Q ss_pred ecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999997543 378899999999999999999965 9999999999999999999999999999754322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......... . ....+...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~----~~~~~~~~-------- 233 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P----RVEKGYKM-------- 233 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---H----HHTTTCCC--------
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHhcCCCC--------
Confidence 223356889999999999999999999999999999998 99998754332211 0 01111100
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.........+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 0111234578889999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=339.75 Aligned_cols=259 Identities=23% Similarity=0.244 Sum_probs=190.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCC------C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------L 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~ 585 (804)
+.+.++||+|+||.||++.....+ +.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTT---EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCCCeEEEEEEECCCC---CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 445678999999999999876543 47999999754 234456789999999999999999999999654 3
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..+|||||++++ |.+.+.. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 569999999865 6666643 488999999999999999999965 9999999999999999999999999999865
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHH-HH--------------
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT-DW-------------- 730 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~-~~-------------- 730 (804)
.. ........||+.|+|||++.+..++.++|||||||+++||++|+.||............ ..
T Consensus 215 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 32 22344567899999999999999999999999999999999999999765433211100 00
Q ss_pred -HHHhhhcCc-ccc-----eecchh---hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 731 -AYDCYCEGI-TEA-----LVEFDI---EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 731 -~~~~~~~~~-~~~-----~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......... ... ...... ...........+.+|+.+||+.||++|||++|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000 000000 00011122567899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.44 Aligned_cols=269 Identities=24% Similarity=0.286 Sum_probs=192.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------ 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 585 (804)
+.+.+.||+|+||.||+|.....+ ..||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp EEEEEEC------CEEEEEETTTC---CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred EEEeEEeeecCCeEEEEEEECCCC---CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 345678999999999999886543 379999996432 233567899999999999999999999997653
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 459999999 8899999875 5688999999999999999999965 9999999999999999999999999999864
Q ss_pred ccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHH----hhhcCcc
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD----CYCEGIT 740 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~----~~~~~~~ 740 (804)
.. ......+|..|+|||.+.+ ..++.++||||+||+++||++|+.||................. .......
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 179 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 32 2344568999999999877 6899999999999999999999999976543321110000000 0000000
Q ss_pred -----------cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCccCCCCC
Q 047263 741 -----------EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVVEVLDPP 795 (804)
Q Consensus 741 -----------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~~~~~pp 795 (804)
.......... ........+.+++.+||+.||.+|||++|+++ .++.+.+....|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~ 321 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred hHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCC
Confidence 0000000000 01122456888999999999999999999987 455554443333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.10 Aligned_cols=266 Identities=25% Similarity=0.380 Sum_probs=191.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHH--HHHhcccccCCccceeeEEe-----CCCc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTE--VNVIGQTHHKNLVRLLGFCD-----DGLN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E--~~~l~~l~h~niv~l~g~~~-----~~~~ 586 (804)
+.+.+.||+|+||.||+|+.. +..||||++... ..+.+..| +..+..++|+||+++++.+. ....
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSLD-----ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hheeeecccCCCeEEEEEEEC-----CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 345678999999999999763 347999998743 23344444 44455689999999998552 2345
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc------CCCeeecCCCCCcEEEcCCCCEEEeecC
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC------STQIIHCDIKPQNILLDDYYNARISDFG 660 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlkp~NILl~~~~~~kl~Dfg 660 (804)
.++||||+++|+|.+++... ..++..+.+++.||++||.|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 68999999999999999654 3488999999999999999999431 1299999999999999999999999999
Q ss_pred cccccccCC-------CCccccccCCCcccccccccc-------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH--
Q 047263 661 LAKLLLLDQ-------SQTHTAIRGTKGYVAPEWFRN-------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-- 724 (804)
Q Consensus 661 la~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~-------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-- 724 (804)
+++.+.... ........||..|+|||.+.+ ..++.++||||||+++|||++|+.|+........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998764322 122234568999999999976 4567899999999999999999877643221100
Q ss_pred H----------HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 725 A----------LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 725 ~----------~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
. .................+.. ...........+.+++.+||+.||++|||+.||++.|+.++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0 00000000000110111100 1111233566799999999999999999999999999987754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=325.07 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=195.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC-------
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD------- 583 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------- 583 (804)
.+.+.++||+|+||.||+++....+ +.||||++.... ......+.+|+.++++++||||+++++++.+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTC---CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ceeEEEEEecCCCcEEEEEEECCCC---CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3455678999999999999986543 379999986432 2334578899999999999999999999976
Q ss_pred -CCceEEEEeecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 584 -GLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 584 -~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
....++||||+++ +|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999986 66666654 46789999999999999999999965 999999999999999999999999999
Q ss_pred ccccccCC---CCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 662 AKLLLLDQ---SQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 662 a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
++.+.... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98764322 222344568999999998876 56899999999999999999999999876544322211111100000
Q ss_pred Ccccceecchh--------hhccc-HH------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDI--------EALND-KK------KLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~--------~~~~~-~~------~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........... ..... .. ....+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000000000 00000 01 1345789999999999999999999886
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.31 Aligned_cols=192 Identities=22% Similarity=0.355 Sum_probs=152.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC-----CCc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-----GLN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~ 586 (804)
+.+.+.||+|+||.||+|+....+ ..||||++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEK---RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp EEECCC-------CEEEEEECC-----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred eEEeeEeeecCCeEEEEEEECCCC---cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 456788999999999999876543 379999986532 2345678999999999999999999999943 356
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.++||||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 899999984 79999998888899999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCC--------------------------CccccccCCCcccccccc-ccCCCCccchhhHHHHHHHHHHcC
Q 047263 667 LDQS--------------------------QTHTAIRGTKGYVAPEWF-RNMPITVKVDVYSFGVLLLEIICC 712 (804)
Q Consensus 667 ~~~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~~~DV~S~Gvll~elltG 712 (804)
.... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3221 123345689999999976 566799999999999999999993
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.46 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=193.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
..||+|+||.||+|.....+ +.||||++........+.+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQ---VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp CEEEECSSSEEEEEEETTTC---CEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEeecCcEEEEEEEECCCC---eEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 37999999999999976543 379999998765566778999999999999999999999999999999999999999
Q ss_pred cHHHhhcCC---CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcccccccCCCCcc
Q 047263 598 TLASFLFGD---LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 598 sL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+||+++. ++.+||+|||++....... ...
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~ 180 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCT 180 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccc
Confidence 999999754 3456888899999999999999965 9999999999999987 8999999999998654321 223
Q ss_pred ccccCCCccccccccccCC--CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhc
Q 047263 674 TAIRGTKGYVAPEWFRNMP--ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~--~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 751 (804)
....|+..|+|||.+.+.. ++.++||||||+++|||++|+.||............. .. ..... .
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~----~~~~~-----~---- 246 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GM----FKVHP-----E---- 246 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HH----HCCCC-----C----
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-cc----ccccc-----c----
Confidence 3456899999999997643 8899999999999999999999996543222111100 00 00000 0
Q ss_pred ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 752 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.||++||++.++++
T Consensus 247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11122356788999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.70 Aligned_cols=257 Identities=25% Similarity=0.313 Sum_probs=180.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.+.||+|+||.||++.....+ ..||||++.... ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKK---EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhheeccccceEEEEEEECCCC---cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 345678999999999999875433 379999986432 3345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC--------CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 593 FLSNGTLASFLFG--------DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 593 y~~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
|+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999863 45689999999999999999999965 999999999999999999999999999986
Q ss_pred cccCCC----CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 665 LLLDQS----QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 665 ~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
...... .......||..|+|||.+.. ..++.++||||||+++|||++|+.||........... . . ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~---~-~~~ 243 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---T---L-QND 243 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---H---H-TSS
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---H---h-ccC
Confidence 543221 12234568999999999875 5689999999999999999999999976543321110 0 0 111
Q ss_pred ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....................+.+++.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000000000001112356788999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.33 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=197.7
Q ss_pred HhhhH-HhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceE
Q 047263 513 TNGFK-EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~-~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 588 (804)
.+.+. ++||+|+||.||++.....+ ..||+|++.... .....++.+|+.++.++ +||||+++++++.+....+
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTG---QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 33344 78999999999999987544 379999987532 34467899999999999 5699999999999999999
Q ss_pred EEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCccc
Q 047263 589 LVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAK 663 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~ 663 (804)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999999999999654 6789999999999999999999965 9999999999999987 7899999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........... .. .... ..
T Consensus 183 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~----~~~~-~~ 252 (327)
T 3lm5_A 183 KIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN---IS----QVNV-DY 252 (327)
T ss_dssp EC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH----HTCC-CC
T ss_pred ccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---HH----hccc-cc
Confidence 75432 222345689999999999999999999999999999999999999976544322111 00 0000 00
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
. ..........+.+++.+||+.||.+|||++++++-
T Consensus 253 ~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 S-----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred C-----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00111233567889999999999999999999763
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=337.35 Aligned_cols=235 Identities=15% Similarity=0.154 Sum_probs=182.5
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHH---HHhcccccCCcccee-------eEEe
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEV---NVIGQTHHKNLVRLL-------GFCD 582 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~---~~l~~l~h~niv~l~-------g~~~ 582 (804)
+.+.||+|+||.||+|+....+ +.||||++... .....+.|.+|+ .++++++||||++++ +++.
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCC---CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred EcceeecCCCEEEEEEEECCCC---cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 4578999999999999975443 37999999732 234567899999 666667899999998 6655
Q ss_pred CCC-----------------ceEEEEeecCCCcHHHhhcCCCCCC-------hhhHHHHHHHHHHHHHHhhhccCCCeee
Q 047263 583 DGL-----------------NRLLVYEFLSNGTLASFLFGDLKPG-------WSRRTDIAFGIARGLLYLHEECSTQIIH 638 (804)
Q Consensus 583 ~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~l~-------~~~~~~i~~~ia~gL~yLH~~~~~~ivH 638 (804)
+.+ ..+|||||+ +|+|.+++.....++ +..++.|+.||+.||.|||+. +|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 543 278999999 689999997543333 478889999999999999965 9999
Q ss_pred cCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCccccccccccC-----------CCCccchhhHHHHHHH
Q 047263 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM-----------PITVKVDVYSFGVLLL 707 (804)
Q Consensus 639 ~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~~DV~S~Gvll~ 707 (804)
|||||+|||++.++.+||+|||+++... .......| ..|+|||++.+. .++.++||||||+++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999998532 23344567 999999999887 8999999999999999
Q ss_pred HHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 708 EIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 708 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
||++|+.||....... ....+... .......+.+++.+||+.||++|||+.++++
T Consensus 305 elltg~~Pf~~~~~~~---------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------C---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCccccccc---------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999986432211 00111110 0112356788999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.99 Aligned_cols=254 Identities=21% Similarity=0.252 Sum_probs=197.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEe--CCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCD--DGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 589 (804)
+.+.+.||+|+||.||++....++ +.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCC---cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 345678999999999999987544 379999986432 344567999999999999999999999874 4567899
Q ss_pred EEeecCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhcc--CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 590 VYEFLSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEEC--STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.. ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999643 45899999999999999999999761 0129999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .. ...++....+
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~i~~~~~~~~ 236 (279)
T 2w5a_A 165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG----KIREGKFRRI 236 (279)
T ss_dssp HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHTCCCCC
T ss_pred eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH----HHhhcccccC
Confidence 654321 112335689999999999998999999999999999999999999976543221 11 1111111111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~ 787 (804)
.......+.+++.+||+.||.+||++.||++.+..
T Consensus 237 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11234578889999999999999999999987753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.24 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=188.9
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--------cccHHHHHHHHHHhcccccCCccceeeEEeC
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--------QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD 583 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 583 (804)
..+.+.+.||+|+||.||+|....... .||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCK---KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCC---EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCc---EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345567889999999999999875543 79999986432 1122358899999999999999999999865
Q ss_pred CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC---CCEEEeecC
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY---YNARISDFG 660 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfg 660 (804)
...++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 45799999999999999999888999999999999999999999965 99999999999999754 459999999
Q ss_pred cccccccCCCCccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 661 LAKLLLLDQSQTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 661 la~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
+++.... ........||+.|+|||++. ...++.++||||||+++|||++|+.||........ +... ...
T Consensus 288 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~----i~~ 359 (419)
T 3i6u_A 288 HSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----ITS 359 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH----HHT
T ss_pred cceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH----Hhc
Confidence 9987543 22334567899999999985 35788999999999999999999999975432211 0000 011
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+... ... . ........+.+++.+||+.||++|||+.|+++
T Consensus 360 ~~~~-~~~-~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYN-FIP-E----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCC-CCH-H----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-CCc-h----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1100 000 0 00112457889999999999999999999886
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.02 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=201.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+...+.||+|+||.||+|+....+ ..||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHhhhhcccCCeEEEEEEECCCC---cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 344678999999999999876443 379999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ..
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999999999964 5689999999999999999999965 99999999999999999999999999998754322 22
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
.....|+..|+|||.+.+..++.++||||||++++||++|+.|+........... . .......+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~----~~~~~~~~--------- 239 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---I----PKNNPPTL--------- 239 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---H----HHSCCCCC---------
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---h----hcCCCCCC---------
Confidence 3445689999999999999999999999999999999999999976543221110 1 01111110
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......+.+++..||+.||.+|||+.+|++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11123467889999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=337.59 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=196.8
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
..+.+.++||+|+||.||+++....+ ..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTH---VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTC---CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCC---cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34566789999999999999986543 379999987532 3345678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCcccccc
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLLL 666 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~~ 666 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999999998888899999999999999999999965 9999999999999976 4559999999998764
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.. .......||+.|+|||++. ..++.++||||+||++|||++|+.||.......... . . ..+... ...+
T Consensus 191 ~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~-i----~~~~~~-~~~~ 259 (494)
T 3lij_A 191 NQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR--K-V----EKGKYT-FDSP 259 (494)
T ss_dssp TT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-H----HHTCCC-CCSG
T ss_pred CC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-H----HhCCCC-CCch
Confidence 32 2334467999999999986 469999999999999999999999997654432111 1 1 111100 0000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. .......+.+++.+||+.||.+|||+.++++
T Consensus 260 ~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 E-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp G-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred h-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 0112356788999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=335.67 Aligned_cols=259 Identities=18% Similarity=0.203 Sum_probs=200.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc-CCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH-KNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|+....+ +.||||++.... ..+++..|+++++.++| +++..+..++.+....+||||
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTC---CEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCC---cEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 345678999999999999976443 379999876432 22457889999999987 556666667778888899999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE---cCCCCEEEeecCcccccccC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfgla~~~~~~ 668 (804)
|+ +++|.+++.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 9999999974 56799999999999999999999965 99999999999999 68899999999999876543
Q ss_pred CCC------ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 669 QSQ------THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 669 ~~~------~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
... ......||..|+|||.+.+..++.++||||||++||||++|+.||........................+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 322 12356799999999999999999999999999999999999999976433211111111111000000000
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+. .....++.+++..||+.+|++||++.+|+++|+.+..
T Consensus 240 l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 240 LC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred Hh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 00 0123578899999999999999999999999988743
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.26 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=197.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.+.||+|+||.||+|.....+ ..||+|++... ...+++.+|+.++++++||||+++++++.+....++||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETG---QIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTC---CEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCC---CEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 33456678999999999999886543 37999998753 34567899999999999999999999999999999999
Q ss_pred eecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++++|.+++. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 9999999999996 456789999999999999999999965 99999999999999999999999999998654322
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ........+..
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~----- 247 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------IPTNPPPTFRK----- 247 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSCCCCCSS-----
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------HhcCCCcccCC-----
Confidence 223345689999999999999999999999999999999999999975543221110 00111111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+||+.||.+|||+.++++
T Consensus 248 --~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 --PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112356788999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.65 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=192.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|+....+ +.||||.+.... .+..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTG---HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECCCC---ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 345678999999999999986443 379999986432 23456889999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 164 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC--
Confidence 99999999999998878899999999999999999999976 9999999999999999999999999999865432
Q ss_pred CccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......++..|+|||.+.+..+ +.++||||||++++||++|+.||......... . ....+... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~----~~~~~~~~------~- 230 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF---K----KIRGGVFY------I- 230 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCCC------C-
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---H----HhhcCccc------C-
Confidence 22234568899999999988765 68999999999999999999999765432211 1 01111100 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+......+.+++.+||+.||++|||+.+|++
T Consensus 231 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 ---PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112346788999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.43 Aligned_cols=243 Identities=23% Similarity=0.256 Sum_probs=184.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhc-ccccCCccceeeEEeC----CCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIG-QTHHKNLVRLLGFCDD----GLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~-~l~h~niv~l~g~~~~----~~~~~lV~E 592 (804)
+.||+|+||.||++.....+ +.||||++... ..+.+|++++. ..+||||+++++++.. ....+||||
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~---~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQ---EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp EEEEEETTEEEEEEEETTTC---CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeccCeEEEEEEECCCC---CEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 57999999999999986544 37999998642 45677888774 4589999999998865 567899999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCccccccc
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLLLL 667 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~~~ 667 (804)
|+++|+|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999999999865 3589999999999999999999965 9999999999999987 78999999999986532
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHH-HHHHHHHHHhhhcCcccceecc
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE-ALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
........||..|+|||++.+..++.++|||||||++|||++|+.||........ ....... ..+... +..
T Consensus 217 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~-~~~- 288 (400)
T 1nxk_A 217 --HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE-FPN- 288 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC-CCT-
T ss_pred --CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc-CCC-
Confidence 2223456789999999999999999999999999999999999999975533210 0000000 011000 000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+||+.||++|||+.||++
T Consensus 289 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 289 ----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001123456889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.29 Aligned_cols=241 Identities=20% Similarity=0.262 Sum_probs=192.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
.+.+.+.||+|+||.||+++....+ ..||+|++.... .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDG---CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCC---ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3455678999999999999986443 379999987532 33456788999999999 99999999999999999999
Q ss_pred EEeecCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC--------------
Q 047263 590 VYEFLSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-------------- 651 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-------------- 651 (804)
||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999754 6689999999999999999999965 99999999999999844
Q ss_pred -----CCEEEeecCcccccccCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH
Q 047263 652 -----YNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA 725 (804)
Q Consensus 652 -----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~ 725 (804)
..+||+|||++...... ....||..|+|||.+.+. .++.++||||||++++||++|..++.......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-- 238 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-- 238 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH--
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH--
Confidence 47999999999865432 223589999999999765 66689999999999999999998765432111
Q ss_pred HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 726 LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 726 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....+....+ +......+.+++.+||+.||++|||+.++++
T Consensus 239 --------~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 --------EIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0111111111 1112356788999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=318.37 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=194.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.+.||+|+||.||+|.....+ ..+|+|.+........+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETG---ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTC---CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred eeecceeccCCCeEEEEEEEcCCC---cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 345678999999999999987543 37999999876666778899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 999999999865 46789999999999999999999965 9999999999999999999999999998643211 111
Q ss_pred cccccCCCcccccccc-----ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 673 HTAIRGTKGYVAPEWF-----RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l-----~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....|+..|+|||.+ ....++.++||||||+++|||++|+.|+........ +.. ..... .....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~~~-~~~~~--- 243 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK----IAKSD-PPTLL--- 243 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH----HHHSC-CCCCS---
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHH----HhccC-CcccC---
Confidence 2334689999999998 466789999999999999999999999976543221 111 01111 11000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.||.+|||+.++++
T Consensus 244 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 ----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11122356788999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.74 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=198.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--------ccHHHHHHHHHHhccc-ccCCccceeeEEeCC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG 584 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 584 (804)
+.+.+.||+|+||.||+++...++ ..||||++..... ...+.+.+|+.++.++ +||||+++++++...
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATG---HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred cccceEEecCCCEEEEEEEECCCC---cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 344578999999999999986443 3799999864321 1245688999999999 799999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
...++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999999999999998878899999999999999999999965 999999999999999999999999999987
Q ss_pred cccCCCCccccccCCCcccccccccc------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRN------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
+... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ + ... ..+
T Consensus 250 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~-~~i----~~~ 320 (365)
T 2y7j_A 250 LEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM--L-RMI----MEG 320 (365)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHH----HHT
T ss_pred cCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--H-HHH----HhC
Confidence 5432 23344678999999999863 3588999999999999999999999976433221 1 000 111
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... ...+.. ......+.+++.+||+.||++|||+.++++
T Consensus 321 ~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100 000000 012346788999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=349.95 Aligned_cols=245 Identities=26% Similarity=0.290 Sum_probs=201.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||+++....+. .||||++... .....+.+..|..++..+ +|+||+++++++.+.+..+|
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~---~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCC---EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCc---EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4556789999999999999875543 7999998743 234456788899999987 79999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||||+.++++||+|||+++.....
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD- 495 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC-
Confidence 999999999999998888899999999999999999999965 9999999999999999999999999999864322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......... . ...+... .
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~---~----~i~~~~~----~---- 560 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---Q----SIMEHNV----A---- 560 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHSSCC----C----
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH---H----HHHhCCC----C----
Confidence 23345577999999999999999999999999999999999999999865433211 0 1111110 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTM-----RKVT 782 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl 782 (804)
.+.....++.+|+..||+.||.+||++ +||+
T Consensus 561 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 561 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred --CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 111234578889999999999999997 6665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=335.75 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=200.8
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
...+.+.++||+|+||.||+++....+ ..||||++.... ....+.+.+|++++++++||||+++++++.+....+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQ---QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTC---CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCC---CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 345667889999999999999986443 379999986432 345678999999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc---CCCCEEEeecCccccc
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLAKLL 665 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfgla~~~ 665 (804)
+||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.+
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999998888899999999999999999999965 999999999999995 5667999999999865
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceec
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 745 (804)
... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||........ +.. ...+...
T Consensus 175 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~-----i~~~~~~---- 240 (486)
T 3mwu_A 175 QQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LKR-----VETGKYA---- 240 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-----HHHTCCC----
T ss_pred CCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhCCCC----
Confidence 432 22344568999999999976 599999999999999999999999976543321 111 1111100
Q ss_pred chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 746 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ........+.+++.+||+.||.+|||+.++++
T Consensus 241 ~~~~--~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 FDLP--QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SCSG--GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCc--ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 01122356789999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.08 Aligned_cols=267 Identities=20% Similarity=0.260 Sum_probs=192.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccccc-HHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.++||+|+||.||+|+....+ ..||+|++....... ...+.+|+.++++++||||+++++++.++...++||||
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTD---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEEEEcCCCCEEEEEEEECCCC---cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 45678999999999999987544 379999987533221 12456799999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKT 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccc
Confidence 98 5888888654 5688999999999999999999965 9999999999999999999999999999864322 222
Q ss_pred cccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch-h--
Q 047263 673 HTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD-I-- 748 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~-- 748 (804)
.....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....................+.......... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 334567999999999876 578999999999999999999999997765433211111000000000000000000 0
Q ss_pred ----------hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCc
Q 047263 749 ----------EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVV 789 (804)
Q Consensus 749 ----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~ 789 (804)
...........+.+++.+||+.||++|||++|+++ .+..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00001112356789999999999999999999986 444443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.55 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=203.6
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
...+.+.+.||+|+||.||+++....+ ..||||++.... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITG---QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCC---CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345667789999999999999986543 379999986432 34567899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE---cCCCCEEEeecCcccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---DDYYNARISDFGLAKL 664 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---~~~~~~kl~Dfgla~~ 664 (804)
++|+||+.+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999999888999999999999999999999965 99999999999999 5678999999999987
Q ss_pred cccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
+... .......||+.|+|||.+.+ .++.++||||+|+++|||++|+.||........ + .. ...+...
T Consensus 179 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~-~~----i~~~~~~--- 245 (484)
T 3nyv_A 179 FEAS--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI--L-KK----VEKGKYT--- 245 (484)
T ss_dssp BCCC--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HH----HHHCCCC---
T ss_pred cccc--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH--H-HH----HHcCCCC---
Confidence 5432 23344568999999999876 689999999999999999999999976543321 1 10 1111100
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ........+.+++.+||+.||.+|||+.|+++
T Consensus 246 -~~~~--~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 -FELP--QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -CCSG--GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCc--ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000 01122456789999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.35 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=195.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.+.||+|+||.||+|.... .+|+|++.... ....+.|.+|+.++++++|+||+++++++.+....++|+
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred eEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 3456789999999999998743 48999986432 233456789999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-
Q 047263 592 EFLSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ- 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~- 669 (804)
||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999998754 689999999999999999999965 999999999999998 6799999999987653211
Q ss_pred ---CCccccccCCCcccccccccc---------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 670 ---SQTHTAIRGTKGYVAPEWFRN---------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 670 ---~~~~~~~~gt~~y~aPE~l~~---------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
........|+..|+|||.+.. ..++.++||||||+++|||++|+.||.......... . ...
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~-~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW------Q-MGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH------H-HHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-hcc
Confidence 122233458899999999864 457889999999999999999999997654332111 0 111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
+....... ......+.+++.+||+.||.+|||+.+|+++|+.+.+..
T Consensus 258 ~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111 012235778999999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=336.04 Aligned_cols=241 Identities=27% Similarity=0.333 Sum_probs=194.6
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.+.||+|+||.||+++....+ +.||+|++.... ....+.+..|+.++++++||||+++++++.+....++||||
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATG---KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECCCC---cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 457999999999999986543 379999996432 24456789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC----CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 594 LSNGTLASFLFGD----LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 594 ~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999999753 4688999999999999999999965 99999999999999999999999999998754322
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH-HHHHHHHHHHhhhcCcccceecchh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA-EALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.... ..... .
T Consensus 344 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i----~~~~~----~--- 411 (543)
T 3c4z_A 344 -TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV----LEQAV----T--- 411 (543)
T ss_dssp -CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH----HHCCC----C---
T ss_pred -cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH----hhccc----C---
Confidence 22334579999999999999999999999999999999999999997653211 11111111 11100 0
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
.+......+.+++.+||+.||.+||++
T Consensus 412 ---~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 ---YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 111234567889999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.54 Aligned_cols=260 Identities=25% Similarity=0.284 Sum_probs=195.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc-----cHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-----GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
+.+.+.||+|+||.||+++....+ +.||||++...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCC---SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred cEEEeEEeecCCEEEEEEEECCCC---cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 445678999999999999886543 37999999743221 1246889999999999999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
+||||+++ +|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999986 888888754 4688999999999999999999965 999999999999999999999999999987543
Q ss_pred CCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce---
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL--- 743 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 743 (804)
. ........+|+.|+|||.+.+. .++.++||||||+++|||++|..||........ +.. .............
T Consensus 165 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~-i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 165 P-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTR-IFETLGTPTEEQWPDM 240 (346)
T ss_dssp C-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTTTSSST
T ss_pred C-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHcCCCChhhhhhh
Confidence 2 2233445689999999998654 589999999999999999999999876543321 111 1111100000000
Q ss_pred ------ecchhhhccc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 744 ------VEFDIEALND-----KKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 744 ------~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.......... ......+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000 1223678899999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.55 Aligned_cols=257 Identities=24% Similarity=0.261 Sum_probs=177.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC------C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------L 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~ 585 (804)
+.+.+.||+|+||.||+|..... ++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKT---GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp EEEEEECC----CCEEEEEETTT---TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred eEEeeEEeecCCeEEEEEEECCC---CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 34567899999999999987644 3479999996532 23456788999999999999999999998654 5
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 679999999 6899998865 5789999999999999999999965 9999999999999999999999999999864
Q ss_pred ccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHH----hhhcCcc
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD----CYCEGIT 740 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~----~~~~~~~ 740 (804)
.. ......||..|+|||.+.+ ..++.++|||||||+++||++|+.||................. .......
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 AD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 32 2334578999999999876 6889999999999999999999999976543321111000000 0000000
Q ss_pred c--------ce---ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 E--------AL---VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 ~--------~~---~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. .+ ........ .......+.+|+.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHH-TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHhccCCCCCCCHHHH-CCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 00 00000000 0012356789999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.00 Aligned_cols=252 Identities=23% Similarity=0.275 Sum_probs=194.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhcccccCCccceeeEE--eCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQTHHKNLVRLLGFC--DDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~--~~~~~~ 587 (804)
+.+.+.||+|+||.||++...... ..+|+|.+.... ....+.+.+|+.++++++|+||+++++++ .+....
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETL---CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTC---CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred eeEeeEEecCCCeEEEEEEECCCC---cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 345678999999999999876443 479999987532 23457899999999999999999999998 455688
Q ss_pred EEEEeecCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 588 LLVYEFLSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
++||||++++ |.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999987 6666654 45688999999999999999999965 9999999999999999999999999999875
Q ss_pred ccCC-CCccccccCCCccccccccccCC--CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 666 LLDQ-SQTHTAIRGTKGYVAPEWFRNMP--ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 666 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~--~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
.... ........|+..|+|||.+.+.. ++.++||||||+++|||++|+.||.......... ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~i~~~~~~- 231 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE-------NIGKGSYA- 231 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHCCCC-
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH-------HHhcCCCC-
Confidence 4322 22233456899999999987644 4789999999999999999999997654322110 01111100
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCc
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVV 789 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~ 789 (804)
. .......+.+++.+||+.||.+|||+.|+++ .+....
T Consensus 232 -----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 232 -----I----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp -----C----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred -----C----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 0 1112346778999999999999999999995 455443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=336.41 Aligned_cols=248 Identities=26% Similarity=0.320 Sum_probs=197.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-------------ccHHHHHHHHHHhcccccCCccceeeE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-------------DGVKEFKTEVNVIGQTHHKNLVRLLGF 580 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-------------~~~~~f~~E~~~l~~l~h~niv~l~g~ 580 (804)
+.+.++||+|+||.||+++...++. .+|+|++..... ...+.+.+|+.++++++||||++++++
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHS---EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCC---EEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eEEEeEecccCCeEEEEEEECCCCc---EEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4456789999999999999875543 799999864321 335678999999999999999999999
Q ss_pred EeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC---CEEEe
Q 047263 581 CDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY---NARIS 657 (804)
Q Consensus 581 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~---~~kl~ 657 (804)
+.+....++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999998888899999999999999999999965 999999999999998765 69999
Q ss_pred ecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 658 DFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
|||++...... .......||+.|+|||.+.+ .++.++||||+|+++|+|++|..||.......... .+ ..
T Consensus 192 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i----~~ 261 (504)
T 3q5i_A 192 DFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK---KV----EK 261 (504)
T ss_dssp CCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH----HH
T ss_pred ECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH----Hc
Confidence 99999875432 23344569999999999874 68999999999999999999999998654432111 01 11
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+.. ...... .......+.+++.+||+.||.+|||++|+++
T Consensus 262 ~~~----~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKY----YFDFND--WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCC----CCCHHH--HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC----CCCccc--cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 110 000000 0112356889999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=314.71 Aligned_cols=256 Identities=20% Similarity=0.247 Sum_probs=194.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeC--CCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDD--GLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV 590 (804)
+.+.++||+|+||.||+|+....+ +.||||++.. ...+.+.+|+.++++++ |+||+++++++.+ ....++|
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNN---EKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred eEEEEEecccCCeEEEEEEECCCC---cEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 445678999999999999876544 3799999874 34577899999999997 9999999999987 6678999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~ 669 (804)
|||+++++|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999985 478899999999999999999965 999999999999999776 89999999998654322
Q ss_pred CCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH-------HHHhhhcCc--
Q 047263 670 SQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW-------AYDCYCEGI-- 739 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~-------~~~~~~~~~-- 739 (804)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .........
T Consensus 186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2334568999999999877 6789999999999999999999999954433221111000 000000000
Q ss_pred ------------ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 740 ------------TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 740 ------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....................+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000001111113467889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=317.51 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=182.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||++.....+ ..||+|++..... ...+.+.++...++.++||||+++++++.++...++||
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSG---QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred hhhHHhcCCCCCeEEEEEEecCCC---eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 445678999999999999986443 4799999975422 22334556666688899999999999999999999999
Q ss_pred eecCCCcHHHhhc----CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 592 EFLSNGTLASFLF----GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 592 Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||++ |+|.+++. ....+++..+..++.||+.||.|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9998 48877764 357889999999999999999999953 3899999999999999999999999999986543
Q ss_pred CCCCccccccCCCcccccccc----ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 668 DQSQTHTAIRGTKGYVAPEWF----RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
. .......||+.|+|||.+ ....++.++||||||+++|||++|+.||.......... ... .... ....
T Consensus 163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~----~~~~-~~~~ 234 (290)
T 3fme_A 163 D--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQV----VEEP-SPQL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH-HHH----HHSC-CCCC
T ss_pred c--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH-HHH----hccC-CCCc
Confidence 2 222334689999999996 56678999999999999999999999997533222111 110 1111 1111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........+.+++.+||+.||++|||+.|+++
T Consensus 235 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 --------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01122356888999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.31 Aligned_cols=248 Identities=22% Similarity=0.261 Sum_probs=198.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---------cccHHHHHHHHHHhcccc-cCCccceeeEEeCC
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---------QDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDG 584 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---------~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~ 584 (804)
.+.+.||+|+||.||++.....+ +.||||++.... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTC---KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ceeeeecCCCceEEEEEEEcCcC---ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 34578999999999999986543 479999986432 123456889999999995 99999999999999
Q ss_pred CceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 585 LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
...++||||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999998878899999999999999999999965 999999999999999999999999999986
Q ss_pred cccCCCCccccccCCCccccccccc------cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFR------NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
.... .......++..|+|||.+. ...++.++||||||++++||++|+.||.......... . ...+
T Consensus 174 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~-----~~~~ 244 (298)
T 1phk_A 174 LDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR--M-----IMSG 244 (298)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-----HHHT
T ss_pred cCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH--H-----HhcC
Confidence 5432 2234456899999999885 4568899999999999999999999997654322110 0 1111
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... .... ........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Ccc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 100 0000 01123456889999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=327.91 Aligned_cols=196 Identities=23% Similarity=0.356 Sum_probs=164.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCC-----Cc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-----LN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 586 (804)
+.+.+.||+|+||.||+|+....+ +.||||++.... ....+.+.+|+.++++++|+||+++++++... ..
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTE---KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred EEEEEEEeecCCEEEEEEEECCCC---cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 456788999999999999986543 479999997532 23456789999999999999999999999766 57
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.++||||++ ++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999987 59999999888899999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCC---------------------CccccccCCCcccccccc-ccCCCCccchhhHHHHHHHHHHcCCCCC
Q 047263 667 LDQS---------------------QTHTAIRGTKGYVAPEWF-RNMPITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 667 ~~~~---------------------~~~~~~~gt~~y~aPE~l-~~~~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
.... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 3321 123556789999999986 5667999999999999999999854443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=330.27 Aligned_cols=250 Identities=11% Similarity=0.012 Sum_probs=176.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhccc--ccCCcccee-------eEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQT--HHKNLVRLL-------GFCD 582 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l--~h~niv~l~-------g~~~ 582 (804)
.+.+.||+|+||.||+|+....+ +.||||++..... ...+.+.+|+.++..+ +||||++++ +++.
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERL---EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTT---EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeccCCCCEEEEEEEECCCC---ceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45678999999999999986543 4799999986432 3455677885544444 699988755 3333
Q ss_pred CC-----------------CceEEEEeecCCCcHHHhhcCC-CCCChhhH------HHHHHHHHHHHHHhhhccCCCeee
Q 047263 583 DG-----------------LNRLLVYEFLSNGTLASFLFGD-LKPGWSRR------TDIAFGIARGLLYLHEECSTQIIH 638 (804)
Q Consensus 583 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivH 638 (804)
.. ...+|||||++ |+|.+++... ..+.+..+ ..++.||++||+|||+. +|+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 22 33799999999 8999999763 34466666 78889999999999965 9999
Q ss_pred cCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCC
Q 047263 639 CDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 639 ~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
|||||+|||++.++.+||+|||+++.... ......+|..|+|||++.+ ..++.++||||||+++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986532 2224456799999999987 78999999999999999999999999
Q ss_pred CcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 717 DMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 717 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......... +........................+.+++.+||+.||++|||+.++++
T Consensus 294 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7653321100 0000000000000000011123457888999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=329.62 Aligned_cols=197 Identities=24% Similarity=0.299 Sum_probs=168.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc------ccCCccceeeEEeCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT------HHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l------~h~niv~l~g~~~~~~~~ 587 (804)
+.+.++||+|+||.||+|.....+ +.||||++... ....+++.+|+.+++.+ +|+||+++++++......
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~---~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVH---QHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTT---EEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred EEEEEEcccCccEEEEEEEECCCC---cEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 455688999999999999876543 47999999753 33345677888887777 577999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC--EEEeecCccc
Q 047263 588 LLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN--ARISDFGLAK 663 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~--~kl~Dfgla~ 663 (804)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6899888754 3589999999999999999999976 9999999999999999887 9999999997
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhH
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNE 722 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~ 722 (804)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 251 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 251 YEH----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp ETT----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ecC----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 532 2233457899999999999999999999999999999999999999766543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=316.32 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=194.4
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--------cccHHHHHHHHHHhcccccCCccceeeEEe
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--------QDGVKEFKTEVNVIGQTHHKNLVRLLGFCD 582 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 582 (804)
...+.+.+.||+|+||.||+++....+ ..||||.+.... ......+.+|++++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTC---KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCC---cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 345667789999999999999886543 479999986432 122345889999999999999999999987
Q ss_pred CCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC---EEEeec
Q 047263 583 DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN---ARISDF 659 (804)
Q Consensus 583 ~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Df 659 (804)
.+. .++||||+++++|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++. +||+||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 655 899999999999999998888899999999999999999999965 9999999999999987654 999999
Q ss_pred CcccccccCCCCccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhh
Q 047263 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC 736 (804)
Q Consensus 660 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 736 (804)
|+++.... ........||..|+|||.+. ...++.++||||||+++|||++|+.||........ +.... .
T Consensus 162 g~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~ 233 (322)
T 2ycf_A 162 GHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----T 233 (322)
T ss_dssp TTCEECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH----H
T ss_pred ccceeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH----H
Confidence 99986532 12223456899999999974 56789999999999999999999999975432211 10101 0
Q ss_pred cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 737 EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+... .. +.. .......+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~-~~-~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN-FI-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC-CC-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc-cC-chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11100 00 000 0112457889999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=315.77 Aligned_cols=260 Identities=21% Similarity=0.286 Sum_probs=198.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC------ccceeeEEeCCCc
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN------LVRLLGFCDDGLN 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~~~~~~~ 586 (804)
.+.+.+.||+|+||.||++..... .+..||||++... ....+.+.+|+.+++.++|++ ++++++++.+...
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ceEEEEEEecCCCeEEEEEEecCC--CCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 445678899999999999987321 2347999999754 334567889999999998765 9999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCCC--CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC--------------
Q 047263 587 RLLVYEFLSNGTLASFLFGDL--KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-------------- 650 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-------------- 650 (804)
.++||||+ +++|.+++.... .+++..+..++.||++||.|||+. +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999997654 678999999999999999999965 9999999999999987
Q ss_pred -----CCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH
Q 047263 651 -----YYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA 725 (804)
Q Consensus 651 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~ 725 (804)
++.+||+|||+++.... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 67899999999986432 233456899999999999999999999999999999999999999765443321
Q ss_pred HHHHHHHHhh-----hcCcccceec----------------------chhhhcccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 726 LLTDWAYDCY-----CEGITEALVE----------------------FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 726 ~l~~~~~~~~-----~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
.......... .......... ..............+.+++.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1111100000 0000000000 000011123456788999999999999999999
Q ss_pred HHHHH
Q 047263 779 RKVTQ 783 (804)
Q Consensus 779 ~eVl~ 783 (804)
.||++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.71 Aligned_cols=260 Identities=20% Similarity=0.214 Sum_probs=189.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEe------------
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCD------------ 582 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~------------ 582 (804)
.+.+.||+|+||.||+|.....+ +.||+|++........+++.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCD---KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp EEEEECC-----CEEEEEETTTT---EEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred eEEEEeccCCCeEEEEEEECCCC---eEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 44678999999999999986543 479999998665666788999999999999999999999873
Q ss_pred --CCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEEeec
Q 047263 583 --DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDF 659 (804)
Q Consensus 583 --~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Df 659 (804)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 4467899999998 699999964 5688999999999999999999965 999999999999997 5679999999
Q ss_pred CcccccccCCC--CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH-----
Q 047263 660 GLAKLLLLDQS--QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA----- 731 (804)
Q Consensus 660 gla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~----- 731 (804)
|+++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...............
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99987543221 12233457889999998865 67899999999999999999999999766433211100000
Q ss_pred ---HHhhhcCcccceecchhh-h-----cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 732 ---YDCYCEGITEALVEFDIE-A-----LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 732 ---~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+...... .......... . .........+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 246 EEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 0000000000 0 000122467889999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.07 Aligned_cols=259 Identities=24% Similarity=0.243 Sum_probs=187.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------ 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 585 (804)
+.+.+.||+|+||.||++.....+ ..||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred eeEeeeeEecCCEEEEEEEECCCC---ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 345678999999999999876443 479999987532 334567889999999999999999999997665
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 67999999975 7888885 3578999999999999999999965 9999999999999999999999999999865
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHH-H---------------
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT-D--------------- 729 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~-~--------------- 729 (804)
.. ........||..|+|||.+.+..++.++||||||+++|||++|+.||............ .
T Consensus 178 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 178 GT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cc--ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 32 22233457899999999999999999999999999999999999999765432211000 0
Q ss_pred HHHHhhhcCcc------cceecchh---hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 730 WAYDCYCEGIT------EALVEFDI---EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 730 ~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........... ..+..... ...........+.+++.+||+.||.+|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000000 00000000 00011223567899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.13 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=198.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccccc-----------------HHHHHHHHHHhcccccCCccc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-----------------VKEFKTEVNVIGQTHHKNLVR 576 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~f~~E~~~l~~l~h~niv~ 576 (804)
+.+.+.||+|+||.||++.. . +..||||++....... .+.+.+|+.++++++||||++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-D----NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-T----TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred eEEEEEEcCCCCeEEEEEEc-C----CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 44567899999999999988 2 3479999986432211 278999999999999999999
Q ss_pred eeeEEeCCCceEEEEeecCCCcHHHh------hcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE
Q 047263 577 LLGFCDDGLNRLLVYEFLSNGTLASF------LFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648 (804)
Q Consensus 577 l~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl 648 (804)
+++++.+.+..++||||+++++|.++ +.. ...+++..+..++.||+.||.|||+ ..+|+||||||+||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence 99999999999999999999999999 665 5778999999999999999999996 1499999999999999
Q ss_pred cCCCCEEEeecCcccccccCCCCccccccCCCccccccccccC-CCCc-cchhhHHHHHHHHHHcCCCCCCcchhHHHHH
Q 047263 649 DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM-PITV-KVDVYSFGVLLLEIICCRRNVDMEVNEAEAL 726 (804)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-~~DV~S~Gvll~elltG~~p~~~~~~~~~~~ 726 (804)
+.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||........ .
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-L 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-H
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-H
Confidence 99999999999999865332 33445689999999999877 6666 99999999999999999999976543111 1
Q ss_pred HHHHHHHhhhcCccccee------cchh---hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 727 LTDWAYDCYCEGITEALV------EFDI---EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 727 l~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. . ....+...... .... ...........+.+++.+||+.||.+|||+.|+++
T Consensus 262 ~-~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 F-N----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H-H----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-H----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1 11111110000 0000 00001223467889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=324.80 Aligned_cols=197 Identities=20% Similarity=0.331 Sum_probs=151.8
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEE--eCCCceEEEEeec
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFC--DDGLNRLLVYEFL 594 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lV~Ey~ 594 (804)
.++||+|+||.||+|+..+.. .+..||||++... ...+.+.+|+.++++++||||+++++++ ..+...++||||+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp SCCCC-----EEEEEEESSSS-CCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred CcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 347999999999999976432 2457999999753 2235688999999999999999999999 4467889999999
Q ss_pred CCCcHHHhhcCC---------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE----cCCCCEEEeecCc
Q 047263 595 SNGTLASFLFGD---------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL----DDYYNARISDFGL 661 (804)
Q Consensus 595 ~~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl----~~~~~~kl~Dfgl 661 (804)
++ +|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 74 777777421 2488999999999999999999965 99999999999999 7789999999999
Q ss_pred ccccccCCC--CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcch
Q 047263 662 AKLLLLDQS--QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEV 720 (804)
Q Consensus 662 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~ 720 (804)
++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 987643221 22344678999999999987 458999999999999999999999996543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=310.79 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=186.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC----------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD---------- 583 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~---------- 583 (804)
+.+.+.||+|+||.||+|+...++ ..||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDS---RYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred chhhheeccCCcEEEEEEEEcCCC---eEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 455678999999999999976443 37999999643 3456789999999999999999999998854
Q ss_pred ---CCceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeec
Q 047263 584 ---GLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDF 659 (804)
Q Consensus 584 ---~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Df 659 (804)
....++||||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 35678999999999999999743 4677889999999999999999965 9999999999999999999999999
Q ss_pred CcccccccCC-------------CCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH
Q 047263 660 GLAKLLLLDQ-------------SQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA 725 (804)
Q Consensus 660 gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~ 725 (804)
|++....... ........|+..|+|||.+.+. .++.++||||||+++|||++ |+....... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~-~ 236 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-N 236 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-H
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH-H
Confidence 9998654221 1222345689999999999764 78999999999999999998 444322111 1
Q ss_pred HHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 726 LLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 726 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. . ....... .............+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~-~----~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 IL-K----KLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH-H----HHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH-H----hcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 1 0111100 0111112233456788999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=322.00 Aligned_cols=255 Identities=20% Similarity=0.236 Sum_probs=189.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC----------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD---------- 583 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~---------- 583 (804)
+.+.+.||+|+||.||+|+....+ +.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESG---KRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTC---CEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred EEEEEEEEeccCEEEEEEEECCCC---CEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 445688999999999999876543 3799999865322 23479999999999999999999843
Q ss_pred ----------------------------CCceEEEEeecCCCcHHHhhc----CCCCCChhhHHHHHHHHHHHHHHhhhc
Q 047263 584 ----------------------------GLNRLLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAFGIARGLLYLHEE 631 (804)
Q Consensus 584 ----------------------------~~~~~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~ 631 (804)
....++||||++ |+|.+.+. ....+++..+..++.||++||.|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~- 159 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS- 159 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence 334789999998 47666654 46788999999999999999999995
Q ss_pred cCCCeeecCCCCCcEEEc-CCCCEEEeecCcccccccCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHH
Q 047263 632 CSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEI 709 (804)
Q Consensus 632 ~~~~ivH~dlkp~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~el 709 (804)
.+|+||||||+|||++ .++.+||+|||+++.+... .......+|..|+|||.+.+. .++.++||||+|+++|||
T Consensus 160 --~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 160 --LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp --TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred --CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 4999999999999998 6889999999999865432 233445679999999998765 589999999999999999
Q ss_pred HcCCCCCCcchhHHHHHHHHHHHH----------hhh----cCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCC
Q 047263 710 ICCRRNVDMEVNEAEALLTDWAYD----------CYC----EGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLR 775 (804)
Q Consensus 710 ltG~~p~~~~~~~~~~~l~~~~~~----------~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 775 (804)
++|+.||.......... ..... ... +.....+................+.+++.+||+.||.+|
T Consensus 236 l~g~~pf~~~~~~~~~~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 236 ILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HhCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999998654432111 10000 000 000000111111111122234568899999999999999
Q ss_pred CCHHHHHH
Q 047263 776 PTMRKVTQ 783 (804)
Q Consensus 776 Psm~eVl~ 783 (804)
||+.|+++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999973
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=323.15 Aligned_cols=260 Identities=21% Similarity=0.246 Sum_probs=195.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc--------cCCccceeeEEe-
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH--------HKNLVRLLGFCD- 582 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~--------h~niv~l~g~~~- 582 (804)
..+.+.++||+|+||.||+++...++ +.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGK---KFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCC---eEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34566788999999999999876543 47999999753 344567889999999986 788999999987
Q ss_pred ---CCCceEEEEeecCCCcHHHhhc-CC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-----
Q 047263 583 ---DGLNRLLVYEFLSNGTLASFLF-GD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY----- 652 (804)
Q Consensus 583 ---~~~~~~lV~Ey~~~gsL~~~l~-~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~----- 652 (804)
+....++||||+.+ +|.+++. .. ..+++..+..++.||+.||.|||+. .+|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHHH
T ss_pred cCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhhh
Confidence 66788999999954 5555554 33 5689999999999999999999953 2899999999999999775
Q ss_pred --------------------------------------------CEEEeecCcccccccCCCCccccccCCCcccccccc
Q 047263 653 --------------------------------------------NARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688 (804)
Q Consensus 653 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l 688 (804)
.+||+|||++...... .....||..|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999865432 3345689999999999
Q ss_pred ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH----HHHHHHHHHHhhhc--------C-cccc----------eec
Q 047263 689 RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA----EALLTDWAYDCYCE--------G-ITEA----------LVE 745 (804)
Q Consensus 689 ~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~----~~~l~~~~~~~~~~--------~-~~~~----------~~~ 745 (804)
.+..++.++|||||||++|||++|+.||....... ...+ ......... + .... +..
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI-ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHH-HHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHH-HHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999997543211 1111 001110000 0 0000 000
Q ss_pred c---------hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 746 F---------DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 746 ~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. .............+.+|+.+||+.||++|||++||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 0001124556778999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.07 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=195.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCC-----Cce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-----LNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 587 (804)
+.+.+.||+|+||.||++..... +..||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred EEEEEEeecCCCeEEEEEEECCC---CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 44567899999999999987644 3479999997533 23346789999999999999999999999654 468
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++|+||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999998 599998864 4689999999999999999999965 999999999999999999999999999987643
Q ss_pred CCCC--ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcc---c
Q 047263 668 DQSQ--THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGIT---E 741 (804)
Q Consensus 668 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~ 741 (804)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............. ........ .
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHHHH
Confidence 3222 2344578999999998754 458999999999999999999999997654332111100 00000000 0
Q ss_pred ce------------ecch--hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 742 AL------------VEFD--IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 742 ~~------------~~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. .... ............+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000 000000112356889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.40 Aligned_cols=258 Identities=20% Similarity=0.236 Sum_probs=191.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCce----
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR---- 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~---- 587 (804)
+.+.+.||+|+||.||+|.....+ +.||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSG---EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred EEEEeEEecCCCeEEEEEEECCCC---CEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 345678999999999999876543 479999997532 23356789999999999999999999999877665
Q ss_pred --EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 588 --LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 588 --~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 68988884 3488999999999999999999965 9999999999999999999999999999864
Q ss_pred ccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHH----hhhcCcc
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD----CYCEGIT 740 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~----~~~~~~~ 740 (804)
.. ......||..|+|||.+.+ ..++.++||||||++++||++|+.||................. .+.....
T Consensus 195 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 195 DA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 32 2334568999999999877 7889999999999999999999999976543321110000000 0000000
Q ss_pred cc--------eecchhh--hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 741 EA--------LVEFDIE--ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 741 ~~--------~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
.. +...... ..........+.+++.+||+.||++|||+.|+++-
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 0000000 00001124678899999999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=315.76 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=189.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeC------CCce
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD------GLNR 587 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~~ 587 (804)
.+.+.||+|+||.||+|+....+ ..||||++... ....+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTG---QLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred EEEEEeccCCCEEEEEEEECCCC---CeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 34678999999999999986443 37999998754 23456789999999999 89999999999976 4678
Q ss_pred EEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 588 LLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++...
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999999999754 5688999999999999999999965 9999999999999999999999999999865
Q ss_pred ccCCCCccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcc
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGIT 740 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (804)
.... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||........... ......
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~ 251 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNPA 251 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSCC
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-------hhcCcc
Confidence 3321 1223456899999999986 56789999999999999999999999975543221110 001111
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+. .......+.+++.+||+.||.+||++.++++
T Consensus 252 ~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1110 1112356788999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.89 Aligned_cols=254 Identities=25% Similarity=0.316 Sum_probs=201.4
Q ss_pred HHHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC
Q 047263 508 DLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL 585 (804)
Q Consensus 508 ~l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 585 (804)
......+.+.+.||+|+||.||+++....+ +.||+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQ---QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCC---cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 334455667789999999999999986443 379999986432 345678999999999999999999999999999
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC---CCEEEeecCcc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY---YNARISDFGLA 662 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~---~~~kl~Dfgla 662 (804)
..++|+||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||||+||+++.+ +.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999999998777899999999999999999999965 99999999999999754 46999999999
Q ss_pred cccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
....... ......++..|+|||.+.+ .++.++||||||++++||++|+.||........ + . ....+...
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~-~----~~~~~~~~- 240 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--L-K----RVETGKYA- 240 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-H----HHHHCCCC-
T ss_pred eeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH--H-H----HHHcCCCC-
Confidence 8654322 2233457889999999876 489999999999999999999999976543221 1 1 01111110
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... ........+.+++.+||+.||++|||+.++++
T Consensus 241 ---~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ---FDLP--QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---CCSG--GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCch--hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 00112356788999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=315.46 Aligned_cols=198 Identities=26% Similarity=0.330 Sum_probs=167.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cC-----CccceeeEEeCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HK-----NLVRLLGFCDDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~ 587 (804)
+.+.+.||+|+||.||+|+....+ +.||||++... ....+++..|+.++..++ |+ +|+++++++......
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQ---EWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCC---cEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 445678999999999999886543 47999999753 334567788888888875 44 499999999999999
Q ss_pred EEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc--CCCCEEEeecCccc
Q 047263 588 LLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD--DYYNARISDFGLAK 663 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfgla~ 663 (804)
++||||++ ++|.+++... ..+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 5999998764 4689999999999999999999954 45899999999999994 57889999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchh
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVN 721 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~ 721 (804)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 210 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6532 23345689999999999999999999999999999999999999986544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=318.86 Aligned_cols=263 Identities=20% Similarity=0.173 Sum_probs=182.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCc-------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN------- 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------- 586 (804)
+.+.+.||+|+||.||+|+....+ ..||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTG---MSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp EEEC----------CEEEEETTTC---CEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 345688999999999999986543 379999986532 233456778888899999999999999865333
Q ss_pred eEEEEeecCCCcHH---HhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCcc
Q 047263 587 RLLVYEFLSNGTLA---SFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLA 662 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~---~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla 662 (804)
.++||||++++.+. .++.....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+||+|||++
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 78999999975332 3334567788999999999999999999943 459999999999999996 899999999999
Q ss_pred cccccCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HH
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YD 733 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~ 733 (804)
+..... .......||..|+|||.+.+. .++.++||||||+++|||++|+.||............... +.
T Consensus 180 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 180 KKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp BCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 865432 223345689999999998654 4899999999999999999999999776443211110000 00
Q ss_pred hhhcCc-cccee------cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 734 CYCEGI-TEALV------EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 734 ~~~~~~-~~~~~------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...... ..... ...............+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 00000 000000111124567899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.54 Aligned_cols=255 Identities=22% Similarity=0.251 Sum_probs=187.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCC------Cce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG------LNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 587 (804)
+.+.+.||+|+||.||+|+....+ +.||||++.... +.+.+|++++++++|+||+++++++... ...
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSG---ELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCC---cEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 344678999999999999987543 379999986532 2234799999999999999999988432 235
Q ss_pred EEEEeecCCCcHHHhhc----CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-CCEEEeecCcc
Q 047263 588 LLVYEFLSNGTLASFLF----GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-YNARISDFGLA 662 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-~~~kl~Dfgla 662 (804)
++||||+++ +|.+.+. ....+++..+..++.||++||.|||+ .+|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 5555543 45778999999999999999999995 499999999999999965 56899999999
Q ss_pred cccccCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHH-------h
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD-------C 734 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-------~ 734 (804)
+.+.... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||........ +...... .
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ 280 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 8754322 23345689999999998764 789999999999999999999999976543321 1111100 0
Q ss_pred hh--cCcccceecch-----hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 735 YC--EGITEALVEFD-----IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 735 ~~--~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+. ......+..+. ...........++.+|+.+||+.||.+|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 00000000000 000111122467889999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.34 Aligned_cols=267 Identities=19% Similarity=0.221 Sum_probs=196.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCC-----Cce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDG-----LNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 587 (804)
+.+.+.||+|+||.||+|.....+ ..||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTG---EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCC---cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 345678999999999999886443 479999997432 23456788999999999999999999988654 678
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99999997 699998865 4689999999999999999999965 999999999999999999999999999987643
Q ss_pred CCCC---------ccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhh-
Q 047263 668 DQSQ---------THTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYC- 736 (804)
Q Consensus 668 ~~~~---------~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~- 736 (804)
.... ......||..|+|||.+.. ..++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 2211 1223468999999998754 6789999999999999999999999976643322111100000000
Q ss_pred cCcccceecchh--------------hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcC
Q 047263 737 EGITEALVEFDI--------------EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGV 788 (804)
Q Consensus 737 ~~~~~~~~~~~~--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~ 788 (804)
............ ...........+.+++.+||+.||++|||+.|+++ .++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000000000000 00000123457789999999999999999999986 45444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.22 Aligned_cols=257 Identities=22% Similarity=0.236 Sum_probs=189.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC------ce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------NR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 587 (804)
+.+.+.||+|+||.||+|+...+. .+|+|++..... ...+|+.+++.++||||+++++++.... ..
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~----~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESD----EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTE----EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCC----eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 445678999999999999986544 388888864322 1246999999999999999999985433 37
Q ss_pred EEEEeecCCCcHHHhh---cCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEEeecCccc
Q 047263 588 LLVYEFLSNGTLASFL---FGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAK 663 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfgla~ 663 (804)
++||||++++.+.... .....+++..+..++.||++||.|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8999999876544333 2357789999999999999999999965 999999999999999 79999999999998
Q ss_pred ccccCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH--------HH-
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA--------YD- 733 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~- 733 (804)
..... .......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||............... ..
T Consensus 191 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 191 ILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp ECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 75332 223345689999999998764 5899999999999999999999999866443211100000 00
Q ss_pred ---hhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 734 ---CYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 734 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.+.+......................+.+++.+||+.||.+|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000111111111111111223457889999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.57 Aligned_cols=243 Identities=24% Similarity=0.338 Sum_probs=190.0
Q ss_pred HHHHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc------cHHHHHHHHHHhccc----ccCCcccee
Q 047263 509 LEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD------GVKEFKTEVNVIGQT----HHKNLVRLL 578 (804)
Q Consensus 509 l~~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l----~h~niv~l~ 578 (804)
.....+.+.+.||+|+||.||+|+....+ +.||||++...... ....+.+|+.++.++ +|+||++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDR---LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTC---CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCC---eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 33445667789999999999999876443 37999999654321 223456788888888 899999999
Q ss_pred eEEeCCCceEEEEee-cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEE
Q 047263 579 GFCDDGLNRLLVYEF-LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARI 656 (804)
Q Consensus 579 g~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl 656 (804)
+++.+.+..++|+|| +.+++|.+++.....+++..+..++.||++||.|||+. +|+||||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 78999999998878899999999999999999999976 999999999999999 8899999
Q ss_pred eecCcccccccCCCCccccccCCCccccccccccCCCC-ccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhh
Q 047263 657 SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT-VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 735 (804)
+|||++...... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||.......
T Consensus 182 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------ 246 (312)
T 2iwi_A 182 IDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------------ 246 (312)
T ss_dssp CCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------------
T ss_pred EEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh------------
Confidence 999999875432 23345689999999999877665 48999999999999999999997532110
Q ss_pred hcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 736 CEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... . ........+.+++.+||+.||++|||++|+++
T Consensus 247 -~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 -EAEL-H---------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HTCC-C---------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hhcc-C---------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0 01112346788999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.52 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=189.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccc--cCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTH--HKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~l 589 (804)
+.+.+.||+|+||.||++.... +..||||++... .....+.+.+|+.++.+++ |+||+++++++.++...++
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred EEEEEEecCCCCEEEEEEEcCC----CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4456789999999999998754 336999998643 2345578999999999997 5999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||| +.+++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||+++ +.+||+|||+++......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999 67889999998888899999999999999999999965 9999999999999975 899999999998764332
Q ss_pred CC-ccccccCCCcccccccccc-----------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 670 SQ-THTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 670 ~~-~~~~~~gt~~y~aPE~l~~-----------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
.. ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... . .....
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~----~~~~~ 255 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-H----AIIDP 255 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-H----HHHCT
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH-H----HHHhc
Confidence 21 2234568999999999875 478889999999999999999999997543322111 0 10111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.....+ .......+.+++.+||+.||.+||++.|+++
T Consensus 256 ~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 256 NHEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TSCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCC---------cccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 110000 0111346788999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=322.18 Aligned_cols=244 Identities=27% Similarity=0.327 Sum_probs=182.3
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEeecC
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
.+.||+|+||+||.+.... ++.||||++... ..+.+.+|+.++.++ +||||+++++++.++...++||||+.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~----g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQ----GRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEECSTTCEEEEEESS----SSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred cCeEeeCCCeEEEEEEEEC----CeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 4679999999997654332 347999998643 345678999999876 89999999999999999999999996
Q ss_pred CCcHHHhhcCCCCC-------ChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC-------------CCEE
Q 047263 596 NGTLASFLFGDLKP-------GWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY-------------YNAR 655 (804)
Q Consensus 596 ~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~-------------~~~k 655 (804)
|+|.+++...... .+..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999765332 3345678999999999999965 99999999999999754 4899
Q ss_pred EeecCcccccccCCCC---ccccccCCCcccccccccc-------CCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHH
Q 047263 656 ISDFGLAKLLLLDQSQ---THTAIRGTKGYVAPEWFRN-------MPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAE 724 (804)
Q Consensus 656 l~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~ 724 (804)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999876543322 1234579999999999965 678999999999999999999 8999875543321
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
..+ .+.. ...............++.+++.+||+.||.+|||+.+|++
T Consensus 249 ~i~---------~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NII---------RGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH---------HTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHh---------cCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 0100 0011112223455678899999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.74 Aligned_cols=267 Identities=21% Similarity=0.239 Sum_probs=189.1
Q ss_pred HHHHHHHHhh--hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-----------ccHHHHHHHHHHhcccccC
Q 047263 506 YKDLEAATNG--FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-----------DGVKEFKTEVNVIGQTHHK 572 (804)
Q Consensus 506 ~~~l~~at~~--f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-----------~~~~~f~~E~~~l~~l~h~ 572 (804)
..++.....+ +.+.||+|+||.||+|.... +..||||++..... ...+.+.+|++++++++||
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence 3444444433 45789999999999998754 34799999864321 1237799999999999999
Q ss_pred CccceeeEEe-----CCCceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 573 NLVRLLGFCD-----DGLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 573 niv~l~g~~~-----~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
||+++++++. .....++||||++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 9999999984 3346799999998 5777777654 4789999999999999999999965 999999999999
Q ss_pred EEcCCCCEEEeecCcccccccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH
Q 047263 647 LLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA 725 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~ 725 (804)
|++.++.+||+|||+++..... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999754322 22334568899999999876 67899999999999999999999999765433211
Q ss_pred H-HHHHH---------------HHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 726 L-LTDWA---------------YDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 726 ~-l~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. +.... ...+............ ...........+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1 00000 0000000000000000 00011122356889999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.16 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=196.2
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC------ccceeeEEeCCCc
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN------LVRLLGFCDDGLN 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~~~~~~~ 586 (804)
.+.+.+.||+|+||.||++...... +..||+|++... ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTT--TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCC--ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4456788999999999999876432 247999999753 344567889999999998776 9999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE----------------
Q 047263 587 RLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL---------------- 648 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl---------------- 648 (804)
.++||||+ +++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 55666666543 468999999999999999999995 499999999999999
Q ss_pred ---cCCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHH
Q 047263 649 ---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEA 725 (804)
Q Consensus 649 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~ 725 (804)
+.++.+||+|||+++.... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 6788999999999986432 233456899999999999999999999999999999999999999865443221
Q ss_pred HHHHHHHHh-----hhcCcccce-ec---------------------chhhhcccHHHHHHHHHHHHHccccCCCCCCCH
Q 047263 726 LLTDWAYDC-----YCEGITEAL-VE---------------------FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTM 778 (804)
Q Consensus 726 ~l~~~~~~~-----~~~~~~~~~-~~---------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 778 (804)
......... +........ .. ..............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 111110000 000000000 00 000001122345678899999999999999999
Q ss_pred HHHHH
Q 047263 779 RKVTQ 783 (804)
Q Consensus 779 ~eVl~ 783 (804)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99974
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=289.84 Aligned_cols=210 Identities=20% Similarity=0.254 Sum_probs=159.0
Q ss_pred hccCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCe
Q 047263 24 QTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGL 103 (804)
Q Consensus 24 ~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L 103 (804)
++.|+|++|++|++++ +| ++|.|+|||+.+++ +.+|+ . +|+||+|||+.| .++.|+|+.||||
T Consensus 6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~gn------l~ly~-~---~~~vW~an~~~~--~~~~l~l~~dGnL 68 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDCN------LVLFD-S---DVRVWASNTAGA--TGCRAVLQSDGLL 68 (236)
T ss_dssp CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTSC------EEEEE-S---SSEEECCCCCSC--SCCBCCBCSSSCB
T ss_pred eccceeCCCCEECCCC---EE--EcCCEEEEECCCCc------EEEEE-C---CEEEEECCCCCC--CCeEEEEcCCCcE
Confidence 4579999999999766 67 59999999985432 33443 2 799999999999 5678999999999
Q ss_pred EEeCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCccccccccCCcccc----------cCCcccCCC-ceEEecC
Q 047263 104 VLTSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTM----------LPSQIFDNG-QFLSSKQ 171 (804)
Q Consensus 104 ~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTl----------Lpg~~l~~~-~~L~S~~ 171 (804)
||.|++|++||+|++... ....|+|+|+|||||++. ++||||||||||+ +|||+++.+ ++|+|
T Consensus 69 vl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s-- 143 (236)
T 1dlp_A 69 VILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA-- 143 (236)
T ss_dssp CCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS--
T ss_pred EEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc--
Confidence 999999999999997643 345799999999999954 8999999998655 777776653 57874
Q ss_pred CCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCCCCC--cceeeeccccEEEeeeccceeeeeeeccccCcc
Q 047263 172 SDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSS--NQLVFNQSGYMYILQEYDQRFALTRRVETSASN 249 (804)
Q Consensus 172 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (804)
.+||++|.|+++++++|+++++ +.. .+||++++++.. ....+...|.++.+..++.+++.++.... .
T Consensus 144 -~~d~s~G~~~l~l~~dG~LvL~--~~~-----~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~---~ 212 (236)
T 1dlp_A 144 -TQSLQLSPYRLSMETDCNLVLF--DRD-----DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRS---A 212 (236)
T ss_dssp -SCCCBCSSCEEEEETTTEEEEE--BTT-----BCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCCCS---S
T ss_pred -CcEeecCcEEEEECCCCcEEEE--cCC-----EeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCCCC---C
Confidence 7899999999999999976653 322 478888776432 23445566766666555555655554322 2
Q ss_pred eeEEEEEeeCCcEEEEe
Q 047263 250 FYYRATINFDGVFTQYQ 266 (804)
Q Consensus 250 ~~~r~~l~~dG~l~~y~ 266 (804)
..+|++|++||++++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 35899999999999995
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.40 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=190.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCc-----
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN----- 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~----- 586 (804)
+.+.+.||+|+||.||+|.....+ ..||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSG---EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred EEEeeeEecCCCeEEEEEEECCCC---CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 344578999999999999886543 479999996532 2335678999999999999999999999987654
Q ss_pred -eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 587 -RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 587 -~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
.++||||+. ++|.+++.. .+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999998 689888853 488999999999999999999965 9999999999999999999999999999864
Q ss_pred ccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh------hhcC
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC------YCEG 738 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~------~~~~ 738 (804)
.. ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ...... +...
T Consensus 177 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 177 DA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPGTEFVQK 250 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--HHHHHHCBCCHHHHTT
T ss_pred CC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHHH
Confidence 32 2234568999999999876 678999999999999999999999997654322110 000000 0000
Q ss_pred cccc--------ee---cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 739 ITEA--------LV---EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 739 ~~~~--------~~---~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.... +. ..... .........+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00 00000 001123467889999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.31 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=172.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHH-HhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVN-VIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||++.....+ ..||||++.... ....+++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSG---QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTT---EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hehheeccCCCEEEEEEEEcCCC---CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 34678999999999999986543 479999997543 233345555655 7788899999999999999999999999
Q ss_pred ecCCCcHHHhhcC-----CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 593 FLSNGTLASFLFG-----DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 593 y~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
|+++ +|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 88877752 56789999999999999999999953 2899999999999999999999999999986543
Q ss_pred CCCCccccccCCCcccccccc----ccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 668 DQSQTHTAIRGTKGYVAPEWF----RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
.. ......||..|+|||.+ .+..++.++||||||+++|||++|+.||.......... .....+....
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~- 249 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------TQVVKGDPPQ- 249 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCC-
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------HHHhcCCCCC-
Confidence 22 22334689999999998 45678999999999999999999999997543211100 0000010000
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
............+.+++.+||+.||.+|||+.+|++
T Consensus 250 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 ----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111123457889999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=315.35 Aligned_cols=238 Identities=24% Similarity=0.379 Sum_probs=194.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccc------cHHHHHHHHHHhcccc--cCCccceeeEEeCCC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD------GVKEFKTEVNVIGQTH--HKNLVRLLGFCDDGL 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~ 585 (804)
+.+.+.||+|+||.||+|+....+ +.||||++...... ..+.+..|+.++++++ |+||+++++++.+.+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTT---EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred eEEEEEEeeCCCeEEEEEEECCCC---cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 455678999999999999876443 47999998753221 2245678999999996 599999999999999
Q ss_pred ceEEEEeecCC-CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEEeecCccc
Q 047263 586 NRLLVYEFLSN-GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAK 663 (804)
Q Consensus 586 ~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfgla~ 663 (804)
..++|+||+.+ ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ +++.+||+|||+++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999986 89999998888899999999999999999999965 999999999999999 78999999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
..... ......||..|+|||++.+..+ +.++||||||+++|||++|+.||....... ....
T Consensus 199 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------------~~~~--- 260 (320)
T 3a99_A 199 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------------RGQV--- 260 (320)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------------HCCC---
T ss_pred ccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh------------cccc---
Confidence 75432 2334568999999999987766 678999999999999999999997542110 0000
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. .......+.+++.+||+.||++|||+++|++
T Consensus 261 ~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0112346788999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.51 Aligned_cols=252 Identities=20% Similarity=0.203 Sum_probs=169.4
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC----CCceEEEEee
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD----GLNRLLVYEF 593 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~Ey 593 (804)
+.||+|+||.||++.....+ +.||||++... . +...+....+..++|+||+++++++.. +...++||||
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTG---QKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp EEEEEETTEEEEEEEETTTC---CEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeeeCCCeEEEEEEECCCC---CEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 46999999999999987544 37999998653 1 222233334566799999999999865 4457999999
Q ss_pred cCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCcccccccC
Q 047263 594 LSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLLLLD 668 (804)
Q Consensus 594 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~~~~ 668 (804)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~- 183 (336)
T 3fhr_A 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183 (336)
T ss_dssp CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence 9999999999765 3689999999999999999999965 9999999999999976 45599999999986532
Q ss_pred CCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.......+|+.|+|||.+....++.++||||||+++|||++|+.||........... .. ......... .
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~----~~~~~~~~~--~ 252 (336)
T 3fhr_A 184 --NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MK----RRIRLGQYG--F 252 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------C--C
T ss_pred --cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HH----Hhhhccccc--c
Confidence 223345679999999999988999999999999999999999999965433211000 00 000000000 0
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCccC
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVVEV 791 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~~~ 791 (804)
...........+.+++.+||+.||.+|||+.|+++ .+......
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 297 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence 00011123457888999999999999999999997 55544333
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=314.34 Aligned_cols=267 Identities=19% Similarity=0.267 Sum_probs=197.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-----------cCCccceeeEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-----------HKNLVRLLGFC 581 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------h~niv~l~g~~ 581 (804)
.+.+.+.||+|+||.||+|+....+ +.||||++... ....+.+.+|+.++++++ |+||+++++++
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNN---THVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCC---cEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 4556789999999999999876443 47999999753 234567889999998886 89999999998
Q ss_pred eCCC----ceEEEEeecCCCcHHHhhcC--CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc------
Q 047263 582 DDGL----NRLLVYEFLSNGTLASFLFG--DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD------ 649 (804)
Q Consensus 582 ~~~~----~~~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~------ 649 (804)
.... ..++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+. .+|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCc
Confidence 7654 789999999 8999999975 34588999999999999999999952 2899999999999994
Q ss_pred CCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH----HH
Q 047263 650 DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA----EA 725 (804)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~----~~ 725 (804)
..+.+||+|||++..... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCC----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 445799999999986533 2234568999999999999999999999999999999999999997553211 11
Q ss_pred HHHHHHHHhhhc-------------------Ccccceecc---------hhhhcccHHHHHHHHHHHHHccccCCCCCCC
Q 047263 726 LLTDWAYDCYCE-------------------GITEALVEF---------DIEALNDKKKLARFVMVAIWCIQEDPSLRPT 777 (804)
Q Consensus 726 ~l~~~~~~~~~~-------------------~~~~~~~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 777 (804)
.+.. ....... +....+... .............+.+++.+||+.||++|||
T Consensus 249 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 249 HIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111 0000000 000000000 0011223556788999999999999999999
Q ss_pred HHHHHH--HhhcCccC
Q 047263 778 MRKVTQ--MLEGVVEV 791 (804)
Q Consensus 778 m~eVl~--~Le~~~~~ 791 (804)
++||++ .+.+....
T Consensus 328 ~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHHTCGGGTTCTTC
T ss_pred HHHHhhChhhhcccCc
Confidence 999987 45554433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=308.97 Aligned_cols=259 Identities=23% Similarity=0.278 Sum_probs=192.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhccc---ccCCccceeeEEe-----C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQT---HHKNLVRLLGFCD-----D 583 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~ 583 (804)
+.+.+.||+|+||.||++..... .+..||+|++..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred eeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 34567899999999999987421 234799999864321 1223466777777666 8999999999987 5
Q ss_pred CCceEEEEeecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCc
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGL 661 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgl 661 (804)
....++||||++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 677899999998 6999999754 3489999999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc----
Q 047263 662 AKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE---- 737 (804)
Q Consensus 662 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 737 (804)
++..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .. .......
T Consensus 167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~-i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GK-ILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCGG
T ss_pred cccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHcCCCCcc
Confidence 9865322 2233456899999999999999999999999999999999999999765443211 11 1110000
Q ss_pred Ccccce------ec---chhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEAL------VE---FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~------~~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...... .. ..............+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00 00000011123456788999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.75 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=174.5
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.||+|+||.||++.....+ ..||||++..... ...+.+.++..+++.++||||+++++++.++...++|||
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTG---HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp EEEEEC------CEEEEEETTTC---CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred cccceeeecCCeeEEEEEEecCC---eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 34578999999999999986543 3799999975422 223345566667888899999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+ ++.+..+... ...+++..+..++.||++||.|||+. .+|+|+||||+||+++.++.+||+|||++...... .
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--K 179 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--c
Confidence 99 4555555543 46789999999999999999999962 28999999999999999999999999999765432 2
Q ss_pred ccccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 672 THTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
......++..|+|||.+. ...++.++||||||+++|||++|+.||......... +.. . . .+....+..
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~-~---~-~~~~~~~~~- 252 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTK-V---L-QEEPPLLPG- 252 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHH-H---H-HSCCCCCCS-
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHH-H---h-ccCCCCCCc-
Confidence 233456899999999984 557889999999999999999999999754322111 111 1 1 111110000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+||+.||.+||++.+|++
T Consensus 253 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 ------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0112346788999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=312.85 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=178.9
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEeec
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
..+.||+|+||+|+...... ++.||||++..... ..+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~----~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFD----NRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEECGGGCEEEEEESS----SSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCeeecCcCEEEEEEEEeC----CeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45689999999965433322 33699999975322 2356799999998 8999999999999999999999999
Q ss_pred CCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-----CCCEEEeecCcccccccC
Q 047263 595 SNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLLLD 668 (804)
Q Consensus 595 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-----~~~~kl~Dfgla~~~~~~ 668 (804)
. |+|.+++.... ...+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 7 59999997653 455667789999999999999965 9999999999999943 346889999999876433
Q ss_pred CC--CccccccCCCccccccccc---cCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 669 QS--QTHTAIRGTKGYVAPEWFR---NMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 669 ~~--~~~~~~~gt~~y~aPE~l~---~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
.. .......||+.|+|||++. ...++.++|||||||++|||++ |..||..........+ .......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--------~~~~~~~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------LGACSLD 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--------TTCCCCT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--------hccCCcc
Confidence 21 2234467999999999997 4567889999999999999999 8888865433221111 0110000
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
.. .........+.+++.+||+.||.+|||+.+|+
T Consensus 249 ~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 249 CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 00 01123345678899999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=326.73 Aligned_cols=260 Identities=25% Similarity=0.248 Sum_probs=194.4
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeC------CC
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD------GL 585 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~ 585 (804)
.+.+.++||+|+||.||+|.....+ ..||||++... .....+.+.+|++++++++||||+++++++.. +.
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg---~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTG---EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTT---CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCC---cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3556789999999999999876443 37999998753 23445679999999999999999999999865 67
Q ss_pred ceEEEEeecCCCcHHHhhcCCC---CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC---EEEeec
Q 047263 586 NRLLVYEFLSNGTLASFLFGDL---KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN---ARISDF 659 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~---~kl~Df 659 (804)
..++||||+++|+|.+++.... .+++..+..++.+|+.||.|||+. +|+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999997643 588999999999999999999965 9999999999999997665 899999
Q ss_pred CcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH--HH-HHHHHhh-
Q 047263 660 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL--LT-DWAYDCY- 735 (804)
Q Consensus 660 gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~--l~-~~~~~~~- 735 (804)
|++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.......... +. .......
T Consensus 169 G~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 999875432 22344678999999999999999999999999999999999999997543221100 00 0000000
Q ss_pred hcCcccceec-c--hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHH
Q 047263 736 CEGITEALVE-F--DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 736 ~~~~~~~~~~-~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e 780 (804)
.+........ . .............+.+++.+||+.||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000000 0 0011122335678899999999999999999977
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=330.99 Aligned_cols=239 Identities=23% Similarity=0.295 Sum_probs=189.5
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCc-----
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN----- 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~----- 586 (804)
.+.+.+.||+|+||.||++..... .++.||||++.... ....+.|.+|+.++++++||||+++++++.+.+.
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 345677899999999999988642 23479999986432 3445678999999999999999999999987665
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.+|||||+++++|.+++.. .+++.+++.|+.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+++...
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 6999999999999998755 789999999999999999999965 99999999999999986 99999999998653
Q ss_pred cCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.. ....||+.|+|||++.+.. +.++||||||++++||++|..|+...... ...
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~~~------ 285 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------GLP------ 285 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------SCC------
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------ccc------
Confidence 32 4456899999999987654 89999999999999999998877532110 000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRP-TMRKVTQMLEGV 788 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~Le~~ 788 (804)
...........+.+++.+||+.||++|| +++++.+.|.++
T Consensus 286 --~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 --EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011112335688899999999999999 567777777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=293.77 Aligned_cols=231 Identities=13% Similarity=0.063 Sum_probs=179.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|..... ++.||||.+..... +..+.|.+|+..+.+++||||+++++++.+++..++|
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTAL---DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTT---TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEecCC---CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 44567899999999999998643 34799999975432 3347799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++++|.+++... ....+..+|+.||+.||.|||+. +|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999999999543 35557889999999999999965 99999999999999999999997443
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
|++ .++.++||||||+++|||++|+.||........... ........... ..
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~---~~ 226 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------AERDTAGQPIE---PA 226 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------CCBCTTSCBCC---HH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------HHHHhccCCCC---hh
Confidence 333 368899999999999999999999976432210000 00000000000 00
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.........+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0111233568899999999999999 999999999886654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=288.66 Aligned_cols=231 Identities=21% Similarity=0.259 Sum_probs=176.1
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHh-cccccCCccceeeEEeC----CCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVI-GQTHHKNLVRLLGFCDD----GLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lV~E 592 (804)
+.||+|+||.||++.....+ +.||+|++... ..+.+|+.++ +.++||||+++++++.+ ....++|||
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQ---EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp EEEEEETTEEEEEEEETTTC---CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cccccCCCeEEEEEEEcCCC---cEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 56999999999999986543 37999998642 4567888887 55699999999999876 677899999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCccccccc
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLLLL 667 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~~~ 667 (804)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 99999999999765 3689999999999999999999965 9999999999999998 7889999999987432
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
+..++.++||||||+++|||++|+.||........ .......+....
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~ 218 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQ 218 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTC
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhcc
Confidence 23567899999999999999999999965432210 001111111100
Q ss_pred h--hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCccCCC
Q 047263 748 I--EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVVEVLD 793 (804)
Q Consensus 748 ~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~~~~~ 793 (804)
. ...........+.+++.+||+.||.+|||+.|+++ .+......+.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~ 268 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence 0 00000123467889999999999999999999986 4444444333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=300.02 Aligned_cols=233 Identities=16% Similarity=0.136 Sum_probs=171.9
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---ccHHHHHHHHHHhccccc-CCccce---------eeE---
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---DGVKEFKTEVNVIGQTHH-KNLVRL---------LGF--- 580 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~h-~niv~l---------~g~--- 580 (804)
.+.||+|+||.||+|+....+. .||||++..... ...+.|.+|+.+++.++| +|.... +..
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~---~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGE---SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCC---EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred ecccccCCCEEEEEEEecCCCC---ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 4689999999999999765443 799999873322 335779999999999977 221111 111
Q ss_pred ---------EeC-----CCceEEEEeecCCCcHHHhhc------C-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeec
Q 047263 581 ---------CDD-----GLNRLLVYEFLSNGTLASFLF------G-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHC 639 (804)
Q Consensus 581 ---------~~~-----~~~~~lV~Ey~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 639 (804)
... ....+++|++ .+++|.+++. . ...+++..++.++.||++||.|||+. +|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 111 1234566665 4689998884 1 23467889999999999999999965 99999
Q ss_pred CCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCcccccccc----------ccCCCCccchhhHHHHHHHHH
Q 047263 640 DIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF----------RNMPITVKVDVYSFGVLLLEI 709 (804)
Q Consensus 640 dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~~~DV~S~Gvll~el 709 (804)
||||+|||++.++.+||+|||+++..... .....| ..|+|||++ ....++.++|||||||++|||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999998864332 344567 999999999 556688999999999999999
Q ss_pred HcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 710 ICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 710 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
++|+.||........ ...+.... ......+.+++.+||+.||++||++.+++
T Consensus 311 ltg~~Pf~~~~~~~~---------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 311 WCADLPNTDDAALGG---------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHSSCCCCTTGGGSC---------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHCCCCCCCcchhhh---------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999975432210 11111100 01235688899999999999999976653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=292.89 Aligned_cols=242 Identities=15% Similarity=0.106 Sum_probs=179.7
Q ss_pred HHHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--------cccHHHHHHHHHHhcccc---------cCC
Q 047263 511 AATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--------QDGVKEFKTEVNVIGQTH---------HKN 573 (804)
Q Consensus 511 ~at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--------~~~~~~f~~E~~~l~~l~---------h~n 573 (804)
...+.+.++||+|+||.||+|+.. ++.||||++.... ....+.+.+|+.++++++ |+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD-----HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET-----TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEeC-----CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 345667789999999999999872 3479999997542 234578889999988886 666
Q ss_pred ccceeeEE-----------------e-------------CCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHH
Q 047263 574 LVRLLGFC-----------------D-------------DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR 623 (804)
Q Consensus 574 iv~l~g~~-----------------~-------------~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~ 623 (804)
|+++.+.+ . +....+|||||+++|++.+.+.+ ..+++..+..++.||+.
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA 172 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 66666653 2 26789999999999977776643 56789999999999999
Q ss_pred HHHHhh-hccCCCeeecCCCCCcEEEcCCC--------------------CEEEeecCcccccccCCCCccccccCCCcc
Q 047263 624 GLLYLH-EECSTQIIHCDIKPQNILLDDYY--------------------NARISDFGLAKLLLLDQSQTHTAIRGTKGY 682 (804)
Q Consensus 624 gL~yLH-~~~~~~ivH~dlkp~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 682 (804)
||.||| +. +|+||||||+|||++.++ .+||+|||+++.... ....||..|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecc
Confidence 999999 76 999999999999999887 899999999987542 234689999
Q ss_pred ccccccccCCCCccchhhHHHHH-HHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHH
Q 047263 683 VAPEWFRNMPITVKVDVYSFGVL-LLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFV 761 (804)
Q Consensus 683 ~aPE~l~~~~~s~~~DV~S~Gvl-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 761 (804)
+|||++.+.. +.++||||++++ .+++++|..||...... ..+. ......... ..............++.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~----~~~~~~~~~---~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLT----DKMLKQMTF---KTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHH----HHHHHTCCC---SSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHH----Hhhhhhhcc---CcccchhhhhhcCHHHH
Confidence 9999998766 899999998776 78889999887432100 0000 000000000 00001111234567899
Q ss_pred HHHHHccccCCCCCCCHHHHH
Q 047263 762 MVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 762 ~l~~~Cl~~dP~~RPsm~eVl 782 (804)
+++.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999865 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=272.64 Aligned_cols=185 Identities=18% Similarity=0.089 Sum_probs=129.8
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccc----------cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCce
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----------QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----------~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 587 (804)
..+.|+.|.+.++....- +..+++|.+.... +...++|.+|+++|+++ +|+||++++++++++...
T Consensus 241 ~~~~~~~~~h~~~rr~~f---g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFF---GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp C-C--------CCEEEEE---CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred ccccCCcccccccccccc---cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 456666666655443322 3368999986431 22346799999999999 799999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
||||||++|++|.++|.....++.. +|+.||+.||.|||++ +||||||||+||||++++++||+|||+++....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999999888777654 5899999999999965 999999999999999999999999999987644
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCC
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR 714 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~ 714 (804)
+. .......||++|||||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 23345679999999999976 46778999999999999876643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-24 Score=244.06 Aligned_cols=182 Identities=19% Similarity=0.196 Sum_probs=143.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--------ccHHHHHHHHHHhcccccCCccceeeEEeCCCceE
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 588 (804)
.+.||+|+||.||++.... ..+++|+...... ...+.|.+|++++++++||||+++..++...++.+
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLD-----FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -------CCEEEEEEECSS-----CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCEEeeCCCEEEEEEEECC-----CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 4589999999999995432 2588887643211 11345899999999999999997777777888889
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
|||||+++++|.+++.. +..++.||++||.|||+. +|+||||||+|||+++ ++||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999999965 668999999999999965 9999999999999999 9999999999976432
Q ss_pred CCCc------cccccCCCcccccccccc--CCCCccchhhHHHHHHHHHHcCCCCC
Q 047263 669 QSQT------HTAIRGTKGYVAPEWFRN--MPITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 669 ~~~~------~~~~~gt~~y~aPE~l~~--~~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
.... .....||+.|+|||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 235678999999999986 56888899999999988888777654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=162.46 Aligned_cols=107 Identities=17% Similarity=0.258 Sum_probs=91.2
Q ss_pred hccCccCCCCceeecCCCCeee--eCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCC
Q 047263 24 QTRGKITIGASLSASQNSSSWL--SPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQ 101 (804)
Q Consensus 24 ~~~~~i~~g~~l~~~~~~~~lv--S~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G 101 (804)
++.++|.+|++|.+++ +|+ |++|.|+|+|+.+++ . +||++ +++||+|||+.| ..++.++|..||
T Consensus 6 ~~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~~dgn----l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dG 71 (119)
T 1b2p_A 6 SKQPDDNHPQILHATE---SLEILFGTHVYRFIMQTDCN----L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDG 71 (119)
T ss_dssp CSCSSSCCCCEEETTC---EEEEEETTEEEEEEECTTSC----E---EEEET---TEEEEECCCTTS-CSSCEEEECTTS
T ss_pred ecCcccCCCCEEcCCC---EEEEeCCCCCEEEEEecCCC----E---EEEEC---CEEEEeCCCccC-CCceEEEEccCC
Confidence 4578999999999876 899 999999999997543 2 57875 799999999877 345789999999
Q ss_pred CeEEeCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 047263 102 GLVLTSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWES 147 (804)
Q Consensus 102 ~L~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQS 147 (804)
||||+|.+++++|+|++..+ +...++|+|+|||||++ .++|||
T Consensus 72 NLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 72 VLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp CEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 99999999999999987543 35679999999999997 389998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=158.22 Aligned_cols=104 Identities=24% Similarity=0.416 Sum_probs=87.8
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
.++|.+|+.|.+++ +|+| |.|.|.|...++ |.++. ..++||+|||++|..+.+.|+|+.||||||
T Consensus 1 kn~L~~g~~L~~g~---~L~s--g~y~l~~q~DgN------Lvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL 65 (105)
T 4h3o_A 1 RNILDNNEGLYAGQ---SLDV--EPYHFIMQDDCN------LVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVV 65 (105)
T ss_dssp CCEECTTEEECTTC---EEEE--TTEEEEECTTSC------EEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEE
T ss_pred CCCcCCCCEEcCCC---EEEE--CCEEEEECCCCe------EEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEE
Confidence 36789999999776 7888 889999965432 66654 358999999999998888999999999999
Q ss_pred eCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 047263 106 TSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWES 147 (804)
Q Consensus 106 ~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQS 147 (804)
+|+++++||+|++... ...+|+|+|+|||||++. .||||
T Consensus 66 ~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 66 YDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp ECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred ECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 9999999999997644 346899999999999964 69998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.3e-20 Score=196.29 Aligned_cols=140 Identities=13% Similarity=0.072 Sum_probs=112.7
Q ss_pred HHhhCCCcceeEEEeeecCccccceeEEEEEcccccc------------------ccHHHHHHHHHHhcccccCCcccee
Q 047263 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ------------------DGVKEFKTEVNVIGQTHHKNLVRLL 578 (804)
Q Consensus 517 ~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~------------------~~~~~f~~E~~~l~~l~h~niv~l~ 578 (804)
.+.||+|+||.||+|.. .+ +..||+|.+..... .....+.+|+.++++++ | +++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~-~~---g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS-EK---FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp EEEEEECSSEEEEEEEE-TT---TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred cCEeccCCCceEEEEEe-CC---CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 47899999999999998 32 33799999964221 13456899999999999 5 6666
Q ss_pred eEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEee
Q 047263 579 GFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISD 658 (804)
Q Consensus 579 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~D 658 (804)
+++.. +..++||||+++++|.+ +. ......++.||+.||.|||+. +|+||||||+|||++ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence 65543 56799999999999998 52 234567999999999999965 999999999999999 99999999
Q ss_pred cCcccccccCCCCccccccCCCccccccccc
Q 047263 659 FGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689 (804)
Q Consensus 659 fgla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 689 (804)
||+++. +..++|||++.
T Consensus 236 FG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHH
Confidence 999974 34578999875
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-19 Score=159.30 Aligned_cols=109 Identities=17% Similarity=0.287 Sum_probs=91.1
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
+|+|.+|++|.+++ +|+ ++|.|+|+|+..++ | |+|+ .+++||.||++.|- .++.++|..||||||
T Consensus 1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGn------l-vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl 65 (110)
T 3a0c_A 1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCN------F-VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVI 65 (110)
T ss_dssp CCEEETTCEECTTC---EEE-ETTTEEEEECTTSC------E-EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCc------E-EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEE
Confidence 47899999999766 889 99999999976543 3 6776 37999999998773 457899999999999
Q ss_pred eCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCccccccccCCc
Q 047263 106 TSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWESFNNPT 152 (804)
Q Consensus 106 ~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PT 152 (804)
.|.+++++|+|++..+ +...++|+|+|||||++. .+||||+||.
T Consensus 66 ~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 66 YDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred ECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 9999999999987644 345799999999999974 7999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-18 Score=156.28 Aligned_cols=109 Identities=21% Similarity=0.364 Sum_probs=90.2
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
.|+|.+||+|..++ +|+ +|.|+|+|+..++ . ++|. ..++||+||++.|. .++.++|..||||||
T Consensus 2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dgn----l---vly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl 65 (115)
T 2dpf_A 2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKCN----L---VKYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVI 65 (115)
T ss_dssp CCEEETTCEEETTE---EEE--ETTEEEEECTTSC----E---EEEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECCCC---EEE--CCCEEEEEcCCCc----E---EEEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEE
Confidence 58999999999766 787 7999999976442 3 2365 37899999999884 457899999999999
Q ss_pred eCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCccccccccCCcc
Q 047263 106 TSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWESFNNPTD 153 (804)
Q Consensus 106 ~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTD 153 (804)
.|.+++++|+|++..+ +...++|+|+|||||++. ++||||.+++.
T Consensus 66 ~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 66 YDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred ECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 9998999999987633 345799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=152.89 Aligned_cols=109 Identities=22% Similarity=0.450 Sum_probs=89.8
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
+|+|.+||+|.+++ +| ++|.|+|+|+.+++ . +||.+ +++||+||++.+ ..++.++|..||||||
T Consensus 1 tdtl~~gq~L~~g~---~L--~~~~~~L~~~~dgn----l---vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl 64 (112)
T 1xd5_A 1 SDRLNSGHQLDTGG---SL--AEGGYLFIIQNDCN----L---VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTC---EE--EETTEEEEECTTSC----E---EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEE
T ss_pred CCCCCCCCEECCCC---EE--eCCCEEEEEcCCCc----E---EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEE
Confidence 48899999999766 67 58999999987654 2 45764 689999999764 3457899999999999
Q ss_pred eCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCccccccccCC
Q 047263 106 TSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWESFNNP 151 (804)
Q Consensus 106 ~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQSFd~P 151 (804)
.| ++.++|+|.+..+ +...++|+++|||||++.++.++||||+|.
T Consensus 65 ~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 65 YS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred Ec-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 99 8889999986543 345799999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=5.8e-17 Score=143.55 Aligned_cols=103 Identities=19% Similarity=0.342 Sum_probs=84.0
Q ss_pred CccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEEe
Q 047263 27 GKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLT 106 (804)
Q Consensus 27 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l~ 106 (804)
++|.+||+|.+++ +|+ +|.|+|+|+..++ .+| |.. .++||+||++.+ ..++.+.|..||||||.
T Consensus 2 ntL~~gq~L~~g~---~L~--~g~~~L~~q~dGn----Lvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~ 65 (109)
T 3dzw_A 2 NILYSGETLSPGE---FLN--NGRYVFIMQEDCN----LVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVY 65 (109)
T ss_dssp CEEETTEEECTTC---EEE--ETTEEEEECTTSC----EEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEE
T ss_pred CCcCCCCEeCCCC---EEE--CCCEEEEEcCCCc----EEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEE
Confidence 6889999998765 675 7999999976543 322 654 589999999876 34578999999999999
Q ss_pred CCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccc
Q 047263 107 SPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESF 148 (804)
Q Consensus 107 ~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSF 148 (804)
|.+++++|+|++.... ...|+|+|+|||||++. ++|||=
T Consensus 66 ~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp CTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred CCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 9999999999976444 35799999999999974 899983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=9e-17 Score=166.74 Aligned_cols=135 Identities=18% Similarity=0.193 Sum_probs=103.2
Q ss_pred hHHhhCCCcceeEEEeeecCcccccee--EEEEEccccccc------------------------cHHHHHHHHHHhccc
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVP--VAVKKLHSVIQD------------------------GVKEFKTEVNVIGQT 569 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~f~~E~~~l~~l 569 (804)
+.+.||+|+||.||+|..... +.. ||||.+...... ....+.+|+..+.++
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~---g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFD---GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEET---TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEcCC---CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 456799999999999987322 236 999986532110 113678999999999
Q ss_pred ccCCc--cceeeEEeCCCceEEEEeecCC-C----cHHHhhcCCCCCChhhHHHHHHHHHHHHHHhh-hccCCCeeecCC
Q 047263 570 HHKNL--VRLLGFCDDGLNRLLVYEFLSN-G----TLASFLFGDLKPGWSRRTDIAFGIARGLLYLH-EECSTQIIHCDI 641 (804)
Q Consensus 570 ~h~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dl 641 (804)
+|+++ ..++.. ...+|||||+.+ | +|.++... .++.....++.||+.+|.||| +. +|+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 98864 444432 367899999942 4 67766532 235678899999999999999 65 9999999
Q ss_pred CCCcEEEcCCCCEEEeecCccccc
Q 047263 642 KPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 642 kp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999753
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.3e-15 Score=133.16 Aligned_cols=104 Identities=14% Similarity=0.207 Sum_probs=81.8
Q ss_pred hccCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCe
Q 047263 24 QTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGL 103 (804)
Q Consensus 24 ~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L 103 (804)
.+.|+|.+||+|..++ +|+| |.|.|-|...+ + |.+ |.. ++||.+|++.. ..++.++|..||||
T Consensus 4 ~~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dG---n---Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNL 66 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDC---N---LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGEL 66 (110)
T ss_dssp CBTTEEETTCEEETTE---EEEC--SSCEEEECTTS---C---EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCE
T ss_pred cccCEECCCCEecCCC---EEEe--CCEEEEEcCCC---e---EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcE
Confidence 4679999999999766 7887 56888663322 2 444 654 48999999863 23468999999999
Q ss_pred EEeCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 047263 104 VLTSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWES 147 (804)
Q Consensus 104 ~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQS 147 (804)
||.|.+++++|+|++... +...|+|+|+|||||++ ..+|+|
T Consensus 67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 999999999999997543 33689999999999997 479987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.59 E-value=8.1e-15 Score=130.42 Aligned_cols=107 Identities=12% Similarity=0.173 Sum_probs=85.0
Q ss_pred hccCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCe
Q 047263 24 QTRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGL 103 (804)
Q Consensus 24 ~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L 103 (804)
.+.++|.+||.|..++ .|. +|.|.|-|...++ |.++..+ ..++||.+|+..+- .++.+.|..||||
T Consensus 4 ~~~~tL~~gq~L~~g~---~L~--~g~~~L~~q~dGN------LvL~~~~--~~~~vWssnt~~~~-~~~~l~l~~dGNL 69 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNA---QLA--TRDYSLVMRDDCN------LVLTKGS--KTNIVWESGTSGRG-QHCFMRLGHSGEL 69 (113)
T ss_dssp CCSSEEETTCEEETTC---EEE--ETTEEEEECTTSC------EEEEETT--TTEEEEECCCTTSC-SSCEEEECTTSCE
T ss_pred ccCCEeCCCCEECCCC---EeE--cCCEEEEEcCCCE------EEEEECC--CCEEEEECCcccCC-cCEEEEEeCCCcE
Confidence 3579999999999766 665 4889998854332 5554432 36899999998763 3578999999999
Q ss_pred EEeCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCcccccc
Q 047263 104 VLTSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWES 147 (804)
Q Consensus 104 ~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQS 147 (804)
||.|.+++++|+|++... +...|+|+|+|||||++ ..+|+|
T Consensus 70 Vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 70 DITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 999999999999998643 33689999999999997 689998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.8e-15 Score=134.03 Aligned_cols=87 Identities=16% Similarity=0.325 Sum_probs=72.2
Q ss_pred CCcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEe
Q 047263 91 SGTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSS 169 (804)
Q Consensus 91 ~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S 169 (804)
....|.|+.||||||++ .+++||++++.... ...++|+|+|||||++.++.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t-------------------- 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT-------------------- 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC--------------------
Confidence 45789999999999998 57899999976433 358999999999999988899999993
Q ss_pred cCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccC
Q 047263 170 KQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT 212 (804)
Q Consensus 170 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 212 (804)
++++|.|+++++++|+++++. .+||.+++
T Consensus 79 -----~~~~g~~~l~l~~dGnlvl~~---------~~~W~S~~ 107 (110)
T 3a0c_A 79 -----NGKEDHYVLVLQQDRNVVIYG---------PVVWATGS 107 (110)
T ss_dssp -----CCSSSCCEEEECTTSCEEEEC---------SEEEECSC
T ss_pred -----CCCCCCEEEEEeCCccEEEEC---------CCEecCCC
Confidence 457899999999999987741 15887754
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.54 E-value=1.9e-14 Score=129.12 Aligned_cols=86 Identities=16% Similarity=0.308 Sum_probs=71.8
Q ss_pred CcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEec
Q 047263 92 GTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSK 170 (804)
Q Consensus 92 ~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~ 170 (804)
...|.|..||+|+|++. +++||++++.... ...++|+|+|||||+|.++.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~---------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS----------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC----------------------
Confidence 35788899999999987 8899999976443 36899999999999998889999999
Q ss_pred CCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccC
Q 047263 171 QSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT 212 (804)
Q Consensus 171 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 212 (804)
.||++|.|+++++++|+++++. .+||++++
T Consensus 88 ---~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp ---CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred ---CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCC
Confidence 3567899999999999977642 26887754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=127.72 Aligned_cols=91 Identities=25% Similarity=0.381 Sum_probs=74.0
Q ss_pred CCcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEe
Q 047263 91 SGTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSS 169 (804)
Q Consensus 91 ~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S 169 (804)
....|.|+.||+|+|++. +++||++++.... ...|+|+|+|||||++ ++.++||||+
T Consensus 19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~-------------------- 76 (112)
T 1xd5_A 19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT-------------------- 76 (112)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc--------------------
Confidence 346899999999999987 7899999976433 4689999999999999 7789999994
Q ss_pred cCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCCC
Q 047263 170 KQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNG 214 (804)
Q Consensus 170 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (804)
||++|.|+++++++|+++++. .. ..+||+++++.
T Consensus 77 -----~~~~g~~~l~l~~dGnlvl~~--~~----~~~~W~S~~~~ 110 (112)
T 1xd5_A 77 -----NRQNGNYYLILQRDRNVVIYD--NS----NNAIWATHTNV 110 (112)
T ss_dssp -----CCSCCCCEEEECTTSCEEEEC--TT----SCEEEECCCCC
T ss_pred -----cCCCCCEEEEEeCCCcEEEEC--CC----CceEEECCCcc
Confidence 456899999999999977752 11 36789887654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.2e-14 Score=124.79 Aligned_cols=107 Identities=21% Similarity=0.351 Sum_probs=84.2
Q ss_pred ccCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeE
Q 047263 25 TRGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLV 104 (804)
Q Consensus 25 ~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~ 104 (804)
+.|+|.+||.|..++ .| .+|.|.|.|...++ | +.|.. +|.+|+..+ ..+..++|..|||||
T Consensus 2 ~~dtL~~gq~L~~g~---~L--~~g~~~L~~q~dGN------L-vl~~~------~Wssnt~~~-~~~~~l~l~~dGnLv 62 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEG---HL--KNGDFDLVMQDDCN------L-VLYNG------NWQSNTANN-GRDCKLTLTDYGELV 62 (109)
T ss_dssp CCSEEETTCEECTTC---EE--EETTEEEEECTTSC------E-EEETT------TEECCCTTS-CSSCEEEECTTSCEE
T ss_pred ccCCcCCCCCcCCCC---Ee--ECCCEEEEEecCCe------E-EEEeC------eEEcCCCCC-CCcEEEEEcCCCeEE
Confidence 468999999998765 66 47999999864332 2 23542 699998765 345789999999999
Q ss_pred EeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCC
Q 047263 105 LTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPS 158 (804)
Q Consensus 105 l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg 158 (804)
|.|.+++++|+|++.... ...|+|+|+|||||++ ..+|+| .|.+||
T Consensus 63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 999999999999876433 4589999999999997 689998 666654
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=7.9e-14 Score=124.65 Aligned_cols=90 Identities=21% Similarity=0.371 Sum_probs=74.1
Q ss_pred CCcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEe
Q 047263 91 SGTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSS 169 (804)
Q Consensus 91 ~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S 169 (804)
....|.+..||||+|++ .+++||++++.... ...++|+++|||||+|.++.++|||||+
T Consensus 20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~------------------- 79 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW------------------- 79 (115)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC-------------------
T ss_pred CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC-------------------
Confidence 34678899999999998 57899999976433 3589999999999999888899999997
Q ss_pred cCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCCCC
Q 047263 170 KQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGS 215 (804)
Q Consensus 170 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (804)
+++|.|++.++++|+++++ + .+||+++++..
T Consensus 80 ------~~~g~~~l~l~~dGnlvl~--~-------~~~W~S~~~~~ 110 (115)
T 2dpf_A 80 ------GDNGKYALVLQKDGRFVIY--G-------PVLWSLGPNGC 110 (115)
T ss_dssp ------CSSSCCEEEECTTSCEEEE--C-------SEEECSSTTCB
T ss_pred ------CCCCCEEEEEeCCCeEEEE--C-------CCEEECCCCCC
Confidence 3578999999999998774 1 16888877653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-14 Score=156.49 Aligned_cols=136 Identities=12% Similarity=0.050 Sum_probs=92.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc--------------ccHHHHH--------HHHHHhcccccC
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ--------------DGVKEFK--------TEVNVIGQTHHK 572 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~--------------~~~~~f~--------~E~~~l~~l~h~ 572 (804)
.+.++||+|++|.||+|....+ +.||||.++.... ....... .|...|.++.+.
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G----~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKG----KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTC----CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCEeeeCCceEEEEEECCCC----CEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 4567899999999999987543 3699998753210 0111222 344444445433
Q ss_pred CccceeeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC
Q 047263 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY 652 (804)
Q Consensus 573 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~ 652 (804)
++.-..-+. ....+|||||+++++|..+.. ......++.||+.+|.|||+. +||||||||.|||+++++
T Consensus 174 gv~vp~p~~--~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 174 GFPVPEPIA--QSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp TCSCCCEEE--EETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred CCCCCeeee--ccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 322111111 123379999999999876542 234467889999999999965 999999999999998776
Q ss_pred ----------CEEEeecCccccc
Q 047263 653 ----------NARISDFGLAKLL 665 (804)
Q Consensus 653 ----------~~kl~Dfgla~~~ 665 (804)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999987653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=114.34 Aligned_cols=102 Identities=11% Similarity=0.199 Sum_probs=78.6
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
.++|.+||.|.+++ .| .+|.|.|-|...++ |-+ |.. .. ||.+|+..+ ...+.++|..||||||
T Consensus 2 ~~~l~~gq~L~~g~---~L--~~g~~~L~~q~dGn------Lvl-~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl 64 (111)
T 3mez_A 2 NNVLLTGDVIHTDN---QL--SYESAAFVMQGDCN------LVL-YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEI 64 (111)
T ss_dssp TTEEETTCEECTTC---EE--EETTEEEEECTTSC------EEE-ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEE
T ss_pred cCEeCCCCEeCCCC---EE--ecCCEEEEEccCCe------EEE-ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEE
Confidence 47899999998766 66 37899999854332 333 542 23 999999876 3357899999999999
Q ss_pred eCCCCc-eEeeccCCC---CceeEEEEccCcCEEEEecCCcccccc
Q 047263 106 TSPQGR-ELWKSDPII---GTVAYGLMNDTGNFVLLSDNTNKLWES 147 (804)
Q Consensus 106 ~~~~~~-~vWst~~~~---~~~~~a~l~d~GNlVl~~~~~~~lWQS 147 (804)
.|.++. ++|+|++.. .....++|+|+|||||++ ..+|+|
T Consensus 65 ~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 65 HSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp ECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 998876 599998632 234589999999999997 689998
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.28 E-value=1e-11 Score=110.29 Aligned_cols=84 Identities=20% Similarity=0.279 Sum_probs=67.0
Q ss_pred CCCCC-CCcEEEEecCCCeEEeCC-CCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccC
Q 047263 86 DSPAA-SGTKVELTADQGLVLTSP-QGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFD 162 (804)
Q Consensus 86 ~~Pv~-~~s~l~~~~~G~L~l~~~-~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~ 162 (804)
+.|+. ....|.++.||||||++. .++++|++++.... ...++|+++|||||++.++.++|||-.+
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~------------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV------------ 85 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC------------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc------------
Confidence 44553 346899999999999988 58899999976433 4589999999999999888899998321
Q ss_pred CCceEEecCCCCCCCCCceEEEecCCCceEEE
Q 047263 163 NGQFLSSKQSDGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 163 ~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 194 (804)
-..|.|.+.++++|+++++
T Consensus 86 -------------~~~~~~~~~L~~dGnlvly 104 (113)
T 3mez_B 86 -------------GQEGDYVLILQINGQAVVY 104 (113)
T ss_dssp -------------CSSSCCEEEECTTSCEEEE
T ss_pred -------------CCCCCEEEEEcCCceEEEe
Confidence 0135689999999999986
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.5e-11 Score=106.40 Aligned_cols=87 Identities=17% Similarity=0.255 Sum_probs=68.7
Q ss_pred CcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCc-cccccccCCcccccCCcccCCCceEEe
Q 047263 92 GTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTN-KLWESFNNPTDTMLPSQIFDNGQFLSS 169 (804)
Q Consensus 92 ~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~-~lWQSFd~PTDTlLpg~~l~~~~~L~S 169 (804)
...|.++.||||||++.++ +|++++.... ...++|+++|||||++.+++ ++|||..+
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------- 79 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-------------------
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-------------------
Confidence 4689999999999998876 9999986543 36899999999999998766 59999621
Q ss_pred cCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccC
Q 047263 170 KQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT 212 (804)
Q Consensus 170 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 212 (804)
.....|.|.+.++++|+++++. .++|.+++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred ----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1113578999999999999862 46787654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=4.4e-11 Score=123.75 Aligned_cols=113 Identities=17% Similarity=0.299 Sum_probs=86.5
Q ss_pred hccCccCCCCc----eeecCCCCeeeeCCCeEEEeeEeCC--CCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEE
Q 047263 24 QTRGKITIGAS----LSASQNSSSWLSPNGDFAFGFHSLD--SNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVEL 97 (804)
Q Consensus 24 ~~~~~i~~g~~----l~~~~~~~~lvS~~g~F~lGFf~~~--~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~ 97 (804)
..+|++.||+. |..++ +|+| ...++.|+|... ...+ ++ + |.+ ..+++|.+++.++- ...+.+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~---~L~S-~~dps~G~fsl~l~~dGn-lv--L-y~~--~~~~yW~Sgt~~~~--~~~l~l 201 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGS---ELVQ-GVVYGAGASKLVFQGDGN-LV--A-YGP--NGAATWNAGTQGKG--AVRAVF 201 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSE---EECT-TCEEEETTEEEEECTTSC-EE--E-ECT--TSSEEEECCCTTTT--CCEEEE
T ss_pred ccccccccccccccccccCc---cccc-CCCCCCceEEEeecCCce-EE--E-EeC--CCeEEEECCCCCCc--cEEEEE
Confidence 45799999998 65443 5655 467777777653 2222 43 3 332 25799999998873 268999
Q ss_pred ecCCCeEEeCCCCceEeeccCCCCceeEEEEccCcCEEEEecCCccccccccC
Q 047263 98 TADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNN 150 (804)
Q Consensus 98 ~~~G~L~l~~~~~~~vWst~~~~~~~~~a~l~d~GNlVl~~~~~~~lWQSFd~ 150 (804)
..+|+|++.|.++.++|++++.......|+|+++|||||++. +++||||||
T Consensus 202 ~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 202 QGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp CTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred cCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 999999999998899999997655557899999999999976 689999997
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=7.6e-11 Score=104.02 Aligned_cols=88 Identities=22% Similarity=0.313 Sum_probs=69.4
Q ss_pred CCcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEe
Q 047263 91 SGTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSS 169 (804)
Q Consensus 91 ~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S 169 (804)
....|.|..||||+|++. ++++|++++.... ...+.|+++|||||++.++.++|||....
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------ 79 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------ 79 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC------------------
Confidence 346899999999999987 6899999976443 36799999999999998888999985321
Q ss_pred cCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCC
Q 047263 170 KQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTN 213 (804)
Q Consensus 170 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 213 (804)
..+.|.+.++++|+++++. .+.|.+++.
T Consensus 80 -------~~~~~~~~L~ddGNlvly~---------~~~W~s~t~ 107 (109)
T 3dzw_A 80 -------ENGNYVCVLQKDRNVVIYG---------TARWATGTN 107 (109)
T ss_dssp -------SSSCEEEEECTTSCEEEEE---------SCCCCCCCC
T ss_pred -------CCCCEEEEEeCCCEEEEEC---------CCEEeCCCc
Confidence 2357899999999999863 256776543
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.1e-10 Score=101.24 Aligned_cols=76 Identities=20% Similarity=0.387 Sum_probs=62.4
Q ss_pred CcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEec
Q 047263 92 GTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSK 170 (804)
Q Consensus 92 ~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~ 170 (804)
...|.++.||||+|++. +++|++++.... ...++|+|+|||||++.++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence 46889999999999876 589999976443 35899999999999998889999994311
Q ss_pred CCCCCCCCCceEEEecCCCceEEE
Q 047263 171 QSDGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 171 ~s~~dps~G~~~~~~~~~g~~~~~ 194 (804)
..|.|.+.++++|+++++
T Consensus 84 ------~~~~~~~~L~~dGNlvly 101 (110)
T 3r0e_B 84 ------KQGEYVLILQDDGFGVIY 101 (110)
T ss_dssp ------SSSCCEEEECTTSCEEEE
T ss_pred ------CCCCEEEEEcCCccEEEe
Confidence 235689999999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.00 E-value=1.5e-09 Score=110.20 Aligned_cols=78 Identities=21% Similarity=0.356 Sum_probs=64.3
Q ss_pred CCcEEEEecCCCeEEeCCCCceEeeccCCCCceeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEec
Q 047263 91 SGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSK 170 (804)
Q Consensus 91 ~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~ 170 (804)
....|.+..||+|+|++. +++||++|........+.|+++|||||+|.++.++|+|+++.
T Consensus 26 g~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~------------------- 85 (236)
T 1dlp_A 26 SSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG------------------- 85 (236)
T ss_dssp TTEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC-------------------
T ss_pred CCEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc-------------------
Confidence 345778888999999876 789999997655556799999999999999899999998751
Q ss_pred CCCCCCCCCceEEEecCCCceEEE
Q 047263 171 QSDGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 171 ~s~~dps~G~~~~~~~~~g~~~~~ 194 (804)
++|.|.+.++++|+++++
T Consensus 86 ------~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 86 ------SIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp ------CSSCCEEEECSSSCEEEE
T ss_pred ------cCCcEEEEEeCCCCEEEe
Confidence 256788999999998885
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=9.3e-10 Score=113.92 Aligned_cols=138 Identities=14% Similarity=0.003 Sum_probs=106.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEeec
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+...++.|+.+.||+..... ..+++|............+.+|+++++.+. |.++.++++++.+....++||||+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~~-----~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGEN-----ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp EEECCSCCSSSEEEEEECSS-----CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred eEeeccCCCCCeEEEEECCC-----CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 34567888889999986432 269999987532223345788999998884 678889999999888999999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE------------------------------------------- 631 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 631 (804)
+|.+|.+.+. +......++.+++++|..||+.
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999987642 2234557889999999999971
Q ss_pred -------------cCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 632 -------------CSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 632 -------------~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799999775
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.99 E-value=9.3e-10 Score=96.85 Aligned_cols=90 Identities=18% Similarity=0.292 Sum_probs=67.7
Q ss_pred CCCCC-CCcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCC
Q 047263 86 DSPAA-SGTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDN 163 (804)
Q Consensus 86 ~~Pv~-~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~ 163 (804)
++|+. ....|.++.||||||+++ +|+|++...+ ...++|+++|||||+|.++.++|+|-..
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~------------- 77 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ------------- 77 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC-------------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc-------------
Confidence 34443 345889999999999984 7999987543 3679999999999999888899976210
Q ss_pred CceEEecCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCC
Q 047263 164 GQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTN 213 (804)
Q Consensus 164 ~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 213 (804)
...+.|.+.++++|+++++. .+.|.++++
T Consensus 78 ------------~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~ 106 (109)
T 3r0e_A 78 ------------SVKGNYAAVVHPDGRLVVFG---------PSVFKIDPW 106 (109)
T ss_dssp ------------CSSSCCEEEEETTTEEEEEC---------SEEEEECTT
T ss_pred ------------CCCcCEEEEEcCCCeEEEEe---------cCEECCCCc
Confidence 12467899999999998862 356776554
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.98 E-value=1.8e-09 Score=94.19 Aligned_cols=77 Identities=25% Similarity=0.487 Sum_probs=62.7
Q ss_pred CcEEEEecCCCeEEeCCCCceEeeccCCCC--ceeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEe
Q 047263 92 GTKVELTADQGLVLTSPQGRELWKSDPIIG--TVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSS 169 (804)
Q Consensus 92 ~s~l~~~~~G~L~l~~~~~~~vWst~~~~~--~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S 169 (804)
.-+|.+..||||||++. +++||++++... ....+.|+++|||||+|.++.++|+|-.
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t-------------------- 78 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS-------------------- 78 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC--------------------
Confidence 35789999999999974 589999997533 3457999999999999999999998721
Q ss_pred cCCCCCCCCCceEEEecCCCceEEE
Q 047263 170 KQSDGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 170 ~~s~~dps~G~~~~~~~~~g~~~~~ 194 (804)
....+.|.+.++++|+++++
T Consensus 79 -----~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 -----TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp -----CCCSSCEEEEECTTSCEEEE
T ss_pred -----CCCCCCEEEEEeCCCeEEEE
Confidence 11356789999999999886
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.83 E-value=7.7e-09 Score=106.57 Aligned_cols=129 Identities=14% Similarity=0.047 Sum_probs=95.4
Q ss_pred hC-CCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC--ccceeeEEeCCCceEEEEeecCC
Q 047263 520 LG-KGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN--LVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG-~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
++ .|..+.||+....++. .+++|..... ....+..|+++++.+++.+ +.+++++..+++..++||||+++
T Consensus 27 ~~~gg~~~~v~~~~~~~g~----~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRP----VLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp CSCTTSSCEEEEEECTTSC----CEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cccCCCCceEEEEecCCCC----eEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 44 5556999998654332 5899987653 2245778899998886544 56689988888889999999999
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc--------------------------------------------
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC-------------------------------------------- 632 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 632 (804)
.+|. ... .....++.++++.|..||...
T Consensus 100 ~~l~--~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 100 QDLL--SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp EETT--TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccC--cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 8884 211 123467788888888888531
Q ss_pred -----------CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 633 -----------STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 633 -----------~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.76 E-value=2.1e-08 Score=108.92 Aligned_cols=140 Identities=17% Similarity=0.210 Sum_probs=104.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcc--ccc-cccHHHHHHHHHHhcccc--cCCccceeeEEeCC---CceEE
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVI-QDGVKEFKTEVNVIGQTH--HKNLVRLLGFCDDG---LNRLL 589 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~--~~~-~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~l 589 (804)
+.|+.|.++.||+....++ .+++|+.. ... ......+.+|+.+++.++ +.++.+++.++.+. ...++
T Consensus 44 ~~l~~G~sn~~y~v~~~~~-----~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQ-----TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECSSC-----EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEECCc-----eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4689999999999876532 57888876 321 122346788999998886 45688999998776 44899
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc-------------------------------------
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC------------------------------------- 632 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 632 (804)
||||+++..+.+... ..++...+..++.++++.|..||...
T Consensus 119 vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999988754221 23567788899999999999999720
Q ss_pred ------------------CCCeeecCCCCCcEEEcCCCC--EEEeecCcccc
Q 047263 633 ------------------STQIIHCDIKPQNILLDDYYN--ARISDFGLAKL 664 (804)
Q Consensus 633 ------------------~~~ivH~dlkp~NILl~~~~~--~kl~Dfgla~~ 664 (804)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.52 E-value=4e-08 Score=104.01 Aligned_cols=181 Identities=18% Similarity=0.129 Sum_probs=118.0
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCC--ccceeeEEeCCC---ceEEEEe
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKN--LVRLLGFCDDGL---NRLLVYE 592 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~E 592 (804)
.++.|....||+.. ..+++|..... .....+..|.++++.+. +.. +.+++....... ..++|||
T Consensus 27 ~~~~G~~n~v~~v~--------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN--------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp EEEECSSEEEEEST--------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred ecCCCCcceEEEEC--------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 47889999999863 14888886532 34567889999998873 332 455555544433 3478999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE----------------------------------------- 631 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 631 (804)
+++|.+|.+... ..++..++..++.++++.+..||..
T Consensus 97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999988875432 2456667778888888888888851
Q ss_pred --------------cCCCeeecCCCCCcEEEcC--CCCEEEeecCcccccccCCCCccccccCCCcc---cccccccc--
Q 047263 632 --------------CSTQIIHCDIKPQNILLDD--YYNARISDFGLAKLLLLDQSQTHTAIRGTKGY---VAPEWFRN-- 690 (804)
Q Consensus 632 --------------~~~~ivH~dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~l~~-- 690 (804)
....++|+|+++.||++++ ...+.|+||+.+..-.. ..... ..... ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~--~~Dl~---~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP--DNDFI---SLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT--THHHH---TTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh--HHHHH---HHHhhccccCHHHHHHHH
Confidence 0135899999999999998 45578999998864211 00000 00000 12221110
Q ss_pred ---CCC---------CccchhhHHHHHHHHHHcCCCCC
Q 047263 691 ---MPI---------TVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 691 ---~~~---------s~~~DV~S~Gvll~elltG~~p~ 716 (804)
+.. ....+.|+++.+++++.+|..++
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 011 12358999999999999998654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.1e-05 Score=83.25 Aligned_cols=134 Identities=16% Similarity=0.064 Sum_probs=95.3
Q ss_pred hCCCcce-eEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEeecCCC
Q 047263 520 LGKGAFG-VVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 520 LG~G~fG-~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
+..|..+ .||+.....+.. .+++|+-... ...++..|...++.+. +-.+.++++++.+++..++|||++++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~---~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAP---ELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCC---CEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCe---EEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445555 588876554332 5888886543 3456788888888774 445788999999999999999999998
Q ss_pred cHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc---------------------------------------------
Q 047263 598 TLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC--------------------------------------------- 632 (804)
Q Consensus 598 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 632 (804)
++.+.... .......++.++++.|.-||...
T Consensus 106 ~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 88766532 12334456666666666666420
Q ss_pred ----------CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 633 ----------STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 633 ----------~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
...++|+|+++.|||+++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987767799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=6.6e-05 Score=79.13 Aligned_cols=134 Identities=19% Similarity=0.179 Sum_probs=92.3
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccC---CccceeeEEe-CCCceEEEEeec
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHK---NLVRLLGFCD-DGLNRLLVYEFL 594 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~Ey~ 594 (804)
.++.|....||+. +. .+++|.... ......+..|.++++.+.+. .+.+++.+.. .....++||||+
T Consensus 26 ~l~~G~~n~v~~v----g~----~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NG----DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEECSSEEEEEE----TT----TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred ecCCCcceeEEEE----CC----EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 4777888889986 22 478887532 23456788999999998653 4667777774 455678999999
Q ss_pred CCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 047263 595 SNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE------------------------------------------- 631 (804)
Q Consensus 595 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 631 (804)
+|.+|.+.... .++...+..++.++++.|..||..
T Consensus 96 ~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 99888763221 223444455555555555555532
Q ss_pred --------------cCCCeeecCCCCCcEEEcC---CCCE-EEeecCcccc
Q 047263 632 --------------CSTQIIHCDIKPQNILLDD---YYNA-RISDFGLAKL 664 (804)
Q Consensus 632 --------------~~~~ivH~dlkp~NILl~~---~~~~-kl~Dfgla~~ 664 (804)
....++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335799999999999987 4564 8999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=3.7e-05 Score=82.89 Aligned_cols=84 Identities=7% Similarity=-0.006 Sum_probs=55.0
Q ss_pred Hhh-CCCcceeEEEeeec---CccccceeEEEEEccccc---cccHHHHHHHHHHhccccc---CCccceeeEEeCC---
Q 047263 518 EEL-GKGAFGVVYKGAIG---MASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHH---KNLVRLLGFCDDG--- 584 (804)
Q Consensus 518 ~~L-G~G~fG~Vykg~~~---~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~~--- 584 (804)
+.| +.|....+|+.... ++...+..+++|...... ......+..|+.+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 78889999987654 110012358888765432 1012456788888888853 3578888888665
Q ss_pred CceEEEEeecCCCcHHH
Q 047263 585 LNRLLVYEFLSNGTLAS 601 (804)
Q Consensus 585 ~~~~lV~Ey~~~gsL~~ 601 (804)
...++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00018 Score=78.73 Aligned_cols=75 Identities=16% Similarity=0.113 Sum_probs=47.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEcccccc-------ccHHHHHHHHHHhccccc--C-CccceeeEEeCCCce
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-------DGVKEFKTEVNVIGQTHH--K-NLVRLLGFCDDGLNR 587 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~h--~-niv~l~g~~~~~~~~ 587 (804)
+.||.|..+.||++....++ ..++||....... .....+..|.++++.+.. + .+.+++.+ +....
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~---~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHD---RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EECCCCceEEEEEEEECCCC---cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 46899999999999764332 2689997653211 122346778888877742 3 34456654 34456
Q ss_pred EEEEeecCCC
Q 047263 588 LLVYEFLSNG 597 (804)
Q Consensus 588 ~lV~Ey~~~g 597 (804)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00082 Score=71.59 Aligned_cols=136 Identities=16% Similarity=0.187 Sum_probs=77.7
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc--CCccceee------EEeCCCceEEE
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH--KNLVRLLG------FCDDGLNRLLV 590 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g------~~~~~~~~~lV 590 (804)
.|+.|....||+....++ .+++|+.... ..++..|..++..+.. -.+.+++. +....+..+++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-----~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-----AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp ECC----CEEEEEEETTE-----EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eccccccCcEEEEEeCCC-----CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 456667889999876432 3888988752 2333445555555532 12344443 11235567899
Q ss_pred EeecCCCcHH--------------Hhhc----CC--C--------CCChhhHH---------------------------
Q 047263 591 YEFLSNGTLA--------------SFLF----GD--L--------KPGWSRRT--------------------------- 615 (804)
Q Consensus 591 ~Ey~~~gsL~--------------~~l~----~~--~--------~l~~~~~~--------------------------- 615 (804)
+||++|..+. ..++ .. . ...|....
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 0111 00 0 01232110
Q ss_pred ----HHHHHHHHHHHHhhh----------ccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 616 ----DIAFGIARGLLYLHE----------ECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 616 ----~i~~~ia~gL~yLH~----------~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
.+...+.+++.+|++ .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666663 125789999999999999888889999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0011 Score=69.54 Aligned_cols=74 Identities=18% Similarity=0.144 Sum_probs=57.5
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc---cCCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.|+.|....+|+.... + ..+++|+.... ....|..|.+.++.+. ...+.+++.++......++||||+
T Consensus 42 ~~l~gG~~n~~y~v~~~-~----~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-V----QTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEECCSSSSEEEEEESS-S----CEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred EEeCCccceeeeEEEEC-C----CeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 35889999999997653 1 25888887642 3567888999888884 357889999988888899999999
Q ss_pred CCCcH
Q 047263 595 SNGTL 599 (804)
Q Consensus 595 ~~gsL 599 (804)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0024 Score=70.30 Aligned_cols=80 Identities=9% Similarity=-0.014 Sum_probs=46.7
Q ss_pred CCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccccccCCCccccccccccC---CCCccchhhHHHHHHHHH
Q 047263 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM---PITVKVDVYSFGVLLLEI 709 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~~DV~S~Gvll~el 709 (804)
...++|+|+++.|||++.++ ++|+||+.+..-............-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 56899999999999998876 99999998864210000000000001245666554311 111234556777777777
Q ss_pred HcCC
Q 047263 710 ICCR 713 (804)
Q Consensus 710 ltG~ 713 (804)
.++.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.003 Score=65.58 Aligned_cols=73 Identities=18% Similarity=0.206 Sum_probs=52.4
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc---CCccceeeEEeCCCceEEEEeec
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH---KNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
+.+|.|..+.||+..+.++. .+++|+...........|..|.+.|+.+.. -.+.++++.. ..++||||+
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~----~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGT----PLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEETTEEEEEEEETTSC----EEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred EecCCCCCeEEEEEEECCCC----EEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 45899999999999987654 599998765444444567889888887742 2455666543 347899999
Q ss_pred CCCc
Q 047263 595 SNGT 598 (804)
Q Consensus 595 ~~gs 598 (804)
+.+.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.41 E-value=0.009 Score=65.81 Aligned_cols=76 Identities=11% Similarity=0.152 Sum_probs=49.1
Q ss_pred HhhCCCcceeEEEeeecCccc----cceeEEEEEccccccccHHHHHHHHHHhcccccCCc-cceeeEEeCCCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASM----YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL-VRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E 592 (804)
+.|+.|....+|+.....+.. ....+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 357888889999988653210 1235888887432 122455678888888854444 667776653 38999
Q ss_pred ecCCCcH
Q 047263 593 FLSNGTL 599 (804)
Q Consensus 593 y~~~gsL 599 (804)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.0036 Score=65.39 Aligned_cols=134 Identities=15% Similarity=0.151 Sum_probs=73.0
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCc-cceeeEEeCCCceEEEEeec-C
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL-VRLLGFCDDGLNRLLVYEFL-S 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~-~ 595 (804)
+.|+.|....+|+. . .+++|+........ .....|..+++.+....+ .+++++ +.+.-++++||+ +
T Consensus 24 ~~l~gG~tN~~~~~-----~----~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----G----DLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp EEEESCSSEEEEEE-----T----TEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred eEcCCcccccccee-----e----eEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 46888989999997 1 48888876432211 112457777777753333 456554 344457899999 6
Q ss_pred CCcHHHh------------------hcCC-CCCC-----hhhHHHHHH--------------HHHHHHHHhh----h-cc
Q 047263 596 NGTLASF------------------LFGD-LKPG-----WSRRTDIAF--------------GIARGLLYLH----E-EC 632 (804)
Q Consensus 596 ~gsL~~~------------------l~~~-~~l~-----~~~~~~i~~--------------~ia~gL~yLH----~-~~ 632 (804)
+.+|... |+.. .... +.....+.. .+.+.+..|. . ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 6554310 1111 0010 111111100 0111111111 1 12
Q ss_pred CCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
...++|+|+.+.||+ .+++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 6667889999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.017 Score=56.14 Aligned_cols=104 Identities=10% Similarity=-0.036 Sum_probs=68.0
Q ss_pred CCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCccc
Q 047263 596 NGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674 (804)
Q Consensus 596 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 674 (804)
.-||.++|.. +.++++++.+.++.|.++.|.-+-.. ... ..+=+-|..|+|..+|.+...+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3489999975 57899999999999999998776221 011 1233446899999999998764 1110
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCC
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNV 716 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~ 716 (804)
.....+.+||... ...+.+.=|||+|+++|.-+--..|-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0122466888764 34567889999999999998655443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.013 Score=63.11 Aligned_cols=141 Identities=16% Similarity=0.192 Sum_probs=81.3
Q ss_pred hhCCCcceeEEEeeecCc----cccceeEEEEEccccccccHHHHHHHHHHhccccc-CCccceeeEEeCCCceEEEEee
Q 047263 519 ELGKGAFGVVYKGAIGMA----SMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH-KNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~----~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~Ey 593 (804)
.|..|-...+|+.....+ ......+++|+.... ........+|.++++.+.. .-..++++++.++ +|+||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 466777888999876431 111236888886332 2345566789998888853 3336677776542 99999
Q ss_pred cCCCcHHHh-----------------hcCC-----CCCC--hhhHHHHHHHHHH-------------------HHHHhhh
Q 047263 594 LSNGTLASF-----------------LFGD-----LKPG--WSRRTDIAFGIAR-------------------GLLYLHE 630 (804)
Q Consensus 594 ~~~gsL~~~-----------------l~~~-----~~l~--~~~~~~i~~~ia~-------------------gL~yLH~ 630 (804)
+++..|..- |+.. .... |.+..++..++.. .+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998665311 1111 1122 3344444433321 2333322
Q ss_pred c-----cCCCeeecCCCCCcEEEcCC----CCEEEeecCcccc
Q 047263 631 E-----CSTQIIHCDIKPQNILLDDY----YNARISDFGLAKL 664 (804)
Q Consensus 631 ~-----~~~~ivH~dlkp~NILl~~~----~~~kl~Dfgla~~ 664 (804)
. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 23468999999999999876 7899999998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.02 Score=60.59 Aligned_cols=32 Identities=31% Similarity=0.344 Sum_probs=27.6
Q ss_pred CCCeeecCCCCCcEEEcCC----CCEEEeecCcccc
Q 047263 633 STQIIHCDIKPQNILLDDY----YNARISDFGLAKL 664 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~----~~~kl~Dfgla~~ 664 (804)
...++|+|+++.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6789999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.09 E-value=0.0088 Score=62.96 Aligned_cols=138 Identities=15% Similarity=0.138 Sum_probs=76.1
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC--ccceeeEE------eCCCceEEE
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN--LVRLLGFC------DDGLNRLLV 590 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV 590 (804)
.|+.|....+|+....++ .+++|...... ...++..|+.++..+.... +.+++... ...+..+++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-----~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-----PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EECC---EEEEEEEESSC-----CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred ccCCCcccceEEEEeCCc-----cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 467788888999876433 47888876521 1224456777776664322 33443221 123456899
Q ss_pred EeecCCCcHHH--------------hhc----C--CCC---C---ChhhHHH------------HHHHHHHHHHHhhhc-
Q 047263 591 YEFLSNGTLAS--------------FLF----G--DLK---P---GWSRRTD------------IAFGIARGLLYLHEE- 631 (804)
Q Consensus 591 ~Ey~~~gsL~~--------------~l~----~--~~~---l---~~~~~~~------------i~~~ia~gL~yLH~~- 631 (804)
+||++|..+.. .++ . ... . .|..... +...+.+.+..+++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99999865321 011 1 010 1 1322110 111234455555532
Q ss_pred ---cCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 632 ---CSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 632 ---~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13579999999999999987556899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.89 E-value=0.041 Score=57.91 Aligned_cols=136 Identities=13% Similarity=0.058 Sum_probs=76.1
Q ss_pred hCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCC--ccceeeE-----EeCCCceEEEEe
Q 047263 520 LGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN--LVRLLGF-----CDDGLNRLLVYE 592 (804)
Q Consensus 520 LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lV~E 592 (804)
++ |....||+....++ ..+++|...... .....+..|..++..+.... +++++.. ...++..++++|
T Consensus 34 l~-g~~n~~y~v~~~~g----~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDR----RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EC-CSSSEEEEECCTTC----CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ec-CcccceEEEEcCCC----CEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 55 77778998765433 258899886321 23456667888877774322 4445543 112345578999
Q ss_pred ecCCCcHHH-----------h---hc----CC-----CCCChhhH----HHH---------------HHHHHHHHHHhhh
Q 047263 593 FLSNGTLAS-----------F---LF----GD-----LKPGWSRR----TDI---------------AFGIARGLLYLHE 630 (804)
Q Consensus 593 y~~~gsL~~-----------~---l~----~~-----~~l~~~~~----~~i---------------~~~ia~gL~yLH~ 630 (804)
|+++..+.. . ++ .. ...++... ..+ ...+.+.+..+.+
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998855320 1 11 00 11121110 000 1111122233322
Q ss_pred c----cCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 631 E----CSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 631 ~----~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
. ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1 245689999999999999 4 89999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.026 Score=62.49 Aligned_cols=74 Identities=14% Similarity=0.120 Sum_probs=44.8
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCc-cceeeEEeCCCceEEEEeecCC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL-VRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+.|+.|-...+|+....+. ...+++|+......... .-..|..++..+...++ .++++.+.. .+|+||+++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~---~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSK---QAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTT---TEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCC---CceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 4578888899999876541 12577887643222111 11477888887764444 567777632 259999987
Q ss_pred CcH
Q 047263 597 GTL 599 (804)
Q Consensus 597 gsL 599 (804)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.036 Score=59.52 Aligned_cols=77 Identities=12% Similarity=0.135 Sum_probs=43.3
Q ss_pred HhhCCCcceeEEEeeecCccc-----cceeEEEEEccccccccHHHHHHHHHHhcccccCC-ccceeeEEeCCCceEEEE
Q 047263 518 EELGKGAFGVVYKGAIGMASM-----YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN-LVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~-----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~ 591 (804)
+.|+.|....+|+.....+.. ....+++|........ ......|.++++.+...+ ..++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 357778888999987653210 0135778876543221 112356777887775444 346665542 37899
Q ss_pred eecCCCcH
Q 047263 592 EFLSNGTL 599 (804)
Q Consensus 592 Ey~~~gsL 599 (804)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.13 E-value=0.35 Score=51.13 Aligned_cols=32 Identities=25% Similarity=0.332 Sum_probs=27.9
Q ss_pred CCCeeecCCCCCcEEEcCCCCEEEeecCcccc
Q 047263 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKL 664 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~ 664 (804)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888899999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.99 E-value=0.64 Score=50.64 Aligned_cols=76 Identities=14% Similarity=0.106 Sum_probs=45.3
Q ss_pred hhCCCcceeEEEeeecCcccc----ceeEEEEEccccccccHHHHHHHHHHhcccccCC-ccceeeEEeCCCceEEEEee
Q 047263 519 ELGKGAFGVVYKGAIGMASMY----QVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKN-LVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~----~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~Ey 593 (804)
.+..|-...+|+.....+... ...+++++........ -.-.+|..+++.+...+ ..++++.+. -++|+||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 467788888999887632211 2358888865432211 12256777777774333 455665432 3789999
Q ss_pred cCCCcH
Q 047263 594 LSNGTL 599 (804)
Q Consensus 594 ~~~gsL 599 (804)
+++..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998664
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=88.52 E-value=9.2 Score=38.51 Aligned_cols=70 Identities=20% Similarity=0.294 Sum_probs=42.5
Q ss_pred EEEEeccCCCCeEEEeecCCCC-------CCCCcEEEEecCCCeEEeCCCCceEeeccCCC-CceeEEEEccCcCEEEEe
Q 047263 67 LSIWYAKIPQKTIVWFANGDSP-------AASGTKVELTADQGLVLTSPQGRELWKSDPII-GTVAYGLMNDTGNFVLLS 138 (804)
Q Consensus 67 lgIw~~~~~~~t~vWvANr~~P-------v~~~s~l~~~~~G~L~l~~~~~~~vWst~~~~-~~~~~a~l~d~GNlVl~~ 138 (804)
+.||= ....+++|...+..+ +.....+.++.++.+..+|.+|+.+|.-.... .....+..+.+||+++-+
T Consensus 17 v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~ 94 (276)
T 3no2_A 17 IAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAW 94 (276)
T ss_dssp EEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEE
T ss_pred EEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEe
Confidence 55663 335678898877542 11122344455555666778899999987532 233456667788887764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.63 E-value=1.7 Score=42.05 Aligned_cols=115 Identities=10% Similarity=0.099 Sum_probs=80.7
Q ss_pred ccCCccceeeEEeCCCceEEEEeecCC-CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEE
Q 047263 570 HHKNLVRLLGFCDDGLNRLLVYEFLSN-GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILL 648 (804)
Q Consensus 570 ~h~niv~l~g~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl 648 (804)
.||+++.. .+-.+++...+.|+.-++ -++.. + +.++...+++++.+|+....+++ .-+|--|+|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEE
Confidence 57888766 455666666676765542 23333 2 35678889999999999887777 34788999999999
Q ss_pred cCCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCC
Q 047263 649 DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVD 717 (804)
Q Consensus 649 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~ 717 (804)
+.++.+++.--|+... ++|. ..+...=.-.+=+++..+++++..|+
T Consensus 113 ~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999987776432 2222 22233334467788999999987765
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=86.88 E-value=0.53 Score=37.85 Aligned_cols=34 Identities=18% Similarity=0.493 Sum_probs=28.4
Q ss_pred CcCChhhHHHHhcCCCceeeEeecC-CceeeeecC
Q 047263 373 TPFTEEGCRQSCLHDCMCAVAIFRS-GDMCWKKKL 406 (804)
Q Consensus 373 ~~~~~~~C~~~Cl~nCsC~a~~y~~-g~~c~~~~~ 406 (804)
...++++|++.|+.+=.|.+|.|+. ...|+++..
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 4568999999999999999999973 335998875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.04 E-value=3.1 Score=40.42 Aligned_cols=114 Identities=11% Similarity=0.055 Sum_probs=79.8
Q ss_pred ccCCccceeeEEeCCCceEEEEeecCCC-cHHHhhcCCCCCChhhHHHHHHHHHHHHH-HhhhccCCCeeecCCCCCcEE
Q 047263 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNG-TLASFLFGDLKPGWSRRTDIAFGIARGLL-YLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 570 ~h~niv~l~g~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~dlkp~NIL 647 (804)
.||++ -...-.+++...+.|+.-+++ ++..+ +.++...+++++.+|+.... +++ .-+|--|+|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 57777 444456777777777765443 44433 36778899999999998887 666 4578899999999
Q ss_pred EcCCCCEEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCC
Q 047263 648 LDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVD 717 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~ 717 (804)
++.++.++|.-.|+-.. ++|. ..+..-=.-++=+++..++.++..|+
T Consensus 117 f~~~~~p~i~hRGi~~~------------------lpP~-----e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES------------------LPPD-----EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT------------------BSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987776432 2332 11222223467788888888887664
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=81.67 E-value=6.1 Score=39.91 Aligned_cols=37 Identities=14% Similarity=0.015 Sum_probs=20.3
Q ss_pred CeEEeCCC-CceEeeccCCC------CceeEEEEccCcCEEEEe
Q 047263 102 GLVLTSPQ-GRELWKSDPII------GTVAYGLMNDTGNFVLLS 138 (804)
Q Consensus 102 ~L~l~~~~-~~~vWst~~~~------~~~~~a~l~d~GNlVl~~ 138 (804)
.++.+|.+ |+++|+-.... .....+.++.+||+++.+
T Consensus 187 ~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 187 CFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp EEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred eEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 35555665 77777654211 113455666677776654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=80.33 E-value=1 Score=48.62 Aligned_cols=30 Identities=27% Similarity=0.361 Sum_probs=25.1
Q ss_pred CeeecCCCCCcEEE------cCCCCEEEeecCcccc
Q 047263 635 QIIHCDIKPQNILL------DDYYNARISDFGLAKL 664 (804)
Q Consensus 635 ~ivH~dlkp~NILl------~~~~~~kl~Dfgla~~ 664 (804)
.++|+|+.+.|||+ +++..++++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 804 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-11 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-04 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-11 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-06 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-07 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-08 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-06 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 7e-06 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 4e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-65
Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 32/280 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
+ +G G+FG VYKG + VAVK L+ + ++ FK EV V+ +T H N
Sbjct: 12 VGQRIGSGSFGTVYKG------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEEC 632
++ +G+ +V ++ +L L + K + DIA A+G+ YLH +
Sbjct: 66 ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLL-LLDQSQTHTAIRGTKGYVAPEWFRNM 691
IIH D+K NI L + +I DFGLA + S + G+ ++APE R
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 692 ---PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748
P + + DVY+FG++L E++ + N + + + + D+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM----------VGRGYLSPDL 231
Query: 749 EALNDK--KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ K + R + C+++ RP ++ +E
Sbjct: 232 SKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 7e-65
Identities = 69/304 (22%), Positives = 131/304 (43%), Gaps = 35/304 (11%)
Query: 504 FTYKDLEAATNGFKEE-----------LGKGAFGVVYKGAIGMASMYQVPVAVKKLHS-V 551
FT++D A F +E +G G FG V G + + ++ VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 552 IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG- 610
+ ++F +E +++GQ H N++ L G +++ EF+ NG+L SFL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 611 WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670
+ + GIA G+ YL + +H D+ +NIL++ ++SDFGL++ L D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 671 QTHT----AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL 726
+ + APE + T DV+S+G+++ E++ ++ + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 727 LTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+E D + + + C Q+D + RP ++ L+
Sbjct: 244 ---------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 787 GVVE 790
++
Sbjct: 289 KMIR 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-62
Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
E LG G FG V+ G VAVK L F E N++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEECS 633
RL ++ E++ NG+L FL +K ++ D+A IA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
IH D++ NIL+ D + +I+DFGLA+L+ ++ + + APE
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 694 TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753
T+K DV+SFG+LL EI+ R + E + +E +
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------------QNLERGYRMVRP 232
Query: 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ C +E P RPT + +LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-59
Identities = 71/289 (24%), Positives = 112/289 (38%), Gaps = 31/289 (10%)
Query: 507 KDLEAATNGFK---EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTE 562
K L + ELG G FG V +G + Q+ VA+K L + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQG-VYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 59
Query: 563 VNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGI 621
++ Q + +VRL+G C +LV E G L FL G + S ++ +
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 622 ARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH--TAIRGT 679
+ G+ YL E+ +H D+ +N+LL + + A+ISDFGL+K L D S +A +
Sbjct: 119 SMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 680 KGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYCE 737
+ APE + + DV+S+GV + E + + M+ E A +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
L C RP V Q +
Sbjct: 236 ECPPELYAL-----------------MSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-59
Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 24/276 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
F +E+G G FG+V+ G + + VA+K + ++F E V+ + H LV
Sbjct: 9 FVQEIGSGQFGLVHLGYW----LNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG-WSRRTDIAFGIARGLLYLHEECST 634
+L G C + LV+EF+ +G L+ +L + + G+ YL E C
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+IH D+ +N L+ + ++SDFG+ + +L DQ + T + + +PE F +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 695 VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754
K DV+SFGVL+ E+ + + +E + E I+ + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----------EDISTGFRLYKPRLAST- 229
Query: 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
+ C +E P RP ++ + L + E
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-58
Identities = 65/281 (23%), Positives = 120/281 (42%), Gaps = 24/281 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNL 574
F E +G+G FG VY G + ++ AVK L+ + G V +F TE ++ H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 575 VRLLGFC-DDGLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEEC 632
+ LLG C + L+V ++ +G L +F+ + P +A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH---TAIRGTKGYVAPEWFR 689
S + +H D+ +N +LD+ + +++DFGLA+ + + + T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749
T K DV+SFGVLL E++ +VN + + + E
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----------VYLLQGRRLLQPE 257
Query: 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
D V + C +RP+ ++ + +
Sbjct: 258 YCPDP-----LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-58
Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 24/272 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
F +ELG G FGVV G Q VA+K + EF E V+ H+ LV
Sbjct: 8 FLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 62
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECST 634
+L G C ++ E+++NG L ++L + ++ + + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+H D+ +N L++D ++SDFGL++ +L D+ + + + PE +
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 695 VKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDK 754
K D+++FGVL+ EI + +E E I + L + ++K
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------EHIAQGLRLYRPHLASEK 229
Query: 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ C E RPT + + +
Sbjct: 230 -----VYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-58
Identities = 74/274 (27%), Positives = 112/274 (40%), Gaps = 28/274 (10%)
Query: 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG--VKEFKTEVNVIGQTHHKNLVR 576
ELG G FG V KG M + + VAVK L + D E E NV+ Q + +VR
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKT-VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQI 636
++G C+ + +LV E G L +L + ++ ++ G+ YL E
Sbjct: 73 MIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---F 128
Query: 637 IHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ--THTAIRGTKGYVAPEWFRNMPIT 694
+H D+ +N+LL + A+ISDFGL+K L D++ T + + APE +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 695 VKVDVYSFGVLLLEIICCRRN--VDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
K DV+SFGVL+ E + M+ +E A+L G + +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL------ 242
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
C D RP V L
Sbjct: 243 -----------MNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 9e-58
Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 32/276 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+ +GKG FG V G VAVK + + + F E +V+ Q H NLV
Sbjct: 11 LLQTIGKGEFGDVMLG-----DYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 576 RLLGFCDDGLNRL-LVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEEC 632
+LLG + L +V E+++ G+L +L G G + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
+H D+ +N+L+ + A++SDFGL K S T + + APE R
Sbjct: 124 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKK 176
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
+ K DV+SFG+LL EI R + + +G + A+
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPPAVY 230
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788
+ V C D ++RP+ ++ + LE +
Sbjct: 231 E---------VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-57
Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 26/282 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+ +LG+G FG V+ G VA+K L + F E V+ + H+ LV
Sbjct: 21 LEVKLGQGCFGEVWMGTW----NGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP--GWSRRTDIAFGIARGLLYLHEECS 633
+L + +V E++S G+L FL G+ + D+A IA G+ Y+
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+H D++ NIL+ + +++DFGLA+L+ ++ + + APE
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 694 TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753
T+K DV+SFG+LL E+ R + E L VE
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---------------DQVERGYRMPCP 236
Query: 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795
+ + C +++P RPT + LE +P
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 59/305 (19%), Positives = 120/305 (39%), Gaps = 38/305 (12%)
Query: 509 LEAATNGFK--EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGV-KEFKTEVNV 565
+E + F+ ELG G GVV+K + +A K +H I+ + + E+ V
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV---SHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 566 IGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGL 625
+ + + +V G + E + G+L L + ++ + +GL
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
YL E+ I+H D+KP NIL++ ++ DFG++ L+ + + GT+ Y++P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSP 172
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRR---------NVDMEVNEAEALLTDWAYDCYC 736
E + +V+ D++S G+ L+E+ R M + E +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 737 EGITEALVEFDIEALNDKKKLARFVMVAIW------------------CIQEDPSLRPTM 778
G + D +L +++ C+ ++P+ R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 779 RKVTQ 783
+++
Sbjct: 293 KQLMV 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 5e-57
Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
K +LG G +G VY+G + Y + VAVK L + V+EF E V+ + H NLV
Sbjct: 21 MKHKLGGGQYGEVYEG---VWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLF--GDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+LLG C ++ EF++ G L +L + +A I+ + YL ++
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN- 135
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
IH D+ +N L+ + + +++DFGL++L+ D H + + APE
Sbjct: 136 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 694 TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753
++K DV++FGVLL EI + ++ ++ L+E D
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---------------ELLEKDYRMERP 238
Query: 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
+ + + C Q +PS RP+ ++ Q E + +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 6e-57
Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 30/298 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+E +GKG FG V++G VAVK S ++ + E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRG-----KWRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENIL 60
Query: 576 RLLGFCDDG----LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
+ + LV ++ +G+L +L +A A GL +LH E
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHME 119
Query: 632 C-----STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTA---IRGTKGYV 683
I H D+K +NIL+ I+D GLA A GTK Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 684 APEWF------RNMPITVKVDVYSFGVLLLEIICCRR----NVDMEVNEAEALLTDWAYD 733
APE ++ + D+Y+ G++ EI + D ++ + + +D + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 734 CYCEGITEALVEFDI-EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
+ + E + +I + L + C + + R T ++ + L + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 71/298 (23%), Positives = 120/298 (40%), Gaps = 40/298 (13%)
Query: 516 FKEELGKGAFGVVYKG--AIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQ-THH 571
F + LG GAFG V + + S + VAVK L S + +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFG------------------DLKPGWSR 613
N+V LLG C G L++ E+ G L +FL +L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 614 RTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT- 672
++ +A+G+ +L + IH D+ +NILL +I DFGLA+ + D +
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY 732
R ++APE N T + DV+S+G+ L E+ + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY----- 258
Query: 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
+++ L+ + A + C DP RPT +++ Q++E +
Sbjct: 259 ---------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 2e-56
Identities = 68/315 (21%), Positives = 125/315 (39%), Gaps = 48/315 (15%)
Query: 506 YKDLEAATNGFK--EELGKGAFGVVYKGAIGMASMYQ--VPVAVKKLH-SVIQDGVKEFK 560
LE N + ++G+GAFG V++ Y+ VAVK L D +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 561 TEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLF---------------- 604
E ++ + + N+V+LLG C G L++E+++ G L FL
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 605 --------GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656
G + + IA +A G+ YL E +H D+ +N L+ + +I
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKI 181
Query: 657 SDFGLAKLLL-LDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRN 715
+DFGL++ + D + ++ PE T + DV+++GV+L EI
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 716 VDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLR 775
+ E + + + +I A + + C + P+ R
Sbjct: 242 PYYGMAHEEVI--------------YYVRDGNILACPE-NCPLELYNLMRLCWSKLPADR 286
Query: 776 PTMRKVTQMLEGVVE 790
P+ + ++L+ + E
Sbjct: 287 PSFCSIHRILQRMCE 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 25/291 (8%)
Query: 510 EAATNGFKEE--LGKGAFGVVYKGAI-GMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNV 565
E + + +G G FG VYKG + + +VPVA+K L + +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 566 IGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARG 624
+GQ H N++RL G +++ E++ NG L FL + + GIA G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 625 LLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT--AIRGTKGY 682
+ YL +H D+ +NIL++ ++SDFGL+++L D T+T + +
Sbjct: 123 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 683 VAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742
APE T DV+SFG+++ E++ E++ E +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---------------K 224
Query: 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793
+ + + + C Q++ + RP + +L+ ++ D
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 66/273 (24%), Positives = 114/273 (41%), Gaps = 29/273 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
F E+G+G+F VYKG + + V VA +L + + + FK E ++ H N
Sbjct: 13 FDIEIGRGSFKTVYKG---LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 574 LVRLLGFCDDGLNR----LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
+VR + + +LV E +++GTL ++L I +GL +LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 630 EECSTQIIHCDIKPQNILLDD-YYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF 688
IIH D+K NI + + +I D GLA L ++ A+ GT ++APE +
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 689 RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748
VDVY+FG+ +LE+ ++ I +
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTSGVK 230
Query: 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
A DK + + CI+++ R +++ +
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-56
Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 25/279 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKE-FKTEVNVIGQTHHKNL 574
+G+G FG V++G + VA+K + D V+E F E + Q H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECS 633
V+L+G + ++ E + G L SFL + A+ ++ L YL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPI 693
+H DI +N+L+ ++ DFGL++ + + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 694 TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL--LTDWAYDCYCEGITEALVEFDIEAL 751
T DV+ FGV + EI+ V + + + + L
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL----- 241
Query: 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
C DPS RP ++ L ++E
Sbjct: 242 ------------MTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-55
Identities = 69/286 (24%), Positives = 107/286 (37%), Gaps = 29/286 (10%)
Query: 507 KDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEV 563
KDL E+LG G+FGVV +G S V VAVK L + + + +F EV
Sbjct: 8 KDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 564 NVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIA 622
N + H+NL+RL G +V E G+L L + A +A
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ--THTAIRGTK 680
G+ YL + IH D+ +N+LL +I DFGL + L + +
Sbjct: 122 EGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGIT 740
+ APE + + D + FGV L E+ + + +N ++ L
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-------------- 224
Query: 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ + + V + C P RPT + L
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-54
Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 45/299 (15%)
Query: 516 FKEELGKGAFGVVYKG--AIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQ-THH 571
F + LG GAFG V + + VAVK L + +E+ ++ Q H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG--------------------- 610
+N+V LLG C L++E+ G L ++L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 611 --WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668
+ A+ +A+G+ +L + +H D+ +N+L+ +I DFGLA+ ++ D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 669 QSQT-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL 727
+ R ++APE T+K DV+S+G+LL EI N +
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 728 TDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
L++ + ++ C D RP+ +T L
Sbjct: 278 --------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-54
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 44/303 (14%)
Query: 506 YKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVN 564
+ D++ F++ +G+G FG V K I ++ A+K++ +D ++F E+
Sbjct: 9 WNDIK-----FQDVIGEGNFGQVLKARI-KKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 565 VIGQ-THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG------------- 610
V+ + HH N++ LLG C+ L E+ +G L FL
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 611 ---WSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667
+ A +ARG+ YL Q IH D+ +NIL+ + Y A+I+DFGL++
Sbjct: 123 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ 177
Query: 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALL 727
+ T R ++A E T DV+S+GVLL EI+ + AE
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--- 234
Query: 728 TDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEG 787
Y+ +G +E + ++ L R C +E P RP+ ++ L
Sbjct: 235 ---LYEKLPQGYR---LEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSLNR 282
Query: 788 VVE 790
++E
Sbjct: 283 MLE 285
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-53
Identities = 60/279 (21%), Positives = 102/279 (36%), Gaps = 32/279 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKN 573
+G G++G K + K+L S+ + + +EVN++ + H N
Sbjct: 8 VLYTIGTGSYGRCQKI---RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 574 LVRLLGFCDDGLNRLL--VYEFLSNGTLASFLFGDLKPG----WSRRTDIAFGIARGLLY 627
+VR D N L V E+ G LAS + K + + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 628 LHE--ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
H + ++H D+KP N+ LD N ++ DFGLA++L D S GT Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRR-NVDMEVNEAEALLTDWAYDCYCEGITEALV 744
E M K D++S G LL E+ E + + + ++ L
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
E + RP++ ++ +
Sbjct: 244 EI-----------------ITRMLNLKDYHRPSVEEILE 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 21/274 (7%)
Query: 516 FKEELGKGAFGVVYKG-AIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKN 573
+ LG GAFG VYKG I ++PVA+K+L + KE E V+ + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 574 LVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECS 633
+ RLLG C +L+ L G + IA+G+ YL +
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 130
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT-AIRGTKGYVAPEWFRNMP 692
+++H D+ +N+L+ + +I+DFGLAKLL ++ + H + ++A E +
Sbjct: 131 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
T + DV+S+GV + E++ YD +++E
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGERLPQ 234
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
M+ + C D RP R++
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-52
Identities = 62/275 (22%), Positives = 115/275 (41%), Gaps = 29/275 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
ELG GAFG VYK V A K + + ++ ++++ E++++ H N+V
Sbjct: 16 IIGELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECST 634
+LL N ++ EF + G + + + +P S+ + L YLH
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DN 129
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF-----R 689
+IIH D+K NIL + +++DFG++ + + GT ++APE +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSK 188
Query: 690 NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749
+ P K DV+S G+ L+E+ E+N L + + +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVL--------------LKIAKSEPP 233
Query: 750 ALNDKKKL-ARFVMVAIWCIQEDPSLRPTMRKVTQ 783
L + + F C++++ R T ++ Q
Sbjct: 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-51
Identities = 68/271 (25%), Positives = 105/271 (38%), Gaps = 29/271 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHK 572
LGKG FG VY + +A+K L + + EV + H
Sbjct: 10 IGRPLGKGKFGNVYLA---REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
N++RL G+ D L+ E+ GT+ L K R +A L Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH--- 123
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
S ++IH DIKP+N+LL +I+DFG + + T + GT Y+ PE
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRM 180
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
KVD++S GVL E + + + E + I+ F
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETY----------KRISRVEFTFPDFVTE 229
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
+ L ++ +PS RP +R+V +
Sbjct: 230 GARDLIS------RLLKHNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-51
Identities = 69/269 (25%), Positives = 116/269 (43%), Gaps = 23/269 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNL 574
+ LG+GA+G V + + + VAVK + D + K E+ + +H+N+
Sbjct: 9 LVQTLGEGAYGEVQLA---VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
V+ G +G + L E+ S G L + D+ + G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD-QSQTHTAIRGTKGYVAPEWFRNMPI 693
I H DIKP+N+LLD+ N +ISDFGLA + + + + + GT YVAPE +
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 694 -TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
VDV+S G++L ++ D +++ +DW + D L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEKKT---YLNPWKKIDSAPLA 238
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
+ + E+PS R T+ +
Sbjct: 239 -------LLH---KILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (457), Expect = 2e-51
Identities = 59/270 (21%), Positives = 96/270 (35%), Gaps = 32/270 (11%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFKTEVNVIGQTHHKNL 574
E+G G+FG VY VA+KK+ + ++ EV + + H N
Sbjct: 21 REIGHGSFGAVYFA---RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
++ G LV E+ + G +GL YLH
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM--- 691
+IH D+K NILL + ++ DFG A ++ + GT ++APE M
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMDEG 189
Query: 692 PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751
KVDV+S G+ +E+ + ++ + + + AL
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP---------------PLFNMNAMSALYHIAQNESPAL 234
Query: 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
F C+Q+ P RPT +
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 62/269 (23%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
E++G+GA G VY M VA+++++ Q + E+ V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTA---MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQII 637
L G +V E+L+ G+L + + + + L +LH Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-EGQIAAVCRECLQALEFLHSN---QVI 138
Query: 638 HCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKV 697
H DIK NILL + +++DFG + +QS+ T + GT ++APE KV
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 197
Query: 698 DVYSFGVLLLEIICCRR--NVDMEVNEAEALLTDWAYDC-YCEGITEALVEFDIEALNDK 754
D++S G++ +E+I + + + T+ + E ++ +F
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF-------- 249
Query: 755 KKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
L R C+ D R + +++ Q
Sbjct: 250 --LNR-------CLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-50
Identities = 74/299 (24%), Positives = 118/299 (39%), Gaps = 41/299 (13%)
Query: 516 FKEELGKGAFGVVYKG----AIGMASMYQVPVAVKKLHS-VIQDGVKEFKTEVNVIGQ-T 569
+ LG+GAFG V VAVK L S + + + +E+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG----------------WSR 613
HKN++ LLG C ++ E+ S G L +L PG
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 614 RTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673
A+ +ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 674 T-AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAY 732
T R ++APE + T + DV+SFGVLL EI + V + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELF 247
Query: 733 DCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791
EG L + C PS RPT +++ + L+ +V +
Sbjct: 248 KLLKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 39/297 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQV--PVAVKKLH-SVIQDGVKEFKTEVNVIGQT-HH 571
+ LG+GAFG V + VAVK L + +E+ ++ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 572 KNLVRLLGFC-DDGLNRLLVYEFLSNGTLASFLFGDLKPG----------------WSRR 614
N+V LLG C G +++ EF G L+++L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 615 TDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHT 674
+F +A+G+ +L S + IH D+ +NILL + +I DFGLA+ + D
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 675 A-IRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD 733
R ++APE + T++ DV+SFGVLL EI + V E
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCR 248
Query: 734 CYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
EG ++ + + C +PS RPT ++ + L +++
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-48
Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 32/289 (11%)
Query: 516 FKEELGKGAFGVVYKG--AIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHK 572
ELG+G+FG+VY+G + + VA+K ++ + EF E +V+ + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD----------LKPGWSRRTDIAFGIA 622
++VRLLG G L++ E ++ G L S+L P S+ +A IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 623 RGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL-LDQSQTHTAIRGTKG 681
G+ YL+ + +H D+ +N ++ + + +I DFG+ + + D +
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 682 YVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE 741
+++PE ++ T DV+SFGV+L EI ++ + L EG
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFVMEG--- 251
Query: 742 ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790
L++ + +L R C Q +P +RP+ ++ ++ +E
Sbjct: 252 GLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (424), Expect = 1e-46
Identities = 62/269 (23%), Positives = 106/269 (39%), Gaps = 24/269 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
EELG GAFGVV++ A K + + + + + E+ + H LV
Sbjct: 30 IHEELGTGAFGVVHRV---TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECST 634
L +D +++YEF+S G L + + + + +GL ++HE
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 635 QIIHCDIKPQNILLDDYYNARI--SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
+H D+KP+NI+ + + DFGL LD Q+ GT + APE P
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVTTGTAEFAAPEVAEGKP 201
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
+ D++S GVL ++ E N+ E L + D A +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETL----------RNVKSCDWNMDDSAFS 250
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
+ + + + DP+ R T+ +
Sbjct: 251 GISEDGKDFI--RKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 56/275 (20%), Positives = 100/275 (36%), Gaps = 27/275 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKL---HSVIQDGVKEFKTEVNVIGQTHHK 572
F + LG+G+F V A+K L H + ++ V E +V+ + H
Sbjct: 12 FGKILGEGSFSTVVLA---RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
V+L D + NG L ++ + F A + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSALEYLH 125
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH-TAIRGTKGYVAPEWFRNM 691
IIH D+KP+NILL++ + +I+DFG AK+L + Q + GT YV+PE
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 692 PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751
D+++ G ++ +++ NE + I + +F +
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIF----------QKIIKLEYDFPEKFF 234
Query: 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ L + D + R ++
Sbjct: 235 PKARDLVE------KLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (412), Expect = 7e-45
Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 24/271 (8%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
EELG GAFGVV++ + K +++ K E++++ Q HH L+
Sbjct: 33 ILEELGSGAFGVVHRC---VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECST 634
L +D +L+ EFLS G L + D K + + GL ++HE
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH--- 146
Query: 635 QIIHCDIKPQNILLDDYYNARI--SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
I+H DIKP+NI+ + + + DFGLA L+ + T + APE P
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
+ D+++ GVL ++ E ++ E L + + EFD +A +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETL----------QNVKRCDWEFDEDAFS 253
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
A+ + +Q++P R T+ +
Sbjct: 254 SVSPEAKDFI--KNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 5e-44
Identities = 73/272 (26%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQDGVKEFKTEVNVIGQTHHKNL 574
F++ LG GAF V Q VA+K + ++ + E+ V+ + H N+
Sbjct: 13 FRDVLGTGAFSEVILA---EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
V L + G + L+ + +S G L + + + F + + YLH+
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG-- 127
Query: 635 QIIHCDIKPQNILL---DDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
I+H D+KP+N+L D+ ISDFGL+K + D + GT GYVAPE
Sbjct: 128 -IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 692 PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751
P + VD +S GV+ ++C E N+A+ E I +A EFD
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDE-NDAKLF----------EQILKAEYEFDSPYW 233
Query: 752 NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
+D A+ + +++DP R T + Q
Sbjct: 234 DDISDSAKDFI--RHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 55/272 (20%), Positives = 105/272 (38%), Gaps = 27/272 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
E+LG+G FG+V++ + + + K + D K E++++ H+N++
Sbjct: 9 IAEDLGRGEFGIVHRC---VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECST 634
L + ++++EF+S + + + + L +LH S
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SH 121
Query: 635 QIIHCDIKPQNILLD--DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
I H DI+P+NI+ +I +FG A+ L + Y APE ++
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
++ D++S G L+ ++ E N+ E I A FD EA
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----------IIENIMNAEYTFDEEAFK 228
Query: 753 D-KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783
+ + FV + ++ R T + Q
Sbjct: 229 EISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (388), Expect = 2e-42
Identities = 59/282 (20%), Positives = 107/282 (37%), Gaps = 37/282 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---------SVIQDGVKEFKTEVNVI 566
KE LG+G VV + + AVK + +Q+ + EV+++
Sbjct: 7 PKEILGRGVSSVVRRC---IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 567 GQTH-HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGL 625
+ H N+++L + LV++ + G L +L + I + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 626 LYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
LH I+H D+KP+NILLDD N +++DFG + LD + + GT Y+AP
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPSYLAP 178
Query: 686 EWFR------NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739
E + +VD++S GV++ ++ + L I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLML----------RMI 227
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
+F +D + ++ + P R T +
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLV--SRFLVVQPQKRYTAEEA 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (382), Expect = 1e-41
Identities = 55/283 (19%), Positives = 99/283 (34%), Gaps = 29/283 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFKTEVNVIGQTHHK 572
E LG G V+ VAVK L + F+ E +H
Sbjct: 11 LGEILGFGGMSEVHLA---RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 573 NLVRLLGFCDD----GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYL 628
+V + + G +V E++ TL + + R ++ + L +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127
Query: 629 HEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH--TAIRGTKGYVAPE 686
IIH D+KP NI++ ++ DFG+A+ + + A+ GT Y++PE
Sbjct: 128 ---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
R + + DVYS G +L E++ + + + + E +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAY---------QHVREDPIPP 234
Query: 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRP-TMRKVTQMLEGV 788
L V+ + ++P R T ++ L V
Sbjct: 235 SARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 8e-41
Identities = 69/268 (25%), Positives = 106/268 (39%), Gaps = 28/268 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFKTEVNVIGQT-HH 571
+ LGKG+FG V+ A+K L ++ D V+ E V+ H
Sbjct: 6 LHKMLGKGSFGKVFLA---EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 572 KNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEE 631
L + N V E+L+ G L + K SR T A I GL +LH +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 632 CSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNM 691
I++ D+K NILLD + +I+DFG+ K +L ++T+T GT Y+APE
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQ 178
Query: 692 PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751
VD +SFGVLL E++ + + E Y + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL----- 233
Query: 752 NDKKKLARFVMVAIWCIQEDPSLRPTMR 779
L + +P R +R
Sbjct: 234 -----LVK-------LFVREPEKRLGVR 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 2e-40
Identities = 52/277 (18%), Positives = 93/277 (33%), Gaps = 36/277 (12%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFKTEVNVI---GQT 569
+G+G FG VY + A+K L ++ G E ++
Sbjct: 8 VHRIIGRGGFGEVYGC---RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
+V + + + ++ G L L + A I GL ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWF- 688
+++ D+KP NILLD++ + RISD GLA + A GT GY+APE
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPEVLQ 178
Query: 689 RNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC---YCEGITEALVE 745
+ + D +S G +L +++ + + + + + L
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782
+E +Q D + R
Sbjct: 239 L-LE----------------GLLQRDVNRRLGCLGRG 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 3e-40
Identities = 49/281 (17%), Positives = 91/281 (32%), Gaps = 27/281 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
++G G+FG +Y G VA+K ++ + E + +
Sbjct: 11 LGRKIGSGSFGDIYLG---TDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGI 65
Query: 576 RLLGFC-DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
+ +C +G ++V E L F F K +A + + Y+H +
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--- 122
Query: 635 QIIHCDIKPQNIL---LDDYYNARISDFGLAKLLLLDQSQTH------TAIRGTKGYVAP 685
IH D+KP N L I DFGLAK ++ H + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
+ + + D+ S G +L+ + + + E L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786
+ A ++ +C +P + Q+
Sbjct: 243 ------GYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH------SVIQDGVKEFKTEVNVIGQT 569
EELG G F VV K + A K + S ++ + EV+++ +
Sbjct: 14 TGEELGSGQFAVVKKC---REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 570 HHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
H N++ L ++ + +L+ E ++ G L FL T+ I G ++
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VY 127
Query: 630 EECSTQIIHCDIKPQNILLDDY----YNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
S QI H D+KP+NI+L D +I DFGLA +D I GT +VAP
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVAP 185
Query: 686 EWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
E P+ ++ D++S GV+ ++ + + E L ++ E
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETL----------ANVSAVNYE 234
Query: 746 FDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
F+ E ++ LA+ + + +DP R T++
Sbjct: 235 FEDEYFSNTSALAKDFI--RRLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 1e-39
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 37/283 (13%)
Query: 504 FTYKDLEAATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFK 560
++ +D + LG G+FG V+ + A+K L V V+
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLI---RSRHNGRYYAMKVLKKEIVVRLKQVEHTN 52
Query: 561 TEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFG 620
E ++ H ++R+ G D ++ +++ G L S L + A
Sbjct: 53 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE 112
Query: 621 IARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTK 680
+ L YLH + II+ D+KP+NILLD + +I+DFG AK + + GT
Sbjct: 113 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTP 165
Query: 681 GYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR-NVDMEVNEAEALLTDWAYDCYCEGI 739
Y+APE P +D +SFG+L+ E++ D + + + +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-FPPFF 224
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782
E + + L+R I D S R +
Sbjct: 225 NEDVKDL----------LSR-------LITRDLSQRLGNLQNG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 60/307 (19%), Positives = 119/307 (38%), Gaps = 30/307 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG-VKEFKTEVNVIGQTHHKNLVR 576
+G+GA+G+V ++ +V VA+KK+ + E+ ++ + H+N++
Sbjct: 14 SYIGEGAYGMVCSA---YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 577 LLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPG---WSRRTDIAFGIARGLLYLHEECS 633
+ + +L + + L+ LK + I RGL Y+H
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-- 128
Query: 634 TQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ--THTAIRGTKGYVAPEWFRN- 690
++H D+KP N+LL+ + +I DFGLA++ D T T+ Y APE N
Sbjct: 129 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 691 MPITVKVDVYSFGVLLLEIICCR-----RNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
T +D++S G +L E++ R ++ ++N +L + + I
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 746 FDIEALNDKKKLARFVMVAI---------WCIQEDPSLRPTMRKVTQ---MLEGVVEVLD 793
+ + + K + + +P R + + + + +
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307
Query: 794 PPCPCPF 800
P PF
Sbjct: 308 PIAEAPF 314
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 32/275 (11%)
Query: 517 KEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNLV 575
+ LG G G V + Q A+K L + + EV + + + ++V
Sbjct: 17 SQVLGLGINGKVLQI---FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIV 68
Query: 576 RLLGFCDDGLNR----LLVYEFLSNGTLASFL--FGDLKPGWSRRTDIAFGIARGLLYLH 629
R++ ++ L+V E L G L S + GD ++I I + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 630 EECSTQIIHCDIKPQNILLDDYYN---ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
S I H D+KP+N+L +++DFG AK + T T YVAPE
Sbjct: 129 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPYYVAPE 183
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
D++S GV++ ++C A I EF
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMKTRIRMGQYEF 236
Query: 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
++ + + ++ ++ +P+ R T+ +
Sbjct: 237 PNPEWSEVSEEVKMLI--RNLLKTEPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 24/284 (8%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-----SVIQDGVKEFKTEVNVIGQTHHK 572
+ LG+G F VYK VA+KK+ + E+ ++ + H
Sbjct: 4 DFLGEGQFATVYKA---RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
N++ LL N LV++F+ L S +GL YLH+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-WFRNM 691
I+H D+KP N+LLD+ +++DFGLAK ++ +T T+ Y APE F
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 692 PITVKVDVYSFGVLLLEIIC------CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVE 745
V VD+++ G +L E++ ++D E L T V
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 746 FDIEALNDKKKLAR-----FVMVAIWCIQEDPSLRPTMRKVTQM 784
F + + + +P R T + +M
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 28/287 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNV---IGQTHHK 572
E+G+GA+G V+K VA+K++ + + EV V + H
Sbjct: 13 AEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 573 NLVRLLGFC----DDGLNRLLVYEFLSNGTLASFLFGDLKPG--WSRRTDIAFGIARGLL 626
N+VRL C D +L + + L ++L +PG D+ F + RGL
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 627 YLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE 686
+LH ++H D+KPQNIL+ +++DFGLA++ T++ T Y APE
Sbjct: 131 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 185
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRR------NVDMEVNEAEALLTDWAYDCYCEGIT 740
VD++S G + E+ + +VD + + D +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 741 EALVEFDIEALNDKKKLARFVMVAI----WCIQEDPSLRPTMRKVTQ 783
A +K + + C+ +P+ R +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (355), Expect = 6e-38
Identities = 50/278 (17%), Positives = 102/278 (36%), Gaps = 21/278 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQTHHKNLV 575
E++G+G +GVVYK + Y A+KK+ +D E++++ + H N+V
Sbjct: 8 EKIGEGTYGVVYKAQ----NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQ 635
+L +LV+E L + + G+ Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITV 695
++H D+KPQN+L++ +I+DFGLA+ + + I + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 696 KVDVYSFGVLLLEIICCRR----NVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEAL 751
+D++S G + E++ + + + +TE +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 752 NDKKKLARFVMVAI--------WCIQEDPSLRPTMRKV 781
+ F+ ++ DP+ R T ++
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (352), Expect = 2e-37
Identities = 44/299 (14%), Positives = 96/299 (32%), Gaps = 33/299 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+G+G+FGV+++G + VA+K + + + E +
Sbjct: 9 VGRRIGEGSFGVIFEG---TNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
+ F +GL+ +LV + L K A + + +HE+
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 635 QIIHCDIKPQNILLDDYYN-----ARISDFGLAKLLLLDQSQTH------TAIRGTKGYV 683
+++ DIKP N L+ + + DFG+ K ++ H + GT Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 684 APEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743
+ + + D+ + G + + + + I E
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--------IGEKK 232
Query: 744 VEFDIEALNDK--KKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPPCPCPF 800
+ L ++ +++ + P + + V+E L+ F
Sbjct: 233 QSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-36
Identities = 62/277 (22%), Positives = 105/277 (37%), Gaps = 43/277 (15%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH-SVIQD-----GVKEFKTEVNVIGQ- 568
LG G FG VY G + +PVA+K + I D EV ++ +
Sbjct: 8 VGPLLGSGGFGSVYSG---IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 569 -THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLL 626
+ ++RLL + + + +L+ E + + + +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 627 YLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP 685
+ H ++H DIK +NIL+D + ++ DFG LL + +T GT+ Y P
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPP 178
Query: 686 EWFRNMP-ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744
EW R V+S G+LL +++C + + E I V
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEIIRGQV 221
Query: 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKV 781
F ++ + L R WC+ PS RPT ++
Sbjct: 222 FFRQRVSSECQHLIR------WCLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 47/279 (16%), Positives = 98/279 (35%), Gaps = 21/279 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQTHHKNLV 575
E++G+G +G V+K VA+K++ D E+ ++ + HKN+V
Sbjct: 8 EKIGEGTYGTVFKA---KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQ 635
RL LV+EF F + F + +GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 636 IIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITV 695
++H D+KPQN+L++ ++++FGLA+ + + F +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 696 KVDVYSFGVLLLEIICCRRNVDMEVNEAEAL---------LTDWAYDCYCEGITEALVEF 746
+D++S G + E+ R + + + L T+ + +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 747 DIEALNDKKKLARFVMVAI----WCIQEDPSLRPTMRKV 781
+ + + ++ +P R + +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 53/279 (18%), Positives = 104/279 (37%), Gaps = 21/279 (7%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNLV 575
E++G+G +GVVYK + VA+KK+ + + E++++ + +H N+V
Sbjct: 8 EKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKP-GWSRRTDIAFGIARGLLYLHEECST 634
+LL LV+EFL L F + +GL + H
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 122
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
++H D+KPQN+L++ +++DFGLA+ + + +
Sbjct: 123 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 695 VKVDVYSFGVLLLEIICCRR------NVDMEVNEAEALLT----DWAYDCYCEGITEALV 744
VD++S G + E++ R +D L T W +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 745 EFDIEALNDKKKLARFVMVAI--WCIQEDPSLRPTMRKV 781
++ + + ++ + DP+ R + +
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 62/270 (22%), Positives = 97/270 (35%), Gaps = 27/270 (10%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFKTEVNVIGQTHHK 572
+ + LGKG FG V A+K L + +D V TE V+ T H
Sbjct: 9 YLKLLGKGTFGKVILV---REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 573 NLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
L L V E+ + G L L + R I L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL---EYLH 122
Query: 633 STQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMP 692
S +++ DIK +N++LD + +I+DFGL K + D + T GT Y+APE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 181
Query: 693 ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752
VD + GV++ E++C R + +E L + ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL------ 235
Query: 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782
LA +++DP R
Sbjct: 236 ----LAG-------LLKKDPKQRLGGGPSD 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-34
Identities = 66/289 (22%), Positives = 110/289 (38%), Gaps = 35/289 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRL 577
+ +G G+FGVVY+ VA+KK+ + E+ ++ + H N+VRL
Sbjct: 26 KVIGNGSFGVVYQA---KLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 578 LGFC------DDGLNRLLVYEFLSNGTLASFLFGDLKPG---WSRRTDIAFGIARGLLYL 628
F D + LV +++ + + R L Y+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 629 HEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAP-E 686
H S I H DIKPQN+LLD D ++ DFG AK L + + + + ++ Y AP
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPEL 193
Query: 687 WFRNMPITVKVDVYSFGVLLLEIICCRR------NVDMEVNEAEALLTDWAYDCYCEGIT 740
F T +DV+S G +L E++ + VD V + L T
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 741 EALVEFDIEALNDKKKLAR------FVMVAIWCIQEDPSLRPTMRKVTQ 783
+F + K+ R + + ++ P+ R T +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 51/293 (17%), Positives = 103/293 (35%), Gaps = 35/293 (11%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH--SVIQDGVKEFKTEVNVIGQTHHKNLV 575
++G+G FG V+K VA+KK+ + + E+ ++ H+N+V
Sbjct: 16 AKIGQGTFGEVFKA---RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 576 RLLGFCDDGLNR--------LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLY 627
L+ C + LV++F + +K S + + GL
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL-- 130
Query: 628 LHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS---QTHTAIRGTKGYVA 684
+ +I+H D+K N+L+ +++DFGLA+ L ++ +T T Y
Sbjct: 131 -YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 685 PEWFRN-MPITVKVDVYSFGVLLLEIICCRR----NVDMEVNEAEALLTDWAYDCYCEGI 739
PE +D++ G ++ E+ N + + L +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 740 TEALVEFDIEALNDKKKLARFVMVAIW-----------CIQEDPSLRPTMRKV 781
+ +E + +K+ + + A + DP+ R
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 7e-33
Identities = 75/308 (24%), Positives = 118/308 (38%), Gaps = 37/308 (12%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQTHHKNLV 575
+ +G GA+G V + VA+KKL+ Q K E+ ++ H+N++
Sbjct: 24 QPVGSGAYGAVCSA---VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 576 RLLGFC------DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
LL DD + LV F+ GT L K G R + + + +GL Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
IIH D+KP N+ +++ +I DFGLA+ T T+ Y APE
Sbjct: 139 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVIL 191
Query: 690 N-MPITVKVDVYSFGVLLLEIICCRR------NVDMEVNEAEALLTDWAYDCYCEGITEA 742
N M T VD++S G ++ E+I + ++D + T A EA
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 743 LVEFDIEALNDKKKLARFVMVAI--------WCIQEDPSLRPTMRKVTQM--LEGVVEVL 792
+KK A + A + D R T + E + +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 793 DPPCPCPF 800
D P +
Sbjct: 312 DEPQVQKY 319
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-32
Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 40/292 (13%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQ-THHKNL 574
+LG+G + V++ + V VK L K+ K E+ ++ N+
Sbjct: 39 LVRKLGRGKYSEVFE---AINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNI 92
Query: 575 VRLLGFCDDGLNRL--LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC 632
+ L D ++R LV+E ++N L+ L R + I + L Y H
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRF--YMYEILKALDYCHSMG 149
Query: 633 STQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPE-WFRN 690
I+H D+KP N+++D ++ R+ D+GLA+ Q + ++ + PE
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 691 MPITVKVDVYSFGVLLLEIICCRR-------NVDMEVNEAEALLTDWAYDCYCEGITEAL 743
+D++S G +L +I + N D V A+ L T+ YD + E
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 744 VEF-DIEALNDKKKLARFVMVAIW-------------CIQEDPSLRPTMRKV 781
F DI + +K+ RFV ++ D R T R+
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-32
Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 27/276 (9%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQ-TH 570
+ LG GA+G V+ A+K L + +TE V+
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 571 HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHE 630
LV L L+ ++++ G L + L + ++ + +L L
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEH 144
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
II+ DIK +NILLD + ++DFGL+K + D+++ GT Y+AP+ R
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 691 MP--ITVKVDVYSFGVLLLEIICCRR--NVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746
VD +S GVL+ E++ VD E N I+ +++
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-------------ISRRILKS 251
Query: 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782
+ + LA+ ++ + +DP R
Sbjct: 252 EPPYPQEMSALAKDLI--QRLLMKDPKKRLGCGPRD 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 2e-31
Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 13/200 (6%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLH---SVIQDGVKEFKTEVNVIGQTHHKNL 574
+ LG G+FG V A+K L V ++ E ++ + L
Sbjct: 47 KTLGTGSFGRVMLV---KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 575 VRLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECST 634
V+L D N +V E+++ G + S L + A I YLH
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL--- 160
Query: 635 QIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPIT 694
+I+ D+KP+N+L+D +++DFG AK + GT +APE +
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 695 VKVDVYSFGVLLLEIICCRR 714
VD ++ GVL+ E+
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-29
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD--GVKEFKTEVNVIGQTHHKNLV 575
+ +G GA G+V ++ VA+KKL Q+ K E+ ++ +HKN++
Sbjct: 23 KPIGSGAQGIVCAA---YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 576 RLLGFC------DDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH 629
LL ++ + LV E + + R + + + + G+ +LH
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH 136
Query: 630 EECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFR 689
IIH D+KP NI++ +I DFGLA+ S T T+ Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 690 NMPITVKVDVYSFGVLLLEIICCR 713
M VD++S G ++ E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-27
Identities = 65/307 (21%), Positives = 110/307 (35%), Gaps = 35/307 (11%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDG--VKEFKTEVNVIGQTHHKNLV 575
+G GA+G V + + VAVKKL Q K E+ ++ H+N++
Sbjct: 24 SPVGSGAYGSVCAA---FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 576 RLLGFCDDG-----LNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHE 630
LL N + + L G + + K + + I RGL Y+H
Sbjct: 81 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 631 ECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRN 690
IIH D+KP N+ +++ +I DFGLA+ T T+ Y APE N
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLN 192
Query: 691 -MPITVKVDVYSFGVLLLEIICCR-----RNVDMEVNEAEALLTDWAYDCYCEGITEALV 744
M VD++S G ++ E++ R + ++ L+ + + +E+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 745 EFDIEALNDKKKLARFVMVAI---------WCIQEDPSLRPTMRKVTQM--LEGVVEVLD 793
+ K V + + D R T + + D
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 794 PPCPCPF 800
P P+
Sbjct: 313 EPVADPY 319
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.3 bits (246), Expect = 5e-23
Identities = 40/216 (18%), Positives = 77/216 (35%), Gaps = 24/216 (11%)
Query: 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLV 575
+LG G F V+ + VA+K + + + + E+ ++ + + +
Sbjct: 17 LVRKLGWGHFSTVWLA---KDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72
Query: 576 RLLGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGW----------------SRRTDIAF 619
+ + + +LL + + G I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 620 GIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLLDQS-QTHTAIR 677
+ GL Y+H C IIH DIKP+N+L++ + +A L + +T
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 678 GTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR 713
T+ Y +PE P D++S L+ E+I
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 1e-17
Identities = 26/205 (12%), Positives = 54/205 (26%), Gaps = 33/205 (16%)
Query: 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHS----------VIQDGVKEFKTEVNVIG 567
+ +G+G V+ S VK G F
Sbjct: 6 KLMGEGKESAVFNCY----SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 568 QTHHKNLVRLLGFCD----DGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIAR 623
+ + L +L G ++ E + L ++ I
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 624 GLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTHTAIRGTKGYV 683
+ + I+H D+ N+L+ + I DF + + + +
Sbjct: 115 EVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE---RDVRN 167
Query: 684 APEWFRNMPITVKVDVYSFGVLLLE 708
+F + D+ S +L+
Sbjct: 168 IITYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 58.8 bits (142), Expect = 3e-11
Identities = 25/112 (22%), Positives = 40/112 (35%), Gaps = 9/112 (8%)
Query: 40 NSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTA 99
+ L + +D L + Y T VW +N G K L +
Sbjct: 5 TNGEGLYAGQSLDVEPYHFIMQEDCNL--VLY---DHSTSVWASNTGILGKKGCKAVLQS 59
Query: 100 DQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWESFNN 150
D V+ +GR LW S + G Y L + + GN V+ + +W +
Sbjct: 60 DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG---SDIWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 39.6 bits (92), Expect = 1e-04
Identities = 19/119 (15%), Positives = 31/119 (26%), Gaps = 22/119 (18%)
Query: 153 DTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT 212
+ + + GQ L + F + + NLVL + + S T
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLY-------DHSTSVWASNT 45
Query: 213 NGSSNQ---LVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHP 268
+ V G + YD + N Y + DG Y
Sbjct: 46 GILGKKGCKAVLQSDGNFVV---YDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD 101
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 58.8 bits (142), Expect = 3e-11
Identities = 23/127 (18%), Positives = 39/127 (30%), Gaps = 26/127 (20%)
Query: 68 SIWYAKIPQKTIVWFANGDSP-AASGTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYG 126
SI Y+ + S ++ + D LVL R + GT
Sbjct: 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRA 70
Query: 127 LMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELN 186
++ G +L++ +W S N + S GR+ F L
Sbjct: 71 VLQPNGRMDVLTNQNIAVWTSGN-------------------------SRSAGRYVFVLQ 105
Query: 187 SNGNLVL 193
+ NL +
Sbjct: 106 PDRNLAI 112
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 44.1 bits (104), Expect = 5e-06
Identities = 24/141 (17%), Positives = 44/141 (31%), Gaps = 21/141 (14%)
Query: 132 GNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNL 191
G+ V+ ++ + L+ + N Q Q L +R + ++ NL
Sbjct: 1 GSVVVANNGNSILYSTQGNDN----HPQTLHATQSLQL---------SPYRLSMETDCNL 47
Query: 192 VLTTVNLPSDYTNEPYYESKTNGSSNQLVFNQSGYMYILQEYDQRFALTRRVETSASNFY 251
VL + TN + G+ + V +G M + + S S
Sbjct: 48 VLFDRDDRVWSTN-----TAGKGTGCRAVLQPNGRMDV---LTNQNIAVWTSGNSRSAGR 99
Query: 252 YRATINFDGVFTQYQHPKNST 272
Y + D Y +T
Sbjct: 100 YVFVLQPDRNLAIYGGALWTT 120
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 53.6 bits (128), Expect = 2e-09
Identities = 22/122 (18%), Positives = 42/122 (34%), Gaps = 16/122 (13%)
Query: 32 GASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAAS 91
G L + + G + F + D N L+ VW + + A S
Sbjct: 7 GHQLDTGGSLA-----EGGYLFIIQN-DCNLVLY---------DNNRAVWASGTNGKA-S 50
Query: 92 GTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLLSDNTNKLWESFNNP 151
G +++ D LV+ S + Y ++ N V+ ++ N +W + N
Sbjct: 51 GCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110
Query: 152 TD 153
+
Sbjct: 111 GN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 46.7 bits (110), Expect = 5e-07
Identities = 21/121 (17%), Positives = 35/121 (28%), Gaps = 18/121 (14%)
Query: 152 TDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESK 211
+D + D G L+ G + F + ++ NLVL N +
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNNRAVWASGTNG---- 47
Query: 212 TNGSSNQLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNS 271
S L G + I + T+ N Y + D Y + N+
Sbjct: 48 -KASGCVLKMQNDGNLVIYSGSRAIW----ASNTNRQNGNYYLILQRDRNVVIYDNSNNA 102
Query: 272 T 272
Sbjct: 103 I 103
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 50.4 bits (120), Expect = 2e-08
Identities = 25/121 (20%), Positives = 39/121 (32%), Gaps = 17/121 (14%)
Query: 153 DTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKT 212
+ + + G+FL+ G F F + + NLVL V+ P TN
Sbjct: 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVLYDVDKPIWATNTG-----G 47
Query: 213 NGSSNQLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNST 272
S L G + + Y+ T N Y + D Y + +T
Sbjct: 48 LSRSCFLSMQTDGNLVV---YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDRWAT 104
Query: 273 G 273
G
Sbjct: 105 G 105
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 43.1 bits (101), Expect = 8e-06
Identities = 22/120 (18%), Positives = 40/120 (33%), Gaps = 20/120 (16%)
Query: 32 GASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAAS 91
G +LS + + G F F D N L ++ P W N +
Sbjct: 7 GETLSTGEFLN-----YGSFVFIMQE-DCN-----LVLYDVDKPI----WATNTGGLS-R 50
Query: 92 GTKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGL-MNDTGNFVLLSDNTNKLWESFNN 150
+ + D LV+ +P + +W S+ Y + N V+ + W + +
Sbjct: 51 SCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.6 bits (118), Expect = 6e-08
Identities = 16/127 (12%), Positives = 35/127 (27%), Gaps = 27/127 (21%)
Query: 68 SIWYAKIPQKTIVWFANGDSPAASGT-KVELTADQGLVLTSPQGRELWKSDPIIGTVAYG 126
+I + + + + + + + +D LVL +W S+ T
Sbjct: 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRA 60
Query: 127 LMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELN 186
++ G V+L+ W S S G + L
Sbjct: 61 VLQSDGLLVILTAQNTIRW-------------------------SSGTKGSIGNYVLVLQ 95
Query: 187 SNGNLVL 193
+ + +
Sbjct: 96 PDRTVTI 102
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.4 bits (102), Expect = 7e-06
Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 9/103 (8%)
Query: 172 SDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGSSNQLVFNQSGYMYILQ 231
+ + FRF + S+ NLVL ++ + S T G++ QS + ++
Sbjct: 19 AAQSLELSSFRFTMQSDCNLVLF-------DSDVRVWASNTAGATGCRAVLQSDGLLVIL 71
Query: 232 EYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGN 274
T S Y + D T Y +G
Sbjct: 72 TAQNTIRW--SSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGT 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.3 bits (112), Expect = 4e-07
Identities = 20/131 (15%), Positives = 38/131 (29%), Gaps = 23/131 (17%)
Query: 145 WESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTN 204
+ +N + + L F +RF + ++ NLVL N
Sbjct: 7 KQPDDNHPQILHA------TESLEI-----LFGTHVYRFIMQTDCNLVLY-------DNN 48
Query: 205 EPYYESKTNGSSN--QLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVF 262
P + + T G N + V G + + + + +Y + D
Sbjct: 49 NPIWATNTGGLGNGCRAVLQPDGVLVV---ITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 263 TQYQHPKNSTG 273
Y +T
Sbjct: 106 VIYGDALWATQ 116
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 804 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.8 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.78 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.76 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.72 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.64 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.46 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.18 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.06 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.02 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.98 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.9 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.95 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.22 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.89 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.47 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 86.18 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.55 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 83.29 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.09 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.48 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.42 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-49 Score=415.10 Aligned_cols=272 Identities=25% Similarity=0.403 Sum_probs=210.8
Q ss_pred ccccCHHHHHHHHhhhH-----------HhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcc
Q 047263 501 LHCFTYKDLEAATNGFK-----------EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQ 568 (804)
Q Consensus 501 ~~~~~~~~l~~at~~f~-----------~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~ 568 (804)
...++|+++.+++.+|. ++||+|+||+||+|+....+.....||||++... ..+..++|.+|++++++
T Consensus 4 ~d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 83 (299)
T d1jpaa_ 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83 (299)
T ss_dssp CCGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT
T ss_pred cCCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh
Confidence 34678889999988774 4699999999999998766555567999998653 34456789999999999
Q ss_pred cccCCccceeeEEeCCCceEEEEeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEE
Q 047263 569 THHKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNIL 647 (804)
Q Consensus 569 l~h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NIL 647 (804)
++|||||+++|++.+++..++||||+++|+|.+++... ..++|.+++.++.|||+||.|||+. +|+||||||+|||
T Consensus 84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence 99999999999999999999999999999999988764 5789999999999999999999965 9999999999999
Q ss_pred EcCCCCEEEeecCcccccccCCCCc----cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhH
Q 047263 648 LDDYYNARISDFGLAKLLLLDQSQT----HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNE 722 (804)
Q Consensus 648 l~~~~~~kl~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~ 722 (804)
|+.++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998765433221 122457899999999999999999999999999999998 89998755432
Q ss_pred HHHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 723 AEALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 723 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
.. ...+ ..+.. ...+......+.+++.+||+.||++||||.||++.|+.+++-
T Consensus 241 ~~---~~~i----~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 DV---INAI----EQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HH---HHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH---HHHH----HcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 21 1111 11110 001122345788999999999999999999999999987664
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=401.28 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=195.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.+.++||+|+||.||+|++.++. .||||++... ....++|.+|++++++++|||||+++|+|.+++..++||||+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~----~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKD----KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTE----EEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCC----EEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 45688999999999999986543 6999999754 345678999999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 595 SNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 595 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
++|+|.+++... ..+++..++.++.|||+||.|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999998755 6688999999999999999999965 999999999999999999999999999987655444444
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||..|+|||++.+..++.++|||||||++|||+|++.|+........ .+ .... .+.. ... +
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-~~-~~i~----~~~~--~~~-------p 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VV-EDIS----TGFR--LYK-------P 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-HH-HHHH----HTCC--CCC-------C
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-HH-HHHH----hcCC--CCC-------c
Confidence 456789999999999999999999999999999999996555433322211 11 1111 1110 000 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.....++.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223568899999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-48 Score=405.94 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=210.9
Q ss_pred HHhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
..+.+.++||+|+||+||+|+....+ +.||||+++.. ....++|.+|+.++++++|||||+++++|.+++..++||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGT---EEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCC---eEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34556789999999999999987543 47999999754 345678999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 592 EFLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||+++|+|.+++... ..+++..+..|+.||++||+|||+. +|+||||||+||||++++.+||+|||+++....+.
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999643 6789999999999999999999965 99999999999999999999999999999765554
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........|+..|+|||++.+..++.++|||||||++|||++|+.|+........ +.. ....+...
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~----~i~~~~~~-------- 235 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKDYRM-------- 235 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHTTCCC--------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHH----HHhcCCCC--------
Confidence 4444555688999999999999999999999999999999998777654332211 111 11111111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
..+.....++.+++.+||+.||++||||+||++.|+.+.+
T Consensus 236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111234578899999999999999999999999988754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=399.14 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=200.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||.||+|+.+. .||||+++.. ..+..+.|++|+.++++++|||||++++++.+ ...++||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEEeeCCCcEEEEEEECC------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3456789999999999997642 4999998643 34556789999999999999999999999865 5689999
Q ss_pred eecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-
Q 047263 592 EFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ- 669 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~- 669 (804)
||+++|+|.++|... ..+++..+.+|+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999754 5689999999999999999999965 99999999999999999999999999998764332
Q ss_pred CCccccccCCCcccccccccc---CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 670 SQTHTAIRGTKGYVAPEWFRN---MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~---~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
........||+.|||||++.+ ..++.++|||||||++|||+||+.||......... ..... .+.. .+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~----~~~~----~p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVG----RGYL----SP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHH----HTSC----CC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHh----cCCC----CC
Confidence 233445679999999999864 35899999999999999999999999764332211 11111 1111 11
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
... .........+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 230 ~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 100 01112345788999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=398.56 Aligned_cols=252 Identities=30% Similarity=0.437 Sum_probs=203.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.+.++||+|+||.||+|.++.+ ..||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HeEEeEEEecCCCcEEEEEEECCC----CEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 345678899999999999998643 36999999754 3456789999999999999999999998865 56799999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++|+|.+++... ..+++..+++|+.||++||.|||+. +|+||||||+||||++++.+||+|||+++.+.....
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999999988654 3689999999999999999999965 999999999999999999999999999998755444
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++|||||||++|||+||+.|+........ +... ...+....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~----i~~~~~~~-------- 230 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN----LERGYRMV-------- 230 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----HHTTCCCC--------
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHhcCCCC--------
Confidence 445556789999999999999999999999999999999997666543322211 1111 11111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
.+.....++.+++.+||+.||++||||++|+++|+.+
T Consensus 231 -~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 0112234688899999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=390.50 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=201.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecC
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLS 595 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~ 595 (804)
++||+|+||.||+|.+.... ..+.||||+++... ....++|.+|++++++++|||||+++++|.+ +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 46999999999999876443 34579999996432 2345679999999999999999999999965 46789999999
Q ss_pred CCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC--cc
Q 047263 596 NGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ--TH 673 (804)
Q Consensus 596 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~ 673 (804)
+|+|.+++.....+++..+++++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999999889999999999999999999999965 9999999999999999999999999999876543332 22
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||........ .. ....+.... .
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~----~i~~~~~~~---------~ 231 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA----MLEKGERMG---------C 231 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTTCCCC---------C
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HH----HHHcCCCCC---------C
Confidence 34568999999999999999999999999999999998 8999976543221 11 111211110 1
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
+.....++.+|+.+||+.||++||||++|+++|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 112235788899999999999999999999998763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=395.49 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=201.7
Q ss_pred hHHhhCCCcceeEEEeeecCcc-ccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 516 FKEELGKGAFGVVYKGAIGMAS-MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.||+|+||.||+|++.... .....||||++.... .....+|.+|+.++++++|||||+++|++.+....++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 4578999999999999987543 334579999996533 34456799999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC-
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ- 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~- 671 (804)
+.+++|.+++... ..++|.++.+++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 167 (283)
T d1mqba_ 91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167 (283)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence 9999999988654 6789999999999999999999965 9999999999999999999999999999876543322
Q ss_pred -ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 -THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 -~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||..|+|||++.+..++.++|||||||++|||++|+.|+........ .+ . ...++...
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~-~----~i~~~~~~--------- 232 (283)
T d1mqba_ 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VM-K----AINDGFRL--------- 232 (283)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HH-H----HHHTTCCC---------
T ss_pred eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HH-H----HHhccCCC---------
Confidence 22335689999999999999999999999999999999997766654332211 11 1 11122111
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLD 793 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~ 793 (804)
..+.....++.+|+.+||+.||++||||.||+++|+.+++.++
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 1111233568899999999999999999999999998877543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=382.70 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=208.2
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeec
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFL 594 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~ 594 (804)
.|.++||+|+||+||+|+.+++ ..||||+++.. ....++|++|+.++++++||||++++|+|.+++..++||||+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTT----EEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred EEeEEEecCCCeEEEEEEECCC----CEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 4678999999999999998633 36999999864 345678999999999999999999999999999999999999
Q ss_pred CCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 595 SNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 595 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
++|+|..++... ..+++..+.+++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999997654 6788999999999999999999965 999999999999999999999999999987665555455
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhcc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALN 752 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (804)
....||..|+|||.+.+..++.++||||||+++|||+| |+.||......... . ...++.. ...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~----~i~~~~~--~~~------- 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---E----HIAQGLR--LYR------- 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---H----HHHTTCC--CCC-------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH---H----HHHhCCC--CCC-------
Confidence 55678999999999999999999999999999999998 78898765433211 1 1112111 111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 753 DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 753 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
+.....++.+++.+||+.||++|||+++|++.|..+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 112235788999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=389.29 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=200.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||+||+|+....+ +.||||++.... .+..+.+.+|++++++++|||||++++++.+++..+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 345688999999999999987543 379999986532 2344578999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC-CC
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ-SQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~-~~ 671 (804)
|+++|+|.++|.....+++.++..++.||++||.|||+. +|+||||||+|||+++++++||+|||+++.+.... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999999888999999999999999999999965 99999999999999999999999999999765433 23
Q ss_pred ccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||........... .. .......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~-----~~~~~~~-------- 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DW-----KEKKTYL-------- 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HH-----HTTCTTS--------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HH-----hcCCCCC--------
Confidence 3455779999999999988876 5789999999999999999999976543221111 10 0110000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112356778999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=391.90 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=202.6
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
...+.++||+|+||.||+|+..++. .||||++... ....+.|.+|+.++++++|+|||++++++.+ +..++|||
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~----~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTT----RVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTE----EEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCC----EEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 3556789999999999999986543 5999999754 3456789999999999999999999999855 56899999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|+++|+|..++... ..++|.+++.++.||++||+|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999998653 5789999999999999999999965 999999999999999999999999999987655444
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++..+.++.++||||||+++|||++|+.|+........ .+ ..+ ..+....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~-~~i----~~~~~~~-------- 234 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VL-DQV----ERGYRMP-------- 234 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HH-HHH----HTTCCCC--------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HH-HHH----HhcCCCC--------
Confidence 445556789999999999999999999999999999999998776654433221 11 111 1111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCC
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp 795 (804)
......+++.+++.+||+.||++||||++|+++|+.......|+
T Consensus 235 -~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 235 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred -CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 11122356889999999999999999999999999877665554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=386.15 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=196.7
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeC----CCceE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD----GLNRL 588 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 588 (804)
.|.++||+|+||+||+|+....+ +.||+|++... .....+.|.+|++++++++|||||++++++.+ +...+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~---~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC---eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 45668999999999999987544 37999998653 23445679999999999999999999999854 35578
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc-CCCCEEEeecCccccccc
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD-DYYNARISDFGLAKLLLL 667 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~-~~~~~kl~Dfgla~~~~~ 667 (804)
+||||+++|+|.+++.....+++..+..++.||++||.|||++ ..+|+||||||+|||++ +++.+||+|||+++....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999998888899999999999999999999965 33499999999999996 588999999999986422
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ + ......+... ..
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~----~~~i~~~~~~----~~ 233 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVKP----AS 233 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCCC----GG
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H----HHHHHcCCCC----cc
Confidence 23345679999999999875 599999999999999999999999975432221 1 1111122111 11
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... ....++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~----~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCc----cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 12345778999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=383.94 Aligned_cols=244 Identities=26% Similarity=0.346 Sum_probs=203.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+|+...++ +.||+|++... .....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSK---FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECCCC---cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 456789999999999999987544 37999998642 234467789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 99999999999998888899999999999999999999965 999999999999999999999999999986532
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ...... ..
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~-----i~~~~~------~~-- 223 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK--R-----ISRVEF------TF-- 223 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H-----HHTTCC------CC--
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH--H-----HHcCCC------CC--
Confidence 23345679999999999999999999999999999999999999997654332110 0 111110 00
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+.....++.+++.+||+.||++|||++|+++
T Consensus 224 --p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 --PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112356788999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=385.91 Aligned_cols=248 Identities=25% Similarity=0.305 Sum_probs=204.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+|+....+ +.||||++........+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~---~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTC---CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEecCcCcEEEEEEECCCC---CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 455678999999999999876543 47999999766556677899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCcc
Q 047263 594 LSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQTH 673 (804)
Q Consensus 594 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 673 (804)
+++|+|.+++.+ ..+++.++..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.+... ....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~ 173 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKR 173 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCCB
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc-cccc
Confidence 999999998865 4689999999999999999999965 9999999999999999999999999999876433 2334
Q ss_pred ccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 674 TAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 674 ~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ........ +. ..
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~----~~~~~~~~-~~-------~~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--L----IATNGTPE-LQ-------NP 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H----HHHHCSCC-CS-------SG
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH--H----HHhCCCCC-CC-------Cc
Confidence 45679999999999999999999999999999999999999997654322111 1 11111100 00 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
......+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122456788999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=384.36 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=201.4
Q ss_pred hhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEeecCCC
Q 047263 519 ELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEFLSNG 597 (804)
Q Consensus 519 ~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey~~~g 597 (804)
+||+|+||.||+|...... .+..||||+++... ....++|.+|++++++++|||||+++|++.+ +..+|||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCC-CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 5999999999999875433 24579999997543 3446789999999999999999999999875 4689999999999
Q ss_pred cHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC--Cccc
Q 047263 598 TLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS--QTHT 674 (804)
Q Consensus 598 sL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~ 674 (804)
+|.+++.. +..+++..+.+++.|||+||.|||+. +|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 94 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (285)
T d1u59a_ 94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170 (285)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence 99999865 46789999999999999999999965 999999999999999999999999999997654332 2223
Q ss_pred cccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhhccc
Q 047263 675 AIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEALND 753 (804)
Q Consensus 675 ~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (804)
...||+.|+|||++....++.++|||||||++|||+| |+.||........ .. ....+..... +
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~----~i~~~~~~~~---------p 234 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA----FIEQGKRMEC---------P 234 (285)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH----HHHTTCCCCC---------C
T ss_pred ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCCCCCC---------C
Confidence 4568899999999999999999999999999999998 8999975543221 11 1112211111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 754 KKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 754 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
.....++.+|+.+||+.||++||||.+|++.|+.+.
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 123357889999999999999999999999997643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=396.13 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=203.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccc--cceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASM--YQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~--~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 588 (804)
...+.++||+|+||+||+|+.....+ ....||||++.... ....+.|.+|+.++.++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 44567899999999999998764332 24469999986432 34456789999999998 8999999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCC-----------------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCc
Q 047263 589 LVYEFLSNGTLASFLFGDL-----------------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQN 645 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~N 645 (804)
+||||+++|+|.++|..+. .+++..++.++.||++||+|||+. +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 9999999999999997542 478999999999999999999965 99999999999
Q ss_pred EEEcCCCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHH
Q 047263 646 ILLDDYYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEA 723 (804)
Q Consensus 646 ILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~ 723 (804)
||++.++.+||+|||+++........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876544332 2334568999999999999999999999999999999998 899987543321
Q ss_pred HHHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 047263 724 EALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLE 786 (804)
Q Consensus 724 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le 786 (804)
. +.. ....+... ..+.....++.+|+.+||+.||++||||+||++.|.
T Consensus 275 ~--~~~----~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 N--FYK----LIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H--HHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHH----HHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 111 11111110 011122357889999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=394.05 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=202.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||+||+|+.... ++.||+|+++... ....+++.+|+.++++++|||||++++++.++.+.+||||
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTT---TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEecCCCeEEEEEEECCC---CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 44567899999999999998644 3479999987543 3345679999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+++|+|.+++.+...+++..+..++.||+.||.|||+. .+|+||||||+|||+++++++||+|||+|+.+... .
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 159 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---T
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---c
Confidence 999999999998888899999999999999999999962 27999999999999999999999999999876432 2
Q ss_pred cccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHH-HHh-----------------
Q 047263 673 HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWA-YDC----------------- 734 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~-~~~----------------- 734 (804)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||............... ...
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 23467999999999999999999999999999999999999999765432211100000 000
Q ss_pred -hhcCccc----cee----cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 735 -YCEGITE----ALV----EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 735 -~~~~~~~----~~~----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
....... +.. ..............++.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000 000 000000001112356888999999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=380.43 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=189.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC--CCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD--GLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 589 (804)
+.+.+.||+|+||.||+|+...++ +.||||++.... +...+.|.+|++++++++|||||++++++.+ +...++
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 456688999999999999987554 379999986542 3345679999999999999999999999865 456799
Q ss_pred EEeecCCCcHHHhhcC----CCCCChhhHHHHHHHHHHHHHHhhhcc--CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 590 VYEFLSNGTLASFLFG----DLKPGWSRRTDIAFGIARGLLYLHEEC--STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
||||+++|+|.+++.. +..+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999863 467899999999999999999999752 2359999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
.+..+. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . . ...++....+
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--~-~----~i~~~~~~~~ 234 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--A-G----KIREGKFRRI 234 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-H----HHHHTCCCCC
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH--H-H----HHHcCCCCCC
Confidence 764332 233456799999999999999999999999999999999999999976543321 1 1 1111211111
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+.....++.+++.+||+.||.+|||++|+++
T Consensus 235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122356888999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=387.15 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=202.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+|+....+ +.||||++.....+..+.|.+|++++++++|||||++++++.+++..+|||||
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETS---VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEeeCCCcEEEEEEECCCC---eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 345678999999999999987544 37999999876666678899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
+++|+|.+++.+ ...+++.++..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++..... ...
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-ccc
Confidence 999999999765 46789999999999999999999965 9999999999999999999999999999764322 112
Q ss_pred cccccCCCccccccccc-----cCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 673 HTAIRGTKGYVAPEWFR-----NMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~-----~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||........ +... . .+....+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i----~-~~~~~~~~--- 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKI----A-KSEPPTLA--- 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH----H-HSCCCCCS---
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHH----H-cCCCCCCC---
Confidence 33467999999999984 45689999999999999999999999976543321 1110 1 11111110
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......++.+++.+||+.||++|||++|+++
T Consensus 237 ----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 ----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11123457888999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=384.33 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=201.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||+||+|+...++ +.||||++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATS---REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 456789999999999999986543 37999998642 234567799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999998888999999999999999999999965 999999999999999999999999999987654332
Q ss_pred -CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 -QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 -~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . . ....... + .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~-~----~i~~~~~----~--~- 229 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--F-Q----KIIKLEY----D--F- 229 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-H----HHHTTCC----C--C-
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH--H-H----HHHcCCC----C--C-
Confidence 233456799999999999999999999999999999999999999986543221 1 0 0111110 0 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVT 782 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 782 (804)
+.....++.+++.+||+.||++|||++|++
T Consensus 230 ---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 230 ---PEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 112235678899999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=382.26 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=197.0
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
.+.+.+.||+|+||.||+|+..........||||+++.... ...+.|.+|+.++++++|||||++++++.+ +..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence 35567889999999999999876655566899999975433 345679999999999999999999999964 6789999
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+++|+|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+||++++++.+||+|||+++.+.....
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 99999999998765 45789999999999999999999965 999999999999999999999999999987655444
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
.......||+.|+|||.+.+..++.++|||||||++|||++ |..|+......... .. ..++....
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~----i~~~~~~~------- 229 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GR----IENGERLP------- 229 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HH----HHTTCCCC-------
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HH----HHcCCCCC-------
Confidence 45556678999999999999999999999999999999998 78888765433211 11 11221111
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.+......+.+++.+||+.||++|||++||++.|+.+++
T Consensus 230 --~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 230 --MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111223578899999999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=386.33 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=205.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeC-CCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E 592 (804)
+|.++||+|+||+||+|++.........||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999998766555567999999743 34456789999999999999999999999865 567899999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+++|+|.+++... ..+++..+++++.|+|+||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998755 5677889999999999999999955 9999999999999999999999999999876543322
Q ss_pred ---ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 672 ---THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 672 ---~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
......||..|+|||.+....++.++||||||+++|||++|+.|+........ +.... ..+.. ...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i----~~g~~--~~~--- 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----LQGRR--LLQ--- 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCC--CCC---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCCC--CCC---
Confidence 22335689999999999999999999999999999999998888765432211 11111 11111 111
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
+......+.+++.+||+.||++||+|.||++.|+.+.+-
T Consensus 256 ----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 256 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111235688999999999999999999999999987653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=383.41 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=206.4
Q ss_pred hhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||+||+|+... +...+..||||++..... +..++|.+|++++++++||||++++++|.+....+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 3457889999999999998753 223456799999975433 3456799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCC------------------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcE
Q 047263 591 YEFLSNGTLASFLFGD------------------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNI 646 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NI 646 (804)
|||+++|+|.++|... ..+++..++.|+.||+.||+|||+. +|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 9999999999999632 2478899999999999999999965 999999999999
Q ss_pred EEcCCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCC-CCCcchhHHH
Q 047263 647 LLDDYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR-NVDMEVNEAE 724 (804)
Q Consensus 647 Ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~-p~~~~~~~~~ 724 (804)
||+.++.+||+|||+++.+..... .......|++.|+|||.+.+..++.++|||||||++|||++|.. |+......+.
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 999999999999999987644332 33345678899999999999999999999999999999999964 5554433221
Q ss_pred HHHHHHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 725 ALLTDWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 725 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+ . ...++..... +.....++.+|+.+||+.+|++||||.||+++|+++.+
T Consensus 252 --~-~----~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 252 --I-Y----YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp --H-H----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --H-H----HHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 1 1112211111 11223468899999999999999999999999998864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=383.85 Aligned_cols=245 Identities=25% Similarity=0.291 Sum_probs=200.2
Q ss_pred HhhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEE
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 589 (804)
.+...++||+|+||.||+|+...++ ..||||++.... ....+.|.+|+.++++++|||||++++++.+++..++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCC---cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 3455678999999999999976543 479999987533 2344678999999999999999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|..++..+..+++.++..++.||+.||.|||+. +|+||||||+|||+++++++||+|||+++....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999999998888888899999999999999999999965 999999999999999999999999999986432
Q ss_pred CCccccccCCCcccccccccc---CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 670 SQTHTAIRGTKGYVAPEWFRN---MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~---~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ + .... .+....+.
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~----~~i~-~~~~~~~~-- 235 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIA-QNESPALQ-- 235 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHH-HSCCCCCS--
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--H----HHHH-hCCCCCCC--
Confidence 234579999999999864 4689999999999999999999999975533221 1 0101 11111111
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......+.+++.+||+.||++|||++|+++
T Consensus 236 ------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122457888999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-44 Score=380.73 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=188.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.+.||+|+||+||+|+....+ +.||||++.... ....+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQ---KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTC---CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeccCeEEEEEEECCCC---CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 566789999999999999986544 379999987533 2334568899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc---CCCCEEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~ 669 (804)
|+++|+|.++|.....+++.....++.||+.||.|||+. +|+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-- 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-- 162 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC--
Confidence 999999999999888999999999999999999999965 999999999999994 578999999999986532
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ...... . .
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i----~~~~~~-~-----~ 229 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQI----LKAEYE-F-----D 229 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHH----HTTCCC-C-----C
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHH----hccCCC-C-----C
Confidence 22334567999999999999999999999999999999999999999765433211 101 111100 0 0
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011122356889999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=377.90 Aligned_cols=256 Identities=26% Similarity=0.319 Sum_probs=197.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||.||+|+........++||||++... ..+..++|.+|+.++++++|||||+++|++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 35678899999999999998765555668999998643 23445789999999999999999999999976 467899
Q ss_pred EeecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
|||+++|+|.+++..+ ..+++..+++++.|||+||.|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999887654 5689999999999999999999965 99999999999999999999999999999764433
Q ss_pred CC--ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 670 SQ--THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 670 ~~--~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.. ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......... . ....++....
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~---~i~~~~~~~~---- 235 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H---KIDKEGERLP---- 235 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---HHHTSCCCCC----
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---H---HHHhCCCCCC----
Confidence 22 2334567889999999999999999999999999999998 89998755433211 1 1111211110
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcC
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGV 788 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~ 788 (804)
........+.+++.+||+.||++||||.||+++|++.
T Consensus 236 -----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 -----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112234688999999999999999999999999764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=373.72 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=192.4
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC-CCceEEEEee
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-GLNRLLVYEF 593 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~Ey 593 (804)
.|.++||+|+||.||+|...+ .+||||+++. ....++|++|++++++++||||++++|+|.+ .+..++||||
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~-----~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp EEEEEEEECSSCEEEEEEETT-----EEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred EEeEEEecCCCeEEEEEEECC-----eEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 466889999999999999742 3699999975 3455789999999999999999999999965 4568999999
Q ss_pred cCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 594 LSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 594 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
+++|+|.++|..+ ..++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC----
Confidence 9999999999754 3589999999999999999999965 999999999999999999999999999986432
Q ss_pred ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 672 THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......++..|+|||++.+..++.++||||||+++|||+| |+.|+....... +... ..++....+
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~~~------- 221 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMDA------- 221 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCCCC-------
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCCCC-------
Confidence 2233457889999999999999999999999999999998 677766543322 1111 112211111
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
+.....++.+++.+||+.||.+||||.+|+++|+.+..
T Consensus 222 --~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11223577899999999999999999999999988653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-43 Score=380.72 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=203.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+|+....+ +.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g---~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATG---NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 556789999999999999986543 47999999876556667899999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc--CCCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD--DYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.+.. .
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--K 179 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--T
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc--c
Confidence 999999999854 46799999999999999999999965 999999999999995 468899999999987543 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.. . ...... +..
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~-i----~~~~~~-~~~----- 246 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRN-V----KSCDWN-MDD----- 246 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-H----HHTCCC-SCC-----
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHH-H----HhCCCC-CCc-----
Confidence 334456799999999999999999999999999999999999999976543221 111 1 011000 000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112346788999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=378.88 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=201.9
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc-ccccHHHHHHHHHHhccc-ccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||.||+|+...++. ...||||++... ..+..++|.+|++++.++ +|||||+++++|.+++..++|||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTE-EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCe-EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 356789999999999999875532 336889998643 334566899999999998 79999999999999999999999
Q ss_pred ecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEE
Q 047263 593 FLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARI 656 (804)
Q Consensus 593 y~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl 656 (804)
|+++|+|.++|+.. ..+++..+.+++.|||+||.|||+. +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999999654 5689999999999999999999965 9999999999999999999999
Q ss_pred eecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCC-CCCcchhHHHHHHHHHHHHhh
Q 047263 657 SDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR-NVDMEVNEAEALLTDWAYDCY 735 (804)
Q Consensus 657 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~~~~ 735 (804)
+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++|.. |+....... +. ...
T Consensus 169 ~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~----~~i 239 (309)
T d1fvra_ 169 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY----EKL 239 (309)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHG
T ss_pred cccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HH----HHH
Confidence 999999864322 22234568999999999999999999999999999999999875 554332221 11 111
Q ss_pred hcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCC
Q 047263 736 CEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVL 792 (804)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~ 792 (804)
.++... ..+.....++.+++.+||+.||++||||+||++.|+++.+-.
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111110 011123457889999999999999999999999999877543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.8e-43 Score=378.77 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=204.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||.||+|+....+ +.||||++........+.+.+|+.++++++|||||++++++.++...+|||||
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATG---RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCC---CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 556789999999999999976543 47999999765555566789999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc--CCCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD--DYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~--~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++|+|.+++... ..+++.+...|+.||+.||.|||+. +|+||||||+||||+ .++.+||+|||+++.+.. .
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--D 182 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--T
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC--C
Confidence 9999999887654 4689999999999999999999965 999999999999998 678999999999987643 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .... ..... ...
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~----~~~~~------~~~ 249 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVK----RCDWE------FDE 249 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----HCCCC------CCS
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCCC------CCc
Confidence 3344567899999999999999999999999999999999999999765433211 1010 11000 000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
........++.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011123356788999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=371.80 Aligned_cols=249 Identities=25% Similarity=0.330 Sum_probs=202.9
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc------cccHHHHHHHHHHhcccccCCccceeeEEeCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI------QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
+.+.++||+|+||+||+|+....+ +.||||++.... ....+.|.+|+.++++++|||||++++++.++...
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~---~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456789999999999999986543 379999986321 22467899999999999999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC----CEEEeecCccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY----NARISDFGLAK 663 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~----~~kl~Dfgla~ 663 (804)
+|||||+++|+|.++|.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999998888899999999999999999999965 999999999999998776 49999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ....... .
T Consensus 166 ~~~~--~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~--~-----i~~~~~~-~ 235 (293)
T d1jksa_ 166 KIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA--N-----VSAVNYE-F 235 (293)
T ss_dssp ECTT--SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-----HHTTCCC-C
T ss_pred hcCC--CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH--H-----HHhcCCC-C
Confidence 7533 233345678999999999999999999999999999999999999998654332110 0 0111000 0
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. .........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 ED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CH-----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cc-----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 001112356788999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=378.57 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=200.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCc-cccceeEEEEEcccc-ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA-SMYQVPVAVKKLHSV-IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~-~~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||+||+|+.... .....+||+|++... ..+..++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 44568999999999999987643 333457999998643 345678899999999999999999999999875 567889
Q ss_pred eecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 592 EFLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 592 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
||+.+|+|.+++.. ...+++..+++++.|||+||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999999988765 46789999999999999999999965 999999999999999999999999999998654333
Q ss_pred Cc-cccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchh
Q 047263 671 QT-HTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDI 748 (804)
Q Consensus 671 ~~-~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 748 (804)
.. .....||..|+|||.+.++.++.++|||||||++|||+| |..||+........ ... ..+.. +
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~---~~i----~~~~~--~----- 232 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SIL----EKGER--L----- 232 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH---HHH----HHTCC--C-----
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HcCCC--C-----
Confidence 22 234568999999999999999999999999999999999 77887654332211 111 11110 0
Q ss_pred hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 749 EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 749 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
..+......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 233 --~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 011123356888999999999999999999999987764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=379.48 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=195.8
Q ss_pred HhhhHHhhCCCcceeEEEeeecCcc--ccceeEEEEEccccc-cccHHHHHHHHHHhccc-ccCCccceeeEEeCC-Cce
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMAS--MYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDG-LNR 587 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~--~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-~~~ 587 (804)
.+.+.++||+|+||.||+|...... ..++.||||++.... ....+++.+|...+.++ +|+||+++++++.+. ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 4556789999999999999875432 334579999997533 34456788888888777 689999999998664 568
Q ss_pred EEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCC
Q 047263 588 LLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDY 651 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~ 651 (804)
++||||+++|+|.++|... ..+++.++..++.||++||.|||+. +|+||||||+||||+++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCC
Confidence 9999999999999999643 3478999999999999999999965 99999999999999999
Q ss_pred CCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCC-CCCcchhHHHHHHHH
Q 047263 652 YNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRR-NVDMEVNEAEALLTD 729 (804)
Q Consensus 652 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~ 729 (804)
+.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|.. ||........ +..
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~~ 248 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR 248 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HHH
Confidence 9999999999987644333 23345679999999999999999999999999999999999764 5654322211 111
Q ss_pred HHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 730 WAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
...++..... +.....++.+++.+||+.||++|||++||++.|+.+++
T Consensus 249 ----~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 249 ----RLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----HHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1112211111 11123468899999999999999999999999998765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=374.44 Aligned_cols=260 Identities=27% Similarity=0.355 Sum_probs=203.9
Q ss_pred HhhhHHhhCCCcceeEEEeeecCcc----ccceeEEEEEcccccc-ccHHHHHHHHHHhccc-ccCCccceeeEEeCCCc
Q 047263 513 TNGFKEELGKGAFGVVYKGAIGMAS----MYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLN 586 (804)
Q Consensus 513 t~~f~~~LG~G~fG~Vykg~~~~~~----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 586 (804)
.+.+.++||+|+||.||+|+..... .....||||+++.... ....++.+|...+.++ +|||||+++++|.++..
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 3445688999999999999865432 2235799999975443 4457889999999888 89999999999999999
Q ss_pred eEEEEeecCCCcHHHhhcCC----------------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC
Q 047263 587 RLLVYEFLSNGTLASFLFGD----------------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD 650 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~ 650 (804)
.++||||+++|+|.++|... ..+++.++++++.||+.||+|||+. +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 99999999999999999644 3578999999999999999999965 9999999999999999
Q ss_pred CCCEEEeecCcccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHc-CCCCCCcchhHHHHHHH
Q 047263 651 YYNARISDFGLAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIIC-CRRNVDMEVNEAEALLT 728 (804)
Q Consensus 651 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~ 728 (804)
++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..||........
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~---- 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---- 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH----
Confidence 999999999999976544332 3344668999999999999999999999999999999998 6777764433221
Q ss_pred HHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 729 DWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
...+..+..... +.....++.+++.+||+.||++|||+.||+++|++++.+
T Consensus 247 ---~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 ---FKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ---HHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111222211111 111234688999999999999999999999999987643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=378.03 Aligned_cols=261 Identities=27% Similarity=0.395 Sum_probs=207.5
Q ss_pred HHhhhHHhhCCCcceeEEEeeecC--ccccceeEEEEEcccccc-ccHHHHHHHHHHhccc-ccCCccceeeEEeCCCce
Q 047263 512 ATNGFKEELGKGAFGVVYKGAIGM--ASMYQVPVAVKKLHSVIQ-DGVKEFKTEVNVIGQT-HHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 512 at~~f~~~LG~G~fG~Vykg~~~~--~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 587 (804)
....+.++||+|+||.||+|+... ....+..||||+++.... ....+|.+|+.+++++ +|||||+++++|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 345567899999999999998743 234566899999975433 3455799999999999 799999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCC------------------CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc
Q 047263 588 LLVYEFLSNGTLASFLFGDL------------------KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD 649 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~ 649 (804)
++||||+++|+|.++|+... .+++..+.+++.||++||+|||++ +++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999997432 578999999999999999999965 999999999999999
Q ss_pred CCCCEEEeecCcccccccCCC-CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHH
Q 047263 650 DYYNARISDFGLAKLLLLDQS-QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT 728 (804)
Q Consensus 650 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 728 (804)
.++.+|++|||+++....... .......||+.|+|||.+....++.++||||||+++|||+|++.|+......... +.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-HH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence 999999999999997654333 2334467899999999999999999999999999999999965554333222111 11
Q ss_pred HHHHHhhhcCcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCc
Q 047263 729 DWAYDCYCEGITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVV 789 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~ 789 (804)
.. ...+.. ...+......+.+|+.+||+.||++||||++|+++|++.+
T Consensus 259 ~~----i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 KM----IKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HH----HHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11 111111 0111123457889999999999999999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=372.50 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=196.3
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCC----ceEEEE
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL----NRLLVY 591 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 591 (804)
+.++||+|+||.||+|+.. +..||||+++.... ....+..|+..+.+++|||||+++++|.+.. ..++||
T Consensus 7 l~~~iG~G~fg~Vy~~~~~-----g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEECCSSSEEEEEEET-----TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEC-----CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4568999999999999864 33699999874321 1122344666667889999999999997643 578999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhcc-----CCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEEC-----STQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
||+++|+|.++|++. .++|..+++++.|+|.||.|||+.. .++|+||||||+||||++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 999999999999754 6899999999999999999999631 3699999999999999999999999999998765
Q ss_pred cCCCC---ccccccCCCccccccccccC------CCCccchhhHHHHHHHHHHcCCCCCCcchhHHH---------HHHH
Q 047263 667 LDQSQ---THTAIRGTKGYVAPEWFRNM------PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAE---------ALLT 728 (804)
Q Consensus 667 ~~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~---------~~l~ 728 (804)
..... ......||+.|+|||++.+. .++.++|||||||+||||+||..|+........ ...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~- 238 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV- 238 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH-
Confidence 43322 23346799999999998754 367799999999999999999887643221100 000
Q ss_pred HHHHHhhhcCcccceecchh-hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccC
Q 047263 729 DWAYDCYCEGITEALVEFDI-EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEV 791 (804)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~ 791 (804)
........++ ...+.+ ......+....+.+++.+||+.||++||||.||++.|+++.+-
T Consensus 239 ~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0011111111 111111 1222334567788999999999999999999999999887643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=371.78 Aligned_cols=246 Identities=25% Similarity=0.259 Sum_probs=204.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.+.||+|+||.||+++....+ ..||||++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 456788999999999999986544 37999999743 234567889999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC-C
Confidence 99999999999999888999999999999999999999965 9999999999999999999999999999865432 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... . ...+...
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~----i~~~~~~--------- 223 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---L----ILMEEIR--------- 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H----HHHCCCC---------
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH---H----HhcCCCC---------
Confidence 33455779999999999999999999999999999999999999998765432111 0 1111110
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
.+.....++.+++.+||+.||.+||+ ++|+++
T Consensus 224 -~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01122346788999999999999995 777765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=373.05 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=205.4
Q ss_pred hhhHHhhCCCcceeEEEeeecCc--cccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMA--SMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~--~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
..+.++||+|+||.||+|..... ......||||+++... .+....|.+|+.++++++||||++++++|..+...++|
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence 34568899999999999987531 2234579999997543 34445799999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCC----------CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecC
Q 047263 591 YEFLSNGTLASFLFGD----------LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFG 660 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfg 660 (804)
|||+++|+|.+++... ..+++..+.+++.|+|+||.|||+. +|+||||||+|||+++++++||+|||
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecc
Confidence 9999999999998632 3468899999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCCC-ccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCC-CCCCcchhHHHHHHHHHHHHhhhcC
Q 047263 661 LAKLLLLDQSQ-THTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCR-RNVDMEVNEAEALLTDWAYDCYCEG 738 (804)
Q Consensus 661 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~ 738 (804)
+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||+||+ .|+........ + . ...++
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~--~-~----~i~~~ 251 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--L-R----FVMEG 251 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--H-H----HHHTT
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH--H-H----HHHhC
Confidence 99876543332 233346899999999999999999999999999999999996 55543322211 1 1 11121
Q ss_pred cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 739 ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
..... +......+.+++.+||+.+|++||||++|+++|++.++
T Consensus 252 ~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11100 11123578899999999999999999999999987655
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-42 Score=364.32 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=199.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHHHHHHHhcccccCCccceeeEEeCCCc----
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLN---- 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~---- 586 (804)
+.+.+.||+|+||.||+|+.... ++.||||+++... .+..+.|.+|+.++++++||||+++++++...+.
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRL---HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCC---CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 45678899999999999997644 3479999997533 2335579999999999999999999999866443
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.+|||||+++++|.+++.....+++.++..++.||++||.|||+. +|+||||||+|||++.++..+|+|||.++...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 789999999999999998888999999999999999999999965 99999999999999999999999999987653
Q ss_pred cCCC--CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccccee
Q 047263 667 LDQS--QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALV 744 (804)
Q Consensus 667 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 744 (804)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP--- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCC---
Confidence 3222 234456799999999999999999999999999999999999999976543321 11111111110
Q ss_pred cchhhhcccHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcCc
Q 047263 745 EFDIEALNDKKKLARFVMVAIWCIQEDPSLRP-TMRKVTQMLEGVV 789 (804)
Q Consensus 745 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~Le~~~ 789 (804)
..........++.+++.+||+.||++|| |++++++.|.++.
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0011112335788899999999999999 8999999887653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=365.55 Aligned_cols=271 Identities=22% Similarity=0.245 Sum_probs=202.7
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccc-----cHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQD-----GVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
+.||+|+||+||+|+....+ +.||||++...... ..+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEETTEEEEEEECSSCC---SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eEeccCcCeEEEEEEECCCC---cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 57999999999999976543 37999998643221 12468899999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+.++++..++..+..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~ 156 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RA 156 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc-cc
Confidence 999999888888788899999999999999999999965 99999999999999999999999999998654332 23
Q ss_pred cccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCccc----------
Q 047263 673 HTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITE---------- 741 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---------- 741 (804)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ...+.......+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhccch
Confidence 344578999999999865 467999999999999999999999997654432111 111111000000
Q ss_pred -----ceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcC-ccCCCCCCCCC
Q 047263 742 -----ALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGV-VEVLDPPCPCP 799 (804)
Q Consensus 742 -----~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~-~~~~~pp~P~~ 799 (804)
......... ........+.+++.+||+.||++|||++|+++ .|... ...+..+.|+|
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~p 298 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298 (299)
T ss_dssp CCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCCC
T ss_pred hhhhccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCCC
Confidence 000000000 00112357889999999999999999999986 45432 22333334554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-42 Score=367.08 Aligned_cols=243 Identities=24% Similarity=0.264 Sum_probs=202.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||+||+|+...++ +.||||++... .....+.+.+|+.++++++|||||++++++.++...++|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEECCCC---CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 456789999999999999986543 37999998642 234567899999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
|||+++|+|..++.....+++.....++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence 9999999999999999999999999999999999999995 5999999999999999999999999999987532
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... . ...+...
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~-i~~~~~~--------- 219 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------K-ILNAELR--------- 219 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H-HHHCCCC---------
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------H-HHcCCCC---------
Confidence 2345679999999999999999999999999999999999999997654332110 0 1111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.+.....++.+++.+||+.||.+|| |++++++
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0111234678899999999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-42 Score=358.89 Aligned_cols=249 Identities=22% Similarity=0.254 Sum_probs=201.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc---------ccHHHHHHHHHHhcccc-cCCccceeeEEeC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ---------DGVKEFKTEVNVIGQTH-HKNLVRLLGFCDD 583 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~---------~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~ 583 (804)
+.+.+.||+|+||+||+++...++ +.+|||++..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~---~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTC---KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CEEceEEecCcCeEEEEEEECCCC---CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 345678999999999999876543 4799999864321 12346889999999997 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
++..+|||||+++|+|.++|..+..+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999998888999999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCcccccccccc------CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhc
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRN------MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCE 737 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 737 (804)
.+.. ........||..|+|||++.+ ..++.++||||+||++|||++|+.||.......... ....
T Consensus 159 ~~~~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~-------~i~~ 229 (277)
T d1phka_ 159 QLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-------MIMS 229 (277)
T ss_dssp ECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHH
T ss_pred EccC--CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH-------HHHh
Confidence 7643 223345679999999999863 356889999999999999999999998664432111 0111
Q ss_pred CcccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
+... ... ......+.++.+++.+||+.||++|||++||++
T Consensus 230 ~~~~-~~~-----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQ-FGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCC-CCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC-CCC-----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1110 001 011123357889999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-41 Score=368.20 Aligned_cols=247 Identities=20% Similarity=0.213 Sum_probs=195.6
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc---cccHHHHH---HHHHHhcccccCCccceeeEEeCCCce
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI---QDGVKEFK---TEVNVIGQTHHKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~---~~~~~~f~---~E~~~l~~l~h~niv~l~g~~~~~~~~ 587 (804)
+.+.+.||+|+||.||+|+....+ +.||||++.... ......+. .|+.+++.++|||||++++++.+.+..
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~---~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCC---CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 345678999999999999986544 379999986321 22233343 457778888999999999999999999
Q ss_pred EEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccccc
Q 047263 588 LLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLL 667 (804)
Q Consensus 588 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~ 667 (804)
++||||+++|+|.++|.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999998888899999999999999999999965 999999999999999999999999999987643
Q ss_pred CCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.. ...... .
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~~---~--- 226 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTMA---V--- 226 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSCC---C---
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccCC---C---
Confidence 2 2344679999999999864 568999999999999999999999997654322111110 000000 0
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
. .+.....++.+++.+||+.||.+||| ++|+++
T Consensus 227 ~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 E----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 01112346788999999999999999 577764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=361.27 Aligned_cols=248 Identities=19% Similarity=0.233 Sum_probs=200.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEee
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYEF 593 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~Ey 593 (804)
+.+.++||+|+||+||+|+...++ +.||||.++... .....+.+|++++++++|||||++++++.+++..+|||||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~---~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSK---KTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 456788999999999999987554 379999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCcHHHhhcCCC-CCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC--CCCEEEeecCcccccccCCC
Q 047263 594 LSNGTLASFLFGDL-KPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD--YYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 594 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~--~~~~kl~Dfgla~~~~~~~~ 670 (804)
+++|+|.++|.... .+++.++..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++.... .
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--G 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--T
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc--C
Confidence 99999999998664 789999999999999999999965 9999999999999984 45899999999986532 2
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
.......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......... ..+ . .... .+...
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---~~i---~-~~~~-~~~~~---- 225 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENI---M-NAEY-TFDEE---- 225 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH---H-HTCC-CCCHH----
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH---HHH---H-hCCC-CCChh----
Confidence 3344567899999999999999999999999999999999999999766443211 000 0 1100 00000
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......++.+++.+||+.||.+|||+.|+++
T Consensus 226 -~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 -AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00012356788999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-41 Score=366.09 Aligned_cols=243 Identities=21% Similarity=0.192 Sum_probs=202.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 590 (804)
+.+.++||+|+||.||+++...++ +.||||++... .....+.+.+|+.+++.++|||||++++++.+....++|
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g---~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEECCCC---CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 455689999999999999986544 37999998642 234467789999999999999999999999999999999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQS 670 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~ 670 (804)
+||+.+|+|..++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 99999999999998888999999999999999999999965 999999999999999999999999999987542
Q ss_pred CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhhh
Q 047263 671 QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIEA 750 (804)
Q Consensus 671 ~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 750 (804)
......||+.|||||++.+..++.++|||||||++|||++|+.||........ + ... ..+...
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~-~~i----~~~~~~--------- 256 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--Y-EKI----VSGKVR--------- 256 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHH----HHCCCC---------
T ss_pred -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH--H-HHH----hcCCCC---------
Confidence 23346799999999999999999999999999999999999999976543221 1 111 111100
Q ss_pred cccHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 047263 751 LNDKKKLARFVMVAIWCIQEDPSLRP-----TMRKVTQ 783 (804)
Q Consensus 751 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 783 (804)
.+.....++.+++.+||+.||.+|+ |++++++
T Consensus 257 -~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0112235678899999999999994 8999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=364.61 Aligned_cols=245 Identities=27% Similarity=0.310 Sum_probs=200.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc---ccccHHHHHHHHHHhc-ccccCCccceeeEEeCCCceEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV---IQDGVKEFKTEVNVIG-QTHHKNLVRLLGFCDDGLNRLL 589 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~-~l~h~niv~l~g~~~~~~~~~l 589 (804)
+.+.++||+|+||+||+|+....+ +.||||+++.. .....+.+..|..++. .++|||||++++++.+++..+|
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~---~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCC---CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 456789999999999999987544 48999999642 2344566777777665 6899999999999999999999
Q ss_pred EEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCC
Q 047263 590 VYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~ 669 (804)
||||+++|+|.+++.....+++.++..++.||+.||.|||+. +|+||||||+|||+++++++||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence 999999999999999888899999999999999999999965 9999999999999999999999999999865432
Q ss_pred CCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecchhh
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFDIE 749 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 749 (804)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ....+.. ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~----~i~~~~~------~~- 222 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---H----SIRMDNP------FY- 222 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCCC------CC-
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH---H----HHHcCCC------CC-
Confidence 33344567999999999999999999999999999999999999999865433211 1 0111110 00
Q ss_pred hcccHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 047263 750 ALNDKKKLARFVMVAIWCIQEDPSLRPTMR-KVT 782 (804)
Q Consensus 750 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 782 (804)
+.....++.+|+.+||+.||.+||++. +++
T Consensus 223 ---p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 ---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 111235678999999999999999995 675
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=360.37 Aligned_cols=244 Identities=23% Similarity=0.248 Sum_probs=191.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccc-ccCCccceeeEEeC----CCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQT-HHKNLVRLLGFCDD----GLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~E 592 (804)
+.||+|+||.||+|+....+ +.||||+++.. +.+.+|++++.++ +|||||++++++.+ +...+||||
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQ---EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp EEEEECSSCEEEEEEETTTC---CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEeeeccCeEEEEEEECCCC---CEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 45999999999999986544 37999998642 4567899886654 89999999999865 466899999
Q ss_pred ecCCCcHHHhhcCC--CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC---CCCEEEeecCccccccc
Q 047263 593 FLSNGTLASFLFGD--LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD---YYNARISDFGLAKLLLL 667 (804)
Q Consensus 593 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~---~~~~kl~Dfgla~~~~~ 667 (804)
|+++|+|.++|... ..+++.++..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++....
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence 99999999999764 5689999999999999999999965 9999999999999985 56799999999987543
Q ss_pred CCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecch
Q 047263 668 DQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEFD 747 (804)
Q Consensus 668 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 747 (804)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...........
T Consensus 167 ~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-------~~~~i~~~~~~-- 235 (335)
T d2ozaa1 167 H--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMGQYE-- 235 (335)
T ss_dssp C--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSS--
T ss_pred C--CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-------HHHHHhcCCCC--
Confidence 2 234456799999999999999999999999999999999999999975433211000 00111100000
Q ss_pred hhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 748 IEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 748 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
...........++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011111233467889999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=350.49 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=195.1
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
.+.++||+|+||+||+|+....+ +.||||+++... ....+.+.+|+.++++++|||||++++++.++.+.++|||
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTC---CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EeccEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 34578999999999999986543 379999996432 2345678999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcC-CCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 593 FLSNGTLASFLFG-DLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 593 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|+.++.+...... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VR 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SB
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC-cc
Confidence 9987655544433 46689999999999999999999965 9999999999999999999999999999875432 23
Q ss_pred ccccccCCCccccccccccCC-CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhh---hcCcccceec--
Q 047263 672 THTAIRGTKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCY---CEGITEALVE-- 745 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~-~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~---~~~~~~~~~~-- 745 (804)
......||+.|+|||.+.... .+.++||||+||++|||++|+.||.......... . ..... .+........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~-i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--R-IFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H-HHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--H-HHHhcCCCchhhcccccccc
Confidence 344557899999999887665 5789999999999999999999997654332111 0 11100 0000000000
Q ss_pred -ch----hhhc-----ccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 746 -FD----IEAL-----NDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 746 -~~----~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. .... ........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 0000 01122357788999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=353.15 Aligned_cols=238 Identities=24% Similarity=0.374 Sum_probs=193.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc------ccHHHHHHHHHHhcccc--cCCccceeeEEeCCC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ------DGVKEFKTEVNVIGQTH--HKNLVRLLGFCDDGL 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~ 585 (804)
+.+.+.||+|+||.||+|+...++ +.||||++..... ...+.+.+|+.++++++ |||||++++++.+.+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred EEEeEEEeeCCCeEEEEEEECCCC---CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 456788999999999999986543 4799999864321 11234678999999986 899999999999999
Q ss_pred ceEEEEeecCC-CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-CCCEEEeecCccc
Q 047263 586 NRLLVYEFLSN-GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-YYNARISDFGLAK 663 (804)
Q Consensus 586 ~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-~~~~kl~Dfgla~ 663 (804)
..++||||+.+ +++.+++.....+++.++..++.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 68888888888899999999999999999999965 9999999999999985 5799999999998
Q ss_pred ccccCCCCccccccCCCccccccccccCCC-CccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc
Q 047263 664 LLLLDQSQTHTAIRGTKGYVAPEWFRNMPI-TVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA 742 (804)
Q Consensus 664 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 742 (804)
.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... . ....
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i----~--------~~~~--- 221 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----I--------RGQV--- 221 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----H--------HCCC---
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH----h--------hccc---
Confidence 6432 23345679999999999987776 56789999999999999999999753211 0 0000
Q ss_pred eecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 743 LVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 743 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
... .....++.+++.+||+.||++|||++|+++
T Consensus 222 ~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 FFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCS--------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC--------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 112356788999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-40 Score=346.29 Aligned_cols=258 Identities=20% Similarity=0.234 Sum_probs=196.8
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEEe
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E 592 (804)
...++||+|+||+||+|+.+.+ +.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++++|
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred eeccEEecCCCcEEEEEEeCCC----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 3467899999999999987643 369999996532 3345789999999999999999999999999999999999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCCc
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQT 672 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 672 (804)
|+.++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence 999988888888888999999999999999999999965 99999999999999999999999999998764332 22
Q ss_pred cccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC---ccc---ce--
Q 047263 673 HTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG---ITE---AL-- 743 (804)
Q Consensus 673 ~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~---~~-- 743 (804)
.....+++.|+|||.+.+. .++.++|||||||+++||++|+.||......... .. ........ ... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MR-IFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HH-HHHhhCCCChhhccchhhhhh
Confidence 3344588999999998754 5689999999999999999999999765432211 11 11100000 000 00
Q ss_pred -------ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 -------VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 -------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
................+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000011112356789999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=343.82 Aligned_cols=265 Identities=18% Similarity=0.212 Sum_probs=196.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEcccc--ccccHHHHHHHHHHhcccccCCccceeeEEeC--------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSV--IQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-------- 583 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-------- 583 (804)
+.+.++||+|+||+||+|+....+ +.||||++... .....+.+.+|+.++++++|+||+++++.+..
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC---CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred EEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 345678999999999999986443 37999998543 23445678999999999999999999999855
Q ss_pred CCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 584 GLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
+...++||||+.++.+..+......++......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 346789999999998888877778889999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCC---CccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCc
Q 047263 664 LLLLDQS---QTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGI 739 (804)
Q Consensus 664 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 739 (804)
.+..... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......................
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 7653322 223335689999999998765 689999999999999999999999976544332221111111000010
Q ss_pred ccceecc--------hhhhcc-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 047263 740 TEALVEF--------DIEALN-------DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM 784 (804)
Q Consensus 740 ~~~~~~~--------~~~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 784 (804)
....... ...... .......+.+|+.+||+.||++|||++|+++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 000000 01113466789999999999999999998853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=347.71 Aligned_cols=254 Identities=22% Similarity=0.212 Sum_probs=204.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc----cccHHHHHHHHHHhccccc-CCccceeeEEeCCCceE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI----QDGVKEFKTEVNVIGQTHH-KNLVRLLGFCDDGLNRL 588 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 588 (804)
+.+.++||+|+||+||+|+...+...++.||||.+.... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 566789999999999999886655556789999986432 2335678899999999976 89999999999999999
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
+++||+.+|+|.+++.....+.......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999998888888899999999999999999965 9999999999999999999999999999877655
Q ss_pred CCCccccccCCCccccccccccC--CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccceecc
Q 047263 669 QSQTHTAIRGTKGYVAPEWFRNM--PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEALVEF 746 (804)
Q Consensus 669 ~~~~~~~~~gt~~y~aPE~l~~~--~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 746 (804)
.........|++.|+|||.+.+. .++.++||||+||+||||++|+.||........... ..........
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~~------ 253 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSEP------ 253 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCCC------
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCCC------
Confidence 55555567799999999998754 468899999999999999999999976543221110 0000000000
Q ss_pred hhhhcccHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 047263 747 DIEALNDKKKLARFVMVAIWCIQEDPSLRPT-----MRKVTQ 783 (804)
Q Consensus 747 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 783 (804)
..+.....++.+++.+||+.||++||| ++|+++
T Consensus 254 ----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011223567888999999999999994 788875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=344.66 Aligned_cols=263 Identities=21% Similarity=0.246 Sum_probs=192.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhccc---ccCCccceeeEEe-----C
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQT---HHKNLVRLLGFCD-----D 583 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~ 583 (804)
+.+.++||+|+||+||+|+..... ++.||||++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTT--TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred EEEEEEEecccCeEEEEEEEECCC--CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 445678999999999999875322 3469999986432 12233456777776665 7999999999984 3
Q ss_pred CCceEEEEeecCCCcHHHhhc-CCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcc
Q 047263 584 GLNRLLVYEFLSNGTLASFLF-GDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLA 662 (804)
Q Consensus 584 ~~~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla 662 (804)
....++++||++++.+..... ....+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 456799999999988865554 446788999999999999999999965 9999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHH-----hhhc
Q 047263 663 KLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYD-----CYCE 737 (804)
Q Consensus 663 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~ 737 (804)
+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||................. .+..
T Consensus 164 ~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 164 RIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 86432 2334556799999999999999999999999999999999999999986644321111000000 0000
Q ss_pred Cc--cccee-cc--hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GI--TEALV-EF--DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~--~~~~~-~~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. ..... .. .............+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000 00 0000011122356778999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-39 Score=340.80 Aligned_cols=260 Identities=19% Similarity=0.190 Sum_probs=194.1
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCcccee-eEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLL-GFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~-g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|+...++ +.||||.+.... ..+++..|++++++++|+|++..+ .+..++...++|||
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEeEEEeeCCCcEEEEEEECCCC---CEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 456789999999999999976543 479999876532 234578899999999877755554 55577788899999
Q ss_pred ecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEc---CCCCEEEeecCcccccccCC
Q 047263 593 FLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLD---DYYNARISDFGLAKLLLLDQ 669 (804)
Q Consensus 593 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~---~~~~~kl~Dfgla~~~~~~~ 669 (804)
|+.++.+..+......+++..+..++.|++.||+|||+. +|+||||||+|||++ .+..+||+|||+++.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 996554444445567899999999999999999999965 999999999999985 45679999999999865433
Q ss_pred C------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccce
Q 047263 670 S------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEAL 743 (804)
Q Consensus 670 ~------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 743 (804)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~------ 234 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------ 234 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH------
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC------
Confidence 2 2234567999999999999999999999999999999999999999765433211110000000000
Q ss_pred ecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCcc
Q 047263 744 VEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVE 790 (804)
Q Consensus 744 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~ 790 (804)
.... ........++.+++..|++.+|++||+++++.+.|+.+..
T Consensus 235 --~~~~-~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 --TPIE-VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --SCHH-HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred --CChh-HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000 0011123567889999999999999999999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-38 Score=334.45 Aligned_cols=264 Identities=16% Similarity=0.172 Sum_probs=201.5
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhccccc-CCccceeeEEeCCCceEEEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHH-KNLVRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E 592 (804)
+.+.++||+|+||.||+|+.... ++.||||.+.... ..+++.+|+++++.++| +|++.+++++.++...++|||
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTT---TEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCC---CCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 45678899999999999997654 3479999886432 22356778888888865 899999999999999999999
Q ss_pred ecCCCcHHHhhcCC-CCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcC-----CCCEEEeecCcccccc
Q 047263 593 FLSNGTLASFLFGD-LKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDD-----YYNARISDFGLAKLLL 666 (804)
Q Consensus 593 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~-----~~~~kl~Dfgla~~~~ 666 (804)
|+ +++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 98 68999988654 578999999999999999999995 59999999999999964 5789999999999765
Q ss_pred cCCC------CccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcc
Q 047263 667 LDQS------QTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGIT 740 (804)
Q Consensus 667 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 740 (804)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 4322 1233467999999999999999999999999999999999999999754332211110101000000000
Q ss_pred cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcCccCCCCC
Q 047263 741 EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQMLEGVVEVLDPP 795 (804)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~Le~~~~~~~pp 795 (804)
.+ +. .....++.+++..|++.+|++||+++.+.+.|+.+.+-....
T Consensus 238 ~~-----l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 238 RE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HH-----hc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 00 00 011246778889999999999999999999998876544333
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=342.56 Aligned_cols=269 Identities=20% Similarity=0.236 Sum_probs=194.7
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc-cccHHHHHHHHHHhcccccCCccceeeEEeCCC----ceE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL----NRL 588 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 588 (804)
+.+.++||+|+||+||+|+...++ +.||||++.... ....+.+++|+.++++++||||+++++++.... ..+
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNK---VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTC---SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred eEEEEEEeeccCeEEEEEEECCCC---cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 345688999999999999876444 379999997543 334567899999999999999999999996653 235
Q ss_pred EEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccC
Q 047263 589 LVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLD 668 (804)
Q Consensus 589 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~ 668 (804)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 66677889999999964 4689999999999999999999965 9999999999999999999999999999876443
Q ss_pred CC--CccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcCcccc---
Q 047263 669 QS--QTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEGITEA--- 742 (804)
Q Consensus 669 ~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 742 (804)
.. .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||..........................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 22345668999999999854 5678999999999999999999999976644322111110000000000000
Q ss_pred --e----ecchhhhcc-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCc
Q 047263 743 --L----VEFDIEALN-----DKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM--LEGVV 789 (804)
Q Consensus 743 --~----~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--Le~~~ 789 (804)
. ......... ......++.+++.+||+.||++|||++|+++- |+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 000000000 00112467899999999999999999999874 44433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=332.02 Aligned_cols=261 Identities=20% Similarity=0.212 Sum_probs=200.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCCceEEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGLNRLLVY 591 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 591 (804)
+.+.++||+|+||+||+|+...++ +.||||+++... ....+.+++|+.++++++||||+++++++.+....++|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEeeeEEecCcCeEEEEEEECCCC---cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 345678999999999999987544 379999986432 344678999999999999999999999999999999999
Q ss_pred eecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccccCCCC
Q 047263 592 EFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLLLDQSQ 671 (804)
Q Consensus 592 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~~~~~~ 671 (804)
|++.+++|..++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++...... .
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~ 156 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-S
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC-c
Confidence 9999999999998888999999999999999999999965 99999999999999999999999999998764332 2
Q ss_pred ccccccCCCccccccccccCC-CCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhhhcC---ccc---ce-
Q 047263 672 THTAIRGTKGYVAPEWFRNMP-ITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCYCEG---ITE---AL- 743 (804)
Q Consensus 672 ~~~~~~gt~~y~aPE~l~~~~-~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~---~~- 743 (804)
......++..|+|||.+.... ++.++||||+||+++||++|+.||........... ......... ... ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK--RIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH--HHHHHHCCCCTTTCTTGGGST
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH--HHHhhcCCCChhhhhhhhhcc
Confidence 333345678899999887654 68999999999999999999999754433222111 111111000 000 00
Q ss_pred -------e-cchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 744 -------V-EFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 744 -------~-~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
. ...............+.+++.+||+.||.+|||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000011122356788999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=342.19 Aligned_cols=262 Identities=21% Similarity=0.239 Sum_probs=191.3
Q ss_pred hhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCccceeeEEeC------CCceE
Q 047263 515 GFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD------GLNRL 588 (804)
Q Consensus 515 ~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~ 588 (804)
...++||+|+||+||+|+....+ +.||||++..... .+.+|++++++++|+||+++++++.. ..+.+
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSG---ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCC---CEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 34568999999999999987544 3799999975432 23479999999999999999999843 33468
Q ss_pred EEEeecCCCcHHHh---hcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecCcccc
Q 047263 589 LVYEFLSNGTLASF---LFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKL 664 (804)
Q Consensus 589 lV~Ey~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~ 664 (804)
|||||++++.+..+ ......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999987754443 3456789999999999999999999995 5999999999999999775 899999999987
Q ss_pred cccCCCCccccccCCCcccccccccc-CCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHH--------HHHhh
Q 047263 665 LLLDQSQTHTAIRGTKGYVAPEWFRN-MPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDW--------AYDCY 735 (804)
Q Consensus 665 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~ 735 (804)
+... .......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.............. .+...
T Consensus 173 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 6432 23344678999999998764 5789999999999999999999999976543321110000 00000
Q ss_pred hcC----cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcC
Q 047263 736 CEG----ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGV 788 (804)
Q Consensus 736 ~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~ 788 (804)
... ....................++.+|+.+||+.||++|||+.|+++ .++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 001111111111112223456888999999999999999999985 34443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=340.65 Aligned_cols=269 Identities=24% Similarity=0.282 Sum_probs=190.8
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeCCC------
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDDGL------ 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 585 (804)
+.+.++||+|+||+||+|+....+ +.||||++.... ....+.+.+|+.++++++|||||++++++...+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp EEEEEEC------CEEEEEETTTC---CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred EEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 445678999999999999976543 479999997432 234567899999999999999999999997654
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
+.++||||+ +.+|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 469999999 557777664 45789999999999999999999965 9999999999999999999999999999865
Q ss_pred ccCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHh----hhcCc-
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDC----YCEGI- 739 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~----~~~~~- 739 (804)
.. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.................. ..+..
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred CC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 32 23456789999999998764 5689999999999999999999999765433211110000000 00000
Q ss_pred ----------ccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcCccCCCCC
Q 047263 740 ----------TEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQM--LEGVVEVLDPP 795 (804)
Q Consensus 740 ----------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--Le~~~~~~~pp 795 (804)
........... ........+.+|+.+||+.||++|||+.|+++- |+.+.+..+.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred chhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence 00000000000 011123467789999999999999999999873 66655444333
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-37 Score=330.21 Aligned_cols=256 Identities=20% Similarity=0.260 Sum_probs=192.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeC--CCceEEE
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDD--GLNRLLV 590 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV 590 (804)
+.+.++||+|+||+||+|+.... ++.||||+++.. ..+++.+|+.++++++ ||||+++++++.. ....++|
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~---~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---TEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCC---CCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 45678999999999999997654 347999998753 3567899999999995 9999999999874 4568999
Q ss_pred EeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCC-CEEEeecCcccccccCC
Q 047263 591 YEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYY-NARISDFGLAKLLLLDQ 669 (804)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~-~~kl~Dfgla~~~~~~~ 669 (804)
|||+++++|..+. +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 9999999998765 4688999999999999999999965 999999999999998655 5899999999875432
Q ss_pred CCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHH-----------HHHHHhhhc
Q 047263 670 SQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLT-----------DWAYDCYCE 737 (804)
Q Consensus 670 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~-----------~~~~~~~~~ 737 (804)
.......+|..|+|||.+.+. .++.++||||+||+++||++|+.||............ .+....-..
T Consensus 184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 233455689999999998765 5799999999999999999999999665432211100 000000000
Q ss_pred Cc------c----cceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 738 GI------T----EALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 738 ~~------~----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.. . ..................++.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 0000000000111122356788999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=334.54 Aligned_cols=275 Identities=22% Similarity=0.236 Sum_probs=198.2
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC-----CCc
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD-----GLN 586 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~ 586 (804)
+...++||+|+||+||+|+.... ++.||||++.... ....+.+.+|+.++++++|+|||++++++.. ...
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKT---GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTT---TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred eEEEEEEecCCCeEEEEEEECCC---CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 44567899999999999987644 3479999997543 2344578899999999999999999999853 334
Q ss_pred eEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCcccccc
Q 047263 587 RLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLLL 666 (804)
Q Consensus 587 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~~ 666 (804)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 5777888899999999954 5689999999999999999999965 99999999999999999999999999997542
Q ss_pred cCCCCccccccCCCccccccccccC-CCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHHHHHHHHHhh-----hcC--
Q 047263 667 LDQSQTHTAIRGTKGYVAPEWFRNM-PITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEALLTDWAYDCY-----CEG-- 738 (804)
Q Consensus 667 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~-----~~~-- 738 (804)
.......|+..|+|||.+.+. .++.++||||+||++|||++|+.||................... ...
T Consensus 173 ----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 ----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp ----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred ----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 233445688899999987665 46889999999999999999999997654332211110000000 000
Q ss_pred --------cccceecchhhhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhcCccCCCCCCCCCC
Q 047263 739 --------ITEALVEFDIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ--MLEGVVEVLDPPCPCPF 800 (804)
Q Consensus 739 --------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~--~Le~~~~~~~pp~P~~~ 800 (804)
............ ........+.+|+.+||+.||.+|||+.|+++ .+.+.......|.+.++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~ 319 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred hhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence 000000000000 00112356788999999999999999999997 56665554444444444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-37 Score=331.49 Aligned_cols=259 Identities=23% Similarity=0.240 Sum_probs=185.0
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccc--cccHHHHHHHHHHhcccccCCccceeeEEeC------CC
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI--QDGVKEFKTEVNVIGQTHHKNLVRLLGFCDD------GL 585 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~ 585 (804)
+.+.++||+|+||+||+|+.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t---~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVL---DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTT---TEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCcCeEEEEEEECCC---CCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 34457899999999999997644 3479999997532 3345578999999999999999999999953 46
Q ss_pred ceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEeecCccccc
Q 047263 586 NRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARISDFGLAKLL 665 (804)
Q Consensus 586 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~~~ 665 (804)
+.++||||+.++.+..+ . ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence 78999999977655544 2 4678999999999999999999965 9999999999999999999999999998865
Q ss_pred ccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHHHHH-HHH---------------
Q 047263 666 LLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEAEAL-LTD--------------- 729 (804)
Q Consensus 666 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~--------------- 729 (804)
.. ........+|+.|+|||++.+..++.++||||+||+++||++|+.||.......... ...
T Consensus 170 ~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 43 233345568999999999999999999999999999999999999996554322110 000
Q ss_pred HHHHhhhcCc-c-----cceecchh---hhcccHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 047263 730 WAYDCYCEGI-T-----EALVEFDI---EALNDKKKLARFVMVAIWCIQEDPSLRPTMRKVTQ 783 (804)
Q Consensus 730 ~~~~~~~~~~-~-----~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 783 (804)
.......... . ........ ...........+.+|+.+||+.||++|||++||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 0 00000000 01112334567889999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=3.8e-32 Score=295.52 Aligned_cols=260 Identities=19% Similarity=0.216 Sum_probs=184.3
Q ss_pred hhhHHhhCCCcceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-----------cCCccceeeEEe
Q 047263 514 NGFKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-----------HKNLVRLLGFCD 582 (804)
Q Consensus 514 ~~f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------h~niv~l~g~~~ 582 (804)
+.+.++||+|+||+||+|+....+ +.||||++.... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g---~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNN---THVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 566789999999999999976543 479999997542 23456788888888775 578999999875
Q ss_pred C--CCceEEEEeecCCCcHHH-hh--cCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCC----
Q 047263 583 D--GLNRLLVYEFLSNGTLAS-FL--FGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYN---- 653 (804)
Q Consensus 583 ~--~~~~~lV~Ey~~~gsL~~-~l--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~---- 653 (804)
. ....+++++++..+.... .. .....+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence 4 345566777665544322 22 2346778889999999999999999962 48999999999999986553
Q ss_pred --EEEeecCcccccccCCCCccccccCCCccccccccccCCCCccchhhHHHHHHHHHHcCCCCCCcchhHH----HHHH
Q 047263 654 --ARISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNMPITVKVDVYSFGVLLLEIICCRRNVDMEVNEA----EALL 727 (804)
Q Consensus 654 --~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~~DV~S~Gvll~elltG~~p~~~~~~~~----~~~l 727 (804)
++++|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||....... ...+
T Consensus 169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 89999999976432 2344568999999999999999999999999999999999999986543211 0111
Q ss_pred HHHHHH-------hhhc-----------Ccccceec---c------hhhhcccHHHHHHHHHHHHHccccCCCCCCCHHH
Q 047263 728 TDWAYD-------CYCE-----------GITEALVE---F------DIEALNDKKKLARFVMVAIWCIQEDPSLRPTMRK 780 (804)
Q Consensus 728 ~~~~~~-------~~~~-----------~~~~~~~~---~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e 780 (804)
...... .... .....+.. . ............++.+++.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 110000 0000 00000000 0 0011223456778999999999999999999999
Q ss_pred HHH
Q 047263 781 VTQ 783 (804)
Q Consensus 781 Vl~ 783 (804)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 987
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.80 E-value=9.1e-20 Score=160.36 Aligned_cols=111 Identities=21% Similarity=0.419 Sum_probs=91.5
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
+|+|.+||.|.+++ .|+| |.|+|+|...++ |.|+. ..++||.||++.|.. .+.+.|+.||+|+|
T Consensus 1 tDtL~~gq~L~~g~---~l~~--g~~~l~~q~DGN------Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG---SLAE--GGYLFIIQNDCN------LVLYD----NNRAVWASGTNGKAS-GCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTC---EEEE--TTEEEEECTTSC------EEEEE----TTEEEEECCCTTSCS-SEEEEECTTSCEEE
T ss_pred CCEecCCCEecCCC---EEEE--CCEEEEEcCCCC------EEEEc----CCcEEEEccCccCCC-CcEEEEeccccEEE
Confidence 48999999999877 7764 999999986543 55655 358999999998853 46899999999999
Q ss_pred eCCCCceEeeccCCCC-ceeEEEEccCcCEEEEecCCccccccccCCcc
Q 047263 106 TSPQGRELWKSDPIIG-TVAYGLMNDTGNFVLLSDNTNKLWESFNNPTD 153 (804)
Q Consensus 106 ~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTD 153 (804)
.|. +.++|++++... +...|+|+|+|||||++.++.++|||+.+|+|
T Consensus 65 ~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 65 YSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred Eec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 986 567777776544 44689999999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=3.6e-20 Score=180.85 Aligned_cols=163 Identities=12% Similarity=0.103 Sum_probs=117.7
Q ss_pred hHHhhCCCcceeEEEeeecCccccceeEEEEEcccccc------------------ccHHHHHHHHHHhcccccCCccce
Q 047263 516 FKEELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVIQ------------------DGVKEFKTEVNVIGQTHHKNLVRL 577 (804)
Q Consensus 516 f~~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~~------------------~~~~~f~~E~~~l~~l~h~niv~l 577 (804)
+.++||+|+||.||+|+..++ ..||||.++.... .....+..|...+.++.|.+++..
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTT----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred hCCEeeeCcceEEEEEECCCC----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 457899999999999987543 3699998652110 011234568888999999999998
Q ss_pred eeEEeCCCceEEEEeecCCCcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhhhccCCCeeecCCCCCcEEEcCCCCEEEe
Q 047263 578 LGFCDDGLNRLLVYEFLSNGTLASFLFGDLKPGWSRRTDIAFGIARGLLYLHEECSTQIIHCDIKPQNILLDDYYNARIS 657 (804)
Q Consensus 578 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlkp~NILl~~~~~~kl~ 657 (804)
+++.. .+++|||+++..+.+ ++......++.|++++|.|||+. +|+||||||+|||++++ .++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 86642 379999999876543 34556678999999999999965 99999999999999965 58999
Q ss_pred ecCcccccccCCCCccccccCCCccccc------cccccCCCCccchhhHHHHHHH
Q 047263 658 DFGLAKLLLLDQSQTHTAIRGTKGYVAP------EWFRNMPITVKVDVYSFGVLLL 707 (804)
Q Consensus 658 Dfgla~~~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~s~~~DV~S~Gvll~ 707 (804)
|||+++........ .|... |. ..+.|..++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence 99999764322111 11111 11 1356788999999765443
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.78 E-value=5.7e-19 Score=153.61 Aligned_cols=107 Identities=25% Similarity=0.398 Sum_probs=88.6
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
.|+|.+|+.|.+++ .|. +|.|.|+|...++ |-++. ..++||+||++.|....+.+.|+.||+|+|
T Consensus 1 ~~~L~~g~~L~~g~---~l~--~g~~~l~~q~dgn------Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl 65 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQ---SLD--VEPYHFIMQEDCN------LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVV 65 (109)
T ss_dssp CCEEETTCEEETTC---EEE--ETTEEEEECTTSC------EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEE
T ss_pred CCCccCCCEEeCCC---EEE--eCCEEEEecCCCe------EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEE
Confidence 36789999999766 665 4899999975332 55544 358999999999998888999999999999
Q ss_pred eCCCCceEeeccCCC-CceeEEEEccCcCEEEEecCCccccccccC
Q 047263 106 TSPQGRELWKSDPII-GTVAYGLMNDTGNFVLLSDNTNKLWESFNN 150 (804)
Q Consensus 106 ~~~~~~~vWst~~~~-~~~~~a~l~d~GNlVl~~~~~~~lWQSFd~ 150 (804)
.|++|++||+|+++. .+...|+|+|+|||||++. .+|||+-|
T Consensus 66 ~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 66 YDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp ECSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred EeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 999999999998764 3456799999999999963 59999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.76 E-value=1.1e-18 Score=151.79 Aligned_cols=106 Identities=17% Similarity=0.309 Sum_probs=87.2
Q ss_pred cCccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEE
Q 047263 26 RGKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVL 105 (804)
Q Consensus 26 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l 105 (804)
.|+|.+|++|.+++ .|. +|.|.|.|+..|+ |.||.. .++||.||++.|- ..+.+.++.||+|+|
T Consensus 1 ~~~L~~g~~L~~G~---~l~--ng~~~l~~q~DGN------Lvly~~----~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl 64 (108)
T d1jpca_ 1 DNILYSGETLSTGE---FLN--YGSFVFIMQEDCN------LVLYDV----DKPIWATNTGGLS-RSCFLSMQTDGNLVV 64 (108)
T ss_dssp CCEEETTEEECTTC---EEE--ETTEEEEECTTSC------EEEEET----TEEEEECCCTTSC-SSCEEEECTTSCEEE
T ss_pred CCCccCCCEecCCC---EEE--cCCEEEEECCCCe------EEEEeC----CceeeEeCCCCCC-CccEEEEeccceEEE
Confidence 36788999998766 664 6999999987654 667653 5789999998884 456899999999999
Q ss_pred eCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccC
Q 047263 106 TSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNN 150 (804)
Q Consensus 106 ~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~ 150 (804)
.|++|.+||+|++.... ...|+|+|+|||||++. .+||||+|
T Consensus 65 ~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 65 YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp ECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred ECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 99999999999876444 35789999999999964 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.72 E-value=5.6e-18 Score=149.69 Aligned_cols=101 Identities=20% Similarity=0.321 Sum_probs=86.8
Q ss_pred EEEeccCCCCeEEEeecCCCCCCCC-cEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCcccc
Q 047263 68 SIWYAKIPQKTIVWFANGDSPAASG-TKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLW 145 (804)
Q Consensus 68 gIw~~~~~~~t~vWvANr~~Pv~~~-s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lW 145 (804)
-|||.+++.++.+|++|++.|+..+ .+|.++.||||+|.+. +.++|++++...+ ...|.|+|+|||||++.+++++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 3999999999999999999999654 5899999999999986 6789999977554 46899999999999999999999
Q ss_pred ccccCCcccccCCcccCCCceEEecCCCCCCCCCceEEEecCCCceEEE
Q 047263 146 ESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 146 QSFd~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 194 (804)
|||. +.++|.|.+.|++||+++++
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9984 33678999999999999886
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=4.6e-17 Score=142.13 Aligned_cols=110 Identities=16% Similarity=0.248 Sum_probs=94.1
Q ss_pred EEeccCCCCeEEEeecCCCCCCCC-cEEEEecCCCeEEeCCCCceEeeccCCCCceeEEEEccCcCEEEEecCCcccccc
Q 047263 69 IWYAKIPQKTIVWFANGDSPAASG-TKVELTADQGLVLTSPQGRELWKSDPIIGTVAYGLMNDTGNFVLLSDNTNKLWES 147 (804)
Q Consensus 69 Iw~~~~~~~t~vWvANr~~Pv~~~-s~l~~~~~G~L~l~~~~~~~vWst~~~~~~~~~a~l~d~GNlVl~~~~~~~lWQS 147 (804)
|||.-.+..+..|+.+.+.++.++ .+|.|+.||||||.+ ++.++|++++....+..+.|+|+|||||++.++.+||||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 788877888889999999999654 589999999999987 468999999877777889999999999999999999998
Q ss_pred ccCCcccccCCcccCCCceEEecCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCC
Q 047263 148 FNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTN 213 (804)
Q Consensus 148 Fd~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 213 (804)
+. +.++|.|.+.|++||+++++ ..++|.+++.
T Consensus 82 ~t-------------------------~~~~g~y~l~Lq~DGNlvlY---------~~~~Wssgt~ 113 (115)
T d1dlpa1 82 GT-------------------------KGSIGNYVLVLQPDRTVTIY---------GPGLWDSGTS 113 (115)
T ss_dssp CC-------------------------CCCSSCCEEEECSSSCEEEE---------CSEEEECSCC
T ss_pred CC-------------------------CCCCCCEEEEECCCCcEEEe---------CCCeecCCCC
Confidence 74 34689999999999999875 1468877654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.46 E-value=1.6e-13 Score=120.28 Aligned_cols=102 Identities=19% Similarity=0.290 Sum_probs=79.1
Q ss_pred CccCCCCceeecCCCCeeeeCCCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEEe
Q 047263 27 GKITIGASLSASQNSSSWLSPNGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLT 106 (804)
Q Consensus 27 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l~ 106 (804)
.+|.++|+|. .++..|.|.|.|...|+ |-+ |. ..++||.||+..|.. .+.+.+..||+|+|.
T Consensus 15 ~~l~~~q~l~-------~~~~~~~y~l~mQ~DGN------LVL-y~---~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~ 76 (119)
T d1b2pa_ 15 QILHATESLE-------ILFGTHVYRFIMQTDCN------LVL-YD---NNNPIWATNTGGLGN-GCRAVLQPDGVLVVI 76 (119)
T ss_dssp CEEETTCEEE-------EEETTEEEEEEECTTSC------EEE-EE---TTEEEEECCCTTSCS-SCEEEECTTSCEEEE
T ss_pred CEEeCCCeEE-------EecCCceEEEEECCCCc------EEE-EE---CCeEEEEecCCCCCc-ceEEEEEeCCCEEEE
Confidence 4555555552 46679999999976544 434 43 367999999987743 478999999999999
Q ss_pred CCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCcccccccc
Q 047263 107 SPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFN 149 (804)
Q Consensus 107 ~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd 149 (804)
|++|.+||++++.... ...++|+|+|||||++ ..+|||-.
T Consensus 77 d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 9999999999876543 4578999999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.18 E-value=1.7e-11 Score=106.41 Aligned_cols=87 Identities=21% Similarity=0.303 Sum_probs=68.4
Q ss_pred CCeEEEeeEeCCCCCCcEEEEEEeccCCCCeEEEeecCCCCCCCCcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEE
Q 047263 48 NGDFAFGFHSLDSNKDLFLLSIWYAKIPQKTIVWFANGDSPAASGTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYG 126 (804)
Q Consensus 48 ~g~F~lGFf~~~~~~~~~~lgIw~~~~~~~t~vWvANr~~Pv~~~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a 126 (804)
+|.|.|.|...|+ |.++. ..++||.+|...+ ..+.+.|..||||||.|.++++||++.+.... ...+
T Consensus 25 ~g~~~l~~q~DGN------LvL~~----~~~~vW~s~t~~~--~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l 92 (115)
T d1dlpa1 25 LSSFRFTMQSDCN------LVLFD----SDVRVWASNTAGA--TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVL 92 (115)
T ss_dssp STTEEEEECTTSC------EEEEE----SSSEEECCCCCSC--SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEE
T ss_pred cCCEEEEECCCCe------EEEEc----CCeeEEEcccCCC--CceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEE
Confidence 5789999876543 66654 2468999997543 45788999999999999999999999876433 3479
Q ss_pred EEccCcCEEEEecCCcccccccc
Q 047263 127 LMNDTGNFVLLSDNTNKLWESFN 149 (804)
Q Consensus 127 ~l~d~GNlVl~~~~~~~lWQSFd 149 (804)
+|+++|||||++ ..+|+|-.
T Consensus 93 ~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 93 VLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp EECSSSCEEEEC---SEEEECSC
T ss_pred EECCCCcEEEeC---CCeecCCC
Confidence 999999999994 47999853
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.06 E-value=2.3e-10 Score=99.79 Aligned_cols=75 Identities=17% Similarity=0.330 Sum_probs=62.4
Q ss_pred EEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEecCC
Q 047263 94 KVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQS 172 (804)
Q Consensus 94 ~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~~s 172 (804)
.|.+..||||||.++ +.++|++++.... ...+.|+++|||||++.++.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 778899999999865 5789999976543 468999999999999999999998732
Q ss_pred CCCCCCCceEEEecCCCceEEE
Q 047263 173 DGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 173 ~~dps~G~~~~~~~~~g~~~~~ 194 (804)
.-+.|.|.+.|+++|+++++
T Consensus 89 --~~~~~~~~l~Lq~DGNlvlY 108 (119)
T d1b2pa_ 89 --AGKAGHYVLVLQPDRNVVIY 108 (119)
T ss_dssp --CCCSSCEEEEECTTSCEEEE
T ss_pred --cCCCCceEEEEcCCCCEEEE
Confidence 11457899999999999885
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.02 E-value=6.3e-10 Score=95.61 Aligned_cols=77 Identities=19% Similarity=0.348 Sum_probs=63.7
Q ss_pred CcEEEEecCCCeEEeCCCCceEeeccCCCCc-eeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEec
Q 047263 92 GTKVELTADQGLVLTSPQGRELWKSDPIIGT-VAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSK 170 (804)
Q Consensus 92 ~s~l~~~~~G~L~l~~~~~~~vWst~~~~~~-~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~ 170 (804)
.-+|.+..||||||.+ .+.+||++++...+ ...+.|+++|||||++.++.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS----------------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS----------------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc-----------------------
Confidence 3578999999999987 45799999987554 3579999999999999999999987
Q ss_pred CCCCCCCCCceEEEecCCCceEEE
Q 047263 171 QSDGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 171 ~s~~dps~G~~~~~~~~~g~~~~~ 194 (804)
......+.|.+.|+++|+++++
T Consensus 76 --~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 --NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp --CCCCSCSCEEEEECTTSCEEEE
T ss_pred --cccCCCCcEEEEEcCCCCEEEe
Confidence 1112467889999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.98 E-value=9.6e-10 Score=94.45 Aligned_cols=77 Identities=25% Similarity=0.440 Sum_probs=62.5
Q ss_pred CcEEEEecCCCeEEeCCCCceEeeccCCCC--ceeEEEEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEe
Q 047263 92 GTKVELTADQGLVLTSPQGRELWKSDPIIG--TVAYGLMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSS 169 (804)
Q Consensus 92 ~s~l~~~~~G~L~l~~~~~~~vWst~~~~~--~~~~a~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S 169 (804)
.-.|.+..||||||.+ ++.+||++++... ....+.|+++|||||++.++.++|+|=
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~--------------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH--------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC---------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe---------------------
Confidence 3578889999999986 5689999987633 345799999999999999999999881
Q ss_pred cCCCCCCCCCceEEEecCCCceEEE
Q 047263 170 KQSDGNFSKGRFRFELNSNGNLVLT 194 (804)
Q Consensus 170 ~~s~~dps~G~~~~~~~~~g~~~~~ 194 (804)
...+.|.|.+.|+++|+++++
T Consensus 78 ----t~~~~~~~~l~L~ddGNlvly 98 (109)
T d1kj1a_ 78 ----SVRGNGNYVLVLQEDGNVVIY 98 (109)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEE
T ss_pred ----eECCCCCEEEEEeCCCcEEEE
Confidence 112357899999999999885
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.90 E-value=1.7e-09 Score=94.44 Aligned_cols=110 Identities=20% Similarity=0.301 Sum_probs=74.5
Q ss_pred EEccCcCEEEEecCCccccccccCCcccccCCcccCCCceEEecCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCC
Q 047263 127 LMNDTGNFVLLSDNTNKLWESFNNPTDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEP 206 (804)
Q Consensus 127 ~l~d~GNlVl~~~~~~~lWQSFd~PTDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~ 206 (804)
+|+|+||+|+.+. +|+|.|++|+.++|.|. .|.|+|.++.+|+++++.. ..+
T Consensus 4 v~~~~~n~il~~~------~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~-------~~~ 55 (120)
T d1dlpa2 4 VVANNGNSILYST------QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDR-------DDR 55 (120)
T ss_dssp CCSSCCCEECCCC--------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBT-------TBC
T ss_pred EEEeCCCeEEEcC------CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecC-------CcE
Confidence 4555566555432 67899999999999864 5779999999999988632 256
Q ss_pred cccccCCCCC--cceeeeccccEEEeeeccceeeeeeeccccCcceeEEEEEeeCCcEEEEec
Q 047263 207 YYESKTNGSS--NQLVFNQSGYMYILQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQH 267 (804)
Q Consensus 207 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~y~~ 267 (804)
+|.+.+.+.. ..+.+...|.+.+.+.++..+.-+... .....++++|++||++++|.-
T Consensus 56 vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~---~~~~~~~l~Lq~DGnlvlY~~ 115 (120)
T d1dlpa2 56 VWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNS---RSAGRYVFVLQPDRNLAIYGG 115 (120)
T ss_dssp CSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCC---CSSSCCEEEECSSSCEEEECC
T ss_pred EEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCC---CCCCcEEEEECCCCcEEEeCC
Confidence 7776655433 346677788887776655555444322 122345899999999999953
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.81 E-value=9e-09 Score=89.02 Aligned_cols=109 Identities=23% Similarity=0.353 Sum_probs=77.8
Q ss_pred cccccCCcccCCCceEEecCCCCCCCCCceEEEecCCCceEEEeecCCCCCCCCCcccccCCCC--CcceeeeccccEEE
Q 047263 152 TDTMLPSQIFDNGQFLSSKQSDGNFSKGRFRFELNSNGNLVLTTVNLPSDYTNEPYYESKTNGS--SNQLVFNQSGYMYI 229 (804)
Q Consensus 152 TDTlLpg~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 229 (804)
||||+|||.|..++.|++ |+|.|.++.||+++++.. ..++|.+.+.++ ...+.+...|.+.+
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~-------~~~vW~s~~~~~~~~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN-------NRAVWASGTNGKASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET-------TEEEEECCCTTSCSSEEEEECTTSCEEE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC-------CcEEEEccCccCCCCcEEEEeccccEEE
Confidence 899999999999999964 999999999999988642 256787766653 33566777788776
Q ss_pred eeeccceeeeeeeccccCcceeEEEEEeeCCcEEEEecCCCCCCCCCeeEEEecCcccc
Q 047263 230 LQEYDQRFALTRRVETSASNFYYRATINFDGVFTQYQHPKNSTGNEGWTAFWSLPDDIC 288 (804)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~y~~~~~~~~~~~W~~~~~~p~~~C 288 (804)
.+. ...+..+- .......++++|+.||+|++|.- .....|+...+.|
T Consensus 65 ~~~-~~~~w~s~---t~~~~~~~~l~L~ddGNlvly~~--------~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 65 YSG-SRAIWASN---TNRQNGNYYLILQRDRNVVIYDN--------SNNAIWATHTNVG 111 (112)
T ss_dssp EET-TEEEEECC---CCCSCCCCEEEECTTSCEEEECT--------TSCEEEECCCCCC
T ss_pred Eec-CCeEEEEe---eccCCCceEEEEcCCCCEEEECC--------CCcEEecCCCccC
Confidence 654 33332221 12233457899999999999942 1356788776655
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.95 E-value=1.6e-05 Score=79.27 Aligned_cols=129 Identities=15% Similarity=0.019 Sum_probs=90.1
Q ss_pred ceeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc-cCCccceeeEEeCCCceEEEEeecCCCcHHHhh
Q 047263 525 FGVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH-HKNLVRLLGFCDDGLNRLLVYEFLSNGTLASFL 603 (804)
Q Consensus 525 fG~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l 603 (804)
...||+....+. .+++|+...........+.+|...+..+. +-.+.+++.+..+++..++|||++++.++.+..
T Consensus 27 ~~~v~rv~~~~~-----~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 27 PAKVYKLVGENE-----NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp SSEEEEEECSSC-----EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCcEEEEEeCCC-----eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 357998754322 47888887554444445677888877663 445788888888888899999999998886654
Q ss_pred cCCCCCChhhHHHHHHHHHHHHHHhhhcc---------------------------------------------------
Q 047263 604 FGDLKPGWSRRTDIAFGIARGLLYLHEEC--------------------------------------------------- 632 (804)
Q Consensus 604 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------------- 632 (804)
.. ......++.++++.+..||+..
T Consensus 102 ~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 102 ED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp TT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred cc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 21 1223445555666666666321
Q ss_pred -----CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 633 -----STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 633 -----~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
...++|+|+.|.|||+++++..-|+||+.+.
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.53 E-value=0.00025 Score=69.70 Aligned_cols=129 Identities=16% Similarity=0.076 Sum_probs=80.8
Q ss_pred hCCCcc-eeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccc--cCCccceeeEEeCCCceEEEEeecCC
Q 047263 520 LGKGAF-GVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTH--HKNLVRLLGFCDDGLNRLLVYEFLSN 596 (804)
Q Consensus 520 LG~G~f-G~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~Ey~~~ 596 (804)
+..|.. ..||+.....+. .+++|....... ..+..|.+.++.+. .-.+.+++.+..+++..++||||+++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~----~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRP----VLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECTTSC----CEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeCCCC----EEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 444443 578988765443 477887654322 23566777776664 33467788888888899999999998
Q ss_pred CcHHHhhcCCCCCChhhHHHHHHHHHHHHHHhh-----------------------------------------------
Q 047263 597 GTLASFLFGDLKPGWSRRTDIAFGIARGLLYLH----------------------------------------------- 629 (804)
Q Consensus 597 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH----------------------------------------------- 629 (804)
.++.+... ....++.++++.|.-||
T Consensus 91 ~~~~~~~~--------~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 91 QDLLSSHL--------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp EETTTSCC--------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccccccc--------cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 76543110 01111222222222222
Q ss_pred ----hc----cCCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 630 ----EE----CSTQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 630 ----~~----~~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
+. ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 12347999999999999987667899999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00041 Score=73.06 Aligned_cols=76 Identities=16% Similarity=0.105 Sum_probs=46.2
Q ss_pred HhhCCCcceeEEEeeecCccccceeEEEEEccccc-------cccHHHHHHHHHHhcccc---cCCccceeeEEeCCCce
Q 047263 518 EELGKGAFGVVYKGAIGMASMYQVPVAVKKLHSVI-------QDGVKEFKTEVNVIGQTH---HKNLVRLLGFCDDGLNR 587 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~~~~~vavK~~~~~~-------~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 587 (804)
+.||.|....||+....+++. .++||.-.... .........|.+.++.+. ...+.+++.+ ++...
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~---svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~ 106 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDR---ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 106 (392)
T ss_dssp EECCSSSSEEEEEEEC----C---EEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEeCCCceEeEEEEEeCCCCe---EEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCC
Confidence 468999999999987665433 68888754211 111223445777776552 2345666655 44566
Q ss_pred EEEEeecCCCc
Q 047263 588 LLVYEFLSNGT 598 (804)
Q Consensus 588 ~lV~Ey~~~gs 598 (804)
++|||++++..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 89999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.87 E-value=0.018 Score=58.34 Aligned_cols=131 Identities=13% Similarity=0.080 Sum_probs=73.7
Q ss_pred eeEEEeeecCccccceeEEEEEccccccccHHHHHHHHHHhcccccCCc--cceee-----EEeCCCceEEEEeecCCCc
Q 047263 526 GVVYKGAIGMASMYQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL--VRLLG-----FCDDGLNRLLVYEFLSNGT 598 (804)
Q Consensus 526 G~Vykg~~~~~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~Ey~~~gs 598 (804)
-.||+....++. .+++|..... ....+++..|...+..|....+ +..+. ....+...+.++++++|..
T Consensus 36 N~vy~v~~~dg~----~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRR----RFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCC----CEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCC----EEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 369998886554 5889887643 2345667788888877753322 11111 1233455688999988644
Q ss_pred HHH-----------hh---c----C-----CCCCChh-------------------hHHHHHHHHHHHHHHhhh----cc
Q 047263 599 LAS-----------FL---F----G-----DLKPGWS-------------------RRTDIAFGIARGLLYLHE----EC 632 (804)
Q Consensus 599 L~~-----------~l---~----~-----~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~ 632 (804)
+.. .+ + . ....++. .+..+...+.+.+..+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 311 00 0 0 0111111 111122222233333322 22
Q ss_pred CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 633 STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
..+++|+|+++.|||++++ ..++||+.+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 4578999999999999753 5689999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.22 E-value=0.035 Score=57.74 Aligned_cols=76 Identities=11% Similarity=0.135 Sum_probs=48.3
Q ss_pred HhhCCCcceeEEEeeecCccc----cceeEEEEEccccccccHHHHHHHHHHhcccccCCc-cceeeEEeCCCceEEEEe
Q 047263 518 EELGKGAFGVVYKGAIGMASM----YQVPVAVKKLHSVIQDGVKEFKTEVNVIGQTHHKNL-VRLLGFCDDGLNRLLVYE 592 (804)
Q Consensus 518 ~~LG~G~fG~Vykg~~~~~~~----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E 592 (804)
+.|+.|-.=.+|+........ ....|.++... .. .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 457888888999988764421 12235555543 22 233345678888888853344 577777754 68999
Q ss_pred ecCCCcH
Q 047263 593 FLSNGTL 599 (804)
Q Consensus 593 y~~~gsL 599 (804)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.30 E-value=0.021 Score=35.38 Aligned_cols=32 Identities=28% Similarity=0.648 Sum_probs=24.9
Q ss_pred cccccccccCCCCCCCCCCccccCCCCCccccCCCCccC
Q 047263 286 DICKASFVSTGSGTCGFNSVCRLNNRRPICECPRGYTLI 324 (804)
Q Consensus 286 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~Gf~~~ 324 (804)
|.|.+ -+.|| ||.|+.--..-.|.|-.||+|.
T Consensus 2 dECsi------gnpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-CceeeecccceEEeecCCcCCC
Confidence 67888 68898 7889753345579999999975
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.89 E-value=0.47 Score=46.78 Aligned_cols=31 Identities=23% Similarity=0.296 Sum_probs=27.6
Q ss_pred CCCeeecCCCCCcEEEcCCCCEEEeecCccc
Q 047263 633 STQIIHCDIKPQNILLDDYYNARISDFGLAK 663 (804)
Q Consensus 633 ~~~ivH~dlkp~NILl~~~~~~kl~Dfgla~ 663 (804)
..++||+|+.++||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5679999999999999988777899999875
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.47 E-value=0.1 Score=34.58 Aligned_cols=26 Identities=27% Similarity=0.607 Sum_probs=21.6
Q ss_pred CCCCCCCCccccCCCCCccccCCCCc
Q 047263 297 SGTCGFNSVCRLNNRRPICECPRGYT 322 (804)
Q Consensus 297 ~g~CG~~g~C~~~~~~~~C~C~~Gf~ 322 (804)
...|..+|.|.....+-.|.|++||+
T Consensus 10 ~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CCCCCCCcEeECCCCCEEeECCCCCc
Confidence 46799999997655567899999996
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.18 E-value=0.17 Score=32.88 Aligned_cols=26 Identities=19% Similarity=0.574 Sum_probs=21.4
Q ss_pred CCCCCCCCccccCCCCCccccCCCCc
Q 047263 297 SGTCGFNSVCRLNNRRPICECPRGYT 322 (804)
Q Consensus 297 ~g~CG~~g~C~~~~~~~~C~C~~Gf~ 322 (804)
...|...|.|......-.|.|++||+
T Consensus 5 ~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 5 TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 47799999997655567899999996
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.55 E-value=0.14 Score=33.27 Aligned_cols=26 Identities=27% Similarity=0.534 Sum_probs=21.6
Q ss_pred CCCCCCCCccccCCCCCccccCCCCc
Q 047263 297 SGTCGFNSVCRLNNRRPICECPRGYT 322 (804)
Q Consensus 297 ~g~CG~~g~C~~~~~~~~C~C~~Gf~ 322 (804)
...|...|.|.....+-.|.|++||+
T Consensus 6 ~~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 6 SNPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence 47799999997655577899999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.29 E-value=0.19 Score=32.67 Aligned_cols=31 Identities=29% Similarity=0.653 Sum_probs=24.8
Q ss_pred ccccccccccCCCCCCCCCCccccCCCCCccccCCCCc
Q 047263 285 DDICKASFVSTGSGTCGFNSVCRLNNRRPICECPRGYT 322 (804)
Q Consensus 285 ~~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~Gf~ 322 (804)
.|+|. ...|-..|.|.....+..|.|++||+
T Consensus 3 ~d~C~-------~~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCE-------SNPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCTTT-------TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred cccCC-------CCCCCCCcEEEcCCCCEEEECCCCCC
Confidence 36676 47899999997655568899999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.09 E-value=0.32 Score=32.23 Aligned_cols=31 Identities=35% Similarity=0.654 Sum_probs=24.0
Q ss_pred cccccccccCCCCCCCCCCccccCCCCCccccCCCCcc
Q 047263 286 DICKASFVSTGSGTCGFNSVCRLNNRRPICECPRGYTL 323 (804)
Q Consensus 286 ~~Cd~~~~~~~~g~CG~~g~C~~~~~~~~C~C~~Gf~~ 323 (804)
|.|.. +.|+.++.|.....+-.|.|++||+.
T Consensus 6 dEC~~-------~~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKE-------PDVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CSSSS-------TTSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eccCC-------cCCCCCCEeECCCCCeEeECCCCccc
Confidence 66765 44667899986566788999999975
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.48 E-value=0.27 Score=31.01 Aligned_cols=26 Identities=38% Similarity=0.749 Sum_probs=21.3
Q ss_pred CCCCCCCCccccCCCCCccccCCCCc
Q 047263 297 SGTCGFNSVCRLNNRRPICECPRGYT 322 (804)
Q Consensus 297 ~g~CG~~g~C~~~~~~~~C~C~~Gf~ 322 (804)
...|...|.|.....+-.|.|++||+
T Consensus 5 ~~PC~ngg~C~~~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 5 SSPCLHNGRCLDKINEFQCECPTGFT 30 (35)
T ss_dssp TCCSTTTCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCcEEECCCCCeEEECCCCCC
Confidence 47799999997544567899999996
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.42 E-value=0.17 Score=33.51 Aligned_cols=27 Identities=33% Similarity=0.656 Sum_probs=21.4
Q ss_pred CCCCCCCCccccCCCCCccccCCCCccC
Q 047263 297 SGTCGFNSVCRLNNRRPICECPRGYTLI 324 (804)
Q Consensus 297 ~g~CG~~g~C~~~~~~~~C~C~~Gf~~~ 324 (804)
.+.|. ++.|.....+-.|.|++||++.
T Consensus 9 ~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 56785 7899765567789999999864
|